data_2mlh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mlh _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.148 0 CA-C-O 121.233 0.352 . . . . 0.0 112.957 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.53 150.51 87.36 Favored 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 123.896 3.064 . . . . 0.0 115.153 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 44.2 p90 -149.45 161.65 41.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.259 -1.791 . . . . 0.0 106.77 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.9 t -130.5 135.51 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 118.385 0.539 . . . . 0.0 110.741 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -120.32 148.53 43.61 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.69 107.5 4.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.476 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -85.79 151.17 24.04 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -171.17 167.78 6.96 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.596 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.476 0.826 0 O-C-N 123.992 0.808 . . . . 0.0 109.868 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 110.526 -0.176 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.31 132.6 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.0 t -114.21 122.08 45.69 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.957 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 p -135.01 153.92 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.403 ' C ' ' CE2' ' A' ' 10' ' ' TYR . . . -175.8 -168.35 36.0 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.379 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -117.0 138.46 51.55 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.3 p30 -105.01 120.25 41.01 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 64' ' ' GLY . 74.9 m-85 -124.19 128.64 49.52 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.29 92.66 0.01 OUTLIER Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 62' ' ' PHE . . . 138.41 -94.1 0.21 Allowed Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -93.0 148.6 21.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.557 0.694 . . . . 0.0 111.444 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -132.17 135.66 46.51 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.963 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.66 128.86 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.75 143.83 47.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.036 0.446 . . . . 0.0 110.76 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.27 134.69 42.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.72 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -111.7 129.41 56.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.91 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -118.62 137.46 53.26 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.409 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.219 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.737 179.635 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 117' ' ' LEU . 10.2 mp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.84 0.352 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -128.86 128.38 5.84 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.44 131.75 36.58 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.9 m -145.72 147.12 31.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.918 0.389 . . . . 0.0 110.428 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.28 113.3 26.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.477 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.436 ' N ' ' CD1' ' A' ' 122' ' ' ILE . 3.4 mp -111.55 146.59 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -112.77 127.21 56.09 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -98.92 125.17 44.28 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 176.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.479 ' C ' ' H ' ' A' ' 127' ' ' ILE . 39.0 m-85 -107.21 120.79 43.08 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -80.93 21.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.826 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 125' ' ' PHE . 21.4 tt -68.29 -39.35 80.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.689 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.412 ' N ' ' CG2' ' A' ' 127' ' ' ILE . 11.2 m120 -93.39 -174.79 3.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.976 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -102.3 -52.55 3.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.266 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.75 -14.2 14.64 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.445 ' O ' ' CD2' ' A' ' 131' ' ' PHE . 48.9 p90 -144.77 125.95 14.67 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.109 0.868 . . . . 0.0 112.093 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.4 mtmm -107.59 129.72 23.82 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.48 140.87 33.9 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 120.975 1.117 . . . . 0.0 109.982 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.662 ' HH ' HH21 ' A' ' 235' ' ' ARG . 28.2 m-85 -107.34 133.94 51.14 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.588 0.232 . . . . 0.0 110.858 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.3 tt -151.85 136.83 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.264 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -175.37 -168.15 35.45 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.224 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.31 156.16 49.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.845 0.355 . . . . 0.0 111.132 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.713 ' NH2' HH11 ' A' ' 213' ' ' ARG . 39.5 ttm180 -106.7 144.84 32.77 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.541 0.686 . . . . 0.0 112.837 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.6 t -130.87 112.7 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.93 126.94 52.97 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 88.2 t80 . . . . . 0 N--CA 1.461 0.116 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.447 178.584 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 CA--C 1.52 -0.203 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -135.51 139.85 11.14 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.446 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.54 147.27 52.52 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 114.398 -0.901 . . . . 0.0 108.785 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -160.5 -172.6 27.99 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.92 153.75 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 111.438 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 95.3 mt -130.94 136.3 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.678 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.49 154.98 32.67 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.123 0.487 . . . . 0.0 111.41 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 173.93 178.92 44.22 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.6 m -136.89 135.73 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -114.78 136.83 13.5 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.429 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -121.07 104.91 10.14 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 0.3 OUTLIER -97.36 143.83 27.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 202' ' ' ILE . 43.7 mm -75.54 -34.74 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.408 ' C ' ' OD2' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -165.79 164.32 11.85 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 101.183 -3.636 . . . . 0.0 101.183 177.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.504 ' C ' ' O ' ' A' ' 237' ' ' ARG . 8.2 Cg_endo -55.11 -15.82 11.31 Favored 'Trans proline' 0 C--N 1.288 -2.629 0 CA-C-N 121.801 1.679 . . . . 0.0 111.66 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 237' ' ' ARG . 0.9 OUTLIER -73.8 -39.45 64.11 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.5 mt -123.08 110.45 15.34 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.626 0.648 . . . . 0.0 111.381 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 t -134.56 138.27 44.46 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 208' ' ' LEU . 5.8 mp -89.78 128.38 36.13 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -133.95 124.8 26.97 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -84.59 111.5 19.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -109.51 139.6 15.38 Favored Glycine 0 N--CA 1.467 0.744 0 C-N-CA 121.272 -0.489 . . . . 0.0 112.655 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -129.95 125.71 36.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.95 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.713 HH11 ' NH2' ' A' ' 138' ' ' ARG . 60.7 ttm-85 -110.64 116.82 32.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 215' ' ' HIS . 60.8 t80 -132.69 156.0 47.79 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.406 0.622 . . . . 0.0 111.939 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.539 ' O ' ' CD2' ' A' ' 214' ' ' TYR . 84.5 t60 -87.34 168.34 13.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.652 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.465 ' N ' ' CG ' ' A' ' 215' ' ' HIS . 65.1 t30 . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.853 0.359 . . . . 0.0 110.636 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 15' ' ' LEU . 12.1 tp . . . . . 0 CA--C 1.514 -0.427 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.9 148.17 19.18 Favored Glycine 0 C--N 1.314 -0.672 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 68.5 t -122.16 128.83 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.674 HH12 ' NH2' ' A' ' 237' ' ' ARG . 45.7 ptt85 -133.29 143.01 48.77 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.77 0.795 . . . . 0.0 111.266 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 53.5 t80 -110.57 126.67 54.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 113.763 -1.562 . . . . 0.0 113.326 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.674 ' NH2' HH12 ' A' ' 235' ' ' ARG . 36.3 ttm180 -140.76 113.0 7.88 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.946 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' A' ' 237' ' ' ARG . 90.5 m-85 . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 117.852 -1.071 . . . . 0.0 111.954 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 10' ' ' TYR . . . . . . . . 0 CA--C 1.533 1.167 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 26.9 Cg_endo -74.48 141.32 28.15 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.607 1.538 . . . . 0.0 111.532 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 63.8 m-85 -147.23 -179.86 7.13 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.603 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 12' ' ' GLN . 2.3 p -128.6 160.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.556 ' OE1' ' NH2' ' A' ' 235' ' ' ARG . 57.2 tt0 -142.71 147.04 34.98 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.851 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.31 156.92 43.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.928 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -160.5 155.78 24.86 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.0 mt -134.15 146.2 49.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.584 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.174 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.7 p -140.64 162.23 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.639 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 t -146.61 151.94 38.1 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.81 163.15 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.326 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.18 178.68 43.45 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.934 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -112.73 131.12 55.81 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.19 0.596 . . . . 0.0 109.813 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -102.08 127.24 49.06 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.545 ' O ' ' N ' ' A' ' 64' ' ' GLY . 90.5 m-85 -124.56 139.55 53.77 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.58 88.82 0.01 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.11 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 62' ' ' PHE . . . 129.77 -82.33 0.33 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -95.99 144.08 26.59 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.675 0.75 . . . . 0.0 111.501 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.752 HH11 HH21 ' A' ' 237' ' ' ARG . 51.2 ttp180 -136.27 137.93 41.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.377 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.93 128.68 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.58 139.32 26.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.08 145.46 50.32 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.107 0.48 . . . . 0.0 111.095 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -93.58 125.96 38.47 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -106.38 141.97 36.82 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.631 0.729 . . . . 0.0 111.789 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.489 -179.837 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.2 mp . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -135.1 142.2 13.58 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 120.468 -0.873 . . . . 0.0 113.392 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.3 mt -120.43 143.47 48.46 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.7 t -139.68 118.02 12.06 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.63 118.54 29.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 46.3 mm -104.77 160.17 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.479 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 62.8 t80 -128.02 99.48 5.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 64' ' ' GLY . 43.8 t0 -138.34 122.8 18.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.843 0.354 . . . . 0.0 110.33 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.433 ' H ' ' HG3' ' A' ' 132' ' ' LYS . 10.9 m-85 -113.19 121.56 44.85 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.823 0.821 . . . . 0.0 112.322 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 126' ' ' GLN . 1.3 mp0 -86.7 -10.51 53.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.915 -1.038 . . . . 0.0 108.841 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 129' ' ' ASP . 96.4 mt -67.84 -41.2 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 95.4 m-20 -69.67 35.35 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.849 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.601 ' H ' ' C ' ' A' ' 127' ' ' ILE . 20.8 t0 92.62 -119.94 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.85 0.719 . . . . 0.0 110.491 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -127.34 23.3 6.42 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.574 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 11.0 p90 -151.13 126.39 9.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 119.568 -0.853 . . . . 0.0 113.287 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.433 ' HG3' ' H ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -135.87 135.71 22.09 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.413 177.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.65 98.34 1.14 Allowed 'Trans proline' 0 C--N 1.325 -0.661 0 N-CA-C 104.217 -3.032 . . . . 0.0 104.217 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -76.66 135.75 39.13 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 118.97 -1.092 . . . . 0.0 113.566 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.2 mt -120.54 134.17 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 CA-C-N 113.465 -1.698 . . . . 0.0 107.75 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.02 166.06 30.38 Favored Glycine 0 N--CA 1.46 0.288 0 C-N-CA 119.897 -1.145 . . . . 0.0 112.145 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.22 134.7 34.13 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -106.97 119.8 40.33 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.195 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.3 123.12 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.77 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.84 129.44 34.48 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 . . . . . 0 C--O 1.237 0.442 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.081 -179.15 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.465 0.279 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -138.32 135.17 7.29 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 119.505 -1.331 . . . . 0.0 114.583 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.59 144.75 50.79 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 163.31 -148.83 15.74 Favored Glycine 0 C--N 1.322 -0.216 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.01 159.19 26.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.767 0.794 . . . . 0.0 112.004 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 19.5 tt -113.11 131.61 64.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.66 150.47 36.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 122.15 0.976 . . . . 0.0 112.769 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 171.58 177.4 41.25 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.68 136.22 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.623 0.725 . . . . 0.0 110.57 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -122.87 120.67 4.34 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -128.25 142.21 51.22 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.836 0.827 . . . . 0.0 109.59 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 13.6 p-10 -49.16 141.8 7.82 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 117.438 2.385 . . . . 0.0 117.438 -173.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 206' ' ' LEU . 49.7 mm -124.31 5.59 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 112.35 -2.204 . . . . 0.0 106.177 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.58 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER 176.15 173.83 0.29 Allowed Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 -178.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.58 ' C ' ' O ' ' A' ' 203' ' ' THR . 3.8 Cg_exo -14.36 -83.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 123.58 2.314 . . . . 0.0 113.687 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -129.61 29.6 5.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.689 0.757 . . . . 0.0 110.604 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 202' ' ' ILE . 4.2 tt -83.66 111.89 19.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 176.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.2 p -120.31 152.73 37.41 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.16 131.77 48.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 112.728 -2.033 . . . . 0.0 105.623 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -108.06 146.82 32.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -145.59 129.51 17.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.531 -1.668 . . . . 0.0 106.673 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -167.68 -168.99 30.64 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 118.903 -1.617 . . . . 0.0 113.038 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -143.81 142.69 30.99 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.526 HH12 ' CD2' ' A' ' 215' ' ' HIS . 8.9 ptm180 -91.41 116.98 29.28 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.95 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -63.47 -46.35 86.59 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.526 ' CD2' HH12 ' A' ' 213' ' ' ARG . 86.3 t60 29.59 84.36 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.206 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.9 t30 . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.38 179.287 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.3 mp . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 121.107 0.48 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -141.58 153.08 23.87 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.011 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 14.2 p -133.44 134.18 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.644 ' NE ' HH12 ' A' ' 66' ' ' ARG . 52.6 ttm-85 -133.29 141.67 48.1 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -107.84 103.57 12.86 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.752 HH21 HH11 ' A' ' 66' ' ' ARG . 41.1 ttm180 -126.44 133.54 51.21 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 124.188 0.93 . . . . 0.0 111.413 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 10.2 t80 . . . . . 0 C--O 1.218 -0.554 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.308 179.493 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.062 0 CA-C-O 120.967 0.204 . . . . 0.0 113.105 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.54 -174.59 2.0 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.308 2.672 . . . . 0.0 112.464 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.691 ' CZ ' ' NH2' ' A' ' 66' ' ' ARG . 3.4 t80 -159.47 141.02 13.06 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 120.904 0.383 . . . . 0.0 111.786 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -132.21 159.39 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.571 ' NE2' ' NE ' ' A' ' 235' ' ' ARG . 7.4 tt0 -157.44 151.79 24.94 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -176.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.7 121.59 10.64 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 113.172 -1.831 . . . . 0.0 107.825 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 38.4 p30 -92.65 133.77 35.66 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.1 mt -126.86 133.87 50.63 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.149 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.768 179.408 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 . . . . . 0 CA--C 1.518 -0.287 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.07 139.3 44.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 121.154 0.502 . . . . 0.0 111.462 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.26 130.27 36.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.91 162.71 37.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.065 0.459 . . . . 0.0 111.155 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.85 -136.21 3.1 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -139.28 151.76 46.71 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 121.482 0.658 . . . . 0.0 112.344 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.563 ' OD2' ' NE ' ' A' ' 237' ' ' ARG . 12.1 t0 -92.39 104.79 17.08 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.125 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -126.33 148.07 49.62 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.256 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.47 125.77 8.07 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 123' ' ' TYR . . . 94.09 -10.73 71.56 Favored Glycine 0 C--N 1.33 0.247 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.539 ' CZ2' ' CG2' ' A' ' 67' ' ' ILE . 22.6 t90 -167.69 142.45 3.72 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.565 -0.817 . . . . 0.0 110.198 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.691 ' NH2' ' CZ ' ' A' ' 10' ' ' TYR . 69.4 mtp180 -144.01 144.34 31.62 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.539 ' CG2' ' CZ2' ' A' ' 65' ' ' TRP . 48.5 pt -120.17 138.34 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.639 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.65 110.16 8.53 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.786 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.07 119.52 29.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -100.14 128.42 46.22 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 112.146 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -153.92 155.23 35.27 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.675 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.475 -179.381 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 117' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.466 0.35 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 162.53 -105.4 0.26 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 118.875 -1.631 . . . . 0.0 112.916 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.28 151.74 33.43 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.4 0.619 . . . . 0.0 111.547 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.0 t -139.48 119.25 13.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.458 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.91 123.23 26.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.089 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.461 ' CD1' HH22 ' A' ' 235' ' ' ARG . 90.7 mt -101.23 135.95 35.25 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' A' ' 64' ' ' GLY . 12.2 m-85 -124.3 107.72 11.47 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.008 0.432 . . . . 0.0 110.301 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.639 ' CG ' HH11 ' A' ' 66' ' ' ARG . 9.5 m-20 -96.96 141.53 30.02 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.933 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.495 ' O ' ' CB ' ' A' ' 132' ' ' LYS . 93.5 m-85 -103.34 153.7 20.17 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -108.59 63.61 0.61 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.43 -41.69 86.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -141.84 -85.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.011 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.4 t70 179.24 -44.22 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.332 0.587 . . . . 0.0 110.297 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.99 -43.31 88.15 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.629 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -142.93 110.73 5.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -175.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -130.58 139.93 37.13 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.46 152.18 70.84 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.323 1.348 . . . . 0.0 109.603 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 0.5 OUTLIER -138.45 133.95 33.42 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.612 -179.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.4 pt -130.4 154.8 41.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.441 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -155.88 163.27 31.72 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.93 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -102.35 122.61 44.59 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -92.66 128.22 38.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.111 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.13 119.22 46.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.32 153.53 46.47 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.419 ' CE1' ' O ' ' A' ' 117' ' ' LEU . 47.6 p90 . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.55 . . . . 0.0 110.927 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -119.33 117.96 3.8 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.22 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 7.8 tt -145.34 127.81 15.99 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -171.73 -163.16 25.21 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.305 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.79 138.37 49.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.47 0.653 . . . . 0.0 110.929 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 67.4 mt -113.51 130.63 67.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -138.16 154.46 49.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.743 0.782 . . . . 0.0 112.849 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 172.32 -171.93 44.55 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.66 135.67 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.213 0.53 . . . . 0.0 110.231 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -96.05 113.15 4.58 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -116.0 117.68 30.82 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 58.9 p30 -57.92 150.29 20.8 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 206' ' ' LEU . 21.5 mm -113.33 -60.63 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.567 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -106.42 176.88 1.49 Allowed Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 174.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.567 ' C ' ' O ' ' A' ' 203' ' ' THR . 15.9 Cg_exo -14.93 -81.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.485 0.974 0 CA-C-N 122.909 2.075 . . . . 0.0 113.746 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -126.73 28.08 5.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.514 0.674 . . . . 0.0 110.761 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 202' ' ' ILE . 2.9 tt -85.8 112.67 21.31 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.4 p -103.93 149.8 24.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -172.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.36 106.07 16.44 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 101.695 -3.446 . . . . 0.0 101.695 173.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -104.09 130.37 51.79 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -174.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -122.14 144.19 49.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.348 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.44 -163.88 32.12 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.0 147.11 46.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -105.18 119.01 38.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.796 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -120.89 163.5 18.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.285 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -124.91 -172.76 2.64 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 216' ' ' ASN . 49.9 t-20 . . . . . 0 C--N 1.33 -0.272 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.496 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 153.4 -166.8 31.79 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.869 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.25 130.64 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.663 ' NH1' HH22 ' A' ' 66' ' ' ARG . 71.2 mtp180 -128.59 142.85 50.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.287 0.565 . . . . 0.0 111.555 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.499 ' O ' ' CD2' ' A' ' 236' ' ' TYR . 5.5 t80 -106.28 106.49 17.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.764 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.563 ' NE ' ' OD2' ' A' ' 61' ' ' ASP . 71.7 ttt180 -133.75 128.63 35.26 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.0 t80 . . . . . 0 C--O 1.222 -0.381 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.847 179.733 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.69 0 N-CA-C 114.617 0.607 . . . . 0.0 114.617 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.72 157.43 27.97 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 124.679 3.586 . . . . 0.0 115.354 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -150.62 165.6 32.85 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.831 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.18 139.27 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -124.81 145.65 49.65 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.58 0.705 . . . . 0.0 112.473 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.77 151.0 34.05 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.998 -1.455 . . . . 0.0 108.476 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 15' ' ' LEU . 38.4 t0 -142.33 144.06 33.04 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.577 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 92.0 mt -126.94 143.69 51.21 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.684 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.428 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.055 179.011 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 57' ' ' SER . 74.9 t -139.37 159.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.381 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.44 ' N ' ' CG1' ' A' ' 56' ' ' VAL . 5.1 m -141.7 141.66 33.32 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.486 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.62 137.49 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.094 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.22 -175.65 32.47 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.037 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -96.97 137.51 35.94 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.977 0.418 . . . . 0.0 111.73 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.531 ' OD1' ' NH2' ' A' ' 66' ' ' ARG . 34.3 t70 -101.37 115.07 29.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.37 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -124.56 120.69 32.66 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.497 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.0 107.24 0.44 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.32 -60.98 0.59 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.439 ' N ' ' CD1' ' A' ' 65' ' ' TRP . 8.7 p-90 -157.98 150.68 22.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.937 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.628 ' NH1' ' NH1' ' A' ' 235' ' ' ARG . 9.3 ptp85 -135.66 167.23 21.51 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.887 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.2 pt -145.22 143.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.193 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.86 145.51 29.88 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.15 0.5 . . . . 0.0 110.71 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.17 127.28 38.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.403 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 24.7 p-10 -98.18 127.56 44.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.487 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 45.2 p90 -139.88 166.24 25.15 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.846 0.831 . . . . 0.0 112.848 -177.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . . . . . . 0 N--CA 1.462 0.173 0 CA-C-N 113.001 -1.909 . . . . 0.0 108.6 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 170.32 -109.72 0.34 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 119.644 -1.265 . . . . 0.0 111.99 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.28 147.63 41.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.292 0.567 . . . . 0.0 110.748 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.3 p -150.81 141.38 22.58 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.68 149.05 32.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.815 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.463 ' O ' ' CG1' ' A' ' 122' ' ' ILE . 3.4 pt -144.36 114.45 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 135' ' ' ILE . 34.2 p90 -90.43 141.91 28.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.575 ' OD1' ' NH1' ' A' ' 66' ' ' ARG . 62.7 m-20 -89.84 115.84 27.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 113.387 -1.733 . . . . 0.0 108.143 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.464 ' O ' ' CB ' ' A' ' 126' ' ' GLN . 87.8 t80 -118.13 121.8 41.44 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.464 ' CB ' ' O ' ' A' ' 125' ' ' PHE . 1.4 mm100 147.96 177.33 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.53 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 93.0 mt -70.21 -1.46 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.753 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 70.9 36.55 1.46 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.632 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.46 -60.39 1.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.889 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -129.06 -48.31 1.22 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.572 ' CD2' ' CE1' ' A' ' 200' ' ' PHE . 1.0 OUTLIER -148.32 146.58 28.61 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.145 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.44 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -134.74 141.82 40.09 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.337 177.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.56 107.96 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 N-CA-C 108.007 -1.574 . . . . 0.0 108.007 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -81.85 131.02 35.25 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.981 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.505 ' O ' ' CD2' ' A' ' 123' ' ' TYR . 2.5 tt -161.83 149.51 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.832 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.69 -144.88 6.25 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.092 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -127.43 164.14 22.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.671 ' NH2' HH21 ' A' ' 213' ' ' ARG . 41.7 ttm180 -125.17 133.89 52.62 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.096 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.88 121.71 61.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.27 146.17 44.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.138 0.494 . . . . 0.0 110.98 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 . . . . . 0 C--O 1.238 0.481 0 CA-C-O 121.698 0.761 . . . . 0.0 111.661 -179.516 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.9 t . . . . . 0 C--O 1.234 0.283 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -137.58 135.74 7.78 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.162 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.4 tp -142.61 131.05 22.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -164.02 -160.93 12.32 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.39 153.25 35.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.986 0.898 . . . . 0.0 111.228 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.6 tt -124.67 134.04 67.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 113.622 -1.626 . . . . 0.0 108.733 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -157.67 156.15 31.25 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 119.634 -0.827 . . . . 0.0 112.454 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 169.06 -171.41 42.96 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.16 135.54 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.517 0.659 . . . . 0.0 111.034 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -116.35 129.9 8.71 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.968 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.572 ' CE1' ' CD2' ' A' ' 131' ' ' PHE . 56.7 m-85 -104.29 109.52 21.39 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.704 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.26 121.6 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 124.662 1.226 . . . . 0.0 110.171 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 42.7 mm -126.57 3.8 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 123.385 1.564 . . . . 0.0 108.635 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.778 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.2 OUTLIER -156.59 73.33 4.81 Favored Pre-proline 0 N--CA 1.425 -1.714 1 N-CA-C 98.664 -4.569 . . . . 0.0 98.664 178.138 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER 1.06 -41.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.826 1 C-N-CA 126.111 4.541 . . . . 0.0 116.747 -170.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.778 ' N ' ' O ' ' A' ' 203' ' ' THR . 61.9 pttt -96.73 0.08 49.01 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 203' ' ' THR . 5.9 tt -109.07 106.67 16.69 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 8.4 t -141.61 140.73 33.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 119.257 -0.977 . . . . 0.0 113.011 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.26 116.67 30.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.422 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -97.22 123.3 40.96 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.371 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -117.31 124.43 48.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -170.15 -173.54 37.59 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 118.946 -1.597 . . . . 0.0 112.705 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -133.79 148.24 51.34 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.671 HH21 ' NH2' ' A' ' 138' ' ' ARG . 84.0 mtp180 -127.05 129.27 47.7 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -152.75 157.34 40.7 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.199 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.533 ' ND1' ' N ' ' A' ' 215' ' ' HIS . 0.0 OUTLIER -151.79 165.49 34.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.191 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.4 ' CG ' ' O ' ' A' ' 215' ' ' HIS . 14.5 p30 . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 121.022 0.439 . . . . 0.0 110.411 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -126.79 152.03 18.38 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.474 -0.393 . . . . 0.0 112.229 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.0 p -126.86 131.45 71.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.628 ' NH1' ' NH1' ' A' ' 66' ' ' ARG . 60.3 ttp180 -130.67 143.45 50.76 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -91.93 126.76 37.14 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 112.93 -1.941 . . . . 0.0 106.441 176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.529 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 1.4 tmm_? -147.13 109.5 4.54 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 122.452 1.12 . . . . 0.0 111.701 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 C--O 1.22 -0.484 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.596 -179.712 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.459 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.78 129.2 22.78 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.806 1.671 . . . . 0.0 114.206 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.411 ' OH ' ' OD2' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -162.26 166.57 25.23 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.608 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.86 157.24 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -135.32 143.79 46.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.775 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.89 149.2 29.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.128 0.489 . . . . 0.0 111.293 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 39.0 p-10 -105.17 120.57 41.85 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.995 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.2 mt -118.63 141.5 48.54 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.998 0.428 . . . . 0.0 111.07 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.186 179.544 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.604 0.24 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.5 p -138.73 154.25 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.156 0.503 . . . . 0.0 111.75 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.5 t -142.9 143.55 32.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.201 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 p -135.28 151.23 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.76 174.56 42.77 Favored Glycine 0 C--O 1.241 0.561 0 C-N-CA 118.302 -1.904 . . . . 0.0 114.191 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.99 138.44 34.52 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 113.446 -1.377 . . . . 0.0 108.161 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -116.72 102.82 9.75 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.41 ' O ' ' C ' ' A' ' 63' ' ' GLY . 78.3 m-85 -107.65 127.53 53.74 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 175.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -41.16 103.9 0.04 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 120.012 -1.089 . . . . 0.0 110.744 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.05 -83.92 0.19 Allowed Glycine 0 C--N 1.343 0.968 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.447 ' CD1' ' N ' ' A' ' 65' ' ' TRP . 2.1 p-90 -133.23 172.92 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.127 0.464 . . . . 0.0 111.433 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.464 ' NH2' ' CD1' ' A' ' 122' ' ' ILE . 50.6 ttp180 -125.1 151.61 45.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.415 ' N ' ' HG2' ' A' ' 66' ' ' ARG . 91.3 mt -108.37 129.7 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -141.62 145.64 35.26 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.63 149.5 49.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 113.606 -1.634 . . . . 0.0 106.667 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 4.1 p-10 -148.92 153.47 38.05 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 119.272 -0.971 . . . . 0.0 113.201 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -108.38 143.05 37.83 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 113.835 -1.529 . . . . 0.0 109.156 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.982 -179.838 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -102.09 124.59 8.25 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -143.01 135.65 27.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 117.6 0.7 . . . . 0.0 109.802 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.8 m -154.81 151.99 29.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.432 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.18 125.89 51.11 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.464 ' CD1' ' NH2' ' A' ' 66' ' ' ARG . 1.7 mp -119.96 154.56 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.542 0.687 . . . . 0.0 112.232 -176.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -103.12 110.35 22.27 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.184 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.411 ' OD2' ' OH ' ' A' ' 10' ' ' TYR . 82.1 m-20 -108.5 122.49 47.15 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -91.36 81.56 5.45 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.49 0.662 . . . . 0.0 109.417 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -67.71 -18.27 64.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.203 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.0 pt -67.91 -30.46 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.812 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 131' ' ' PHE . 11.5 m120 -70.66 121.53 18.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 67.8 t0 -63.97 -41.85 97.42 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -105.37 -18.95 13.95 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 20.8 p90 -158.2 133.87 8.99 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.289 1.404 . . . . 0.0 114.368 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -118.09 103.64 49.54 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.0 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.57 123.14 11.56 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 15.3 p90 -106.58 133.46 51.22 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.093 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.9 tt -145.76 147.53 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.109 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.45 -171.85 37.69 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 119.69 -1.243 . . . . 0.0 113.605 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.53 136.98 39.56 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 20.1 ttt-85 -124.98 120.89 32.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.38 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.17 135.6 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.942 0.877 . . . . 0.0 112.11 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.25 124.9 50.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.029 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.4 t80 . . . . . 0 C--N 1.325 -0.479 0 CA-C-O 121.096 0.474 . . . . 0.0 111.933 -177.82 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.233 0.188 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -130.93 150.58 19.4 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.929 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.4 pp -168.2 136.72 2.32 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.661 0.743 . . . . 0.0 112.618 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -169.41 -140.54 2.99 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.49 164.31 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.483 0.658 . . . . 0.0 111.763 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.7 tt -129.84 138.09 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.549 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.455 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . -152.74 164.23 38.17 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.477 ' O ' ' CD2' ' A' ' 134' ' ' TYR . . . 155.47 170.6 21.14 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.062 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 59.8 t -131.29 138.41 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 117.274 0.537 . . . . 0.0 111.804 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 131' ' ' PHE . . . -105.46 134.02 11.87 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -131.29 105.82 7.89 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.79 153.27 33.01 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -175.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 66.6 mt -113.18 -10.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 123.298 1.523 . . . . 0.0 107.888 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.699 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.5 m -166.75 103.5 0.65 Allowed Pre-proline 0 C--N 1.3 -1.562 1 N-CA-C 99.445 -4.28 . . . . 0.0 99.445 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.466 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -11.56 -42.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 123.557 2.838 . . . . 0.0 115.63 -172.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 203' ' ' THR . 13.6 pttm -77.87 -34.72 51.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 203' ' ' THR . 50.5 tp -83.93 105.76 15.07 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.2 m -128.61 131.28 48.12 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 10.0 mp -96.8 141.57 29.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -134.67 144.77 48.0 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.012 0.911 . . . . 0.0 113.335 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -101.86 113.08 25.95 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -152.58 157.56 27.35 Favored Glycine 0 N--CA 1.462 0.387 0 C-N-CA 118.556 -1.783 . . . . 0.0 113.895 -176.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -169.31 163.91 10.79 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.645 ' N ' ' NE ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -124.48 154.15 40.96 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.932 0.396 . . . . 0.0 110.129 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -142.78 133.51 25.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.94 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -74.59 144.91 43.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.174 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.4 t30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.158 179.429 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 71.1 mt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.507 0.67 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -143.75 137.92 7.77 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.6 145.39 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 117.393 0.597 . . . . 0.0 110.621 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -124.55 142.77 51.09 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.328 0.585 . . . . 0.0 111.063 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -110.34 106.07 15.31 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.431 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.545 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 2.4 tmt_? -114.06 96.13 5.65 Favored 'General case' 0 C--O 1.255 1.37 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 237' ' ' ARG . 72.3 m-85 . . . . . 0 N--CA 1.472 0.661 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.447 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.293 0 CA-C-O 119.699 -0.501 . . . . 0.0 112.118 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.461 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 58.6 Cg_endo -90.74 143.41 3.48 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.896 2.397 . . . . 0.0 113.477 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.728 ' HH ' HE22 ' A' ' 126' ' ' GLN . 1.7 m-85 -159.63 146.59 16.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.21 0.528 . . . . 0.0 112.221 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.3 t -141.19 137.06 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.946 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -135.31 149.49 49.78 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.52 152.17 32.6 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.837 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -107.0 155.43 19.81 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.626 0.25 . . . . 0.0 111.003 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 232' ' ' LEU . 0.2 OUTLIER -139.29 128.93 24.55 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 120.728 0.299 . . . . 0.0 111.415 -179.516 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.6 mtm-85 . . . . . 0 C--O 1.232 0.158 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.76 134.14 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.842 0.353 . . . . 0.0 111.034 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -133.37 143.39 48.91 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.514 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.71 160.33 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.052 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.56 177.04 40.33 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.415 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -121.13 155.65 34.03 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 47.4 t0 -137.72 124.08 20.65 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -177.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 63' ' ' GLY . 16.5 m-85 -116.67 104.83 11.77 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -24.85 97.2 0.01 OUTLIER Glycine 0 CA--C 1.533 1.203 0 CA-C-N 117.718 0.235 . . . . 0.0 113.097 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.18 -13.74 7.93 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 66' ' ' ARG . 15.6 t90 -165.88 136.56 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.012 0.406 . . . . 0.0 110.823 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.608 ' NH2' ' CZ ' ' A' ' 10' ' ' TYR . 14.8 ptp180 -148.17 148.44 30.55 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.843 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.6 pt -108.93 147.71 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.779 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.0 141.35 36.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 110.857 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.88 129.13 25.55 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.498 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 24.8 p30 -106.2 143.76 33.87 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.476 0.655 . . . . 0.0 111.906 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.09 146.2 50.02 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.992 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.142 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.074 179.475 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 N--CA 1.463 0.222 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 70' ' ' ASP . . . -133.01 115.45 1.57 Allowed Glycine 0 N--CA 1.469 0.847 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 119' ' ' LEU . 1.7 pt? -141.11 153.62 45.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.327 0.563 . . . . 0.0 111.498 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.3 m -146.42 153.58 40.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.065 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.43 125.03 46.66 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 97.3 mt -123.6 152.32 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -111.25 131.94 54.74 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.158 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 15.6 p-10 -132.9 125.25 29.48 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 123.801 0.688 . . . . 0.0 110.813 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.476 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 81.2 m-85 -115.69 80.63 1.47 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.728 HE22 ' HH ' ' A' ' 10' ' ' TYR . 24.5 pt20 -105.07 7.32 33.87 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 110.003 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.437 HD11 HG21 ' A' ' 127' ' ' ILE . 0.3 OUTLIER -67.84 -28.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -62.08 -49.97 73.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.4 t0 179.16 -102.75 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.287 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -117.77 0.9 12.09 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 10.8 m-85 -113.25 111.28 21.78 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.476 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -133.31 142.7 45.24 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 117.93 0.332 . . . . 0.0 111.066 178.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -91.28 120.13 0.62 Allowed 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 122.36 2.04 . . . . 0.0 109.281 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.594 ' CE1' ' OD2' ' A' ' 209' ' ' ASP . 40.1 p90 -92.02 128.26 37.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.528 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 47.8 mm -134.78 131.99 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.777 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.76 174.84 38.31 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.611 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.37 131.06 55.38 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.95 125.42 50.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.186 0.517 . . . . 0.0 111.089 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.98 139.18 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.122 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.01 137.39 52.16 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.526 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 121.203 0.525 . . . . 0.0 111.19 179.446 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.236 0.375 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -146.92 159.32 27.98 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.329 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 192' ' ' LEU . 0.4 OUTLIER -117.46 146.89 43.19 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.641 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -168.19 -177.57 39.45 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.716 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.62 156.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.606 0.717 . . . . 0.0 111.636 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.2 tt -127.06 135.55 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.041 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.3 161.01 37.64 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . 157.81 -167.06 34.14 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.51 162.32 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 122.73 -0.277 . . . . 0.0 110.978 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.12 165.04 34.64 Favored Glycine 0 CA--C 1.545 1.916 0 C-N-CA 119.842 -1.17 . . . . 0.0 114.616 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -130.82 128.71 41.22 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.683 1.193 . . . . 0.0 109.004 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 4.6 p30 -89.88 151.18 21.87 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.98 -37.93 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 103.005 -2.961 . . . . 0.0 103.005 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.675 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.0 OUTLIER -176.31 148.97 0.91 Allowed Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 100.612 -3.847 . . . . 0.0 100.612 176.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.445 ' C ' ' O ' ' A' ' 237' ' ' ARG . 32.0 Cg_exo -35.86 -17.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.295 -2.25 0 C-N-CA 121.313 1.342 . . . . 0.0 113.419 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.675 ' N ' ' O ' ' A' ' 203' ' ' THR . 87.1 tttt -68.87 -44.52 73.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 119.309 -0.377 . . . . 0.0 111.868 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.98 114.65 14.86 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.941 0.401 . . . . 0.0 111.056 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.8 t -127.87 133.79 49.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.818 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.0 123.03 32.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.594 ' OD2' ' CE1' ' A' ' 134' ' ' TYR . 13.4 t70 -109.52 110.94 22.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.878 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -102.75 134.72 45.67 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.14 36.98 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 119.97 -1.109 . . . . 0.0 112.199 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -133.61 134.39 43.18 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -89.45 108.56 19.71 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.998 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -102.65 127.87 49.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -125.25 161.54 26.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.024 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.5 m120 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.223 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 15' ' ' LEU . 6.8 tt . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -115.06 172.51 14.24 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 62.1 t -139.68 131.56 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.588 0.233 . . . . 0.0 110.918 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.442 HH11 ' NH1' ' A' ' 66' ' ' ARG . 36.6 ttm180 -132.7 142.07 48.88 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 236' ' ' TYR . 1.1 t80 -118.72 137.68 53.17 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 204' ' ' PRO . 14.3 ttt-85 -150.38 112.5 4.6 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.626 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.398 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.957 0 N-CA-C 112.166 -0.374 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.405 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 48.9 Cg_endo -92.74 165.08 2.73 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.558 2.838 . . . . 0.0 114.951 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.414 ' CE2' ' NH2' ' A' ' 235' ' ' ARG . 22.5 p90 -163.85 164.39 23.5 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.575 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 p -135.39 155.22 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-O 120.524 0.202 . . . . 0.0 111.088 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -134.81 147.76 50.02 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.2 152.6 34.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.742 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 31.7 p-10 -153.24 159.06 42.53 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -133.3 152.39 51.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.042 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.68 0.276 . . . . 0.0 110.73 179.639 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.6 155.28 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.574 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -135.45 128.7 31.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.288 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 m -140.91 165.34 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.19 -152.25 12.58 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.552 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -113.98 139.12 49.5 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-O 120.762 0.315 . . . . 0.0 111.543 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.1 p30 -103.26 101.01 10.93 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 124.835 1.335 . . . . 0.0 112.874 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.545 ' CZ ' ' O ' ' A' ' 65' ' ' TRP . 23.9 p90 -125.37 125.26 43.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -39.51 131.61 2.22 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.98 -84.59 0.37 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.545 ' O ' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -117.32 153.73 32.47 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.361 0.6 . . . . 0.0 110.33 179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.622 ' NH1' ' NH2' ' A' ' 235' ' ' ARG . 0.6 OUTLIER -129.82 130.94 45.94 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.403 HG21 HD12 ' A' ' 67' ' ' ILE . 38.8 mm -102.77 128.57 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.0 124.66 19.56 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 120.922 0.391 . . . . 0.0 110.571 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.31 138.59 39.87 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.02 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -100.56 128.72 46.53 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.302 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -129.13 156.94 43.1 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.757 0.789 . . . . 0.0 111.95 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.202 0 CA-C-N 113.617 -1.628 . . . . 0.0 108.462 178.612 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.7 -157.96 20.94 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.233 -1.461 . . . . 0.0 112.373 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.1 mt -127.42 144.69 51.02 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.269 0.557 . . . . 0.0 110.571 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 84.0 p -147.47 140.44 25.02 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.63 127.75 53.6 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 87.9 mt -101.51 135.09 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.537 ' O ' ' CG ' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -128.77 102.88 6.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.255 0.934 . . . . 0.0 112.127 -176.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.532 ' CG ' HH21 ' A' ' 66' ' ' ARG . 3.4 m-20 -89.94 135.74 33.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.841 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -113.22 81.36 1.49 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -70.32 85.8 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.038 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.5 tt -70.21 -41.29 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.129 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.3 t30 177.67 -47.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.384 0.428 . . . . 0.0 110.199 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -59.91 -169.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.088 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -100.48 -1.72 35.03 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.495 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 7.1 p90 -138.34 128.97 26.46 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.41 156.8 79.36 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 121.021 0.439 . . . . 0.0 111.059 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.7 146.3 21.05 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.922 1.748 . . . . 0.0 109.675 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 134' ' ' TYR . 6.8 p90 -138.25 138.13 38.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.207 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 136' ' ' GLY . 32.2 mt -136.56 164.43 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.86 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.488 ' N ' ' CG2' ' A' ' 135' ' ' ILE . . . -164.93 -176.67 36.83 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.669 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -133.2 155.46 49.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.24 -0.98 . . . . 0.0 108.753 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -135.56 128.1 30.65 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.33 121.75 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -124.75 124.3 41.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 110.506 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 . . . . . 0 N--CA 1.464 0.246 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.564 -179.754 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -141.16 140.43 10.34 Favored Glycine 0 N--CA 1.476 1.305 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.698 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 216' ' ' ASN . 47.1 tp -133.61 125.1 28.04 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -156.12 -169.78 20.68 Favored Glycine 0 C--N 1.32 -0.345 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.8 158.98 42.71 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 CA-C-O 122.306 1.051 . . . . 0.0 112.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.8 mm -109.57 130.48 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 112.639 -2.073 . . . . 0.0 107.312 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.3 156.86 42.32 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.514 -0.741 . . . . 0.0 111.834 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.408 ' C ' ' CE2' ' A' ' 134' ' ' TYR . . . 150.05 -176.98 28.46 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.42 159.68 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -136.84 140.74 11.7 Favored Glycine 0 N--CA 1.47 0.93 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.781 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -122.04 105.44 10.29 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -96.0 137.16 35.46 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 202' ' ' ILE . 1.2 mp -69.54 -39.16 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 173.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -155.25 156.08 30.66 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 101.284 -3.598 . . . . 0.0 101.284 175.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.509 ' C ' ' O ' ' A' ' 237' ' ' ARG . 32.3 Cg_exo -48.78 -17.51 1.17 Allowed 'Trans proline' 0 C--N 1.288 -2.622 0 CA-C-N 121.706 1.645 . . . . 0.0 111.267 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 203' ' ' THR . 60.4 tttp -67.82 -39.77 83.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.286 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 9.0 mt -124.05 107.79 11.67 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.123 0.874 . . . . 0.0 111.925 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.81 141.03 42.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.63 0.728 . . . . 0.0 112.948 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.44 ' O ' ' OD1' ' A' ' 209' ' ' ASP . 84.0 mt -99.1 148.3 24.19 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 208' ' ' LEU . 28.3 m-20 -139.3 137.0 35.46 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -83.65 133.43 34.82 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.86 151.62 19.66 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 120.236 -0.983 . . . . 0.0 114.59 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -135.22 142.18 45.96 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.195 -1.002 . . . . 0.0 109.03 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 86.0 mmt-85 -110.75 125.04 53.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -127.83 161.39 29.14 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.604 0.716 . . . . 0.0 112.862 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.698 ' CG ' ' H ' ' A' ' 216' ' ' ASN . 69.1 t60 -126.97 -175.46 3.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.486 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.698 ' H ' ' CG ' ' A' ' 215' ' ' HIS . 45.4 t-20 . . . . . 0 C--N 1.328 -0.346 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.554 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 25.4 mt . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 121.11 0.481 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -131.77 148.2 18.94 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.306 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.6 p -131.39 137.83 54.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.622 ' NH2' ' NH1' ' A' ' 66' ' ' ARG . 10.8 ptm180 -136.55 146.74 46.51 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -101.99 113.07 25.99 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 113.254 -1.793 . . . . 0.0 108.967 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.606 HH11 ' NH2' ' A' ' 66' ' ' ARG . 75.0 ttt180 -139.23 115.55 10.46 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 122.354 1.073 . . . . 0.0 112.113 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.522 ' OXT' ' CD1' ' A' ' 238' ' ' PHE . 1.2 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.21 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.448 ' C ' ' CE2' ' A' ' 10' ' ' TYR . . . . . . . . 0 CA--C 1.539 1.561 0 N-CA-C 112.139 -0.385 . . . . 0.0 112.139 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 77.5 Cg_endo -80.82 127.19 6.15 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.877 2.384 . . . . 0.0 111.695 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 52.4 m-85 -141.24 -178.23 5.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.888 -0.142 . . . . 0.0 111.287 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.62 162.6 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -130.51 131.62 45.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.972 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.88 140.14 22.23 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.967 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -161.05 168.83 23.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 232' ' ' LEU . 0.4 OUTLIER -172.12 179.88 2.52 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.499 179.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 121.172 0.511 . . . . 0.0 111.946 -179.613 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.696 0.284 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.0 t -131.09 155.49 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.249 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.9 m -137.33 151.85 49.09 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.982 0.42 . . . . 0.0 111.622 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.02 145.68 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.336 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.72 -179.96 39.07 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 119.61 -1.281 . . . . 0.0 114.184 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -106.68 132.85 52.19 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -97.65 121.18 39.25 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -125.37 113.64 17.82 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.42 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -43.35 103.94 0.05 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 123' ' ' TYR . . . 136.88 -36.07 2.02 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.426 ' N ' ' CD1' ' A' ' 65' ' ' TRP . 0.3 OUTLIER -170.18 156.3 5.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.979 0.418 . . . . 0.0 110.879 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -134.55 135.38 42.26 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 67' ' ' ILE . 49.3 mm -99.98 127.92 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.38 130.93 14.86 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 119.454 -0.898 . . . . 0.0 112.169 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.49 144.2 26.84 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.989 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -104.28 128.01 52.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.129 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -134.35 162.02 33.37 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.012 0.435 . . . . 0.0 111.242 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.37 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.434 179.718 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.521 -0.164 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.33 -126.6 1.03 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.926 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 62.1 tp -135.52 149.47 49.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 120.993 0.425 . . . . 0.0 110.277 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.1 p -152.55 152.37 31.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.46 130.03 51.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.009 0.433 . . . . 0.0 110.767 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.422 ' N ' ' CD1' ' A' ' 122' ' ' ILE . 1.9 mp -97.72 148.17 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 177.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.546 ' OH ' ' CD2' ' A' ' 125' ' ' PHE . 4.2 t80 -138.7 123.98 19.26 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 118.941 -1.104 . . . . 0.0 113.64 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.624 ' CB ' HH22 ' A' ' 237' ' ' ARG . 32.6 p-10 -110.36 120.29 41.97 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 113.489 -1.687 . . . . 0.0 106.588 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.546 ' CD2' ' OH ' ' A' ' 123' ' ' TYR . 5.1 t80 -70.26 129.32 39.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.248 0.546 . . . . 0.0 111.675 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.424 ' O ' ' O ' ' A' ' 125' ' ' PHE . 88.0 mt-30 39.98 -167.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.903 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.526 ' O ' ' C ' ' A' ' 128' ' ' ASN . 1.3 mp -105.0 20.83 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.656 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 127' ' ' ILE . 65.6 m-80 -11.46 -73.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.593 0.558 . . . . 0.0 111.828 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 128' ' ' ASN . 4.7 p30 153.89 -51.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.875 0.734 . . . . 0.0 111.441 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.81 -19.0 3.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -146.98 122.81 10.62 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.021 0.828 . . . . 0.0 113.146 -178.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -134.24 133.0 21.37 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.045 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -51.12 133.62 41.71 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 CA-C-N 119.95 1.018 . . . . 0.0 110.325 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -96.76 130.0 44.08 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.463 ' N ' ' CD1' ' A' ' 134' ' ' TYR . 96.7 mt -136.62 136.51 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -129.27 139.28 10.84 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.984 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -118.38 128.79 54.97 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -129.99 131.44 45.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.247 0.546 . . . . 0.0 112.025 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.42 113.31 2.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.44 144.95 35.36 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.92 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.4 p90 . . . . . 0 C--O 1.236 0.356 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.313 -179.93 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.234 0.254 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -123.55 147.83 16.69 Favored Glycine 0 N--CA 1.472 1.099 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.003 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 tt -144.49 127.51 16.51 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.783 -0.709 . . . . 0.0 109.236 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -150.3 170.34 30.26 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.09 140.73 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.837 0.827 . . . . 0.0 111.987 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.1 mt -118.64 134.56 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.476 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -148.42 153.27 38.3 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.503 0.668 . . . . 0.0 111.97 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 179.08 -140.59 4.47 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.611 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.43 140.82 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.83 0.315 . . . . 0.0 111.123 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -119.48 123.31 5.6 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.195 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -123.61 106.71 10.79 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 0.3 OUTLIER -74.54 152.58 39.31 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -176.165 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 203' ' ' THR . 8.1 tt -64.72 -36.91 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 113.068 -1.878 . . . . 0.0 108.208 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.827 ' O ' ' N ' ' A' ' 205' ' ' LYS . 29.7 m 178.62 100.26 0.15 Allowed Pre-proline 0 C--N 1.315 -0.93 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 238' ' ' PHE . 0.1 OUTLIER -14.55 58.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 124.02 3.146 . . . . 0.0 115.139 -173.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.827 ' N ' ' O ' ' A' ' 203' ' ' THR . 75.4 tttt -135.24 -44.81 0.7 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.063 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 26.5 tp -143.81 121.32 11.74 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.67 145.26 25.41 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -176.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.416 ' C ' ' CD1' ' A' ' 208' ' ' LEU . 1.0 OUTLIER -107.63 117.65 34.67 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -141.37 146.35 36.51 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -100.06 148.86 24.09 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.361 -1.745 . . . . 0.0 107.032 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -174.53 115.44 0.55 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 118.777 -1.678 . . . . 0.0 113.713 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -170.31 139.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -148.8 -86.09 0.09 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 215' ' ' HIS . 18.7 t80 -170.46 -178.46 2.7 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.394 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.545 ' O ' ' CE2' ' A' ' 214' ' ' TYR . 10.4 p-80 -149.34 165.91 30.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.233 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 . . . . . 0 C--N 1.33 -0.274 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.13 179.917 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 15' ' ' LEU . 10.0 mp . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 120.781 0.324 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -146.36 143.71 11.88 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.575 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 12.8 p -123.69 129.72 74.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -133.54 144.33 49.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.32 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 3.1 m-85 -76.34 122.83 25.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.624 HH22 ' CB ' ' A' ' 124' ' ' ASP . 16.6 tpt180 -138.69 113.13 8.85 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 124.277 0.985 . . . . 0.0 111.86 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.446 ' OXT' ' CG ' ' A' ' 238' ' ' PHE . 78.5 t80 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.013 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.443 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . . . . . . 0 CA--C 1.53 1.016 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.94 158.28 30.95 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.011 2.474 . . . . 0.0 112.776 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.43 ' CZ ' ' CG ' ' A' ' 66' ' ' ARG . 20.6 p90 -154.25 163.29 40.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.456 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.9 t -129.02 144.17 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 120.88 0.371 . . . . 0.0 111.813 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -123.1 131.54 53.73 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.112 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.68 142.74 24.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.072 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 51.4 p-10 -95.96 143.33 27.24 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.506 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 97.5 mt -143.67 162.34 36.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.186 0.517 . . . . 0.0 112.036 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.471 0.585 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.343 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 119.739 -0.172 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -155.25 161.5 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 119.386 -0.925 . . . . 0.0 112.709 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 m -132.5 133.03 43.29 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.698 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 m -140.05 165.95 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 111.609 0.225 . . . . 0.0 111.609 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.52 -162.04 24.75 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 119.721 -1.228 . . . . 0.0 114.188 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -112.53 151.18 30.29 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.499 -0.851 . . . . 0.0 108.915 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 8' ' ' GLY . 3.6 p-10 -136.95 114.36 10.93 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.529 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 38.9 p90 -125.05 105.35 9.11 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.29 177.03 7.5 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 105.888 -2.885 . . . . 0.0 105.888 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.532 ' CA ' ' H ' ' A' ' 124' ' ' ASP . . . -47.05 -36.16 8.89 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 120.013 1.907 . . . . 0.0 111.305 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -48.48 97.42 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.647 ' HE ' ' CD1' ' A' ' 122' ' ' ILE . 26.5 ttp-105 -130.07 119.76 23.59 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.674 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.4 pt -126.88 137.79 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.956 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.88 146.0 45.03 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.234 0.54 . . . . 0.0 111.661 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.1 140.53 29.91 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.218 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -102.25 127.4 49.23 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.299 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -112.4 136.77 51.48 Favored 'General case' 0 C--O 1.248 0.979 0 O-C-N 124.627 1.204 . . . . 0.0 110.394 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.325 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.568 179.813 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.1 tp . . . . . 0 CA--C 1.524 -0.027 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -149.43 178.27 27.06 Favored Glycine 0 N--CA 1.476 1.332 0 C-N-CA 118.901 -1.619 . . . . 0.0 112.6 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -134.49 150.75 50.83 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.852 0.834 . . . . 0.0 111.519 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.1 t -134.29 102.47 5.37 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.24 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.32 122.56 39.32 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.647 ' CD1' ' HE ' ' A' ' 66' ' ' ARG . 3.4 pt -121.87 146.3 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -127.69 128.93 46.28 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.56 ' OD1' ' NZ ' ' A' ' 132' ' ' LYS . 13.7 t70 -112.51 134.38 54.07 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.788 0.804 . . . . 0.0 111.885 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.63 ' C ' ' H ' ' A' ' 127' ' ' ILE . 76.9 m-85 -93.4 85.47 4.97 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.752 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.573 ' NE2' HH12 ' A' ' 237' ' ' ARG . 97.7 mt-30 -60.34 16.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.059 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.63 ' H ' ' C ' ' A' ' 125' ' ' PHE . 38.4 mm -68.3 -42.0 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.477 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -75.59 143.63 42.25 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.136 0.494 . . . . 0.0 110.164 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.6 -40.65 97.6 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -127.35 -7.35 5.84 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 20.2 p90 -168.91 127.0 1.02 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.911 1.687 . . . . 0.0 115.291 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.56 ' NZ ' ' OD1' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -136.76 149.28 66.49 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -69.65 137.43 35.76 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.791 1.318 . . . . 0.0 111.798 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 28.3 p90 -105.95 130.86 53.81 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 106.617 -1.624 . . . . 0.0 106.617 175.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.5 pt -127.92 149.15 32.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.74 174.36 37.38 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.952 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.04 139.14 53.65 Favored 'General case' 0 CA--C 1.523 -0.062 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 193' ' ' GLY . 0.0 OUTLIER -126.32 126.13 43.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.767 0.318 . . . . 0.0 110.882 -178.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.18 146.21 33.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.81 0.814 . . . . 0.0 111.274 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.97 127.01 44.79 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.61 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.1 t80 . . . . . 0 C--O 1.237 0.426 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.865 179.883 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -142.73 148.38 20.1 Favored Glycine 0 N--CA 1.473 1.127 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.845 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -115.51 154.79 28.7 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 138' ' ' ARG . . . -170.14 -178.77 41.28 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.46 155.67 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.567 0.699 . . . . 0.0 111.34 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 16.0 tt -131.95 130.49 61.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.94 161.58 42.37 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 119.956 -0.698 . . . . 0.0 112.084 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.406 ' HA3' ' HH ' ' A' ' 134' ' ' TYR . . . 160.68 -178.36 36.71 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.88 136.57 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 117.822 0.811 . . . . 0.0 110.612 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -97.69 137.52 13.35 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -121.58 100.23 6.9 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.613 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -100.46 152.85 19.89 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -172.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 28.2 mm -89.27 -67.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 103.776 -2.676 . . . . 0.0 103.776 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.5 p -103.89 -166.33 0.1 OUTLIER Pre-proline 0 CA--C 1.542 0.668 1 N-CA-C 100.1 -4.037 . . . . 0.0 100.1 172.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -81.03 -16.63 9.81 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 CA-C-N 126.373 3.312 . . . . 0.0 112.303 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.573 ' HA ' ' H ' ' A' ' 237' ' ' ARG . 47.7 pttt -81.86 -43.95 17.53 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -81.03 104.38 11.49 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.205 -178.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.79 131.55 24.23 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.728 0.694 . . . . 0.0 112.523 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 36.7 tp -94.79 130.3 41.39 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -110.81 123.41 50.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -107.44 118.27 36.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -157.11 -175.35 27.93 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 118.023 -2.037 . . . . 0.0 114.411 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.543 ' CE2' ' CD1' ' A' ' 214' ' ' TYR . 69.5 t80 -141.25 110.03 6.09 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 113.557 -1.322 . . . . 0.0 108.724 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -104.3 128.91 52.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.142 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.543 ' CD1' ' CE2' ' A' ' 212' ' ' TYR . 37.1 p90 -151.27 156.38 40.73 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.249 0.547 . . . . 0.0 111.361 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -154.45 165.99 34.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.417 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 62.1 t30 . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 120.913 0.387 . . . . 0.0 111.052 -178.976 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 15' ' ' LEU . 87.9 mt . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 121.298 0.571 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -154.48 164.97 31.78 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.13 150.94 17.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 CA-C-N 117.653 0.726 . . . . 0.0 110.917 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.473 ' NH2' ' CE1' ' A' ' 134' ' ' TYR . 99.7 mtt180 -132.6 142.54 49.18 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.467 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -107.28 110.4 22.41 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.573 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 76.2 ttt-85 -131.88 108.88 9.7 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-O 122.096 0.951 . . . . 0.0 113.422 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.438 ' C ' ' O ' ' A' ' 237' ' ' ARG . 2.6 t80 . . . . . 0 N--CA 1.47 0.54 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.182 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.261 0 N-CA-C 114.15 0.42 . . . . 0.0 114.15 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.71 159.79 19.58 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 124.359 3.373 . . . . 0.0 115.493 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -167.13 136.96 2.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.141 -1.845 . . . . 0.0 107.95 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.81 156.84 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -154.21 148.39 25.87 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.91 122.3 7.87 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.646 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -86.42 116.46 24.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.89 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 232' ' ' LEU . 11.8 tp -84.85 128.59 34.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.492 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.533 179.62 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.15 161.38 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.832 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.3 t -144.35 146.16 32.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.002 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.43 153.47 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.3 179.49 39.1 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.893 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -111.51 140.7 45.89 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.851 -0.674 . . . . 0.0 110.331 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -89.27 107.56 19.12 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.49 1.119 . . . . 0.0 110.72 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -126.02 142.25 51.6 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.575 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.99 127.29 24.63 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.89 -61.11 0.71 Allowed Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -125.34 158.55 33.95 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.607 0.718 . . . . 0.0 111.967 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.48 HH21 ' NE ' ' A' ' 237' ' ' ARG . 70.7 mtt85 -133.18 147.38 52.04 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.8 mt -111.74 126.38 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.13 135.59 35.88 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.324 0.583 . . . . 0.0 111.949 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.62 122.67 47.89 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.862 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 42.5 p-10 -99.84 128.45 45.93 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -153.93 171.77 18.47 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 122.161 0.982 . . . . 0.0 112.342 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.298 0 CA-C-N 113.294 -1.776 . . . . 0.0 108.048 179.91 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.461 0.122 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 177.31 -146.25 7.63 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.319 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 mp -137.38 148.83 46.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.19 0.519 . . . . 0.0 110.185 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 77.3 p -146.35 138.59 25.09 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.38 114.35 28.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.163 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 55.2 mt -88.87 129.83 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 135' ' ' ILE . 16.0 m-85 -100.98 116.53 33.05 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.256 0.551 . . . . 0.0 109.93 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.47 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 66.8 t0 -100.15 124.28 45.37 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.523 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.485 ' C ' ' H ' ' A' ' 127' ' ' ILE . 68.5 m-85 -110.03 82.6 1.62 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.693 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -58.6 -6.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 110.44 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.521 ' C ' ' H ' ' A' ' 129' ' ' ASP . 66.7 mt -68.83 -40.45 81.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.792 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -73.2 27.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.649 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 127' ' ' ILE . 34.9 t0 68.53 -119.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.981 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -90.52 -12.26 37.71 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.42 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 4.1 p90 -118.2 102.49 9.03 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.359 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.411 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -109.6 130.58 22.62 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 179.086 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -76.94 120.15 5.35 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 120.728 0.952 . . . . 0.0 110.048 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -75.91 130.71 38.92 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.456 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.556 ' O ' ' CD2' ' A' ' 123' ' ' TYR . 28.6 mm -135.96 135.6 50.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.46 169.98 37.1 Favored Glycine 0 C--N 1.322 -0.25 0 C-N-CA 118.979 -1.582 . . . . 0.0 113.203 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -104.34 140.42 37.92 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -118.49 124.38 47.44 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.0 123.23 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -147.21 146.41 29.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.844 0.354 . . . . 0.0 110.377 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 . . . . . 0 C--O 1.235 0.305 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.947 -179.366 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.232 0.146 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -130.59 102.87 0.54 Allowed Glycine 0 N--CA 1.468 0.771 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 10.7 mp -127.75 133.89 49.51 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.068 0.461 . . . . 0.0 110.143 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -179.33 -140.17 3.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.33 152.47 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.442 0.639 . . . . 0.0 110.547 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.3 tp -111.96 142.1 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.59 174.66 13.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 111.81 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 155.91 -176.99 33.23 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.66 136.65 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -131.86 135.07 7.97 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 120.431 -0.89 . . . . 0.0 114.467 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -106.74 113.1 26.4 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 113.684 -1.258 . . . . 0.0 108.224 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 201' ' ' ASP . 43.6 p30 -51.34 147.03 6.23 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.092 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.0 mm -108.9 -51.48 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.3 OUTLIER -106.79 -174.06 0.3 Allowed Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 176.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.445 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.0 Cg_exo -32.87 -70.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 122.55 1.947 . . . . 0.0 114.311 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -126.8 20.72 7.06 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.171 0.986 . . . . 0.0 110.425 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.5 tt -88.24 127.62 35.45 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.0 t -137.09 152.75 50.38 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.1 tt -105.7 124.25 49.25 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.465 ' CG ' ' NH1' ' A' ' 235' ' ' ARG . 2.2 p30 -137.1 147.62 46.17 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -174.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -91.08 127.03 36.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -114.93 150.5 18.71 Favored Glycine 0 N--CA 1.471 0.977 0 C-N-CA 121.287 -0.482 . . . . 0.0 113.001 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.64 127.84 37.84 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -89.85 136.64 32.92 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.61 101.08 6.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.682 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.613 ' NE2' ' ND2' ' A' ' 216' ' ' ASN . 84.7 t60 -97.42 126.77 42.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.613 ' ND2' ' NE2' ' A' ' 215' ' ' HIS . 94.4 m-20 . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 110.757 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 15' ' ' LEU . 5.8 tt . . . . . 0 C--O 1.225 -0.196 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -115.36 171.28 13.63 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.278 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.31 129.73 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 113.708 -1.246 . . . . 0.0 108.32 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.465 ' NH1' ' CG ' ' A' ' 209' ' ' ASP . 83.8 mtt85 -132.48 141.79 48.95 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.805 0.335 . . . . 0.0 110.353 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -122.0 112.16 17.93 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.658 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.48 ' NE ' HH21 ' A' ' 66' ' ' ARG . 87.5 mtm-85 -134.06 126.65 30.59 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 . . . . . 0 C--O 1.218 -0.563 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.453 -178.915 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.448 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . . . . . . 0 CA--C 1.541 1.68 0 CA-C-O 119.995 -0.336 . . . . 0.0 113.487 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.464 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 71.4 Cg_endo -82.25 158.29 17.45 Favored 'Trans proline' 0 N--CA 1.507 2.277 0 C-N-CA 122.899 2.399 . . . . 0.0 111.989 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.623 ' CE2' ' NH1' ' A' ' 66' ' ' ARG . 3.4 t80 -148.1 137.71 22.34 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.84 135.15 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -136.46 144.27 44.31 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -174.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.434 ' O ' ' OD1' ' A' ' 14' ' ' ASP . . . -152.99 149.43 28.18 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.304 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 13' ' ' ALA . 86.0 m-20 -144.44 125.71 14.71 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.175 -0.328 . . . . 0.0 110.661 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 mp -140.66 163.46 32.81 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.353 0.596 . . . . 0.0 111.903 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.467 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.133 179.591 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 . . . . . 0 N--CA 1.462 0.139 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.7 p -150.01 154.42 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 119.567 -0.853 . . . . 0.0 113.065 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.2 t -135.67 134.49 39.24 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.009 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.36 163.34 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.295 0.569 . . . . 0.0 111.933 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.64 -160.35 25.52 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -128.9 143.67 50.96 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 120.84 0.352 . . . . 0.0 110.345 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 9' ' ' PRO . 18.1 p-10 -124.72 115.39 20.66 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -126.91 158.02 37.88 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.49 123.02 32.05 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.426 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.06 -89.07 0.28 Allowed Glycine 0 N--CA 1.474 1.184 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.3 p-90 -127.79 174.04 9.45 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.623 ' NH1' ' CE2' ' A' ' 10' ' ' TYR . 25.3 ttp85 -147.32 147.42 30.34 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.354 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.39 144.24 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.39 150.18 19.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.364 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.88 159.14 31.8 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 55.6 p30 -140.45 153.07 46.13 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.51 169.26 24.21 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.363 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 120.946 0.403 . . . . 0.0 111.305 -179.124 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 117' ' ' LEU . 3.2 mm? . . . . . 0 N--CA 1.464 0.243 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.73 134.71 7.5 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.188 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.2 tt -123.94 140.76 52.66 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.9 t -133.27 123.01 24.74 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.39 130.72 40.62 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 88.2 mt -129.73 159.36 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.486 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 55.8 m-85 -118.42 118.15 30.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 237' ' ' ARG . 54.4 t0 -140.0 114.9 9.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.909 0.385 . . . . 0.0 111.478 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -122.11 96.18 4.95 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.574 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.564 ' NE2' ' OD1' ' A' ' 201' ' ' ASP . 47.9 tt0 -93.51 -0.62 56.27 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.397 0.618 . . . . 0.0 109.907 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.0 -23.56 29.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 12.7 t-20 -60.79 -42.63 97.94 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.165 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 128' ' ' ASN . 52.2 m-20 -175.21 -110.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.677 0.611 . . . . 0.0 109.366 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -118.22 1.05 11.86 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.665 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -128.81 131.67 47.78 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.485 0.491 . . . . 0.0 110.116 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.66 ' NZ ' HH22 ' A' ' 237' ' ' ARG . 0.5 OUTLIER -116.56 128.04 26.3 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.025 -178.055 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.13 129.55 29.02 Favored 'Trans proline' 0 N--CA 1.482 0.816 0 N-CA-C 107.187 -1.89 . . . . 0.0 107.187 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -115.16 129.15 56.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.368 0.604 . . . . 0.0 111.234 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.2 tt -162.2 148.77 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.509 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -169.22 -177.23 39.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 119.637 -1.268 . . . . 0.0 113.157 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.48 144.03 30.76 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.044 0.45 . . . . 0.0 110.326 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -119.1 118.85 32.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.949 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.25 128.99 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.938 0.399 . . . . 0.0 110.657 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.31 128.06 43.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.1 p90 . . . . . 0 C--O 1.239 0.512 0 CA-C-O 121.783 0.802 . . . . 0.0 111.749 -178.905 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.231 0.115 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -136.04 151.34 20.7 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 119.904 -1.141 . . . . 0.0 112.973 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.8 pp -166.89 147.54 5.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.144 0.497 . . . . 0.0 111.273 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -172.86 -156.84 13.32 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.92 147.92 33.08 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-O 122.063 0.935 . . . . 0.0 113.041 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 7.5 tp -116.89 148.01 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.204 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.09 167.12 30.31 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.897 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 150.98 -168.31 30.66 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.5 m -140.53 159.7 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 117.317 0.558 . . . . 0.0 110.407 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -143.91 133.78 5.49 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.787 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -130.51 127.23 38.73 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.564 ' OD1' ' NE2' ' A' ' 126' ' ' GLN . 0.1 OUTLIER -79.19 152.02 30.91 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 -173.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.498 ' CD1' ' N ' ' A' ' 202' ' ' ILE . 1.2 mp -62.36 -42.85 97.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 174.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.1 OUTLIER -164.5 171.9 5.22 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 176.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.569 ' O ' ' C ' ' A' ' 238' ' ' PHE . 13.8 Cg_endo -65.91 63.72 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 CA-C-N 121.722 1.651 . . . . 0.0 110.598 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 203' ' ' THR . 16.3 ptpt -134.21 -46.4 0.77 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.12 0.568 . . . . 0.0 110.516 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.5 tt -160.63 153.21 20.82 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.1 t -134.48 152.84 52.05 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.67 133.26 34.26 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 112.881 -1.963 . . . . 0.0 106.482 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.576 ' CG ' HH12 ' A' ' 235' ' ' ARG . 6.1 t70 -135.66 133.91 38.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.908 0.861 . . . . 0.0 112.564 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -101.94 117.99 35.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.06 143.89 15.12 Favored Glycine 0 N--CA 1.467 0.735 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.983 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -171.32 136.06 1.0 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.373 -0.913 . . . . 0.0 108.597 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.527 ' O ' ' CD1' ' A' ' 214' ' ' TYR . 0.0 OUTLIER -166.15 -139.84 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.251 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 213' ' ' ARG . 75.8 m-85 -155.48 -158.88 0.86 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.471 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -141.47 167.46 22.11 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.212 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.58 -179.577 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.273 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -117.65 152.36 17.69 Favored Glycine 0 CA--C 1.517 0.2 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.86 128.04 75.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.595 ' CD ' ' HH ' ' A' ' 10' ' ' TYR . 80.5 mtm-85 -126.24 141.16 52.03 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.397 0.618 . . . . 0.0 110.03 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -90.62 115.57 27.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.121 -176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.66 HH22 ' NZ ' ' A' ' 132' ' ' LYS . 31.3 ttm105 -124.04 87.88 2.81 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.569 ' C ' ' O ' ' A' ' 204' ' ' PRO . 33.3 t80 . . . . . 0 CA--C 1.512 -0.505 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.721 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.524 ' O ' ' CD2' ' A' ' 10' ' ' TYR . . . . . . . . 0 CA--C 1.55 2.253 0 CA-C-O 119.716 -0.491 . . . . 0.0 113.394 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.576 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 71.8 Cg_exo -45.65 106.63 0.09 OUTLIER 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.232 2.621 . . . . 0.0 116.825 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 16.7 m-85 -146.51 157.2 43.71 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.97 154.66 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.077 -1.049 . . . . 0.0 112.703 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.538 HE21 ' C ' ' A' ' 13' ' ' ALA . 46.9 tp60 -120.24 149.67 41.9 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.307 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.538 ' C ' HE21 ' A' ' 12' ' ' GLN . . . -137.7 125.87 23.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.209 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 53.1 p-10 -91.91 149.75 21.39 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 178.49 174.54 0.62 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.591 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.917 179.183 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.469 ' CG2' ' N ' ' A' ' 57' ' ' SER . 9.1 p -163.57 157.33 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 117.696 -1.602 . . . . 0.0 114.929 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.469 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 21.8 t -117.7 121.6 41.3 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 113.946 -1.479 . . . . 0.0 107.783 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -132.97 148.72 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.64 0.257 . . . . 0.0 110.607 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -157.77 165.9 33.73 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.327 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -112.85 147.65 36.53 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 24.9 t70 -157.08 153.97 28.71 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -177.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 4.8 p90 -130.77 155.07 47.28 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 110.629 -2.987 . . . . 0.0 106.146 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -42.85 117.35 1.48 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.509 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 124' ' ' ASP . . . 144.82 -89.65 0.16 Allowed Glycine 0 CA--C 1.534 1.241 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 25.1 p-90 -152.86 173.27 15.55 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.688 HH22 ' NH1' ' A' ' 237' ' ' ARG . 0.2 OUTLIER -130.88 173.02 11.37 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.042 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.5 mt -116.7 125.38 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 171.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.4 111.78 13.16 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.31 126.53 32.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.723 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -90.82 127.81 36.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -119.13 113.03 20.27 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.91 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.116 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.786 179.691 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 177.18 -141.63 5.42 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.101 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.2 130.57 53.32 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.53 0.681 . . . . 0.0 111.694 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.4 m -132.25 111.32 11.29 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.47 127.76 38.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 1.9 mp -90.34 161.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 176.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.447 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 2.4 t80 -139.76 108.0 5.79 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.524 ' CB ' HH12 ' A' ' 66' ' ' ARG . 18.3 t70 -123.7 132.44 53.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.36 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.522 ' C ' ' H ' ' A' ' 127' ' ' ILE . 27.6 m-85 -93.99 84.1 4.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.798 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -52.14 -4.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.786 -0.571 . . . . 0.0 111.352 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.522 ' H ' ' C ' ' A' ' 125' ' ' PHE . 92.7 mt -66.59 -42.71 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 120.228 -0.589 . . . . 0.0 112.304 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 22.4 t-20 -68.02 -40.35 82.95 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.189 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 128' ' ' ASN . 11.4 t0 88.6 -55.15 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.031 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -79.33 -51.74 9.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 2.0 p90 -151.55 128.22 10.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.75 153.34 78.77 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.56 136.01 48.27 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 120.514 0.81 . . . . 0.0 110.68 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.81 128.2 34.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.7 mt -141.55 139.77 31.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -171.2 175.01 44.93 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.231 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.69 152.81 48.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -124.86 130.8 53.09 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.0 t -130.71 118.52 42.61 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.23 130.2 42.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.024 0.44 . . . . 0.0 110.563 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 . . . . . 0 C--O 1.236 0.388 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.43 -179.94 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.52 -0.187 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -134.6 131.73 6.02 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.212 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.1 mp -136.7 132.62 35.15 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.583 0.706 . . . . 0.0 109.902 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -162.42 -170.5 27.31 Favored Glycine 0 C--N 1.321 -0.27 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.1 m -134.69 160.91 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.435 1.118 . . . . 0.0 113.653 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mt -110.12 136.26 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 113.032 -1.895 . . . . 0.0 110.251 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -160.67 147.0 15.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.693 0.758 . . . . 0.0 110.871 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 163.06 -172.44 39.07 Favored Glycine 0 C--O 1.221 -0.686 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 33.8 m -136.93 155.05 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 118.303 1.051 . . . . 0.0 109.472 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -154.78 159.51 29.03 Favored Glycine 0 C--O 1.241 0.555 0 C-N-CA 119.452 -1.356 . . . . 0.0 112.181 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.84 153.15 37.68 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.541 0.686 . . . . 0.0 110.557 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -59.52 149.5 29.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.065 -1.425 . . . . 0.0 113.971 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 206' ' ' LEU . 47.0 mm -111.31 -46.13 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.55 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.2 OUTLIER -127.43 -172.93 0.28 Allowed Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 175.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.55 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.8 OUTLIER -14.06 -85.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.401 0 CA-C-N 124.04 2.478 . . . . 0.0 114.869 -178.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -126.7 21.39 7.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.007 0.908 . . . . 0.0 110.057 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 202' ' ' ILE . 1.0 OUTLIER -75.08 112.98 11.88 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.6 t -130.87 152.59 50.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.45 143.07 44.2 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 113.082 -1.872 . . . . 0.0 107.9 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.81 150.68 49.05 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -126.31 134.15 51.2 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -174.57 -164.13 28.95 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 119.431 -1.366 . . . . 0.0 113.419 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -156.28 151.23 26.22 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 115.221 -0.49 . . . . 0.0 109.795 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 80.2 mtm-85 -92.6 124.93 36.98 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -107.07 125.41 51.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 109.97 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -56.61 156.97 5.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.556 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 . . . . . 0 C--O 1.233 0.187 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.578 179.883 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.517 -0.293 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 147.7 -166.83 28.75 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.461 ' N ' HE22 ' A' ' 12' ' ' GLN . 3.0 m -134.71 144.98 33.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -118.21 136.63 53.53 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -101.32 107.88 19.35 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.017 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.688 ' NH1' HH22 ' A' ' 66' ' ' ARG . 81.8 mtp180 -113.93 113.58 25.04 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.431 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 93.3 m-85 . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.428 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.409 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.21 160.05 33.05 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.902 1.734 . . . . 0.0 109.583 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.708 ' CD2' ' NH2' ' A' ' 66' ' ' ARG . 33.1 t80 -151.07 136.98 18.15 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.45 -0.9 . . . . 0.0 113.01 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.0 t -141.49 160.41 21.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -147.78 140.02 24.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.882 0.765 . . . . 0.0 112.856 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.01 122.9 45.53 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.158 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -83.11 124.82 30.84 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.4 tp -116.52 132.37 56.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.998 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.28 179.928 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.401 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 39.6 mmt180 . . . . . 0 CA--C 1.522 -0.117 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.401 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 8.3 m -157.18 -176.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 119.206 -0.998 . . . . 0.0 112.961 -176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.89 136.4 54.93 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.875 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.2 p -141.85 148.98 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.017 0.437 . . . . 0.0 111.776 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.58 -155.61 20.26 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -131.83 154.15 49.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 2.5 p30 -130.01 133.17 46.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -175.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.73 123.51 33.22 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.945 -1.48 . . . . 0.0 107.479 175.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -34.77 134.73 0.4 Allowed Glycine 0 N--CA 1.472 1.038 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.522 ' O ' ' CD2' ' A' ' 123' ' ' TYR . . . 97.64 -63.45 0.93 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -131.23 136.02 47.87 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.342 0.591 . . . . 0.0 111.153 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.708 ' NH2' ' CD2' ' A' ' 10' ' ' TYR . 54.9 mtp180 -137.01 156.05 48.92 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.1 tt -139.64 140.68 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.377 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.18 147.22 10.97 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.83 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.85 149.49 26.35 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -115.99 145.63 42.8 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.505 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 80.3 m-85 67.41 -98.08 0.04 OUTLIER 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.192 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . . . . . . 0 N--CA 1.472 0.644 0 O-C-N 124.468 1.105 . . . . 0.0 110.3 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 168.22 -151.76 19.12 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 118.931 -1.604 . . . . 0.0 113.768 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.8 mt -113.32 160.17 18.63 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 114.993 -0.604 . . . . 0.0 109.84 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 p -143.67 129.17 19.07 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 111.818 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.0 130.03 40.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 73.0 mt -123.9 161.59 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -175.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 64' ' ' GLY . 50.5 t80 -140.65 141.16 35.08 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.407 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 24.1 p-10 -143.38 138.63 29.54 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.279 0.561 . . . . 0.0 111.598 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.476 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 14.8 m-85 -83.97 83.56 7.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.048 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.432 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 70.2 mm-40 -85.33 6.09 27.84 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.28 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 20.4 tt -69.21 -40.16 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.421 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.548 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 20.1 p30 -90.65 -40.53 11.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.749 0.309 . . . . 0.0 110.202 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 1.2 m-20 77.1 -30.43 0.17 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.277 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -65.34 -45.04 85.8 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.059 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -154.49 116.16 4.15 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.568 0.699 . . . . 0.0 110.928 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.476 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 1.1 ptpp? -115.54 119.66 37.51 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.233 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -53.14 118.16 4.53 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 CA-C-N 119.736 0.941 . . . . 0.0 110.066 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -76.28 127.82 33.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.8 tt -155.98 146.46 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 118.768 -1.173 . . . . 0.0 112.818 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -169.76 178.63 42.62 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.22 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -116.19 157.4 24.9 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -124.83 138.47 54.26 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.33 114.05 32.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.97 152.65 51.91 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.24 0.555 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.426 177.765 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 N--CA 1.463 0.181 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -137.84 136.38 8.14 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 119.177 -1.487 . . . . 0.0 113.756 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -117.52 148.75 41.57 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.378 -0.911 . . . . 0.0 108.81 178.408 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -169.28 -169.63 32.85 Favored Glycine 0 C--N 1.32 -0.312 0 N-CA-C 107.906 -2.077 . . . . 0.0 107.906 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.0 m -137.98 155.08 29.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.981 0.896 . . . . 0.0 111.972 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.6 tp -113.86 131.69 65.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.015 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.76 149.19 33.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.119 0.485 . . . . 0.0 111.259 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.94 -167.17 37.26 Favored Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 p -145.13 140.13 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 117.284 0.542 . . . . 0.0 110.46 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.48 130.55 9.18 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.38 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.606 ' N ' ' OG1' ' A' ' 207' ' ' THR . 2.6 t80 -115.09 118.71 34.14 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -61.26 149.88 36.42 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 206' ' ' LEU . 51.4 mm -113.35 -61.13 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.515 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.7 OUTLIER -102.11 -173.14 0.28 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 175.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.515 ' C ' ' O ' ' A' ' 203' ' ' THR . 5.5 Cg_exo -22.76 -79.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.352 0 CA-C-N 123.281 2.208 . . . . 0.0 114.486 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -128.33 34.89 4.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.543 0.687 . . . . 0.0 111.181 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 202' ' ' ILE . 0.3 OUTLIER -90.31 111.7 23.01 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.606 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 0.9 OUTLIER -132.51 152.52 51.53 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.17 140.52 29.42 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.453 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 233' ' ' GLY . 4.4 m-20 -118.94 138.83 52.51 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -121.69 123.43 41.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 113.717 -1.583 . . . . 0.0 107.841 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -160.17 -175.81 31.56 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.365 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -141.96 154.21 44.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.78 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.533 ' N ' ' NE ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -83.5 139.1 33.12 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -128.38 89.96 2.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.72 0.295 . . . . 0.0 110.667 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -101.64 140.01 36.52 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.65 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.8 t30 . . . . . 0 N--CA 1.465 0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 111.16 179.041 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 26.8 tp . . . . . 0 N--CA 1.461 0.08 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.429 ' O ' ' OD2' ' A' ' 209' ' ' ASP . . . 160.57 -168.82 36.17 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 119.929 -1.129 . . . . 0.0 112.781 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.0 127.92 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.708 ' NH2' HH11 ' A' ' 237' ' ' ARG . 0.2 OUTLIER -104.95 141.95 35.64 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.05 0.453 . . . . 0.0 110.425 -179.028 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -107.62 108.68 20.06 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.053 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.708 HH11 ' NH2' ' A' ' 235' ' ' ARG . 82.4 mtp180 -129.38 120.11 25.0 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.407 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 1.6 m-85 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.707 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.413 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . . . . . . 0 CA--C 1.536 1.403 0 CA-C-O 121.005 0.225 . . . . 0.0 112.708 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.471 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 95.9 Cg_endo -82.69 176.65 7.59 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.884 3.056 . . . . 0.0 113.525 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.401 ' CE1' ' NH1' ' A' ' 66' ' ' ARG . 75.8 t80 -141.26 145.09 35.11 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 t -152.7 145.41 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 114.417 -1.265 . . . . 0.0 108.027 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.53 150.6 27.95 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.94 147.01 52.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 112.13 -2.304 . . . . 0.0 105.931 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -152.76 137.57 17.06 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.52 133.39 45.03 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.063 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.268 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.522 179.636 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 p -142.71 146.05 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.424 ' OG ' ' OD1' ' A' ' 70' ' ' ASP . 2.6 m -128.86 149.09 50.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.207 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.31 153.29 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.81 -148.73 7.53 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 61' ' ' ASP . 16.4 t80 -138.8 155.95 47.75 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 9' ' ' PRO . 7.4 p-10 -133.06 134.68 44.66 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -127.12 147.93 50.16 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 175.528 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.34 140.58 32.33 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.841 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.2 -35.21 2.98 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.11 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.454 ' O ' ' O ' ' A' ' 62' ' ' PHE . 84.6 m95 -139.4 131.13 27.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.406 0.603 . . . . 0.0 111.606 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.401 ' NH1' ' CE1' ' A' ' 10' ' ' TYR . 46.0 ttp180 -144.21 132.5 21.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.751 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.433 HG22 HD13 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -139.35 153.62 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.923 0.868 . . . . 0.0 112.358 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.39 140.0 8.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.934 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.98 146.01 24.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.698 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.424 ' OD1' ' OG ' ' A' ' 57' ' ' SER . 96.9 m-20 -93.31 128.74 39.46 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.515 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -109.24 140.14 43.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.498 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.486 178.868 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -109.4 147.7 16.99 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.372 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.9 tp -128.3 133.0 48.65 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.3 m -137.27 116.42 12.54 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.555 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.98 134.14 55.44 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.168 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 74.5 mt -119.73 158.94 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.476 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 31.7 m-85 -113.73 109.71 19.0 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' OD2' ' NH1' ' A' ' 237' ' ' ARG . 20.9 t70 -107.36 138.64 43.19 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -116.87 152.37 34.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.677 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.597 HE21 ' HZ2' ' A' ' 205' ' ' LYS . 26.1 mm100 -147.37 44.22 1.13 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 127' ' ' ILE . 59.7 mt -69.18 -42.46 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -96.0 -13.15 24.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.41 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 61.88 29.42 17.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.336 0.588 . . . . 0.0 109.984 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -125.64 -51.5 1.6 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.846 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 131' ' ' PHE . 43.1 p90 -175.16 131.78 0.3 Allowed 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.247 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -134.21 151.64 76.81 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.846 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.22 130.98 20.99 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.507 1.471 . . . . 0.0 109.899 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.474 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 2.4 p90 -120.55 133.32 55.4 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 39.9 pt -135.55 152.76 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.286 0.565 . . . . 0.0 111.424 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.84 174.89 39.24 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -117.2 143.08 46.25 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.935 0.398 . . . . 0.0 110.194 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -116.92 116.89 28.28 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.6 p -124.65 158.95 31.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -135.71 142.97 45.14 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.647 0.737 . . . . 0.0 112.572 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.304 178.31 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -130.34 126.2 4.89 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 7.4 tt -120.57 123.52 43.08 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 122.066 0.936 . . . . 0.0 111.415 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -138.06 157.37 24.31 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.59 139.63 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 117.41 0.605 . . . . 0.0 111.463 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 tt -116.42 132.98 64.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.472 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.52 34.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.04 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 162.5 -165.88 36.35 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.3 p -136.41 146.57 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 120.975 0.417 . . . . 0.0 109.974 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -117.67 137.37 13.18 Favored Glycine 0 C--O 1.244 0.754 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.977 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.634 ' N ' ' OG1' ' A' ' 207' ' ' THR . 10.7 t80 -122.16 120.0 32.94 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.689 0.876 . . . . 0.0 109.301 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 22.6 p30 -61.94 139.38 58.4 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.528 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.9 mt -125.18 -5.59 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-O 122.523 1.154 . . . . 0.0 109.499 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.581 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -160.35 -178.64 0.92 Allowed Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 101.271 -3.603 . . . . 0.0 101.271 177.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.581 ' C ' ' O ' ' A' ' 203' ' ' THR . 13.8 Cg_exo -18.95 -83.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 CA-C-N 123.965 2.452 . . . . 0.0 114.089 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.597 ' HZ2' HE21 ' A' ' 126' ' ' GLN . 29.4 mmtp -128.92 20.2 5.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.661 0.743 . . . . 0.0 109.884 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.9 tt -78.98 124.18 28.01 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 1.8 t -143.42 154.08 43.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -175.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 7.7 tt -91.55 126.65 36.71 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 112.92 -1.945 . . . . 0.0 105.797 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 210' ' ' ALA . 41.5 t0 -102.12 144.49 30.61 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -175.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . 0.517 ' N ' ' OD1' ' A' ' 209' ' ' ASP . . . -125.17 113.68 18.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.346 -1.752 . . . . 0.0 107.538 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -175.38 -165.27 31.25 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -147.07 161.36 41.0 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.951 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.2 ttp-105 -129.57 103.24 6.76 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.432 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -174.68 148.69 1.15 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.064 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -159.1 -84.61 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.66 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.469 0.505 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.907 -179.08 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 59.4 mt . . . . . 0 C--O 1.233 0.193 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -148.63 165.75 29.17 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.339 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.19 127.4 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.77 145.58 44.74 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.083 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -112.91 116.35 29.85 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.405 ' NH1' ' OD2' ' A' ' 124' ' ' ASP . 81.4 mtm180 -124.34 133.05 53.55 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.904 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.548 ' OXT' ' CG ' ' A' ' 238' ' ' PHE . 85.1 t80 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.546 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.476 0 N-CA-C 112.159 -0.376 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.66 152.71 25.99 Favored 'Trans proline' 0 N--CA 1.507 2.291 0 C-N-CA 124.153 3.236 . . . . 0.0 116.397 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.53 ' CD2' ' NH2' ' A' ' 66' ' ' ARG . 6.7 p90 -148.69 164.67 33.66 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.442 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 p -131.99 153.99 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.402 0.62 . . . . 0.0 112.527 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.545 ' NE2' HH22 ' A' ' 235' ' ' ARG . 63.8 tt0 -120.95 142.61 49.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.032 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 14' ' ' ASP . . . -142.87 149.86 39.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.471 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 13' ' ' ALA . 92.4 m-20 -140.52 147.26 39.26 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -168.16 -175.77 2.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.721 177.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 120.897 0.38 . . . . 0.0 110.179 179.166 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 111.277 0.103 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.6 t -142.69 159.06 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.83 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.5 t -146.75 138.16 24.32 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.626 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -138.22 157.56 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.63 -178.63 38.17 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 119.844 -1.169 . . . . 0.0 113.605 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -104.93 129.64 53.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.395 -0.902 . . . . 0.0 109.224 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.433 ' HB2' HH21 ' A' ' 66' ' ' ARG . 61.1 t0 -100.41 121.5 41.63 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -175.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -125.4 121.64 34.45 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -50.54 113.88 2.31 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' A' ' 65' ' ' TRP . . . 120.01 -49.38 0.88 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 64' ' ' GLY . 8.3 m0 -146.46 136.09 23.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 117.136 0.468 . . . . 0.0 109.986 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.672 HH12 ' CZ ' ' A' ' 237' ' ' ARG . 26.7 mtp180 -133.8 147.13 51.22 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.988 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.2 126.36 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.44 113.4 15.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.006 0.431 . . . . 0.0 110.024 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.78 127.08 34.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.893 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 17.7 p-10 -101.8 128.9 47.95 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -149.68 159.15 44.57 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.92 0.867 . . . . 0.0 111.892 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.455 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.528 179.159 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 178.87 -145.53 6.79 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.124 -1.512 . . . . 0.0 113.083 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 95.5 mt -117.69 154.35 31.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.608 0.718 . . . . 0.0 110.91 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.6 m -144.96 98.73 3.22 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.42 114.66 11.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.311 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.406 HD11 HG23 ' A' ' 122' ' ' ILE . 96.1 mt -110.81 134.02 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 177.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.452 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 29.4 p90 -132.6 120.45 21.82 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.408 -177.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -97.74 143.22 28.6 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 112.904 -1.953 . . . . 0.0 108.328 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.615 ' C ' ' H ' ' A' ' 127' ' ' ILE . 15.0 m-85 -102.45 113.01 25.98 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.631 0.729 . . . . 0.0 111.376 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -65.37 11.88 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.253 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.615 ' H ' ' C ' ' A' ' 125' ' ' PHE . 8.3 tp -68.06 -40.31 82.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.19 0.519 . . . . 0.0 110.484 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.446 ' N ' ' CG2' ' A' ' 127' ' ' ILE . 72.8 m-20 -99.77 141.3 32.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.301 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -79.45 -60.81 2.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -66.33 -41.89 88.96 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 131' ' ' PHE . 48.0 p90 -145.61 143.16 29.71 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 119.194 -0.432 . . . . 0.0 111.472 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.62 132.82 23.68 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 118.254 0.479 . . . . 0.0 110.267 178.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.62 136.68 21.6 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 N-CA-C 108.05 -1.558 . . . . 0.0 108.05 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 199' ' ' GLY . 0.8 OUTLIER -132.41 144.24 50.36 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 122.329 1.062 . . . . 0.0 112.312 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.452 ' O ' ' CE1' ' A' ' 123' ' ' TYR . 94.2 mt -135.04 161.48 40.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 113.338 -1.756 . . . . 0.0 107.895 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.22 160.03 31.73 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 118.929 -1.605 . . . . 0.0 114.185 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -107.94 135.45 49.3 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -118.43 125.79 50.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 18.4 m -117.89 113.92 43.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.09 125.53 51.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.36 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 C--O 1.238 0.46 0 CA-C-O 121.716 0.77 . . . . 0.0 112.522 -178.636 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.233 0.197 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.35 130.35 4.57 Favored Glycine 0 N--CA 1.47 0.935 0 C-N-CA 119.888 -1.149 . . . . 0.0 113.425 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.83 137.09 53.14 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -164.26 -168.75 26.81 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.84 145.52 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.539 0.685 . . . . 0.0 111.847 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.0 mm -112.53 128.92 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.79 162.61 38.23 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.385 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.489 ' O ' ' CD1' ' A' ' 134' ' ' TYR . . . 157.99 178.87 32.43 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.423 ' C ' ' HH ' ' A' ' 134' ' ' TYR . 3.6 p -135.16 139.82 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 134' ' ' TYR . . . -120.83 137.85 12.29 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 120.169 -1.015 . . . . 0.0 114.475 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.422 ' C ' ' OG1' ' A' ' 207' ' ' THR . 90.6 m-85 -104.62 106.67 17.26 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 114.131 -1.034 . . . . 0.0 108.593 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 201' ' ' ASP . 9.9 p30 -63.31 149.79 44.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.463 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.8 mm -102.98 -74.73 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.462 ' O ' ' C ' ' A' ' 204' ' ' PRO . 1.4 p -80.18 -167.85 0.15 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.462 ' C ' ' O ' ' A' ' 203' ' ' THR . 1.5 Cg_exo -33.76 -74.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 CA-C-N 122.69 1.996 . . . . 0.0 114.678 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 237' ' ' ARG . 10.0 mptt -125.19 20.19 8.19 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.251 0.932 . . . . 0.0 110.789 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 206' ' ' LEU . 0.9 OUTLIER -76.88 122.94 25.54 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 176.079 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.422 ' OG1' ' C ' ' A' ' 200' ' ' PHE . 2.8 t -136.41 148.57 47.86 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 50.3 tp -99.15 118.1 35.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -130.12 142.73 50.57 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -87.76 109.05 19.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.5 144.05 15.4 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.342 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -137.83 153.54 49.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.033 -0.583 . . . . 0.0 109.955 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.401 ' NH1' ' NE2' ' A' ' 215' ' ' HIS . 3.7 ppt_? -120.57 140.46 51.47 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -140.01 155.66 46.98 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.005 0.431 . . . . 0.0 111.437 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.401 ' NE2' ' NH1' ' A' ' 213' ' ' ARG . 13.9 m170 -99.17 142.19 30.97 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.758 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.169 -179.874 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.8 tp . . . . . 0 N--CA 1.468 0.469 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -100.05 162.94 19.18 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.307 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 39.4 t -126.13 128.98 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.545 HH22 ' NE2' ' A' ' 12' ' ' GLN . 90.4 mtt-85 -134.09 147.07 50.83 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -174.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -110.83 99.69 8.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.136 175.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.672 ' CZ ' HH12 ' A' ' 66' ' ' ARG . 99.0 mtt180 -130.28 130.86 45.07 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.838 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.462 ' C ' ' O ' ' A' ' 237' ' ' ARG . 61.3 m-85 . . . . . 0 N--CA 1.474 0.732 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.834 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.479 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.57 167.99 25.9 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.382 2.055 . . . . 0.0 114.183 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -141.01 143.48 34.45 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.6 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.8 t -132.03 146.38 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -148.31 130.99 15.94 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.36 132.71 12.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.825 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -96.08 151.93 19.01 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.12 0.486 . . . . 0.0 111.859 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.8 tp -123.99 131.21 53.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.671 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.779 179.379 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 p -155.95 131.54 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.906 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 t -138.51 135.85 35.52 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -148.58 168.67 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.756 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.76 -153.3 12.99 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -121.43 143.33 49.3 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.144 0.497 . . . . 0.0 111.561 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -86.71 112.97 22.17 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.866 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -125.48 150.47 47.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.968 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.22 103.6 2.62 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.48 -68.32 0.52 Allowed Glycine 0 CA--C 1.52 0.391 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -148.05 160.77 42.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -113.73 162.01 16.8 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 120.897 0.38 . . . . 0.0 111.608 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.406 HD11 HG23 ' A' ' 67' ' ' ILE . 40.0 mm -104.14 126.71 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 102.11 -3.293 . . . . 0.0 102.11 172.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.47 125.25 9.76 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 119.149 -1.021 . . . . 0.0 111.946 -176.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.23 153.41 20.0 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.553 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -134.24 128.07 33.15 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -151.45 161.27 42.99 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.185 0.993 . . . . 0.0 113.188 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 113.224 -1.807 . . . . 0.0 107.418 178.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -176.45 -138.14 2.82 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.051 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 119' ' ' LEU . 1.2 pt? -131.2 160.55 34.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.2 0.524 . . . . 0.0 111.992 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 m -148.74 147.62 29.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.423 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.01 135.98 53.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 96.7 mt -118.96 158.06 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.556 0.693 . . . . 0.0 112.552 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.425 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -106.07 101.49 10.98 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -104.72 122.71 46.26 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 123.67 0.606 . . . . 0.0 111.234 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -96.72 105.36 17.46 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.084 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.415 ' CD ' HH22 ' A' ' 237' ' ' ARG . 59.1 tt0 -87.83 -11.35 48.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.698 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.4 tt -67.52 -40.67 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.947 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -78.68 -11.78 59.99 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.0 t0 59.7 -78.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.177 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -66.27 -46.26 77.67 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -105.58 117.52 34.24 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.42 ' CD ' ' O ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -131.85 96.53 20.28 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.17 109.56 0.64 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.035 1.156 . . . . 0.0 109.387 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.421 ' CZ ' ' HA3' ' A' ' 197' ' ' GLY . 21.9 p90 -78.66 129.9 35.25 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 118.712 -1.195 . . . . 0.0 109.78 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.17 142.51 40.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.646 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -171.79 -176.8 40.99 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 118.28 -1.914 . . . . 0.0 113.709 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.73 137.57 51.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -130.12 131.17 45.59 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.45 132.35 64.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.682 0.753 . . . . 0.0 109.125 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -113.54 150.44 32.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.121 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.1 p90 . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.297 -179.954 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 C--O 1.232 0.163 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -135.15 142.08 13.44 Favored Glycine 0 N--CA 1.466 0.67 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.821 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.2 pp -133.39 141.89 48.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.304 -0.948 . . . . 0.0 108.755 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -153.45 174.15 32.13 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.04 138.59 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.902 0.382 . . . . 0.0 110.988 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.8 mt -111.06 131.08 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.859 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.53 148.43 32.17 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.421 ' HA3' ' CZ ' ' A' ' 134' ' ' TYR . . . 158.05 -176.89 34.99 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.4 p -138.75 142.3 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 118.728 1.264 . . . . 0.0 113.346 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -103.88 144.83 15.98 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.761 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.426 ' N ' ' OG1' ' A' ' 207' ' ' THR . 14.3 t80 -137.72 105.69 5.67 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.446 ' N ' ' HG1' ' A' ' 207' ' ' THR . 0.0 OUTLIER -91.59 154.22 19.2 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -176.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.403 ' CG1' ' H ' ' A' ' 203' ' ' THR . 5.3 pt -95.15 -47.1 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.652 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.7 OUTLIER -122.76 115.25 29.53 Favored Pre-proline 0 N--CA 1.433 -1.296 0 N-CA-C 100.563 -3.865 . . . . 0.0 100.563 172.17 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -12.15 -40.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 124.069 3.179 . . . . 0.0 117.176 -174.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 203' ' ' THR . 11.7 pttm -84.72 -32.37 23.55 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 3.2 mm? -85.4 105.14 15.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 121.475 1.943 . . . . 0.0 107.751 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.446 ' HG1' ' N ' ' A' ' 201' ' ' ASP . 1.0 OUTLIER -131.75 140.23 49.18 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 75.9 mt -93.37 135.36 34.68 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 113.734 -1.576 . . . . 0.0 108.749 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.595 ' CG ' HH11 ' A' ' 235' ' ' ARG . 42.7 m-20 -118.22 145.91 44.64 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -135.49 113.02 10.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 114.059 -1.428 . . . . 0.0 107.292 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -162.22 -177.65 35.44 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.56 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.35 152.42 49.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.594 -0.803 . . . . 0.0 110.97 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -106.88 127.28 53.29 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -112.09 150.65 30.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.295 0.569 . . . . 0.0 112.271 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' A' ' 216' ' ' ASN . 77.3 t60 -129.1 128.96 44.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.723 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 215' ' ' HIS . 97.1 m-20 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.462 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.28 169.25 30.26 Favored Glycine 0 CA--C 1.517 0.203 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.95 136.28 57.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.449 0.643 . . . . 0.0 111.378 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.595 HH11 ' CG ' ' A' ' 209' ' ' ASP . 81.1 mtt85 -121.27 130.21 53.54 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.95 106.29 17.2 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.575 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.545 ' O ' ' CB ' ' A' ' 238' ' ' PHE . 3.6 tmt_? -119.79 109.14 15.25 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.229 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.545 ' CB ' ' O ' ' A' ' 237' ' ' ARG . 28.5 t80 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.679 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.184 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.43 124.05 9.11 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 122.717 2.278 . . . . 0.0 112.822 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -144.95 148.29 33.65 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.429 ' H ' ' HB2' ' A' ' 236' ' ' TYR . 78.7 t -138.68 146.31 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.553 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -132.4 126.53 33.37 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.992 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.95 148.0 27.86 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 15' ' ' LEU . 57.2 t0 -162.6 134.58 5.36 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.514 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 0.8 OUTLIER -173.48 -171.0 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.025 178.524 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.411 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.861 179.848 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.446 0.165 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.37 135.13 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.639 0.257 . . . . 0.0 110.949 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 m -118.47 125.9 50.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.85 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.17 137.98 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.871 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.82 172.06 36.29 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.666 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -109.91 144.8 37.88 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 65' ' ' TRP . 44.4 t0 -150.84 130.96 13.49 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.584 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 31.6 p90 -128.41 105.87 8.62 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.807 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . 6.95 95.46 0.0 OUTLIER Glycine 0 N--CA 1.481 1.692 0 O-C-N 123.251 0.345 . . . . 0.0 113.186 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.96 -110.77 0.46 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.417 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 10.2 p-90 -103.74 -177.67 3.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.685 ' NH1' ' HE ' ' A' ' 235' ' ' ARG . 75.3 ttt180 -153.42 151.42 29.88 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.27 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.5 tp -129.58 142.4 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.431 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.56 143.03 19.51 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.89 155.99 16.54 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 71' ' ' TYR . 48.2 t0 -146.25 133.11 20.1 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.478 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 49.0 p90 175.5 -172.06 0.07 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.755 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.816 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 117' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.238 0.479 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -122.0 126.57 6.5 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.17 140.35 47.99 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.8 m -120.26 124.54 45.9 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.68 122.37 42.59 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 94.4 mt -126.45 160.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -175.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.487 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 70.6 m-85 -128.38 103.15 6.98 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 177.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.463 ' OD2' ' CZ ' ' A' ' 235' ' ' ARG . 67.6 t0 -138.83 129.94 26.78 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.494 ' CD1' ' NZ ' ' A' ' 132' ' ' LYS . 65.0 m-85 -120.86 133.26 55.31 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.439 177.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.5 pp0? -105.71 -13.75 15.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.269 0.557 . . . . 0.0 109.559 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 129' ' ' ASP . 65.9 mt -70.9 -40.51 76.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.777 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -55.6 89.64 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 127' ' ' ILE . 90.5 m-20 47.1 -114.25 0.54 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.865 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -131.2 22.73 4.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.086 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -167.28 127.3 1.45 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.492 -178.165 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.57 ' H ' HH22 ' A' ' 237' ' ' ARG . 12.8 tptm -134.63 129.56 19.47 Favored Pre-proline 0 C--O 1.238 0.5 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.497 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.38 129.96 28.56 Favored 'Trans proline' 0 N--CA 1.479 0.671 0 N-CA-C 107.404 -1.806 . . . . 0.0 107.404 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.622 ' CG ' ' NH1' ' A' ' 235' ' ' ARG . 52.0 p90 -122.64 148.6 45.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.525 0.602 . . . . 0.0 111.008 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.3 pt -141.05 163.62 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.555 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.34 173.78 41.82 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.188 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -117.26 159.78 22.12 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -127.79 130.99 49.62 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.939 0.4 . . . . 0.0 111.222 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 20.2 m -130.62 128.69 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.069 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.7 136.2 50.29 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.678 0.275 . . . . 0.0 110.931 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.7 p90 . . . . . 0 N--CA 1.467 0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.288 179.997 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.234 0.253 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -120.4 130.73 8.47 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.275 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.9 mp -135.83 148.62 48.76 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.631 0.729 . . . . 0.0 110.583 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.5 174.21 42.6 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.94 146.82 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 117.418 0.609 . . . . 0.0 110.2 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.9 tt -115.77 144.6 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.849 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.21 145.19 26.1 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -173.41 -179.32 44.0 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.124 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 57.8 t -132.54 135.95 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.596 0.236 . . . . 0.0 111.305 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -108.56 122.33 6.59 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.269 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.436 ' N ' ' CG2' ' A' ' 207' ' ' THR . 54.3 t80 -124.91 106.55 10.08 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.685 0.794 . . . . 0.0 109.166 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.617 ' OD1' ' O ' ' A' ' 203' ' ' THR . 32.5 t70 -61.88 151.31 34.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 206' ' ' LEU . 28.9 mm -117.79 -29.12 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 176.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.617 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 31.5 m -155.08 120.34 2.59 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 100.219 -3.993 . . . . 0.0 100.219 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.589 ' N ' ' OD2' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -6.54 -56.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 123.408 2.738 . . . . 0.0 115.336 -172.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 203' ' ' THR . 37.0 pttt -83.94 -30.47 26.25 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 203' ' ' THR . 80.0 mt -78.62 110.92 14.17 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 119.62 1.1 . . . . 0.0 109.634 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' A' ' 200' ' ' PHE . 2.1 m -125.99 145.81 50.14 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.412 ' C ' ' CD1' ' A' ' 208' ' ' LEU . 1.6 tm? -94.12 119.57 33.15 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 210' ' ' ALA . 45.7 t0 -106.21 145.81 31.08 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 209' ' ' ASP . . . -132.37 126.8 34.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.774 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -168.86 176.74 42.98 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 119.53 -1.319 . . . . 0.0 113.468 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -156.97 168.73 26.61 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.837 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.498 HH12 ' CD2' ' A' ' 215' ' ' HIS . 68.1 ttt-85 -108.11 124.73 50.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.038 0.447 . . . . 0.0 111.61 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' A' ' 216' ' ' ASN . 79.9 t80 -65.5 -49.65 68.22 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.266 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.498 ' CD2' HH12 ' A' ' 213' ' ' ARG . 20.6 t-160 58.84 112.97 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.411 ' O ' ' CE2' ' A' ' 214' ' ' TYR . 15.1 m120 . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 120.829 0.347 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -157.47 176.74 34.55 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.493 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 11.2 m -128.27 131.71 68.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.685 ' HE ' ' NH1' ' A' ' 66' ' ' ARG . 62.2 ttt180 -117.83 142.27 47.5 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.429 ' HB2' ' H ' ' A' ' 11' ' ' VAL . 15.8 m-85 -108.55 125.26 51.62 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.572 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 99.1 mtt180 -126.4 90.19 3.14 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 7.2 t80 . . . . . 0 C--O 1.219 -0.513 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.077 -177.866 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.52 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.85 111.28 2.47 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.98 1.787 . . . . 0.0 112.772 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.479 ' HH ' ' CD ' ' A' ' 12' ' ' GLN . 0.1 OUTLIER -107.57 169.7 8.42 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.498 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 12' ' ' GLN . 61.0 t -126.04 157.72 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.464 0.65 . . . . 0.0 112.43 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.479 ' CD ' ' HH ' ' A' ' 10' ' ' TYR . 53.9 mt-30 -130.94 130.98 44.14 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.281 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.86 135.12 29.24 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.452 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.99 144.47 25.88 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 tp -139.39 123.7 18.08 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.985 0.421 . . . . 0.0 110.617 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.852 179.801 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 . . . . . 0 CA--C 1.521 -0.154 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.13 161.81 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.376 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.5 t -148.23 133.24 18.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.982 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.14 157.51 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.615 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.57 -170.25 38.22 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.309 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -112.9 153.96 27.12 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 47.4 p-10 -141.47 129.2 21.62 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 121.634 0.73 . . . . 0.0 112.842 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 4.2 p90 -127.46 148.24 50.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.676 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -43.26 111.14 0.35 Allowed Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.34 -83.42 0.27 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.581 ' N ' ' CD1' ' A' ' 65' ' ' TRP . 1.4 p-90 -143.92 169.86 17.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.953 0.406 . . . . 0.0 111.5 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.463 HH21 ' NH1' ' A' ' 237' ' ' ARG . 54.8 mtt180 -129.39 172.61 11.34 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.578 0.704 . . . . 0.0 111.369 -178.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.4 mt -140.58 132.59 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.12 152.76 31.65 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.97 159.65 15.63 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 71' ' ' TYR . 41.3 t0 -157.2 167.21 31.04 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.424 -178.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.463 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 97.5 m-85 82.16 -126.08 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 125.08 1.488 . . . . 0.0 111.855 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.272 0 O-C-N 123.676 0.61 . . . . 0.0 111.262 -179.356 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -143.31 147.16 18.43 Favored Glycine 0 C--N 1.342 0.909 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.841 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.74 151.93 38.93 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.5 m -135.58 118.07 15.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.007 0.432 . . . . 0.0 111.559 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.77 131.15 43.77 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 96.8 mt -125.29 158.71 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.414 0.626 . . . . 0.0 112.661 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.453 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 63.3 m-85 -112.95 122.09 46.6 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.301 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -109.07 122.83 48.1 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.783 0.677 . . . . 0.0 110.095 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.478 ' O ' ' CB ' ' A' ' 126' ' ' GLN . 0.5 OUTLIER -111.51 177.67 4.58 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.214 0.53 . . . . 0.0 110.954 -179.447 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 131' ' ' PHE . 2.4 tp-100 88.24 128.16 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.933 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.8 tt -118.67 -3.97 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.749 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 40.3 p-10 -151.02 -45.13 0.12 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.326 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 73.9 m-20 -71.97 -158.41 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.59 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -128.27 25.98 5.77 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.66 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.1 OUTLIER -138.65 111.28 7.62 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.292 0.951 . . . . 0.0 113.119 -177.186 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 137.15 30.03 Favored Pre-proline 0 C--N 1.351 0.661 0 CA-C-N 118.145 0.43 . . . . 0.0 110.424 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.16 116.66 3.39 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 122.089 1.859 . . . . 0.0 110.033 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.416 ' CE1' ' C ' ' A' ' 197' ' ' GLY . 36.5 p90 -81.12 129.97 34.81 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.798 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 91.4 mt -133.96 140.13 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.974 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -173.17 -172.97 39.19 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.698 -1.239 . . . . 0.0 112.785 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.55 142.23 33.53 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.423 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -121.52 133.48 55.03 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.323 0.582 . . . . 0.0 110.161 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.6 m -129.25 131.63 67.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.005 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.48 130.92 55.83 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.558 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.6 t80 . . . . . 0 C--O 1.238 0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 111.946 -178.997 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.234 0.265 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.83 130.71 9.22 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mp -134.95 145.37 48.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.677 0.275 . . . . 0.0 110.662 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -163.44 -169.33 26.75 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.8 146.0 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.613 0.72 . . . . 0.0 112.243 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.1 mm -112.94 131.62 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.83 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -156.69 151.08 25.38 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.849 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.416 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . 160.39 -169.86 36.28 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.61 148.18 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.309 0.576 . . . . 0.0 111.327 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -145.9 158.79 27.79 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.602 ' N ' ' OG1' ' A' ' 207' ' ' THR . 1.6 p90 -137.96 153.41 49.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.658 0.742 . . . . 0.0 111.497 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 1.2 m-20 -56.75 142.45 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.945 -176.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 206' ' ' LEU . 72.0 mt -101.31 -23.63 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 123.065 1.412 . . . . 0.0 107.812 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.587 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.7 OUTLIER -165.13 -174.69 0.4 Allowed Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.587 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.2 OUTLIER -5.31 -93.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.144 0 CA-C-N 124.82 2.757 . . . . 0.0 114.454 -179.128 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -128.09 17.93 6.62 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 120.909 1.686 . . . . 0.0 113.297 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 202' ' ' ILE . 10.0 mp -74.46 127.32 32.76 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 176.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 5.2 t -139.34 152.74 47.41 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -177.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.49 ' N ' ' HG1' ' A' ' 207' ' ' THR . 8.0 tt -97.57 141.46 30.58 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.62 144.15 50.71 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -176.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.09 114.01 19.77 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -145.02 -179.84 21.64 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 119.426 -1.368 . . . . 0.0 113.816 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -129.03 159.34 36.24 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 113.955 -1.123 . . . . 0.0 109.331 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -141.72 148.51 39.15 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -142.34 160.55 40.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.646 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.531 ' ND1' ' N ' ' A' ' 215' ' ' HIS . 0.0 OUTLIER -122.56 147.58 46.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.357 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.349 -179.924 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 121.216 0.531 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -128.11 148.21 17.67 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.1 130.21 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 122.728 -0.277 . . . . 0.0 110.433 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -130.29 116.88 18.97 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -99.74 107.13 19.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.301 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.463 ' NH1' HH21 ' A' ' 66' ' ' ARG . 76.8 mtp180 -125.44 128.04 47.47 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.976 0.417 . . . . 0.0 110.893 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 . . . . . 0 C--O 1.218 -0.583 0 CA-C-O 117.938 -1.029 . . . . 0.0 111.13 179.853 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.328 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.03 116.2 3.37 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 CA-C-N 119.614 1.707 . . . . 0.0 113.829 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.629 ' CZ ' ' NE ' ' A' ' 66' ' ' ARG . 11.4 p90 -115.65 167.61 10.76 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.76 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.0 t -125.71 149.32 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-O 120.926 0.393 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -118.96 139.7 51.23 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.033 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.92 156.06 44.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.85 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 38.0 p30 -150.26 136.4 18.66 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.86 170.02 16.49 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.625 178.938 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? . . . . . 0 C--O 1.232 0.139 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.9 t -148.53 155.2 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.193 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.5 m -135.17 148.11 49.6 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.842 0.353 . . . . 0.0 110.432 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.6 t -129.35 141.15 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.92 170.72 31.33 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 119.804 -1.189 . . . . 0.0 113.724 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -102.2 140.47 36.45 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-N 114.942 -0.629 . . . . 0.0 110.232 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.426 ' CG ' ' NH1' ' A' ' 237' ' ' ARG . 44.9 t0 -90.06 114.12 25.95 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 124.177 0.923 . . . . 0.0 113.252 -177.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' TRP . 34.3 m-85 -124.78 118.8 27.2 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.392 -1.277 . . . . 0.0 108.825 177.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.56 105.5 0.83 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.22 -52.36 0.83 Allowed Glycine 0 N--CA 1.466 0.64 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.417 ' O ' ' O ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -140.98 166.31 25.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.634 ' NH1' ' NH2' ' A' ' 237' ' ' ARG . 16.4 ttp180 -146.43 162.68 37.73 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.854 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.2 tp -135.24 134.1 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.631 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.15 137.87 23.63 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.299 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.79 137.45 40.07 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.577 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -99.0 125.67 44.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.505 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -129.09 139.56 51.94 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.175 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.349 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.277 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 167.61 -137.28 4.53 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.002 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.1 148.81 51.98 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.4 p -153.9 139.8 18.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.68 135.55 46.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.519 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.417 ' O ' ' CB ' ' A' ' 66' ' ' ARG . 99.1 mt -122.15 133.75 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -101.73 113.75 27.2 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -90.24 113.16 24.93 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.36 105.82 16.92 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -74.77 56.97 0.74 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.614 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.6 pt -76.27 -20.48 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -135.88 -102.16 0.21 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.155 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -178.44 -27.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.859 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -99.35 -19.6 16.94 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -161.55 137.67 8.04 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.376 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.59 149.43 73.03 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.238 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.38 104.61 1.36 Allowed 'Trans proline' 0 N--CA 1.485 1.003 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.601 ' CD2' ' NH2' ' A' ' 235' ' ' ARG . 36.4 p90 -86.14 133.09 33.89 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.616 0.722 . . . . 0.0 112.352 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 tp -133.84 138.52 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.835 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.38 167.01 31.3 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.81 157.97 37.85 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -137.0 134.51 36.7 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 37.1 t -128.63 123.87 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.56 141.61 35.21 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.693 0.759 . . . . 0.0 111.996 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 . . . . . 0 C--O 1.237 0.444 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.617 179.456 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -142.07 142.97 12.28 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 119.042 -1.551 . . . . 0.0 113.092 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.87 146.03 35.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.362 -0.919 . . . . 0.0 110.005 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -165.55 175.47 41.26 Favored Glycine 0 C--N 1.314 -0.673 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.2 m -133.47 150.17 31.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.9 pt -119.96 151.82 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.74 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -167.75 158.7 11.16 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.931 0.872 . . . . 0.0 112.478 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.482 ' C ' ' CE2' ' A' ' 134' ' ' TYR . . . 174.12 -165.57 37.27 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.61 135.69 57.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.356 0.598 . . . . 0.0 110.037 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -102.91 136.72 13.01 Favored Glycine 0 C--O 1.224 -0.513 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.996 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.93 109.79 9.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 45.8 p30 -54.97 144.74 22.24 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -176.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.7 tt -125.98 2.05 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.809 1.29 . . . . 0.0 109.292 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.582 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -160.56 162.66 22.9 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 100.327 -3.953 . . . . 0.0 100.327 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.582 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.3 OUTLIER -10.57 -79.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.775 2.317 . . . . 0.0 113.771 -177.023 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 237' ' ' ARG . 12.8 mptt -129.03 25.4 5.56 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.472 0.578 . . . . 0.0 110.304 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 3.4 tp -78.92 110.69 14.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 53.6 p -106.25 145.64 31.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 14.9 tp -106.25 122.18 45.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 111.991 -2.368 . . . . 0.0 106.03 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -110.09 136.37 49.44 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -175.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -108.68 112.69 25.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 173.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -145.88 179.41 22.94 Favored Glycine 0 N--CA 1.463 0.486 0 C-N-CA 119.28 -1.438 . . . . 0.0 113.938 -175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.22 157.26 43.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.244 -1.478 . . . . 0.0 109.742 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -107.97 133.05 52.85 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -114.67 108.05 16.29 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 216' ' ' ASN . 52.9 p-80 -106.93 132.04 53.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.082 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 215' ' ' HIS . 59.5 t30 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 121.123 0.487 . . . . 0.0 111.42 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 CA--C 1.512 -0.507 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -98.71 121.55 7.22 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.663 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 71.1 t -115.55 125.05 72.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.601 ' NH2' ' CD2' ' A' ' 134' ' ' TYR . 1.7 mtt180 -133.33 144.43 49.65 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.509 0.671 . . . . 0.0 111.515 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.416 ' O ' ' CD2' ' A' ' 236' ' ' TYR . 6.9 t80 -103.09 103.3 13.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.378 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.634 ' NH2' ' NH1' ' A' ' 66' ' ' ARG . 55.9 ttm-85 -130.59 129.76 43.16 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.484 ' C ' ' O ' ' A' ' 237' ' ' ARG . 69.6 m-85 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 118.025 -0.988 . . . . 0.0 112.547 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.45 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.567 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 94.0 Cg_endo -84.35 119.68 2.4 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 122.962 2.441 . . . . 0.0 111.749 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.567 ' CG ' ' O ' ' A' ' 9' ' ' PRO . 71.9 m-85 -152.01 -175.94 5.45 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 12' ' ' GLN . 12.5 p -124.46 163.86 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -174.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.479 ' N ' ' CG2' ' A' ' 11' ' ' VAL . 10.7 tm0? -135.31 149.92 49.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.805 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.04 130.75 15.98 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -101.97 130.96 48.62 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.99 0.424 . . . . 0.0 111.957 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.83 155.44 47.79 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.526 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.392 179.521 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.56 139.5 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 p -141.88 153.49 44.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.02 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.17 147.44 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.362 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.46 -154.08 10.6 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -135.99 154.47 51.07 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 53.5 p30 -121.84 149.63 43.08 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -176.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -126.53 159.95 31.98 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 112.246 -2.252 . . . . 0.0 105.14 175.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.58 100.7 0.1 OUTLIER Glycine 0 CA--C 1.535 1.301 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.259 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.562 ' O ' ' CD1' ' A' ' 65' ' ' TRP . . . 61.84 48.52 83.34 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.771 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 64' ' ' GLY . 16.7 m95 -165.8 89.24 0.42 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.609 ' NH1' ' NH1' ' A' ' 235' ' ' ARG . 70.9 ttt180 -127.33 150.43 49.59 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -176.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.43 141.35 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.397 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.72 137.91 19.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.384 0.611 . . . . 0.0 112.488 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.88 156.13 16.81 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -151.39 159.03 44.45 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -160.64 165.99 29.65 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.46 -1.7 . . . . 0.0 108.902 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.13 -179.666 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 117' ' ' LEU . 3.0 mm? . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.69 138.81 14.47 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tp -149.45 140.01 22.53 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.7 p -157.12 155.64 31.38 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.365 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.91 137.34 52.09 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.474 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 4.6 mp -126.31 156.13 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.348 0.594 . . . . 0.0 111.175 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.426 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 57.6 m-85 -117.48 113.05 21.47 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.837 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -106.64 122.9 47.26 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.201 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -75.68 104.01 6.04 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.037 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -71.2 -29.7 65.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.136 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.8 -41.67 88.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.421 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -58.65 126.81 29.17 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.581 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.48 -21.87 59.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -128.1 -48.94 1.33 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.529 ' O ' ' CD2' ' A' ' 131' ' ' PHE . 52.9 p90 -115.65 132.59 56.59 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.14 110.77 41.03 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.319 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.14 109.63 1.58 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 N-CA-C 108.882 -1.238 . . . . 0.0 108.882 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 1.8 p90 -83.21 132.73 35.05 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.223 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 63.6 mt -134.33 154.87 38.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.75 -173.16 44.89 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 118.113 -1.994 . . . . 0.0 113.858 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.91 141.98 50.73 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -123.66 131.23 53.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.992 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.04 130.44 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.235 0.541 . . . . 0.0 111.477 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.26 117.8 34.92 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.961 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 78.1 t80 . . . . . 0 N--CA 1.469 0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.952 -178.242 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.466 0.356 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -102.05 111.66 4.12 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.1 pp -143.76 159.13 43.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 112.375 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -177.93 -155.66 14.67 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.68 157.0 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 117.247 0.523 . . . . 0.0 110.747 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.9 pt -130.08 145.41 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.874 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -156.19 150.52 25.57 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.086 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 175.9 -173.5 46.3 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.8 143.94 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 117.731 0.765 . . . . 0.0 111.066 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -143.41 160.72 27.66 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.14 152.38 49.9 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.45 0.643 . . . . 0.0 111.532 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 6.3 p30 -69.36 146.89 51.76 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 113.717 -1.583 . . . . 0.0 115.195 -175.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.542 ' C ' ' HG1' ' A' ' 203' ' ' THR . 43.8 mt -119.91 -1.17 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 123.335 1.54 . . . . 0.0 107.123 176.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.542 ' HG1' ' C ' ' A' ' 202' ' ' ILE . 0.2 OUTLIER -165.15 147.98 6.96 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 100.5 -3.889 . . . . 0.0 100.5 178.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.541 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -6.62 -67.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 123.249 2.633 . . . . 0.0 114.191 -176.178 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 237' ' ' ARG . 58.8 mmtt -130.77 33.07 4.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.359 0.982 . . . . 0.0 112.292 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 202' ' ' ILE . 0.9 OUTLIER -92.55 108.07 19.69 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 176.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.0 t -137.35 154.88 49.94 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -174.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.96 141.85 45.1 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 113.023 -1.899 . . . . 0.0 107.578 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -135.73 147.89 48.63 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.27 150.6 43.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -179.36 -172.89 44.04 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.612 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -123.55 167.98 13.2 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.843 -0.678 . . . . 0.0 109.837 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -140.85 141.66 34.64 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.599 0.238 . . . . 0.0 110.84 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -109.75 11.21 24.54 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.256 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 216' ' ' ASN . 50.0 p-80 -37.6 115.42 0.41 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 215' ' ' HIS . 7.7 t-20 . . . . . 0 N--CA 1.475 0.781 0 O-C-N 123.855 0.722 . . . . 0.0 112.643 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 121.287 0.565 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -102.1 151.14 18.35 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.724 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.86 129.76 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.609 ' NH1' ' NH1' ' A' ' 66' ' ' ARG . 93.7 mtt180 -133.41 140.92 47.6 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -113.52 102.06 9.94 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 102.203 -3.258 . . . . 0.0 102.203 173.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.533 ' O ' ' HB2' ' A' ' 205' ' ' LYS . 62.1 ttp85 -148.82 136.65 20.66 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.474 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.934 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.9 p -64.57 -23.66 67.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.533 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.26 141.94 47.16 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.247 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -62.39 -43.85 97.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.0 -135.93 48.76 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -131.77 23.81 4.16 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -74.97 136.43 41.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.29 -168.71 34.19 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.957 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.53 150.51 87.36 Favored 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 123.896 3.064 . . . . 0.0 115.153 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 44.2 p90 -149.45 161.65 41.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.259 -1.791 . . . . 0.0 106.77 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.9 t -130.5 135.51 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 118.385 0.539 . . . . 0.0 110.741 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -120.32 148.53 43.61 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.69 107.5 4.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.476 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -85.79 151.17 24.04 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -171.17 167.78 6.96 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.596 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . 144.43 -116.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.992 0.808 . . . . 0.0 109.868 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 16' ' ' ALA . 61.8 t80 58.23 147.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.893 0.378 . . . . 0.0 110.662 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.34 147.79 29.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.641 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -155.41 161.7 40.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.483 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -152.77 93.59 1.78 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.525 ' C ' ' H ' ' A' ' 23' ' ' THR . 61.9 m170 -103.51 -171.61 1.97 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.246 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 tt -73.74 38.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.419 0.628 . . . . 0.0 109.884 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.525 ' H ' ' C ' ' A' ' 21' ' ' HIS . 14.6 t -58.69 -45.8 88.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.16 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.45 ' N ' ' CG2' ' A' ' 23' ' ' THR . 77.3 t60 -124.73 101.61 7.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.939 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 51.0 t0 -81.11 162.35 23.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.52 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.447 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 64.8 m-85 -121.47 65.13 16.21 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.394 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.36 156.29 58.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.518 2.146 . . . . 0.0 112.313 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -176.28 -55.66 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.17 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.51 -15.56 19.59 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.99 1.793 . . . . 0.0 112.312 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 p -101.07 7.53 43.32 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.048 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 59.26 156.01 0.1 OUTLIER Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.94 122.01 9.67 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.453 2.102 . . . . 0.0 112.032 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -129.32 12.58 6.02 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.611 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -106.73 150.84 25.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.93 0.395 . . . . 0.0 110.768 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.525 ' CG ' ' H ' ' A' ' 36' ' ' LYS . 63.2 t30 -78.32 -170.74 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.798 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.525 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 28.5 tptp -60.67 -47.23 87.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.26 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 tt -137.03 -15.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.345 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.6 m 54.79 88.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.739 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.1 m -65.42 132.63 49.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.502 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -79.34 136.07 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.551 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 m -142.84 -103.28 0.13 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.89 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -64.4 -33.9 76.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.236 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -58.73 -44.98 90.61 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.985 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -130.41 134.89 47.48 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.781 0.324 . . . . 0.0 110.373 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -63.72 -44.81 92.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.082 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.54 ' CG ' ' H ' ' A' ' 47' ' ' ILE . 3.3 p-10 176.21 -77.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.532 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.54 ' H ' ' CG ' ' A' ' 46' ' ' ASN . 96.5 mt 56.84 151.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.583 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.455 ' O ' ' OG1' ' A' ' 49' ' ' THR . 55.4 ttm-85 60.14 167.75 0.08 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.134 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.477 ' HG1' ' N ' ' A' ' 50' ' ' ARG . 2.6 p 71.53 -44.14 0.58 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.382 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.477 ' N ' ' HG1' ' A' ' 49' ' ' THR . 84.6 mtt85 -99.78 136.14 40.16 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.879 0.371 . . . . 0.0 110.524 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.8 m 48.99 88.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.574 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.61 ' CG1' ' H ' ' A' ' 53' ' ' HIS . 2.3 p -73.02 -94.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.177 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.61 ' H ' ' CG1' ' A' ' 52' ' ' VAL . 2.2 p80 179.45 71.5 0.15 Allowed Pre-proline 0 CA--C 1.53 0.189 0 C-N-CA 121.239 -0.184 . . . . 0.0 111.088 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' ARG . 44.7 Cg_endo -69.46 -62.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.652 1.568 . . . . 0.0 111.461 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' PRO . 37.3 ttm180 32.94 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.204 0.315 . . . . 0.0 110.526 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.31 132.6 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.0 t -114.21 122.08 45.69 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.957 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 p -135.01 153.92 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.403 ' C ' ' CE2' ' A' ' 10' ' ' TYR . . . -175.8 -168.35 36.0 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.379 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -117.0 138.46 51.55 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.3 p30 -105.01 120.25 41.01 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 64' ' ' GLY . 74.9 m-85 -124.19 128.64 49.52 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.29 92.66 0.01 OUTLIER Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 62' ' ' PHE . . . 138.41 -94.1 0.21 Allowed Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -93.0 148.6 21.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.557 0.694 . . . . 0.0 111.444 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -132.17 135.66 46.51 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.963 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.66 128.86 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.75 143.83 47.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.036 0.446 . . . . 0.0 110.76 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.27 134.69 42.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.72 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -111.7 129.41 56.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.91 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -118.62 137.46 53.26 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.409 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.03 -43.09 4.72 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.737 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' A' ' 74' ' ' TYR . 78.2 ttt180 59.05 150.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.586 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.599 ' HH ' HD22 ' A' ' 78' ' ' ASN . 19.9 t80 95.52 105.38 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.069 0.855 . . . . 0.0 110.406 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -116.54 40.3 2.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.592 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.5 tttm 63.5 4.25 1.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.545 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -97.31 120.45 37.69 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.829 0.347 . . . . 0.0 110.107 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.599 HD22 ' HH ' ' A' ' 74' ' ' TYR . 13.4 m120 -97.55 90.6 5.09 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.328 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 80' ' ' ASN . 99.0 m-20 -64.38 -39.95 94.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.521 ' CG ' ' H ' ' A' ' 81' ' ' LYS . 18.9 t-20 49.51 179.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.346 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.521 ' H ' ' CG ' ' A' ' 80' ' ' ASN . 55.6 mtpt -63.41 138.4 58.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.883 0.373 . . . . 0.0 110.525 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -54.1 89.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.858 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 81' ' ' LYS . 47.5 t -158.78 155.45 27.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.092 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.8 m -107.69 144.72 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.518 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 57.4 38.65 28.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.912 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.412 ' CG2' ' N ' ' A' ' 87' ' ' GLU . 3.7 tp -64.38 -41.1 91.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.537 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.412 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 22.4 pt-20 -109.06 142.19 40.13 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.599 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -84.5 123.56 30.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.4 t -64.37 -45.04 97.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.429 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -80.55 136.53 36.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.379 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.7 pt -130.35 149.74 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -80.4 -21.45 42.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.296 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -72.84 131.47 42.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.824 0.345 . . . . 0.0 110.811 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -70.14 -35.69 74.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -61.44 141.38 57.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.703 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -158.65 -96.39 0.11 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 83.9 mt 56.62 77.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.96 0.409 . . . . 0.0 109.993 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -66.6 -38.92 88.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.301 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.5 tt -124.02 126.26 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.923 0.392 . . . . 0.0 111.053 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -99.72 5.05 45.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.612 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -49.59 131.09 21.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.358 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -106.48 145.02 32.33 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.579 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.526 ' HG1' ' H ' ' A' ' 104' ' ' GLU . 3.6 t -82.57 163.3 21.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.349 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.526 ' H ' ' HG1' ' A' ' 103' ' ' THR . 80.4 mm-40 54.79 25.8 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.283 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -127.65 -51.47 1.36 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.259 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 45.33 70.11 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.369 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -65.45 145.1 56.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.55 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.462 ' OD1' ' NH2' ' A' ' 224' ' ' ARG . 16.4 m120 -78.8 148.75 32.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.846 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.8 -156.56 9.07 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 t -125.56 128.82 48.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.862 0.363 . . . . 0.0 110.44 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -152.14 -6.82 0.22 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.739 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -65.71 -41.1 92.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.696 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -153.16 123.75 7.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.55 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 115' ' ' SER . 80.2 t -129.56 131.92 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.953 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 114' ' ' VAL . 1.5 t 49.04 101.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.916 0.388 . . . . 0.0 110.33 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 91.1 p -150.69 162.97 39.66 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.966 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 117' ' ' LEU . 10.2 mp -78.96 138.05 37.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.48 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -128.86 128.38 5.84 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.44 131.75 36.58 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.9 m -145.72 147.12 31.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.918 0.389 . . . . 0.0 110.428 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.28 113.3 26.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.477 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.436 ' N ' ' CD1' ' A' ' 122' ' ' ILE . 3.4 mp -111.55 146.59 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -112.77 127.21 56.09 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -98.92 125.17 44.28 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 176.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.479 ' C ' ' H ' ' A' ' 127' ' ' ILE . 39.0 m-85 -107.21 120.79 43.08 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -80.93 21.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.826 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 125' ' ' PHE . 21.4 tt -68.29 -39.35 80.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.689 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.412 ' N ' ' CG2' ' A' ' 127' ' ' ILE . 11.2 m120 -93.39 -174.79 3.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.976 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -102.3 -52.55 3.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.266 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.75 -14.2 14.64 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.445 ' O ' ' CD2' ' A' ' 131' ' ' PHE . 48.9 p90 -144.77 125.95 14.67 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.109 0.868 . . . . 0.0 112.093 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.4 mtmm -107.59 129.72 23.82 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.48 140.87 33.9 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 120.975 1.117 . . . . 0.0 109.982 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.662 ' HH ' HH21 ' A' ' 235' ' ' ARG . 28.2 m-85 -107.34 133.94 51.14 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.588 0.232 . . . . 0.0 110.858 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.3 tt -151.85 136.83 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.264 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -175.37 -168.15 35.45 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.224 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.31 156.16 49.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.845 0.355 . . . . 0.0 111.132 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.713 ' NH2' HH11 ' A' ' 213' ' ' ARG . 39.5 ttm180 -106.7 144.84 32.77 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.541 0.686 . . . . 0.0 112.837 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.6 t -130.87 112.7 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.93 126.94 52.97 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.439 ' CG ' ' N ' ' A' ' 142' ' ' GLY . 88.2 t80 -126.26 156.77 39.78 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.447 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.439 ' N ' ' CG ' ' A' ' 141' ' ' TYR . . . -159.34 169.67 35.51 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -65.91 119.39 11.22 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.981 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.53 -24.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.325 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -120.16 139.78 52.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.4 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -111.81 -65.49 1.17 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.813 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.9 m -75.18 152.66 38.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.986 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.43 HG23 HD11 ' A' ' 148' ' ' ILE . 0.2 OUTLIER -65.29 -42.69 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.412 ' N ' ' CG2' ' A' ' 148' ' ' ILE . 42.4 t0 -159.56 160.79 34.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.78 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.9 m -83.63 -97.18 0.05 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.521 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 70.9 p -138.45 157.53 46.02 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.438 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -63.92 -41.67 97.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.608 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -79.47 143.11 35.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.776 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 81.7 p -111.95 10.22 20.57 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.583 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 155' ' ' ILE . 21.8 mm -76.83 129.18 37.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.255 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -112.02 147.14 36.61 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.913 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 158' ' ' THR . 14.6 p -62.48 -43.03 97.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.418 ' N ' ' CG1' ' A' ' 157' ' ' VAL . 56.9 m -71.66 133.28 45.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.448 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.2 m -79.82 129.53 34.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.407 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 44.0 t -72.31 113.8 23.97 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.46 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.82 -10.01 16.92 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.967 1.778 . . . . 0.0 112.393 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.3 t -60.89 -44.44 97.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.354 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -141.48 79.19 1.67 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.667 0.27 . . . . 0.0 111.135 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.605 ' N ' ' CD ' ' A' ' 165' ' ' PRO . . . -84.99 -42.74 0.67 Allowed Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 164' ' ' ALA . 24.1 Cg_exo -62.24 144.93 96.15 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.532 2.154 . . . . 0.0 111.373 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -146.58 -5.66 0.55 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.661 0.267 . . . . 0.0 110.787 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 61.2 63.2 5.1 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.43 82.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.753 0.311 . . . . 0.0 110.342 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 170' ' ' THR . 8.9 p -128.24 129.48 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.155 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 171' ' ' THR . 77.0 p 50.58 174.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.613 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 170' ' ' THR . 82.7 p 52.09 111.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.059 0.456 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -142.46 159.35 42.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.548 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 56.7 35.67 26.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.141 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 46.4 p -67.75 -31.45 71.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.715 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -111.23 93.06 17.14 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 116.856 -0.156 . . . . 0.0 111.28 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.54 -6.17 8.0 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.678 2.252 . . . . 0.0 112.734 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.511 ' O ' ' NE2' ' A' ' 179' ' ' GLN . 71.4 mmtt -69.57 144.35 53.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.069 0.462 . . . . 0.0 110.769 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 60.2 p -68.05 139.2 56.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.964 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -124.4 120.34 31.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.043 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -63.6 -41.27 98.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.59 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 48.95 75.8 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -78.71 137.95 38.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.217 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -99.23 -96.19 0.24 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.701 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.2 m -72.73 144.14 47.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.916 0.389 . . . . 0.0 110.835 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -97.1 104.91 16.96 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.17 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 39.2 t -132.55 106.92 8.12 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.733 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.0 tt -67.5 -39.85 83.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.135 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -50.45 102.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.052 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -90.58 140.64 29.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.865 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.0 p -73.67 155.82 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -135.51 139.85 11.14 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.446 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.54 147.27 52.52 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 114.398 -0.901 . . . . 0.0 108.785 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -160.5 -172.6 27.99 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.92 153.75 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 111.438 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 95.3 mt -130.94 136.3 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.678 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.49 154.98 32.67 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.123 0.487 . . . . 0.0 111.41 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 173.93 178.92 44.22 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.6 m -136.89 135.73 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -114.78 136.83 13.5 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.429 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -121.07 104.91 10.14 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 0.3 OUTLIER -97.36 143.83 27.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 202' ' ' ILE . 43.7 mm -75.54 -34.74 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.408 ' C ' ' OD2' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -165.79 164.32 11.85 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 101.183 -3.636 . . . . 0.0 101.183 177.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.504 ' C ' ' O ' ' A' ' 237' ' ' ARG . 8.2 Cg_endo -55.11 -15.82 11.31 Favored 'Trans proline' 0 C--N 1.288 -2.629 0 CA-C-N 121.801 1.679 . . . . 0.0 111.66 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 237' ' ' ARG . 0.9 OUTLIER -73.8 -39.45 64.11 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.5 mt -123.08 110.45 15.34 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.626 0.648 . . . . 0.0 111.381 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 t -134.56 138.27 44.46 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 208' ' ' LEU . 5.8 mp -89.78 128.38 36.13 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -133.95 124.8 26.97 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -84.59 111.5 19.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -109.51 139.6 15.38 Favored Glycine 0 N--CA 1.467 0.744 0 C-N-CA 121.272 -0.489 . . . . 0.0 112.655 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -129.95 125.71 36.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.95 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.713 HH11 ' NH2' ' A' ' 138' ' ' ARG . 60.7 ttm-85 -110.64 116.82 32.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 215' ' ' HIS . 60.8 t80 -132.69 156.0 47.79 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.406 0.622 . . . . 0.0 111.939 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.539 ' O ' ' CD2' ' A' ' 214' ' ' TYR . 84.5 t60 -87.34 168.34 13.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.652 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.465 ' N ' ' CG ' ' A' ' 215' ' ' HIS . 65.1 t30 -71.8 146.09 48.26 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.853 0.359 . . . . 0.0 110.636 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 35.8 t-105 -77.52 112.81 14.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.28 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -118.62 -146.71 8.07 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -66.18 99.37 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 0.0 110.516 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 220' ' ' LEU . 9.5 mp 53.34 174.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.535 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -81.34 76.86 8.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.553 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -104.76 7.71 34.73 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.721 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 21.1 m -64.19 134.22 54.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.914 0.388 . . . . 0.0 110.664 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.462 ' NH2' ' OD1' ' A' ' 108' ' ' ASN . 12.1 tpt180 -72.92 -72.17 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.789 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -74.26 144.07 44.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.932 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.22 -122.05 0.15 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.752 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 229' ' ' GLU . 59.4 p -66.96 -30.0 70.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.041 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.433 ' CD2' HH22 ' A' ' 55' ' ' ARG . 13.2 t60 65.85 -69.02 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.563 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 227' ' ' THR . 80.6 tt0 -154.5 82.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.343 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 231' ' ' SER . . . -163.3 150.53 12.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.023 0.44 . . . . 0.0 111.137 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 230' ' ' ALA . 0.6 OUTLIER 163.8 -50.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.054 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 15' ' ' LEU . 12.1 tp -130.04 145.39 51.66 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.9 148.17 19.18 Favored Glycine 0 C--N 1.314 -0.672 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 68.5 t -122.16 128.83 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.674 HH12 ' NH2' ' A' ' 237' ' ' ARG . 45.7 ptt85 -133.29 143.01 48.77 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.77 0.795 . . . . 0.0 111.266 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 53.5 t80 -110.57 126.67 54.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 113.763 -1.562 . . . . 0.0 113.326 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.674 ' NH2' HH12 ' A' ' 235' ' ' ARG . 36.3 ttm180 -140.76 113.0 7.88 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.946 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' A' ' 237' ' ' ARG . 90.5 m-85 . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 117.852 -1.071 . . . . 0.0 111.954 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 t -72.27 133.48 45.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.822 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.453 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 46.2 mp0 -71.37 -39.03 71.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.085 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 6' ' ' GLY . 47.9 t0 -61.4 -45.0 96.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.304 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.54 -35.82 0.83 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 4' ' ' ASP . . . 81.88 7.5 87.89 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -140.67 141.82 34.98 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 122.553 -0.38 . . . . 0.0 110.261 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 10' ' ' TYR . . . -134.84 88.22 0.24 Allowed Glycine 0 CA--C 1.533 1.167 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 26.9 Cg_endo -74.48 141.32 28.15 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.607 1.538 . . . . 0.0 111.532 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 63.8 m-85 -147.23 -179.86 7.13 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.603 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 12' ' ' GLN . 2.3 p -128.6 160.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.556 ' OE1' ' NH2' ' A' ' 235' ' ' ARG . 57.2 tt0 -142.71 147.04 34.98 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.851 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.31 156.92 43.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.928 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -160.5 155.78 24.86 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.0 mt -134.15 146.2 49.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.584 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.53 -42.86 61.19 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' A' ' 17' ' ' TYR . 84.7 t80 56.28 25.89 9.86 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.909 0.385 . . . . 0.0 110.42 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.36 142.76 52.1 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 111.782 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -74.83 -111.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.232 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 41.77 76.38 0.07 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.799 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.506 ' CG ' ' N ' ' A' ' 22' ' ' ILE . 83.7 t60 -93.99 167.7 11.43 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.974 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.506 ' N ' ' CG ' ' A' ' 21' ' ' HIS . 97.5 mt -61.51 -88.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.164 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.7 p -134.4 161.31 35.37 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.852 0.358 . . . . 0.0 110.921 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 25' ' ' ASP . 96.4 m-70 -99.99 55.41 0.93 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.775 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 24' ' ' HIS . 98.7 m-20 56.39 118.7 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.871 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 27' ' ' PRO . 68.2 m-85 -58.57 155.23 30.22 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.403 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 26' ' ' TYR . 53.1 Cg_exo -53.0 -146.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.112 1.874 . . . . 0.0 112.942 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 65.58 65.72 0.88 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.308 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' O ' ' OG1' ' A' ' 30' ' ' THR . 90.8 Cg_endo -90.46 -173.41 0.63 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.979 2.453 . . . . 0.0 111.843 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 29' ' ' PRO . 6.7 p 59.74 113.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.017 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.84 56.48 17.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.542 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.69 60.48 5.19 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.585 2.19 . . . . 0.0 111.292 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -67.01 -20.84 65.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.522 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -74.81 100.42 4.04 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.962 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -104.67 8.16 35.09 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.208 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 38' ' ' SER . 8.2 mtmp? -84.44 -11.01 57.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.734 0.302 . . . . 0.0 110.526 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.412 HG23 HD13 ' A' ' 37' ' ' ILE . 41.7 mm 42.32 -88.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 36' ' ' LYS . 33.8 p -155.4 163.45 40.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.791 0.329 . . . . 0.0 110.322 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 t -132.64 141.39 48.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.296 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 p -173.63 -12.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.474 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.0 p -153.87 167.19 30.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.667 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 43' ' ' TYR . 42.8 p-10 -64.73 -32.1 73.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.488 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 57.4 m-85 55.59 35.96 26.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.132 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -92.51 117.96 30.49 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.811 0.338 . . . . 0.0 110.475 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -168.48 22.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.446 0.641 . . . . 0.0 109.388 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -63.62 -39.89 95.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.692 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.5 mm -76.2 128.43 37.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.523 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -88.37 140.98 28.91 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.553 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.474 ' HG1' ' N ' ' A' ' 50' ' ' ARG . 15.4 t -142.67 163.51 32.61 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.576 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.474 ' N ' ' HG1' ' A' ' 49' ' ' THR . 85.5 mtp180 47.71 97.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.696 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.2 t -72.13 150.02 44.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.23 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.95 148.06 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.719 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.501 ' N ' ' ND1' ' A' ' 53' ' ' HIS . 5.1 p-80 -116.61 73.5 5.88 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.613 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -40.83 146.87 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.667 2.245 . . . . 0.0 113.487 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.68 138.07 41.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.161 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.7 p -140.64 162.23 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.639 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 t -146.61 151.94 38.1 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.81 163.15 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.326 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.18 178.68 43.45 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.934 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -112.73 131.12 55.81 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.19 0.596 . . . . 0.0 109.813 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -102.08 127.24 49.06 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.545 ' O ' ' N ' ' A' ' 64' ' ' GLY . 90.5 m-85 -124.56 139.55 53.77 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.58 88.82 0.01 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.11 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 62' ' ' PHE . . . 129.77 -82.33 0.33 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -95.99 144.08 26.59 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.675 0.75 . . . . 0.0 111.501 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.752 HH11 HH21 ' A' ' 237' ' ' ARG . 51.2 ttp180 -136.27 137.93 41.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.377 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.93 128.68 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.58 139.32 26.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.08 145.46 50.32 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.107 0.48 . . . . 0.0 111.095 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -93.58 125.96 38.47 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -106.38 141.97 36.82 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.631 0.729 . . . . 0.0 111.789 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -166.06 101.51 0.65 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.489 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.425 ' HG2' ' H ' ' A' ' 75' ' ' ARG . 73.6 ttt180 -83.65 155.81 22.99 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 111.111 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.46 ' O ' ' O ' ' A' ' 75' ' ' ARG . 69.1 m-85 -87.6 14.34 8.55 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 74' ' ' TYR . 40.9 ttm180 40.34 106.42 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.358 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 75' ' ' ARG . 22.3 tptm 55.21 114.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.142 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -88.17 133.33 34.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.007 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.65 163.19 14.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 47.5 p-10 -48.66 137.5 11.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.494 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -84.92 94.09 8.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.636 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -144.39 49.82 1.32 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.335 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 40.66 -101.05 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.862 0.363 . . . . 0.0 110.836 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 83' ' ' SER . 10.4 t 56.04 53.73 8.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.601 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.04 -41.44 92.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.19 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -134.33 89.86 2.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.026 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.1 tp -66.44 -40.85 87.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.781 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -138.06 136.81 37.17 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.855 0.36 . . . . 0.0 110.251 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -99.09 136.72 38.65 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.556 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.7 m -78.94 -12.87 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.676 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 62.37 76.05 0.38 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.303 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.4 tt -87.52 134.72 27.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.6 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -130.89 140.04 50.17 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.647 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -148.18 125.77 11.76 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.94 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -111.23 124.66 52.67 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.472 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -94.96 172.78 7.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.432 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.45 -19.95 1.87 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.44 133.59 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.929 0.395 . . . . 0.0 110.287 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -40.96 130.32 2.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.797 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.2 tp -97.71 125.95 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.303 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -132.68 103.83 6.32 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.076 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -70.4 81.67 0.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.444 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -66.24 -35.71 81.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.431 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -65.84 131.61 46.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.604 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -134.33 -0.27 3.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.326 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -91.34 104.48 17.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.462 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -80.06 133.26 36.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.712 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -76.83 131.91 38.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.371 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -91.5 119.89 31.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -150.33 -150.65 5.33 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.2 p -68.23 140.84 56.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.754 0.311 . . . . 0.0 110.631 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.531 ' O ' ' CG ' ' A' ' 112' ' ' HIS . 96.7 m-85 -60.85 -48.11 83.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.695 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 111' ' ' PHE . 99.0 m-70 -159.03 159.98 35.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.752 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.04 -11.47 59.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.255 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.62 111.65 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.876 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.8 t -62.9 -43.43 98.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.584 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 74.09 151.65 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.2 mp -95.74 140.52 30.43 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -135.1 142.2 13.58 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 120.468 -0.873 . . . . 0.0 113.392 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.3 mt -120.43 143.47 48.46 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.7 t -139.68 118.02 12.06 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.63 118.54 29.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 46.3 mm -104.77 160.17 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.479 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 62.8 t80 -128.02 99.48 5.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 64' ' ' GLY . 43.8 t0 -138.34 122.8 18.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.843 0.354 . . . . 0.0 110.33 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.433 ' H ' ' HG3' ' A' ' 132' ' ' LYS . 10.9 m-85 -113.19 121.56 44.85 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.823 0.821 . . . . 0.0 112.322 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 126' ' ' GLN . 1.3 mp0 -86.7 -10.51 53.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.915 -1.038 . . . . 0.0 108.841 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 129' ' ' ASP . 96.4 mt -67.84 -41.2 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 95.4 m-20 -69.67 35.35 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.849 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.601 ' H ' ' C ' ' A' ' 127' ' ' ILE . 20.8 t0 92.62 -119.94 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.85 0.719 . . . . 0.0 110.491 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -127.34 23.3 6.42 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.574 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 11.0 p90 -151.13 126.39 9.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 119.568 -0.853 . . . . 0.0 113.287 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.433 ' HG3' ' H ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -135.87 135.71 22.09 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.413 177.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.65 98.34 1.14 Allowed 'Trans proline' 0 C--N 1.325 -0.661 0 N-CA-C 104.217 -3.032 . . . . 0.0 104.217 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -76.66 135.75 39.13 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 118.97 -1.092 . . . . 0.0 113.566 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.2 mt -120.54 134.17 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 CA-C-N 113.465 -1.698 . . . . 0.0 107.75 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.02 166.06 30.38 Favored Glycine 0 N--CA 1.46 0.288 0 C-N-CA 119.897 -1.145 . . . . 0.0 112.145 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.22 134.7 34.13 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -106.97 119.8 40.33 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.195 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.3 123.12 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.77 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.84 129.44 34.48 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.95 136.95 46.79 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.081 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.22 -48.97 4.62 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.476 ' CG ' ' O ' ' A' ' 143' ' ' HIS . 47.3 p-80 -154.96 119.3 4.72 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.957 0.408 . . . . 0.0 111.206 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.481 ' O ' ' ND1' ' A' ' 146' ' ' HIS . 9.8 p -86.56 -1.32 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.895 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.512 ' O ' ' CG ' ' A' ' 146' ' ' HIS . 95.6 mtt-85 -64.46 144.77 56.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.273 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' A' ' 145' ' ' ARG . 70.8 m80 -158.66 -128.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.879 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 148' ' ' ILE . 50.0 m -149.95 151.23 33.03 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.518 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 147' ' ' SER . 28.0 pt 31.78 51.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.822 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.24 -43.19 99.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.638 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.2 p -77.14 162.04 27.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.428 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 152' ' ' LYS . 98.0 m -131.07 -89.85 0.45 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.612 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 151' ' ' THR . 55.2 mtpt 44.58 -172.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.776 0.322 . . . . 0.0 110.694 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -79.18 139.76 37.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.455 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.47 ' HG1' ' H ' ' A' ' 155' ' ' ILE . 10.7 t -152.64 175.71 12.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.748 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.47 ' H ' ' HG1' ' A' ' 154' ' ' THR . 95.0 mt -74.64 131.3 35.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.228 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -141.09 163.78 32.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.072 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.2 t 62.35 27.89 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-O 121.054 0.454 . . . . 0.0 110.454 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.44 ' HG1' ' CG2' ' A' ' 155' ' ' ILE . 98.4 m -116.21 121.15 41.21 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.1 m -65.89 133.9 51.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.311 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.5 m -94.47 146.63 31.84 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.907 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.64 -34.26 7.36 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.096 1.864 . . . . 0.0 112.525 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 70.8 m -79.33 152.84 30.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.146 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.14 134.66 38.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.804 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.59 146.45 98.57 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.0 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.05 146.81 47.59 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.127 1.884 . . . . 0.0 111.795 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -79.92 124.83 29.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.229 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 62.21 -131.28 44.97 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.47 -50.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 0.0 110.393 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.43 132.03 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.039 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 8.9 t -87.6 129.54 35.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.229 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 62.1 m -108.91 124.38 50.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.593 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -174.66 -70.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.219 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.436 ' O ' ' OG1' ' A' ' 174' ' ' THR . 51.2 t-20 -156.31 -127.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.227 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 173' ' ' ASN . 78.7 p 52.06 -92.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.328 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.401 ' N ' ' OG1' ' A' ' 174' ' ' THR . 34.6 t70 -113.73 91.59 21.85 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.464 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 177' ' ' LYS . 51.7 Cg_endo -91.15 5.29 4.01 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.948 2.432 . . . . 0.0 111.92 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 176' ' ' PRO . 98.5 mttt 58.62 120.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.198 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.7 t -73.35 170.17 15.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.877 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -54.39 115.3 2.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.288 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -154.07 174.54 14.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.7 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -63.27 -37.04 85.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.852 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.08 133.24 44.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.421 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -151.59 -65.55 0.18 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.531 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.5 t -81.94 172.87 12.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.037 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -90.29 10.84 23.23 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.3 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 11.3 m -60.6 173.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.404 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 96.3 mt -73.85 128.02 36.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.993 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -85.47 142.8 28.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.296 0.57 . . . . 0.0 111.808 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? 47.12 77.25 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.431 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 14.1 p -126.63 131.89 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -138.32 135.17 7.29 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 119.505 -1.331 . . . . 0.0 114.583 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.59 144.75 50.79 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 163.31 -148.83 15.74 Favored Glycine 0 C--N 1.322 -0.216 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.01 159.19 26.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.767 0.794 . . . . 0.0 112.004 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 19.5 tt -113.11 131.61 64.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.66 150.47 36.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 122.15 0.976 . . . . 0.0 112.769 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 171.58 177.4 41.25 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.68 136.22 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.623 0.725 . . . . 0.0 110.57 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -122.87 120.67 4.34 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -128.25 142.21 51.22 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.836 0.827 . . . . 0.0 109.59 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 13.6 p-10 -49.16 141.8 7.82 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 117.438 2.385 . . . . 0.0 117.438 -173.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 206' ' ' LEU . 49.7 mm -124.31 5.59 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 112.35 -2.204 . . . . 0.0 106.177 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.58 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER 176.15 173.83 0.29 Allowed Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 -178.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.58 ' C ' ' O ' ' A' ' 203' ' ' THR . 3.8 Cg_exo -14.36 -83.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 123.58 2.314 . . . . 0.0 113.687 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -129.61 29.6 5.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.689 0.757 . . . . 0.0 110.604 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 202' ' ' ILE . 4.2 tt -83.66 111.89 19.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 176.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.2 p -120.31 152.73 37.41 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.16 131.77 48.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 112.728 -2.033 . . . . 0.0 105.623 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -108.06 146.82 32.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -145.59 129.51 17.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.531 -1.668 . . . . 0.0 106.673 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -167.68 -168.99 30.64 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 118.903 -1.617 . . . . 0.0 113.038 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -143.81 142.69 30.99 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.526 HH12 ' CD2' ' A' ' 215' ' ' HIS . 8.9 ptm180 -91.41 116.98 29.28 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.95 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -63.47 -46.35 86.59 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.526 ' CD2' HH12 ' A' ' 213' ' ' ARG . 86.3 t60 29.59 84.36 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.206 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.9 t30 43.27 94.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.38 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 34.82 -122.44 0.11 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.348 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -165.65 68.18 0.2 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 220' ' ' LEU . 15.1 tpt85 -67.33 -18.78 65.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.73 0.3 . . . . 0.0 110.449 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 219' ' ' ARG . 10.0 mp -43.4 -95.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.566 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 221' ' ' GLU . 9.2 tm-20 40.13 94.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.055 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.436 ' ND2' ' N ' ' A' ' 222' ' ' ASN . 0.3 OUTLIER -136.13 2.78 2.83 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.334 179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 60.9 p -138.71 156.06 47.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.152 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -65.07 -40.77 95.16 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.878 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.532 ' CD2' ' N ' ' A' ' 226' ' ' LYS . 67.7 t80 -135.37 -101.37 0.22 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.892 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.532 ' N ' ' CD2' ' A' ' 225' ' ' PHE . 44.9 mmtm 40.73 34.88 0.28 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.338 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.5 m -64.95 119.53 10.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.42 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -149.78 -91.09 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.874 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 45.86 31.35 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.135 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.07 154.04 39.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.671 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 71.8 p -137.75 131.29 31.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.787 0.327 . . . . 0.0 110.166 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.3 mp -110.3 136.72 49.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.789 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -141.58 153.08 23.87 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.011 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 14.2 p -133.44 134.18 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.644 ' NE ' HH12 ' A' ' 66' ' ' ARG . 52.6 ttm-85 -133.29 141.67 48.1 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -107.84 103.57 12.86 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.752 HH21 HH11 ' A' ' 66' ' ' ARG . 41.1 ttm180 -126.44 133.54 51.21 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 124.188 0.93 . . . . 0.0 111.413 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 10.2 t80 . . . . . 0 C--O 1.218 -0.554 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.308 179.493 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 1' ' ' ALA . 4.9 p 48.16 99.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.486 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -76.87 144.29 39.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.897 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.89 -39.65 95.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.34 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.76 -24.58 10.88 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.14 -39.78 3.08 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -71.82 137.11 47.33 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.83 -160.93 11.63 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.105 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.54 -174.59 2.0 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.308 2.672 . . . . 0.0 112.464 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.691 ' CZ ' ' NH2' ' A' ' 66' ' ' ARG . 3.4 t80 -159.47 141.02 13.06 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 120.904 0.383 . . . . 0.0 111.786 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -132.21 159.39 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.571 ' NE2' ' NE ' ' A' ' 235' ' ' ARG . 7.4 tt0 -157.44 151.79 24.94 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -176.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.7 121.59 10.64 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 113.172 -1.831 . . . . 0.0 107.825 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 38.4 p30 -92.65 133.77 35.66 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.1 mt -126.86 133.87 50.63 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.149 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.28 -31.22 0.32 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.768 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -82.43 142.93 31.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.032 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.92 -127.38 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.684 0.278 . . . . 0.0 110.704 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -60.16 -44.63 94.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.842 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.26 136.4 54.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.544 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 22' ' ' ILE . 25.9 t-80 -122.34 -80.87 0.63 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.354 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' HIS . 2.6 tp 31.43 104.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.62 0.724 . . . . 0.0 112.114 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 25' ' ' ASP . 19.5 p -69.74 164.41 23.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.626 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 24' ' ' HIS . 80.0 t60 -79.99 26.36 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.389 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' THR . 32.8 t70 -88.26 109.74 20.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.91 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -162.21 64.89 1.72 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.283 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.13 -62.45 0.25 Allowed 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 122.736 2.29 . . . . 0.0 113.012 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 34.78 58.09 2.27 Favored Pre-proline 0 N--CA 1.467 0.406 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -75.43 -30.69 6.33 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.67 2.247 . . . . 0.0 111.98 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -64.55 -20.0 65.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.379 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -117.67 86.07 23.01 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.861 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.58 ' CB ' HD22 ' A' ' 35' ' ' ASN . 27.3 Cg_exo -60.24 145.25 98.95 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.37 2.046 . . . . 0.0 111.594 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.461 ' N ' ' ND2' ' A' ' 35' ' ' ASN . 17.1 p30 -132.13 134.4 45.4 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.568 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp 44.83 37.94 2.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.628 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.658 ' N ' HD21 ' A' ' 35' ' ' ASN . 0.0 OUTLIER -154.22 172.01 18.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.681 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -96.28 -170.51 2.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.553 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.64 -16.96 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.559 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 39' ' ' THR . 69.0 m -55.32 -41.53 72.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.607 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 40' ' ' VAL . 53.9 m 54.54 164.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.709 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.484 ' N ' ' CG2' ' A' ' 39' ' ' THR . 10.6 p -69.94 136.81 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.591 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 p -75.37 163.94 26.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.547 ' C ' ' H ' ' A' ' 44' ' ' PHE . 43.6 t0 -62.68 -177.06 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.644 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.542 ' H ' ' CG ' ' A' ' 42' ' ' ASP . 16.5 t80 70.82 -35.02 0.31 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.573 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.547 ' H ' ' C ' ' A' ' 42' ' ' ASP . 78.4 t80 -59.95 -43.83 94.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -64.35 143.37 57.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.842 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -149.36 147.6 28.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.342 . . . . 0.0 110.665 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.438 ' N ' ' CD1' ' A' ' 47' ' ' ILE . 3.1 mp -76.55 130.52 36.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.021 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -120.62 141.55 50.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.14 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 98.4 m -126.56 130.43 50.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.178 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -127.9 133.62 49.31 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.784 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.4 p -168.85 -108.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.749 0.309 . . . . 0.0 110.596 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.5 m -112.67 132.16 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.06 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 55' ' ' ARG . 83.5 m-70 -146.55 72.52 12.83 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.85 76.57 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 120.961 1.107 . . . . 0.0 110.577 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 53' ' ' HIS . 43.9 ttm180 -72.41 146.48 46.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.952 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.07 139.3 44.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 121.154 0.502 . . . . 0.0 111.462 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.26 130.27 36.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.91 162.71 37.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.065 0.459 . . . . 0.0 111.155 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.85 -136.21 3.1 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -139.28 151.76 46.71 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 121.482 0.658 . . . . 0.0 112.344 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.563 ' OD2' ' NE ' ' A' ' 237' ' ' ARG . 12.1 t0 -92.39 104.79 17.08 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.125 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -126.33 148.07 49.62 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.256 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.47 125.77 8.07 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 123' ' ' TYR . . . 94.09 -10.73 71.56 Favored Glycine 0 C--N 1.33 0.247 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.539 ' CZ2' ' CG2' ' A' ' 67' ' ' ILE . 22.6 t90 -167.69 142.45 3.72 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.565 -0.817 . . . . 0.0 110.198 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.691 ' NH2' ' CZ ' ' A' ' 10' ' ' TYR . 69.4 mtp180 -144.01 144.34 31.62 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.539 ' CG2' ' CZ2' ' A' ' 65' ' ' TRP . 48.5 pt -120.17 138.34 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.639 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.65 110.16 8.53 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.786 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.07 119.52 29.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -100.14 128.42 46.22 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 112.146 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -153.92 155.23 35.27 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.675 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 73' ' ' ARG . . . -150.94 -63.04 0.19 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.475 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 72' ' ' ALA . 91.0 mtm180 56.28 125.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.507 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 71.0 t80 -147.23 31.67 0.91 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.123 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? -130.27 138.75 50.66 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.329 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -77.56 142.99 38.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.452 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -83.1 -116.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.538 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 79' ' ' ASN . 56.8 p30 -131.78 53.23 2.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.759 0.314 . . . . 0.0 110.412 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 78' ' ' ASN . 98.3 m-20 50.17 179.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.155 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 44.1 p30 -86.25 137.24 32.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.001 0.429 . . . . 0.0 110.351 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -143.16 158.76 43.32 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.452 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 83' ' ' SER . 55.2 p90 -111.07 145.19 38.96 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.342 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 82' ' ' TYR . 31.6 t 49.44 179.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.429 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.5 133.79 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.368 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -126.02 130.05 50.39 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.22 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.587 ' H ' ' CD1' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -102.39 3.48 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.573 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.96 -38.71 92.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.395 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.6 m120 54.09 52.81 12.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.58 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 p -61.79 -43.56 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.602 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -76.61 135.72 39.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 110.245 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 92' ' ' ARG . 41.6 pt -132.82 161.86 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.012 0.434 . . . . 0.0 111.199 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 91' ' ' ILE . 80.0 mtp85 54.59 161.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.136 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -142.09 166.45 24.68 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.784 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -46.78 123.81 5.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.026 0.441 . . . . 0.0 110.954 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -158.37 170.96 21.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.513 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.56 -55.58 0.69 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.66 -43.45 98.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.664 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -122.39 141.51 51.51 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.002 0.43 . . . . 0.0 110.758 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.8 tt -146.64 1.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.037 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -61.44 -43.46 98.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.646 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -77.95 129.05 34.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.215 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.64 0.76 45.41 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.969 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.9 m -86.84 128.4 35.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.789 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 106' ' ' GLN . 11.9 pm0 -70.92 -168.2 0.26 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.323 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.449 ' ND2' ' ND2' ' A' ' 108' ' ' ASN . 45.8 t-20 64.61 -64.75 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.818 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.541 ' C ' ' H ' ' A' ' 108' ' ' ASN . 14.9 mm100 53.56 -168.58 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.519 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 64.51 -38.18 0.22 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.801 0.688 . . . . 0.0 111.395 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.541 ' H ' ' C ' ' A' ' 106' ' ' GLN . 99.0 m-20 -64.2 -39.88 94.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.786 0.327 . . . . 0.0 110.421 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.07 -103.33 2.88 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.5 p -80.37 166.34 21.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.754 0.311 . . . . 0.0 110.562 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -102.52 -162.74 0.94 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.322 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.625 ' CG ' ' H ' ' A' ' 113' ' ' ALA . 10.1 t-80 71.61 -149.72 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.294 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.625 ' H ' ' CG ' ' A' ' 112' ' ' HIS . . . 57.52 -149.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.573 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.4 t 53.16 -83.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.522 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 113' ' ' ALA . 42.9 t -118.04 99.67 7.04 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.107 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.0 m -160.99 -165.58 1.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.632 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 117' ' ' LEU . 2.8 mm? 58.92 -150.4 0.44 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 162.53 -105.4 0.26 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 118.875 -1.631 . . . . 0.0 112.916 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.28 151.74 33.43 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.4 0.619 . . . . 0.0 111.547 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.0 t -139.48 119.25 13.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.458 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.91 123.23 26.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.089 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.461 ' CD1' HH22 ' A' ' 235' ' ' ARG . 90.7 mt -101.23 135.95 35.25 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' A' ' 64' ' ' GLY . 12.2 m-85 -124.3 107.72 11.47 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.008 0.432 . . . . 0.0 110.301 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.639 ' CG ' HH11 ' A' ' 66' ' ' ARG . 9.5 m-20 -96.96 141.53 30.02 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.933 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.495 ' O ' ' CB ' ' A' ' 132' ' ' LYS . 93.5 m-85 -103.34 153.7 20.17 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -108.59 63.61 0.61 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.43 -41.69 86.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -141.84 -85.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.011 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.4 t70 179.24 -44.22 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.332 0.587 . . . . 0.0 110.297 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.99 -43.31 88.15 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.629 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -142.93 110.73 5.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -175.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -130.58 139.93 37.13 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.46 152.18 70.84 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.323 1.348 . . . . 0.0 109.603 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 0.5 OUTLIER -138.45 133.95 33.42 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.612 -179.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.4 pt -130.4 154.8 41.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.441 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -155.88 163.27 31.72 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.93 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -102.35 122.61 44.59 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -92.66 128.22 38.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.111 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.13 119.22 46.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.32 153.53 46.47 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.419 ' CE1' ' O ' ' A' ' 117' ' ' LEU . 47.6 p90 -142.21 164.72 29.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.55 . . . . 0.0 110.927 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.52 -119.87 0.63 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -62.57 99.91 0.17 Allowed 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.2 p -142.87 141.04 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.906 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -108.99 127.31 53.97 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.6 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.556 ' CD2' ' HG ' ' A' ' 147' ' ' SER . 86.4 t60 -164.01 -82.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.596 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.556 ' HG ' ' CD2' ' A' ' 146' ' ' HIS . 60.1 p -165.99 -144.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.572 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 149' ' ' ASP . 72.0 mt 57.55 74.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.15 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 148' ' ' ILE . 66.6 t0 35.91 95.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.264 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.4 t -128.82 152.76 48.13 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.603 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.1 m -62.28 161.1 11.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.74 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -58.73 137.41 57.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.707 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 155' ' ' ILE . 53.6 mtmt -102.58 -165.95 1.23 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.699 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.4 p -74.22 25.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.515 ' H ' ' C ' ' A' ' 153' ' ' LYS . 41.5 pt -90.51 -5.03 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.963 0.411 . . . . 0.0 110.288 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' A' ' 157' ' ' VAL . 0.0 OUTLIER -42.17 164.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.804 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.419 ' O ' ' OE1' ' A' ' 156' ' ' GLU . 31.1 m -57.44 160.12 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.624 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 67.3 p -61.04 137.19 58.24 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.7 t -142.71 156.69 45.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.918 0.39 . . . . 0.0 110.933 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.61 129.96 84.85 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.567 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.08 131.75 8.58 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.302 1.334 . . . . 0.0 111.979 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 78.2 p -61.79 -42.51 99.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.293 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -150.95 129.97 12.58 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.931 0.396 . . . . 0.0 110.875 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.99 152.72 95.81 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.803 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.57 109.28 2.82 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.877 1.718 . . . . 0.0 111.806 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.87 4.11 49.68 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.241 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.48 149.24 2.84 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 179.59 -38.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.917 0.389 . . . . 0.0 110.169 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 95.6 t -75.77 133.53 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.363 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.5 t -137.73 161.25 37.01 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.655 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.5 m 65.22 165.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.591 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -74.69 -2.86 28.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.606 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 57.11 40.82 28.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.408 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.4 m -62.2 134.42 56.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.292 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -113.44 91.71 20.98 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.112 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -87.45 114.07 0.97 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.441 2.094 . . . . 0.0 111.446 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -75.44 -95.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.602 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.8 p -66.95 -35.26 79.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.876 0.369 . . . . 0.0 110.478 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -160.62 -47.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.183 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' A' ' 181' ' ' ASP . 12.8 p-10 -150.12 -68.44 0.2 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.358 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 182' ' ' TYR . 32.8 t70 47.39 -177.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.534 ' H ' ' CG ' ' A' ' 181' ' ' ASP . 99.0 m-85 -113.11 146.17 39.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.456 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 185' ' ' ASN . 29.7 pt20 -63.46 -37.59 87.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.986 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 26.9 t 49.01 -94.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.661 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 183' ' ' GLN . 99.5 m-20 -81.83 107.74 14.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.362 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 26.6 t -74.43 -91.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.855 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 94.1 mt -130.06 128.56 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.945 0.402 . . . . 0.0 111.043 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -154.88 -24.51 0.12 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.03 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 51.25 72.5 0.36 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.67 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.4 p -133.04 154.87 40.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -119.33 117.96 3.8 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.22 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 7.8 tt -145.34 127.81 15.99 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -171.73 -163.16 25.21 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.305 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.79 138.37 49.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.47 0.653 . . . . 0.0 110.929 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 67.4 mt -113.51 130.63 67.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -138.16 154.46 49.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.743 0.782 . . . . 0.0 112.849 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 172.32 -171.93 44.55 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.66 135.67 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.213 0.53 . . . . 0.0 110.231 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -96.05 113.15 4.58 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -116.0 117.68 30.82 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 58.9 p30 -57.92 150.29 20.8 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 206' ' ' LEU . 21.5 mm -113.33 -60.63 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.567 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -106.42 176.88 1.49 Allowed Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 174.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.567 ' C ' ' O ' ' A' ' 203' ' ' THR . 15.9 Cg_exo -14.93 -81.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.485 0.974 0 CA-C-N 122.909 2.075 . . . . 0.0 113.746 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -126.73 28.08 5.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.514 0.674 . . . . 0.0 110.761 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 202' ' ' ILE . 2.9 tt -85.8 112.67 21.31 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.4 p -103.93 149.8 24.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -172.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.36 106.07 16.44 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 101.695 -3.446 . . . . 0.0 101.695 173.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -104.09 130.37 51.79 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -174.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -122.14 144.19 49.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.348 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.44 -163.88 32.12 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.0 147.11 46.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -105.18 119.01 38.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.796 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -120.89 163.5 18.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.285 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -124.91 -172.76 2.64 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 216' ' ' ASN . 49.9 t-20 -56.39 -40.21 74.26 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.496 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -108.83 147.11 32.59 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.855 0.359 . . . . 0.0 110.61 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -66.78 -133.93 0.03 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -85.46 132.08 34.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.908 0.385 . . . . 0.0 110.474 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 220' ' ' LEU . 3.5 mm? -63.49 -42.96 98.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.909 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -144.11 124.77 14.09 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.744 0.307 . . . . 0.0 110.861 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -100.87 104.68 15.91 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.31 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.91 -17.85 1.22 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.83 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -138.6 151.12 46.98 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.89 0.376 . . . . 0.0 110.68 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -105.36 115.76 30.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.498 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -158.21 108.56 2.12 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.563 ' C ' ' H ' ' A' ' 229' ' ' GLU . 1.6 t -165.28 -120.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.492 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.533 ' N ' ' OG1' ' A' ' 227' ' ' THR . 86.4 t60 52.97 6.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.758 0.314 . . . . 0.0 110.384 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.563 ' H ' ' C ' ' A' ' 227' ' ' THR . 97.3 mt-10 -54.43 -176.14 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.207 0.527 . . . . 0.0 110.186 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -165.8 84.78 0.34 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.7 p -154.2 167.23 30.58 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 122.012 0.91 . . . . 0.0 112.442 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.61 -57.36 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.567 -1.651 . . . . 0.0 107.143 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 153.4 -166.8 31.79 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.869 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.25 130.64 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.663 ' NH1' HH22 ' A' ' 66' ' ' ARG . 71.2 mtp180 -128.59 142.85 50.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.287 0.565 . . . . 0.0 111.555 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.499 ' O ' ' CD2' ' A' ' 236' ' ' TYR . 5.5 t80 -106.28 106.49 17.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.764 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.563 ' NE ' ' OD2' ' A' ' 61' ' ' ASP . 71.7 ttt180 -133.75 128.63 35.26 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.0 t80 . . . . . 0 C--O 1.222 -0.381 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.847 179.733 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 p -156.6 163.58 39.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.48 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.44 129.83 42.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.532 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -155.22 175.16 14.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.402 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.23 -141.6 0.18 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.49 -109.5 2.82 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.04 154.02 39.03 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.84 -165.6 38.94 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 118.756 -1.687 . . . . 0.0 114.617 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.72 157.43 27.97 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 124.679 3.586 . . . . 0.0 115.354 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -150.62 165.6 32.85 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.831 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.18 139.27 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -124.81 145.65 49.65 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.58 0.705 . . . . 0.0 112.473 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.77 151.0 34.05 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.998 -1.455 . . . . 0.0 108.476 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 15' ' ' LEU . 38.4 t0 -142.33 144.06 33.04 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.577 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 92.0 mt -126.94 143.69 51.21 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.684 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.62 -89.89 0.43 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.055 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -148.89 157.93 43.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.539 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.48 151.21 37.01 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.259 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -142.17 140.67 32.47 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.973 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -79.8 106.32 11.74 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -74.98 -69.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.298 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.417 HG21 HD12 ' A' ' 22' ' ' ILE . 96.6 mt -122.03 133.2 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.779 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.0 m -111.73 130.6 55.74 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.999 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -58.22 -44.78 88.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.275 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 55.15 75.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.625 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 54.4 77.27 0.45 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.96 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.45 146.4 27.63 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.128 1.885 . . . . 0.0 111.734 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 13.5 pt-20 -177.8 54.73 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 28' ' ' GLU . 95.6 Cg_endo -74.08 152.88 46.27 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.797 2.331 . . . . 0.0 112.167 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.0 p -99.5 116.73 32.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.258 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -173.84 57.31 0.2 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.554 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.82 -20.55 58.57 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.477 2.118 . . . . 0.0 111.811 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 33' ' ' ASN . 43.6 p-10 -78.34 120.4 23.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -131.91 144.85 51.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.86 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.515 ' CG ' ' H ' ' A' ' 36' ' ' LYS . 19.3 t-20 -127.69 -124.07 0.23 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.575 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.515 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 88.7 tttt 57.68 90.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.803 0.335 . . . . 0.0 110.538 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mm -108.54 125.65 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.16 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.0 m -81.0 -95.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.518 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.4 m -158.11 -57.94 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.598 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.51 130.22 39.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.484 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -78.46 -149.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.571 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 40.27 86.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -146.41 155.31 42.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.451 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -160.29 -12.6 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.379 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.447 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 99.9 mtt180 -76.73 136.62 39.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.272 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 28.8 m120 -157.36 120.15 3.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.78 0.324 . . . . 0.0 111.048 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.7 tp -142.11 131.54 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.123 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.9 ttp85 -124.77 102.25 7.48 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.936 0.398 . . . . 0.0 110.305 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.1 m -133.81 132.58 40.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 51' ' ' SER . 42.2 ttm180 -142.0 87.02 2.01 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.069 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 50' ' ' ARG . 1.2 t 54.94 113.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.017 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -110.28 -5.4 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.204 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.0 m80 55.54 64.42 5.49 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.003 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -95.9 84.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.087 2.525 . . . . 0.0 112.777 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.27 118.19 31.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.203 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 57' ' ' SER . 74.9 t -139.37 159.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.381 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.44 ' N ' ' CG1' ' A' ' 56' ' ' VAL . 5.1 m -141.7 141.66 33.32 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.486 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.62 137.49 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.094 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.22 -175.65 32.47 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.037 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -96.97 137.51 35.94 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.977 0.418 . . . . 0.0 111.73 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.531 ' OD1' ' NH2' ' A' ' 66' ' ' ARG . 34.3 t70 -101.37 115.07 29.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.37 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -124.56 120.69 32.66 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.497 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.0 107.24 0.44 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.32 -60.98 0.59 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.439 ' N ' ' CD1' ' A' ' 65' ' ' TRP . 8.7 p-90 -157.98 150.68 22.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.937 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.628 ' NH1' ' NH1' ' A' ' 235' ' ' ARG . 9.3 ptp85 -135.66 167.23 21.51 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.887 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.2 pt -145.22 143.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.193 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.86 145.51 29.88 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.15 0.5 . . . . 0.0 110.71 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.17 127.28 38.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.403 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 24.7 p-10 -98.18 127.56 44.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.487 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 45.2 p90 -139.88 166.24 25.15 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.846 0.831 . . . . 0.0 112.848 -177.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . 145.59 42.17 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 113.001 -1.909 . . . . 0.0 108.6 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -78.95 172.35 13.92 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.578 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 76' ' ' LYS . 92.8 m-85 -62.08 -34.0 75.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.127 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 55.35 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 74' ' ' TYR . 58.2 tttm -134.77 126.18 28.43 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 110.51 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.524 ' O ' ' ND2' ' A' ' 78' ' ' ASN . 21.0 t-105 -77.34 -76.65 0.17 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.566 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 77' ' ' TRP . 14.3 m120 -149.75 137.67 20.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.583 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 80' ' ' ASN . 20.6 p30 -68.08 -33.61 74.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.632 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 62.4 t-20 -85.37 109.36 18.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.342 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 82' ' ' TYR . 53.9 mtmt -88.17 109.54 19.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.885 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 81' ' ' LYS . 96.2 m-85 53.49 163.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.19 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.4 m -71.91 153.02 42.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.273 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 86' ' ' ILE . 96.9 t -88.58 114.85 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.114 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 42.59 -91.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.706 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 84' ' ' VAL . 44.4 pt -129.47 160.51 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 120.845 0.355 . . . . 0.0 110.791 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.51 -20.0 65.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.636 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 59.93 98.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -109.42 131.56 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.79 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -48.78 -76.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.297 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.0 tp -149.54 105.39 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.981 0.42 . . . . 0.0 110.587 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -135.92 138.59 42.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.11 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -95.31 -50.41 5.04 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.267 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -171.36 115.25 0.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.809 0.338 . . . . 0.0 110.84 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -63.78 -41.05 98.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.693 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 97' ' ' ILE . . . 80.98 165.48 33.98 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 96' ' ' GLY . 9.7 mm 45.13 97.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 110.443 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -112.63 84.93 2.06 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.031 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.34 -43.88 94.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.273 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.8 t0 64.07 112.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.971 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 103' ' ' THR . 33.5 ttp180 -161.11 -140.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.827 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 101' ' ' ARG . 6.7 tppt? 60.57 -70.36 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.678 0.275 . . . . 0.0 110.535 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.546 ' N ' ' O ' ' A' ' 101' ' ' ARG . 61.5 p -64.74 -30.89 71.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -51.95 136.54 28.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.204 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -71.55 -99.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.715 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 44.52 83.39 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.135 0.493 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -138.18 147.57 43.98 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.12 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.433 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 46.5 p30 -78.46 79.03 4.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.68 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.08 123.75 0.6 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.9 t -137.95 156.81 47.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.723 0.297 . . . . 0.0 110.204 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 37.31 90.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.241 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -85.33 55.79 3.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.402 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 66.25 159.16 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.698 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.61 132.87 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.86 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.9 p -119.28 19.51 12.79 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.944 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.6 m 54.94 175.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp -139.99 162.51 35.02 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 170.32 -109.72 0.34 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 119.644 -1.265 . . . . 0.0 111.99 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.28 147.63 41.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.292 0.567 . . . . 0.0 110.748 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.3 p -150.81 141.38 22.58 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.68 149.05 32.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.815 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.463 ' O ' ' CG1' ' A' ' 122' ' ' ILE . 3.4 pt -144.36 114.45 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 135' ' ' ILE . 34.2 p90 -90.43 141.91 28.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.575 ' OD1' ' NH1' ' A' ' 66' ' ' ARG . 62.7 m-20 -89.84 115.84 27.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 113.387 -1.733 . . . . 0.0 108.143 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.464 ' O ' ' CB ' ' A' ' 126' ' ' GLN . 87.8 t80 -118.13 121.8 41.44 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.464 ' CB ' ' O ' ' A' ' 125' ' ' PHE . 1.4 mm100 147.96 177.33 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.53 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 93.0 mt -70.21 -1.46 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.753 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 70.9 36.55 1.46 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.632 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.46 -60.39 1.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.889 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -129.06 -48.31 1.22 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.572 ' CD2' ' CE1' ' A' ' 200' ' ' PHE . 1.0 OUTLIER -148.32 146.58 28.61 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.145 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.44 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -134.74 141.82 40.09 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.337 177.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.56 107.96 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 N-CA-C 108.007 -1.574 . . . . 0.0 108.007 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -81.85 131.02 35.25 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.981 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.505 ' O ' ' CD2' ' A' ' 123' ' ' TYR . 2.5 tt -161.83 149.51 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.832 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.69 -144.88 6.25 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.092 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -127.43 164.14 22.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.671 ' NH2' HH21 ' A' ' 213' ' ' ARG . 41.7 ttm180 -125.17 133.89 52.62 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.096 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.88 121.71 61.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.27 146.17 44.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.138 0.494 . . . . 0.0 110.98 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -131.27 160.97 33.35 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.698 0.761 . . . . 0.0 111.661 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.35 47.96 0.48 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -52.09 -13.18 0.28 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.011 -0.594 . . . . 0.0 112.145 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.3 t -71.04 157.94 6.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.171 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.529 ' O ' ' ND1' ' A' ' 146' ' ' HIS . 35.1 ttm180 65.3 154.25 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.276 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.529 ' ND1' ' O ' ' A' ' 145' ' ' ARG . 54.3 p-80 42.77 40.4 2.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.905 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.8 t -64.61 -17.67 64.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.093 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 31.5 pt -68.03 -131.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.691 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.6 t0 64.26 45.42 3.93 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.672 0.272 . . . . 0.0 111.201 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.513 ' HG ' ' H ' ' A' ' 151' ' ' THR . 78.8 p -64.11 -65.92 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.871 0.367 . . . . 0.0 110.145 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.513 ' H ' ' HG ' ' A' ' 150' ' ' SER . 60.5 p -138.75 155.97 47.75 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.395 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -139.83 151.22 45.54 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.632 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -75.06 146.92 41.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.297 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 92.4 m -121.02 127.27 51.59 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.915 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 9.1 tp -140.62 131.48 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.081 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -174.27 -34.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.811 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.89 132.06 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.923 0.392 . . . . 0.0 110.257 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 2.9 t -132.22 153.58 50.46 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.282 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.1 t -63.1 133.44 54.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.984 0.421 . . . . 0.0 110.727 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 4.1 m -84.39 153.89 62.43 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.877 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -39.23 139.25 0.6 Allowed 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 121.893 1.729 . . . . 0.0 111.999 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.3 p -81.68 -8.86 59.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.079 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -138.33 113.51 9.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.958 0.409 . . . . 0.0 110.884 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.447 ' CB ' ' CD ' ' A' ' 165' ' ' PRO . . . -172.01 -178.19 0.44 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.483 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 164' ' ' ALA . 28.7 Cg_exo -60.61 142.24 97.35 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.104 1.869 . . . . 0.0 111.745 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -64.92 -40.33 94.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.795 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.67 -167.27 48.19 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -152.62 151.56 30.76 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.951 0.405 . . . . 0.0 110.751 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.42 141.08 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.335 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.469 ' CG2' ' H ' ' A' ' 171' ' ' THR . 1.9 m -147.51 -138.77 0.09 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.389 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.469 ' H ' ' CG2' ' A' ' 170' ' ' THR . 23.4 p 51.91 171.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.794 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -105.65 140.98 37.88 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.712 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 52.9 p30 -90.95 4.12 52.8 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.291 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 21.3 p 46.01 -119.51 0.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.032 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -111.36 154.38 43.74 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -40.57 125.38 2.01 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.645 1.563 . . . . 0.0 111.798 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.98 -42.02 94.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.162 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 86.9 m 45.07 79.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.384 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -117.86 -98.15 0.45 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.36 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 56.53 34.4 24.28 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.64 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -97.4 7.79 45.85 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.599 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -44.59 161.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.637 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -45.26 113.61 0.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.802 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 39.9 t -155.87 152.58 28.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.655 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.638 ' N ' HD21 ' A' ' 185' ' ' ASN . 0.0 OUTLIER -152.11 171.1 18.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.233 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 41.5 t -67.63 125.33 25.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 110.725 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.632 ' CD1' ' H ' ' A' ' 187' ' ' ILE . 3.1 mp -67.44 -45.03 86.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.747 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.82 140.77 29.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.807 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -81.4 84.43 6.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.331 0.586 . . . . 0.0 111.157 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.9 t -121.35 162.4 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -137.58 135.74 7.78 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.162 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.4 tp -142.61 131.05 22.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -164.02 -160.93 12.32 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.39 153.25 35.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.986 0.898 . . . . 0.0 111.228 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.6 tt -124.67 134.04 67.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 113.622 -1.626 . . . . 0.0 108.733 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -157.67 156.15 31.25 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 119.634 -0.827 . . . . 0.0 112.454 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 169.06 -171.41 42.96 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.16 135.54 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.517 0.659 . . . . 0.0 111.034 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -116.35 129.9 8.71 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.968 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.572 ' CE1' ' CD2' ' A' ' 131' ' ' PHE . 56.7 m-85 -104.29 109.52 21.39 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.704 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.26 121.6 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 124.662 1.226 . . . . 0.0 110.171 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 42.7 mm -126.57 3.8 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 123.385 1.564 . . . . 0.0 108.635 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.778 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.2 OUTLIER -156.59 73.33 4.81 Favored Pre-proline 0 N--CA 1.425 -1.714 1 N-CA-C 98.664 -4.569 . . . . 0.0 98.664 178.138 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER 1.06 -41.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.826 1 C-N-CA 126.111 4.541 . . . . 0.0 116.747 -170.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.778 ' N ' ' O ' ' A' ' 203' ' ' THR . 61.9 pttt -96.73 0.08 49.01 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 203' ' ' THR . 5.9 tt -109.07 106.67 16.69 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 8.4 t -141.61 140.73 33.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 119.257 -0.977 . . . . 0.0 113.011 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.26 116.67 30.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.422 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -97.22 123.3 40.96 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.371 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -117.31 124.43 48.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -170.15 -173.54 37.59 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 118.946 -1.597 . . . . 0.0 112.705 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -133.79 148.24 51.34 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.671 HH21 ' NH2' ' A' ' 138' ' ' ARG . 84.0 mtp180 -127.05 129.27 47.7 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -152.75 157.34 40.7 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.199 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.533 ' ND1' ' N ' ' A' ' 215' ' ' HIS . 0.0 OUTLIER -151.79 165.49 34.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.191 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.528 ' OD1' ' CD2' ' A' ' 217' ' ' TRP . 14.5 p30 44.55 17.99 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.022 0.439 . . . . 0.0 110.411 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.528 ' CD2' ' OD1' ' A' ' 216' ' ' ASN . 1.9 m-90 -146.75 157.64 43.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.751 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 142.02 -13.92 2.6 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -102.26 144.69 30.47 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.929 0.395 . . . . 0.0 110.912 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 220' ' ' LEU . 10.0 mp -84.12 -0.27 51.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.244 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.69 -38.34 84.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.533 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 222' ' ' ASN . 44.0 p-10 -156.69 90.6 1.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 111.101 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 81.0 p -83.61 72.84 10.29 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.107 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -64.37 -44.04 92.64 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.446 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -164.13 136.34 4.85 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.694 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 228' ' ' HIS . 63.0 tttp -148.14 -79.28 0.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.317 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 226' ' ' LYS . 1.8 p 30.59 38.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.873 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.456 ' CE1' ' H ' ' A' ' 213' ' ' ARG . 51.4 t-80 -70.22 122.79 20.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 110.42 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -86.68 160.11 18.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.534 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.14 140.74 58.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.388 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.7 p -115.76 140.16 49.48 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.42 131.94 53.73 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -126.79 152.03 18.38 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.474 -0.393 . . . . 0.0 112.229 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.0 p -126.86 131.45 71.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.628 ' NH1' ' NH1' ' A' ' 66' ' ' ARG . 60.3 ttp180 -130.67 143.45 50.76 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -91.93 126.76 37.14 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 112.93 -1.941 . . . . 0.0 106.441 176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.529 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 1.4 tmm_? -147.13 109.5 4.54 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 122.452 1.12 . . . . 0.0 111.701 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 C--O 1.22 -0.484 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.596 -179.712 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 2' ' ' SER . 8.8 p 59.08 101.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.566 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -132.76 -33.38 1.2 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.392 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.6 143.94 53.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.678 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.56 -135.59 4.0 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.67 -35.17 91.5 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -64.26 136.02 56.78 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.27 -94.94 0.9 Allowed Glycine 0 CA--C 1.537 1.459 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.78 129.2 22.78 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.806 1.671 . . . . 0.0 114.206 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.411 ' OH ' ' OD2' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -162.26 166.57 25.23 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.608 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.86 157.24 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -135.32 143.79 46.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.775 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.89 149.2 29.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.128 0.489 . . . . 0.0 111.293 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 39.0 p-10 -105.17 120.57 41.85 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.995 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.2 mt -118.63 141.5 48.54 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.998 0.428 . . . . 0.0 111.07 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.89 -72.95 0.44 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.186 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.457 ' CD2' ' N ' ' A' ' 18' ' ' ALA . 85.7 t80 -163.67 -83.32 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.454 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.457 ' N ' ' CD2' ' A' ' 17' ' ' TYR . . . -172.34 158.11 4.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.566 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -95.08 132.86 39.51 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.4 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -85.34 -179.12 6.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.044 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 75.5 m80 39.86 -122.94 0.39 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.152 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.2 tt -140.68 145.65 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.53 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 p -76.62 170.21 16.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.684 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.524 ' O ' ' ND1' ' A' ' 24' ' ' HIS . 0.2 OUTLIER -58.17 133.49 55.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.526 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.99 -39.48 94.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.978 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.607 ' H ' ' CD ' ' A' ' 27' ' ' PRO . 1.5 t80 -168.7 -40.68 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.312 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.607 ' CD ' ' H ' ' A' ' 26' ' ' TYR . 22.3 Cg_exo -64.51 146.37 89.2 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.38 2.054 . . . . 0.0 111.823 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -176.93 76.21 0.25 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.931 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.45 141.33 97.32 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.374 2.049 . . . . 0.0 111.554 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.9 p -69.37 -35.26 75.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.795 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.549 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -179.15 -45.07 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.342 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 31' ' ' ALA . 35.4 Cg_exo -60.49 143.45 99.46 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.47 2.113 . . . . 0.0 111.861 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 11.3 p-10 -156.18 -58.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.67 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -101.73 150.01 23.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.842 0.353 . . . . 0.0 110.351 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.454 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.4 p-10 -72.5 -10.61 60.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.639 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -78.15 142.33 38.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.172 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.401 HG22 HD13 ' A' ' 37' ' ' ILE . 82.9 mt -106.37 117.26 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.139 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.7 p -79.19 152.2 30.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.904 0.383 . . . . 0.0 110.89 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.6 m -98.58 -42.73 7.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.506 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' A' ' 42' ' ' ASP . 5.7 p -143.14 -22.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.496 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.444 ' C ' ' H ' ' A' ' 43' ' ' TYR . 1.9 m 62.51 -2.38 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.982 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 40' ' ' VAL . 98.9 m-20 50.48 13.96 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.607 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 42' ' ' ASP . 76.7 m-85 -158.67 85.79 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.385 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -75.2 -19.65 59.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.184 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 47' ' ' ILE . 35.1 ttm180 62.14 35.03 15.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.629 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 39.15 -96.2 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.738 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 45' ' ' ARG . 40.5 pt -113.94 -167.8 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.955 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -138.83 142.82 38.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 0.0 110.611 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.6 m -125.33 7.43 7.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.544 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -62.41 -40.42 96.46 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.529 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.8 t -154.01 99.16 2.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.178 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.4 m -101.52 2.29 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 61.57 109.77 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.745 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.12 130.53 35.56 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.119 1.213 . . . . 0.0 110.522 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -92.95 152.77 19.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.761 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.5 p -138.73 154.25 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.156 0.503 . . . . 0.0 111.75 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.5 t -142.9 143.55 32.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.201 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 p -135.28 151.23 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.76 174.56 42.77 Favored Glycine 0 C--O 1.241 0.561 0 C-N-CA 118.302 -1.904 . . . . 0.0 114.191 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.99 138.44 34.52 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 113.446 -1.377 . . . . 0.0 108.161 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -116.72 102.82 9.75 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.41 ' O ' ' C ' ' A' ' 63' ' ' GLY . 78.3 m-85 -107.65 127.53 53.74 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 175.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -41.16 103.9 0.04 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 120.012 -1.089 . . . . 0.0 110.744 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.05 -83.92 0.19 Allowed Glycine 0 C--N 1.343 0.968 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.447 ' CD1' ' N ' ' A' ' 65' ' ' TRP . 2.1 p-90 -133.23 172.92 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.127 0.464 . . . . 0.0 111.433 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.464 ' NH2' ' CD1' ' A' ' 122' ' ' ILE . 50.6 ttp180 -125.1 151.61 45.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.415 ' N ' ' HG2' ' A' ' 66' ' ' ARG . 91.3 mt -108.37 129.7 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -141.62 145.64 35.26 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.63 149.5 49.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 113.606 -1.634 . . . . 0.0 106.667 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 4.1 p-10 -148.92 153.47 38.05 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 119.272 -0.971 . . . . 0.0 113.201 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -108.38 143.05 37.83 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 113.835 -1.529 . . . . 0.0 109.156 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -156.34 4.73 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.982 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -89.32 157.23 18.27 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 110.571 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -76.09 142.47 41.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.411 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -91.5 115.29 27.91 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.087 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.94 -42.99 89.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.963 0.411 . . . . 0.0 110.372 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.667 ' HE1' HD21 ' A' ' 79' ' ' ASN . 56.0 t-105 39.74 86.34 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.209 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 80' ' ' ASN . 60.9 m-80 -63.49 -40.38 96.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.819 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.667 HD21 ' HE1' ' A' ' 77' ' ' TRP . 17.3 t-20 61.7 2.67 0.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.35 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 78' ' ' ASN . 11.1 m120 -109.22 114.89 28.99 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.691 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -77.42 142.6 39.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.098 0.475 . . . . 0.0 110.671 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 9.6 p90 -143.79 -134.86 0.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.028 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 0.8 OUTLIER 82.78 12.33 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.032 0.444 . . . . 0.0 109.955 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.71 -43.25 96.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.697 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.3 t30 67.31 87.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.957 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.53 104.03 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.048 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.38 -37.39 74.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.021 0.439 . . . . 0.0 109.962 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 56.84 40.07 29.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.731 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.54 -35.44 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.286 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' ILE . 94.1 mtt180 -72.88 146.04 46.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.442 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.451 ' O ' ' O ' ' A' ' 90' ' ' ARG . 88.7 mt 56.28 116.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.565 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 93' ' ' LYS . 83.3 mtp180 -64.88 -42.58 94.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.779 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 92' ' ' ARG . 87.2 tttt 53.22 105.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -65.27 -41.83 93.81 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.578 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 52.09 40.02 27.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.676 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.04 151.81 0.67 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.7 pt -77.92 -21.93 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.784 0.326 . . . . 0.0 110.678 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 99' ' ' ILE . 99.8 mtt180 -78.18 145.51 35.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.744 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 98' ' ' ARG . 17.5 mm 46.54 97.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.423 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -80.35 -87.19 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.698 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -97.17 133.48 41.75 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.395 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -134.7 27.23 3.66 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.556 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 59.1 p -65.06 -32.37 74.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.316 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 54.86 59.7 3.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.637 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -90.48 8.81 31.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.888 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.43 -40.64 91.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.786 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.65 150.81 27.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.998 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 56.56 42.25 27.48 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.291 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.86 -121.15 2.16 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 111' ' ' PHE . 67.3 p -82.15 165.05 20.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.07 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 110' ' ' THR . 89.3 m-85 56.73 147.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.23 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 60.4 m170 -83.34 137.4 33.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.638 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -147.44 134.63 20.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.1 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.73 160.5 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.661 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 116' ' ' SER . 66.1 m -116.28 97.37 6.01 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.658 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 115' ' ' SER . 1.4 m 57.73 140.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.67 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -142.72 124.69 15.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.868 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -102.09 124.59 8.25 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -143.01 135.65 27.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 117.6 0.7 . . . . 0.0 109.802 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.8 m -154.81 151.99 29.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.432 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.18 125.89 51.11 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.464 ' CD1' ' NH2' ' A' ' 66' ' ' ARG . 1.7 mp -119.96 154.56 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.542 0.687 . . . . 0.0 112.232 -176.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -103.12 110.35 22.27 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.184 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.411 ' OD2' ' OH ' ' A' ' 10' ' ' TYR . 82.1 m-20 -108.5 122.49 47.15 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -91.36 81.56 5.45 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.49 0.662 . . . . 0.0 109.417 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -67.71 -18.27 64.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.203 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.0 pt -67.91 -30.46 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.812 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 131' ' ' PHE . 11.5 m120 -70.66 121.53 18.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 67.8 t0 -63.97 -41.85 97.42 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -105.37 -18.95 13.95 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 20.8 p90 -158.2 133.87 8.99 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.289 1.404 . . . . 0.0 114.368 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -118.09 103.64 49.54 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.0 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.57 123.14 11.56 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 15.3 p90 -106.58 133.46 51.22 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.093 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.9 tt -145.76 147.53 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.109 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.45 -171.85 37.69 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 119.69 -1.243 . . . . 0.0 113.605 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.53 136.98 39.56 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 20.1 ttt-85 -124.98 120.89 32.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.38 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.17 135.6 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.942 0.877 . . . . 0.0 112.11 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.25 124.9 50.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.029 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -129.46 144.84 51.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.096 0.474 . . . . 0.0 111.933 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -178.24 -164.42 31.33 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 47.73 -139.76 0.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.61 149.35 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.725 0.297 . . . . 0.0 110.438 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 -59.9 -42.82 94.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.87 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -79.48 68.38 5.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.044 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.668 ' HG ' ' NE ' ' A' ' 189' ' ' ARG . 25.7 t -80.54 162.08 24.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.621 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 21.2 tt -96.49 129.68 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.135 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -86.3 98.67 11.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.581 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.9 m -60.85 -42.19 97.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.402 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 93.4 m -123.61 129.36 51.05 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.341 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -75.77 139.45 41.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.614 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -95.53 -3.24 46.97 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.545 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 m 58.08 163.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.838 0.351 . . . . 0.0 110.579 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 19.2 tt -130.42 134.54 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.525 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 58.21 102.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.671 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.17 161.57 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.385 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.73 123.94 44.99 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.215 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 24.1 m -66.92 135.14 53.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.871 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.9 t -56.33 132.21 75.97 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.705 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.12 156.69 46.94 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.078 1.852 . . . . 0.0 112.118 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.0 m -65.86 105.03 1.2 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.459 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 164' ' ' ALA . 52.9 t30 -160.74 -87.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.663 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . 59.21 150.19 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.41 147.9 59.68 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.052 1.835 . . . . 0.0 111.776 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -84.65 139.17 32.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.605 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -160.05 -94.59 0.1 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 169' ' ' VAL . . . -67.44 143.34 56.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.748 0.309 . . . . 0.0 110.538 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 168' ' ' ALA . 4.9 t 59.65 138.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.613 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 87.3 m -62.53 -45.67 91.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 95.8 m -121.4 129.1 52.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.49 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 172' ' ' TYR . 53.2 p90 -84.94 130.33 34.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.751 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -117.5 119.21 34.36 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.283 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 179.38 78.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.328 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -57.1 110.57 2.52 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.309 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.24 159.73 17.65 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.099 1.866 . . . . 0.0 111.755 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 178' ' ' THR . 98.6 mttt -142.71 -75.75 0.27 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.904 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 177' ' ' LYS . 2.6 p 36.77 51.21 0.91 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.275 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -69.73 138.6 52.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.566 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -82.47 136.02 35.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.788 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 181' ' ' ASP . 40.4 p30 -152.55 82.17 1.23 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.724 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 181' ' ' ASP . 63.0 t80 44.0 98.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.93 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -159.23 105.94 1.74 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.483 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.3 p -152.59 129.52 11.0 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.821 0.343 . . . . 0.0 110.776 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 53.64 41.13 32.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.612 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.571 ' C ' ' H ' ' A' ' 188' ' ' ARG . 14.2 p -64.54 -89.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.762 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.7 mt 67.07 -36.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.725 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.571 ' H ' ' C ' ' A' ' 186' ' ' SER . 61.9 ttt85 52.35 82.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.361 . . . . 0.0 111.954 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.668 ' NE ' ' HG ' ' A' ' 147' ' ' SER . 78.0 mtp85 -109.51 -2.15 17.82 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 33.5 m -135.96 161.49 37.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.375 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -130.93 150.58 19.4 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.929 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.4 pp -168.2 136.72 2.32 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.661 0.743 . . . . 0.0 112.618 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -169.41 -140.54 2.99 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.49 164.31 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.483 0.658 . . . . 0.0 111.763 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.7 tt -129.84 138.09 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.549 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.455 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . -152.74 164.23 38.17 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.477 ' O ' ' CD2' ' A' ' 134' ' ' TYR . . . 155.47 170.6 21.14 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.062 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 59.8 t -131.29 138.41 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 117.274 0.537 . . . . 0.0 111.804 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 131' ' ' PHE . . . -105.46 134.02 11.87 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -131.29 105.82 7.89 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.79 153.27 33.01 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -175.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 66.6 mt -113.18 -10.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 123.298 1.523 . . . . 0.0 107.888 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.699 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.5 m -166.75 103.5 0.65 Allowed Pre-proline 0 C--N 1.3 -1.562 1 N-CA-C 99.445 -4.28 . . . . 0.0 99.445 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.466 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -11.56 -42.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 123.557 2.838 . . . . 0.0 115.63 -172.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 203' ' ' THR . 13.6 pttm -77.87 -34.72 51.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 203' ' ' THR . 50.5 tp -83.93 105.76 15.07 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.2 m -128.61 131.28 48.12 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 10.0 mp -96.8 141.57 29.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -134.67 144.77 48.0 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.012 0.911 . . . . 0.0 113.335 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -101.86 113.08 25.95 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -152.58 157.56 27.35 Favored Glycine 0 N--CA 1.462 0.387 0 C-N-CA 118.556 -1.783 . . . . 0.0 113.895 -176.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -169.31 163.91 10.79 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.645 ' N ' ' NE ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -124.48 154.15 40.96 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.932 0.396 . . . . 0.0 110.129 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -142.78 133.51 25.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.94 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -74.59 144.91 43.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.174 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -93.22 107.48 19.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.158 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -151.63 -18.1 0.19 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.178 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 219' ' ' ARG . . . 84.01 16.17 68.09 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 221' ' ' GLU . 25.8 ptt180 11.84 -110.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.5 mp 62.55 -65.91 0.09 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.46 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 219' ' ' ARG . 44.3 tt0 -46.68 -38.84 10.41 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.581 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 222' ' ' ASN . 10.1 p30 -91.16 111.05 22.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.915 0.388 . . . . 0.0 110.858 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.4 p -85.75 169.43 13.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.856 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 57.74 -164.48 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.877 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 225' ' ' PHE . 72.1 t80 55.49 28.66 12.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.17 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.463 ' O ' ' ND1' ' A' ' 228' ' ' HIS . 69.0 mttm -76.49 -15.87 59.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.975 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 29.7 m -64.36 129.13 38.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.557 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 226' ' ' LYS . 81.0 m80 -113.8 130.45 56.46 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.198 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 230' ' ' ALA . 81.2 tt0 -67.55 -39.63 84.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.564 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 229' ' ' GLU . . . 62.17 152.81 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 26.9 p -155.24 162.53 40.88 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.164 -1.014 . . . . 0.0 112.326 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 71.1 mt -81.51 148.03 29.39 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.04 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -143.75 137.92 7.77 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.6 145.39 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 117.393 0.597 . . . . 0.0 110.621 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -124.55 142.77 51.09 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.328 0.585 . . . . 0.0 111.063 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -110.34 106.07 15.31 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.431 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.545 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 2.4 tmt_? -114.06 96.13 5.65 Favored 'General case' 0 C--O 1.255 1.37 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 237' ' ' ARG . 72.3 m-85 . . . . . 0 N--CA 1.472 0.661 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.447 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 t 53.96 93.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.658 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -143.17 154.93 44.39 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 110.988 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -71.41 149.31 46.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.276 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.71 111.68 0.51 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.892 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.463 ' C ' ' NH2' ' A' ' 237' ' ' ARG . . . 43.24 -115.49 1.08 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-O 121.101 0.278 . . . . 0.0 112.586 178.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.688 ' N ' ' NH2' ' A' ' 237' ' ' ARG . 84.9 mtm180 -60.46 159.14 10.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.043 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.92 -62.4 0.6 Allowed Glycine 0 CA--C 1.535 1.293 0 CA-C-O 119.699 -0.501 . . . . 0.0 112.118 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.461 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 58.6 Cg_endo -90.74 143.41 3.48 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.896 2.397 . . . . 0.0 113.477 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.728 ' HH ' HE22 ' A' ' 126' ' ' GLN . 1.7 m-85 -159.63 146.59 16.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.21 0.528 . . . . 0.0 112.221 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.3 t -141.19 137.06 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.946 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -135.31 149.49 49.78 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.52 152.17 32.6 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.837 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -107.0 155.43 19.81 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.626 0.25 . . . . 0.0 111.003 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 232' ' ' LEU . 0.2 OUTLIER -139.29 128.93 24.55 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 17' ' ' TYR . . . -96.02 76.18 3.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.728 0.299 . . . . 0.0 111.415 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 16' ' ' ALA . 76.3 t80 56.28 155.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.135 0.493 . . . . 0.0 111.405 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 49.63 -148.23 0.29 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.071 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 20' ' ' GLU . 82.6 t80 -153.69 107.38 2.99 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.527 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 19' ' ' TYR . 46.4 tp10 48.64 104.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.707 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -73.06 125.23 27.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.796 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.4 mt -67.27 -43.92 87.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.143 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.3 p -130.57 165.79 22.01 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.884 0.373 . . . . 0.0 110.903 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -70.52 129.48 39.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.674 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -80.14 160.08 25.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.397 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 52.88 73.39 0.95 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.3 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.09 -35.94 83.39 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.967 2.445 . . . . 0.0 112.274 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -121.99 79.11 41.91 Favored Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.937 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.48 9.86 3.94 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.75 2.3 . . . . 0.0 111.726 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.2 m 58.69 84.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.419 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -172.86 77.24 0.42 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.473 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.34 145.75 97.99 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.652 2.235 . . . . 0.0 111.703 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -134.07 80.11 1.85 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.23 -41.3 99.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.24 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 m120 55.54 68.05 0.92 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.955 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -62.35 -43.41 98.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.39 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 38' ' ' SER . 96.7 mt -92.22 -86.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.469 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 37' ' ' ILE . 6.5 p 46.62 104.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.21 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 63.4 p -130.37 155.14 46.87 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.425 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.31 129.2 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.462 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.1 t -63.22 -44.4 95.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.805 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -102.61 132.52 48.65 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.822 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -112.32 10.16 19.94 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.49 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -74.87 145.26 42.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.76 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -71.46 142.17 50.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.378 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -154.39 24.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.671 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -91.9 121.28 42.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.994 0.426 . . . . 0.0 110.114 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.4 ttp-105 -170.77 -45.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.013 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 t -79.8 125.14 29.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.307 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -65.63 -41.93 92.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.699 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.523 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 37.1 t -135.27 154.16 51.65 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.841 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.496 ' C ' ' CG ' ' A' ' 53' ' ' HIS . 34.8 m -83.61 -0.29 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.182 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER 64.12 173.98 0.07 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.057 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.66 160.85 3.5 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 122.791 2.327 . . . . 0.0 112.365 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.6 mtm-85 -72.62 156.67 38.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.248 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.76 134.14 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.842 0.353 . . . . 0.0 111.034 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -133.37 143.39 48.91 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.514 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.71 160.33 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.052 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.56 177.04 40.33 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.415 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -121.13 155.65 34.03 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 47.4 t0 -137.72 124.08 20.65 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -177.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 63' ' ' GLY . 16.5 m-85 -116.67 104.83 11.77 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -24.85 97.2 0.01 OUTLIER Glycine 0 CA--C 1.533 1.203 0 CA-C-N 117.718 0.235 . . . . 0.0 113.097 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.18 -13.74 7.93 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 66' ' ' ARG . 15.6 t90 -165.88 136.56 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.012 0.406 . . . . 0.0 110.823 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.608 ' NH2' ' CZ ' ' A' ' 10' ' ' TYR . 14.8 ptp180 -148.17 148.44 30.55 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.843 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.6 pt -108.93 147.71 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.779 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.0 141.35 36.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 110.857 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.88 129.13 25.55 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.498 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 24.8 p30 -106.2 143.76 33.87 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.476 0.655 . . . . 0.0 111.906 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.09 146.2 50.02 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.992 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.83 -108.61 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.074 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -138.6 143.02 39.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.712 0.292 . . . . 0.0 110.258 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -73.85 -66.58 0.69 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 56.62 82.96 0.1 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.953 0.406 . . . . 0.0 109.938 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -125.68 146.62 49.66 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.89 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.498 ' CG ' ' O ' ' A' ' 77' ' ' TRP . 26.2 t90 -163.63 14.83 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.807 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -63.33 -41.65 98.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.011 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 39.66 -118.57 0.28 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.964 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.69 38.1 29.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.888 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -59.26 -83.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.178 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 82' ' ' TYR . 71.2 t80 -100.53 3.83 43.1 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.961 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 84' ' ' VAL . 38.8 t -62.0 -41.63 98.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.801 0.334 . . . . 0.0 110.444 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 83' ' ' SER . 86.8 t 56.28 159.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.584 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.409 ' N ' ' CG1' ' A' ' 84' ' ' VAL . 59.4 t30 -86.38 109.34 18.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.624 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.8 pt -74.53 -20.11 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.779 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -79.17 6.17 10.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.158 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.489 ' N ' ' OD1' ' A' ' 88' ' ' ASN . 10.2 p-10 -44.71 -68.52 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.46 ' H ' ' CG ' ' A' ' 88' ' ' ASN . 22.9 t 38.33 81.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.934 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 89' ' ' VAL . 84.6 mtt85 55.27 111.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.97 0.414 . . . . 0.0 110.399 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 91' ' ' ILE . 22.0 mm -78.01 130.81 35.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.664 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -91.95 141.78 28.26 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.105 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -160.74 125.97 3.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.507 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.44 ' O ' ' O ' ' A' ' 95' ' ' ASN . 8.0 pt-20 -175.21 101.19 0.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.051 0.453 . . . . 0.0 111.15 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 94' ' ' GLU . 99.6 m-20 41.92 -167.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.067 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.21 -81.82 1.29 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.0 mm -66.14 -26.37 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.342 . . . . 0.0 110.568 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 45.76 36.18 2.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.49 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 100' ' ' ASP . 21.7 mt 48.1 -121.65 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.979 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 99' ' ' ILE . 45.5 t0 52.86 168.47 0.01 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.951 0.405 . . . . 0.0 110.981 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -72.87 133.96 44.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.381 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -67.82 135.5 52.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.084 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.43 -36.4 8.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.21 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -72.89 -163.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.48 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 107' ' ' GLU . 54.7 t-20 59.46 42.65 17.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -65.95 3.69 0.78 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.431 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 105' ' ' ASN . 80.0 mm-40 57.13 -92.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.954 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 110' ' ' THR . 18.4 t-20 -90.77 100.23 13.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.876 0.37 . . . . 0.0 110.789 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.65 -34.51 89.15 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 111' ' ' PHE . 69.0 p -75.3 168.9 19.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.805 0.336 . . . . 0.0 110.681 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.455 ' O ' ' O ' ' A' ' 110' ' ' THR . 83.8 m-85 43.12 -171.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.888 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -97.72 -6.12 33.62 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.401 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 62.61 -151.06 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.385 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 t -90.13 87.8 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.322 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.0 p -174.53 78.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.693 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -153.82 137.27 15.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.959 0.409 . . . . 0.0 111.104 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.1 mt -125.09 126.06 44.74 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.878 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 70' ' ' ASP . . . -133.01 115.45 1.57 Allowed Glycine 0 N--CA 1.469 0.847 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 119' ' ' LEU . 1.7 pt? -141.11 153.62 45.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.327 0.563 . . . . 0.0 111.498 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.3 m -146.42 153.58 40.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.065 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.43 125.03 46.66 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 97.3 mt -123.6 152.32 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -111.25 131.94 54.74 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.158 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 15.6 p-10 -132.9 125.25 29.48 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 123.801 0.688 . . . . 0.0 110.813 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.476 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 81.2 m-85 -115.69 80.63 1.47 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.728 HE22 ' HH ' ' A' ' 10' ' ' TYR . 24.5 pt20 -105.07 7.32 33.87 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 110.003 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.437 HD11 HG21 ' A' ' 127' ' ' ILE . 0.3 OUTLIER -67.84 -28.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -62.08 -49.97 73.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.4 t0 179.16 -102.75 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.287 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -117.77 0.9 12.09 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 10.8 m-85 -113.25 111.28 21.78 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.476 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -133.31 142.7 45.24 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 117.93 0.332 . . . . 0.0 111.066 178.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -91.28 120.13 0.62 Allowed 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 122.36 2.04 . . . . 0.0 109.281 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.594 ' CE1' ' OD2' ' A' ' 209' ' ' ASP . 40.1 p90 -92.02 128.26 37.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.528 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 47.8 mm -134.78 131.99 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.777 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.76 174.84 38.31 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.611 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.37 131.06 55.38 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.95 125.42 50.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.186 0.517 . . . . 0.0 111.089 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.98 139.18 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.122 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.01 137.39 52.16 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.526 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -135.94 137.76 41.66 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.203 0.525 . . . . 0.0 111.19 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 144' ' ' VAL . . . -123.59 143.38 14.96 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -66.03 67.06 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.383 0.592 . . . . 0.0 110.783 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 142' ' ' GLY . 72.3 t -135.53 135.26 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.562 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 40.33 79.15 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.022 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -90.13 -6.99 54.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.433 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 87.6 p -71.34 150.37 45.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.009 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 40.5 pt -126.46 -13.86 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.497 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.33 143.51 48.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.971 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.1 m -84.49 61.2 6.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.377 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.5 m -61.95 -47.56 84.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.597 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -173.44 -2.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.722 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -68.71 -12.45 61.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.504 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 63.3 p -80.45 163.73 23.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.851 0.358 . . . . 0.0 110.576 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 92.3 mt 42.52 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.448 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.03 140.05 32.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.947 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.1 m -121.72 131.27 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.917 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 73.3 p -131.34 153.31 49.74 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.786 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.3 t -147.38 151.52 36.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.39 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.58 118.31 65.32 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.809 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.7 133.84 39.52 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 120.948 1.099 . . . . 0.0 111.599 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 26.3 m -98.15 155.0 17.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.902 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 56.52 43.13 26.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.217 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.407 ' N ' ' CD ' ' A' ' 165' ' ' PRO . . . -170.66 54.61 0.22 Allowed Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.209 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 164' ' ' ALA . 73.3 Cg_endo -72.63 145.21 41.28 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.634 2.223 . . . . 0.0 111.636 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.8 p30 -155.64 -1.82 0.14 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.781 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -82.14 -3.69 90.48 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 61.27 -168.65 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.739 0.304 . . . . 0.0 110.404 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.5 m -77.14 138.56 20.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.587 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.5 t -142.98 159.24 42.62 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.509 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.0 t -72.29 143.72 48.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.985 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -130.03 158.3 39.98 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.584 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 64.8 t30 61.65 24.11 14.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.722 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 20.2 m -64.56 -45.57 86.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.532 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.95 152.31 48.27 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.666 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.64 -156.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.426 2.084 . . . . 0.0 111.475 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.0 -41.1 95.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.704 0.288 . . . . 0.0 110.721 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 10.8 t -96.96 138.3 34.71 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.769 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.466 ' N ' ' CD ' ' A' ' 179' ' ' GLN . 1.5 pm0 -130.82 153.5 49.01 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -90.61 -168.89 2.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.065 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -78.27 -2.91 40.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.916 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.9 t80 70.04 -56.47 0.58 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.664 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -73.9 128.17 34.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.709 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 68.5 m -146.11 149.03 33.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.537 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.33 34.21 22.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.631 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 48.4 t -160.68 92.68 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.804 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 189' ' ' ARG . 96.3 mt -135.24 -82.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.064 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 57.9 ttm-85 64.05 -19.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.584 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.584 ' H ' ' C ' ' A' ' 187' ' ' ILE . 10.3 mpt_? -54.46 -92.81 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.0 t -135.8 118.6 22.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -146.92 159.32 27.98 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.329 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 192' ' ' LEU . 0.4 OUTLIER -117.46 146.89 43.19 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.641 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -168.19 -177.57 39.45 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.716 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.62 156.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.606 0.717 . . . . 0.0 111.636 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.2 tt -127.06 135.55 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.041 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.3 161.01 37.64 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . 157.81 -167.06 34.14 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.51 162.32 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 122.73 -0.277 . . . . 0.0 110.978 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.12 165.04 34.64 Favored Glycine 0 CA--C 1.545 1.916 0 C-N-CA 119.842 -1.17 . . . . 0.0 114.616 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -130.82 128.71 41.22 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.683 1.193 . . . . 0.0 109.004 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 4.6 p30 -89.88 151.18 21.87 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.98 -37.93 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 103.005 -2.961 . . . . 0.0 103.005 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.675 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.0 OUTLIER -176.31 148.97 0.91 Allowed Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 100.612 -3.847 . . . . 0.0 100.612 176.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.445 ' C ' ' O ' ' A' ' 237' ' ' ARG . 32.0 Cg_exo -35.86 -17.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.295 -2.25 0 C-N-CA 121.313 1.342 . . . . 0.0 113.419 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.675 ' N ' ' O ' ' A' ' 203' ' ' THR . 87.1 tttt -68.87 -44.52 73.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 119.309 -0.377 . . . . 0.0 111.868 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.98 114.65 14.86 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.941 0.401 . . . . 0.0 111.056 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.8 t -127.87 133.79 49.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.818 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.0 123.03 32.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.594 ' OD2' ' CE1' ' A' ' 134' ' ' TYR . 13.4 t70 -109.52 110.94 22.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.878 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -102.75 134.72 45.67 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.14 36.98 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 119.97 -1.109 . . . . 0.0 112.199 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -133.61 134.39 43.18 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -89.45 108.56 19.71 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.998 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -102.65 127.87 49.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -125.25 161.54 26.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.024 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.5 m120 57.22 88.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.223 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -38.27 -75.41 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.933 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -98.81 146.6 18.2 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.545 ' C ' ' H ' ' A' ' 221' ' ' GLU . 35.0 ptt180 -140.67 -39.09 0.43 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.666 0.27 . . . . 0.0 110.581 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 8.0 mp 45.77 12.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 219' ' ' ARG . 83.7 tt0 -68.38 -34.7 76.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.404 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 65.6 t30 60.02 39.07 20.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.809 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 5.7 m -164.32 53.74 0.14 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.434 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -143.83 -19.23 0.59 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.685 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 43.98 -159.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.523 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.85 150.7 40.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.783 0.325 . . . . 0.0 110.704 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 85.5 m -119.47 129.06 54.55 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.197 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.447 ' CG ' ' N ' ' A' ' 229' ' ' GLU . 23.7 t-160 -61.92 -105.39 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.1 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.447 ' N ' ' CG ' ' A' ' 228' ' ' HIS . 80.1 mm-40 55.81 168.85 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.882 0.372 . . . . 0.0 110.892 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.491 ' O ' ' CB ' ' A' ' 231' ' ' SER . . . 47.49 -111.51 0.39 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.19 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 232' ' ' LEU . 4.1 p 84.86 -65.16 0.06 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.781 -0.19 . . . . 0.0 110.973 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.521 ' N ' ' OG ' ' A' ' 231' ' ' SER . 6.8 tt -130.48 119.17 22.22 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -115.06 172.51 14.24 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 62.1 t -139.68 131.56 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.588 0.233 . . . . 0.0 110.918 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.442 HH11 ' NH1' ' A' ' 66' ' ' ARG . 36.6 ttm180 -132.7 142.07 48.88 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 236' ' ' TYR . 1.1 t80 -118.72 137.68 53.17 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.688 ' NH2' ' N ' ' A' ' 7' ' ' ARG . 14.3 ttt-85 -150.38 112.5 4.6 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.626 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.398 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.401 ' H2 ' ' H ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.401 ' H ' ' H2 ' ' A' ' 1' ' ' ALA . 12.3 p -76.92 162.6 27.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.659 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.569 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.1 pm0 -66.48 -40.36 89.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.225 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -71.71 140.66 49.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.356 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.63 -178.76 26.93 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.1 -127.82 21.3 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -86.25 127.55 34.77 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.08 -175.24 13.69 Favored Glycine 0 N--CA 1.47 0.957 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.166 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.405 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 48.9 Cg_endo -92.74 165.08 2.73 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.558 2.838 . . . . 0.0 114.951 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.414 ' CE2' ' NH2' ' A' ' 235' ' ' ARG . 22.5 p90 -163.85 164.39 23.5 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.575 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 p -135.39 155.22 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-O 120.524 0.202 . . . . 0.0 111.088 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -134.81 147.76 50.02 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.2 152.6 34.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.742 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 31.7 p-10 -153.24 159.06 42.53 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -133.3 152.39 51.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.042 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.35 175.75 6.73 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.68 0.276 . . . . 0.0 110.73 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -70.21 139.84 52.35 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.955 0.407 . . . . 0.0 110.952 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 47.92 -168.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.281 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 20' ' ' GLU . 66.9 t80 -83.08 123.63 29.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.808 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 19' ' ' TYR . 82.0 tt0 55.35 154.37 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.067 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -66.69 -39.8 88.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.292 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.4 pt -99.04 159.12 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.178 0.514 . . . . 0.0 111.311 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.0 p -65.51 -32.54 74.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.835 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' A' ' 24' ' ' HIS . 25.3 t-80 50.61 41.02 25.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 27.7 t70 -92.19 9.22 34.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.945 0.402 . . . . 0.0 110.184 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 25' ' ' ASP . 2.0 m-85 -149.06 55.5 2.03 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.037 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -33.69 -49.85 0.51 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.848 2.365 . . . . 0.0 112.755 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.418 ' OE1' ' ND2' ' A' ' 105' ' ' ASN . 4.0 pt-20 -179.74 150.44 0.56 Allowed Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.729 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -72.38 -53.06 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.323 2.016 . . . . 0.0 111.718 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 t -149.75 149.96 31.34 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.58 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 171.23 74.06 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.317 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.9 144.45 99.57 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.674 2.25 . . . . 0.0 111.729 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 33' ' ' ASN . 44.5 p-10 -100.75 107.07 18.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.957 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -82.11 148.24 28.64 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -68.18 121.09 15.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.89 0.376 . . . . 0.0 110.588 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -114.47 131.07 56.74 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.438 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' A' ' 38' ' ' SER . 10.4 tp -86.42 -39.82 13.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.795 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.4 ' N ' ' CG2' ' A' ' 37' ' ' ILE . 32.2 p -155.55 163.94 39.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.646 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.7 p -71.36 124.23 24.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.0 p -90.27 -40.05 12.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.302 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.9 p -161.49 86.35 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.513 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.501 ' OD1' ' NZ ' ' A' ' 102' ' ' LYS . 99.5 m-20 -71.17 142.53 50.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.717 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -85.55 165.56 16.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.19 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -56.37 -19.13 13.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.699 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 63.6 ttm-85 -59.72 -42.22 92.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.485 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -45.49 147.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.081 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.8 mt 61.39 69.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.824 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -147.22 -43.58 0.17 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.919 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 t -147.31 159.0 44.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.417 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -141.31 160.58 39.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.312 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' VAL . 45.7 t -67.81 139.8 56.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.528 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 51' ' ' SER . 46.6 t 56.42 157.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.548 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.598 ' CD2' ' HE ' ' A' ' 73' ' ' ARG . 80.8 t60 56.67 83.44 0.22 Allowed Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.686 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -86.18 -100.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.844 2.363 . . . . 0.0 112.71 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -125.66 157.76 36.46 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.6 155.28 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.574 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -135.45 128.7 31.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.288 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 m -140.91 165.34 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.19 -152.25 12.58 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.552 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -113.98 139.12 49.5 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-O 120.762 0.315 . . . . 0.0 111.543 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.1 p30 -103.26 101.01 10.93 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 124.835 1.335 . . . . 0.0 112.874 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.545 ' CZ ' ' O ' ' A' ' 65' ' ' TRP . 23.9 p90 -125.37 125.26 43.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -39.51 131.61 2.22 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.98 -84.59 0.37 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.545 ' O ' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -117.32 153.73 32.47 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.361 0.6 . . . . 0.0 110.33 179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.622 ' NH1' ' NH2' ' A' ' 235' ' ' ARG . 0.6 OUTLIER -129.82 130.94 45.94 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.403 HG21 HD12 ' A' ' 67' ' ' ILE . 38.8 mm -102.77 128.57 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.0 124.66 19.56 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 120.922 0.391 . . . . 0.0 110.571 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.31 138.59 39.87 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.02 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -100.56 128.72 46.53 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.302 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -129.13 156.94 43.1 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.757 0.789 . . . . 0.0 111.95 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.25 151.0 44.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 113.617 -1.628 . . . . 0.0 108.462 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.598 ' HE ' ' CD2' ' A' ' 53' ' ' HIS . 95.6 mtt-85 -62.96 -66.13 0.59 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.588 -0.445 . . . . 0.0 112.177 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.3 t80 69.64 -24.39 0.15 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.557 0.218 . . . . 0.0 111.026 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.573 ' H ' ' C ' ' A' ' 73' ' ' ARG . 85.8 mtm-85 59.53 60.97 2.11 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.859 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -94.79 -13.06 25.97 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.659 0.266 . . . . 0.0 111.017 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -61.71 -41.0 97.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 0.0 110.644 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.633 ' N ' HD21 ' A' ' 78' ' ' ASN . 0.1 OUTLIER -54.1 129.74 35.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.423 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 78' ' ' ASN . 96.5 m-20 -145.65 -35.21 0.3 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.078 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.3 m120 57.09 39.56 29.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.909 0.385 . . . . 0.0 110.567 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.97 -38.09 87.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.959 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -59.46 -47.49 85.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.13 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.1 p -68.45 144.46 54.66 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.638 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.3 t -126.67 130.49 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.228 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.428 ' O ' ' OD1' ' A' ' 85' ' ' ASN . 10.2 p30 -153.97 94.31 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.399 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.8 mt -113.8 127.08 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.102 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 46.78 73.3 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.357 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -78.21 93.39 4.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.038 0.447 . . . . 0.0 110.693 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.52 ' C ' ' H ' ' A' ' 91' ' ' ILE . 14.6 p -65.69 -22.88 31.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.59 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -53.67 -7.53 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.191 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.52 ' H ' ' C ' ' A' ' 89' ' ' VAL . 10.3 tp -62.11 134.55 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.531 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -130.83 153.25 49.29 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.63 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -67.42 134.91 52.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.089 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -163.26 131.83 3.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.651 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 39.09 -105.48 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.028 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.63 86.47 0.12 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.6 tt -132.55 134.94 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 110.131 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' NH1' ' OD1' ' A' ' 100' ' ' ASP . 9.2 ptm180 -69.78 134.81 48.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.094 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.6 pt -104.25 27.67 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.982 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.413 ' OD1' ' NH1' ' A' ' 98' ' ' ARG . 90.8 m-20 58.2 -91.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.922 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -134.24 132.9 40.23 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.913 0.387 . . . . 0.0 110.743 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.501 ' NZ ' ' OD1' ' A' ' 42' ' ' ASP . 38.3 ttmt -79.01 141.88 37.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.188 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.1 t -136.85 143.96 43.35 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.232 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -110.25 37.77 2.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.394 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.418 ' ND2' ' OE1' ' A' ' 28' ' ' GLU . 94.0 m-20 -62.48 -39.54 93.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.897 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -40.65 -66.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.796 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -69.53 -20.94 63.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.492 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.6 t30 60.23 50.55 6.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -48.66 175.24 0.03 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.4 m -69.1 119.67 13.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 0.0 110.66 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.21 -43.6 97.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.409 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -57.11 -39.09 74.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.115 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 73.88 101.11 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.662 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.5 t -125.88 133.08 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.964 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.6 t -154.3 -151.81 0.38 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.891 0.377 . . . . 0.0 110.549 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.2 m 61.74 139.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.647 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.76 163.27 13.25 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.7 -157.96 20.94 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.233 -1.461 . . . . 0.0 112.373 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.1 mt -127.42 144.69 51.02 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.269 0.557 . . . . 0.0 110.571 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 84.0 p -147.47 140.44 25.02 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.63 127.75 53.6 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 87.9 mt -101.51 135.09 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.537 ' O ' ' CG ' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -128.77 102.88 6.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.255 0.934 . . . . 0.0 112.127 -176.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.532 ' CG ' HH21 ' A' ' 66' ' ' ARG . 3.4 m-20 -89.94 135.74 33.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.841 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -113.22 81.36 1.49 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -70.32 85.8 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.038 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.5 tt -70.21 -41.29 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.129 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.3 t30 177.67 -47.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.384 0.428 . . . . 0.0 110.199 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -59.91 -169.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.088 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -100.48 -1.72 35.03 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.495 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 7.1 p90 -138.34 128.97 26.46 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.41 156.8 79.36 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 121.021 0.439 . . . . 0.0 111.059 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.7 146.3 21.05 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.922 1.748 . . . . 0.0 109.675 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 134' ' ' TYR . 6.8 p90 -138.25 138.13 38.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.207 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 136' ' ' GLY . 32.2 mt -136.56 164.43 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.86 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.488 ' N ' ' CG2' ' A' ' 135' ' ' ILE . . . -164.93 -176.67 36.83 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.669 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -133.2 155.46 49.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.24 -0.98 . . . . 0.0 108.753 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -135.56 128.1 30.65 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.33 121.75 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -124.75 124.3 41.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 110.506 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -136.44 165.5 25.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.564 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.81 91.57 2.23 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -149.65 -97.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.76 -0.259 . . . . 0.0 111.002 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.9 t -64.51 -45.68 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -82.27 153.3 25.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.938 0.399 . . . . 0.0 111.345 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.488 ' O ' ' ND1' ' A' ' 146' ' ' HIS . 11.0 p80 -147.12 144.41 29.0 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.34 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.55 ' HG ' ' H ' ' A' ' 148' ' ' ILE . 91.0 p 44.18 -122.32 0.84 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.737 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.55 ' H ' ' HG ' ' A' ' 147' ' ' SER . 89.3 mt -99.98 128.56 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.343 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 151' ' ' THR . 92.2 m-20 -61.65 -42.73 99.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.13 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.9 p 43.74 17.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.881 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 149' ' ' ASP . 63.4 m -114.48 116.28 28.6 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.257 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -65.55 -45.75 82.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.724 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -178.24 26.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.053 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 156' ' ' GLU . 1.8 m -76.95 157.1 31.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.092 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 155' ' ' ILE . 96.2 mt 57.75 -78.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.35 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 154' ' ' THR . 76.1 mt-10 -43.96 157.77 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.8 0.333 . . . . 0.0 111.026 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.9 t 65.68 61.06 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.671 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 90.7 m -125.26 128.39 48.2 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.991 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 54.4 p -73.86 134.61 43.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.681 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.7 m -109.8 158.46 34.8 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 162' ' ' SER . 31.8 Cg_exo -55.28 143.32 76.37 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.219 1.279 . . . . 0.0 111.852 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 161' ' ' PRO . 42.1 m 53.47 112.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.969 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.56 ' N ' HD21 ' A' ' 163' ' ' ASN . 0.1 OUTLIER -80.38 20.33 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.723 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 162' ' ' SER . . . 69.41 59.86 0.58 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.04 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -71.1 150.85 60.73 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.564 2.176 . . . . 0.0 111.664 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 166' ' ' ASN . 19.7 t-20 56.92 36.45 27.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.081 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 55.43 -129.35 46.27 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.63 151.04 48.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.743 0.306 . . . . 0.0 110.349 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 73.1 t -60.89 -46.17 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.496 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 76.2 p -112.52 115.43 28.64 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.37 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 173' ' ' ASN . 10.6 p -111.97 -49.84 2.95 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.694 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 84.5 t80 44.37 -88.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.441 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.553 ' N ' ' O ' ' A' ' 171' ' ' THR . 52.2 p30 -97.32 149.3 22.24 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 99.3 m -65.44 -27.56 68.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.728 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -113.39 91.86 21.23 Favored Pre-proline 0 N--CA 1.469 0.498 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -88.57 166.12 6.31 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.868 2.378 . . . . 0.0 111.915 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.441 ' O ' ' OG1' ' A' ' 178' ' ' THR . 88.8 tttt -66.93 133.31 49.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.48 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 177' ' ' LYS . 15.9 p 50.93 172.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.975 0.417 . . . . 0.0 111.017 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -156.68 96.75 1.66 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.337 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -156.7 -34.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.6 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.528 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 96.6 m-20 42.72 -122.38 0.66 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.641 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 181' ' ' ASP . 96.5 m-85 -159.07 -113.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.803 0.335 . . . . 0.0 110.538 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -66.49 -25.69 66.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.209 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.463 ' HG ' ' N ' ' A' ' 185' ' ' ASN . 77.9 p -58.81 -38.6 78.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.641 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.463 ' N ' ' HG ' ' A' ' 184' ' ' SER . 71.2 m-80 -132.41 113.29 12.98 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.447 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.8 t -169.43 73.53 0.08 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.621 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.3 pp -95.42 -0.38 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.567 ' O ' ' N ' ' A' ' 190' ' ' VAL . 59.2 ttp180 -70.5 -82.13 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.823 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 50.9 -87.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 188' ' ' ARG . 73.7 t -76.6 163.74 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 175.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -141.16 140.43 10.34 Favored Glycine 0 N--CA 1.476 1.305 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.698 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 216' ' ' ASN . 47.1 tp -133.61 125.1 28.04 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -156.12 -169.78 20.68 Favored Glycine 0 C--N 1.32 -0.345 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.8 158.98 42.71 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 CA-C-O 122.306 1.051 . . . . 0.0 112.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.8 mm -109.57 130.48 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 112.639 -2.073 . . . . 0.0 107.312 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.3 156.86 42.32 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.514 -0.741 . . . . 0.0 111.834 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.408 ' C ' ' CE2' ' A' ' 134' ' ' TYR . . . 150.05 -176.98 28.46 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.42 159.68 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -136.84 140.74 11.7 Favored Glycine 0 N--CA 1.47 0.93 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.781 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -122.04 105.44 10.29 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -96.0 137.16 35.46 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 202' ' ' ILE . 1.2 mp -69.54 -39.16 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 173.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -155.25 156.08 30.66 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 101.284 -3.598 . . . . 0.0 101.284 175.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.509 ' C ' ' O ' ' A' ' 237' ' ' ARG . 32.3 Cg_exo -48.78 -17.51 1.17 Allowed 'Trans proline' 0 C--N 1.288 -2.622 0 CA-C-N 121.706 1.645 . . . . 0.0 111.267 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 203' ' ' THR . 60.4 tttp -67.82 -39.77 83.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.286 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 9.0 mt -124.05 107.79 11.67 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.123 0.874 . . . . 0.0 111.925 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.81 141.03 42.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.63 0.728 . . . . 0.0 112.948 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.44 ' O ' ' OD1' ' A' ' 209' ' ' ASP . 84.0 mt -99.1 148.3 24.19 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 208' ' ' LEU . 28.3 m-20 -139.3 137.0 35.46 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -83.65 133.43 34.82 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.86 151.62 19.66 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 120.236 -0.983 . . . . 0.0 114.59 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -135.22 142.18 45.96 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.195 -1.002 . . . . 0.0 109.03 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 86.0 mmt-85 -110.75 125.04 53.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -127.83 161.39 29.14 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.604 0.716 . . . . 0.0 112.862 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.698 ' CG ' ' H ' ' A' ' 216' ' ' ASN . 69.1 t60 -126.97 -175.46 3.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.486 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.698 ' H ' ' CG ' ' A' ' 215' ' ' HIS . 45.4 t-20 -63.17 111.6 2.29 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.554 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -102.85 91.51 4.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.939 0.399 . . . . 0.0 110.328 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -88.43 -166.6 42.46 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -87.18 1.86 51.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.051 0.453 . . . . 0.0 110.177 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.78 -41.41 99.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.317 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 57.26 71.92 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.073 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -87.86 115.91 25.65 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -70.81 130.61 42.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.032 0.444 . . . . 0.0 111.127 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -146.47 168.51 21.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.087 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -61.68 135.68 57.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 0.0 110.701 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.42 ' C ' ' HG1' ' A' ' 227' ' ' THR . 99.1 mttt 35.21 -121.25 0.12 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.428 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.42 ' HG1' ' C ' ' A' ' 226' ' ' LYS . 12.3 m -165.69 7.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.901 0.381 . . . . 0.0 110.296 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 70.4 m80 52.88 78.38 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.032 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -127.49 -175.03 3.33 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.78 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 76.5 84.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.826 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 57.7 m -131.75 152.61 50.81 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.314 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 25.4 mt -128.6 131.94 48.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.11 0.481 . . . . 0.0 111.12 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -131.77 148.2 18.94 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.306 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.6 p -131.39 137.83 54.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.622 ' NH2' ' NH1' ' A' ' 66' ' ' ARG . 10.8 ptm180 -136.55 146.74 46.51 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -101.99 113.07 25.99 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 113.254 -1.793 . . . . 0.0 108.967 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.606 HH11 ' NH2' ' A' ' 66' ' ' ARG . 75.0 ttt180 -139.23 115.55 10.46 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 122.354 1.073 . . . . 0.0 112.113 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.522 ' OXT' ' CD1' ' A' ' 238' ' ' PHE . 1.2 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.21 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 4' ' ' ASP . 39.5 t -146.74 109.88 4.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.508 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -66.58 -35.01 79.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.937 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 2' ' ' SER . 53.9 p30 -144.33 174.35 10.98 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.016 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -44.43 -90.8 0.01 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.46 9.46 85.97 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -138.69 125.25 20.67 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 110.58 -0.155 . . . . 0.0 110.58 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.448 ' C ' ' CE2' ' A' ' 10' ' ' TYR . . . -179.69 151.55 10.16 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.139 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 77.5 Cg_endo -80.82 127.19 6.15 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.877 2.384 . . . . 0.0 111.695 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 52.4 m-85 -141.24 -178.23 5.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.888 -0.142 . . . . 0.0 111.287 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.62 162.6 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -130.51 131.62 45.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.972 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.88 140.14 22.23 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.967 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -161.05 168.83 23.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 230' ' ' ALA . 0.4 OUTLIER -172.12 179.88 2.52 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.499 179.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -131.68 158.08 42.05 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.172 0.511 . . . . 0.0 111.946 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -106.65 134.43 49.81 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.353 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -159.41 156.2 28.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.858 0.361 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -148.63 162.79 39.0 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.205 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -158.32 49.4 0.38 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.908 0.385 . . . . 0.0 110.694 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.407 ' O ' ' C ' ' A' ' 22' ' ' ILE . 3.7 m80 -68.19 -43.28 78.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.872 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 23' ' ' THR . 20.4 pt 32.29 -123.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.796 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 22' ' ' ILE . 9.6 p 52.13 113.76 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.089 0.471 . . . . 0.0 111.026 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.573 ' ND1' ' CD2' ' A' ' 26' ' ' TYR . 56.6 t-80 -65.36 -44.37 87.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.711 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.58 50.71 12.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.218 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.573 ' CD2' ' ND1' ' A' ' 24' ' ' HIS . 1.9 m-85 -35.49 99.41 0.17 Allowed Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.488 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.48 145.55 94.03 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.622 1.548 . . . . 0.0 111.688 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -146.46 69.92 12.67 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.932 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -83.02 85.29 1.6 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.788 2.325 . . . . 0.0 111.933 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.6 p -104.91 -3.61 23.17 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.618 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.39 152.7 81.5 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.321 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.83 159.58 52.14 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.424 2.083 . . . . 0.0 111.627 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -55.61 123.62 14.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.417 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' C ' ' H ' ' A' ' 36' ' ' LYS . 35.8 tttm -119.65 -143.22 0.35 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.02 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.9 t30 68.85 -38.53 0.39 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.519 ' H ' ' C ' ' A' ' 34' ' ' LYS . 68.6 mttm -64.0 -44.16 93.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.512 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -128.18 128.72 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.373 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 40' ' ' VAL . 58.5 p -149.63 -23.36 0.27 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.642 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 m 61.16 -71.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.39 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 38' ' ' SER . 88.1 t -96.61 128.74 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.239 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 42' ' ' ASP . 34.0 t -77.5 -89.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.398 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 41' ' ' SER . 99.1 m-20 56.56 127.89 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.178 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -146.74 160.43 42.25 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.436 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 51.0 p90 -92.13 131.4 37.41 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.979 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -94.72 134.38 37.37 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.424 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -119.92 127.14 52.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.624 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.522 ' N ' ' CD1' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -136.06 148.27 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.46 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -154.49 149.22 26.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.813 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.7 m -128.65 130.71 47.62 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.593 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -109.86 149.5 29.78 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.315 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.538 ' CB ' HH12 ' A' ' 75' ' ' ARG . 36.9 m -80.44 -93.21 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.515 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.469 ' O ' ' CG ' ' A' ' 53' ' ' HIS . 24.7 t 53.26 112.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.056 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.469 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 93.4 m-70 -156.22 77.83 4.33 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.943 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.11 149.33 90.86 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 123.059 2.506 . . . . 0.0 112.292 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.31 162.26 29.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.485 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.0 t -131.09 155.49 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.249 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.9 m -137.33 151.85 49.09 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.982 0.42 . . . . 0.0 111.622 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.02 145.68 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.336 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.72 -179.96 39.07 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 119.61 -1.281 . . . . 0.0 114.184 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -106.68 132.85 52.19 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -97.65 121.18 39.25 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -125.37 113.64 17.82 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.42 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -43.35 103.94 0.05 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 123' ' ' TYR . . . 136.88 -36.07 2.02 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.426 ' N ' ' CD1' ' A' ' 65' ' ' TRP . 0.3 OUTLIER -170.18 156.3 5.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.979 0.418 . . . . 0.0 110.879 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -134.55 135.38 42.26 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 67' ' ' ILE . 49.3 mm -99.98 127.92 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.38 130.93 14.86 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 119.454 -0.898 . . . . 0.0 112.169 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.49 144.2 26.84 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.989 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -104.28 128.01 52.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.129 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -134.35 162.02 33.37 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.012 0.435 . . . . 0.0 111.242 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.32 160.39 40.36 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.434 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -105.35 151.09 24.62 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.863 0.363 . . . . 0.0 111.092 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.497 ' O ' ' CD1' ' A' ' 77' ' ' TRP . 94.9 m-85 -102.01 101.41 11.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.235 0.54 . . . . 0.0 109.975 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.538 HH12 ' CB ' ' A' ' 51' ' ' SER . 84.5 mtp180 -55.9 -24.5 37.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.464 -178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 77' ' ' TRP . 52.7 mtpt -61.08 -44.89 96.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.536 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.497 ' CD1' ' O ' ' A' ' 74' ' ' TYR . 83.4 m95 37.94 -113.72 0.12 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.643 0.259 . . . . 0.0 110.889 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 m120 54.21 67.08 1.06 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.749 0.309 . . . . 0.0 110.587 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -61.47 -41.4 97.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.223 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -105.28 133.25 50.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.441 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -122.74 121.4 36.24 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.296 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -61.73 -46.67 88.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.2 m -138.66 150.34 46.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 110.821 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.413 ' O ' ' ND2' ' A' ' 85' ' ' ASN . 96.2 t -65.62 -68.7 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.415 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 84' ' ' VAL . 23.5 m120 -152.14 -73.3 0.15 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.501 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.61 128.24 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.555 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -171.71 -116.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.055 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 90' ' ' ARG . 23.2 t-20 -148.0 -110.79 0.08 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.685 0.279 . . . . 0.0 110.475 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.405 ' N ' ' CG ' ' A' ' 88' ' ' ASN . 60.5 t 57.45 -76.17 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 88' ' ' ASN . 89.1 mtm180 47.33 -173.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.757 0.313 . . . . 0.0 110.446 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 91' ' ' ILE . 8.0 pt -118.75 119.46 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.232 0.539 . . . . 0.0 110.594 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -68.96 -41.85 77.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.874 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 94' ' ' GLU . 64.7 mttp -70.22 140.84 52.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.777 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 93' ' ' LYS . 97.6 mt-10 45.6 95.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.627 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 95' ' ' ASN . 48.4 p-10 -85.8 137.61 32.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.498 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -79.55 130.88 10.16 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.41 ' O ' ' O ' ' A' ' 98' ' ' ARG . 7.4 tp -142.03 139.63 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.909 0.385 . . . . 0.0 110.642 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.41 ' O ' ' O ' ' A' ' 97' ' ' ILE . 77.2 ttt180 41.73 95.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.952 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.3 tp -131.24 130.83 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.257 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 101' ' ' ARG . 52.7 t0 -145.68 -22.62 0.47 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.521 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 100' ' ' ASP . 23.9 mmm180 53.08 109.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.623 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -37.34 85.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.429 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 96.6 m -123.25 127.18 48.23 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.229 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 104' ' ' GLU . 58.2 mp0 -110.69 116.93 32.17 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.246 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -63.17 -40.92 98.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.326 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -81.37 138.09 35.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.728 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.54 37.1 3.87 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.364 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.2 m120 56.96 78.32 0.23 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.664 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.39 116.17 0.89 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.544 ' C ' ' H ' ' A' ' 112' ' ' HIS . 49.1 m -127.81 136.89 52.08 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.728 0.299 . . . . 0.0 110.279 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 112' ' ' HIS . 71.5 t80 -57.14 -0.72 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.952 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.544 ' H ' ' C ' ' A' ' 110' ' ' THR . 86.5 t60 51.49 105.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.969 0.414 . . . . 0.0 110.718 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 53.37 -160.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.451 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.54 ' C ' ' H ' ' A' ' 116' ' ' SER . 9.0 p -139.42 153.45 23.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.202 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 94.6 p -69.78 10.91 0.32 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.177 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 114' ' ' VAL . 1.0 OUTLIER 51.5 -151.6 0.24 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.839 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.51 173.07 14.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.33 -126.6 1.03 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.926 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 62.1 tp -135.52 149.47 49.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 120.993 0.425 . . . . 0.0 110.277 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.1 p -152.55 152.37 31.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.46 130.03 51.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.009 0.433 . . . . 0.0 110.767 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.422 ' N ' ' CD1' ' A' ' 122' ' ' ILE . 1.9 mp -97.72 148.17 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 177.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.546 ' OH ' ' CD2' ' A' ' 125' ' ' PHE . 4.2 t80 -138.7 123.98 19.26 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 118.941 -1.104 . . . . 0.0 113.64 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.624 ' CB ' HH22 ' A' ' 237' ' ' ARG . 32.6 p-10 -110.36 120.29 41.97 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 113.489 -1.687 . . . . 0.0 106.588 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.546 ' CD2' ' OH ' ' A' ' 123' ' ' TYR . 5.1 t80 -70.26 129.32 39.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.248 0.546 . . . . 0.0 111.675 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.424 ' O ' ' O ' ' A' ' 125' ' ' PHE . 88.0 mt-30 39.98 -167.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.903 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.526 ' O ' ' C ' ' A' ' 128' ' ' ASN . 1.3 mp -105.0 20.83 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.656 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 127' ' ' ILE . 65.6 m-80 -11.46 -73.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.593 0.558 . . . . 0.0 111.828 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 128' ' ' ASN . 4.7 p30 153.89 -51.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.875 0.734 . . . . 0.0 111.441 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.81 -19.0 3.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -146.98 122.81 10.62 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.021 0.828 . . . . 0.0 113.146 -178.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -134.24 133.0 21.37 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.045 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -51.12 133.62 41.71 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 CA-C-N 119.95 1.018 . . . . 0.0 110.325 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -96.76 130.0 44.08 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.463 ' N ' ' CD1' ' A' ' 134' ' ' TYR . 96.7 mt -136.62 136.51 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -129.27 139.28 10.84 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.984 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -118.38 128.79 54.97 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -129.99 131.44 45.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.247 0.546 . . . . 0.0 112.025 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.42 113.31 2.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.44 144.95 35.36 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.92 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -150.94 171.28 17.52 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.313 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.17 175.66 47.49 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -80.14 104.0 10.4 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.307 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 145' ' ' ARG . 93.8 t -128.31 127.81 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.733 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 144' ' ' VAL . 33.1 mmt180 40.21 -166.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.192 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -159.22 146.41 17.15 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.114 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 74.7 m -131.69 151.06 51.92 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.962 0.41 . . . . 0.0 110.854 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.9 tt -135.17 131.42 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.071 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -91.38 106.66 18.66 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.039 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.1 m -80.77 147.73 30.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.247 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 t -148.35 155.14 40.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.875 0.369 . . . . 0.0 110.667 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -130.67 143.12 50.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.216 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 154' ' ' THR . 9.0 pttp -88.0 -93.15 0.1 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.24 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER 32.72 98.89 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.623 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.2 mt -104.58 127.8 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.196 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.64 115.72 15.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.38 -44.0 97.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 3.6 t -132.05 153.03 50.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.805 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.9 t -84.19 128.55 34.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.0 110.814 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.76 157.3 80.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.665 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.85 -39.6 48.61 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.404 1.402 . . . . 0.0 111.949 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.2 m -72.4 149.59 44.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.689 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 56.86 44.94 22.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.426 ' N ' ' CD ' ' A' ' 165' ' ' PRO . . . -146.77 53.66 1.78 Allowed Pre-proline 0 N--CA 1.463 0.197 0 CA-C-O 120.691 0.282 . . . . 0.0 111.008 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 164' ' ' ALA . 84.0 Cg_endo -73.55 160.48 44.19 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.818 2.345 . . . . 0.0 111.82 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -62.23 -39.85 94.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.509 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.02 -155.55 21.53 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 62.82 120.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.683 0.277 . . . . 0.0 110.261 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.1 p -122.66 130.09 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.51 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.8 m -132.13 -1.82 3.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.281 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 77.5 m -112.12 125.77 54.47 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.672 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.02 8.47 32.39 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.384 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -73.29 148.29 43.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.552 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 43.6 p 41.61 80.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.637 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.71 150.56 81.87 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.532 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.49 157.75 48.71 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.53 2.153 . . . . 0.0 111.988 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -74.51 -7.54 53.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.596 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.6 m 59.39 157.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.735 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -77.26 143.21 39.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.541 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -86.11 109.06 18.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -72.26 146.16 47.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.661 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -102.34 137.39 40.65 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.498 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 183' ' ' GLN . 2.3 pm0 -125.17 -120.68 0.26 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.373 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 183' ' ' GLN . 5.1 p 49.48 100.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.849 0.357 . . . . 0.0 110.517 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.483 ' OD1' ' N ' ' A' ' 186' ' ' SER . 57.6 p30 -158.65 -128.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.324 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.483 ' N ' ' OD1' ' A' ' 185' ' ' ASN . 1.9 m 63.92 87.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.893 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.0 tt -128.93 139.46 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.589 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.13 61.17 6.34 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -59.93 -38.88 83.66 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.09 154.66 31.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -123.55 147.83 16.69 Favored Glycine 0 N--CA 1.472 1.099 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.003 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 tt -144.49 127.51 16.51 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.783 -0.709 . . . . 0.0 109.236 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -150.3 170.34 30.26 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.09 140.73 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.837 0.827 . . . . 0.0 111.987 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.1 mt -118.64 134.56 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.476 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -148.42 153.27 38.3 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.503 0.668 . . . . 0.0 111.97 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 179.08 -140.59 4.47 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.611 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.43 140.82 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.83 0.315 . . . . 0.0 111.123 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -119.48 123.31 5.6 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.195 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -123.61 106.71 10.79 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 0.3 OUTLIER -74.54 152.58 39.31 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -176.165 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 203' ' ' THR . 8.1 tt -64.72 -36.91 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 113.068 -1.878 . . . . 0.0 108.208 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.827 ' O ' ' N ' ' A' ' 205' ' ' LYS . 29.7 m 178.62 100.26 0.15 Allowed Pre-proline 0 C--N 1.315 -0.93 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 238' ' ' PHE . 0.1 OUTLIER -14.55 58.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 124.02 3.146 . . . . 0.0 115.139 -173.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.827 ' N ' ' O ' ' A' ' 203' ' ' THR . 75.4 tttt -135.24 -44.81 0.7 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.063 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 26.5 tp -143.81 121.32 11.74 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.67 145.26 25.41 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -176.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.416 ' C ' ' CD1' ' A' ' 208' ' ' LEU . 1.0 OUTLIER -107.63 117.65 34.67 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -141.37 146.35 36.51 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -100.06 148.86 24.09 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.361 -1.745 . . . . 0.0 107.032 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -174.53 115.44 0.55 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 118.777 -1.678 . . . . 0.0 113.713 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -170.31 139.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -148.8 -86.09 0.09 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 215' ' ' HIS . 18.7 t80 -170.46 -178.46 2.7 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.394 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.545 ' O ' ' CE2' ' A' ' 214' ' ' TYR . 10.4 p-80 -149.34 165.91 30.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.233 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.63 95.94 1.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.13 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 49.0 t90 -154.61 121.46 5.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.57 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -85.38 -179.81 50.61 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -100.58 118.0 35.86 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.881 0.372 . . . . 0.0 110.284 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.3 tp -90.42 -2.08 57.93 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.231 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 56.77 38.14 29.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.562 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 223' ' ' THR . 0.5 OUTLIER -150.78 -138.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.186 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.528 ' H ' ' CG ' ' A' ' 222' ' ' ASN . 1.3 t 32.5 -116.08 0.06 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.802 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.521 ' N ' ' OG1' ' A' ' 223' ' ' THR . 10.2 tpt180 -155.09 154.61 32.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.792 0.33 . . . . 0.0 110.343 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -80.6 -0.83 39.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.244 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.428 ' O ' ' OG1' ' A' ' 227' ' ' THR . 99.2 mttt -73.28 141.73 47.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.761 0.315 . . . . 0.0 110.664 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 226' ' ' LYS . 4.3 m -166.41 -126.06 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.645 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 227' ' ' THR . 96.7 m-70 59.45 134.14 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.845 0.355 . . . . 0.0 110.788 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -164.88 64.18 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.541 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 15' ' ' LEU . . . -175.92 -109.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.789 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.9 t 63.15 -82.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.098 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 15' ' ' LEU . 10.0 mp -86.38 130.34 34.54 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.127 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -146.36 143.71 11.88 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.575 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 12.8 p -123.69 129.72 74.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -133.54 144.33 49.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.32 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 3.1 m-85 -76.34 122.83 25.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.624 HH22 ' CB ' ' A' ' 124' ' ' ASP . 16.6 tpt180 -138.69 113.13 8.85 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 124.277 0.985 . . . . 0.0 111.86 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.446 ' OXT' ' CG ' ' A' ' 238' ' ' PHE . 78.5 t80 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.013 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 m -72.99 147.85 44.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.504 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -172.41 -130.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.913 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -146.86 107.57 4.12 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.76 0.314 . . . . 0.0 110.532 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.54 -3.25 90.67 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.29 7.49 76.46 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -102.23 126.85 49.33 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.443 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . -158.74 165.18 33.97 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.94 158.28 30.95 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.011 2.474 . . . . 0.0 112.776 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.43 ' CZ ' ' CG ' ' A' ' 66' ' ' ARG . 20.6 p90 -154.25 163.29 40.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.456 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.9 t -129.02 144.17 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 120.88 0.371 . . . . 0.0 111.813 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -123.1 131.54 53.73 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.112 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.68 142.74 24.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.072 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 51.4 p-10 -95.96 143.33 27.24 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.506 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 97.5 mt -143.67 162.34 36.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.186 0.517 . . . . 0.0 112.036 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . 86.7 142.99 0.05 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.343 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -127.01 131.31 51.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.779 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.94 144.68 55.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.448 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -72.61 -75.5 0.14 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.912 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 22' ' ' ILE . 19.0 pt-20 -66.58 -37.79 85.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.667 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 59.64 -73.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.512 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 20' ' ' GLU . 86.9 mt -108.03 126.97 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.151 0.5 . . . . 0.0 111.729 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.1 p -128.53 -38.09 1.75 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.168 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.516 ' CG ' ' N ' ' A' ' 25' ' ' ASP . 82.3 t60 42.73 -111.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.929 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' N ' ' CG ' ' A' ' 24' ' ' HIS . 54.3 p-10 -83.75 173.77 11.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.733 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -38.35 106.19 0.36 Allowed Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.678 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -53.23 142.59 55.68 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.588 1.525 . . . . 0.0 112.589 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 57.71 63.9 4.38 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.507 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -92.46 -99.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.894 2.396 . . . . 0.0 111.694 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.7 p -142.15 35.16 1.53 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.026 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -154.16 57.74 1.92 Allowed Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.683 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.22 146.79 87.25 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.548 2.165 . . . . 0.0 111.877 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -135.6 119.05 16.85 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.699 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -166.49 -164.58 0.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.521 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 58.03 36.26 25.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.658 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -98.83 93.95 6.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.554 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 38' ' ' SER . 5.1 mp -133.29 132.03 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.543 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 37' ' ' ILE . 3.1 m 47.45 100.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.0 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.8 t -145.61 151.19 37.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.403 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 40' ' ' VAL . 7.1 p 35.61 27.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.22 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 39' ' ' THR . 9.4 t 52.44 91.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.641 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -121.24 155.53 34.41 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.913 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 55.12 96.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.061 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -66.01 -39.9 90.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.73 146.62 49.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.501 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -144.54 -44.68 0.24 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.044 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.405 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 74.2 mt -88.5 13.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.5 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.485 ' C ' ' H ' ' A' ' 50' ' ' ARG . 90.0 mtm180 55.75 -101.04 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.679 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 48' ' ' ARG . 18.0 p 50.14 10.39 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.372 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 48' ' ' ARG . 76.3 ttt180 -171.41 86.48 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 110.33 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.9 p -140.69 92.37 2.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.67 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.09 133.71 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.634 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.457 ' ND1' ' N ' ' A' ' 53' ' ' HIS . 10.0 p-80 -174.77 79.56 0.33 Allowed Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.819 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 55' ' ' ARG . 51.7 Cg_exo -53.48 -44.6 47.61 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.703 2.269 . . . . 0.0 112.928 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 54' ' ' PRO . 99.9 mtt180 42.28 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.538 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -155.25 161.5 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 119.386 -0.925 . . . . 0.0 112.709 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 m -132.5 133.03 43.29 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.698 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 m -140.05 165.95 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 111.609 0.225 . . . . 0.0 111.609 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.52 -162.04 24.75 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 119.721 -1.228 . . . . 0.0 114.188 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -112.53 151.18 30.29 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.499 -0.851 . . . . 0.0 108.915 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 8' ' ' GLY . 3.6 p-10 -136.95 114.36 10.93 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.529 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 38.9 p90 -125.05 105.35 9.11 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.29 177.03 7.5 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 105.888 -2.885 . . . . 0.0 105.888 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.532 ' CA ' ' H ' ' A' ' 124' ' ' ASP . . . -47.05 -36.16 8.89 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 120.013 1.907 . . . . 0.0 111.305 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -48.48 97.42 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.647 ' HE ' ' CD1' ' A' ' 122' ' ' ILE . 26.5 ttp-105 -130.07 119.76 23.59 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.674 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.4 pt -126.88 137.79 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.956 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.88 146.0 45.03 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.234 0.54 . . . . 0.0 111.661 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.1 140.53 29.91 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.218 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -102.25 127.4 49.23 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.299 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -112.4 136.77 51.48 Favored 'General case' 0 C--O 1.248 0.979 0 O-C-N 124.627 1.204 . . . . 0.0 110.394 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.37 -156.03 0.66 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.568 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.403 ' O ' ' CD1' ' A' ' 74' ' ' TYR . 74.3 mtp85 -104.96 150.81 24.6 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.812 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.2 m-85 -142.67 -71.06 0.33 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.824 0.345 . . . . 0.0 111.449 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -53.08 76.27 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.418 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 74' ' ' TYR . 88.8 tttt -68.78 -42.74 76.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.068 0.461 . . . . 0.0 110.148 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -94.19 144.93 25.08 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.945 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -101.78 13.01 36.12 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.463 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.3 m120 57.06 34.11 24.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.713 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.617 HD21 ' ND2' ' A' ' 85' ' ' ASN . 12.4 m120 46.1 69.32 0.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.632 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.22 -46.21 90.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.221 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -164.47 -59.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.38 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 85' ' ' ASN . 56.4 m -153.28 -164.93 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.21 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 t 61.11 -70.72 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.703 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.617 ' ND2' HD21 ' A' ' 80' ' ' ASN . 99.0 m-20 48.97 -102.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.725 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -127.69 -46.96 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.809 0.338 . . . . 0.0 110.298 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 18.6 pt-20 -87.56 142.51 27.8 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.8 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -135.22 -67.63 0.54 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.627 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.8 t -125.37 132.84 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.546 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -99.6 136.11 40.01 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.19 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 95.9 mt -91.54 -86.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.747 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -145.71 91.41 2.1 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.623 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -126.34 130.35 50.63 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -172.59 111.98 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.345 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -98.09 98.54 9.84 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.383 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -93.12 -10.84 59.29 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 96.0 mt -117.23 127.89 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.917 0.389 . . . . 0.0 110.451 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -169.65 -17.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.666 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 76.2 mt -66.19 -25.51 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.422 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.589 ' C ' ' H ' ' A' ' 102' ' ' LYS . 54.9 t0 -63.2 143.99 57.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.871 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.488 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 62.1 ttp180 63.8 -28.61 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.859 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.589 ' H ' ' C ' ' A' ' 100' ' ' ASP . 74.8 tttt 68.53 -61.47 0.4 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.705 0.288 . . . . 0.0 110.734 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.5 m -59.57 131.59 51.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.175 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -70.35 -119.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.572 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.706 HD22 HH22 ' A' ' 219' ' ' ARG . 22.3 t-20 -86.61 152.5 22.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.862 0.363 . . . . 0.0 110.577 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.43 ' N ' ' OD1' ' A' ' 105' ' ' ASN . 9.4 pt20 -77.9 166.62 22.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.663 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 58.29 -166.01 0.16 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.855 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.07 -40.44 97.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.79 170.53 44.37 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.1 p -74.35 96.85 2.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.869 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -156.31 79.89 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.111 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -163.37 129.12 3.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.457 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.62 142.54 51.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.536 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.72 151.65 4.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.009 0.433 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.7 p -53.13 120.7 6.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.756 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.529 ' O ' ' CZ ' ' A' ' 74' ' ' TYR . 51.4 m -61.67 -44.29 97.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.328 0.585 . . . . 0.0 109.755 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.1 tp -156.01 140.63 16.94 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -149.43 178.27 27.06 Favored Glycine 0 N--CA 1.476 1.332 0 C-N-CA 118.901 -1.619 . . . . 0.0 112.6 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -134.49 150.75 50.83 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.852 0.834 . . . . 0.0 111.519 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.1 t -134.29 102.47 5.37 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.24 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.32 122.56 39.32 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.647 ' CD1' ' HE ' ' A' ' 66' ' ' ARG . 3.4 pt -121.87 146.3 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -127.69 128.93 46.28 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.56 ' OD1' ' NZ ' ' A' ' 132' ' ' LYS . 13.7 t70 -112.51 134.38 54.07 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.788 0.804 . . . . 0.0 111.885 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.63 ' C ' ' H ' ' A' ' 127' ' ' ILE . 76.9 m-85 -93.4 85.47 4.97 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.752 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.573 ' NE2' HH12 ' A' ' 237' ' ' ARG . 97.7 mt-30 -60.34 16.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.059 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.63 ' H ' ' C ' ' A' ' 125' ' ' PHE . 38.4 mm -68.3 -42.0 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.477 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -75.59 143.63 42.25 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.136 0.494 . . . . 0.0 110.164 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.6 -40.65 97.6 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -127.35 -7.35 5.84 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 20.2 p90 -168.91 127.0 1.02 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.911 1.687 . . . . 0.0 115.291 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.56 ' NZ ' ' OD1' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -136.76 149.28 66.49 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -69.65 137.43 35.76 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.791 1.318 . . . . 0.0 111.798 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 28.3 p90 -105.95 130.86 53.81 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 106.617 -1.624 . . . . 0.0 106.617 175.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.5 pt -127.92 149.15 32.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.74 174.36 37.38 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.952 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.04 139.14 53.65 Favored 'General case' 0 CA--C 1.523 -0.062 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 193' ' ' GLY . 0.0 OUTLIER -126.32 126.13 43.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.767 0.318 . . . . 0.0 110.882 -178.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.18 146.21 33.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.81 0.814 . . . . 0.0 111.274 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.97 127.01 44.79 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.61 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -109.6 122.92 48.52 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -153.91 86.91 0.13 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -73.04 138.95 46.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.975 0.417 . . . . 0.0 110.562 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.419 ' O ' ' CB ' ' A' ' 145' ' ' ARG . 14.5 p -76.22 -3.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.178 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.419 ' CB ' ' O ' ' A' ' 144' ' ' VAL . 44.6 ttm-85 80.26 88.38 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.277 0.361 . . . . 0.0 110.352 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.51 ' CE1' ' O ' ' A' ' 148' ' ' ILE . 7.6 t60 -85.44 85.88 7.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.352 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.6 t -62.58 -44.16 97.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.977 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.51 ' O ' ' CE1' ' A' ' 146' ' ' HIS . 84.2 mt -108.39 125.72 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.552 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 150' ' ' SER . 41.8 p-10 -65.72 -37.88 87.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.748 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.535 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 47.8 t -73.98 149.68 41.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.645 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 m 62.68 114.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.816 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -65.73 -5.13 7.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.512 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 75.6 tttt 67.63 56.44 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.076 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.6 m -62.25 -44.64 96.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.15 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.443 ' O ' ' N ' ' A' ' 157' ' ' VAL . 69.7 mt -74.75 130.94 35.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -43.19 -20.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.28 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 155' ' ' ILE . 9.2 p -140.15 142.18 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.225 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 18.7 m -61.3 136.02 57.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.244 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 29.5 m -60.46 131.89 52.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.4 m -91.15 156.4 43.94 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.659 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.65 -38.29 16.73 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.649 1.566 . . . . 0.0 112.076 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 99.7 p -148.55 100.81 3.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 110.721 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -70.12 -104.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.47 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.45 ' CB ' ' CD ' ' A' ' 165' ' ' PRO . . . -174.41 -178.11 0.35 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 164' ' ' ALA . 27.6 Cg_exo -60.68 144.25 99.52 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.969 1.779 . . . . 0.0 111.331 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 166' ' ' ASN . 40.4 p-10 -80.11 115.57 19.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.988 0.423 . . . . 0.0 110.725 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.65 -129.38 0.88 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.19 137.82 56.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.716 0.293 . . . . 0.0 110.419 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.4 131.12 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.325 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.517 ' C ' ' H ' ' A' ' 172' ' ' TYR . 81.0 p -129.62 -7.94 4.59 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.451 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 173' ' ' ASN . 41.7 p 47.55 10.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.135 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.517 ' H ' ' C ' ' A' ' 170' ' ' THR . 28.5 p90 34.2 31.23 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 111.607 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 174' ' ' THR . 50.5 p30 -65.67 -17.52 64.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.7 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 173' ' ' ASN . 45.7 p -69.01 134.9 50.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.245 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 5.8 p-10 -113.55 92.15 22.91 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.873 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 177' ' ' LYS . 87.3 Cg_endo -86.81 116.91 1.35 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.457 2.105 . . . . 0.0 111.538 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 176' ' ' PRO . 17.9 ptpt 33.72 -141.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.256 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 69.3 m -105.64 117.36 33.83 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.717 0.294 . . . . 0.0 110.466 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -174.18 52.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.856 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.529 ' O ' ' NH1' ' A' ' 188' ' ' ARG . 25.3 m120 -89.52 103.6 16.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.782 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 24.4 p-10 -148.48 -56.18 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.418 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -63.24 -41.65 99.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.455 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -55.99 171.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.333 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.0 m -89.21 -8.09 54.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.626 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 187' ' ' ILE . 82.7 m-20 -88.34 161.37 17.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.309 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 31.6 t 58.22 -76.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.178 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 185' ' ' ASN . 51.6 mm 55.79 78.68 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 180' ' ' ASN . 29.7 ptt-85 -90.37 31.3 1.03 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.459 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -60.38 -43.52 96.52 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.8 t -67.2 163.98 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -142.73 148.38 20.1 Favored Glycine 0 N--CA 1.473 1.127 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.845 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -115.51 154.79 28.7 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 138' ' ' ARG . . . -170.14 -178.77 41.28 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.46 155.67 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.567 0.699 . . . . 0.0 111.34 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 16.0 tt -131.95 130.49 61.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.94 161.58 42.37 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 119.956 -0.698 . . . . 0.0 112.084 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.406 ' HA3' ' HH ' ' A' ' 134' ' ' TYR . . . 160.68 -178.36 36.71 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.88 136.57 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 117.822 0.811 . . . . 0.0 110.612 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -97.69 137.52 13.35 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -121.58 100.23 6.9 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.613 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -100.46 152.85 19.89 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -172.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 28.2 mm -89.27 -67.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 103.776 -2.676 . . . . 0.0 103.776 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.5 p -103.89 -166.33 0.1 OUTLIER Pre-proline 0 CA--C 1.542 0.668 1 N-CA-C 100.1 -4.037 . . . . 0.0 100.1 172.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -81.03 -16.63 9.81 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 CA-C-N 126.373 3.312 . . . . 0.0 112.303 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.573 ' HA ' ' H ' ' A' ' 237' ' ' ARG . 47.7 pttt -81.86 -43.95 17.53 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -81.03 104.38 11.49 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.205 -178.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.79 131.55 24.23 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.728 0.694 . . . . 0.0 112.523 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 36.7 tp -94.79 130.3 41.39 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -110.81 123.41 50.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -107.44 118.27 36.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -157.11 -175.35 27.93 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 118.023 -2.037 . . . . 0.0 114.411 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.543 ' CE2' ' CD1' ' A' ' 214' ' ' TYR . 69.5 t80 -141.25 110.03 6.09 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 113.557 -1.322 . . . . 0.0 108.724 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -104.3 128.91 52.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.142 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.543 ' CD1' ' CE2' ' A' ' 212' ' ' TYR . 37.1 p90 -151.27 156.38 40.73 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.249 0.547 . . . . 0.0 111.361 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.633 ' NE2' ' CE3' ' A' ' 217' ' ' TRP . 3.2 p80 -154.45 165.99 34.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.417 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -101.0 110.88 22.96 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.913 0.387 . . . . 0.0 111.052 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.666 ' HE1' ' N ' ' A' ' 220' ' ' LEU . 18.5 p90 -138.41 -53.04 0.61 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.611 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.64 ' N ' ' CG ' ' A' ' 217' ' ' TRP . . . 88.55 106.74 1.03 Allowed Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.706 HH22 HD22 ' A' ' 105' ' ' ASN . 5.3 tpt180 51.13 88.17 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.861 0.363 . . . . 0.0 111.176 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.666 ' N ' ' HE1' ' A' ' 217' ' ' TRP . 11.8 tp -79.65 156.05 27.79 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.29 -0.413 . . . . 0.0 109.953 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.89 -37.9 86.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.827 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -69.22 146.12 52.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.62 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 3.7 t -145.04 174.16 11.28 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.102 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 65.52 -47.32 0.38 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.806 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -103.59 114.64 29.06 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.848 0.356 . . . . 0.0 110.319 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -145.3 74.94 1.42 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.351 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 229' ' ' GLU . 16.8 p -95.87 -0.95 50.39 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.929 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 228' ' ' HIS . 51.0 t-80 -80.02 18.67 0.8 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.095 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 227' ' ' THR . 83.6 tt0 -135.3 117.26 15.26 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.592 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 43.57 88.83 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 12.9 p -165.32 173.66 10.96 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.482 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 15' ' ' LEU . 87.9 mt -90.99 160.7 15.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.298 0.571 . . . . 0.0 110.337 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -154.48 164.97 31.78 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.13 150.94 17.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 CA-C-N 117.653 0.726 . . . . 0.0 110.917 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.473 ' NH2' ' CE1' ' A' ' 134' ' ' TYR . 99.7 mtt180 -132.6 142.54 49.18 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.467 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -107.28 110.4 22.41 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.573 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 76.2 ttt-85 -131.88 108.88 9.7 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-O 122.096 0.951 . . . . 0.0 113.422 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.438 ' C ' ' O ' ' A' ' 237' ' ' ARG . 2.6 t80 . . . . . 0 N--CA 1.47 0.54 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.182 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p 55.85 26.93 10.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.696 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 4' ' ' ASP . 81.0 tt0 -66.66 -37.69 85.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.577 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' GLU . 98.8 m-20 53.55 167.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.39 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.91 22.18 0.02 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.949 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.02 13.68 71.19 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.575 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -84.54 121.14 27.18 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -165.83 -166.86 25.56 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 118.896 -1.621 . . . . 0.0 114.15 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.71 159.79 19.58 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 124.359 3.373 . . . . 0.0 115.493 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -167.13 136.96 2.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.141 -1.845 . . . . 0.0 107.95 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.81 156.84 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -154.21 148.39 25.87 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.91 122.3 7.87 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.646 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -86.42 116.46 24.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.89 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 232' ' ' LEU . 11.8 tp -84.85 128.59 34.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.492 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.44 153.82 23.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.533 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.525 ' CD2' ' N ' ' A' ' 18' ' ' ALA . 81.2 t80 -42.45 -90.42 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.275 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.525 ' N ' ' CD2' ' A' ' 17' ' ' TYR . . . -169.31 154.54 5.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.164 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 19' ' ' TYR . 44.8 p90 -69.64 129.79 40.62 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.223 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -97.69 116.45 29.93 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.497 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.542 ' O ' ' NE2' ' A' ' 24' ' ' HIS . 67.6 m80 -150.0 85.79 1.42 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.488 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.405 HD13 HG23 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -65.82 -40.02 86.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.6 t -63.31 126.61 28.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.626 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.542 ' NE2' ' O ' ' A' ' 21' ' ' HIS . 66.3 m-70 -147.1 93.61 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.261 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 68.4 t0 -64.78 132.92 50.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.26 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 12.4 m-85 -54.03 152.57 10.44 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.207 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.19 -89.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.182 1.921 . . . . 0.0 112.568 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -136.77 151.55 72.69 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.18 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.69 98.4 1.13 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.98 1.787 . . . . 0.0 111.726 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.9 m -63.74 -46.23 86.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.077 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.499 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . 177.31 -46.7 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.9 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 31' ' ' ALA . 53.9 Cg_exo -52.58 -39.17 76.0 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.214 1.943 . . . . 0.0 111.923 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -88.6 80.78 7.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.211 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.12 -46.17 90.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.435 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -150.18 101.11 2.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.253 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -100.69 131.55 46.53 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.072 0.463 . . . . 0.0 110.643 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.7 pt -80.63 -16.38 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.745 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.6 m -76.45 93.64 3.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.33 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -176.92 91.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.514 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.51 142.67 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.819 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.2 m 49.63 59.84 4.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.571 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 43' ' ' TYR . 79.3 m-20 -63.28 -132.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 42' ' ' ASP . 62.4 t80 54.36 110.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.826 0.346 . . . . 0.0 110.821 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -135.48 151.25 50.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.422 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.94 154.74 23.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.031 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 48' ' ' ARG . 10.8 p30 -73.16 113.95 10.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.475 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 67.5 mt 47.86 -88.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.145 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 46' ' ' ASN . 37.7 ptt180 -149.32 168.26 23.84 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.726 0.298 . . . . 0.0 110.416 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.5 p -125.85 165.81 18.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.663 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 56.29 -179.49 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.311 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 51' ' ' SER . 5.1 t 51.5 35.61 14.82 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.163 0.506 . . . . 0.0 110.582 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.39 -45.94 94.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.627 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -81.21 132.48 56.14 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.755 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.17 151.54 30.31 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.931 1.754 . . . . 0.0 111.739 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -88.43 128.7 35.53 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.15 161.38 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.832 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.3 t -144.35 146.16 32.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.002 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.43 153.47 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.3 179.49 39.1 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.893 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -111.51 140.7 45.89 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.851 -0.674 . . . . 0.0 110.331 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -89.27 107.56 19.12 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.49 1.119 . . . . 0.0 110.72 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -126.02 142.25 51.6 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.575 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.99 127.29 24.63 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.89 -61.11 0.71 Allowed Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -125.34 158.55 33.95 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.607 0.718 . . . . 0.0 111.967 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.48 HH21 ' NE ' ' A' ' 237' ' ' ARG . 70.7 mtt85 -133.18 147.38 52.04 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.8 mt -111.74 126.38 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.13 135.59 35.88 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.324 0.583 . . . . 0.0 111.949 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.62 122.67 47.89 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.862 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 42.5 p-10 -99.84 128.45 45.93 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -153.93 171.77 18.47 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 122.161 0.982 . . . . 0.0 112.342 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -177.55 101.66 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 113.294 -1.776 . . . . 0.0 108.048 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -142.71 157.79 44.3 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.059 0.457 . . . . 0.0 111.715 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -146.35 121.22 9.95 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.302 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -140.19 -76.45 0.33 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.875 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 77' ' ' TRP . 10.5 mtpm? 53.12 105.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.214 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.45 ' O ' ' O ' ' A' ' 76' ' ' LYS . 10.2 m-90 49.06 107.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.101 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -96.16 109.08 21.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.983 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 50.6 t30 57.66 68.66 0.82 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -78.04 155.76 30.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.005 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.33 39.82 30.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.223 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.407 ' O ' ' O ' ' A' ' 83' ' ' SER . 70.5 t80 -101.07 -42.38 6.4 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.319 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 82' ' ' TYR . 15.7 m 49.69 98.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.793 0.33 . . . . 0.0 110.523 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 85' ' ' ASN . 11.4 p -62.73 -46.8 95.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.974 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.404 ' N ' ' CG1' ' A' ' 84' ' ' VAL . 22.9 t-20 -104.74 99.32 8.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.549 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 87' ' ' GLU . 20.7 tt -121.26 -51.77 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.603 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.495 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 83.3 tt0 -174.99 97.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.042 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -98.54 7.71 45.81 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.549 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 96.3 t -106.78 120.21 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.389 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -173.11 -52.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.213 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.529 ' C ' ' H ' ' A' ' 93' ' ' LYS . 41.4 mm -89.82 -81.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.494 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 mmp_? 46.53 9.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.671 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 91' ' ' ILE . 51.7 mtpt -100.32 -109.81 0.2 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 95' ' ' ASN . 83.4 tt0 -80.04 151.61 29.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.313 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 94' ' ' GLU . 53.7 t-20 59.7 133.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.584 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.61 -173.83 5.72 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.413 ' O ' ' O ' ' A' ' 98' ' ' ARG . 16.0 tt -64.86 -40.21 88.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.254 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' A' ' 97' ' ' ILE . 16.3 tpp180 60.63 136.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.94 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 99' ' ' ILE . 37.6 mm -64.13 -44.26 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.049 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.7 t0 59.09 163.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.919 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 48.8 mmm-85 38.3 91.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.926 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -78.21 -13.71 59.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.473 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.9 m -64.37 131.25 46.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.45 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -75.77 157.19 33.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.599 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -71.61 137.52 48.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.715 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -127.29 121.59 31.54 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.426 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' A' ' 107' ' ' GLU . 56.0 mp0 -85.28 -112.87 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.741 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -64.32 -41.04 97.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.367 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.77 44.99 0.04 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.9 p -92.16 113.12 25.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.797 0.332 . . . . 0.0 110.342 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -148.85 140.46 23.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.463 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 43.11 93.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.44 151.78 31.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.307 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.54 132.49 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.65 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.4 p -156.47 163.68 39.13 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.148 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.7 p -154.51 157.87 39.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.345 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.93 160.06 44.16 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 177.31 -146.25 7.63 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.319 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 mp -137.38 148.83 46.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.19 0.519 . . . . 0.0 110.185 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 77.3 p -146.35 138.59 25.09 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.38 114.35 28.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.163 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 55.2 mt -88.87 129.83 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 135' ' ' ILE . 16.0 m-85 -100.98 116.53 33.05 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.256 0.551 . . . . 0.0 109.93 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.47 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 66.8 t0 -100.15 124.28 45.37 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.523 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.485 ' C ' ' H ' ' A' ' 127' ' ' ILE . 68.5 m-85 -110.03 82.6 1.62 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.693 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -58.6 -6.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 110.44 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.521 ' C ' ' H ' ' A' ' 129' ' ' ASP . 66.7 mt -68.83 -40.45 81.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.792 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -73.2 27.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.649 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 127' ' ' ILE . 34.9 t0 68.53 -119.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.981 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -90.52 -12.26 37.71 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.42 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 4.1 p90 -118.2 102.49 9.03 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.359 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.411 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -109.6 130.58 22.62 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 179.086 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -76.94 120.15 5.35 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 120.728 0.952 . . . . 0.0 110.048 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -75.91 130.71 38.92 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.456 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.556 ' O ' ' CD2' ' A' ' 123' ' ' TYR . 28.6 mm -135.96 135.6 50.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.46 169.98 37.1 Favored Glycine 0 C--N 1.322 -0.25 0 C-N-CA 118.979 -1.582 . . . . 0.0 113.203 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -104.34 140.42 37.92 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -118.49 124.38 47.44 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.0 123.23 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -147.21 146.41 29.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.844 0.354 . . . . 0.0 110.377 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -130.8 155.65 46.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.947 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.41 -179.48 42.4 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 63.2 t60 -114.1 95.03 5.08 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.689 0.281 . . . . 0.0 111.184 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 99.0 t -100.95 -82.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.118 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -148.89 -123.76 0.05 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.064 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -147.7 85.06 1.55 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.655 0.264 . . . . 0.0 110.706 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 94.6 p -86.26 -16.53 37.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.964 0.412 . . . . 0.0 110.518 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 16.8 tt -67.85 -39.75 82.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.795 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -138.28 -176.49 4.47 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.695 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.0 p -154.14 162.74 40.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.628 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.7 p -143.61 -145.88 0.18 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.423 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -81.48 23.12 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.622 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -60.85 -46.45 90.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.275 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.04 101.97 2.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.305 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 155' ' ' ILE . 97.4 mt -64.73 -44.08 96.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.537 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -104.88 122.0 44.88 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.146 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.9 p -129.6 133.32 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.804 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 2.6 t -132.24 148.75 52.46 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.901 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.8 m -122.5 127.74 49.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.951 0.405 . . . . 0.0 110.882 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.9 t -49.1 111.61 2.03 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.578 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -51.39 138.66 46.76 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.356 1.371 . . . . 0.0 111.838 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.9 t -61.76 -44.51 96.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.179 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -167.95 -82.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.311 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.93 -63.9 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.1 146.31 51.65 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.118 1.879 . . . . 0.0 111.191 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -138.33 109.31 6.75 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.883 0.373 . . . . 0.0 111.008 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 169' ' ' VAL . . . 54.17 -135.58 43.74 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 70.18 -39.61 0.44 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.808 0.337 . . . . 0.0 110.728 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.518 ' H ' ' C ' ' A' ' 167' ' ' GLY . 34.0 m -71.45 -32.95 48.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 34.88 76.35 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 58.7 p -67.04 -32.55 73.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.158 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 83.4 t80 45.64 93.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.914 0.388 . . . . 0.0 110.459 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -135.87 137.3 41.3 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.34 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.3 m -81.11 81.59 7.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.402 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -114.74 90.64 22.82 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.056 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -89.65 116.52 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.651 2.234 . . . . 0.0 111.457 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -147.09 -30.54 0.34 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.692 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.4 t -122.13 -22.88 5.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.72 0.295 . . . . 0.0 110.975 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 51.2 98.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.931 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 66.0 t30 49.77 96.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.152 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 181' ' ' ASP . 67.4 t0 -159.63 44.47 0.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.386 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.495 ' CD2' ' N ' ' A' ' 183' ' ' GLN . 53.2 p90 -61.73 -46.41 89.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.896 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.495 ' N ' ' CD2' ' A' ' 182' ' ' TYR . 58.5 tt0 -157.36 -24.22 0.09 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.824 0.345 . . . . 0.0 110.7 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.0 m -83.52 -174.93 5.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.756 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 57.21 38.16 28.67 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.409 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.3 t -61.51 164.89 5.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.563 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 38.4 pt -65.55 -40.76 89.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.172 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -164.31 84.39 0.43 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.21 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -137.23 -18.59 1.3 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.1 163.21 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 114.291 -1.322 . . . . 0.0 107.661 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -130.59 102.87 0.54 Allowed Glycine 0 N--CA 1.468 0.771 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 10.7 mp -127.75 133.89 49.51 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.068 0.461 . . . . 0.0 110.143 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -179.33 -140.17 3.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.33 152.47 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.442 0.639 . . . . 0.0 110.547 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.3 tp -111.96 142.1 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.59 174.66 13.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 111.81 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 155.91 -176.99 33.23 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.66 136.65 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -131.86 135.07 7.97 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 120.431 -0.89 . . . . 0.0 114.467 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -106.74 113.1 26.4 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 113.684 -1.258 . . . . 0.0 108.224 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 43.6 p30 -51.34 147.03 6.23 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.092 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.0 mm -108.9 -51.48 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.3 OUTLIER -106.79 -174.06 0.3 Allowed Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 176.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.445 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.0 Cg_exo -32.87 -70.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 122.55 1.947 . . . . 0.0 114.311 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -126.8 20.72 7.06 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.171 0.986 . . . . 0.0 110.425 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.5 tt -88.24 127.62 35.45 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.0 t -137.09 152.75 50.38 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.1 tt -105.7 124.25 49.25 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.465 ' CG ' ' NH1' ' A' ' 235' ' ' ARG . 2.2 p30 -137.1 147.62 46.17 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -174.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -91.08 127.03 36.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -114.93 150.5 18.71 Favored Glycine 0 N--CA 1.471 0.977 0 C-N-CA 121.287 -0.482 . . . . 0.0 113.001 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.64 127.84 37.84 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -89.85 136.64 32.92 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.61 101.08 6.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.682 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.613 ' NE2' ' ND2' ' A' ' 216' ' ' ASN . 84.7 t60 -97.42 126.77 42.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.613 ' ND2' ' NE2' ' A' ' 215' ' ' HIS . 94.4 m-20 42.62 -168.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 110.757 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -86.8 131.68 34.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.015 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -90.73 135.27 12.77 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -152.62 170.9 19.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.738 0.304 . . . . 0.0 110.571 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' A' ' 220' ' ' LEU . 3.5 mm? -75.64 133.54 40.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.202 0.525 . . . . 0.0 111.145 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -173.82 118.16 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.583 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 223' ' ' THR . 55.4 t-20 58.65 34.63 23.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.093 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.41 ' C ' ' O ' ' A' ' 222' ' ' ASN . 69.2 p 29.98 82.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.141 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -86.61 149.47 24.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.972 0.415 . . . . 0.0 110.76 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -143.84 -160.36 1.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.747 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.1 tttp 60.53 77.08 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.848 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.0 m -139.59 73.82 1.44 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.804 0.335 . . . . 0.0 110.552 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.578 ' CD2' ' H ' ' A' ' 229' ' ' GLU . 11.2 t-80 -146.3 171.02 15.61 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.133 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.578 ' H ' ' CD2' ' A' ' 228' ' ' HIS . 97.0 mt-10 55.98 38.65 30.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.384 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -41.23 -85.66 0.0 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.528 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 97.1 p -163.24 156.51 19.25 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.981 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 15' ' ' LEU . 5.8 tt -124.23 126.24 45.76 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 177.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -115.36 171.28 13.63 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.278 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.31 129.73 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 113.708 -1.246 . . . . 0.0 108.32 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.465 ' NH1' ' CG ' ' A' ' 209' ' ' ASP . 83.8 mtt85 -132.48 141.79 48.95 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.805 0.335 . . . . 0.0 110.353 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -122.0 112.16 17.93 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.658 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.48 ' NE ' HH21 ' A' ' 66' ' ' ARG . 87.5 mtm-85 -134.06 126.65 30.59 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 . . . . . 0 C--O 1.218 -0.563 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.453 -178.915 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 4' ' ' ASP . 48.4 t -61.45 -177.52 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.518 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 59.13 -73.63 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.67 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 2' ' ' SER . 99.9 m-20 -62.5 -40.37 96.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.868 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.07 -143.53 22.14 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.17 -121.97 0.78 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.439 ' HD2' ' H ' ' A' ' 7' ' ' ARG . 3.2 mpt_? -75.68 152.53 37.52 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.448 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . 169.31 -78.55 0.1 Allowed Glycine 0 CA--C 1.541 1.68 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.487 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.464 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 71.4 Cg_endo -82.25 158.29 17.45 Favored 'Trans proline' 0 N--CA 1.507 2.277 0 C-N-CA 122.899 2.399 . . . . 0.0 111.989 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.623 ' CE2' ' NH1' ' A' ' 66' ' ' ARG . 3.4 t80 -148.1 137.71 22.34 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.84 135.15 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -136.46 144.27 44.31 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -174.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.434 ' O ' ' OD1' ' A' ' 14' ' ' ASP . . . -152.99 149.43 28.18 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.304 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 13' ' ' ALA . 86.0 m-20 -144.44 125.71 14.71 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.175 -0.328 . . . . 0.0 110.661 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 mp -140.66 163.46 32.81 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.353 0.596 . . . . 0.0 111.903 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 17' ' ' TYR . . . -131.32 -112.68 0.24 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.133 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' ALA . 67.2 t80 58.21 129.96 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.773 0.321 . . . . 0.0 111.124 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -157.88 43.72 0.32 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.183 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.439 ' O ' ' OH ' ' A' ' 17' ' ' TYR . 83.2 t80 -134.98 127.29 30.23 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.157 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -100.79 175.59 5.58 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.985 0.421 . . . . 0.0 111.031 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.479 ' CG ' ' H ' ' A' ' 22' ' ' ILE . 70.5 t60 61.16 170.76 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.862 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.479 ' H ' ' CG ' ' A' ' 21' ' ' HIS . 19.8 tt -83.42 153.94 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.852 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.524 ' C ' ' H ' ' A' ' 25' ' ' ASP . 14.9 m -72.15 99.93 2.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.504 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 24' ' ' HIS . 85.0 t60 45.53 10.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.794 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 26' ' ' TYR . 35.4 t70 58.03 -178.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.791 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.527 ' H ' ' CG ' ' A' ' 25' ' ' ASP . 43.5 m-85 57.39 68.25 2.09 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.67 -39.23 89.99 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 123.121 2.548 . . . . 0.0 113.38 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.76 152.44 32.12 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.106 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.65 -99.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.281 1.988 . . . . 0.0 111.793 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 47.2 p -110.88 -87.6 0.53 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.607 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.445 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -177.39 53.11 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.65 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 31' ' ' ALA . 37.5 Cg_endo -65.35 -24.23 57.81 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.721 2.281 . . . . 0.0 112.065 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 32' ' ' PRO . 89.9 m-20 -150.21 115.22 5.35 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.702 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -147.7 135.64 21.18 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.522 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.532 ' CG ' ' H ' ' A' ' 36' ' ' LYS . 62.6 t30 -162.47 -144.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.148 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.532 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 86.0 tttt -145.49 -79.34 0.18 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.3 mt -139.58 -54.73 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.535 ' HG ' ' H ' ' A' ' 39' ' ' THR . 16.5 t 40.81 -158.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.886 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.535 ' H ' ' HG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER 71.69 -164.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.225 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.3 t -62.68 -45.39 98.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.804 0.335 . . . . 0.0 110.494 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.6 t -65.58 140.71 58.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.536 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 54.4 p-10 -154.18 76.85 1.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.264 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -107.72 130.78 54.91 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.662 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -71.72 -14.35 61.99 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -73.3 148.34 43.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.705 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -134.23 91.93 2.87 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' A' ' 47' ' ' ILE . 2.4 mp -68.17 -21.54 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -60.08 143.59 51.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.209 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 t -144.83 173.21 12.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -42.97 -66.97 0.31 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.918 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 71.1 m -161.39 -123.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.044 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.537 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 14.8 p -63.92 -26.13 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.453 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.585 ' O ' ' CG ' ' A' ' 53' ' ' HIS . 20.2 p80 43.61 99.95 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.496 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.95 140.16 69.35 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.375 1.383 . . . . 0.0 112.775 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -139.11 -160.77 1.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.036 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.7 p -150.01 154.42 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 119.567 -0.853 . . . . 0.0 113.065 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.2 t -135.67 134.49 39.24 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.009 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.36 163.34 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.295 0.569 . . . . 0.0 111.933 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.64 -160.35 25.52 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -128.9 143.67 50.96 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 120.84 0.352 . . . . 0.0 110.345 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 9' ' ' PRO . 18.1 p-10 -124.72 115.39 20.66 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -126.91 158.02 37.88 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.49 123.02 32.05 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.426 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.06 -89.07 0.28 Allowed Glycine 0 N--CA 1.474 1.184 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.3 p-90 -127.79 174.04 9.45 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.623 ' NH1' ' CE2' ' A' ' 10' ' ' TYR . 25.3 ttp85 -147.32 147.42 30.34 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.354 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.39 144.24 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.39 150.18 19.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.364 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.88 159.14 31.8 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 55.6 p30 -140.45 153.07 46.13 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.51 169.26 24.21 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.363 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.5 -155.13 0.67 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.946 0.403 . . . . 0.0 111.305 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -147.86 60.63 1.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.735 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -145.11 -1.21 0.85 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.999 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -71.03 -21.46 62.26 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.759 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' TRP . 65.4 tttm -139.89 -81.94 0.27 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.716 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.579 ' CG ' ' N ' ' A' ' 78' ' ' ASN . 25.4 t90 51.15 176.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.135 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.579 ' N ' ' CG ' ' A' ' 77' ' ' TRP . 99.0 m-20 55.27 36.29 26.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.909 0.385 . . . . 0.0 110.123 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -62.31 -40.04 95.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.68 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -80.97 107.5 13.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -78.71 155.37 29.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.641 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 82' ' ' TYR . 52.8 p90 -85.78 122.76 30.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.027 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.3 p -83.76 175.85 9.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.361 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.3 t 61.01 112.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.425 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -94.78 137.92 33.25 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.638 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.4 pt -127.02 121.94 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.59 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 87' ' ' GLU . 44.7 mp0 38.45 32.13 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.191 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -95.08 1.84 55.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.886 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.5 p -122.94 -37.17 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 120.828 0.346 . . . . 0.0 110.6 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -64.07 -36.88 85.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.636 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.3 pt -66.14 151.24 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.768 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -127.16 152.37 47.43 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.714 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.64 164.98 29.34 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.631 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -146.54 156.55 43.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.599 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -139.26 128.97 24.66 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.283 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -153.82 74.48 0.24 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 98' ' ' ARG . 96.1 mt -118.32 130.86 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.812 0.339 . . . . 0.0 110.203 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 97' ' ' ILE . 89.4 mtm180 -50.94 -104.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.7 pt -133.83 155.68 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.869 0.366 . . . . 0.0 110.763 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 101' ' ' ARG . 44.3 t0 -86.94 177.07 7.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.597 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.55 HH11 HD21 ' A' ' 105' ' ' ASN . 85.0 mtp180 -52.63 -176.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.552 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -62.52 -43.52 98.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.44 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.6 p -140.1 163.48 32.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.377 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -62.47 160.8 12.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.066 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.55 HD21 HH11 ' A' ' 101' ' ' ARG . 30.6 p30 -141.97 176.2 9.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.728 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 76.13 21.85 1.45 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.915 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -147.18 -45.98 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.599 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -90.52 115.32 27.57 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.168 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 160.44 -92.9 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.8 m -63.79 144.03 57.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 0.0 110.787 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 42.78 -165.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.866 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.501 ' CG ' ' HG ' ' A' ' 115' ' ' SER . 13.9 p80 -66.39 133.18 49.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.641 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.53 -50.47 71.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.202 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 68.2 t -131.43 135.1 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.944 0.402 . . . . 0.0 111.033 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.501 ' HG ' ' CG ' ' A' ' 112' ' ' HIS . 58.5 m -161.95 87.63 0.66 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.019 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.447 ' OG ' ' N ' ' A' ' 117' ' ' LEU . 91.0 p -88.92 -79.39 0.32 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 117' ' ' LEU . 3.2 mm? -89.83 131.89 35.53 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.73 134.71 7.5 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.188 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.2 tt -123.94 140.76 52.66 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.9 t -133.27 123.01 24.74 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.39 130.72 40.62 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 88.2 mt -129.73 159.36 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.486 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 55.8 m-85 -118.42 118.15 30.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 237' ' ' ARG . 54.4 t0 -140.0 114.9 9.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.909 0.385 . . . . 0.0 111.478 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -122.11 96.18 4.95 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.574 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.564 ' NE2' ' OD1' ' A' ' 201' ' ' ASP . 47.9 tt0 -93.51 -0.62 56.27 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.397 0.618 . . . . 0.0 109.907 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.0 -23.56 29.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 12.7 t-20 -60.79 -42.63 97.94 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.165 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 128' ' ' ASN . 52.2 m-20 -175.21 -110.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.677 0.611 . . . . 0.0 109.366 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -118.22 1.05 11.86 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.665 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -128.81 131.67 47.78 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.485 0.491 . . . . 0.0 110.116 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.66 ' NZ ' HH22 ' A' ' 237' ' ' ARG . 0.5 OUTLIER -116.56 128.04 26.3 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.025 -178.055 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.13 129.55 29.02 Favored 'Trans proline' 0 N--CA 1.482 0.816 0 N-CA-C 107.187 -1.89 . . . . 0.0 107.187 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -115.16 129.15 56.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.368 0.604 . . . . 0.0 111.234 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.2 tt -162.2 148.77 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.509 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -169.22 -177.23 39.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 119.637 -1.268 . . . . 0.0 113.157 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.48 144.03 30.76 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.044 0.45 . . . . 0.0 110.326 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -119.1 118.85 32.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.949 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.25 128.99 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.938 0.399 . . . . 0.0 110.657 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.31 128.06 43.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -142.38 165.77 26.5 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.783 0.802 . . . . 0.0 111.749 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.16 -6.78 0.08 OUTLIER Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 189' ' ' ARG . 79.5 m80 -88.75 166.68 13.88 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.872 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 98.5 t -80.38 131.71 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.068 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -95.66 132.82 40.43 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.952 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -153.89 -82.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.315 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.4 m -80.75 -80.28 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.434 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 23.0 mm 65.85 -51.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.935 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.427 ' O ' ' O ' ' A' ' 150' ' ' SER . 63.8 t0 -62.18 -41.44 98.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.661 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 149' ' ' ASP . 24.5 p 41.18 93.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.579 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 m -62.65 -45.39 93.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.799 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.4 ' HG3' ' H ' ' A' ' 153' ' ' LYS . 15.1 ptmt -151.07 -113.21 0.05 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.517 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.4 ' H ' ' HG3' ' A' ' 152' ' ' LYS . 99.6 mttt 57.97 -168.74 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.005 0.431 . . . . 0.0 111.021 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 60.9 m 54.97 81.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.776 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.2 pt -131.09 161.88 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.284 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -73.47 107.67 5.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 111.229 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.2 m -108.55 -2.31 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 28.4 p -103.32 138.98 39.35 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.29 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.7 t -144.19 156.14 44.19 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.517 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.97 148.96 50.0 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.19 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 163' ' ' ASN . 94.5 Cg_endo -76.13 -96.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.134 1.889 . . . . 0.0 112.084 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.7 t 45.24 16.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 161' ' ' PRO . 64.9 t30 55.75 38.31 29.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.98 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . 58.14 152.21 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.258 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.59 137.55 27.87 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 121.984 1.79 . . . . 0.0 111.616 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -162.9 170.55 18.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.748 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 153.06 109.8 0.4 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.45 -4.29 58.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.058 0.456 . . . . 0.0 110.174 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.36 -17.2 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.717 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.7 t -132.95 155.52 48.97 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.023 0.44 . . . . 0.0 110.768 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.6 p -82.15 172.23 13.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.836 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -65.58 140.67 58.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.568 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -86.41 110.17 19.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.844 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 65.6 p -70.38 138.72 51.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.466 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -92.3 150.18 39.71 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.623 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.97 158.83 45.65 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.506 2.137 . . . . 0.0 111.901 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 45.43 -156.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.301 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 70.5 p -130.42 159.46 36.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 110.828 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 48.76 89.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.526 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -142.79 90.05 2.18 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.572 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 181' ' ' ASP . 33.7 p-10 -117.2 12.77 14.52 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.578 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -78.55 139.12 38.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.896 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -154.79 -29.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.366 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 34.1 p -156.61 162.14 39.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.579 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -151.98 155.37 37.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.325 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 84.0 p -75.37 159.99 30.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.389 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.5 tt -87.38 126.25 41.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.163 0.506 . . . . 0.0 110.274 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.539 ' C ' ' H ' ' A' ' 190' ' ' VAL . 87.4 mtm180 -65.35 -35.47 81.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.224 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.524 ' O ' ' ND1' ' A' ' 143' ' ' HIS . 69.2 mtm180 67.15 -5.0 0.75 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.275 0.559 . . . . 0.0 109.67 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.539 ' H ' ' C ' ' A' ' 188' ' ' ARG . 14.9 p -137.85 153.97 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -136.04 151.34 20.7 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 119.904 -1.141 . . . . 0.0 112.973 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.8 pp -166.89 147.54 5.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.144 0.497 . . . . 0.0 111.273 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -172.86 -156.84 13.32 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.92 147.92 33.08 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-O 122.063 0.935 . . . . 0.0 113.041 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 7.5 tp -116.89 148.01 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.204 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.09 167.12 30.31 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.897 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 150.98 -168.31 30.66 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.5 m -140.53 159.7 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 117.317 0.558 . . . . 0.0 110.407 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -143.91 133.78 5.49 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.787 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -130.51 127.23 38.73 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.564 ' OD1' ' NE2' ' A' ' 126' ' ' GLN . 0.1 OUTLIER -79.19 152.02 30.91 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 -173.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.498 ' CD1' ' N ' ' A' ' 202' ' ' ILE . 1.2 mp -62.36 -42.85 97.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 174.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.1 OUTLIER -164.5 171.9 5.22 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 176.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.569 ' O ' ' C ' ' A' ' 238' ' ' PHE . 13.8 Cg_endo -65.91 63.72 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 CA-C-N 121.722 1.651 . . . . 0.0 110.598 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 203' ' ' THR . 16.3 ptpt -134.21 -46.4 0.77 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.12 0.568 . . . . 0.0 110.516 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.5 tt -160.63 153.21 20.82 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.1 t -134.48 152.84 52.05 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.67 133.26 34.26 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 112.881 -1.963 . . . . 0.0 106.482 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.576 ' CG ' HH12 ' A' ' 235' ' ' ARG . 6.1 t70 -135.66 133.91 38.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.908 0.861 . . . . 0.0 112.564 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -101.94 117.99 35.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.06 143.89 15.12 Favored Glycine 0 N--CA 1.467 0.735 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.983 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -171.32 136.06 1.0 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.373 -0.913 . . . . 0.0 108.597 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.527 ' O ' ' CD1' ' A' ' 214' ' ' TYR . 0.0 OUTLIER -166.15 -139.84 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.251 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 213' ' ' ARG . 75.8 m-85 -155.48 -158.88 0.86 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.471 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -141.47 167.46 22.11 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.212 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 62.98 90.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.58 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -96.33 137.74 34.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.392 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 152.41 -117.95 0.85 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.426 ' O ' ' ND2' ' A' ' 222' ' ' ASN . 93.9 mtt-85 -70.4 147.13 49.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.787 0.327 . . . . 0.0 110.254 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 220' ' ' LEU . 3.4 mm? -62.21 -42.03 98.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -92.19 107.4 19.19 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.572 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 219' ' ' ARG . 10.3 p30 -162.08 117.47 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.559 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.514 ' CG2' ' H ' ' A' ' 224' ' ' ARG . 28.2 m 50.85 175.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.615 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.514 ' H ' ' CG2' ' A' ' 223' ' ' THR . 2.5 mpt_? -65.71 147.92 52.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.018 0.437 . . . . 0.0 110.356 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -63.78 -37.73 88.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.938 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 56.08 96.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.136 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 69.2 p -78.31 165.53 23.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.515 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.52 164.17 37.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.293 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -82.56 -86.92 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.481 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -171.48 162.68 6.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.581 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 32.1 t -140.84 123.05 15.74 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.889 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.27 127.96 42.75 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -117.65 152.36 17.69 Favored Glycine 0 CA--C 1.517 0.2 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.86 128.04 75.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.595 ' CD ' ' HH ' ' A' ' 10' ' ' TYR . 80.5 mtm-85 -126.24 141.16 52.03 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.397 0.618 . . . . 0.0 110.03 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -90.62 115.57 27.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.121 -176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.66 HH22 ' NZ ' ' A' ' 132' ' ' LYS . 31.3 ttm105 -124.04 87.88 2.81 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.569 ' C ' ' O ' ' A' ' 204' ' ' PRO . 33.3 t80 . . . . . 0 CA--C 1.512 -0.505 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.721 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.9 p -155.51 163.09 40.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.415 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 57.0 mp0 -80.76 127.19 32.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.36 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -72.28 -117.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.245 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.36 11.23 85.22 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.64 -143.54 8.51 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.551 HH22 HE22 ' A' ' 126' ' ' GLN . 95.9 mtt-85 -82.92 156.31 23.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.814 -0.193 . . . . 0.0 110.792 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.524 ' O ' ' CD2' ' A' ' 10' ' ' TYR . . . 120.54 -95.22 0.57 Allowed Glycine 0 CA--C 1.55 2.253 0 CA-C-O 119.716 -0.491 . . . . 0.0 113.394 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.576 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 71.8 Cg_exo -45.65 106.63 0.09 OUTLIER 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.232 2.621 . . . . 0.0 116.825 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 16.7 m-85 -146.51 157.2 43.71 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.97 154.66 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.077 -1.049 . . . . 0.0 112.703 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.538 HE21 ' C ' ' A' ' 13' ' ' ALA . 46.9 tp60 -120.24 149.67 41.9 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.307 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.538 ' C ' HE21 ' A' ' 12' ' ' GLN . . . -137.7 125.87 23.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.209 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 53.1 p-10 -91.91 149.75 21.39 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.444 ' O ' ' OG ' ' A' ' 231' ' ' SER . 1.0 OUTLIER 178.49 174.54 0.62 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.591 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.33 156.67 34.89 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.917 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -107.15 136.28 47.25 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.952 0.406 . . . . 0.0 111.198 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.81 104.07 0.06 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.673 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' A' ' 20' ' ' GLU . 86.2 t80 -142.36 155.95 45.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.37 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.543 ' O ' ' CD2' ' A' ' 19' ' ' TYR . 57.7 mp0 -81.7 148.3 29.05 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.929 0.395 . . . . 0.0 111.202 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -175.19 45.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.588 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.95 97.47 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.221 0.534 . . . . 0.0 111.044 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.3 m -66.66 -44.55 81.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.737 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 60.69 90.83 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.633 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 25' ' ' ASP . 40.4 p-10 -132.44 110.56 10.61 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.656 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.564 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.7 OUTLIER -165.83 44.97 0.11 Allowed Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 121.143 0.497 . . . . 0.0 110.255 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 26' ' ' TYR . 37.9 Cg_endo -64.31 -22.56 66.37 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.574 2.183 . . . . 0.0 112.074 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 27' ' ' PRO . 43.2 mt-10 56.91 150.6 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.103 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.57 87.19 1.57 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.25 1.966 . . . . 0.0 111.47 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.436 ' O ' ' C ' ' A' ' 31' ' ' ALA . 90.3 m -65.06 -86.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.05 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 30' ' ' THR . . . -26.63 91.77 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 O-C-N 123.611 0.57 . . . . 0.0 112.177 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.09 146.59 14.4 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 122.119 1.879 . . . . 0.0 111.978 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 55.01 35.0 23.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.852 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -62.27 -45.44 93.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.458 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -124.8 149.07 47.78 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.279 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -61.68 -44.99 95.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.268 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.22 128.16 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.245 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -155.97 76.86 0.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.596 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -159.22 28.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.643 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.443 ' O ' ' OG ' ' A' ' 41' ' ' SER . 35.9 m -135.38 162.97 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.914 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 40' ' ' VAL . 79.2 p 51.68 175.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.945 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.9 t0 60.3 50.33 6.29 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.49 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -73.63 -126.12 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.947 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 45' ' ' ARG . 91.1 m-85 -65.11 -44.84 87.46 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.319 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 44' ' ' PHE . 28.3 mmt180 42.43 96.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.913 0.387 . . . . 0.0 110.856 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -78.89 143.98 35.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.677 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.91 132.1 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.308 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -77.15 148.49 35.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.744 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 t -146.33 160.67 41.71 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.659 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -137.66 90.0 2.46 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.538 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.8 t -155.88 123.62 5.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.279 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.97 162.89 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.264 0.555 . . . . 0.0 111.378 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -60.29 153.7 57.03 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.997 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.2 42.17 0.84 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.5 2.133 . . . . 0.0 111.541 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 53.58 -129.5 2.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.787 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.469 ' CG2' ' N ' ' A' ' 57' ' ' SER . 9.1 p -163.57 157.33 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 117.696 -1.602 . . . . 0.0 114.929 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.469 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 21.8 t -117.7 121.6 41.3 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 113.946 -1.479 . . . . 0.0 107.783 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -132.97 148.72 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.64 0.257 . . . . 0.0 110.607 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -157.77 165.9 33.73 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.327 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -112.85 147.65 36.53 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 24.9 t70 -157.08 153.97 28.71 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -177.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 4.8 p90 -130.77 155.07 47.28 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 110.629 -2.987 . . . . 0.0 106.146 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -42.85 117.35 1.48 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.509 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 124' ' ' ASP . . . 144.82 -89.65 0.16 Allowed Glycine 0 CA--C 1.534 1.241 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 25.1 p-90 -152.86 173.27 15.55 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.688 HH22 ' NH1' ' A' ' 237' ' ' ARG . 0.2 OUTLIER -130.88 173.02 11.37 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.042 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.5 mt -116.7 125.38 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 171.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.4 111.78 13.16 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.31 126.53 32.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.723 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -90.82 127.81 36.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -119.13 113.03 20.27 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.91 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -170.47 122.83 0.65 Allowed 'General case' 0 C--N 1.339 0.116 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.786 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -147.56 135.33 21.07 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.922 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -139.89 -20.99 0.89 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.934 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -93.26 60.98 3.27 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.836 0.351 . . . . 0.0 111.147 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.68 -77.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.368 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -158.17 147.98 19.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.945 0.402 . . . . 0.0 110.61 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -147.6 145.0 28.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.006 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 81' ' ' LYS . 47.0 t30 48.47 -116.36 0.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.287 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.488 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 13.6 t-20 58.07 -75.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.686 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 79' ' ' ASN . 68.1 mttm -63.04 -43.68 98.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.46 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 84' ' ' VAL . 87.9 m-85 -63.34 -42.46 98.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.082 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.0 t 57.34 -77.76 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.853 0.359 . . . . 0.0 110.477 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 82' ' ' TYR . 35.9 m -126.62 160.61 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.661 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 87' ' ' GLU . 98.6 m-20 -83.35 72.75 10.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.319 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 85' ' ' ASN . 43.8 mm 31.36 -86.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.91 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 85' ' ' ASN . 74.1 mm-40 -63.68 143.65 57.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.916 0.388 . . . . 0.0 110.696 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -98.93 143.86 28.76 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.72 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.0 p -79.73 131.53 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.297 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 91' ' ' ILE . 78.8 ttt-85 -165.2 -57.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.665 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 90' ' ' ARG . 18.5 pt 32.02 -121.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.915 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -93.12 35.7 1.06 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.68 0.276 . . . . 0.0 111.321 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.7 mttp 54.08 -170.57 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.626 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 53.59 94.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.785 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -63.55 -41.15 98.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.767 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.52 -135.33 4.09 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.9 pt -80.34 136.83 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.91 0.386 . . . . 0.0 110.464 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -144.76 -44.53 0.24 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.65 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.6 mm -63.83 -43.64 97.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.0 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -78.17 92.18 4.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.358 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -73.12 142.95 47.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.385 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -138.85 151.43 46.99 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.272 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.17 135.33 53.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.422 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -125.97 -22.14 4.2 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.779 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 59.39 46.89 11.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.105 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 107' ' ' GLU . 77.2 mt-30 -57.01 133.06 54.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.051 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 106' ' ' GLN . 97.0 mt-10 55.16 165.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -159.54 81.28 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.601 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.47 -3.83 57.89 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.422 ' CG2' ' H ' ' A' ' 112' ' ' HIS . 22.3 m -65.85 131.02 45.28 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.202 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -88.35 -3.6 58.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.301 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.422 ' H ' ' CG2' ' A' ' 110' ' ' THR . 27.7 t-80 69.39 -1.61 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.607 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.32 144.34 26.39 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.996 0.427 . . . . 0.0 110.782 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.34 162.85 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.826 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.6 p -45.56 115.24 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.076 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.2 m -81.77 -135.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.176 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.02 144.48 50.37 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 177.18 -141.63 5.42 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.101 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.2 130.57 53.32 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.53 0.681 . . . . 0.0 111.694 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.4 m -132.25 111.32 11.29 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.47 127.76 38.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 1.9 mp -90.34 161.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 176.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.447 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 2.4 t80 -139.76 108.0 5.79 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.524 ' CB ' HH12 ' A' ' 66' ' ' ARG . 18.3 t70 -123.7 132.44 53.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.36 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.522 ' C ' ' H ' ' A' ' 127' ' ' ILE . 27.6 m-85 -93.99 84.1 4.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.798 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.551 HE22 HH22 ' A' ' 7' ' ' ARG . 54.9 tt0 -52.14 -4.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.786 -0.571 . . . . 0.0 111.352 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.522 ' H ' ' C ' ' A' ' 125' ' ' PHE . 92.7 mt -66.59 -42.71 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 120.228 -0.589 . . . . 0.0 112.304 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 22.4 t-20 -68.02 -40.35 82.95 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.189 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 128' ' ' ASN . 11.4 t0 88.6 -55.15 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.031 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -79.33 -51.74 9.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 2.0 p90 -151.55 128.22 10.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.75 153.34 78.77 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.56 136.01 48.27 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 120.514 0.81 . . . . 0.0 110.68 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.81 128.2 34.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.7 mt -141.55 139.77 31.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -171.2 175.01 44.93 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.231 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.69 152.81 48.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -124.86 130.8 53.09 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.0 t -130.71 118.52 42.61 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.23 130.2 42.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.024 0.44 . . . . 0.0 110.563 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -111.48 136.71 50.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.43 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -90.57 -70.44 1.21 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -154.44 130.53 10.28 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.707 0.289 . . . . 0.0 110.444 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.99 110.78 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.208 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -96.21 3.57 53.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.194 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 51.1 m170 -95.17 130.45 41.9 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.963 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 149' ' ' ASP . 22.7 t -139.14 140.21 37.83 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.426 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.414 HD12 HG22 ' A' ' 148' ' ' ILE . 90.6 mt 47.28 -86.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.543 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 147' ' ' SER . 97.8 m-20 57.01 45.27 21.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.195 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 152' ' ' LYS . 11.5 t -61.62 -43.54 98.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.002 0.43 . . . . 0.0 110.402 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 93.9 m 43.75 -89.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.767 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 150' ' ' SER . 25.4 pttm -72.95 133.35 44.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.727 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -114.56 -113.36 0.34 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.872 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 155' ' ' ILE . 77.3 p -73.2 -20.43 60.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.924 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 154' ' ' THR . 93.7 mt 55.11 109.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.468 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.41 -109.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.017 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.03 136.13 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.269 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 57.1 p -131.15 152.66 50.21 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.018 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 98.8 m -88.25 126.57 35.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.783 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.4 m -85.93 151.31 54.63 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.822 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -41.86 140.21 2.09 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.07 1.847 . . . . 0.0 112.591 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 163' ' ' ASN . 61.9 m -107.75 69.4 0.74 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.827 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 162' ' ' SER . 64.1 t30 60.54 128.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.487 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.51 79.28 4.4 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.186 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -60.79 147.77 94.14 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.49 2.127 . . . . 0.0 110.975 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -139.87 170.56 15.65 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.956 0.408 . . . . 0.0 111.058 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 168' ' ' ALA . . . 154.18 -52.39 0.46 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 167' ' ' GLY . . . 54.73 161.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.779 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -64.25 -29.35 47.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.443 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 69.0 p -74.31 169.77 16.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 81.1 p -76.52 165.04 25.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -142.68 10.0 1.8 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.647 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -63.0 -41.15 99.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.257 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 81.2 p -108.81 128.48 54.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.977 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -97.05 150.9 37.34 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.577 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -37.39 -54.77 1.1 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 122.404 2.07 . . . . 0.0 112.527 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -165.46 -29.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.073 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 36.2 m -66.76 133.51 50.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.826 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -151.17 81.14 1.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.835 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.6 t30 56.9 33.84 23.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.401 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -89.03 168.54 12.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.446 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -81.83 142.98 32.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.349 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.488 ' CD ' ' H ' ' A' ' 183' ' ' GLN . 1.7 mp0 -51.26 149.88 3.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.544 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.2 t 46.28 -159.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.808 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -129.19 139.93 51.7 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.799 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.1 t -68.72 -148.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.985 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.5 mp -73.7 125.48 32.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.52 HH22 ' CZ ' ' A' ' 189' ' ' ARG . 9.5 ptm180 -81.17 157.91 25.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.306 0.575 . . . . 0.0 111.46 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.52 ' CZ ' HH22 ' A' ' 188' ' ' ARG . 99.7 mtt180 54.48 61.61 2.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.861 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.28 155.97 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -134.6 131.73 6.02 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.212 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.1 mp -136.7 132.62 35.15 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.583 0.706 . . . . 0.0 109.902 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -162.42 -170.5 27.31 Favored Glycine 0 C--N 1.321 -0.27 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.1 m -134.69 160.91 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.435 1.118 . . . . 0.0 113.653 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mt -110.12 136.26 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 113.032 -1.895 . . . . 0.0 110.251 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -160.67 147.0 15.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.693 0.758 . . . . 0.0 110.871 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 163.06 -172.44 39.07 Favored Glycine 0 C--O 1.221 -0.686 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 33.8 m -136.93 155.05 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 118.303 1.051 . . . . 0.0 109.472 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -154.78 159.51 29.03 Favored Glycine 0 C--O 1.241 0.555 0 C-N-CA 119.452 -1.356 . . . . 0.0 112.181 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.84 153.15 37.68 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.541 0.686 . . . . 0.0 110.557 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -59.52 149.5 29.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.065 -1.425 . . . . 0.0 113.971 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 206' ' ' LEU . 47.0 mm -111.31 -46.13 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.55 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.2 OUTLIER -127.43 -172.93 0.28 Allowed Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 175.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.55 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.8 OUTLIER -14.06 -85.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.401 0 CA-C-N 124.04 2.478 . . . . 0.0 114.869 -178.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -126.7 21.39 7.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.007 0.908 . . . . 0.0 110.057 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 202' ' ' ILE . 1.0 OUTLIER -75.08 112.98 11.88 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.6 t -130.87 152.59 50.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.45 143.07 44.2 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 113.082 -1.872 . . . . 0.0 107.9 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.81 150.68 49.05 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -126.31 134.15 51.2 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 231' ' ' SER . . . -174.57 -164.13 28.95 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 119.431 -1.366 . . . . 0.0 113.419 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -156.28 151.23 26.22 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 115.221 -0.49 . . . . 0.0 109.795 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 80.2 mtm-85 -92.6 124.93 36.98 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -107.07 125.41 51.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 109.97 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -56.61 156.97 5.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.556 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -45.38 160.24 0.05 OUTLIER 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.578 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -78.45 143.67 36.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.547 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -170.77 84.23 0.08 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -71.92 -22.04 61.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.544 0.211 . . . . 0.0 111.458 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.13 -41.45 98.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.12 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -157.03 133.15 9.66 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.97 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.612 ' ND2' ' HZ2' ' A' ' 226' ' ' LYS . 58.8 t-20 -161.91 70.54 0.33 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.98 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 19.7 m -66.33 -43.24 86.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.76 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -56.44 149.49 16.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.244 0.545 . . . . 0.0 111.189 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -101.55 152.03 21.27 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.009 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.612 ' HZ2' ' ND2' ' A' ' 222' ' ' ASN . 36.9 mmtm -88.27 -178.59 5.95 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.947 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.4 m -144.8 157.94 43.98 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.129 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -117.11 123.98 48.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.196 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -139.76 151.2 45.61 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.923 0.392 . . . . 0.0 110.623 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -97.88 76.13 2.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 211' ' ' GLY . 29.6 t -157.87 158.34 34.91 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.565 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -178.05 -72.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 147.7 -166.83 28.75 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.461 ' N ' HE22 ' A' ' 12' ' ' GLN . 3.0 m -134.71 144.98 33.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -118.21 136.63 53.53 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -101.32 107.88 19.35 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.017 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.688 ' NH1' HH22 ' A' ' 66' ' ' ARG . 81.8 mtp180 -113.93 113.58 25.04 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.431 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 93.3 m-85 . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.428 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.6 p -102.72 75.14 1.4 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.748 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.521 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 56.3 mp0 -82.81 22.7 0.88 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.215 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -64.78 141.53 58.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.001 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.62 177.3 46.79 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.89 16.64 50.51 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.131 -0.787 . . . . 0.0 111.131 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -129.06 157.99 40.19 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.47 124.77 6.83 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.21 160.05 33.05 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.902 1.734 . . . . 0.0 109.583 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.708 ' CD2' ' NH2' ' A' ' 66' ' ' ARG . 33.1 t80 -151.07 136.98 18.15 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.45 -0.9 . . . . 0.0 113.01 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.0 t -141.49 160.41 21.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -147.78 140.02 24.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.882 0.765 . . . . 0.0 112.856 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.01 122.9 45.53 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.158 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -83.11 124.82 30.84 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.4 tp -116.52 132.37 56.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.998 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.88 47.5 0.78 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.28 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' CD2' ' N ' ' A' ' 18' ' ' ALA . 68.1 t80 47.85 -104.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.926 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.45 ' N ' ' CD2' ' A' ' 17' ' ' TYR . . . -157.4 -134.72 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.761 0.315 . . . . 0.0 110.701 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -146.71 161.96 39.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.577 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -120.53 137.72 54.23 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.516 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -153.08 164.16 38.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.745 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.0 tt -128.48 126.3 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.956 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.454 ' C ' ' ND1' ' A' ' 24' ' ' HIS . 69.2 p -129.59 -11.6 4.45 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.547 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.454 ' ND1' ' C ' ' A' ' 23' ' ' THR . 46.3 p-80 36.22 46.75 0.41 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.598 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -97.45 114.37 26.21 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.174 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 7.3 m-85 -54.31 149.66 19.07 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.58 152.76 78.76 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.871 1.714 . . . . 0.0 111.297 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 28' ' ' GLU . 20.2 mp0 -124.9 78.95 65.11 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.607 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -89.88 115.73 0.62 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 123.016 2.477 . . . . 0.0 112.251 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.47 -45.98 81.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.068 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 59.09 60.73 4.85 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.175 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.52 151.51 53.14 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.701 2.268 . . . . 0.0 112.036 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -103.82 144.83 30.97 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.681 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.81 125.22 28.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.382 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -159.3 171.73 19.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.424 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -89.69 96.13 10.56 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.9 pt -69.24 -40.85 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 m 58.34 9.25 0.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.778 0.323 . . . . 0.0 110.861 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.7 p -135.1 157.21 47.5 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.657 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 t -89.26 131.08 37.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.357 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.1 m -113.79 146.33 40.09 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.936 0.398 . . . . 0.0 110.537 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -86.75 155.05 20.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.885 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -110.5 149.96 29.58 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.437 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -99.27 130.89 45.59 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.028 0.442 . . . . 0.0 110.818 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -63.75 -158.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.937 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.1 m120 57.14 60.0 3.16 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.25 -48.59 88.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.429 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -161.41 160.39 29.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.602 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.4 p -134.86 155.79 50.05 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.938 0.399 . . . . 0.0 110.723 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.446 ' O ' ' OG ' ' A' ' 51' ' ' SER . 41.3 ttm180 -161.28 -48.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.075 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 50' ' ' ARG . 88.8 p 54.51 -162.52 0.13 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.828 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 51' ' ' SER . 4.5 t 60.93 127.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 52' ' ' VAL . 49.7 m80 -153.04 94.01 3.12 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -80.78 118.35 3.44 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.824 1.683 . . . . 0.0 110.006 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.401 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 39.6 mmt180 -71.08 -122.61 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.401 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 8.3 m -157.18 -176.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 119.206 -0.998 . . . . 0.0 112.961 -176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.89 136.4 54.93 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.875 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.2 p -141.85 148.98 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.017 0.437 . . . . 0.0 111.776 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.58 -155.61 20.26 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -131.83 154.15 49.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 2.5 p30 -130.01 133.17 46.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -175.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.73 123.51 33.22 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.945 -1.48 . . . . 0.0 107.479 175.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -34.77 134.73 0.4 Allowed Glycine 0 N--CA 1.472 1.038 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.522 ' O ' ' CD2' ' A' ' 123' ' ' TYR . . . 97.64 -63.45 0.93 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -131.23 136.02 47.87 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.342 0.591 . . . . 0.0 111.153 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.708 ' NH2' ' CD2' ' A' ' 10' ' ' TYR . 54.9 mtp180 -137.01 156.05 48.92 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.1 tt -139.64 140.68 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.377 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.18 147.22 10.97 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.83 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.85 149.49 26.35 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -115.99 145.63 42.8 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.505 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 80.3 m-85 67.41 -98.08 0.04 OUTLIER 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.192 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . 96.83 81.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.468 1.105 . . . . 0.0 110.3 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -151.59 144.72 24.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 111.198 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 75' ' ' ARG . 32.0 p90 -178.59 13.09 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.509 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 74' ' ' TYR . 83.6 mtp180 -54.06 -123.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.723 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.1 tptp 64.95 48.84 2.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.646 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -92.57 148.99 21.64 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.618 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.514 ' CG ' ' H ' ' A' ' 79' ' ' ASN . 41.4 t-20 47.73 -139.86 0.63 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.234 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 13.6 m120 55.33 43.03 29.62 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.765 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -56.11 109.88 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 0.0 110.146 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.96 155.69 47.83 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.539 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -62.88 121.77 14.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.0 110.89 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.7 p -161.44 -12.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.974 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 85' ' ' ASN . 55.5 t -124.38 133.75 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.06 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.42 ' O ' ' O ' ' A' ' 84' ' ' VAL . 12.8 m120 56.07 111.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.555 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.405 HD12 HG21 ' A' ' 86' ' ' ILE . 95.9 mt -80.61 128.42 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.596 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -132.81 142.71 49.12 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.212 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 90' ' ' ARG . 49.3 p-10 -68.57 -27.07 65.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.804 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 88' ' ' ASN . 40.2 t 45.7 -87.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.517 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.547 ' N ' ' O ' ' A' ' 88' ' ' ASN . 89.7 mtm-85 -78.62 142.58 37.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.844 0.354 . . . . 0.0 110.348 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.527 ' C ' ' H ' ' A' ' 93' ' ' LYS . 42.7 pt -104.77 -141.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.865 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 94' ' ' GLU . 69.7 ttt180 68.52 -11.84 0.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.527 ' H ' ' C ' ' A' ' 91' ' ' ILE . 54.3 mtmt 48.89 -87.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.94 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 92' ' ' ARG . 49.9 tp10 -67.58 91.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.534 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -64.7 -40.97 96.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.719 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.0 98.82 0.09 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.0 pt -129.93 160.54 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 120.794 0.331 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -78.78 147.28 33.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.845 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.2 mt -81.25 128.09 39.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.228 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 101' ' ' ARG . 34.2 t70 -124.39 42.39 3.27 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.701 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 100' ' ' ASP . 77.2 ttt-85 58.01 150.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.333 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 103' ' ' THR . 63.6 mttp -64.54 -45.42 87.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.619 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER 27.56 -107.37 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.459 0.475 . . . . 0.0 111.621 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.508 ' N ' ' OG1' ' A' ' 103' ' ' THR . 97.6 mt-10 -83.76 151.85 24.99 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 107' ' ' GLU . 55.6 p30 -150.76 171.09 17.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.922 0.391 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -55.08 90.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.355 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 105' ' ' ASN . 80.8 tt0 -78.06 141.1 39.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.436 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.572 HD22 ' CE1' ' A' ' 112' ' ' HIS . 64.9 t30 56.95 46.9 18.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.607 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -71.09 48.64 0.86 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 t -137.42 160.09 40.09 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.771 0.32 . . . . 0.0 110.376 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -95.8 136.84 35.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.992 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.572 ' CE1' HD22 ' A' ' 108' ' ' ASN . 70.6 m80 -83.55 152.91 24.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.652 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -153.45 39.53 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.437 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 115' ' ' SER . 69.1 t -62.76 -46.76 95.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.986 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 114' ' ' VAL . 2.9 t 34.79 97.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.638 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.441 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 26.3 t -158.99 74.02 0.63 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.748 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.34 142.6 49.39 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 168.22 -151.76 19.12 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 118.931 -1.604 . . . . 0.0 113.768 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.8 mt -113.32 160.17 18.63 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 114.993 -0.604 . . . . 0.0 109.84 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 p -143.67 129.17 19.07 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 111.818 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.0 130.03 40.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 73.0 mt -123.9 161.59 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -175.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 64' ' ' GLY . 50.5 t80 -140.65 141.16 35.08 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.407 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 24.1 p-10 -143.38 138.63 29.54 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.279 0.561 . . . . 0.0 111.598 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.476 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 14.8 m-85 -83.97 83.56 7.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.048 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.432 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 70.2 mm-40 -85.33 6.09 27.84 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.28 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 20.4 tt -69.21 -40.16 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.421 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.548 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 20.1 p30 -90.65 -40.53 11.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.749 0.309 . . . . 0.0 110.202 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 1.2 m-20 77.1 -30.43 0.17 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.277 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -65.34 -45.04 85.8 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.059 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -154.49 116.16 4.15 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.568 0.699 . . . . 0.0 110.928 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.476 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 1.1 ptpp? -115.54 119.66 37.51 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.233 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -53.14 118.16 4.53 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 CA-C-N 119.736 0.941 . . . . 0.0 110.066 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -76.28 127.82 33.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.8 tt -155.98 146.46 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 118.768 -1.173 . . . . 0.0 112.818 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -169.76 178.63 42.62 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.22 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -116.19 157.4 24.9 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -124.83 138.47 54.26 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.33 114.05 32.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.97 152.65 51.91 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -104.26 160.75 14.62 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.426 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -126.62 -54.59 0.15 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -119.94 109.78 15.93 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.9 m -89.69 3.32 6.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.241 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.468 ' O ' ' CG ' ' A' ' 146' ' ' HIS . 59.1 ttm-85 55.71 -120.64 1.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.468 ' CG ' ' O ' ' A' ' 145' ' ' ARG . 79.0 m80 -157.77 -56.09 0.08 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.807 0.337 . . . . 0.0 110.457 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 85.6 p -73.96 151.9 40.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 21.4 tt -133.19 -37.94 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.097 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -70.18 147.78 49.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.633 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.7 m 60.02 115.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.802 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.7 p -129.92 -49.2 1.13 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.589 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -147.86 135.79 21.12 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.389 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 154' ' ' THR . 60.2 tttp -136.98 133.2 35.34 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.711 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 153' ' ' LYS . 5.6 m 57.47 153.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 156' ' ' GLU . 20.3 mm -106.17 117.71 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.549 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 155' ' ' ILE . 80.1 mm-40 56.82 140.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.338 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.9 m -106.11 -12.47 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.521 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 15.4 p -86.2 155.01 20.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.241 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 86.5 m -119.06 128.37 54.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.216 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.6 m -73.87 146.65 85.56 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.251 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.3 161.03 43.79 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.463 2.109 . . . . 0.0 112.235 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 70.7 m -68.65 148.81 49.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.773 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 57.72 34.7 24.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.296 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.59 -60.7 6.11 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.25 -172.48 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.222 1.948 . . . . 0.0 110.967 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 166' ' ' ASN . 61.7 t-20 57.11 38.27 28.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.866 0.365 . . . . 0.0 110.421 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -115.9 17.63 15.18 Favored Glycine 0 N--CA 1.466 0.636 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 61.28 -153.41 0.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.332 . . . . 0.0 110.53 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.7 m -113.05 131.96 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.911 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.6 m -61.77 -46.44 89.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.702 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 5.3 m -162.21 -47.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.095 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -83.26 137.93 33.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.132 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -63.8 -40.24 96.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.601 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 85.4 m 48.68 90.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.503 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -87.02 135.75 34.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.72 67.05 8.76 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.096 1.864 . . . . 0.0 111.504 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -62.65 -41.0 98.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.382 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.8 t -144.31 154.99 43.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.987 0.422 . . . . 0.0 110.913 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -103.31 147.55 26.93 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.327 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -95.85 11.33 34.08 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.562 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.28 108.02 13.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.978 0.418 . . . . 0.0 110.613 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -147.41 136.1 21.96 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.101 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -49.96 110.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.535 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.9 m -73.13 145.41 46.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.739 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -163.81 32.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.161 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 187' ' ' ILE . 75.1 p -58.3 -88.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.029 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.407 ' N ' ' OG ' ' A' ' 186' ' ' SER . 37.6 mm 50.24 87.78 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 42.38 -135.34 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.356 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -106.35 122.3 45.97 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.453 0.644 . . . . 0.0 111.816 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.5 t -121.15 132.78 69.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -137.84 136.38 8.14 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 119.177 -1.487 . . . . 0.0 113.756 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -117.52 148.75 41.57 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.378 -0.911 . . . . 0.0 108.81 178.408 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -169.28 -169.63 32.85 Favored Glycine 0 C--N 1.32 -0.312 0 N-CA-C 107.906 -2.077 . . . . 0.0 107.906 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.0 m -137.98 155.08 29.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.981 0.896 . . . . 0.0 111.972 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.6 tp -113.86 131.69 65.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.015 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.76 149.19 33.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.119 0.485 . . . . 0.0 111.259 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.94 -167.17 37.26 Favored Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 p -145.13 140.13 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 117.284 0.542 . . . . 0.0 110.46 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.48 130.55 9.18 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.38 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.606 ' N ' ' OG1' ' A' ' 207' ' ' THR . 2.6 t80 -115.09 118.71 34.14 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -61.26 149.88 36.42 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 206' ' ' LEU . 51.4 mm -113.35 -61.13 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.515 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.7 OUTLIER -102.11 -173.14 0.28 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 175.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.515 ' C ' ' O ' ' A' ' 203' ' ' THR . 5.5 Cg_exo -22.76 -79.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.352 0 CA-C-N 123.281 2.208 . . . . 0.0 114.486 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -128.33 34.89 4.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.543 0.687 . . . . 0.0 111.181 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 202' ' ' ILE . 0.3 OUTLIER -90.31 111.7 23.01 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.606 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 0.9 OUTLIER -132.51 152.52 51.53 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.17 140.52 29.42 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.453 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 233' ' ' GLY . 4.4 m-20 -118.94 138.83 52.51 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -121.69 123.43 41.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 113.717 -1.583 . . . . 0.0 107.841 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -160.17 -175.81 31.56 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.365 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -141.96 154.21 44.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.78 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.533 ' N ' ' NE ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -83.5 139.1 33.12 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -128.38 89.96 2.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.72 0.295 . . . . 0.0 110.667 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -101.64 140.01 36.52 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.65 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.8 t30 60.29 70.47 0.62 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 111.16 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -59.65 -41.56 90.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.959 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -126.82 -142.9 5.72 Favored Glycine 0 N--CA 1.468 0.816 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 56.45 66.63 1.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.749 0.309 . . . . 0.0 110.261 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 40.9 tp 40.61 80.82 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.685 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -87.53 123.41 32.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.559 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -82.71 141.75 32.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.93 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 23.8 m -73.33 120.1 18.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.963 0.411 . . . . 0.0 110.996 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -160.31 152.84 20.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.854 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -148.94 152.26 36.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.87 0.367 . . . . 0.0 110.861 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -146.94 -69.56 0.25 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.508 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.9 p -62.77 -78.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.214 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 71.9 t60 38.71 78.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.949 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -145.17 -92.01 0.1 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.324 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 169.18 86.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 38.6 p -160.2 167.66 27.13 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.099 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 26.8 tp -177.72 -63.9 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.807 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.429 ' O ' ' OD2' ' A' ' 209' ' ' ASP . . . 160.57 -168.82 36.17 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 119.929 -1.129 . . . . 0.0 112.781 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.0 127.92 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.708 ' NH2' HH11 ' A' ' 237' ' ' ARG . 0.2 OUTLIER -104.95 141.95 35.64 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.05 0.453 . . . . 0.0 110.425 -179.028 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -107.62 108.68 20.06 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.053 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.708 HH11 ' NH2' ' A' ' 235' ' ' ARG . 82.4 mtp180 -129.38 120.11 25.0 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.407 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 1.6 m-85 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.707 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 4' ' ' ASP . 34.2 t -85.41 65.13 9.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.497 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 4' ' ' ASP . 83.1 tt0 47.42 -97.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.522 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 3' ' ' GLU . 6.8 p-10 41.43 -169.18 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.908 0.385 . . . . 0.0 111.029 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.51 14.56 50.47 Favored Glycine 0 N--CA 1.465 0.627 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.18 -57.81 15.35 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.031 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -139.76 148.12 41.81 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 117.03 0.415 . . . . 0.0 110.896 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.413 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . -166.35 -174.84 36.12 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.708 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.471 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 95.9 Cg_endo -82.69 176.65 7.59 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.884 3.056 . . . . 0.0 113.525 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.401 ' CE1' ' NH1' ' A' ' 66' ' ' ARG . 75.8 t80 -141.26 145.09 35.11 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 t -152.7 145.41 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 114.417 -1.265 . . . . 0.0 108.027 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.53 150.6 27.95 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.94 147.01 52.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 112.13 -2.304 . . . . 0.0 105.931 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -152.76 137.57 17.06 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.52 133.39 45.03 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.063 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.15 -87.55 0.48 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.522 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -120.81 122.99 41.51 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.463 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.2 162.37 16.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.845 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -148.4 160.21 43.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.32 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.89 119.62 39.44 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.448 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.671 ' CG ' ' H ' ' A' ' 22' ' ' ILE . 81.3 t60 -87.63 178.55 6.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.429 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.671 ' H ' ' CG ' ' A' ' 21' ' ' HIS . 20.7 tt -118.43 140.02 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.538 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.3 p -129.79 164.32 24.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.287 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -81.5 112.77 19.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.624 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -76.29 145.05 39.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.653 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -43.52 163.49 0.16 Allowed Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.149 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.43 ' O ' ' OE1' ' A' ' 28' ' ' GLU . 25.5 Cg_exo -60.76 146.92 96.58 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.478 1.452 . . . . 0.0 111.975 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 1.3 tp10 -179.01 -45.44 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.437 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 28' ' ' GLU . 51.8 Cg_exo -54.26 -37.29 88.19 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.333 2.022 . . . . 0.0 112.225 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 t -80.45 159.07 25.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.486 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . 177.82 -47.92 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.473 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 31' ' ' ALA . 50.8 Cg_exo -53.73 -41.08 77.09 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.251 1.967 . . . . 0.0 112.319 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' LYS . 20.4 t-20 -175.07 -93.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 0.0 110.455 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.479 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 45.3 mmtm 49.7 -177.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.075 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -152.3 58.28 0.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.595 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -72.67 -79.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.8 pt -75.18 -23.26 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.101 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -60.21 -42.35 94.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.089 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.4 m -124.59 132.3 53.44 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.9 0.381 . . . . 0.0 110.672 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.85 134.6 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.167 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 t -164.63 22.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.452 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -80.3 166.18 21.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.749 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -147.25 159.32 43.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -73.42 139.99 46.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.53 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -156.08 156.35 34.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 48' ' ' ARG . 98.8 m-20 54.44 103.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.992 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.611 ' H ' ' CD1' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -77.02 27.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.647 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 46' ' ' ASN . 11.6 ptp180 -44.62 -21.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.953 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.42 ' N ' ' C ' ' A' ' 47' ' ' ILE . 22.7 p -69.08 81.68 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.533 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -147.08 129.49 15.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 110.662 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 52' ' ' VAL . 47.1 t -139.79 -85.68 0.22 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.797 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 51' ' ' SER . 3.0 t 56.41 152.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.804 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.3 m170 55.18 79.1 0.35 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.245 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 55' ' ' ARG . 56.5 Cg_endo -90.22 79.67 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.011 2.474 . . . . 0.0 112.834 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 54' ' ' PRO . 56.8 ttp180 29.85 102.91 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 p -142.71 146.05 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.424 ' OG ' ' OD1' ' A' ' 70' ' ' ASP . 2.6 m -128.86 149.09 50.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.207 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.31 153.29 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.81 -148.73 7.53 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 61' ' ' ASP . 16.4 t80 -138.8 155.95 47.75 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 9' ' ' PRO . 7.4 p-10 -133.06 134.68 44.66 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -127.12 147.93 50.16 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 175.528 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.34 140.58 32.33 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.841 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.2 -35.21 2.98 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.11 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.454 ' O ' ' O ' ' A' ' 62' ' ' PHE . 84.6 m95 -139.4 131.13 27.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.406 0.603 . . . . 0.0 111.606 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.401 ' NH1' ' CE1' ' A' ' 10' ' ' TYR . 46.0 ttp180 -144.21 132.5 21.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.751 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.433 HG22 HD13 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -139.35 153.62 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.923 0.868 . . . . 0.0 112.358 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.39 140.0 8.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.934 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.98 146.01 24.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.698 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.424 ' OD1' ' OG ' ' A' ' 57' ' ' SER . 96.9 m-20 -93.31 128.74 39.46 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.515 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -109.24 140.14 43.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.498 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 73' ' ' ARG . . . -150.65 -75.49 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.486 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 72' ' ' ALA . 66.6 ttt180 56.73 136.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.162 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -145.21 149.88 35.71 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.149 0.5 . . . . 0.0 111.28 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -164.4 -174.41 3.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.829 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.4 tttm 67.19 47.85 1.28 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.833 0.349 . . . . 0.0 110.581 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.417 ' O ' ' O ' ' A' ' 78' ' ' ASN . 51.0 t90 -60.78 -46.47 90.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.816 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 77' ' ' TRP . 91.4 m-20 39.94 -161.94 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.793 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -65.0 141.74 58.67 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 82' ' ' TYR . 53.0 t-20 -101.0 -122.32 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.002 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 82' ' ' TYR . 17.8 ptpt -70.78 25.24 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.427 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.547 ' CG ' ' O ' ' A' ' 81' ' ' LYS . 53.9 p90 43.04 -170.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.02 0.438 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 84' ' ' VAL . 78.4 p -156.03 120.26 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.36 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 83' ' ' SER . 24.2 t 47.15 102.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.218 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -153.23 -85.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.572 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' GLU . 43.9 pt -91.47 -158.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.69 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 86' ' ' ILE . 83.0 tt0 59.59 124.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.332 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 87' ' ' GLU . 92.1 m-20 -145.72 178.9 7.81 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.713 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.8 p -91.33 136.78 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.39 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -120.2 131.85 55.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.751 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 86.9 mt 35.17 -101.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.33 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -171.57 92.25 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.037 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -84.13 153.92 23.44 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -41.26 110.01 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.867 0.365 . . . . 0.0 110.695 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -63.08 -40.79 98.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.931 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 99' ' ' ILE . . . 83.76 57.61 2.4 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.71 -42.95 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.762 0.315 . . . . 0.0 110.647 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.0 tpp85 -57.87 -46.36 84.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.848 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.444 ' O ' ' O ' ' A' ' 96' ' ' GLY . 42.1 pt -137.61 148.22 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.924 0.392 . . . . 0.0 110.772 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -79.85 152.63 29.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -69.83 148.58 48.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.36 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -143.24 156.5 44.76 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.73 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 t -144.41 156.28 44.14 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.438 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -124.92 -160.46 0.95 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.544 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 m120 57.74 36.53 26.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.861 0.362 . . . . 0.0 110.44 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.52 -12.7 61.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.347 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -70.18 -3.39 16.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.33 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -62.24 -41.19 98.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.582 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.37 145.93 31.1 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.7 p -116.4 130.71 56.91 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.833 0.349 . . . . 0.0 110.327 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -77.36 145.13 37.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.561 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -93.18 109.04 20.54 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.55 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.37 144.41 44.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.737 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.27 139.69 18.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.001 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.9 p -56.85 139.46 51.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.143 0.497 . . . . 0.0 111.769 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.8 m -161.45 147.84 14.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.365 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.1 mt -91.5 130.94 37.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -109.4 147.7 16.99 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.372 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.9 tp -128.3 133.0 48.65 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.3 m -137.27 116.42 12.54 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.555 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.98 134.14 55.44 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.168 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 74.5 mt -119.73 158.94 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.476 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 31.7 m-85 -113.73 109.71 19.0 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' OD2' ' NH1' ' A' ' 237' ' ' ARG . 20.9 t70 -107.36 138.64 43.19 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -116.87 152.37 34.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.677 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.597 HE21 ' HZ2' ' A' ' 205' ' ' LYS . 26.1 mm100 -147.37 44.22 1.13 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 127' ' ' ILE . 59.7 mt -69.18 -42.46 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -96.0 -13.15 24.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.41 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 61.88 29.42 17.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.336 0.588 . . . . 0.0 109.984 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -125.64 -51.5 1.6 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.846 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 131' ' ' PHE . 43.1 p90 -175.16 131.78 0.3 Allowed 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.247 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -134.21 151.64 76.81 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.846 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.22 130.98 20.99 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.507 1.471 . . . . 0.0 109.899 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.474 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 2.4 p90 -120.55 133.32 55.4 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 39.9 pt -135.55 152.76 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.286 0.565 . . . . 0.0 111.424 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.84 174.89 39.24 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -117.2 143.08 46.25 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.935 0.398 . . . . 0.0 110.194 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -116.92 116.89 28.28 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.6 p -124.65 158.95 31.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -135.71 142.97 45.14 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.647 0.737 . . . . 0.0 112.572 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -132.39 132.5 42.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.304 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -96.78 -133.85 7.89 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.842 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -142.17 165.9 26.17 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.5 m -133.35 158.57 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.07 0.462 . . . . 0.0 110.866 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -103.39 153.91 19.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.303 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -60.22 103.72 0.26 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.155 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.5 t -61.73 -42.19 98.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.325 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 92.2 mt -89.79 121.1 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.293 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 151' ' ' THR . 53.4 p30 -157.37 174.93 14.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.667 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 152' ' ' LYS . 10.3 m 53.49 -83.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.924 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.516 ' N ' ' O ' ' A' ' 149' ' ' ASP . 24.4 p -47.3 89.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 150' ' ' SER . 52.5 tptt -64.95 -45.26 86.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.46 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 55.96 168.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.486 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.2 t -149.24 171.21 16.84 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.908 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 34.2 pt -67.67 140.25 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.797 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -74.05 121.49 21.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.304 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.73 -42.7 93.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 58.9 p -120.55 153.49 36.67 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.49 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.7 m -99.14 126.08 44.82 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.999 0.428 . . . . 0.0 111.218 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 52.2 t -115.82 110.99 43.6 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.617 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -53.3 144.52 48.74 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.358 1.372 . . . . 0.0 112.149 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 85.9 p -73.81 154.36 39.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.804 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -107.56 6.86 28.38 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.704 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.13 62.46 0.76 Allowed Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.454 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.8 158.44 42.95 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.668 2.245 . . . . 0.0 111.536 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -77.64 106.55 9.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 0.0 110.481 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -69.21 149.0 48.37 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.55 -11.37 60.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.679 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.8 t -84.23 119.22 32.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.72 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.514 ' C ' ' H ' ' A' ' 172' ' ' TYR . 5.2 m -158.88 -14.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.35 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.524 ' C ' ' H ' ' A' ' 173' ' ' ASN . 51.2 p 47.53 11.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.035 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 172' ' ' TYR . 89.8 t80 49.61 9.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.029 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.524 ' H ' ' C ' ' A' ' 171' ' ' THR . 57.3 t-20 -140.46 -0.12 1.61 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.03 0.443 . . . . 0.0 110.172 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 93.7 m -63.67 -45.18 91.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.929 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -86.86 132.5 41.91 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.853 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.66 116.46 3.51 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.084 1.856 . . . . 0.0 111.856 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -87.64 118.47 27.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.831 0.348 . . . . 0.0 110.618 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 180' ' ' ASN . 3.0 t -147.86 146.29 29.02 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.437 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.419 ' O ' ' ND2' ' A' ' 180' ' ' ASN . 88.5 mt-30 44.31 14.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.078 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 178' ' ' THR . 15.9 m120 -137.25 27.24 2.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.442 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.51 143.66 57.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.849 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -146.53 158.07 43.84 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.433 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -73.78 -89.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.286 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.8 m -140.41 67.2 1.37 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.073 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 43.15 -105.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.575 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.4 t 53.69 73.72 0.36 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 65.8 mt -62.91 -45.17 99.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.031 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -70.66 140.78 51.63 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -80.57 151.89 28.88 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.81 148.83 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 114.029 -1.442 . . . . 0.0 108.855 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -130.34 126.2 4.89 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 7.4 tt -120.57 123.52 43.08 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 122.066 0.936 . . . . 0.0 111.415 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -138.06 157.37 24.31 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.59 139.63 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 117.41 0.605 . . . . 0.0 111.463 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 tt -116.42 132.98 64.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.472 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.52 34.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.04 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 162.5 -165.88 36.35 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.3 p -136.41 146.57 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 120.975 0.417 . . . . 0.0 109.974 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -117.67 137.37 13.18 Favored Glycine 0 C--O 1.244 0.754 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.977 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.634 ' N ' ' OG1' ' A' ' 207' ' ' THR . 10.7 t80 -122.16 120.0 32.94 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.689 0.876 . . . . 0.0 109.301 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 22.6 p30 -61.94 139.38 58.4 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.528 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.9 mt -125.18 -5.59 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-O 122.523 1.154 . . . . 0.0 109.499 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.581 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -160.35 -178.64 0.92 Allowed Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 101.271 -3.603 . . . . 0.0 101.271 177.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.581 ' C ' ' O ' ' A' ' 203' ' ' THR . 13.8 Cg_exo -18.95 -83.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 CA-C-N 123.965 2.452 . . . . 0.0 114.089 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.597 ' HZ2' HE21 ' A' ' 126' ' ' GLN . 29.4 mmtp -128.92 20.2 5.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.661 0.743 . . . . 0.0 109.884 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.9 tt -78.98 124.18 28.01 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 1.8 t -143.42 154.08 43.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -175.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 7.7 tt -91.55 126.65 36.71 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 112.92 -1.945 . . . . 0.0 105.797 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 210' ' ' ALA . 41.5 t0 -102.12 144.49 30.61 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -175.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . 0.517 ' N ' ' OD1' ' A' ' 209' ' ' ASP . . . -125.17 113.68 18.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.346 -1.752 . . . . 0.0 107.538 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -175.38 -165.27 31.25 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -147.07 161.36 41.0 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.951 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.2 ttp-105 -129.57 103.24 6.76 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.432 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.529 ' CD1' ' NE2' ' A' ' 228' ' ' HIS . 84.6 t80 -174.68 148.69 1.15 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.064 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -159.1 -84.61 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.66 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -84.49 153.12 23.51 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.907 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -59.41 -47.78 84.17 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.446 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 79.29 152.91 7.23 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 45.97 -172.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.982 0.42 . . . . 0.0 111.292 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 222' ' ' ASN . 2.1 mm? -76.1 142.69 41.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.672 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -70.83 31.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.141 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.52 ' H ' ' C ' ' A' ' 220' ' ' LEU . 8.6 p30 -68.52 102.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER 34.57 -103.87 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.78 -179.067 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.55 ' N ' ' OG1' ' A' ' 223' ' ' THR . 34.4 mmt180 28.07 98.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.336 0.398 . . . . 0.0 111.918 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 225' ' ' PHE . 52.1 p90 -105.91 129.72 54.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.51 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -111.41 -177.83 3.29 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.339 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.9 t -145.11 154.55 42.58 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.254 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.529 ' NE2' ' CD1' ' A' ' 214' ' ' TYR . 28.1 m170 -106.97 -63.48 1.28 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.039 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 52.04 44.18 29.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.987 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 51.48 -177.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.362 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.1 t -149.26 143.42 25.86 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 120.989 0.423 . . . . 0.0 110.543 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 59.4 mt -112.78 137.68 50.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -148.63 165.75 29.17 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.339 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.19 127.4 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.77 145.58 44.74 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.083 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -112.91 116.35 29.85 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.405 ' NH1' ' OD2' ' A' ' 124' ' ' ASP . 81.4 mtm180 -124.34 133.05 53.55 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.904 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.548 ' OXT' ' CG ' ' A' ' 238' ' ' PHE . 85.1 t80 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.546 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 t -69.78 143.29 53.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.552 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -163.95 97.98 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.915 0.388 . . . . 0.0 110.643 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -91.84 106.22 18.3 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.403 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.91 168.65 37.69 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.535 ' O ' ' CZ ' ' A' ' 238' ' ' PHE . . . 168.24 -82.81 0.1 OUTLIER Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.931 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -78.74 142.34 37.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 111.62 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.29 178.56 40.15 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.159 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.66 152.71 25.99 Favored 'Trans proline' 0 N--CA 1.507 2.291 0 C-N-CA 124.153 3.236 . . . . 0.0 116.397 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.53 ' CD2' ' NH2' ' A' ' 66' ' ' ARG . 6.7 p90 -148.69 164.67 33.66 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.442 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 p -131.99 153.99 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.402 0.62 . . . . 0.0 112.527 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.545 ' NE2' HH22 ' A' ' 235' ' ' ARG . 63.8 tt0 -120.95 142.61 49.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.032 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 14' ' ' ASP . . . -142.87 149.86 39.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.471 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 13' ' ' ALA . 92.4 m-20 -140.52 147.26 39.26 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -168.16 -175.77 2.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.721 177.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.89 -60.79 0.77 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.897 0.38 . . . . 0.0 110.179 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.0 t80 58.96 119.76 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.774 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -165.45 -80.9 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.342 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -144.63 93.29 2.4 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.327 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -82.12 142.56 32.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.749 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -111.74 131.0 55.61 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.399 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.17 164.62 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.561 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.7 m -62.33 134.56 56.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.228 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -64.97 106.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.212 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.05 -45.48 92.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.568 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -38.67 101.35 0.23 Allowed Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.817 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.52 -38.96 75.78 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.807 1.671 . . . . 0.0 112.518 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -124.14 85.78 54.61 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.003 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.56 162.41 30.38 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.177 1.918 . . . . 0.0 111.643 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.7 p -48.38 130.35 16.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 110.586 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 177.06 74.63 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.268 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.96 -40.61 75.53 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.691 2.261 . . . . 0.0 112.206 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -149.43 93.31 2.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.744 0.307 . . . . 0.0 111.064 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -141.14 119.26 12.01 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -103.31 6.97 38.32 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.364 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -65.33 -27.88 68.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.913 0.387 . . . . 0.0 110.553 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.409 HG22 HD12 ' A' ' 37' ' ' ILE . 36.6 mm -60.67 -43.91 95.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.723 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.7 t -59.61 141.99 53.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.612 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 60.7 m 49.29 97.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.577 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.6 t -100.96 114.27 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.545 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.5 m -89.74 -12.15 40.21 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -88.63 116.06 26.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.732 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.31 137.22 35.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.556 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -83.22 129.47 35.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.655 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -129.47 152.32 49.14 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.242 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 50.9 p-10 -146.45 88.62 1.79 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.351 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.8 tt -65.63 -40.04 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.803 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -78.37 88.75 4.37 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.57 -61.38 1.39 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.593 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -71.51 130.57 41.6 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.282 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 p -83.25 146.79 28.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.124 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 p -161.67 78.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.524 0.678 . . . . 0.0 109.624 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.622 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 25.0 m170 -91.89 -26.66 0.29 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 53' ' ' HIS . 84.4 Cg_exo -47.65 -71.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.565 1.51 . . . . 0.0 111.942 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.559 HH12 ' CD2' ' A' ' 228' ' ' HIS . 86.8 mtm180 31.63 97.59 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.552 0.532 . . . . 0.0 111.277 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.6 t -142.69 159.06 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.83 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.5 t -146.75 138.16 24.32 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.626 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -138.22 157.56 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.63 -178.63 38.17 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 119.844 -1.169 . . . . 0.0 113.605 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -104.93 129.64 53.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.395 -0.902 . . . . 0.0 109.224 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.433 ' HB2' HH21 ' A' ' 66' ' ' ARG . 61.1 t0 -100.41 121.5 41.63 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -175.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -125.4 121.64 34.45 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -50.54 113.88 2.31 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' A' ' 65' ' ' TRP . . . 120.01 -49.38 0.88 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 64' ' ' GLY . 8.3 m0 -146.46 136.09 23.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 117.136 0.468 . . . . 0.0 109.986 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.672 HH12 ' CZ ' ' A' ' 237' ' ' ARG . 26.7 mtp180 -133.8 147.13 51.22 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.988 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.2 126.36 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.44 113.4 15.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.006 0.431 . . . . 0.0 110.024 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.78 127.08 34.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.893 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 17.7 p-10 -101.8 128.9 47.95 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -149.68 159.15 44.57 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.92 0.867 . . . . 0.0 111.892 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -156.97 -160.63 0.98 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.528 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -96.9 139.35 33.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.408 . . . . 0.0 111.09 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 75' ' ' ARG . 41.6 t80 -111.21 -43.51 3.71 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.371 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 74' ' ' TYR . 6.6 mmp_? 40.56 111.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.748 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' A' ' 78' ' ' ASN . 78.5 tttt -135.87 138.3 42.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.454 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -48.81 -14.37 0.07 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.281 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 76' ' ' LYS . 66.1 t30 59.14 58.73 2.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.556 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -84.93 102.27 13.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.619 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.57 -40.81 96.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.525 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -136.22 139.53 42.84 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.001 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.48 140.77 46.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.994 0.426 . . . . 0.0 110.913 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.4 t -96.63 96.88 8.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.124 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 p -140.91 137.78 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.485 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -121.47 44.34 2.58 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.986 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.602 ' CG2' ' H ' ' A' ' 87' ' ' GLU . 13.7 tt -62.04 -63.97 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.757 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.602 ' H ' ' CG2' ' A' ' 86' ' ' ILE . 97.6 mt-10 37.9 22.92 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.732 0.301 . . . . 0.0 111.245 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.558 ' N ' ' O ' ' A' ' 86' ' ' ILE . 99.0 m-20 -71.31 -70.69 0.3 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.739 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 89' ' ' VAL . 7.1 p 36.65 25.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.322 0.582 . . . . 0.0 110.876 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 88' ' ' ASN . 34.0 ptt180 -119.96 12.76 12.08 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.675 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 95.5 mt -90.29 122.84 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.232 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -63.41 -43.97 96.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.234 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -173.75 130.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.37 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' OE1' ' OD1' ' A' ' 95' ' ' ASN . 6.5 tm-20 -172.61 -43.63 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.467 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 97' ' ' ILE . 99.1 m-20 -96.16 14.28 24.49 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.656 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.79 37.89 0.5 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.528 ' H ' ' C ' ' A' ' 95' ' ' ASN . 97.0 mt -63.88 -43.6 97.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.622 0.249 . . . . 0.0 111.182 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 100' ' ' ASP . 31.3 mmt180 55.03 96.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 0.0 110.346 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 102' ' ' LYS . 82.4 mt 45.68 -94.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.375 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 102' ' ' LYS . 56.2 t0 42.53 63.48 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.359 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 102' ' ' LYS . 67.2 ttp85 62.67 -3.41 0.3 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.634 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 100' ' ' ASP . 99.7 mttt 54.0 169.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.15 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.1 p -100.74 1.61 40.54 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 55.43 46.44 23.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.445 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 49.71 -95.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.446 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -91.33 122.72 34.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.316 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -85.2 -178.83 6.87 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.83 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.0 m120 53.7 -92.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.991 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.18 161.95 32.98 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.5 t -135.27 148.38 49.53 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.876 0.369 . . . . 0.0 110.206 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -107.56 127.11 53.34 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.274 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -72.57 134.93 45.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.27 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.15 122.94 18.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.993 0.425 . . . . 0.0 110.669 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.97 133.36 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.779 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.6 t -162.94 54.1 0.19 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.731 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 97.3 p -87.02 104.75 16.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.45 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.34 121.67 19.27 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 178.87 -145.53 6.79 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.124 -1.512 . . . . 0.0 113.083 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 95.5 mt -117.69 154.35 31.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.608 0.718 . . . . 0.0 110.91 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.6 m -144.96 98.73 3.22 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.42 114.66 11.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.311 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.406 HD11 HG23 ' A' ' 122' ' ' ILE . 96.1 mt -110.81 134.02 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 177.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.452 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 29.4 p90 -132.6 120.45 21.82 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.408 -177.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -97.74 143.22 28.6 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 112.904 -1.953 . . . . 0.0 108.328 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.615 ' C ' ' H ' ' A' ' 127' ' ' ILE . 15.0 m-85 -102.45 113.01 25.98 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.631 0.729 . . . . 0.0 111.376 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -65.37 11.88 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.253 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.615 ' H ' ' C ' ' A' ' 125' ' ' PHE . 8.3 tp -68.06 -40.31 82.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.19 0.519 . . . . 0.0 110.484 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.446 ' N ' ' CG2' ' A' ' 127' ' ' ILE . 72.8 m-20 -99.77 141.3 32.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.301 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -79.45 -60.81 2.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -66.33 -41.89 88.96 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 131' ' ' PHE . 48.0 p90 -145.61 143.16 29.71 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 119.194 -0.432 . . . . 0.0 111.472 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.62 132.82 23.68 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 118.254 0.479 . . . . 0.0 110.267 178.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.62 136.68 21.6 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 N-CA-C 108.05 -1.558 . . . . 0.0 108.05 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 199' ' ' GLY . 0.8 OUTLIER -132.41 144.24 50.36 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 122.329 1.062 . . . . 0.0 112.312 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.452 ' O ' ' CE1' ' A' ' 123' ' ' TYR . 94.2 mt -135.04 161.48 40.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 113.338 -1.756 . . . . 0.0 107.895 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.22 160.03 31.73 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 118.929 -1.605 . . . . 0.0 114.185 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -107.94 135.45 49.3 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -118.43 125.79 50.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 18.4 m -117.89 113.92 43.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.09 125.53 51.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.36 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -112.26 153.18 27.54 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.716 0.77 . . . . 0.0 112.522 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -123.95 -102.51 1.52 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.429 ' N ' ' ND1' ' A' ' 143' ' ' HIS . 0.0 OUTLIER -157.17 150.49 23.96 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.092 0.473 . . . . 0.0 111.834 178.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 50.7 t -126.58 135.08 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.225 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 121.49 26.15 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.475 ' CG ' ' N ' ' A' ' 147' ' ' SER . 56.3 p-80 -149.64 -45.45 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.407 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.483 ' OG ' ' NZ ' ' A' ' 153' ' ' LYS . 6.5 p 58.93 134.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.707 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 82.5 mt -104.28 116.39 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.188 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 150' ' ' SER . 52.4 t0 -155.76 78.82 1.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 149' ' ' ASP . 15.7 t 57.32 153.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.011 0.434 . . . . 0.0 110.758 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.4 m -63.68 -31.9 73.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.821 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.4 -42.64 96.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.79 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.526 ' CD ' ' H ' ' A' ' 154' ' ' THR . 1.6 tmtm? 63.81 -162.29 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.988 0.423 . . . . 0.0 110.472 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.526 ' H ' ' CD ' ' A' ' 153' ' ' LYS . 44.6 p 52.87 -136.01 1.43 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.54 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 91.6 mt 49.92 -87.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.609 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 154' ' ' THR . 73.0 mm-40 -65.09 132.98 50.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.734 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 156' ' ' GLU . 38.5 t 52.02 168.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.826 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.432 ' N ' ' CG1' ' A' ' 157' ' ' VAL . 71.4 p -76.57 153.77 35.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.004 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 13.7 t -114.06 157.25 22.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.922 0.391 . . . . 0.0 110.719 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.8 t -59.67 125.23 79.36 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.957 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -42.18 145.25 0.89 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.936 1.757 . . . . 0.0 112.93 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.7 t -61.55 -43.54 98.67 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.515 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 55.53 50.95 13.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.669 0.271 . . . . 0.0 110.665 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.87 149.64 0.8 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.425 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -73.02 150.41 48.47 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.232 1.954 . . . . 0.0 111.854 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -144.04 130.22 19.68 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 110.849 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.43 66.35 2.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 169' ' ' VAL . . . -63.57 141.83 58.62 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.156 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 168' ' ' ALA . 46.9 t 54.07 106.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.569 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.73 114.03 13.67 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.399 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 42.0 p -69.24 -33.31 73.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.114 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -94.75 134.37 37.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.044 0.449 . . . . 0.0 111.262 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.523 ' CB ' ' NE2' ' A' ' 179' ' ' GLN . 50.6 p-10 -154.47 45.0 0.54 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.001 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.2 t -109.31 19.93 18.83 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.486 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 32.0 p-10 -66.73 137.77 95.11 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.723 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.69 31.56 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.199 1.933 . . . . 0.0 111.834 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 178' ' ' THR . 22.6 pttm -157.32 134.7 10.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.927 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 177' ' ' LYS . 59.3 p 45.67 -173.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.887 0.375 . . . . 0.0 110.685 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.523 ' NE2' ' CB ' ' A' ' 173' ' ' ASN . 58.3 tt0 56.18 96.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.343 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 62.0 t30 58.85 32.65 22.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.769 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 181' ' ' ASP . 65.2 t0 -70.95 -39.36 72.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.911 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -141.82 157.7 44.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.782 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 43.81 -99.37 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.145 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.692 ' HG ' ' N ' ' A' ' 185' ' ' ASN . 3.4 t -145.74 -90.04 0.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.692 ' N ' ' HG ' ' A' ' 184' ' ' SER . 98.1 m-20 -130.59 -6.11 4.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.753 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.642 ' HG ' ' H ' ' A' ' 188' ' ' ARG . 42.7 t -150.86 147.63 27.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.447 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.417 ' CD1' ' C ' ' A' ' 187' ' ' ILE . 2.3 pp -97.73 9.14 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.27 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.642 ' H ' ' HG ' ' A' ' 186' ' ' SER . 39.4 ptt180 -48.92 135.29 15.81 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -98.2 97.67 9.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.502 0.668 . . . . 0.0 112.248 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.56 160.6 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.35 130.35 4.57 Favored Glycine 0 N--CA 1.47 0.935 0 C-N-CA 119.888 -1.149 . . . . 0.0 113.425 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.83 137.09 53.14 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -164.26 -168.75 26.81 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.84 145.52 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.539 0.685 . . . . 0.0 111.847 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.0 mm -112.53 128.92 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.79 162.61 38.23 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.385 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.489 ' O ' ' CD1' ' A' ' 134' ' ' TYR . . . 157.99 178.87 32.43 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.423 ' C ' ' HH ' ' A' ' 134' ' ' TYR . 3.6 p -135.16 139.82 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 134' ' ' TYR . . . -120.83 137.85 12.29 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 120.169 -1.015 . . . . 0.0 114.475 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.422 ' C ' ' OG1' ' A' ' 207' ' ' THR . 90.6 m-85 -104.62 106.67 17.26 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 114.131 -1.034 . . . . 0.0 108.593 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 201' ' ' ASP . 9.9 p30 -63.31 149.79 44.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.463 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.8 mm -102.98 -74.73 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.462 ' O ' ' C ' ' A' ' 204' ' ' PRO . 1.4 p -80.18 -167.85 0.15 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.462 ' C ' ' O ' ' A' ' 203' ' ' THR . 1.5 Cg_exo -33.76 -74.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 CA-C-N 122.69 1.996 . . . . 0.0 114.678 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 237' ' ' ARG . 10.0 mptt -125.19 20.19 8.19 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.251 0.932 . . . . 0.0 110.789 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 206' ' ' LEU . 0.9 OUTLIER -76.88 122.94 25.54 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 176.079 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.422 ' OG1' ' C ' ' A' ' 200' ' ' PHE . 2.8 t -136.41 148.57 47.86 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 50.3 tp -99.15 118.1 35.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -130.12 142.73 50.57 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -87.76 109.05 19.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 231' ' ' SER . . . -130.5 144.05 15.4 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.342 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -137.83 153.54 49.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.033 -0.583 . . . . 0.0 109.955 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.401 ' NH1' ' NE2' ' A' ' 215' ' ' HIS . 3.7 ppt_? -120.57 140.46 51.47 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -140.01 155.66 46.98 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.005 0.431 . . . . 0.0 111.437 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.401 ' NE2' ' NH1' ' A' ' 213' ' ' ARG . 13.9 m170 -99.17 142.19 30.97 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.758 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 217' ' ' TRP . 38.0 p-10 -64.12 -41.75 97.11 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.169 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.479 ' N ' ' OD1' ' A' ' 216' ' ' ASN . 57.4 t-105 -118.53 137.49 53.18 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -77.0 91.57 1.01 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -110.14 6.41 22.76 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.759 0.314 . . . . 0.0 110.545 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 220' ' ' LEU . 10.2 mp -74.02 145.26 44.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.534 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -56.11 -172.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.494 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' A' ' 224' ' ' ARG . 23.6 t-20 -63.86 -39.51 94.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 2.1 m -67.49 35.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.41 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.555 ' H ' ' C ' ' A' ' 222' ' ' ASN . 54.3 ptt85 -77.16 -5.22 48.28 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.488 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -59.97 -46.34 89.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.68 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -132.4 125.04 29.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.962 0.41 . . . . 0.0 110.927 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.539 ' HG1' ' N ' ' A' ' 228' ' ' HIS . 3.5 t -152.1 158.43 42.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.245 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.559 ' CD2' HH12 ' A' ' 55' ' ' ARG . 86.3 t60 -75.85 127.11 32.32 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.413 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -152.18 160.47 43.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.905 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -52.95 -177.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.92 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 211' ' ' GLY . 1.7 t 174.44 -53.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.8 tp -136.57 110.65 8.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -100.05 162.94 19.18 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.307 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 39.4 t -126.13 128.98 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.545 HH22 ' NE2' ' A' ' 12' ' ' GLN . 90.4 mtt-85 -134.09 147.07 50.83 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -174.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -110.83 99.69 8.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.136 175.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.672 ' CZ ' HH12 ' A' ' 66' ' ' ARG . 99.0 mtt180 -130.28 130.86 45.07 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.838 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.535 ' CZ ' ' O ' ' A' ' 6' ' ' GLY . 61.3 m-85 . . . . . 0 N--CA 1.474 0.732 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.834 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.5 m -71.04 148.64 47.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.613 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 42.15 -123.23 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.572 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -94.79 1.77 55.44 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.875 0.369 . . . . 0.0 110.492 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.94 122.82 3.5 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.08 -75.5 0.28 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -87.53 152.25 22.35 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.73 -152.03 6.72 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.33 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.57 167.99 25.9 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.382 2.055 . . . . 0.0 114.183 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -141.01 143.48 34.45 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.6 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.8 t -132.03 146.38 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -148.31 130.99 15.94 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.36 132.71 12.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.825 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -96.08 151.93 19.01 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.12 0.486 . . . . 0.0 111.859 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.8 tp -123.99 131.21 53.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.671 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.46 -123.29 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.779 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.449 ' CG ' ' O ' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -137.77 125.86 22.9 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.278 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 179.22 114.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.36 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -151.31 132.1 14.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.751 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -160.7 -92.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.472 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.4 ' O ' ' ND1' ' A' ' 21' ' ' HIS . 57.8 t-80 38.91 58.8 1.72 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.849 0.357 . . . . 0.0 110.551 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.9 108.58 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.247 0.546 . . . . 0.0 110.544 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.6 p -141.37 173.16 11.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.984 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -148.44 156.55 42.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.892 0.377 . . . . 0.0 110.616 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -76.67 162.47 27.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.596 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -147.79 80.62 8.81 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.678 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.86 159.73 34.42 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.438 2.092 . . . . 0.0 112.012 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.521 ' OE2' ' ND2' ' A' ' 35' ' ' ASN . 45.7 tt0 -139.01 81.2 22.02 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.203 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.46 159.2 22.56 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.534 2.156 . . . . 0.0 112.139 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -63.5 137.22 58.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.21 176.36 2.74 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.353 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.21 -39.49 86.15 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.375 2.05 . . . . 0.0 112.384 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -96.39 143.31 27.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.741 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -90.08 155.64 18.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.416 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.521 ' ND2' ' OE2' ' A' ' 28' ' ' GLU . 98.1 m-20 -72.77 141.7 48.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.601 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -76.83 138.48 39.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.0 pt -128.23 149.92 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.553 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.2 m -136.63 150.54 48.59 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.551 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.7 m -153.11 94.95 1.9 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.378 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -172.12 -18.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.78 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -65.28 136.17 56.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.858 0.361 . . . . 0.0 110.616 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -89.11 179.92 6.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.623 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -101.35 132.1 47.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.132 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -158.73 3.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.804 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -68.93 135.22 50.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.624 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -89.49 -64.71 1.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.374 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.2 tp -162.0 139.34 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.416 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.2 mtp85 -138.28 89.87 2.42 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.423 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -86.23 165.32 16.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.489 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 31.3 ptt85 -121.4 -46.89 2.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.45 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 73' ' ' ARG . 10.9 t 49.01 92.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.786 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.37 53.15 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.534 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -161.91 67.59 2.13 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.506 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -91.17 -166.42 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.375 2.717 . . . . 0.0 113.477 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 58.7 82.81 0.13 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.498 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 p -155.95 131.54 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.906 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 t -138.51 135.85 35.52 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -148.58 168.67 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.756 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.76 -153.3 12.99 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -121.43 143.33 49.3 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.144 0.497 . . . . 0.0 111.561 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -86.71 112.97 22.17 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.866 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -125.48 150.47 47.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.968 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.22 103.6 2.62 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.48 -68.32 0.52 Allowed Glycine 0 CA--C 1.52 0.391 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -148.05 160.77 42.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -113.73 162.01 16.8 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 120.897 0.38 . . . . 0.0 111.608 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.406 HD11 HG23 ' A' ' 67' ' ' ILE . 40.0 mm -104.14 126.71 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 102.11 -3.293 . . . . 0.0 102.11 172.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.47 125.25 9.76 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 119.149 -1.021 . . . . 0.0 111.946 -176.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.23 153.41 20.0 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.553 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -134.24 128.07 33.15 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -151.45 161.27 42.99 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.185 0.993 . . . . 0.0 113.188 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.48 151.3 15.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.224 -1.807 . . . . 0.0 107.418 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.435 ' O ' ' OG ' ' A' ' 51' ' ' SER . 9.1 ptm180 -141.79 135.5 29.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.281 0.562 . . . . 0.0 111.669 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 44.9 p90 -172.83 107.63 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.602 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -101.63 136.77 40.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.635 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.551 ' HZ1' ' ND2' ' A' ' 80' ' ' ASN . 40.6 tttm 43.96 39.67 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.5 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 49.35 -93.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.927 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 76' ' ' LYS . 62.9 t-20 -175.67 -60.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.374 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -64.34 125.82 25.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.802 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.551 ' ND2' ' HZ1' ' A' ' 76' ' ' LYS . 61.1 t-20 -141.86 88.21 2.1 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.623 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -83.76 -11.63 56.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.936 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.04 142.0 30.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.1 t -155.84 156.69 35.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.176 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.4 t -118.14 130.83 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.949 0.404 . . . . 0.0 110.252 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 87' ' ' GLU . 51.4 p30 -162.8 61.39 0.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.512 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.4 HD13 HG22 ' A' ' 86' ' ' ILE . 94.2 mt 44.75 -88.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.68 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 85' ' ' ASN . 97.5 mt-10 -64.61 131.01 45.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.436 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 88' ' ' ASN . 43.1 p-10 -163.66 91.18 0.65 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.859 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.4 m -123.8 130.5 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.511 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -86.58 151.2 23.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.358 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 91' ' ' ILE . 20.5 mm -87.39 91.78 3.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.173 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -133.28 150.38 51.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.594 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -78.08 147.68 34.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.24 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 95' ' ' ASN . 46.8 tp10 -72.52 111.25 7.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.848 0.356 . . . . 0.0 110.276 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 94' ' ' GLU . 82.1 m-20 -158.8 162.21 37.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.413 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.2 146.28 42.46 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.1 tt -131.54 129.56 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.908 0.385 . . . . 0.0 110.633 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.6 ptt-85 -149.21 155.03 40.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.466 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.2 pt -82.31 135.78 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.175 0.512 . . . . 0.0 110.619 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -144.54 -33.72 0.38 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.085 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -151.57 154.14 35.89 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.485 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.436 ' O ' ' OG1' ' A' ' 103' ' ' THR . 98.8 mttt -79.9 -2.12 42.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.728 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.55 ' HG1' ' H ' ' A' ' 104' ' ' GLU . 56.4 p 50.3 -100.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.266 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.55 ' H ' ' HG1' ' A' ' 103' ' ' THR . 80.1 mm-40 -76.22 130.95 38.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.16 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -94.09 168.84 10.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.644 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -126.77 98.92 5.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.907 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -67.05 -40.35 87.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.692 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -87.26 101.69 13.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.632 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' A' ' 111' ' ' PHE . . . -90.73 179.15 42.89 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.7 p -71.95 135.72 46.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 0.0 110.539 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 109' ' ' GLY . 92.3 m-85 -136.0 -45.72 0.65 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.665 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.412 ' ND1' ' N ' ' A' ' 113' ' ' ALA . 51.4 t-80 -151.99 -93.87 0.05 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.515 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' N ' ' ND1' ' A' ' 112' ' ' HIS . . . 47.05 31.93 1.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.832 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.425 ' O ' ' OG ' ' A' ' 115' ' ' SER . 58.6 t -69.44 -26.77 32.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.655 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 115' ' ' SER . 5.0 p 69.51 103.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.426 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.6 p -167.24 163.79 15.42 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.037 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -156.89 157.4 34.81 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.877 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -176.45 -138.14 2.82 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.051 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 119' ' ' LEU . 1.2 pt? -131.2 160.55 34.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.2 0.524 . . . . 0.0 111.992 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 m -148.74 147.62 29.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.423 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.01 135.98 53.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 96.7 mt -118.96 158.06 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.556 0.693 . . . . 0.0 112.552 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.425 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -106.07 101.49 10.98 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -104.72 122.71 46.26 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 123.67 0.606 . . . . 0.0 111.234 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -96.72 105.36 17.46 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.084 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.415 ' CD ' HH22 ' A' ' 237' ' ' ARG . 59.1 tt0 -87.83 -11.35 48.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.698 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.4 tt -67.52 -40.67 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.947 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -78.68 -11.78 59.99 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.0 t0 59.7 -78.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.177 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -66.27 -46.26 77.67 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -105.58 117.52 34.24 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.42 ' CD ' ' O ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -131.85 96.53 20.28 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.17 109.56 0.64 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.035 1.156 . . . . 0.0 109.387 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.421 ' CZ ' ' HA3' ' A' ' 197' ' ' GLY . 21.9 p90 -78.66 129.9 35.25 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 118.712 -1.195 . . . . 0.0 109.78 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.17 142.51 40.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.646 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -171.79 -176.8 40.99 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 118.28 -1.914 . . . . 0.0 113.709 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.73 137.57 51.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -130.12 131.17 45.59 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.45 132.35 64.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.682 0.753 . . . . 0.0 109.125 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -113.54 150.44 32.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.121 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -156.72 168.15 28.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.297 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -117.15 134.01 10.97 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 144' ' ' VAL . 77.4 t60 -55.12 -76.37 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 143' ' ' HIS . 5.4 t 53.22 121.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.625 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 146' ' ' HIS . 23.7 mmt85 -62.55 -36.24 82.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.259 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 145' ' ' ARG . 85.8 t60 49.42 96.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 146' ' ' HIS . 7.8 t 61.34 131.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.317 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 15.6 tt -154.51 -16.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.348 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -61.32 -49.15 78.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.521 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.7 t -160.04 152.92 21.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.705 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.4 p -149.47 101.85 3.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.256 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -155.1 -34.09 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.627 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -73.3 130.95 41.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.611 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.39 -12.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.223 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 20.3 tt -129.12 131.35 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.159 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 158' ' ' THR . 43.4 tp10 -99.4 71.91 1.79 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.604 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.05 -34.12 66.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.405 ' O ' ' OE2' ' A' ' 156' ' ' GLU . 5.0 t -132.59 153.1 51.35 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.863 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 t -95.25 144.83 25.52 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.281 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.2 t -59.51 130.01 87.46 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.08 -42.31 21.08 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.502 1.468 . . . . 0.0 112.975 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 78.1 p -63.83 -39.66 94.74 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.039 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -105.22 75.88 1.19 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.884 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.0 179.62 0.1 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.44 142.58 98.39 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.709 1.606 . . . . 0.0 111.304 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -100.97 8.12 43.21 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.482 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 158.27 -154.78 25.84 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -156.46 -117.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.28 131.23 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.919 0.39 . . . . 0.0 110.256 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 91.5 m -118.41 126.22 51.61 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.068 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.12 -36.34 18.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.877 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -153.77 -73.28 0.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.766 0.317 . . . . 0.0 110.673 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 174' ' ' THR . 28.3 t-20 42.79 -109.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.618 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 173' ' ' ASN . 63.8 p -120.99 133.06 55.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.156 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -113.45 91.7 21.0 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.808 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -87.49 -17.96 2.69 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.684 2.256 . . . . 0.0 112.874 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -80.83 126.32 31.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.019 0.438 . . . . 0.0 111.546 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.35 -41.39 56.68 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.449 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -103.15 129.4 50.02 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.265 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 181' ' ' ASP . 93.0 m-20 -89.4 93.9 9.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.901 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 180' ' ' ASN . 6.6 p-10 42.59 -173.52 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.58 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.627 ' CG ' ' N ' ' A' ' 183' ' ' GLN . 60.9 t80 -174.13 177.0 2.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.969 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.627 ' N ' ' CG ' ' A' ' 182' ' ' TYR . 26.5 mt-30 -59.86 -31.4 69.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.886 0.374 . . . . 0.0 110.484 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.529 ' HG ' ' C ' ' A' ' 183' ' ' GLN . 12.9 p 47.19 96.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.319 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 55.3 p30 -87.46 -175.37 5.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.558 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 60.0 m -57.92 132.3 53.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.728 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 188' ' ' ARG . 42.4 pt -88.43 -15.27 9.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.137 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 187' ' ' ILE . 81.5 mtp180 -60.03 -149.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.876 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -126.71 118.44 24.73 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.326 0.584 . . . . 0.0 111.57 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.21 153.66 37.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -135.15 142.08 13.44 Favored Glycine 0 N--CA 1.466 0.67 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.821 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.2 pp -133.39 141.89 48.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.304 -0.948 . . . . 0.0 108.755 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -153.45 174.15 32.13 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.04 138.59 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.902 0.382 . . . . 0.0 110.988 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.8 mt -111.06 131.08 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.859 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.53 148.43 32.17 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.421 ' HA3' ' CZ ' ' A' ' 134' ' ' TYR . . . 158.05 -176.89 34.99 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.4 p -138.75 142.3 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 118.728 1.264 . . . . 0.0 113.346 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -103.88 144.83 15.98 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.761 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.426 ' N ' ' OG1' ' A' ' 207' ' ' THR . 14.3 t80 -137.72 105.69 5.67 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.446 ' N ' ' HG1' ' A' ' 207' ' ' THR . 0.0 OUTLIER -91.59 154.22 19.2 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -176.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.403 ' CG1' ' H ' ' A' ' 203' ' ' THR . 5.3 pt -95.15 -47.1 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.652 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.7 OUTLIER -122.76 115.25 29.53 Favored Pre-proline 0 N--CA 1.433 -1.296 0 N-CA-C 100.563 -3.865 . . . . 0.0 100.563 172.17 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -12.15 -40.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 124.069 3.179 . . . . 0.0 117.176 -174.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 203' ' ' THR . 11.7 pttm -84.72 -32.37 23.55 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 3.2 mm? -85.4 105.14 15.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 121.475 1.943 . . . . 0.0 107.751 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.446 ' HG1' ' N ' ' A' ' 201' ' ' ASP . 1.0 OUTLIER -131.75 140.23 49.18 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 75.9 mt -93.37 135.36 34.68 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 113.734 -1.576 . . . . 0.0 108.749 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.595 ' CG ' HH11 ' A' ' 235' ' ' ARG . 42.7 m-20 -118.22 145.91 44.64 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -135.49 113.02 10.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 114.059 -1.428 . . . . 0.0 107.292 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -162.22 -177.65 35.44 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.56 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.35 152.42 49.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.594 -0.803 . . . . 0.0 110.97 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -106.88 127.28 53.29 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -112.09 150.65 30.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.295 0.569 . . . . 0.0 112.271 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' A' ' 216' ' ' ASN . 77.3 t60 -129.1 128.96 44.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.723 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 215' ' ' HIS . 97.1 m-20 51.41 107.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.462 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -143.38 99.85 3.51 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.825 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -159.84 -116.93 0.45 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 220' ' ' LEU . 18.2 tpp180 -63.61 144.98 56.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.855 0.359 . . . . 0.0 110.246 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.64 ' CD2' ' H ' ' A' ' 220' ' ' LEU . 1.9 mm? -57.28 -159.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.195 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 66.19 61.68 0.6 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.378 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.42 ' O ' ' OD1' ' A' ' 222' ' ' ASN . 12.4 p30 -98.52 123.9 42.95 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.001 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.7 m -63.77 -47.95 78.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.184 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -114.14 150.85 33.54 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.996 0.427 . . . . 0.0 110.78 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -161.47 21.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.886 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -97.57 40.97 1.14 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.872 0.367 . . . . 0.0 110.488 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 73.1 m -116.39 123.59 47.95 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.271 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -173.55 86.38 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.652 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -139.51 132.38 29.24 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.598 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -86.08 162.28 18.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.391 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.461 ' HG ' ' N ' ' A' ' 232' ' ' LEU . 46.9 t -151.96 154.21 35.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.675 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.461 ' N ' ' HG ' ' A' ' 231' ' ' SER . 7.0 tt -111.02 140.12 45.82 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.28 169.25 30.26 Favored Glycine 0 CA--C 1.517 0.203 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.95 136.28 57.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.449 0.643 . . . . 0.0 111.378 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.595 HH11 ' CG ' ' A' ' 209' ' ' ASP . 81.1 mtt85 -121.27 130.21 53.54 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.95 106.29 17.2 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.575 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.545 ' O ' ' CB ' ' A' ' 238' ' ' PHE . 3.6 tmt_? -119.79 109.14 15.25 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.229 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.545 ' CB ' ' O ' ' A' ' 237' ' ' ARG . 28.5 t80 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.679 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 3' ' ' GLU . 86.7 p -75.86 164.41 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.601 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 2' ' ' SER . 43.5 tp10 59.88 129.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.48 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 55.73 28.41 12.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.477 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 46.55 -131.21 11.86 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 129.56 -150.66 19.02 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -68.79 159.79 31.71 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.52 -73.07 0.4 Allowed Glycine 0 CA--C 1.533 1.184 0 C-N-CA 120.961 -0.637 . . . . 0.0 111.923 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.43 124.05 9.11 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 122.717 2.278 . . . . 0.0 112.822 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -144.95 148.29 33.65 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.429 ' H ' ' HB2' ' A' ' 236' ' ' TYR . 78.7 t -138.68 146.31 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.553 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -132.4 126.53 33.37 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.992 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.95 148.0 27.86 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 15' ' ' LEU . 57.2 t0 -162.6 134.58 5.36 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.514 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 0.8 OUTLIER -173.48 -171.0 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.025 178.524 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.73 71.57 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.861 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' O ' ' O ' ' A' ' 18' ' ' ALA . 78.9 t80 -62.94 -49.65 73.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 17' ' ' TYR . . . 57.03 162.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.513 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -87.88 163.29 16.47 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.721 0.296 . . . . 0.0 110.954 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.53 ' OE2' ' N ' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -124.39 -30.72 3.36 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.667 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.53 ' N ' ' OE2' ' A' ' 20' ' ' GLU . 59.4 t-80 -166.78 -22.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 110.635 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.411 ' O ' ' O ' ' A' ' 21' ' ' HIS . 43.2 mt 58.3 118.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.581 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 24' ' ' HIS . 1.3 t -172.9 -117.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.593 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.524 ' N ' ' OG1' ' A' ' 23' ' ' THR . 15.9 m80 63.43 123.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.842 0.353 . . . . 0.0 110.502 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -135.76 94.03 3.02 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.623 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.608 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 91.7 t80 -99.08 -33.31 0.24 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.546 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 26' ' ' TYR . 89.0 Cg_endo -83.2 156.84 14.88 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.773 1.648 . . . . 0.0 111.904 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -68.14 148.11 98.32 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.883 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 31' ' ' ALA . 72.8 Cg_endo -73.2 86.75 1.1 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.18 1.92 . . . . 0.0 111.898 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 p 39.9 -96.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.335 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -57.94 151.4 44.5 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.309 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.44 -83.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.263 1.976 . . . . 0.0 111.725 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 36' ' ' LYS . 52.0 p-10 -103.06 6.01 38.41 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.442 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.522 ' C ' ' H ' ' A' ' 36' ' ' LYS . 6.2 tmtt? 42.3 37.07 0.83 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.697 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 64.28 -4.86 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.759 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 34' ' ' LYS . 63.3 pttt -172.44 146.48 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.346 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 tt -125.63 126.11 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.884 0.373 . . . . 0.0 110.389 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.2 p -102.24 -6.65 22.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.578 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.5 p -87.84 132.54 34.15 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.331 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 41' ' ' SER . 0.4 OUTLIER -96.98 -96.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.581 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.402 ' H ' ' CG2' ' A' ' 40' ' ' VAL . 86.0 p -159.37 177.66 10.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t0 72.3 -56.71 0.64 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.857 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -61.36 -44.92 96.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.969 0.414 . . . . 0.0 110.006 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.4 ' CG ' ' N ' ' A' ' 45' ' ' ARG . 88.7 t80 -60.83 155.81 18.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.149 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 25.1 ttm180 61.13 -133.66 0.67 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.6 t30 50.73 38.64 19.92 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.105 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.3 pt -90.36 45.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -76.33 97.57 4.26 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.088 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.3 p -149.19 24.8 0.91 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.024 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -74.37 137.77 42.98 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.575 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 52' ' ' VAL . 37.0 p -88.91 -35.78 16.3 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.516 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 51' ' ' SER . 35.6 t 48.79 101.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.908 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -173.1 60.95 0.26 Allowed Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.102 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.18 148.65 44.59 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.714 2.276 . . . . 0.0 112.309 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -167.19 111.51 0.72 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.702 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.37 135.13 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.639 0.257 . . . . 0.0 110.949 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 m -118.47 125.9 50.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.85 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.17 137.98 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.871 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.82 172.06 36.29 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.666 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -109.91 144.8 37.88 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 65' ' ' TRP . 44.4 t0 -150.84 130.96 13.49 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.584 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 31.6 p90 -128.41 105.87 8.62 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.807 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . 6.95 95.46 0.0 OUTLIER Glycine 0 N--CA 1.481 1.692 0 O-C-N 123.251 0.345 . . . . 0.0 113.186 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.96 -110.77 0.46 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.417 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 10.2 p-90 -103.74 -177.67 3.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.685 ' NH1' ' HE ' ' A' ' 235' ' ' ARG . 75.3 ttt180 -153.42 151.42 29.88 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.27 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.5 tp -129.58 142.4 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.431 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.56 143.03 19.51 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.89 155.99 16.54 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 71' ' ' TYR . 48.2 t0 -146.25 133.11 20.1 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.478 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 49.0 p90 175.5 -172.06 0.07 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.755 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 166.58 68.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -151.26 146.62 26.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.641 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -150.75 -127.65 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.461 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 60.23 73.43 0.48 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.556 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.639 ' N ' HD22 ' A' ' 79' ' ' ASN . 68.4 mttm -78.08 -176.9 4.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.593 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -59.7 -40.11 86.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.151 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 57.8 t30 -90.57 102.71 15.45 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.771 0.32 . . . . 0.0 110.639 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.639 HD22 ' N ' ' A' ' 76' ' ' LYS . 81.6 m-20 -159.21 176.88 11.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.457 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 48.55 -169.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.073 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt 56.28 60.94 2.91 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -61.94 -42.12 98.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.366 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.4 p -71.46 161.9 30.3 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.717 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.66 148.34 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.043 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -97.33 144.57 26.96 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.582 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.1 mm -63.45 -44.37 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.728 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -143.26 -62.56 0.41 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.494 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -165.73 54.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.84 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.3 t -99.41 119.68 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.401 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -172.8 -68.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.908 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.51 ' N ' ' CD1' ' A' ' 91' ' ' ILE . 2.0 mp 46.96 94.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.324 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -80.23 -22.88 41.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.78 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.3 tptt 73.69 164.21 0.28 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.116 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -62.41 136.24 57.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.873 0.368 . . . . 0.0 110.775 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 95' ' ' ASN . 38.4 t-20 -153.12 -22.57 0.15 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.736 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.28 173.8 52.61 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.451 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 2.5 mt -119.01 -145.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.451 ' H ' ' CG2' ' A' ' 97' ' ' ILE . 85.0 mtt85 -105.55 1.59 27.61 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.973 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.6 tt -106.21 144.26 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 57.31 98.54 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.05 0.452 . . . . 0.0 109.834 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -62.81 -40.3 96.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.524 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -125.75 145.47 50.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.935 0.398 . . . . 0.0 110.946 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.0 p -83.1 -139.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.488 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 55.23 40.61 31.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 110.233 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -86.06 103.31 14.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.765 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -68.76 -21.36 64.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.137 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 62.3 -101.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.418 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -87.55 116.94 26.01 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.82 0.343 . . . . 0.0 110.804 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.58 156.06 27.78 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.1 m -69.35 135.95 51.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.732 0.301 . . . . 0.0 110.68 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -104.7 41.05 1.38 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.662 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -153.71 48.76 0.66 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.023 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 112' ' ' HIS . . . 57.43 150.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.098 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 115' ' ' SER . 27.0 m -139.45 167.2 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.809 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 114' ' ' VAL . 4.8 p 89.28 125.13 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.779 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 141' ' ' TYR . 40.4 t -155.66 149.32 25.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.738 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 117' ' ' LEU . 10.5 mp -86.23 141.61 29.18 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.84 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -122.0 126.57 6.5 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.17 140.35 47.99 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.8 m -120.26 124.54 45.9 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.68 122.37 42.59 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 94.4 mt -126.45 160.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -175.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.487 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 70.6 m-85 -128.38 103.15 6.98 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 177.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.463 ' OD2' ' CZ ' ' A' ' 235' ' ' ARG . 67.6 t0 -138.83 129.94 26.78 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.494 ' CD1' ' NZ ' ' A' ' 132' ' ' LYS . 65.0 m-85 -120.86 133.26 55.31 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.439 177.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.5 pp0? -105.71 -13.75 15.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.269 0.557 . . . . 0.0 109.559 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 129' ' ' ASP . 65.9 mt -70.9 -40.51 76.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.777 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -55.6 89.64 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 127' ' ' ILE . 90.5 m-20 47.1 -114.25 0.54 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.865 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -131.2 22.73 4.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.086 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -167.28 127.3 1.45 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.492 -178.165 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.57 ' H ' HH22 ' A' ' 237' ' ' ARG . 12.8 tptm -134.63 129.56 19.47 Favored Pre-proline 0 C--O 1.238 0.5 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.497 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.38 129.96 28.56 Favored 'Trans proline' 0 N--CA 1.479 0.671 0 N-CA-C 107.404 -1.806 . . . . 0.0 107.404 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.622 ' CG ' ' NH1' ' A' ' 235' ' ' ARG . 52.0 p90 -122.64 148.6 45.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.525 0.602 . . . . 0.0 111.008 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.3 pt -141.05 163.62 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.555 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.34 173.78 41.82 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.188 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -117.26 159.78 22.12 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -127.79 130.99 49.62 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.939 0.4 . . . . 0.0 111.222 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 20.2 m -130.62 128.69 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.069 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.7 136.2 50.29 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.678 0.275 . . . . 0.0 110.931 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.423 ' O ' ' OG ' ' A' ' 116' ' ' SER . 46.7 p90 -147.95 158.16 43.9 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.288 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -110.85 -168.73 19.15 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.476 ' ND1' ' N ' ' A' ' 143' ' ' HIS . 4.5 p-80 -92.52 156.95 16.81 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.023 0.439 . . . . 0.0 110.807 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 39.6 t 58.04 114.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.395 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -94.64 -109.61 0.13 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.745 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -153.52 141.67 20.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.216 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 p -153.21 130.48 11.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.909 0.385 . . . . 0.0 110.517 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 96.2 mt -124.12 129.42 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.205 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -86.55 110.62 19.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.43 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.4 m -60.24 -42.13 94.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.362 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.7 p -83.63 165.21 19.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.468 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 153' ' ' LYS . 30.6 mmtp -107.55 11.58 28.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.214 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 152' ' ' LYS . 51.9 tttp 59.6 136.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.905 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.0 m 63.5 106.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.584 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 19.8 tt -131.08 142.28 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.385 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 158' ' ' THR . 97.2 mt-10 -71.74 52.5 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.505 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 63.3 t 49.81 -86.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.39 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 156' ' ' GLU . 24.7 m -66.85 133.6 50.4 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 52.4 p -67.91 137.01 54.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.84 0.352 . . . . 0.0 110.747 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.76 122.93 74.83 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.11 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.65 -40.27 46.65 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.317 1.345 . . . . 0.0 112.123 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.0 m -81.77 103.14 11.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.634 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 164' ' ' ALA . 54.7 p30 -155.38 -19.73 0.11 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.637 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.525 ' N ' ' OD1' ' A' ' 163' ' ' ASN . . . 178.36 151.84 0.45 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.077 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.93 152.51 57.7 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.305 2.003 . . . . 0.0 112.072 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -91.52 35.75 0.95 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.317 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 170' ' ' THR . . . 82.08 18.48 67.16 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 58.94 -147.68 0.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 110.454 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.5 m -92.4 24.26 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.654 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 167' ' ' GLY . 2.9 t -144.92 157.09 44.26 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.822 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.9 t -82.23 173.22 12.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.326 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -81.99 132.39 35.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.345 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -103.75 105.99 16.36 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.851 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 63.7 p 41.2 -137.91 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.067 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -85.52 150.06 53.15 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.115 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.56 158.6 39.94 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.699 2.266 . . . . 0.0 111.974 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -69.26 -76.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.448 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.5 p -81.17 166.89 20.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -80.39 94.92 6.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.473 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 181' ' ' ASP . 50.1 p30 -69.16 -19.0 64.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.733 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 180' ' ' ASN . 98.3 m-20 -90.22 110.73 21.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.021 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -103.6 6.84 37.47 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.085 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -87.11 49.23 1.78 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.521 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.3 t -138.69 134.22 33.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.595 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -143.15 106.55 4.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.225 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 27.9 p -75.98 160.41 29.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.302 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 188' ' ' ARG . 18.8 tt -155.95 -54.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.584 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.48 ' N ' ' CG2' ' A' ' 187' ' ' ILE . 79.4 mtp85 39.96 84.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.223 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -143.21 77.95 1.58 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.663 0.744 . . . . 0.0 111.417 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.45 156.85 33.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -120.4 130.73 8.47 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.275 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.9 mp -135.83 148.62 48.76 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.631 0.729 . . . . 0.0 110.583 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.5 174.21 42.6 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.94 146.82 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 117.418 0.609 . . . . 0.0 110.2 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.9 tt -115.77 144.6 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.849 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.21 145.19 26.1 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -173.41 -179.32 44.0 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.124 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 57.8 t -132.54 135.95 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.596 0.236 . . . . 0.0 111.305 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -108.56 122.33 6.59 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.269 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.436 ' N ' ' CG2' ' A' ' 207' ' ' THR . 54.3 t80 -124.91 106.55 10.08 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.685 0.794 . . . . 0.0 109.166 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.617 ' OD1' ' O ' ' A' ' 203' ' ' THR . 32.5 t70 -61.88 151.31 34.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 206' ' ' LEU . 28.9 mm -117.79 -29.12 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 176.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.617 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 31.5 m -155.08 120.34 2.59 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 100.219 -3.993 . . . . 0.0 100.219 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.589 ' N ' ' OD2' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -6.54 -56.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 123.408 2.738 . . . . 0.0 115.336 -172.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 203' ' ' THR . 37.0 pttt -83.94 -30.47 26.25 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 203' ' ' THR . 80.0 mt -78.62 110.92 14.17 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 119.62 1.1 . . . . 0.0 109.634 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' A' ' 200' ' ' PHE . 2.1 m -125.99 145.81 50.14 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.412 ' C ' ' CD1' ' A' ' 208' ' ' LEU . 1.6 tm? -94.12 119.57 33.15 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 210' ' ' ALA . 45.7 t0 -106.21 145.81 31.08 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 209' ' ' ASP . . . -132.37 126.8 34.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.774 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -168.86 176.74 42.98 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 119.53 -1.319 . . . . 0.0 113.468 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -156.97 168.73 26.61 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.837 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.498 HH12 ' CD2' ' A' ' 215' ' ' HIS . 68.1 ttt-85 -108.11 124.73 50.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.038 0.447 . . . . 0.0 111.61 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.472 ' OH ' ' NH2' ' A' ' 219' ' ' ARG . 79.9 t80 -65.5 -49.65 68.22 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.266 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.498 ' CD2' HH12 ' A' ' 213' ' ' ARG . 20.6 t-160 58.84 112.97 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.411 ' O ' ' CE2' ' A' ' 214' ' ' TYR . 15.1 m120 33.53 -156.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 177.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.542 ' CB ' HH11 ' A' ' 219' ' ' ARG . 55.3 p-90 -131.67 169.26 16.41 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.091 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -140.39 24.13 2.66 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.542 HH11 ' CB ' ' A' ' 217' ' ' TRP . 7.8 mpt_? -65.19 179.85 0.67 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.037 0.446 . . . . 0.0 110.751 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.565 ' C ' ' H ' ' A' ' 222' ' ' ASN . 11.1 mp 58.91 151.32 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.007 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 66.94 -26.19 0.12 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.315 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.565 ' H ' ' C ' ' A' ' 220' ' ' LEU . 98.0 m-20 54.68 51.56 13.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.569 0.223 . . . . 0.0 111.507 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 77.1 m -123.65 130.27 52.4 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.792 0.33 . . . . 0.0 110.433 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.38 138.42 39.33 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.219 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 225' ' ' PHE . 88.8 t80 -152.16 8.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.688 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -143.37 151.76 40.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 110.832 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.5 p -131.95 171.5 13.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.131 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -143.96 155.87 44.2 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 110.888 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -139.48 159.97 40.93 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.646 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -75.82 155.88 34.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.429 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 60.8 m -134.33 153.62 51.78 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.357 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 90.0 mt -97.7 149.35 22.38 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.829 0.347 . . . . 0.0 110.129 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -157.47 176.74 34.55 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.493 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 11.2 m -128.27 131.71 68.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.685 ' HE ' ' NH1' ' A' ' 66' ' ' ARG . 62.2 ttt180 -117.83 142.27 47.5 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.429 ' HB2' ' H ' ' A' ' 11' ' ' VAL . 15.8 m-85 -108.55 125.26 51.62 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.572 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 99.1 mtt180 -126.4 90.19 3.14 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 7.2 t80 . . . . . 0 C--O 1.219 -0.513 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.077 -177.866 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.5 m -70.67 139.91 51.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.762 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -111.23 -8.11 14.39 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.258 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' GLY . 47.4 p-10 -89.7 2.82 54.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.592 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' ASP . . . -56.53 -157.38 0.01 OUTLIER Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.55 133.65 9.29 Favored Glycine 0 N--CA 1.468 0.787 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -130.97 138.04 49.53 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.69 142.86 14.27 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.85 111.28 2.47 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.98 1.787 . . . . 0.0 112.772 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.479 ' HH ' ' CD ' ' A' ' 12' ' ' GLN . 0.1 OUTLIER -107.57 169.7 8.42 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.498 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 12' ' ' GLN . 61.0 t -126.04 157.72 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.464 0.65 . . . . 0.0 112.43 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.479 ' CD ' ' HH ' ' A' ' 10' ' ' TYR . 53.9 mt-30 -130.94 130.98 44.14 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.281 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.86 135.12 29.24 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.452 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.99 144.47 25.88 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 tp -139.39 123.7 18.08 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.985 0.421 . . . . 0.0 110.617 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -170.6 -42.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.852 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -85.12 141.4 30.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.319 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.61 144.08 48.95 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.342 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.526 ' O ' ' CD2' ' A' ' 19' ' ' TYR . 28.8 p90 -107.2 105.97 16.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.287 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -139.91 122.9 16.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.0 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -170.04 84.97 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.761 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 22' ' ' ILE . 95.4 mt -117.39 100.86 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.843 0.354 . . . . 0.0 110.487 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.421 ' HG1' ' CD2' ' A' ' 24' ' ' HIS . 44.2 p -145.8 164.86 30.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.493 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.421 ' CD2' ' HG1' ' A' ' 23' ' ' THR . 59.9 m-70 59.65 128.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.003 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -68.56 136.83 53.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.43 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.95 165.0 2.81 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.988 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.57 149.39 87.22 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.728 1.618 . . . . 0.0 112.087 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.449 ' H ' ' HD2' ' A' ' 29' ' ' PRO . 2.0 mt-10 -171.98 -52.49 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.628 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD2' ' H ' ' A' ' 28' ' ' GLU . 89.8 Cg_endo -82.43 -165.28 0.32 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.258 1.972 . . . . 0.0 112.578 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.6 m 61.97 151.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.085 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 60.54 69.87 1.08 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.058 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 33' ' ' ASN . 23.6 Cg_exo -62.27 144.51 95.49 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.518 2.145 . . . . 0.0 111.655 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 32' ' ' PRO . 82.3 m-20 47.12 -178.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.802 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -162.78 12.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.767 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.92 -46.46 84.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.441 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 38' ' ' SER . 63.0 mttp -151.89 -173.71 4.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.016 0.436 . . . . 0.0 111.034 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.1 mt 47.02 -87.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.694 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' LYS . 4.6 m -87.78 112.1 22.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.176 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.8 t -152.14 152.49 32.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.65 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.77 -23.49 25.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.216 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m 49.37 -112.57 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.702 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -148.69 129.3 14.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.986 0.422 . . . . 0.0 110.927 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -134.99 83.54 2.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.914 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 38.23 -103.82 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.992 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -138.62 -161.61 1.2 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.038 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -71.06 175.92 4.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.273 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.1 pt -69.99 -13.54 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.651 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 61.41 133.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.529 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.6 t -139.68 161.98 36.22 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.417 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -69.91 141.37 53.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.686 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 52' ' ' VAL . 11.7 t -109.05 -0.45 19.48 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.096 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 51' ' ' SER . 59.9 t 55.25 164.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.419 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 70.6 t60 -153.96 90.78 3.26 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.76 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.26 144.87 99.24 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.71 1.607 . . . . 0.0 110.84 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -70.55 161.26 30.98 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.226 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.13 161.81 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.376 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.5 t -148.23 133.24 18.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.982 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.14 157.51 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.615 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.57 -170.25 38.22 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.309 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -112.9 153.96 27.12 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 47.4 p-10 -141.47 129.2 21.62 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 121.634 0.73 . . . . 0.0 112.842 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 4.2 p90 -127.46 148.24 50.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.676 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -43.26 111.14 0.35 Allowed Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.34 -83.42 0.27 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.581 ' N ' ' CD1' ' A' ' 65' ' ' TRP . 1.4 p-90 -143.92 169.86 17.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.953 0.406 . . . . 0.0 111.5 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.463 HH21 ' NH1' ' A' ' 237' ' ' ARG . 54.8 mtt180 -129.39 172.61 11.34 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.578 0.704 . . . . 0.0 111.369 -178.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.4 mt -140.58 132.59 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.12 152.76 31.65 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.97 159.65 15.63 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 71' ' ' TYR . 41.3 t0 -157.2 167.21 31.04 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.424 -178.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.463 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 97.5 m-85 82.16 -126.08 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 125.08 1.488 . . . . 0.0 111.855 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 71.32 101.96 0.06 Allowed 'General case' 0 CA--C 1.532 0.272 0 O-C-N 123.676 0.61 . . . . 0.0 111.262 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -160.19 107.09 1.59 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.918 0.39 . . . . 0.0 110.962 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -125.36 133.15 52.66 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.42 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -165.4 23.23 0.05 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.304 -0.559 . . . . 0.0 111.211 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -63.21 -42.9 99.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.65 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -157.29 132.6 9.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.834 0.35 . . . . 0.0 111.011 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -108.55 145.61 34.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.24 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 57.5 p30 -83.78 163.2 20.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.76 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -145.27 138.12 26.2 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.641 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -103.42 155.26 18.62 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.266 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 82' ' ' TYR . 49.3 p90 -119.95 131.11 55.08 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.583 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.3 m -76.27 -68.64 0.57 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.611 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.28 162.94 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.372 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -67.6 139.22 56.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.336 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.1 126.44 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.473 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -91.45 -0.81 57.67 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.507 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -88.5 9.25 24.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.494 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.56 131.31 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.913 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' HG2' ' H ' ' A' ' 91' ' ' ILE . 46.6 ttt180 -136.53 -139.27 0.15 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.099 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.401 ' H ' ' HG2' ' A' ' 90' ' ' ARG . 12.8 mm 59.38 42.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.261 0.553 . . . . 0.0 109.707 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 94' ' ' GLU . 60.0 ttm-85 -62.26 -43.1 99.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.635 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp 51.2 -88.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.373 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 92' ' ' ARG . 14.6 tm-20 -68.54 125.29 26.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.303 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -149.17 18.34 0.96 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.981 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.82 11.66 0.03 OUTLIER Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.365 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.0 pt -127.28 154.19 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.787 0.327 . . . . 0.0 110.543 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -144.09 65.12 1.3 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.702 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 100' ' ' ASP . 10.4 tp -67.34 -41.17 86.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.565 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.408 ' N ' ' CG2' ' A' ' 99' ' ' ILE . 99.5 m-20 53.24 -99.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.527 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 38.11 66.31 0.5 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.022 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -145.34 152.26 39.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.305 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 85.5 m -61.32 -44.93 96.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.34 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -81.88 119.7 24.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.158 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.405 ' O ' ' O ' ' A' ' 106' ' ' GLN . 99.3 m-20 -99.34 33.76 2.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.405 ' O ' ' O ' ' A' ' 105' ' ' ASN . 88.6 mt-30 56.5 160.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.99 0.424 . . . . 0.0 110.867 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.59 -31.12 71.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.871 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.52 9.84 12.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.699 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.37 -33.36 87.03 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.9 p -128.33 163.0 25.75 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.055 0.455 . . . . 0.0 110.75 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -73.18 148.17 44.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.873 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -134.18 136.79 44.0 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.747 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -175.33 -110.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.335 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.5 t 45.44 81.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.404 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.3 m -81.89 148.44 28.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.13 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.9 m -143.29 152.26 41.47 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.943 0.401 . . . . 0.0 111.718 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.46 165.71 32.35 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.963 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -143.31 147.16 18.43 Favored Glycine 0 C--N 1.342 0.909 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.841 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.74 151.93 38.93 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.5 m -135.58 118.07 15.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.007 0.432 . . . . 0.0 111.559 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.77 131.15 43.77 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 96.8 mt -125.29 158.71 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.414 0.626 . . . . 0.0 112.661 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.453 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 63.3 m-85 -112.95 122.09 46.6 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.301 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -109.07 122.83 48.1 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.783 0.677 . . . . 0.0 110.095 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.478 ' O ' ' CB ' ' A' ' 126' ' ' GLN . 0.5 OUTLIER -111.51 177.67 4.58 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.214 0.53 . . . . 0.0 110.954 -179.447 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 131' ' ' PHE . 2.4 tp-100 88.24 128.16 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.933 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.8 tt -118.67 -3.97 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.749 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 40.3 p-10 -151.02 -45.13 0.12 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.326 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 73.9 m-20 -71.97 -158.41 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.59 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -128.27 25.98 5.77 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.66 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.1 OUTLIER -138.65 111.28 7.62 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.292 0.951 . . . . 0.0 113.119 -177.186 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 137.15 30.03 Favored Pre-proline 0 C--N 1.351 0.661 0 CA-C-N 118.145 0.43 . . . . 0.0 110.424 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.16 116.66 3.39 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 122.089 1.859 . . . . 0.0 110.033 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.416 ' CE1' ' C ' ' A' ' 197' ' ' GLY . 36.5 p90 -81.12 129.97 34.81 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.798 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 91.4 mt -133.96 140.13 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.974 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -173.17 -172.97 39.19 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.698 -1.239 . . . . 0.0 112.785 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.55 142.23 33.53 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.423 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -121.52 133.48 55.03 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.323 0.582 . . . . 0.0 110.161 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.6 m -129.25 131.63 67.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.005 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.48 130.92 55.83 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.558 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 142' ' ' GLY . 90.6 t80 -134.1 161.63 34.33 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 111.946 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.512 ' N ' ' CG ' ' A' ' 141' ' ' TYR . . . -168.21 174.91 43.05 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -101.76 126.98 48.73 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 117.231 0.515 . . . . 0.0 111.081 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.9 m -124.49 131.98 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.2 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -115.36 102.54 9.94 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.93 0.395 . . . . 0.0 110.963 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 147' ' ' SER . 77.9 m80 -141.74 89.61 2.21 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.692 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 146' ' ' HIS . 2.8 p 61.03 133.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.1 mm -101.32 120.8 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.885 0.374 . . . . 0.0 110.808 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.4 t0 42.51 -106.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.041 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.8 t 55.59 87.85 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.495 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.5 p -81.56 165.91 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.44 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -91.67 93.32 8.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.474 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -95.73 -7.22 37.9 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.915 0.388 . . . . 0.0 110.447 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.0 m -62.25 -46.33 89.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.646 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 41.7 pt -94.26 140.53 16.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.658 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -149.29 75.53 1.29 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.409 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.17 -43.0 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.984 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 5.7 t -117.16 145.5 43.8 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.214 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.9 p -78.41 165.88 23.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.375 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 162' ' ' SER . 33.9 m -72.17 149.14 91.8 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.256 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -38.75 89.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.036 1.824 . . . . 0.0 112.068 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 160' ' ' VAL . 69.1 m -60.48 -43.81 96.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.912 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -170.48 25.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.826 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 61.27 82.94 0.21 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -60.15 146.6 95.88 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.538 2.159 . . . . 0.0 111.903 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -60.37 -179.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.287 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -62.7 131.45 43.62 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -90.59 -7.14 53.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.709 0.29 . . . . 0.0 110.391 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 170' ' ' THR . 83.7 t -65.45 -46.64 89.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 170' ' ' THR . 0.7 OUTLIER 31.08 51.24 0.12 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.542 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.466 ' O ' ' OG1' ' A' ' 171' ' ' THR . 0.3 OUTLIER 34.26 41.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.076 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -63.72 -76.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.025 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -151.72 110.19 3.78 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 65.8 p 44.79 -156.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 18.9 p-10 -83.83 150.24 58.56 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.656 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.58 -99.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.348 2.032 . . . . 0.0 112.191 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -88.3 141.05 28.86 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.704 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.7 m -129.98 127.09 39.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.813 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 36.77 89.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.554 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -63.53 -41.86 98.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.411 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 39.74 82.5 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.189 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -71.06 137.1 48.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.163 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 184' ' ' SER . 54.8 tt0 -48.54 -67.65 0.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.265 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 183' ' ' GLN . 7.6 t 60.04 139.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.78 0.324 . . . . 0.0 110.332 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -150.4 32.25 0.65 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.007 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 43.0 t -150.38 91.61 1.77 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.889 0.376 . . . . 0.0 111.027 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 17.5 mt -143.36 51.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 190' ' ' VAL . 15.3 mmt85 -108.54 -111.79 0.31 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.475 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 42.04 -86.2 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.206 0.317 . . . . 0.0 110.28 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 188' ' ' ARG . 13.5 t -69.92 133.66 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.83 130.71 9.22 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mp -134.95 145.37 48.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.677 0.275 . . . . 0.0 110.662 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -163.44 -169.33 26.75 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.8 146.0 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.613 0.72 . . . . 0.0 112.243 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.1 mm -112.94 131.62 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.83 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -156.69 151.08 25.38 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.849 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.416 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . 160.39 -169.86 36.28 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.61 148.18 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.309 0.576 . . . . 0.0 111.327 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -145.9 158.79 27.79 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.602 ' N ' ' OG1' ' A' ' 207' ' ' THR . 1.6 p90 -137.96 153.41 49.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.658 0.742 . . . . 0.0 111.497 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 1.2 m-20 -56.75 142.45 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.945 -176.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 206' ' ' LEU . 72.0 mt -101.31 -23.63 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 123.065 1.412 . . . . 0.0 107.812 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.587 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.7 OUTLIER -165.13 -174.69 0.4 Allowed Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.587 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.2 OUTLIER -5.31 -93.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.144 0 CA-C-N 124.82 2.757 . . . . 0.0 114.454 -179.128 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -128.09 17.93 6.62 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 120.909 1.686 . . . . 0.0 113.297 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 202' ' ' ILE . 10.0 mp -74.46 127.32 32.76 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 176.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 5.2 t -139.34 152.74 47.41 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -177.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.49 ' N ' ' HG1' ' A' ' 207' ' ' THR . 8.0 tt -97.57 141.46 30.58 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.62 144.15 50.71 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -176.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.09 114.01 19.77 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -145.02 -179.84 21.64 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 119.426 -1.368 . . . . 0.0 113.816 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -129.03 159.34 36.24 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 113.955 -1.123 . . . . 0.0 109.331 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -141.72 148.51 39.15 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -142.34 160.55 40.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.646 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.531 ' ND1' ' N ' ' A' ' 215' ' ' HIS . 0.0 OUTLIER -122.56 147.58 46.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.357 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 51.66 77.38 0.14 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.349 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -78.24 142.84 37.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.972 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 158.56 -111.54 0.49 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -128.69 143.52 50.95 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.534 ' CD2' ' N ' ' A' ' 220' ' ' LEU . 3.3 mm? -75.58 139.49 42.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.217 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -141.43 -173.05 3.65 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.538 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -52.59 165.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.753 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 72.3 p 49.23 82.03 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.634 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -78.9 144.28 35.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.589 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -103.62 145.92 29.33 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.603 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -139.85 137.05 34.61 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.291 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 7.7 m -147.26 -59.82 0.27 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.74 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.485 ' N ' ' ND1' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -153.96 158.58 40.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.447 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -120.47 -126.76 0.27 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.543 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.48 144.33 57.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 110.978 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 49.6 m -153.89 167.49 29.54 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.451 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 92.1 mt -86.12 143.99 27.75 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.924 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -128.11 148.21 17.67 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.1 130.21 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 122.728 -0.277 . . . . 0.0 110.433 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -130.29 116.88 18.97 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -99.74 107.13 19.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.301 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.463 ' NH1' HH21 ' A' ' 66' ' ' ARG . 76.8 mtp180 -125.44 128.04 47.47 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.976 0.417 . . . . 0.0 110.893 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 . . . . . 0 C--O 1.218 -0.583 0 CA-C-O 117.938 -1.029 . . . . 0.0 111.13 179.853 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -60.33 -41.93 94.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.585 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -150.85 128.72 11.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.262 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -89.62 112.33 23.53 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.729 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.74 -133.64 52.66 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.53 25.12 68.62 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -68.16 131.97 46.35 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.33 108.03 3.16 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.023 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.03 116.2 3.37 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 CA-C-N 119.614 1.707 . . . . 0.0 113.829 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.629 ' CZ ' ' NE ' ' A' ' 66' ' ' ARG . 11.4 p90 -115.65 167.61 10.76 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.76 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.0 t -125.71 149.32 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-O 120.926 0.393 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -118.96 139.7 51.23 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.033 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.92 156.06 44.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.85 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 38.0 p30 -150.26 136.4 18.66 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.86 170.02 16.49 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.47 -120.8 0.11 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.625 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -113.05 142.29 45.89 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.03 -163.51 1.75 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.852 0.358 . . . . 0.0 111.051 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -142.6 159.95 41.24 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.525 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -73.64 150.98 40.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.331 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -77.31 136.23 38.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.543 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 tt -95.72 133.78 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.946 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.7 m -103.68 125.71 50.35 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.488 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -78.86 -65.48 0.99 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.72 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -159.05 176.84 11.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.492 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 26' ' ' TYR . 18.8 p90 -161.88 60.79 1.18 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.847 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.69 141.6 79.93 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.052 1.835 . . . . 0.0 111.94 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.669 ' H ' ' CD ' ' A' ' 29' ' ' PRO . 3.6 mt-10 -126.11 -38.34 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.588 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.063 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.669 ' CD ' ' H ' ' A' ' 28' ' ' GLU . 91.5 Cg_endo -90.95 10.2 2.88 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.527 2.151 . . . . 0.0 112.693 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.5 p -129.23 160.16 33.82 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.833 0.349 . . . . 0.0 110.645 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 32' ' ' PRO . . . -163.0 75.99 1.91 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.932 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 31' ' ' ALA . 32.3 Cg_exo -56.94 -143.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.736 2.29 . . . . 0.0 111.821 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 58.56 40.88 23.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -124.22 110.77 15.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.658 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -149.36 -57.9 0.2 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.429 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.7 pttm -158.45 163.82 36.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.795 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 37' ' ' ILE . 96.4 mt -79.22 131.57 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.148 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.1 p -149.27 -136.78 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.038 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.9 m -61.75 135.93 57.8 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.089 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.37 155.23 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.965 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.6 p -151.75 163.51 38.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.399 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -65.62 136.32 56.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.596 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.435 ' C ' ' H ' ' A' ' 45' ' ' ARG . 91.9 t80 -62.6 -46.57 87.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.818 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -76.35 42.81 0.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.524 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 43' ' ' TYR . 8.5 tpm_? -58.48 -67.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.482 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.493 ' CG ' ' H ' ' A' ' 47' ' ' ILE . 63.3 t30 -171.92 -179.56 2.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.434 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.493 ' H ' ' CG ' ' A' ' 46' ' ' ASN . 14.3 tt -86.55 135.25 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.591 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -63.3 -41.98 99.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.784 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.5 t -92.25 168.19 11.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.012 0.434 . . . . 0.0 110.814 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -167.42 34.62 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.803 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.2 p -78.57 111.76 14.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.631 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.5 m -136.87 163.02 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.557 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 71.24 57.36 0.42 Allowed Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.508 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.78 148.86 65.87 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.388 2.058 . . . . 0.0 110.982 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -56.63 100.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.9 t -148.53 155.2 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.193 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.5 m -135.17 148.11 49.6 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.842 0.353 . . . . 0.0 110.432 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.6 t -129.35 141.15 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.92 170.72 31.33 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 119.804 -1.189 . . . . 0.0 113.724 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -102.2 140.47 36.45 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-N 114.942 -0.629 . . . . 0.0 110.232 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' CG ' ' NH1' ' A' ' 237' ' ' ARG . 44.9 t0 -90.06 114.12 25.95 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 124.177 0.923 . . . . 0.0 113.252 -177.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' TRP . 34.3 m-85 -124.78 118.8 27.2 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.392 -1.277 . . . . 0.0 108.825 177.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.56 105.5 0.83 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.22 -52.36 0.83 Allowed Glycine 0 N--CA 1.466 0.64 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.417 ' O ' ' O ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -140.98 166.31 25.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.634 ' NH1' ' NH2' ' A' ' 237' ' ' ARG . 16.4 ttp180 -146.43 162.68 37.73 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.854 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.2 tp -135.24 134.1 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.631 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.15 137.87 23.63 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.299 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.79 137.45 40.07 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.577 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -99.0 125.67 44.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.505 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -129.09 139.56 51.94 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 73' ' ' ARG . . . -172.81 133.4 0.57 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.349 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.634 ' HE ' ' NH2' ' A' ' 75' ' ' ARG . 81.0 mtp85 38.8 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.975 0.417 . . . . 0.0 111.307 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -66.94 -39.34 87.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.145 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.634 ' NH2' ' HE ' ' A' ' 73' ' ' ARG . 84.6 mtt85 59.73 88.32 0.07 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.766 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.528 ' O ' ' CD1' ' A' ' 77' ' ' TRP . 62.3 tttm -173.39 95.25 0.11 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.675 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.528 ' CD1' ' O ' ' A' ' 76' ' ' LYS . 4.7 m-90 -148.12 121.39 8.97 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.533 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -64.74 -40.83 95.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.771 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -126.28 81.02 1.96 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.632 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -63.15 -42.17 99.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.643 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -144.54 -15.04 0.56 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.597 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 82' ' ' TYR . 31.9 p90 -114.4 108.16 16.51 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.962 0.41 . . . . 0.0 110.879 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.5 t -62.28 -44.9 95.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.295 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.7 m -149.42 3.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.187 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.5 t30 60.38 93.83 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.643 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.31 -43.41 98.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.473 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.04 102.57 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.524 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.564 ' H ' HD21 ' A' ' 88' ' ' ASN . 0.7 OUTLIER -65.16 -35.71 81.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.355 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.51 157.43 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.355 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -70.72 -96.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.8 pt -129.13 162.02 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.628 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.522 ' N ' ' CD ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -146.17 10.05 1.13 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.371 -179.653 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -76.73 -8.77 57.92 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.599 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 93' ' ' LYS . 97.9 mt-10 56.51 116.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.018 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 94' ' ' GLU . 9.1 m120 57.11 117.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.887 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -155.67 152.37 23.84 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 96.1 mt -122.54 126.99 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.848 0.356 . . . . 0.0 110.423 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -165.12 50.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.761 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.0 mt -103.3 113.95 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.846 0.355 . . . . 0.0 110.482 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -94.26 -22.73 18.21 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.137 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -63.79 -39.16 93.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.115 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 45.37 -113.0 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.554 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.525 ' C ' ' H ' ' A' ' 105' ' ' ASN . 81.1 p -116.24 9.6 14.63 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.187 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 104' ' ' GLU . 1.1 tm-20 -72.51 20.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.553 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.525 ' H ' ' C ' ' A' ' 103' ' ' THR . 90.3 m-20 55.45 169.51 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.97 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -79.59 -163.82 0.57 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.225 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.44 129.55 42.54 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.239 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -91.44 117.29 29.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.687 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.32 -168.48 26.47 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 t -75.83 174.75 9.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.436 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -72.96 142.46 47.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.715 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -84.33 129.31 34.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.449 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.45 146.16 54.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.398 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.3 t -70.93 131.44 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.415 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.7 t -72.34 124.7 25.65 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.1 t -171.04 133.78 0.91 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.881 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.95 158.89 44.52 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 167.61 -137.28 4.53 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.002 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.1 148.81 51.98 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.4 p -153.9 139.8 18.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.68 135.55 46.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.519 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.417 ' O ' ' CB ' ' A' ' 66' ' ' ARG . 99.1 mt -122.15 133.75 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -101.73 113.75 27.2 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -90.24 113.16 24.93 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.36 105.82 16.92 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -74.77 56.97 0.74 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.614 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.6 pt -76.27 -20.48 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -135.88 -102.16 0.21 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.155 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -178.44 -27.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.859 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -99.35 -19.6 16.94 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -161.55 137.67 8.04 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.376 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.59 149.43 73.03 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.238 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.38 104.61 1.36 Allowed 'Trans proline' 0 N--CA 1.485 1.003 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.601 ' CD2' ' NH2' ' A' ' 235' ' ' ARG . 36.4 p90 -86.14 133.09 33.89 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.616 0.722 . . . . 0.0 112.352 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 tp -133.84 138.52 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.835 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.38 167.01 31.3 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.81 157.97 37.85 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -137.0 134.51 36.7 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 37.1 t -128.63 123.87 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.56 141.61 35.21 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.693 0.759 . . . . 0.0 111.996 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -103.79 157.13 17.29 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.617 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -131.0 141.42 12.7 Favored Glycine 0 N--CA 1.466 0.678 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 52.7 m170 42.65 92.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.993 0.425 . . . . 0.0 110.728 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.81 142.19 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.479 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.54 ' C ' ' H ' ' A' ' 147' ' ' SER . 87.4 mtm180 56.51 -97.26 0.07 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.169 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 69.42 -37.71 0.38 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.705 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 145' ' ' ARG . 11.3 p -77.82 168.67 19.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.43 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 96.1 mt -67.48 135.14 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.488 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -79.47 107.38 12.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.1 m -139.54 150.24 44.85 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.385 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 76.3 p -108.93 61.61 0.6 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.158 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -61.91 -44.87 95.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.49 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.401 ' CD ' ' O ' ' A' ' 155' ' ' ILE . 18.1 ptpt -147.32 146.2 29.61 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.943 0.401 . . . . 0.0 110.476 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 37.0 p -67.72 -34.97 77.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.542 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.466 ' CG2' ' H ' ' A' ' 156' ' ' GLU . 3.1 mt -141.21 -141.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.694 0.283 . . . . 0.0 110.262 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.466 ' H ' ' CG2' ' A' ' 155' ' ' ILE . 17.6 pt-20 -157.79 -8.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.378 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.6 m -63.03 -40.1 87.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 24.7 m -63.9 134.39 55.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.801 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.4 t -96.18 125.46 40.72 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.004 0.43 . . . . 0.0 110.824 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.3 m -95.48 152.82 39.51 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.72 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -39.42 136.46 1.03 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.888 1.726 . . . . 0.0 112.304 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 163' ' ' ASN . 26.7 t -79.97 -115.03 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.426 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.448 ' N ' ' OG ' ' A' ' 162' ' ' SER . 53.2 p-10 -151.0 19.04 0.78 Allowed 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.28 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.456 ' CB ' ' CD ' ' A' ' 165' ' ' PRO . . . -60.72 -66.59 1.44 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.506 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 164' ' ' ALA . 56.9 Cg_endo -67.16 143.68 65.93 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.09 1.86 . . . . 0.0 110.969 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 50.84 50.9 18.1 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.556 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -144.8 159.8 27.89 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.9 89.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.65 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 t 48.12 94.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.475 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.608 ' C ' ' H ' ' A' ' 172' ' ' TYR . 99.2 m -69.1 -73.66 0.15 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.713 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 5.1 m 64.9 -19.82 0.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.522 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.608 ' H ' ' C ' ' A' ' 170' ' ' THR . 87.9 t80 -63.84 -25.01 67.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.641 0.258 . . . . 0.0 110.78 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -65.88 101.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.527 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.6 m -63.44 -46.31 86.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.89 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -65.49 113.67 12.59 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.859 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 178' ' ' THR . 92.3 Cg_endo -83.14 116.17 2.39 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 121.714 1.609 . . . . 0.0 111.758 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 179' ' ' GLN . 32.4 mmtp 40.33 -89.21 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.757 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 176' ' ' PRO . 21.3 m 58.68 -78.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.708 0.289 . . . . 0.0 110.609 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.514 ' N ' ' O ' ' A' ' 177' ' ' LYS . 11.7 tp-100 -90.55 104.36 16.95 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.21 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -63.56 -40.96 98.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.817 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -83.6 98.39 9.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.092 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -99.31 -47.93 4.99 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.503 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -157.44 142.17 16.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.112 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 18.9 m 38.16 88.14 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.112 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -126.14 93.87 3.93 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.442 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 27.3 t -155.14 131.51 10.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.025 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.2 tt -142.63 127.58 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.713 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -165.94 23.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.834 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.504 ' HE ' ' HA ' ' A' ' 189' ' ' ARG . 2.2 tpm_? -64.79 -14.23 58.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.22 158.54 20.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -142.07 142.97 12.28 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 119.042 -1.551 . . . . 0.0 113.092 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.87 146.03 35.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.362 -0.919 . . . . 0.0 110.005 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -165.55 175.47 41.26 Favored Glycine 0 C--N 1.314 -0.673 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.2 m -133.47 150.17 31.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.9 pt -119.96 151.82 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.74 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -167.75 158.7 11.16 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.931 0.872 . . . . 0.0 112.478 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.482 ' C ' ' CE2' ' A' ' 134' ' ' TYR . . . 174.12 -165.57 37.27 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.61 135.69 57.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.356 0.598 . . . . 0.0 110.037 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -102.91 136.72 13.01 Favored Glycine 0 C--O 1.224 -0.513 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.996 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.93 109.79 9.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 45.8 p30 -54.97 144.74 22.24 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -176.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.7 tt -125.98 2.05 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.809 1.29 . . . . 0.0 109.292 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.582 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -160.56 162.66 22.9 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 100.327 -3.953 . . . . 0.0 100.327 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.582 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.3 OUTLIER -10.57 -79.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.775 2.317 . . . . 0.0 113.771 -177.023 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 237' ' ' ARG . 12.8 mptt -129.03 25.4 5.56 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.472 0.578 . . . . 0.0 110.304 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 3.4 tp -78.92 110.69 14.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 53.6 p -106.25 145.64 31.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 14.9 tp -106.25 122.18 45.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 111.991 -2.368 . . . . 0.0 106.03 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -110.09 136.37 49.44 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -175.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -108.68 112.69 25.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 173.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -145.88 179.41 22.94 Favored Glycine 0 N--CA 1.463 0.486 0 C-N-CA 119.28 -1.438 . . . . 0.0 113.938 -175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.22 157.26 43.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.244 -1.478 . . . . 0.0 109.742 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -107.97 133.05 52.85 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' A' ' 217' ' ' TRP . 74.3 t80 -114.67 108.05 16.29 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 216' ' ' ASN . 52.9 p-80 -106.93 132.04 53.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.082 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 215' ' ' HIS . 59.5 t30 57.67 148.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.123 0.487 . . . . 0.0 111.42 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.422 ' O ' ' OH ' ' A' ' 214' ' ' TYR . 14.0 m-90 -63.68 -42.12 98.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.598 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 121.69 -90.11 0.44 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 34.6 -148.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.764 0.316 . . . . 0.0 111.483 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 220' ' ' LEU . 2.2 mm? -74.75 159.37 32.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.247 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 220' ' ' LEU . 97.4 mt-10 59.46 127.48 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.844 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 10.1 m120 55.6 51.75 12.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.672 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 21.1 p -70.08 137.94 51.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.55 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.437 ' HD3' ' H ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -84.63 158.49 20.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.845 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.415 ' O ' ' OG1' ' A' ' 227' ' ' THR . 33.8 t80 -134.56 130.04 35.94 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.83 0.348 . . . . 0.0 110.695 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.4 tttt 37.42 -95.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.39 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 225' ' ' PHE . 6.0 m 39.87 83.9 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.761 0.315 . . . . 0.0 110.999 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.653 ' CG ' ' H ' ' A' ' 229' ' ' GLU . 83.6 t60 -102.47 -119.02 0.19 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.581 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.653 ' H ' ' CG ' ' A' ' 228' ' ' HIS . 43.5 tt0 -68.34 130.47 42.98 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.98 0.419 . . . . 0.0 110.584 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -168.49 29.49 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.438 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.2 t -139.89 125.79 19.6 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.863 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 86.2 mt -108.65 104.49 13.8 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -98.71 121.55 7.22 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.663 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 71.1 t -115.55 125.05 72.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.601 ' NH2' ' CD2' ' A' ' 134' ' ' TYR . 1.7 mtt180 -133.33 144.43 49.65 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.509 0.671 . . . . 0.0 111.515 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.416 ' O ' ' CD2' ' A' ' 236' ' ' TYR . 6.9 t80 -103.09 103.3 13.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.378 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.634 ' NH2' ' NH1' ' A' ' 66' ' ' ARG . 55.9 ttm-85 -130.59 129.76 43.16 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.484 ' C ' ' O ' ' A' ' 237' ' ' ARG . 69.6 m-85 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 118.025 -0.988 . . . . 0.0 112.547 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 3' ' ' GLU . 11.6 m 45.18 -92.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.564 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 1' ' ' ALA . 32.8 tp10 57.71 156.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.08 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -76.98 117.08 18.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.448 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.66 169.49 37.65 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.92 -143.72 0.41 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -92.18 136.38 33.23 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 110.605 -0.146 . . . . 0.0 110.605 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -110.11 96.2 0.92 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.204 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.567 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 94.0 Cg_endo -84.35 119.68 2.4 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 122.962 2.441 . . . . 0.0 111.749 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.567 ' CG ' ' O ' ' A' ' 9' ' ' PRO . 71.9 m-85 -152.01 -175.94 5.45 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 12' ' ' GLN . 12.5 p -124.46 163.86 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -174.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.479 ' N ' ' CG2' ' A' ' 11' ' ' VAL . 10.7 tm0? -135.31 149.92 49.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.805 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.04 130.75 15.98 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -101.97 130.96 48.62 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.99 0.424 . . . . 0.0 111.957 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.83 155.44 47.79 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.526 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.61 124.19 7.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.392 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -102.15 3.62 38.67 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 110.375 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.75 -30.17 71.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.085 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -75.31 135.72 40.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.735 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.36 -78.02 0.56 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.836 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -145.32 132.8 20.77 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.678 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -127.33 129.96 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.521 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.09 -62.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.272 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 25' ' ' ASP . 70.2 m80 -66.53 -41.78 88.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.682 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 42.2 t0 56.48 159.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.115 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -54.0 110.21 1.96 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.76 -23.19 14.59 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.642 1.561 . . . . 0.0 112.567 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -156.27 91.21 2.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.449 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.05 147.79 72.8 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.068 1.845 . . . . 0.0 111.668 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.1 p -57.61 -40.41 79.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.553 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 43.28 80.43 0.29 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.553 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.86 144.35 98.74 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.366 2.044 . . . . 0.0 112.004 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 58.12 36.72 26.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.065 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -64.22 -36.52 84.35 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.369 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 36' ' ' LYS . 9.1 m120 56.88 39.63 29.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.282 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 35' ' ' ASN . 54.1 mtmt 55.17 112.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.864 0.364 . . . . 0.0 110.748 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.62 126.22 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.495 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -162.5 -63.46 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.691 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.7 p -132.64 109.74 9.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.617 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 41' ' ' SER . 20.0 m -133.92 135.45 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.349 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 40' ' ' VAL . 33.7 m -55.25 -165.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.736 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -79.72 55.82 2.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.372 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -82.19 142.65 32.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.804 0.335 . . . . 0.0 110.478 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -72.6 140.27 47.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.18 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -144.6 -35.3 0.34 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.364 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 54.02 80.74 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.444 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.499 ' C ' ' H ' ' A' ' 49' ' ' THR . 19.8 tt -123.6 161.93 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.987 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 67.27 -2.55 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 51' ' ' SER . 35.4 m -92.36 -4.0 54.5 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.04 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -58.91 -4.8 0.51 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.066 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 49' ' ' THR . 40.4 t -60.83 -170.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.592 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.478 ' N ' ' OG ' ' A' ' 51' ' ' SER . 4.6 t 61.52 117.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.329 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -131.77 87.91 43.91 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.055 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.413 ' HG2' HH21 ' A' ' 138' ' ' ARG . 36.9 Cg_exo -57.69 144.88 92.03 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.443 2.095 . . . . 0.0 110.638 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -148.23 -43.09 0.16 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.56 139.5 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 p -141.88 153.49 44.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.02 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.17 147.44 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.362 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.46 -154.08 10.6 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -135.99 154.47 51.07 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 53.5 p30 -121.84 149.63 43.08 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -176.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -126.53 159.95 31.98 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 112.246 -2.252 . . . . 0.0 105.14 175.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.58 100.7 0.1 OUTLIER Glycine 0 CA--C 1.535 1.301 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.259 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.562 ' O ' ' CD1' ' A' ' 65' ' ' TRP . . . 61.84 48.52 83.34 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.771 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 64' ' ' GLY . 16.7 m95 -165.8 89.24 0.42 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.609 ' NH1' ' NH1' ' A' ' 235' ' ' ARG . 70.9 ttt180 -127.33 150.43 49.59 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -176.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.43 141.35 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.397 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.72 137.91 19.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.384 0.611 . . . . 0.0 112.488 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.88 156.13 16.81 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -151.39 159.03 44.45 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -160.64 165.99 29.65 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.46 -1.7 . . . . 0.0 108.902 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.73 -165.16 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.13 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -126.12 124.16 39.94 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.898 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -174.03 -10.69 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.524 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.545 HH11 ' HG ' ' A' ' 115' ' ' SER . 37.7 ptt180 -71.79 141.99 49.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.167 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -87.12 137.0 32.72 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -114.54 128.95 56.6 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.895 0.379 . . . . 0.0 110.559 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -147.8 95.82 2.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.334 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -96.71 9.09 42.7 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.246 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -150.02 170.41 18.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.054 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -88.79 -170.98 3.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.926 0.394 . . . . 0.0 110.758 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -62.38 -36.33 81.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.387 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.5 p -134.88 156.71 48.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.982 0.42 . . . . 0.0 110.904 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.6 t -76.86 133.59 30.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.607 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ILE . 62.7 t30 64.74 94.84 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.695 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.407 ' O ' ' O ' ' A' ' 85' ' ' ASN . 23.9 mm 60.34 140.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.687 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -65.49 140.44 58.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.766 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 89' ' ' VAL . 59.8 t-20 -77.44 150.79 34.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.177 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.534 ' N ' ' OD1' ' A' ' 88' ' ' ASN . 5.9 t -82.68 100.92 6.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.366 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.9 mtp180 -84.36 -59.92 2.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.664 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.9 tt -152.61 145.24 15.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.459 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -73.2 136.49 44.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 110.902 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -156.23 138.28 14.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.281 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 95' ' ' ASN . 80.8 tt0 -154.13 133.1 12.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.785 0.326 . . . . 0.0 110.706 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 94' ' ' GLU . 88.7 m-20 -152.77 170.19 20.9 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.493 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 97' ' ' ILE . . . -81.17 -172.1 45.92 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 96' ' ' GLY . 1.6 tp 35.32 96.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.481 0.658 . . . . 0.0 111.186 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -53.18 118.82 4.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.945 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 100' ' ' ASP . 17.2 tt -68.64 -37.64 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.34 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.427 ' O ' ' O ' ' A' ' 99' ' ' ILE . 98.6 m-20 57.42 152.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.729 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -70.71 -167.34 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.399 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -73.5 -15.45 61.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.81 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.4 p -104.08 118.84 37.62 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.582 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -83.94 -80.26 0.19 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.408 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 106' ' ' GLN . 28.2 t-20 -141.21 97.09 3.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.393 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 105' ' ' ASN . 50.7 tt0 46.16 98.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.756 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -161.39 100.25 1.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.486 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 56.51 35.77 26.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.487 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.61 7.68 65.81 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.2 p -133.58 160.89 36.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.966 0.412 . . . . 0.0 110.972 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 42.85 -123.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.93 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -75.41 141.79 43.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.913 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -158.39 -79.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.314 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.69 -34.36 69.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.545 ' HG ' HH11 ' A' ' 75' ' ' ARG . 21.7 m -70.35 145.69 50.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.856 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.8 m -139.57 154.56 47.65 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 117' ' ' LEU . 3.0 mm? -87.2 132.12 33.98 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.364 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.69 138.81 14.47 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tp -149.45 140.01 22.53 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.7 p -157.12 155.64 31.38 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.365 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.91 137.34 52.09 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.474 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 4.6 mp -126.31 156.13 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.348 0.594 . . . . 0.0 111.175 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.426 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 57.6 m-85 -117.48 113.05 21.47 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.837 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -106.64 122.9 47.26 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.201 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -75.68 104.01 6.04 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.037 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -71.2 -29.7 65.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.136 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.8 -41.67 88.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.421 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -58.65 126.81 29.17 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.581 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.48 -21.87 59.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -128.1 -48.94 1.33 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.529 ' O ' ' CD2' ' A' ' 131' ' ' PHE . 52.9 p90 -115.65 132.59 56.59 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.14 110.77 41.03 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.319 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.14 109.63 1.58 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 N-CA-C 108.882 -1.238 . . . . 0.0 108.882 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 1.8 p90 -83.21 132.73 35.05 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.223 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 63.6 mt -134.33 154.87 38.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.75 -173.16 44.89 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 118.113 -1.994 . . . . 0.0 113.858 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.91 141.98 50.73 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.413 HH21 ' HG2' ' A' ' 54' ' ' PRO . 78.7 ttt180 -123.66 131.23 53.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.992 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.04 130.44 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.235 0.541 . . . . 0.0 111.477 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.26 117.8 34.92 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.961 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -120.31 140.97 50.47 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.952 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.99 -144.19 4.65 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -83.86 109.6 17.69 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.811 0.339 . . . . 0.0 110.438 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.3 p -143.94 156.37 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.008 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 56.9 79.07 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.813 0.339 . . . . 0.0 110.407 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.515 ' O ' ' ND1' ' A' ' 146' ' ' HIS . 64.3 t-80 -169.24 59.33 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.599 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.611 ' HG ' ' N ' ' A' ' 148' ' ' ILE . 78.4 p -65.88 -55.62 16.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.029 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.611 ' N ' ' HG ' ' A' ' 147' ' ' SER . 21.1 tt -155.53 147.32 12.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.441 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 150' ' ' SER . 32.1 t0 -144.71 -143.03 0.14 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.187 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.553 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 22.1 m -68.84 138.26 54.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.748 0.309 . . . . 0.0 110.446 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.7 p -90.54 162.32 15.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.76 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.83 -37.9 89.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.971 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 64.5 mttp 59.73 20.59 9.33 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.615 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 156' ' ' GLU . 74.5 p -136.44 161.89 34.59 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.023 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.405 HG21 HD12 ' A' ' 155' ' ' ILE . 94.8 mt 54.0 -87.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.389 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 154' ' ' THR . 18.2 pt-20 -133.58 161.81 33.61 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.041 0.448 . . . . 0.0 111.11 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.3 m -118.78 132.84 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.184 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 5.7 p -78.84 154.26 29.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.564 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 21.7 p -79.88 164.83 23.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.35 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.37 149.69 97.24 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.122 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -40.25 -55.68 1.75 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.173 1.915 . . . . 0.0 112.69 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.1 p -159.09 164.02 35.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.701 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 164' ' ' ALA . 51.5 p-10 -84.09 -32.32 24.83 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.694 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.524 ' N ' ' OD1' ' A' ' 163' ' ' ASN . . . -179.04 78.87 0.21 Allowed Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.365 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 166' ' ' ASN . 90.2 Cg_endo -80.22 151.85 20.8 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.372 2.048 . . . . 0.0 111.731 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 165' ' ' PRO . 71.4 m-20 58.45 141.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.949 0.405 . . . . 0.0 110.835 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -85.65 174.7 48.54 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.93 111.53 20.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.762 0.315 . . . . 0.0 110.533 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.3 t 38.34 84.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.098 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 171' ' ' THR . 50.7 p -82.06 -100.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.494 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 170' ' ' THR . 33.6 m -166.96 97.68 0.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.795 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 173' ' ' ASN . 98.7 m-85 -74.37 -107.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.232 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.525 ' CG ' ' H ' ' A' ' 174' ' ' THR . 60.8 t30 43.92 -171.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.944 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.525 ' H ' ' CG ' ' A' ' 173' ' ' ASN . 2.5 m 66.75 0.08 1.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.63 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 173' ' ' ASN . 4.4 m-20 -76.14 147.34 79.81 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.527 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.45 154.44 45.34 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.28 1.987 . . . . 0.0 111.984 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -92.31 80.39 4.98 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.777 0.322 . . . . 0.0 110.277 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 65.5 p -85.1 167.4 15.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -55.03 174.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.803 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 65.7 t30 57.46 53.28 7.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -61.37 -42.04 98.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.628 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 184' ' ' SER . 93.7 t80 -144.87 -69.26 0.3 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.518 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 49.2 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 182' ' ' TYR . 12.3 p -155.42 161.9 40.89 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.897 0.38 . . . . 0.0 110.804 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -99.68 118.73 36.83 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.713 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.3 t -146.99 -156.22 0.7 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.414 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 187' ' ' ILE . 96.0 mt 54.63 90.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.09 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -115.71 42.95 2.19 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.649 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 49.72 26.62 1.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.155 0.502 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.46 136.69 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -102.05 111.66 4.12 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.1 pp -143.76 159.13 43.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 112.375 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -177.93 -155.66 14.67 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.68 157.0 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 117.247 0.523 . . . . 0.0 110.747 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.9 pt -130.08 145.41 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.874 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -156.19 150.52 25.57 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.086 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 175.9 -173.5 46.3 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.8 143.94 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 117.731 0.765 . . . . 0.0 111.066 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -143.41 160.72 27.66 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.14 152.38 49.9 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.45 0.643 . . . . 0.0 111.532 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 6.3 p30 -69.36 146.89 51.76 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 113.717 -1.583 . . . . 0.0 115.195 -175.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.542 ' C ' ' HG1' ' A' ' 203' ' ' THR . 43.8 mt -119.91 -1.17 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 123.335 1.54 . . . . 0.0 107.123 176.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.542 ' HG1' ' C ' ' A' ' 202' ' ' ILE . 0.2 OUTLIER -165.15 147.98 6.96 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 100.5 -3.889 . . . . 0.0 100.5 178.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.541 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -6.62 -67.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 123.249 2.633 . . . . 0.0 114.191 -176.178 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 237' ' ' ARG . 58.8 mmtt -130.77 33.07 4.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.359 0.982 . . . . 0.0 112.292 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 202' ' ' ILE . 0.9 OUTLIER -92.55 108.07 19.69 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 176.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.0 t -137.35 154.88 49.94 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -174.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.96 141.85 45.1 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 113.023 -1.899 . . . . 0.0 107.578 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -135.73 147.89 48.63 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.27 150.6 43.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -179.36 -172.89 44.04 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.612 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -123.55 167.98 13.2 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.843 -0.678 . . . . 0.0 109.837 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -140.85 141.66 34.64 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.599 0.238 . . . . 0.0 110.84 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -109.75 11.21 24.54 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.256 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 216' ' ' ASN . 50.0 p-80 -37.6 115.42 0.41 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 215' ' ' HIS . 7.7 t-20 24.33 105.86 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.855 0.722 . . . . 0.0 112.643 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -71.4 152.96 42.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.815 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 102.44 -21.03 42.53 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.33 -41.21 94.2 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.528 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 90.4 mt -129.53 113.97 15.51 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.769 0.318 . . . . 0.0 110.715 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -71.03 -38.62 72.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.786 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 50.3 -99.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.516 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.3 m 58.09 98.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.291 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -141.67 154.51 45.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.501 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.14 -47.24 87.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.88 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -143.55 128.2 18.14 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.645 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 88.3 m -127.43 129.79 48.13 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.39 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -100.58 139.37 36.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.603 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 55.65 -178.22 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.169 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -155.59 -88.62 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.326 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 50.5 m -132.74 124.19 27.66 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.12 135.83 54.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.287 0.565 . . . . 0.0 111.578 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -102.1 151.14 18.35 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.724 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.86 129.76 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.609 ' NH1' ' NH1' ' A' ' 66' ' ' ARG . 93.7 mtt180 -133.41 140.92 47.6 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -113.52 102.06 9.94 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 102.203 -3.258 . . . . 0.0 102.203 173.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.533 ' O ' ' HB2' ' A' ' 205' ' ' LYS . 62.1 ttp85 -148.82 136.65 20.66 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.474 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.934 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.148 0 CA-C-O 121.233 0.352 . . . . 0.0 112.957 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.53 150.51 87.36 Favored 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 123.896 3.064 . . . . 0.0 115.153 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 44.2 p90 -149.45 161.65 41.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.259 -1.791 . . . . 0.0 106.77 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.9 t -130.5 135.51 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 118.385 0.539 . . . . 0.0 110.741 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -120.32 148.53 43.61 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.69 107.5 4.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.476 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -85.79 151.17 24.04 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.722 ' C ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -171.17 167.78 6.96 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.596 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.476 0.826 0 O-C-N 123.992 0.808 . . . . 0.0 109.868 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 110.526 -0.176 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.31 132.6 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.0 t -114.21 122.08 45.69 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.957 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 59' ' ' GLY . 3.9 p -135.01 153.92 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.405 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -175.8 -168.35 36.0 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.379 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -117.0 138.46 51.55 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.3 p30 -105.01 120.25 41.01 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 64' ' ' GLY . 74.9 m-85 -124.19 128.64 49.52 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.29 92.66 0.01 OUTLIER Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 62' ' ' PHE . . . 138.41 -94.1 0.21 Allowed Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -93.0 148.6 21.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.557 0.694 . . . . 0.0 111.444 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -132.17 135.66 46.51 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.963 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.66 128.86 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.75 143.83 47.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.036 0.446 . . . . 0.0 110.76 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.27 134.69 42.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.72 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -111.7 129.41 56.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.91 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -118.62 137.46 53.26 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.409 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.219 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.737 179.635 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.2 mp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.84 0.352 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -128.86 128.38 5.84 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.44 131.75 36.58 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.9 m -145.72 147.12 31.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.918 0.389 . . . . 0.0 110.428 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.28 113.3 26.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.477 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.684 ' N ' HD12 ' A' ' 122' ' ' ILE . 3.4 mp -111.55 146.59 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -112.77 127.21 56.09 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -98.92 125.17 44.28 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 176.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.46 ' C ' ' H ' ' A' ' 127' ' ' ILE . 39.0 m-85 -107.21 120.79 43.08 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -80.93 21.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.826 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 128' ' ' ASN . 21.4 tt -68.29 -39.35 80.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.689 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.49 ' N ' HG23 ' A' ' 127' ' ' ILE . 96.7 m-20 -93.39 -174.79 3.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.976 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -102.3 -52.55 3.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.266 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.75 -14.2 14.64 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.445 ' O ' ' CD2' ' A' ' 131' ' ' PHE . 48.9 p90 -144.77 125.95 14.67 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.109 0.868 . . . . 0.0 112.093 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.4 mtmm -107.59 129.72 23.82 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.48 140.87 33.9 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 120.975 1.117 . . . . 0.0 109.982 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -107.34 133.94 51.14 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.588 0.232 . . . . 0.0 110.858 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.3 tt -151.85 136.83 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.264 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -175.37 -168.15 35.45 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.224 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.31 156.16 49.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.845 0.355 . . . . 0.0 111.132 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.731 ' NH2' HH11 ' A' ' 213' ' ' ARG . 39.5 ttm180 -106.7 144.84 32.77 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.541 0.686 . . . . 0.0 112.837 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.6 t -130.87 112.7 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.93 126.94 52.97 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 88.2 t80 . . . . . 0 N--CA 1.461 0.116 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.447 178.584 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 CA--C 1.52 -0.203 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -135.51 139.85 11.14 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.446 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.54 147.27 52.52 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 114.398 -0.901 . . . . 0.0 108.785 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -160.5 -172.6 27.99 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.92 153.75 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 111.438 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 95.3 mt -130.94 136.3 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.678 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.49 154.98 32.67 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.123 0.487 . . . . 0.0 111.41 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 173.93 178.92 44.22 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.6 m -136.89 135.73 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -114.78 136.83 13.5 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.429 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -121.07 104.91 10.14 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 0.3 OUTLIER -97.36 143.83 27.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.248 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 43.7 mm -75.54 -34.74 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 175.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.45 HG22 ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -165.79 164.32 11.85 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 101.183 -3.636 . . . . 0.0 101.183 177.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.504 ' C ' ' O ' ' A' ' 237' ' ' ARG . 8.2 Cg_endo -55.11 -15.82 11.31 Favored 'Trans proline' 0 C--N 1.288 -2.629 0 CA-C-N 121.801 1.679 . . . . 0.0 111.66 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.458 ' HA ' ' H ' ' A' ' 237' ' ' ARG . 0.9 OUTLIER -73.8 -39.45 64.11 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.5 mt -123.08 110.45 15.34 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.626 0.648 . . . . 0.0 111.381 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 t -134.56 138.27 44.46 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.615 ' N ' HD12 ' A' ' 208' ' ' LEU . 5.8 mp -89.78 128.38 36.13 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -133.95 124.8 26.97 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -84.59 111.5 19.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -109.51 139.6 15.38 Favored Glycine 0 N--CA 1.467 0.744 0 C-N-CA 121.272 -0.489 . . . . 0.0 112.655 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -129.95 125.71 36.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.95 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.731 HH11 ' NH2' ' A' ' 138' ' ' ARG . 60.7 ttm-85 -110.64 116.82 32.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 215' ' ' HIS . 60.8 t80 -132.69 156.0 47.79 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.406 0.622 . . . . 0.0 111.939 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.539 ' O ' ' CD2' ' A' ' 214' ' ' TYR . 84.5 t60 -87.34 168.34 13.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.652 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.465 ' N ' ' CG ' ' A' ' 215' ' ' HIS . 65.1 t30 . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.853 0.359 . . . . 0.0 110.636 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 15' ' ' LEU . 12.1 tp . . . . . 0 CA--C 1.514 -0.427 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.9 148.17 19.18 Favored Glycine 0 C--N 1.314 -0.672 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 68.5 t -122.16 128.83 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.693 HH12 ' NH2' ' A' ' 237' ' ' ARG . 45.7 ptt85 -133.29 143.01 48.77 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.77 0.795 . . . . 0.0 111.266 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 53.5 t80 -110.57 126.67 54.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 113.763 -1.562 . . . . 0.0 113.326 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.693 ' NH2' HH12 ' A' ' 235' ' ' ARG . 36.3 ttm180 -140.76 113.0 7.88 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.946 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' A' ' 237' ' ' ARG . 90.5 m-85 . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 117.852 -1.071 . . . . 0.0 111.954 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 10' ' ' TYR . . . . . . . . 0 CA--C 1.533 1.167 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 26.9 Cg_endo -74.48 141.32 28.15 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.607 1.538 . . . . 0.0 111.532 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 63.8 m-85 -147.23 -179.86 7.13 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.603 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 12' ' ' GLN . 2.3 p -128.6 160.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.556 ' OE1' ' NH2' ' A' ' 235' ' ' ARG . 57.2 tt0 -142.71 147.04 34.98 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.851 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.31 156.92 43.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.928 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -160.5 155.78 24.86 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.0 mt -134.15 146.2 49.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.584 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.174 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 57' ' ' SER . 13.7 p -140.64 162.23 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.639 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.511 ' N ' HG22 ' A' ' 56' ' ' VAL . 28.3 t -146.61 151.94 38.1 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.81 163.15 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.326 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.18 178.68 43.45 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.934 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -112.73 131.12 55.81 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.19 0.596 . . . . 0.0 109.813 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -102.08 127.24 49.06 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.545 ' O ' ' N ' ' A' ' 64' ' ' GLY . 90.5 m-85 -124.56 139.55 53.77 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.58 88.82 0.01 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.11 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 62' ' ' PHE . . . 129.77 -82.33 0.33 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -95.99 144.08 26.59 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.675 0.75 . . . . 0.0 111.501 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.782 HH11 HH21 ' A' ' 237' ' ' ARG . 51.2 ttp180 -136.27 137.93 41.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.377 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.93 128.68 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.58 139.32 26.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.08 145.46 50.32 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.107 0.48 . . . . 0.0 111.095 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -93.58 125.96 38.47 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -106.38 141.97 36.82 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.631 0.729 . . . . 0.0 111.789 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.489 -179.837 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.2 mp . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -135.1 142.2 13.58 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 120.468 -0.873 . . . . 0.0 113.392 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.3 mt -120.43 143.47 48.46 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.7 t -139.68 118.02 12.06 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.63 118.54 29.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.548 HG22 ' N ' ' A' ' 123' ' ' TYR . 46.3 mm -104.77 160.17 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.548 ' N ' HG22 ' A' ' 122' ' ' ILE . 62.8 t80 -128.02 99.48 5.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 64' ' ' GLY . 43.8 t0 -138.34 122.8 18.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.843 0.354 . . . . 0.0 110.33 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.504 ' H ' ' CG ' ' A' ' 132' ' ' LYS . 10.9 m-85 -113.19 121.56 44.85 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.823 0.821 . . . . 0.0 112.322 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 126' ' ' GLN . 1.3 mp0 -86.7 -10.51 53.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.915 -1.038 . . . . 0.0 108.841 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.571 ' C ' ' H ' ' A' ' 129' ' ' ASP . 96.4 mt -67.84 -41.2 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 95.4 m-20 -69.67 35.35 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.849 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' A' ' 127' ' ' ILE . 20.8 t0 92.62 -119.94 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.85 0.719 . . . . 0.0 110.491 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -127.34 23.3 6.42 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.574 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 11.0 p90 -151.13 126.39 9.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 119.568 -0.853 . . . . 0.0 113.287 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.504 ' CG ' ' H ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -135.87 135.71 22.09 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.413 177.623 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.65 98.34 1.14 Allowed 'Trans proline' 0 C--N 1.325 -0.661 0 N-CA-C 104.217 -3.032 . . . . 0.0 104.217 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -76.66 135.75 39.13 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 118.97 -1.092 . . . . 0.0 113.566 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.2 mt -120.54 134.17 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 CA-C-N 113.465 -1.698 . . . . 0.0 107.75 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.02 166.06 30.38 Favored Glycine 0 N--CA 1.46 0.288 0 C-N-CA 119.897 -1.145 . . . . 0.0 112.145 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.22 134.7 34.13 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -106.97 119.8 40.33 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.195 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 139' ' ' VAL . 9.8 p -136.3 123.12 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.77 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.84 129.44 34.48 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 . . . . . 0 C--O 1.237 0.442 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.081 -179.15 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 190' ' ' VAL . 14.1 p . . . . . 0 N--CA 1.465 0.279 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -138.32 135.17 7.29 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 119.505 -1.331 . . . . 0.0 114.583 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.59 144.75 50.79 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 163.31 -148.83 15.74 Favored Glycine 0 C--N 1.322 -0.216 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.01 159.19 26.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.767 0.794 . . . . 0.0 112.004 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 19.5 tt -113.11 131.61 64.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.66 150.47 36.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 122.15 0.976 . . . . 0.0 112.769 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 171.58 177.4 41.25 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.68 136.22 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.623 0.725 . . . . 0.0 110.57 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -122.87 120.67 4.34 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -128.25 142.21 51.22 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.836 0.827 . . . . 0.0 109.59 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 13.6 p-10 -49.16 141.8 7.82 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 117.438 2.385 . . . . 0.0 117.438 -173.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.532 ' O ' HG22 ' A' ' 202' ' ' ILE . 49.7 mm -124.31 5.59 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 112.35 -2.204 . . . . 0.0 106.177 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.58 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER 176.15 173.83 0.29 Allowed Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 -178.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.58 ' C ' ' O ' ' A' ' 203' ' ' THR . 3.8 Cg_exo -14.36 -83.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 123.58 2.314 . . . . 0.0 113.687 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.435 ' O ' HG23 ' A' ' 207' ' ' THR . 58.7 mttp -129.61 29.6 5.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.689 0.757 . . . . 0.0 110.604 177.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 202' ' ' ILE . 4.2 tt -83.66 111.89 19.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 176.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 205' ' ' LYS . 3.2 p -120.31 152.73 37.41 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.16 131.77 48.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 112.728 -2.033 . . . . 0.0 105.623 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -108.06 146.82 32.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -145.59 129.51 17.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.531 -1.668 . . . . 0.0 106.673 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -167.68 -168.99 30.64 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 118.903 -1.617 . . . . 0.0 113.038 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -143.81 142.69 30.99 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.542 HH12 ' CD2' ' A' ' 215' ' ' HIS . 8.9 ptm180 -91.41 116.98 29.28 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.95 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -63.47 -46.35 86.59 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.542 ' CD2' HH12 ' A' ' 213' ' ' ARG . 86.3 t60 29.59 84.36 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.206 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.9 t30 . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.38 179.287 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 232' ' ' LEU . 11.3 mp . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 121.107 0.48 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -141.58 153.08 23.87 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.011 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 14.2 p -133.44 134.18 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.652 ' NE ' HH12 ' A' ' 66' ' ' ARG . 52.6 ttm-85 -133.29 141.67 48.1 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 80.4 t80 -107.84 103.57 12.86 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.782 HH21 HH11 ' A' ' 66' ' ' ARG . 41.1 ttm180 -126.44 133.54 51.21 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 124.188 0.93 . . . . 0.0 111.413 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 10.2 t80 . . . . . 0 C--O 1.218 -0.554 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.308 179.493 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.062 0 CA-C-O 120.967 0.204 . . . . 0.0 113.105 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.54 -174.59 2.0 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.308 2.672 . . . . 0.0 112.464 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.691 ' CZ ' ' NH2' ' A' ' 66' ' ' ARG . 3.4 t80 -159.47 141.02 13.06 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 120.904 0.383 . . . . 0.0 111.786 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 12' ' ' GLN . 58.0 t -132.21 159.39 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.451 ' N ' HG12 ' A' ' 11' ' ' VAL . 44.4 tt0 -157.44 151.79 24.94 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -176.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.7 121.59 10.64 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 113.172 -1.831 . . . . 0.0 107.825 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 38.4 p30 -92.65 133.77 35.66 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.1 mt -126.86 133.87 50.63 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.149 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.768 179.408 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 . . . . . 0 CA--C 1.518 -0.287 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.07 139.3 44.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 121.154 0.502 . . . . 0.0 111.462 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.26 130.27 36.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.91 162.71 37.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.065 0.459 . . . . 0.0 111.155 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.85 -136.21 3.1 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -139.28 151.76 46.71 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 121.482 0.658 . . . . 0.0 112.344 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.563 ' OD2' ' NE ' ' A' ' 237' ' ' ARG . 12.1 t0 -92.39 104.79 17.08 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.125 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -126.33 148.07 49.62 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.256 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.47 125.77 8.07 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 123' ' ' TYR . . . 94.09 -10.73 71.56 Favored Glycine 0 C--N 1.33 0.247 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.539 ' CZ2' ' CG2' ' A' ' 67' ' ' ILE . 22.6 t90 -167.69 142.45 3.72 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.565 -0.817 . . . . 0.0 110.198 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.691 ' NH2' ' CZ ' ' A' ' 10' ' ' TYR . 69.4 mtp180 -144.01 144.34 31.62 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.539 ' CG2' ' CZ2' ' A' ' 65' ' ' TRP . 48.5 pt -120.17 138.34 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.639 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.65 110.16 8.53 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.786 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.07 119.52 29.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -100.14 128.42 46.22 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 112.146 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -153.92 155.23 35.27 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.675 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.475 -179.381 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 117' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.466 0.35 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 162.53 -105.4 0.26 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 118.875 -1.631 . . . . 0.0 112.916 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.28 151.74 33.43 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.4 0.619 . . . . 0.0 111.547 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.0 t -139.48 119.25 13.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.458 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.91 123.23 26.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.089 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.504 HD13 HH22 ' A' ' 235' ' ' ARG . 90.7 mt -101.23 135.95 35.25 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' A' ' 64' ' ' GLY . 12.2 m-85 -124.3 107.72 11.47 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.008 0.432 . . . . 0.0 110.301 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.666 ' CG ' HH11 ' A' ' 66' ' ' ARG . 9.5 m-20 -96.96 141.53 30.02 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.933 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.495 ' O ' ' CB ' ' A' ' 132' ' ' LYS . 93.5 m-85 -103.34 153.7 20.17 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -108.59 63.61 0.61 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.8 mp -67.43 -41.69 86.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -141.84 -85.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.011 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.4 t70 179.24 -44.22 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.332 0.587 . . . . 0.0 110.297 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.99 -43.31 88.15 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.629 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -142.93 110.73 5.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -175.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -130.58 139.93 37.13 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.353 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.46 152.18 70.84 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.323 1.348 . . . . 0.0 109.603 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 0.5 OUTLIER -138.45 133.95 33.42 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.612 -179.135 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.4 pt -130.4 154.8 41.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.441 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -155.88 163.27 31.72 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.93 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -102.35 122.61 44.59 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -92.66 128.22 38.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.111 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.13 119.22 46.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.32 153.53 46.47 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.419 ' CE1' ' O ' ' A' ' 117' ' ' LEU . 47.6 p90 . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.55 . . . . 0.0 110.927 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -119.33 117.96 3.8 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.22 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 7.8 tt -145.34 127.81 15.99 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -171.73 -163.16 25.21 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.305 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.79 138.37 49.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.47 0.653 . . . . 0.0 110.929 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 67.4 mt -113.51 130.63 67.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -138.16 154.46 49.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.743 0.782 . . . . 0.0 112.849 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 172.32 -171.93 44.55 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.66 135.67 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.213 0.53 . . . . 0.0 110.231 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -96.05 113.15 4.58 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -116.0 117.68 30.82 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 58.9 p30 -57.92 150.29 20.8 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 206' ' ' LEU . 21.5 mm -113.33 -60.63 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.567 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -106.42 176.88 1.49 Allowed Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 174.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.567 ' C ' ' O ' ' A' ' 203' ' ' THR . 15.9 Cg_exo -14.93 -81.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.485 0.974 0 CA-C-N 122.909 2.075 . . . . 0.0 113.746 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 237' ' ' ARG . 97.3 mttt -126.73 28.08 5.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.514 0.674 . . . . 0.0 110.761 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 202' ' ' ILE . 2.9 tt -85.8 112.67 21.31 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.4 p -103.93 149.8 24.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -172.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 208' ' ' LEU . 0.4 OUTLIER -104.36 106.07 16.44 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 101.695 -3.446 . . . . 0.0 101.695 173.064 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -104.09 130.37 51.79 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -174.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -122.14 144.19 49.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.348 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.44 -163.88 32.12 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.0 147.11 46.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -105.18 119.01 38.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.796 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -120.89 163.5 18.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.285 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -124.91 -172.76 2.64 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 216' ' ' ASN . 49.9 t-20 . . . . . 0 C--N 1.33 -0.272 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.496 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 153.4 -166.8 31.79 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.869 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.25 130.64 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.681 ' NH1' HH22 ' A' ' 66' ' ' ARG . 71.2 mtp180 -128.59 142.85 50.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.287 0.565 . . . . 0.0 111.555 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.499 ' O ' ' CD2' ' A' ' 236' ' ' TYR . 5.5 t80 -106.28 106.49 17.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.764 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.563 ' NE ' ' OD2' ' A' ' 61' ' ' ASP . 71.7 ttt180 -133.75 128.63 35.26 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.0 t80 . . . . . 0 C--O 1.222 -0.381 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.847 179.733 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.69 0 N-CA-C 114.617 0.607 . . . . 0.0 114.617 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.72 157.43 27.97 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 124.679 3.586 . . . . 0.0 115.354 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -150.62 165.6 32.85 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.831 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.18 139.27 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -124.81 145.65 49.65 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.58 0.705 . . . . 0.0 112.473 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.77 151.0 34.05 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.998 -1.455 . . . . 0.0 108.476 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 15' ' ' LEU . 38.4 t0 -142.33 144.06 33.04 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.577 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 92.0 mt -126.94 143.69 51.21 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.684 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.428 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.055 179.011 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 57' ' ' SER . 74.9 t -139.37 159.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.381 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.484 ' N ' HG12 ' A' ' 56' ' ' VAL . 5.1 m -141.7 141.66 33.32 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.486 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.62 137.49 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.094 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.22 -175.65 32.47 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.037 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -96.97 137.51 35.94 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.977 0.418 . . . . 0.0 111.73 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.531 ' OD1' ' NH2' ' A' ' 66' ' ' ARG . 34.3 t70 -101.37 115.07 29.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.37 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -124.56 120.69 32.66 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.497 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.0 107.24 0.44 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.32 -60.98 0.59 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.439 ' N ' ' CD1' ' A' ' 65' ' ' TRP . 8.7 p-90 -157.98 150.68 22.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.937 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.628 ' NH1' ' NH1' ' A' ' 235' ' ' ARG . 9.3 ptp85 -135.66 167.23 21.51 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.887 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.2 pt -145.22 143.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.193 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.86 145.51 29.88 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.15 0.5 . . . . 0.0 110.71 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.17 127.28 38.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.403 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -98.18 127.56 44.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.558 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 45.2 p90 -139.88 166.24 25.15 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.846 0.831 . . . . 0.0 112.848 -177.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 71' ' ' TYR . . . . . . . . 0 N--CA 1.462 0.173 0 CA-C-N 113.001 -1.909 . . . . 0.0 108.6 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 170.32 -109.72 0.34 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 119.644 -1.265 . . . . 0.0 111.99 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.28 147.63 41.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.292 0.567 . . . . 0.0 110.748 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.3 p -150.81 141.38 22.58 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.68 149.05 32.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.815 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.463 ' O ' ' CG1' ' A' ' 122' ' ' ILE . 3.4 pt -144.36 114.45 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.587 ' CZ ' HG23 ' A' ' 135' ' ' ILE . 34.2 p90 -90.43 141.91 28.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.575 ' OD1' ' NH1' ' A' ' 66' ' ' ARG . 62.7 m-20 -89.84 115.84 27.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 113.387 -1.733 . . . . 0.0 108.143 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.476 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 87.8 t80 -118.13 121.8 41.44 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.464 ' CB ' ' O ' ' A' ' 125' ' ' PHE . 1.4 mm100 147.96 177.33 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.53 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.56 ' O ' HG22 ' A' ' 127' ' ' ILE . 93.0 mt -70.21 -1.46 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.753 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 70.9 36.55 1.46 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.632 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.46 -60.39 1.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.889 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -129.06 -48.31 1.22 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.572 ' CD2' ' CE1' ' A' ' 200' ' ' PHE . 1.0 OUTLIER -148.32 146.58 28.61 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.145 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.476 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -134.74 141.82 40.09 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.337 177.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.56 107.96 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 N-CA-C 108.007 -1.574 . . . . 0.0 108.007 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -81.85 131.02 35.25 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.981 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.587 HG23 ' CZ ' ' A' ' 123' ' ' TYR . 2.5 tt -161.83 149.51 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.832 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.69 -144.88 6.25 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.092 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -127.43 164.14 22.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.69 ' NH2' HH21 ' A' ' 213' ' ' ARG . 41.7 ttm180 -125.17 133.89 52.62 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.096 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.88 121.71 61.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.27 146.17 44.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.138 0.494 . . . . 0.0 110.98 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 . . . . . 0 C--O 1.238 0.481 0 CA-C-O 121.698 0.761 . . . . 0.0 111.661 -179.516 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 191' ' ' GLY . 54.9 t . . . . . 0 C--O 1.234 0.283 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 190' ' ' VAL . . . -137.58 135.74 7.78 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.162 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.4 tp -142.61 131.05 22.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -164.02 -160.93 12.32 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.39 153.25 35.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.986 0.898 . . . . 0.0 111.228 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.6 tt -124.67 134.04 67.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 113.622 -1.626 . . . . 0.0 108.733 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -157.67 156.15 31.25 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 119.634 -0.827 . . . . 0.0 112.454 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 169.06 -171.41 42.96 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.16 135.54 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.517 0.659 . . . . 0.0 111.034 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -116.35 129.9 8.71 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.968 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.572 ' CE1' ' CD2' ' A' ' 131' ' ' PHE . 56.7 m-85 -104.29 109.52 21.39 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.704 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.26 121.6 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 124.662 1.226 . . . . 0.0 110.171 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.554 ' O ' HG22 ' A' ' 202' ' ' ILE . 42.7 mm -126.57 3.8 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 123.385 1.564 . . . . 0.0 108.635 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.778 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.2 OUTLIER -156.59 73.33 4.81 Favored Pre-proline 0 N--CA 1.425 -1.714 1 N-CA-C 98.664 -4.569 . . . . 0.0 98.664 178.138 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER 1.06 -41.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.826 1 C-N-CA 126.111 4.541 . . . . 0.0 116.747 -170.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.778 ' N ' ' O ' ' A' ' 203' ' ' THR . 61.9 pttt -96.73 0.08 49.01 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.623 HD23 ' C ' ' A' ' 206' ' ' LEU . 5.9 tt -109.07 106.67 16.69 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 8.4 t -141.61 140.73 33.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 119.257 -0.977 . . . . 0.0 113.011 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.26 116.67 30.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.422 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -97.22 123.3 40.96 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.371 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -117.31 124.43 48.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -170.15 -173.54 37.59 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 118.946 -1.597 . . . . 0.0 112.705 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -133.79 148.24 51.34 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.69 HH21 ' NH2' ' A' ' 138' ' ' ARG . 84.0 mtp180 -127.05 129.27 47.7 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -152.75 157.34 40.7 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.199 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.533 ' ND1' ' N ' ' A' ' 215' ' ' HIS . 0.0 OUTLIER -151.79 165.49 34.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.191 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.4 ' CG ' ' O ' ' A' ' 215' ' ' HIS . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 121.022 0.439 . . . . 0.0 110.411 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 232' ' ' LEU . 10.9 mp . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -126.79 152.03 18.38 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.474 -0.393 . . . . 0.0 112.229 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.0 p -126.86 131.45 71.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.628 ' NH1' ' NH1' ' A' ' 66' ' ' ARG . 60.3 ttp180 -130.67 143.45 50.76 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -91.93 126.76 37.14 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 112.93 -1.941 . . . . 0.0 106.441 176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.574 ' H ' ' CA ' ' A' ' 205' ' ' LYS . 1.4 tmm_? -147.13 109.5 4.54 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 122.452 1.12 . . . . 0.0 111.701 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 C--O 1.22 -0.484 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.596 -179.712 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.459 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.78 129.2 22.78 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.806 1.671 . . . . 0.0 114.206 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -162.26 166.57 25.23 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.608 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 12' ' ' GLN . 40.9 t -128.86 157.24 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.473 ' N ' HG12 ' A' ' 11' ' ' VAL . 32.0 tp60 -135.32 143.79 46.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.775 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.89 149.2 29.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.128 0.489 . . . . 0.0 111.293 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 39.0 p-10 -105.17 120.57 41.85 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.995 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.2 mt -118.63 141.5 48.54 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.998 0.428 . . . . 0.0 111.07 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.186 179.544 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.604 0.24 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 57' ' ' SER . 12.5 p -138.73 154.25 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.156 0.503 . . . . 0.0 111.75 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.475 ' N ' HG22 ' A' ' 56' ' ' VAL . 26.5 t -142.9 143.55 32.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.201 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 p -135.28 151.23 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.76 174.56 42.77 Favored Glycine 0 C--O 1.241 0.561 0 C-N-CA 118.302 -1.904 . . . . 0.0 114.191 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.99 138.44 34.52 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 113.446 -1.377 . . . . 0.0 108.161 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -116.72 102.82 9.75 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.41 ' O ' ' C ' ' A' ' 63' ' ' GLY . 78.3 m-85 -107.65 127.53 53.74 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 175.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -41.16 103.9 0.04 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 120.012 -1.089 . . . . 0.0 110.744 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.05 -83.92 0.19 Allowed Glycine 0 C--N 1.343 0.968 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.447 ' CD1' ' N ' ' A' ' 65' ' ' TRP . 2.1 p-90 -133.23 172.92 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.127 0.464 . . . . 0.0 111.433 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.855 HH21 HD13 ' A' ' 122' ' ' ILE . 50.6 ttp180 -125.1 151.61 45.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.452 ' N ' ' HG2' ' A' ' 66' ' ' ARG . 91.3 mt -108.37 129.7 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -141.62 145.64 35.26 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.63 149.5 49.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 113.606 -1.634 . . . . 0.0 106.667 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 4.1 p-10 -148.92 153.47 38.05 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 119.272 -0.971 . . . . 0.0 113.201 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -108.38 143.05 37.83 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 113.835 -1.529 . . . . 0.0 109.156 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.982 -179.838 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -102.09 124.59 8.25 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -143.01 135.65 27.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 117.6 0.7 . . . . 0.0 109.802 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.8 m -154.81 151.99 29.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.432 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.678 ' C ' HD12 ' A' ' 122' ' ' ILE . . . -118.18 125.89 51.11 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.855 HD13 HH21 ' A' ' 66' ' ' ARG . 1.7 mp -119.96 154.56 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.542 0.687 . . . . 0.0 112.232 -176.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -103.12 110.35 22.27 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.184 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -108.5 122.49 47.15 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -91.36 81.56 5.45 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.49 0.662 . . . . 0.0 109.417 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -67.71 -18.27 64.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.203 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.0 pt -67.91 -30.46 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.812 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 131' ' ' PHE . 89.2 m-20 -70.66 121.53 18.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 67.8 t0 -63.97 -41.85 97.42 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -105.37 -18.95 13.95 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 20.8 p90 -158.2 133.87 8.99 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.289 1.404 . . . . 0.0 114.368 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -118.09 103.64 49.54 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.0 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.602 ' HA ' HG22 ' A' ' 198' ' ' VAL . 24.8 Cg_exo -63.57 123.14 11.56 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 15.3 p90 -106.58 133.46 51.22 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.093 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.9 tt -145.76 147.53 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.109 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.45 -171.85 37.69 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 119.69 -1.243 . . . . 0.0 113.605 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.53 136.98 39.56 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 20.1 ttt-85 -124.98 120.89 32.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.38 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.17 135.6 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.942 0.877 . . . . 0.0 112.11 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.25 124.9 50.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.029 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.4 t80 . . . . . 0 C--N 1.325 -0.479 0 CA-C-O 121.096 0.474 . . . . 0.0 111.933 -177.82 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.233 0.188 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -130.93 150.58 19.4 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.929 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.4 pp -168.2 136.72 2.32 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.661 0.743 . . . . 0.0 112.618 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -169.41 -140.54 2.99 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.49 164.31 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.483 0.658 . . . . 0.0 111.763 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.7 tt -129.84 138.09 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.549 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.455 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . -152.74 164.23 38.17 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.477 ' O ' ' CD2' ' A' ' 134' ' ' TYR . . . 155.47 170.6 21.14 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.062 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 133' ' ' PRO . 59.8 t -131.29 138.41 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 117.274 0.537 . . . . 0.0 111.804 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -105.46 134.02 11.87 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -131.29 105.82 7.89 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.79 153.27 33.01 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -175.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 66.6 mt -113.18 -10.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 123.298 1.523 . . . . 0.0 107.888 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.699 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.5 m -166.75 103.5 0.65 Allowed Pre-proline 0 C--N 1.3 -1.562 1 N-CA-C 99.445 -4.28 . . . . 0.0 99.445 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.466 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -11.56 -42.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 123.557 2.838 . . . . 0.0 115.63 -172.527 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 203' ' ' THR . 13.6 pttm -77.87 -34.72 51.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 203' ' ' THR . 50.5 tp -83.93 105.76 15.07 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.2 m -128.61 131.28 48.12 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 208' ' ' LEU . 10.0 mp -96.8 141.57 29.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -134.67 144.77 48.0 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.012 0.911 . . . . 0.0 113.335 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -101.86 113.08 25.95 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -152.58 157.56 27.35 Favored Glycine 0 N--CA 1.462 0.387 0 C-N-CA 118.556 -1.783 . . . . 0.0 113.895 -176.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -169.31 163.91 10.79 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.645 ' N ' ' NE ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -124.48 154.15 40.96 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.932 0.396 . . . . 0.0 110.129 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -142.78 133.51 25.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.94 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -74.59 144.91 43.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.174 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.4 t30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.158 179.429 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 71.1 mt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.507 0.67 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -143.75 137.92 7.77 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.6 145.39 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 117.393 0.597 . . . . 0.0 110.621 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -124.55 142.77 51.09 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.328 0.585 . . . . 0.0 111.063 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -110.34 106.07 15.31 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.431 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.661 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 2.4 tmt_? -114.06 96.13 5.65 Favored 'General case' 0 C--O 1.255 1.37 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 237' ' ' ARG . 72.3 m-85 . . . . . 0 N--CA 1.472 0.661 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.447 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.293 0 CA-C-O 119.699 -0.501 . . . . 0.0 112.118 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.461 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 58.6 Cg_endo -90.74 143.41 3.48 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.896 2.397 . . . . 0.0 113.477 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.608 ' CZ ' ' NH2' ' A' ' 66' ' ' ARG . 1.7 m-85 -159.63 146.59 16.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.21 0.528 . . . . 0.0 112.221 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.3 t -141.19 137.06 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.946 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -135.31 149.49 49.78 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.52 152.17 32.6 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.837 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -107.0 155.43 19.81 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.626 0.25 . . . . 0.0 111.003 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -139.29 128.93 24.55 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.624 ' N ' HD13 ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 120.728 0.299 . . . . 0.0 111.415 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.6 mtm-85 . . . . . 0 C--O 1.232 0.158 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.76 134.14 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.842 0.353 . . . . 0.0 111.034 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -133.37 143.39 48.91 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.514 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.71 160.33 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.052 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.56 177.04 40.33 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.415 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -121.13 155.65 34.03 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 47.4 t0 -137.72 124.08 20.65 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -177.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 63' ' ' GLY . 16.5 m-85 -116.67 104.83 11.77 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -24.85 97.2 0.01 OUTLIER Glycine 0 CA--C 1.533 1.203 0 CA-C-N 117.718 0.235 . . . . 0.0 113.097 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.18 -13.74 7.93 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 66' ' ' ARG . 15.6 t90 -165.88 136.56 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.012 0.406 . . . . 0.0 110.823 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.608 ' NH2' ' CZ ' ' A' ' 10' ' ' TYR . 14.8 ptp180 -148.17 148.44 30.55 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.843 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.6 pt -108.93 147.71 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.779 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.0 141.35 36.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 110.857 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.88 129.13 25.55 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.498 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 24.8 p30 -106.2 143.76 33.87 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.476 0.655 . . . . 0.0 111.906 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.09 146.2 50.02 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.992 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.142 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.074 179.475 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 N--CA 1.463 0.222 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 70' ' ' ASP . . . -133.01 115.45 1.57 Allowed Glycine 0 N--CA 1.469 0.847 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.787 ' H ' HD23 ' A' ' 119' ' ' LEU . 1.7 pt? -141.11 153.62 45.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.327 0.563 . . . . 0.0 111.498 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.3 m -146.42 153.58 40.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.065 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.43 125.03 46.66 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 97.3 mt -123.6 152.32 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -111.25 131.94 54.74 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.158 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 15.6 p-10 -132.9 125.25 29.48 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 123.801 0.688 . . . . 0.0 110.813 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.497 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 81.2 m-85 -115.69 80.63 1.47 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -105.07 7.32 33.87 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 110.003 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER -67.84 -28.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -62.08 -49.97 73.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.4 t0 179.16 -102.75 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.287 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -117.77 0.9 12.09 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 10.8 m-85 -113.25 111.28 21.78 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.497 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -133.31 142.7 45.24 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 117.93 0.332 . . . . 0.0 111.066 178.405 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -91.28 120.13 0.62 Allowed 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 122.36 2.04 . . . . 0.0 109.281 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.594 ' CE1' ' OD2' ' A' ' 209' ' ' ASP . 40.1 p90 -92.02 128.26 37.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.528 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 47.8 mm -134.78 131.99 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.777 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.76 174.84 38.31 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.611 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.37 131.06 55.38 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.95 125.42 50.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.186 0.517 . . . . 0.0 111.089 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.98 139.18 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.122 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.01 137.39 52.16 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.526 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 121.203 0.525 . . . . 0.0 111.19 179.446 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.236 0.375 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.543 ' C ' HD22 ' A' ' 192' ' ' LEU . . . -146.92 159.32 27.98 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.329 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.842 HD22 ' N ' ' A' ' 192' ' ' LEU . 0.4 OUTLIER -117.46 146.89 43.19 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.641 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -168.19 -177.57 39.45 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.716 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.62 156.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.606 0.717 . . . . 0.0 111.636 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.2 tt -127.06 135.55 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.041 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.3 161.01 37.64 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . 157.81 -167.06 34.14 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.51 162.32 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 122.73 -0.277 . . . . 0.0 110.978 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.12 165.04 34.64 Favored Glycine 0 CA--C 1.545 1.916 0 C-N-CA 119.842 -1.17 . . . . 0.0 114.616 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -130.82 128.71 41.22 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.683 1.193 . . . . 0.0 109.004 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 4.6 p30 -89.88 151.18 21.87 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.488 HG22 ' OG1' ' A' ' 203' ' ' THR . 0.8 OUTLIER -67.98 -37.93 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 103.005 -2.961 . . . . 0.0 103.005 174.061 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.675 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.0 OUTLIER -176.31 148.97 0.91 Allowed Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 100.612 -3.847 . . . . 0.0 100.612 176.639 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.445 ' C ' ' O ' ' A' ' 237' ' ' ARG . 32.0 Cg_exo -35.86 -17.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.295 -2.25 0 C-N-CA 121.313 1.342 . . . . 0.0 113.419 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.675 ' N ' ' O ' ' A' ' 203' ' ' THR . 87.1 tttt -68.87 -44.52 73.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 119.309 -0.377 . . . . 0.0 111.868 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.98 114.65 14.86 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.941 0.401 . . . . 0.0 111.056 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 201' ' ' ASP . 4.8 t -127.87 133.79 49.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.818 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.0 123.03 32.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.594 ' OD2' ' CE1' ' A' ' 134' ' ' TYR . 13.4 t70 -109.52 110.94 22.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.878 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -102.75 134.72 45.67 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.14 36.98 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 119.97 -1.109 . . . . 0.0 112.199 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -133.61 134.39 43.18 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -89.45 108.56 19.71 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.998 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -102.65 127.87 49.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -125.25 161.54 26.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.024 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.223 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 15' ' ' LEU . 6.8 tt . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -115.06 172.51 14.24 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 62.1 t -139.68 131.56 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.588 0.233 . . . . 0.0 110.918 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.459 HH11 ' NH1' ' A' ' 66' ' ' ARG . 36.6 ttm180 -132.7 142.07 48.88 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 236' ' ' TYR . 1.1 t80 -118.72 137.68 53.17 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 204' ' ' PRO . 14.3 ttt-85 -150.38 112.5 4.6 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.626 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.398 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.957 0 N-CA-C 112.166 -0.374 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.405 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 48.9 Cg_endo -92.74 165.08 2.73 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.558 2.838 . . . . 0.0 114.951 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.596 ' OH ' ' HB2' ' A' ' 68' ' ' ALA . 22.5 p90 -163.85 164.39 23.5 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.575 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 p -135.39 155.22 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-O 120.524 0.202 . . . . 0.0 111.088 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -134.81 147.76 50.02 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.2 152.6 34.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.742 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 31.7 p-10 -153.24 159.06 42.53 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -133.3 152.39 51.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.042 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.68 0.276 . . . . 0.0 110.73 179.639 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.6 155.28 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.574 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -135.45 128.7 31.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.288 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 m -140.91 165.34 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.19 -152.25 12.58 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.552 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -113.98 139.12 49.5 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-O 120.762 0.315 . . . . 0.0 111.543 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.1 p30 -103.26 101.01 10.93 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 124.835 1.335 . . . . 0.0 112.874 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.545 ' CZ ' ' O ' ' A' ' 65' ' ' TRP . 23.9 p90 -125.37 125.26 43.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -39.51 131.61 2.22 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.98 -84.59 0.37 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.545 ' O ' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -117.32 153.73 32.47 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.361 0.6 . . . . 0.0 110.33 179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.622 ' NH1' ' NH2' ' A' ' 235' ' ' ARG . 0.6 OUTLIER -129.82 130.94 45.94 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.77 128.57 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.596 ' HB2' ' OH ' ' A' ' 10' ' ' TYR . . . -139.0 124.66 19.56 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 120.922 0.391 . . . . 0.0 110.571 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.31 138.59 39.87 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.02 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -100.56 128.72 46.53 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.302 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -129.13 156.94 43.1 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.757 0.789 . . . . 0.0 111.95 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.202 0 CA-C-N 113.617 -1.628 . . . . 0.0 108.462 178.612 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 117' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.7 -157.96 20.94 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.233 -1.461 . . . . 0.0 112.373 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.1 mt -127.42 144.69 51.02 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.269 0.557 . . . . 0.0 110.571 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 84.0 p -147.47 140.44 25.02 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.63 127.75 53.6 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 87.9 mt -101.51 135.09 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.537 ' O ' ' CG ' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -128.77 102.88 6.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.255 0.934 . . . . 0.0 112.127 -176.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.547 ' CG ' HH21 ' A' ' 66' ' ' ARG . 3.4 m-20 -89.94 135.74 33.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.841 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 132' ' ' LYS . 41.9 t80 -113.22 81.36 1.49 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -70.32 85.8 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.038 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 128' ' ' ASN . 17.5 tt -70.21 -41.29 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.129 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.431 ' N ' HG23 ' A' ' 127' ' ' ILE . 40.3 t30 177.67 -47.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.384 0.428 . . . . 0.0 110.199 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -59.91 -169.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.088 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -100.48 -1.72 35.03 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.495 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 7.1 p90 -138.34 128.97 26.46 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.435 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -133.41 156.8 79.36 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 121.021 0.439 . . . . 0.0 111.059 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.7 146.3 21.05 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.922 1.748 . . . . 0.0 109.675 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 134' ' ' TYR . 6.8 p90 -138.25 138.13 38.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.207 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 136' ' ' GLY . 32.2 mt -136.56 164.43 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.86 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.488 ' N ' ' CG2' ' A' ' 135' ' ' ILE . . . -164.93 -176.67 36.83 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.669 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -133.2 155.46 49.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.24 -0.98 . . . . 0.0 108.753 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -135.56 128.1 30.65 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.33 121.75 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -124.75 124.3 41.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 110.506 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 . . . . . 0 N--CA 1.464 0.246 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.564 -179.754 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 191' ' ' GLY . 73.7 t . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.441 ' N ' HG12 ' A' ' 190' ' ' VAL . . . -141.16 140.43 10.34 Favored Glycine 0 N--CA 1.476 1.305 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.698 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 216' ' ' ASN . 47.1 tp -133.61 125.1 28.04 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -156.12 -169.78 20.68 Favored Glycine 0 C--N 1.32 -0.345 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.8 158.98 42.71 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 CA-C-O 122.306 1.051 . . . . 0.0 112.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.8 mm -109.57 130.48 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 112.639 -2.073 . . . . 0.0 107.312 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.3 156.86 42.32 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.514 -0.741 . . . . 0.0 111.834 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.408 ' C ' ' CE2' ' A' ' 134' ' ' TYR . . . 150.05 -176.98 28.46 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.42 159.68 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -136.84 140.74 11.7 Favored Glycine 0 N--CA 1.47 0.93 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.781 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -122.04 105.44 10.29 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -96.0 137.16 35.46 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 202' ' ' ILE . 1.2 mp -69.54 -39.16 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 173.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -155.25 156.08 30.66 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 101.284 -3.598 . . . . 0.0 101.284 175.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.509 ' C ' ' O ' ' A' ' 237' ' ' ARG . 32.3 Cg_exo -48.78 -17.51 1.17 Allowed 'Trans proline' 0 C--N 1.288 -2.622 0 CA-C-N 121.706 1.645 . . . . 0.0 111.267 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 203' ' ' THR . 60.4 tttp -67.82 -39.77 83.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.286 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 9.0 mt -124.05 107.79 11.67 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.123 0.874 . . . . 0.0 111.925 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.596 HG23 ' HG2' ' A' ' 235' ' ' ARG . 0.3 OUTLIER -136.81 141.03 42.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.63 0.728 . . . . 0.0 112.948 177.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.44 ' O ' ' OD1' ' A' ' 209' ' ' ASP . 84.0 mt -99.1 148.3 24.19 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 208' ' ' LEU . 28.3 m-20 -139.3 137.0 35.46 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -83.65 133.43 34.82 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.86 151.62 19.66 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 120.236 -0.983 . . . . 0.0 114.59 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -135.22 142.18 45.96 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.195 -1.002 . . . . 0.0 109.03 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 86.0 mmt-85 -110.75 125.04 53.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -127.83 161.39 29.14 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.604 0.716 . . . . 0.0 112.862 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.661 ' CG ' ' H ' ' A' ' 216' ' ' ASN . 69.1 t60 -126.97 -175.46 3.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.486 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.661 ' H ' ' CG ' ' A' ' 215' ' ' HIS . 45.4 t-20 . . . . . 0 C--N 1.328 -0.346 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.554 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 25.4 mt . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 121.11 0.481 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -131.77 148.2 18.94 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.306 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.6 p -131.39 137.83 54.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.622 ' NH2' ' NH1' ' A' ' 66' ' ' ARG . 10.8 ptm180 -136.55 146.74 46.51 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -101.99 113.07 25.99 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 113.254 -1.793 . . . . 0.0 108.967 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.611 HH11 ' NH2' ' A' ' 66' ' ' ARG . 75.0 ttt180 -139.23 115.55 10.46 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 122.354 1.073 . . . . 0.0 112.113 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.522 ' OXT' ' CD1' ' A' ' 238' ' ' PHE . 1.2 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.21 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.448 ' C ' ' CE2' ' A' ' 10' ' ' TYR . . . . . . . . 0 CA--C 1.539 1.561 0 N-CA-C 112.139 -0.385 . . . . 0.0 112.139 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 77.5 Cg_endo -80.82 127.19 6.15 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.877 2.384 . . . . 0.0 111.695 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 52.4 m-85 -141.24 -178.23 5.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.888 -0.142 . . . . 0.0 111.287 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 12' ' ' GLN . 6.2 t -138.62 162.6 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.476 ' N ' HG12 ' A' ' 11' ' ' VAL . 8.9 tm0? -130.51 131.62 45.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.972 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.88 140.14 22.23 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.967 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -161.05 168.83 23.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 232' ' ' LEU . 0.4 OUTLIER -172.12 179.88 2.52 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.499 179.63 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 121.172 0.511 . . . . 0.0 111.946 -179.613 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.696 0.284 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.0 t -131.09 155.49 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.249 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.9 m -137.33 151.85 49.09 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.982 0.42 . . . . 0.0 111.622 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.02 145.68 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.336 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 67' ' ' ILE . . . -164.72 -179.96 39.07 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 119.61 -1.281 . . . . 0.0 114.184 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -106.68 132.85 52.19 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -97.65 121.18 39.25 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -125.37 113.64 17.82 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.42 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -43.35 103.94 0.05 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 123' ' ' TYR . . . 136.88 -36.07 2.02 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.426 ' N ' ' CD1' ' A' ' 65' ' ' TRP . 0.3 OUTLIER -170.18 156.3 5.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.979 0.418 . . . . 0.0 110.879 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.487 HH21 HG21 ' A' ' 122' ' ' ILE . 17.3 ttp85 -134.55 135.38 42.26 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.404 ' O ' ' HA3' ' A' ' 59' ' ' GLY . 49.3 mm -99.98 127.92 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.38 130.93 14.86 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 119.454 -0.898 . . . . 0.0 112.169 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.49 144.2 26.84 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.989 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -104.28 128.01 52.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.129 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -134.35 162.02 33.37 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.012 0.435 . . . . 0.0 111.242 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.37 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.434 179.718 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.521 -0.164 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.33 -126.6 1.03 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.926 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 62.1 tp -135.52 149.47 49.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 120.993 0.425 . . . . 0.0 110.277 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.1 p -152.55 152.37 31.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.46 130.03 51.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.009 0.433 . . . . 0.0 110.767 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.612 ' N ' HD12 ' A' ' 122' ' ' ILE . 1.9 mp -97.72 148.17 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 177.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.541 ' CE1' ' O ' ' A' ' 64' ' ' GLY . 4.2 t80 -138.7 123.98 19.26 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 118.941 -1.104 . . . . 0.0 113.64 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.644 ' CB ' HH22 ' A' ' 237' ' ' ARG . 32.6 p-10 -110.36 120.29 41.97 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 113.489 -1.687 . . . . 0.0 106.588 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.473 ' CD2' ' OH ' ' A' ' 123' ' ' TYR . 5.1 t80 -70.26 129.32 39.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.248 0.546 . . . . 0.0 111.675 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.424 ' O ' ' O ' ' A' ' 125' ' ' PHE . 88.0 mt-30 39.98 -167.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.903 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.526 ' O ' ' C ' ' A' ' 128' ' ' ASN . 1.3 mp -105.0 20.83 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.656 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 127' ' ' ILE . 65.6 m-80 -11.46 -73.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.593 0.558 . . . . 0.0 111.828 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 128' ' ' ASN . 4.7 p30 153.89 -51.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.875 0.734 . . . . 0.0 111.441 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.81 -19.0 3.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -146.98 122.81 10.62 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.021 0.828 . . . . 0.0 113.146 -178.247 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.409 ' HB3' ' N ' ' A' ' 125' ' ' PHE . 1.3 mptt -134.24 133.0 21.37 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.045 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -51.12 133.62 41.71 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 CA-C-N 119.95 1.018 . . . . 0.0 110.325 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -96.76 130.0 44.08 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.463 ' N ' ' CD1' ' A' ' 134' ' ' TYR . 96.7 mt -136.62 136.51 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -129.27 139.28 10.84 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.984 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -118.38 128.79 54.97 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -129.99 131.44 45.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.247 0.546 . . . . 0.0 112.025 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.42 113.31 2.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.44 144.95 35.36 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.92 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.4 p90 . . . . . 0 C--O 1.236 0.356 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.313 -179.93 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.234 0.254 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -123.55 147.83 16.69 Favored Glycine 0 N--CA 1.472 1.099 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.003 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 tt -144.49 127.51 16.51 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.783 -0.709 . . . . 0.0 109.236 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -150.3 170.34 30.26 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.09 140.73 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.837 0.827 . . . . 0.0 111.987 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.1 mt -118.64 134.56 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.476 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -148.42 153.27 38.3 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.503 0.668 . . . . 0.0 111.97 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 179.08 -140.59 4.47 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.611 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.43 140.82 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.83 0.315 . . . . 0.0 111.123 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -119.48 123.31 5.6 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.195 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -123.61 106.71 10.79 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 0.3 OUTLIER -74.54 152.58 39.31 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -176.165 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.54 HG23 ' N ' ' A' ' 203' ' ' THR . 8.1 tt -64.72 -36.91 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 113.068 -1.878 . . . . 0.0 108.208 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.827 ' O ' ' N ' ' A' ' 205' ' ' LYS . 29.7 m 178.62 100.26 0.15 Allowed Pre-proline 0 C--N 1.315 -0.93 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 238' ' ' PHE . 0.1 OUTLIER -14.55 58.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 124.02 3.146 . . . . 0.0 115.139 -173.575 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.827 ' N ' ' O ' ' A' ' 203' ' ' THR . 75.4 tttt -135.24 -44.81 0.7 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.063 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 26.5 tp -143.81 121.32 11.74 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.467 HG21 ' HE ' ' A' ' 235' ' ' ARG . 0.7 OUTLIER -95.67 145.26 25.41 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -176.221 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 209' ' ' ASP . 1.0 OUTLIER -107.63 117.65 34.67 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.363 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.561 ' N ' HD13 ' A' ' 208' ' ' LEU . 3.8 p30 -141.37 146.35 36.51 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -100.06 148.86 24.09 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.361 -1.745 . . . . 0.0 107.032 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -174.53 115.44 0.55 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 118.777 -1.678 . . . . 0.0 113.713 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -170.31 139.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -148.8 -86.09 0.09 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 215' ' ' HIS . 18.7 t80 -170.46 -178.46 2.7 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.394 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.545 ' O ' ' CE2' ' A' ' 214' ' ' TYR . 10.4 p-80 -149.34 165.91 30.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.233 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 . . . . . 0 C--N 1.33 -0.274 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.13 179.917 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 232' ' ' LEU . 10.0 mp . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 120.781 0.324 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -146.36 143.71 11.88 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.575 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 234' ' ' VAL . 12.8 p -123.69 129.72 74.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.467 ' HE ' HG21 ' A' ' 207' ' ' THR . 52.9 mtm180 -133.54 144.33 49.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.32 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 3.1 m-85 -76.34 122.83 25.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.644 HH22 ' CB ' ' A' ' 124' ' ' ASP . 16.6 tpt180 -138.69 113.13 8.85 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 124.277 0.985 . . . . 0.0 111.86 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.446 ' OXT' ' CG ' ' A' ' 238' ' ' PHE . 78.5 t80 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.013 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.443 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . . . . . . 0 CA--C 1.53 1.016 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.94 158.28 30.95 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.011 2.474 . . . . 0.0 112.776 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.43 ' CZ ' ' CG ' ' A' ' 66' ' ' ARG . 20.6 p90 -154.25 163.29 40.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.456 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.9 t -129.02 144.17 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 120.88 0.371 . . . . 0.0 111.813 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -123.1 131.54 53.73 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.112 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.68 142.74 24.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.072 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 51.4 p-10 -95.96 143.33 27.24 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.506 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.623 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 97.5 mt -143.67 162.34 36.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.186 0.517 . . . . 0.0 112.036 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.471 0.585 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.343 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 119.739 -0.172 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 57' ' ' SER . 9.4 p -155.25 161.5 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 119.386 -0.925 . . . . 0.0 112.709 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 56' ' ' VAL . 49.9 m -132.5 133.03 43.29 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.698 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.516 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 4.3 m -140.05 165.95 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 111.609 0.225 . . . . 0.0 111.609 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.52 -162.04 24.75 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 119.721 -1.228 . . . . 0.0 114.188 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -112.53 151.18 30.29 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.499 -0.851 . . . . 0.0 108.915 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 8' ' ' GLY . 3.6 p-10 -136.95 114.36 10.93 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.529 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 38.9 p90 -125.05 105.35 9.11 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.29 177.03 7.5 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 105.888 -2.885 . . . . 0.0 105.888 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.601 ' CA ' ' H ' ' A' ' 124' ' ' ASP . . . -47.05 -36.16 8.89 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 120.013 1.907 . . . . 0.0 111.305 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -48.48 97.42 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.69 ' HE ' ' CD1' ' A' ' 122' ' ' ILE . 26.5 ttp-105 -130.07 119.76 23.59 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.674 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.4 pt -126.88 137.79 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.956 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 58' ' ' VAL . . . -136.88 146.0 45.03 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.234 0.54 . . . . 0.0 111.661 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.1 140.53 29.91 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.218 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -102.25 127.4 49.23 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.299 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -112.4 136.77 51.48 Favored 'General case' 0 C--O 1.248 0.979 0 O-C-N 124.627 1.204 . . . . 0.0 110.394 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.325 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.568 179.813 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.1 tp . . . . . 0 CA--C 1.524 -0.027 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -149.43 178.27 27.06 Favored Glycine 0 N--CA 1.476 1.332 0 C-N-CA 118.901 -1.619 . . . . 0.0 112.6 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.753 ' N ' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -134.49 150.75 50.83 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.852 0.834 . . . . 0.0 111.519 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.1 t -134.29 102.47 5.37 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.24 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.32 122.56 39.32 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.69 ' CD1' ' HE ' ' A' ' 66' ' ' ARG . 3.4 pt -121.87 146.3 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -127.69 128.93 46.28 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.601 ' H ' ' CA ' ' A' ' 64' ' ' GLY . 13.7 t70 -112.51 134.38 54.07 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.788 0.804 . . . . 0.0 111.885 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.605 ' C ' ' H ' ' A' ' 127' ' ' ILE . 76.9 m-85 -93.4 85.47 4.97 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.752 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -60.34 16.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.059 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.605 ' H ' ' C ' ' A' ' 125' ' ' PHE . 38.4 mm -68.3 -42.0 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.477 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -75.59 143.63 42.25 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.136 0.494 . . . . 0.0 110.164 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.6 -40.65 97.6 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -127.35 -7.35 5.84 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 20.2 p90 -168.91 127.0 1.02 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.911 1.687 . . . . 0.0 115.291 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.56 ' NZ ' ' OD1' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -136.76 149.28 66.49 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -69.65 137.43 35.76 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.791 1.318 . . . . 0.0 111.798 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 28.3 p90 -105.95 130.86 53.81 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 106.617 -1.624 . . . . 0.0 106.617 175.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.5 pt -127.92 149.15 32.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.74 174.36 37.38 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.952 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.04 139.14 53.65 Favored 'General case' 0 CA--C 1.523 -0.062 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 193' ' ' GLY . 0.0 OUTLIER -126.32 126.13 43.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.767 0.318 . . . . 0.0 110.882 -178.418 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.18 146.21 33.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.81 0.814 . . . . 0.0 111.274 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.97 127.01 44.79 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.61 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.1 t80 . . . . . 0 C--O 1.237 0.426 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.865 179.883 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.434 ' C ' HD22 ' A' ' 192' ' ' LEU . . . -142.73 148.38 20.1 Favored Glycine 0 N--CA 1.473 1.127 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.845 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.434 HD22 ' C ' ' A' ' 191' ' ' GLY . 1.7 mm? -115.51 154.79 28.7 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 138' ' ' ARG . . . -170.14 -178.77 41.28 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.46 155.67 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.567 0.699 . . . . 0.0 111.34 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 195' ' ' ILE . 16.0 tt -131.95 130.49 61.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.94 161.58 42.37 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 119.956 -0.698 . . . . 0.0 112.084 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.68 -178.36 36.71 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.88 136.57 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 117.822 0.811 . . . . 0.0 110.612 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -97.69 137.52 13.35 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -121.58 100.23 6.9 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.596 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -100.46 152.85 19.89 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -172.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 28.2 mm -89.27 -67.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 103.776 -2.676 . . . . 0.0 103.776 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.5 p -103.89 -166.33 0.1 OUTLIER Pre-proline 0 CA--C 1.542 0.668 1 N-CA-C 100.1 -4.037 . . . . 0.0 100.1 172.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -81.03 -16.63 9.81 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 CA-C-N 126.373 3.312 . . . . 0.0 112.303 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.657 ' HA ' ' H ' ' A' ' 237' ' ' ARG . 47.7 pttt -81.86 -43.95 17.53 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -81.03 104.38 11.49 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.205 -178.497 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.79 131.55 24.23 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.728 0.694 . . . . 0.0 112.523 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 36.7 tp -94.79 130.3 41.39 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -110.81 123.41 50.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -107.44 118.27 36.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -157.11 -175.35 27.93 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 118.023 -2.037 . . . . 0.0 114.411 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.543 ' CE2' ' CD1' ' A' ' 214' ' ' TYR . 69.5 t80 -141.25 110.03 6.09 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 113.557 -1.322 . . . . 0.0 108.724 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -104.3 128.91 52.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.142 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.543 ' CD1' ' CE2' ' A' ' 212' ' ' TYR . 37.1 p90 -151.27 156.38 40.73 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.249 0.547 . . . . 0.0 111.361 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -154.45 165.99 34.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.417 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 62.1 t30 . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 120.913 0.387 . . . . 0.0 111.052 -178.976 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 15' ' ' LEU . 87.9 mt . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 121.298 0.571 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -154.48 164.97 31.78 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.13 150.94 17.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 CA-C-N 117.653 0.726 . . . . 0.0 110.917 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.473 ' NH2' ' CE1' ' A' ' 134' ' ' TYR . 99.7 mtt180 -132.6 142.54 49.18 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.467 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -107.28 110.4 22.41 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.657 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 76.2 ttt-85 -131.88 108.88 9.7 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-O 122.096 0.951 . . . . 0.0 113.422 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.438 ' C ' ' O ' ' A' ' 237' ' ' ARG . 2.6 t80 . . . . . 0 N--CA 1.47 0.54 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.182 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.261 0 N-CA-C 114.15 0.42 . . . . 0.0 114.15 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.71 159.79 19.58 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 124.359 3.373 . . . . 0.0 115.493 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -167.13 136.96 2.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.141 -1.845 . . . . 0.0 107.95 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 12' ' ' GLN . 3.5 p -134.81 156.84 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.465 ' N ' HG22 ' A' ' 11' ' ' VAL . 27.4 pt20 -154.21 148.39 25.87 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.91 122.3 7.87 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.646 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -86.42 116.46 24.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.89 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 232' ' ' LEU . 11.8 tp -84.85 128.59 34.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.492 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.533 179.62 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.15 161.38 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.832 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.3 t -144.35 146.16 32.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.002 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.43 153.47 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.3 179.49 39.1 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.893 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -111.51 140.7 45.89 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.851 -0.674 . . . . 0.0 110.331 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -89.27 107.56 19.12 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.49 1.119 . . . . 0.0 110.72 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -126.02 142.25 51.6 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.575 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.99 127.29 24.63 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.89 -61.11 0.71 Allowed Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -125.34 158.55 33.95 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.607 0.718 . . . . 0.0 111.967 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.492 HH21 ' NE ' ' A' ' 237' ' ' ARG . 70.7 mtt85 -133.18 147.38 52.04 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.8 mt -111.74 126.38 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.13 135.59 35.88 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.324 0.583 . . . . 0.0 111.949 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.62 122.67 47.89 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.862 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 42.5 p-10 -99.84 128.45 45.93 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -153.93 171.77 18.47 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 122.161 0.982 . . . . 0.0 112.342 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.298 0 CA-C-N 113.294 -1.776 . . . . 0.0 108.048 179.91 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.461 0.122 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 177.31 -146.25 7.63 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.319 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 mp -137.38 148.83 46.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.19 0.519 . . . . 0.0 110.185 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 77.3 p -146.35 138.59 25.09 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.38 114.35 28.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.163 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 55.2 mt -88.87 129.83 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 135' ' ' ILE . 16.0 m-85 -100.98 116.53 33.05 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.256 0.551 . . . . 0.0 109.93 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.47 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 66.8 t0 -100.15 124.28 45.37 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.523 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.495 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 68.5 m-85 -110.03 82.6 1.62 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.693 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -58.6 -6.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 110.44 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 129' ' ' ASP . 66.7 mt -68.83 -40.45 81.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.792 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -73.2 27.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.649 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 127' ' ' ILE . 34.9 t0 68.53 -119.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.981 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -90.52 -12.26 37.71 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.42 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 4.1 p90 -118.2 102.49 9.03 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.359 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -109.6 130.58 22.62 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 179.086 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -76.94 120.15 5.35 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 120.728 0.952 . . . . 0.0 110.048 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' A' ' 207' ' ' THR . 24.4 m-85 -75.91 130.71 38.92 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.456 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.556 ' O ' ' CD2' ' A' ' 123' ' ' TYR . 28.6 mm -135.96 135.6 50.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.46 169.98 37.1 Favored Glycine 0 C--N 1.322 -0.25 0 C-N-CA 118.979 -1.582 . . . . 0.0 113.203 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -104.34 140.42 37.92 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -118.49 124.38 47.44 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.0 123.23 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -147.21 146.41 29.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.844 0.354 . . . . 0.0 110.377 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 . . . . . 0 C--O 1.235 0.305 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.947 -179.366 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.232 0.146 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.672 ' C ' HD12 ' A' ' 192' ' ' LEU . . . -130.59 102.87 0.54 Allowed Glycine 0 N--CA 1.468 0.771 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.672 HD12 ' C ' ' A' ' 191' ' ' GLY . 10.7 mp -127.75 133.89 49.51 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.068 0.461 . . . . 0.0 110.143 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -179.33 -140.17 3.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.33 152.47 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.442 0.639 . . . . 0.0 110.547 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.3 tp -111.96 142.1 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.59 174.66 13.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 111.81 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 155.91 -176.99 33.23 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.66 136.65 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -131.86 135.07 7.97 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 120.431 -0.89 . . . . 0.0 114.467 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -106.74 113.1 26.4 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 113.684 -1.258 . . . . 0.0 108.224 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 43.6 p30 -51.34 147.03 6.23 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.092 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.0 mm -108.9 -51.48 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.522 HG22 ' HD2' ' A' ' 204' ' ' PRO . 0.3 OUTLIER -106.79 -174.06 0.3 Allowed Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 176.038 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.522 ' HD2' HG22 ' A' ' 203' ' ' THR . 11.0 Cg_exo -32.87 -70.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 122.55 1.947 . . . . 0.0 114.311 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -126.8 20.72 7.06 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.171 0.986 . . . . 0.0 110.425 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.5 tt -88.24 127.62 35.45 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.425 HG21 ' OH ' ' A' ' 134' ' ' TYR . 6.0 t -137.09 152.75 50.38 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.1 tt -105.7 124.25 49.25 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.465 ' CG ' ' NH1' ' A' ' 235' ' ' ARG . 2.2 p30 -137.1 147.62 46.17 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -174.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -91.08 127.03 36.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -114.93 150.5 18.71 Favored Glycine 0 N--CA 1.471 0.977 0 C-N-CA 121.287 -0.482 . . . . 0.0 113.001 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.64 127.84 37.84 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -89.85 136.64 32.92 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.61 101.08 6.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.682 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.47 ' NE2' ' OD1' ' A' ' 216' ' ' ASN . 84.7 t60 -97.42 126.77 42.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.47 ' OD1' ' NE2' ' A' ' 215' ' ' HIS . 13.4 m120 . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 110.757 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 233' ' ' GLY . 5.8 tt . . . . . 0 C--O 1.225 -0.196 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.555 ' N ' HD23 ' A' ' 232' ' ' LEU . . . -115.36 171.28 13.63 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.278 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.31 129.73 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 113.708 -1.246 . . . . 0.0 108.32 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.465 ' NH1' ' CG ' ' A' ' 209' ' ' ASP . 83.8 mtt85 -132.48 141.79 48.95 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.805 0.335 . . . . 0.0 110.353 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -122.0 112.16 17.93 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.658 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.492 ' NE ' HH21 ' A' ' 66' ' ' ARG . 87.5 mtm-85 -134.06 126.65 30.59 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 . . . . . 0 C--O 1.218 -0.563 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.453 -178.915 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.448 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . . . . . . 0 CA--C 1.541 1.68 0 CA-C-O 119.995 -0.336 . . . . 0.0 113.487 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.464 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 71.4 Cg_endo -82.25 158.29 17.45 Favored 'Trans proline' 0 N--CA 1.507 2.277 0 C-N-CA 122.899 2.399 . . . . 0.0 111.989 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.623 ' CE2' ' NH1' ' A' ' 66' ' ' ARG . 3.4 t80 -148.1 137.71 22.34 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 236' ' ' TYR . 57.6 t -131.84 135.15 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -136.46 144.27 44.31 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -174.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.434 ' O ' ' OD1' ' A' ' 14' ' ' ASP . . . -152.99 149.43 28.18 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.304 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 13' ' ' ALA . 86.0 m-20 -144.44 125.71 14.71 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.175 -0.328 . . . . 0.0 110.661 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.401 HD12 ' C ' ' A' ' 14' ' ' ASP . 5.3 mp -140.66 163.46 32.81 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.353 0.596 . . . . 0.0 111.903 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.467 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.133 179.591 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 . . . . . 0 N--CA 1.462 0.139 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.464 HG22 ' N ' ' A' ' 57' ' ' SER . 9.7 p -150.01 154.42 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 119.567 -0.853 . . . . 0.0 113.065 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 56' ' ' VAL . 15.2 t -135.67 134.49 39.24 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.009 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.36 163.34 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.295 0.569 . . . . 0.0 111.933 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.64 -160.35 25.52 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -128.9 143.67 50.96 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 120.84 0.352 . . . . 0.0 110.345 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 9' ' ' PRO . 18.1 p-10 -124.72 115.39 20.66 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -126.91 158.02 37.88 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.49 123.02 32.05 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.426 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.06 -89.07 0.28 Allowed Glycine 0 N--CA 1.474 1.184 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.3 p-90 -127.79 174.04 9.45 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.623 ' NH1' ' CE2' ' A' ' 10' ' ' TYR . 25.3 ttp85 -147.32 147.42 30.34 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.354 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.39 144.24 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.39 150.18 19.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.364 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.88 159.14 31.8 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 55.6 p30 -140.45 153.07 46.13 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.51 169.26 24.21 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.363 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 120.946 0.403 . . . . 0.0 111.305 -179.124 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.543 ' N ' HD22 ' A' ' 117' ' ' LEU . 3.2 mm? . . . . . 0 N--CA 1.464 0.243 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.73 134.71 7.5 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.188 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.2 tt -123.94 140.76 52.66 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.9 t -133.27 123.01 24.74 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' A' ' 136' ' ' GLY . . . -94.39 130.72 40.62 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 123' ' ' TYR . 88.2 mt -129.73 159.36 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.499 ' N ' HG22 ' A' ' 122' ' ' ILE . 55.8 m-85 -118.42 118.15 30.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 237' ' ' ARG . 54.4 t0 -140.0 114.9 9.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.909 0.385 . . . . 0.0 111.478 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -122.11 96.18 4.95 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.574 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.564 ' NE2' ' OD1' ' A' ' 201' ' ' ASP . 47.9 tt0 -93.51 -0.62 56.27 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.397 0.618 . . . . 0.0 109.907 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.0 -23.56 29.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 12.7 t-20 -60.79 -42.63 97.94 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.165 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 128' ' ' ASN . 52.2 m-20 -175.21 -110.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.677 0.611 . . . . 0.0 109.366 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -118.22 1.05 11.86 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.665 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -128.81 131.67 47.78 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.485 0.491 . . . . 0.0 110.116 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.675 ' NZ ' HH22 ' A' ' 237' ' ' ARG . 0.5 OUTLIER -116.56 128.04 26.3 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.025 -178.055 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.13 129.55 29.02 Favored 'Trans proline' 0 N--CA 1.482 0.816 0 N-CA-C 107.187 -1.89 . . . . 0.0 107.187 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -115.16 129.15 56.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.368 0.604 . . . . 0.0 111.234 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.2 tt -162.2 148.77 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.509 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 121' ' ' ALA . . . -169.22 -177.23 39.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 119.637 -1.268 . . . . 0.0 113.157 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.48 144.03 30.76 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.044 0.45 . . . . 0.0 110.326 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -119.1 118.85 32.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.949 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.25 128.99 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.938 0.399 . . . . 0.0 110.657 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.31 128.06 43.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.1 p90 . . . . . 0 C--O 1.239 0.512 0 CA-C-O 121.783 0.802 . . . . 0.0 111.749 -178.905 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.231 0.115 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -136.04 151.34 20.7 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 119.904 -1.141 . . . . 0.0 112.973 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.8 pp -166.89 147.54 5.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.144 0.497 . . . . 0.0 111.273 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -172.86 -156.84 13.32 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.92 147.92 33.08 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-O 122.063 0.935 . . . . 0.0 113.041 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 7.5 tp -116.89 148.01 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.204 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.09 167.12 30.31 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.897 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 150.98 -168.31 30.66 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.5 m -140.53 159.7 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 117.317 0.558 . . . . 0.0 110.407 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -143.91 133.78 5.49 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.787 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -130.51 127.23 38.73 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.564 ' OD1' ' NE2' ' A' ' 126' ' ' GLN . 0.1 OUTLIER -79.19 152.02 30.91 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 -173.485 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 202' ' ' ILE . 1.2 mp -62.36 -42.85 97.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 174.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.1 OUTLIER -164.5 171.9 5.22 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 176.263 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.569 ' O ' ' C ' ' A' ' 238' ' ' PHE . 13.8 Cg_endo -65.91 63.72 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 CA-C-N 121.722 1.651 . . . . 0.0 110.598 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 203' ' ' THR . 16.3 ptpt -134.21 -46.4 0.77 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.12 0.568 . . . . 0.0 110.516 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.408 ' N ' ' HG3' ' A' ' 205' ' ' LYS . 7.5 tt -160.63 153.21 20.82 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.1 t -134.48 152.84 52.05 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.67 133.26 34.26 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 112.881 -1.963 . . . . 0.0 106.482 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.598 ' CG ' HH12 ' A' ' 235' ' ' ARG . 6.1 t70 -135.66 133.91 38.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.908 0.861 . . . . 0.0 112.564 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -101.94 117.99 35.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.06 143.89 15.12 Favored Glycine 0 N--CA 1.467 0.735 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.983 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -171.32 136.06 1.0 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.373 -0.913 . . . . 0.0 108.597 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.527 ' O ' ' CD1' ' A' ' 214' ' ' TYR . 0.0 OUTLIER -166.15 -139.84 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.251 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 213' ' ' ARG . 75.8 m-85 -155.48 -158.88 0.86 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.471 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -141.47 167.46 22.11 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.212 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.58 -179.577 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.273 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -117.65 152.36 17.69 Favored Glycine 0 CA--C 1.517 0.2 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 234' ' ' VAL . 33.3 m -122.86 128.04 75.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.598 HH12 ' CG ' ' A' ' 209' ' ' ASP . 80.5 mtm-85 -126.24 141.16 52.03 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.397 0.618 . . . . 0.0 110.03 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.455 ' HB3' ' H ' ' A' ' 11' ' ' VAL . 41.1 t80 -90.62 115.57 27.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.121 -176.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.675 HH22 ' NZ ' ' A' ' 132' ' ' LYS . 31.3 ttm105 -124.04 87.88 2.81 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.569 ' C ' ' O ' ' A' ' 204' ' ' PRO . 33.3 t80 . . . . . 0 CA--C 1.512 -0.505 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.721 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.524 ' O ' ' CD2' ' A' ' 10' ' ' TYR . . . . . . . . 0 CA--C 1.55 2.253 0 CA-C-O 119.716 -0.491 . . . . 0.0 113.394 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.576 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 71.8 Cg_exo -45.65 106.63 0.09 OUTLIER 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.232 2.621 . . . . 0.0 116.825 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 16.7 m-85 -146.51 157.2 43.71 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.97 154.66 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.077 -1.049 . . . . 0.0 112.703 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -120.24 149.67 41.9 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.307 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.7 125.87 23.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.209 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 53.1 p-10 -91.91 149.75 21.39 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 15' ' ' LEU . 1.0 OUTLIER 178.49 174.54 0.62 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.591 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.917 179.183 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 57' ' ' SER . 9.1 p -163.57 157.33 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 117.696 -1.602 . . . . 0.0 114.929 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.54 ' N ' HG22 ' A' ' 56' ' ' VAL . 21.8 t -117.7 121.6 41.3 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 113.946 -1.479 . . . . 0.0 107.783 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -132.97 148.72 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.64 0.257 . . . . 0.0 110.607 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -157.77 165.9 33.73 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.327 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -112.85 147.65 36.53 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 24.9 t70 -157.08 153.97 28.71 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -177.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 4.8 p90 -130.77 155.07 47.28 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 110.629 -2.987 . . . . 0.0 106.146 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -42.85 117.35 1.48 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.509 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 124' ' ' ASP . . . 144.82 -89.65 0.16 Allowed Glycine 0 CA--C 1.534 1.241 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 25.1 p-90 -152.86 173.27 15.55 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.7 HH22 ' NH1' ' A' ' 237' ' ' ARG . 0.2 OUTLIER -130.88 173.02 11.37 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.042 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.5 mt -116.7 125.38 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 171.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.4 111.78 13.16 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.31 126.53 32.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.723 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -90.82 127.81 36.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -119.13 113.03 20.27 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.91 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.116 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.786 179.691 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 177.18 -141.63 5.42 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.101 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.2 130.57 53.32 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.53 0.681 . . . . 0.0 111.694 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.4 m -132.25 111.32 11.29 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.47 127.76 38.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 1.9 mp -90.34 161.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 176.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.447 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 2.4 t80 -139.76 108.0 5.79 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.548 ' CB ' HH12 ' A' ' 66' ' ' ARG . 18.3 t70 -123.7 132.44 53.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.36 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.508 ' C ' ' H ' ' A' ' 127' ' ' ILE . 27.6 m-85 -93.99 84.1 4.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.798 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -52.14 -4.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.786 -0.571 . . . . 0.0 111.352 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.508 ' H ' ' C ' ' A' ' 125' ' ' PHE . 92.7 mt -66.59 -42.71 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 120.228 -0.589 . . . . 0.0 112.304 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 22.4 t-20 -68.02 -40.35 82.95 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.189 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 128' ' ' ASN . 11.4 t0 88.6 -55.15 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.031 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -79.33 -51.74 9.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 2.0 p90 -151.55 128.22 10.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -134.75 153.34 78.77 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.122 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.472 ' HA ' HG12 ' A' ' 198' ' ' VAL . 17.2 Cg_exo -64.56 136.01 48.27 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 120.514 0.81 . . . . 0.0 110.68 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.81 128.2 34.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.7 mt -141.55 139.77 31.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -171.2 175.01 44.93 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.231 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.69 152.81 48.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -124.86 130.8 53.09 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.0 t -130.71 118.52 42.61 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.23 130.2 42.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.024 0.44 . . . . 0.0 110.563 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 . . . . . 0 C--O 1.236 0.388 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.43 -179.94 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.52 -0.187 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -134.6 131.73 6.02 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.212 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.1 mp -136.7 132.62 35.15 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.583 0.706 . . . . 0.0 109.902 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -162.42 -170.5 27.31 Favored Glycine 0 C--N 1.321 -0.27 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.1 m -134.69 160.91 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.435 1.118 . . . . 0.0 113.653 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mt -110.12 136.26 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 113.032 -1.895 . . . . 0.0 110.251 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -160.67 147.0 15.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.693 0.758 . . . . 0.0 110.871 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 163.06 -172.44 39.07 Favored Glycine 0 C--O 1.221 -0.686 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 133' ' ' PRO . 33.8 m -136.93 155.05 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 118.303 1.051 . . . . 0.0 109.472 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -154.78 159.51 29.03 Favored Glycine 0 C--O 1.241 0.555 0 C-N-CA 119.452 -1.356 . . . . 0.0 112.181 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.84 153.15 37.68 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.541 0.686 . . . . 0.0 110.557 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -59.52 149.5 29.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.065 -1.425 . . . . 0.0 113.971 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 206' ' ' LEU . 47.0 mm -111.31 -46.13 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.55 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.2 OUTLIER -127.43 -172.93 0.28 Allowed Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 175.171 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.55 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.8 OUTLIER -14.06 -85.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.401 0 CA-C-N 124.04 2.478 . . . . 0.0 114.869 -178.763 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -126.7 21.39 7.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.007 0.908 . . . . 0.0 110.057 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 202' ' ' ILE . 1.0 OUTLIER -75.08 112.98 11.88 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.515 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.6 t -130.87 152.59 50.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.45 143.07 44.2 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 113.082 -1.872 . . . . 0.0 107.9 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.81 150.68 49.05 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -126.31 134.15 51.2 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -174.57 -164.13 28.95 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 119.431 -1.366 . . . . 0.0 113.419 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -156.28 151.23 26.22 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 115.221 -0.49 . . . . 0.0 109.795 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 80.2 mtm-85 -92.6 124.93 36.98 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -107.07 125.41 51.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 109.97 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -56.61 156.97 5.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.556 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 . . . . . 0 C--O 1.233 0.187 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.578 179.883 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.419 ' C ' HD13 ' A' ' 232' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.517 -0.293 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 147.7 -166.83 28.75 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.71 144.98 33.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -118.21 136.63 53.53 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -101.32 107.88 19.35 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.017 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.7 ' NH1' HH22 ' A' ' 66' ' ' ARG . 81.8 mtp180 -113.93 113.58 25.04 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.431 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 93.3 m-85 . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.428 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.409 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.21 160.05 33.05 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.902 1.734 . . . . 0.0 109.583 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.708 ' CD2' ' NH2' ' A' ' 66' ' ' ARG . 33.1 t80 -151.07 136.98 18.15 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.45 -0.9 . . . . 0.0 113.01 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 12' ' ' GLN . 52.0 t -141.49 160.41 21.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.457 ' N ' HG12 ' A' ' 11' ' ' VAL . 57.6 tt0 -147.78 140.02 24.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.882 0.765 . . . . 0.0 112.856 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.01 122.9 45.53 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.158 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -83.11 124.82 30.84 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.4 tp -116.52 132.37 56.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.998 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.28 179.928 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' HG13 ' A' ' 56' ' ' VAL . 39.6 mmt180 . . . . . 0 CA--C 1.522 -0.117 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 55' ' ' ARG . 8.3 m -157.18 -176.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 119.206 -0.998 . . . . 0.0 112.961 -176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.89 136.4 54.93 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.875 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.2 p -141.85 148.98 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.017 0.437 . . . . 0.0 111.776 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.58 -155.61 20.26 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -131.83 154.15 49.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.47 ' HB3' ' HE ' ' A' ' 66' ' ' ARG . 2.5 p30 -130.01 133.17 46.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -175.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.73 123.51 33.22 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.945 -1.48 . . . . 0.0 107.479 175.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -34.77 134.73 0.4 Allowed Glycine 0 N--CA 1.472 1.038 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.522 ' O ' ' CD2' ' A' ' 123' ' ' TYR . . . 97.64 -63.45 0.93 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -131.23 136.02 47.87 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.342 0.591 . . . . 0.0 111.153 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.708 ' NH2' ' CD2' ' A' ' 10' ' ' TYR . 54.9 mtp180 -137.01 156.05 48.92 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.1 tt -139.64 140.68 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.377 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.18 147.22 10.97 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.83 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.85 149.49 26.35 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -115.99 145.63 42.8 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.596 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 80.3 m-85 67.41 -98.08 0.04 OUTLIER 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.192 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 71' ' ' TYR . . . . . . . . 0 N--CA 1.472 0.644 0 O-C-N 124.468 1.105 . . . . 0.0 110.3 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 168.22 -151.76 19.12 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 118.931 -1.604 . . . . 0.0 113.768 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.8 mt -113.32 160.17 18.63 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 114.993 -0.604 . . . . 0.0 109.84 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 p -143.67 129.17 19.07 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 111.818 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.0 130.03 40.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 123' ' ' TYR . 73.0 mt -123.9 161.59 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -175.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.526 ' N ' HG22 ' A' ' 122' ' ' ILE . 50.5 t80 -140.65 141.16 35.08 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.407 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 24.1 p-10 -143.38 138.63 29.54 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.279 0.561 . . . . 0.0 111.598 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.5 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 14.8 m-85 -83.97 83.56 7.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.048 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.432 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 13.9 mm100 -85.33 6.09 27.84 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.28 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 128' ' ' ASN . 20.4 tt -69.21 -40.16 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.421 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.548 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 20.1 p30 -90.65 -40.53 11.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.749 0.309 . . . . 0.0 110.202 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 1.2 m-20 77.1 -30.43 0.17 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.277 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -65.34 -45.04 85.8 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.059 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -154.49 116.16 4.15 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.568 0.699 . . . . 0.0 110.928 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.5 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 1.1 ptpp? -115.54 119.66 37.51 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.233 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -53.14 118.16 4.53 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 CA-C-N 119.736 0.941 . . . . 0.0 110.066 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -76.28 127.82 33.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.8 tt -155.98 146.46 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 118.768 -1.173 . . . . 0.0 112.818 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -169.76 178.63 42.62 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.22 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -116.19 157.4 24.9 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -124.83 138.47 54.26 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.33 114.05 32.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.97 152.65 51.91 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.24 0.555 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.426 177.765 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 N--CA 1.463 0.181 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.853 ' C ' HD13 ' A' ' 192' ' ' LEU . . . -137.84 136.38 8.14 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 119.177 -1.487 . . . . 0.0 113.756 -176.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 1.059 ' H ' HD22 ' A' ' 192' ' ' LEU . 0.0 OUTLIER -117.52 148.75 41.57 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.378 -0.911 . . . . 0.0 108.81 178.408 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -169.28 -169.63 32.85 Favored Glycine 0 C--N 1.32 -0.312 0 N-CA-C 107.906 -2.077 . . . . 0.0 107.906 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.0 m -137.98 155.08 29.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.981 0.896 . . . . 0.0 111.972 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.6 tp -113.86 131.69 65.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.015 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.76 149.19 33.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.119 0.485 . . . . 0.0 111.259 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.94 -167.17 37.26 Favored Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 p -145.13 140.13 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 117.284 0.542 . . . . 0.0 110.46 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.48 130.55 9.18 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.38 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.606 ' N ' ' OG1' ' A' ' 207' ' ' THR . 2.6 t80 -115.09 118.71 34.14 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -61.26 149.88 36.42 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 206' ' ' LEU . 51.4 mm -113.35 -61.13 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.515 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.7 OUTLIER -102.11 -173.14 0.28 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 175.46 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.515 ' C ' ' O ' ' A' ' 203' ' ' THR . 5.5 Cg_exo -22.76 -79.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.352 0 CA-C-N 123.281 2.208 . . . . 0.0 114.486 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -128.33 34.89 4.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.543 0.687 . . . . 0.0 111.181 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 202' ' ' ILE . 0.3 OUTLIER -90.31 111.7 23.01 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.207 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.606 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 0.9 OUTLIER -132.51 152.52 51.53 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.17 140.52 29.42 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.453 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 233' ' ' GLY . 4.4 m-20 -118.94 138.83 52.51 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -121.69 123.43 41.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 113.717 -1.583 . . . . 0.0 107.841 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -160.17 -175.81 31.56 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.365 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -141.96 154.21 44.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.78 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.533 ' N ' ' NE ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -83.5 139.1 33.12 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -128.38 89.96 2.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.72 0.295 . . . . 0.0 110.667 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -101.64 140.01 36.52 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.65 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.8 t30 . . . . . 0 N--CA 1.465 0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 111.16 179.041 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 26.8 tp . . . . . 0 N--CA 1.461 0.08 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.429 ' O ' ' OD2' ' A' ' 209' ' ' ASP . . . 160.57 -168.82 36.17 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 119.929 -1.129 . . . . 0.0 112.781 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.0 127.92 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.731 ' NH2' HH11 ' A' ' 237' ' ' ARG . 0.2 OUTLIER -104.95 141.95 35.64 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.05 0.453 . . . . 0.0 110.425 -179.028 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -107.62 108.68 20.06 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.053 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.731 HH11 ' NH2' ' A' ' 235' ' ' ARG . 82.4 mtp180 -129.38 120.11 25.0 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.407 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 1.6 m-85 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.707 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.413 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . . . . . . 0 CA--C 1.536 1.403 0 CA-C-O 121.005 0.225 . . . . 0.0 112.708 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.471 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 95.9 Cg_endo -82.69 176.65 7.59 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.884 3.056 . . . . 0.0 113.525 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.401 ' CE1' ' NH1' ' A' ' 66' ' ' ARG . 75.8 t80 -141.26 145.09 35.11 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 t -152.7 145.41 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 114.417 -1.265 . . . . 0.0 108.027 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.53 150.6 27.95 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.94 147.01 52.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 112.13 -2.304 . . . . 0.0 105.931 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -152.76 137.57 17.06 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.52 133.39 45.03 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.063 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.268 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.522 179.636 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 p -142.71 146.05 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.6 m -128.86 149.09 50.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.207 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.31 153.29 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.81 -148.73 7.53 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 61' ' ' ASP . 16.4 t80 -138.8 155.95 47.75 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 9' ' ' PRO . 7.4 p-10 -133.06 134.68 44.66 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -127.12 147.93 50.16 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 175.528 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.34 140.58 32.33 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.841 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.2 -35.21 2.98 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.11 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.454 ' O ' ' O ' ' A' ' 62' ' ' PHE . 84.6 m95 -139.4 131.13 27.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.406 0.603 . . . . 0.0 111.606 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.401 ' NH1' ' CE1' ' A' ' 10' ' ' TYR . 46.0 ttp180 -144.21 132.5 21.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.751 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.622 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -139.35 153.62 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.923 0.868 . . . . 0.0 112.358 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.39 140.0 8.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.934 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.98 146.01 24.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.698 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -93.31 128.74 39.46 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.515 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -109.24 140.14 43.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.498 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.486 178.868 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -109.4 147.7 16.99 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.372 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.9 tp -128.3 133.0 48.65 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.3 m -137.27 116.42 12.54 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.555 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.98 134.14 55.44 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.168 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 123' ' ' TYR . 74.5 mt -119.73 158.94 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.522 ' N ' HG22 ' A' ' 122' ' ' ILE . 31.7 m-85 -113.73 109.71 19.0 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' OD2' ' NH1' ' A' ' 237' ' ' ARG . 20.9 t70 -107.36 138.64 43.19 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -116.87 152.37 34.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.677 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -147.37 44.22 1.13 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.7 mt -69.18 -42.46 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -96.0 -13.15 24.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.41 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 61.88 29.42 17.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.336 0.588 . . . . 0.0 109.984 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -125.64 -51.5 1.6 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.846 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 131' ' ' PHE . 43.1 p90 -175.16 131.78 0.3 Allowed 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.247 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -134.21 151.64 76.81 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.846 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.22 130.98 20.99 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.507 1.471 . . . . 0.0 109.899 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.474 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 2.4 p90 -120.55 133.32 55.4 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 39.9 pt -135.55 152.76 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.286 0.565 . . . . 0.0 111.424 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.84 174.89 39.24 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -117.2 143.08 46.25 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.935 0.398 . . . . 0.0 110.194 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -116.92 116.89 28.28 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.401 HG22 ' N ' ' A' ' 140' ' ' ALA . 12.6 p -124.65 158.95 31.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' ' 139' ' ' VAL . . . -135.71 142.97 45.14 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.647 0.737 . . . . 0.0 112.572 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.304 178.31 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -130.34 126.2 4.89 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 7.4 tt -120.57 123.52 43.08 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 122.066 0.936 . . . . 0.0 111.415 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -138.06 157.37 24.31 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.59 139.63 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 117.41 0.605 . . . . 0.0 111.463 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 tt -116.42 132.98 64.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.472 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.52 34.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.04 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 162.5 -165.88 36.35 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.3 p -136.41 146.57 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 120.975 0.417 . . . . 0.0 109.974 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -117.67 137.37 13.18 Favored Glycine 0 C--O 1.244 0.754 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.977 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.634 ' N ' ' OG1' ' A' ' 207' ' ' THR . 10.7 t80 -122.16 120.0 32.94 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.689 0.876 . . . . 0.0 109.301 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 22.6 p30 -61.94 139.38 58.4 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.528 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 202' ' ' ILE . 63.9 mt -125.18 -5.59 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-O 122.523 1.154 . . . . 0.0 109.499 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.581 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -160.35 -178.64 0.92 Allowed Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 101.271 -3.603 . . . . 0.0 101.271 177.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.581 ' C ' ' O ' ' A' ' 203' ' ' THR . 13.8 Cg_exo -18.95 -83.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 CA-C-N 123.965 2.452 . . . . 0.0 114.089 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -128.92 20.2 5.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.661 0.743 . . . . 0.0 109.884 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.408 ' HB3' ' OG1' ' A' ' 203' ' ' THR . 5.9 tt -78.98 124.18 28.01 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 1.8 t -143.42 154.08 43.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.411 HD23 ' C ' ' A' ' 208' ' ' LEU . 7.7 tt -91.55 126.65 36.71 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 112.92 -1.945 . . . . 0.0 105.797 175.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 210' ' ' ALA . 41.5 t0 -102.12 144.49 30.61 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -175.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 0.517 ' N ' ' OD1' ' A' ' 209' ' ' ASP . . . -125.17 113.68 18.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.346 -1.752 . . . . 0.0 107.538 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -175.38 -165.27 31.25 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -147.07 161.36 41.0 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.951 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.2 ttp-105 -129.57 103.24 6.76 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.432 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -174.68 148.69 1.15 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.064 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -159.1 -84.61 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.66 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.469 0.505 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.907 -179.08 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 59.4 mt . . . . . 0 C--O 1.233 0.193 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -148.63 165.75 29.17 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.339 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.19 127.4 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.77 145.58 44.74 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.083 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -112.91 116.35 29.85 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.405 ' NH1' ' OD2' ' A' ' 124' ' ' ASP . 81.4 mtm180 -124.34 133.05 53.55 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.904 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.548 ' OXT' ' CG ' ' A' ' 238' ' ' PHE . 85.1 t80 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.546 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.476 0 N-CA-C 112.159 -0.376 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.66 152.71 25.99 Favored 'Trans proline' 0 N--CA 1.507 2.291 0 C-N-CA 124.153 3.236 . . . . 0.0 116.397 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.53 ' CD2' ' NH2' ' A' ' 66' ' ' ARG . 6.7 p90 -148.69 164.67 33.66 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.442 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 p -131.99 153.99 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.402 0.62 . . . . 0.0 112.527 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -120.95 142.61 49.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.032 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 14' ' ' ASP . . . -142.87 149.86 39.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.471 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 13' ' ' ALA . 92.4 m-20 -140.52 147.26 39.26 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.491 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -168.16 -175.77 2.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.721 177.841 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 120.897 0.38 . . . . 0.0 110.179 179.166 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 111.277 0.103 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 57' ' ' SER . 29.6 t -142.69 159.06 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.83 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.501 ' N ' HG12 ' A' ' 56' ' ' VAL . 42.5 t -146.75 138.16 24.32 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.626 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -138.22 157.56 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.63 -178.63 38.17 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 119.844 -1.169 . . . . 0.0 113.605 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -104.93 129.64 53.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.395 -0.902 . . . . 0.0 109.224 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB2' HH21 ' A' ' 66' ' ' ARG . 61.1 t0 -100.41 121.5 41.63 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -175.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -125.4 121.64 34.45 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -50.54 113.88 2.31 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' A' ' 65' ' ' TRP . . . 120.01 -49.38 0.88 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 64' ' ' GLY . 8.3 m0 -146.46 136.09 23.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 117.136 0.468 . . . . 0.0 109.986 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.698 HH12 ' CZ ' ' A' ' 237' ' ' ARG . 26.7 mtp180 -133.8 147.13 51.22 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.988 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.2 126.36 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 120' ' ' SER . . . -128.44 113.4 15.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.006 0.431 . . . . 0.0 110.024 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.78 127.08 34.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.893 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -101.8 128.9 47.95 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -149.68 159.15 44.57 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.92 0.867 . . . . 0.0 111.892 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.455 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.528 179.159 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.435 HD23 ' C ' ' A' ' 117' ' ' LEU . 6.4 tt . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 178.87 -145.53 6.79 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.124 -1.512 . . . . 0.0 113.083 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 95.5 mt -117.69 154.35 31.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.608 0.718 . . . . 0.0 110.91 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 69.6 m -144.96 98.73 3.22 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.42 114.66 11.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.311 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.1 mt -110.81 134.02 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.452 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 29.4 p90 -132.6 120.45 21.82 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.408 -177.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -97.74 143.22 28.6 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 112.904 -1.953 . . . . 0.0 108.328 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.579 ' C ' ' H ' ' A' ' 127' ' ' ILE . 15.0 m-85 -102.45 113.01 25.98 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.631 0.729 . . . . 0.0 111.376 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -65.37 11.88 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.253 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.579 ' H ' ' C ' ' A' ' 125' ' ' PHE . 8.3 tp -68.06 -40.31 82.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.19 0.519 . . . . 0.0 110.484 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.495 ' N ' HG23 ' A' ' 127' ' ' ILE . 24.4 m120 -99.77 141.3 32.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.301 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -79.45 -60.81 2.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -66.33 -41.89 88.96 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 131' ' ' PHE . 48.0 p90 -145.61 143.16 29.71 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 119.194 -0.432 . . . . 0.0 111.472 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.62 132.82 23.68 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 118.254 0.479 . . . . 0.0 110.267 178.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.62 136.68 21.6 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 N-CA-C 108.05 -1.558 . . . . 0.0 108.05 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 199' ' ' GLY . 0.8 OUTLIER -132.41 144.24 50.36 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 122.329 1.062 . . . . 0.0 112.312 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 136' ' ' GLY . 94.2 mt -135.04 161.48 40.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 113.338 -1.756 . . . . 0.0 107.895 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 135' ' ' ILE . . . -161.22 160.03 31.73 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 118.929 -1.605 . . . . 0.0 114.185 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -107.94 135.45 49.3 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -118.43 125.79 50.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 139' ' ' VAL . 18.4 m -117.89 113.92 43.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.09 125.53 51.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.36 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 C--O 1.238 0.46 0 CA-C-O 121.716 0.77 . . . . 0.0 112.522 -178.636 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.233 0.197 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.35 130.35 4.57 Favored Glycine 0 N--CA 1.47 0.935 0 C-N-CA 119.888 -1.149 . . . . 0.0 113.425 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.83 137.09 53.14 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -164.26 -168.75 26.81 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.84 145.52 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.539 0.685 . . . . 0.0 111.847 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.0 mm -112.53 128.92 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.79 162.61 38.23 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.385 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.489 ' O ' ' CD1' ' A' ' 134' ' ' TYR . . . 157.99 178.87 32.43 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.16 139.82 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 134' ' ' TYR . . . -120.83 137.85 12.29 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 120.169 -1.015 . . . . 0.0 114.475 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.422 ' C ' ' OG1' ' A' ' 207' ' ' THR . 90.6 m-85 -104.62 106.67 17.26 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 114.131 -1.034 . . . . 0.0 108.593 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 201' ' ' ASP . 9.9 p30 -63.31 149.79 44.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.463 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.8 mm -102.98 -74.73 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.462 ' O ' ' C ' ' A' ' 204' ' ' PRO . 1.4 p -80.18 -167.85 0.15 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.462 ' C ' ' O ' ' A' ' 203' ' ' THR . 1.5 Cg_exo -33.76 -74.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 CA-C-N 122.69 1.996 . . . . 0.0 114.678 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 237' ' ' ARG . 10.0 mptt -125.19 20.19 8.19 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.251 0.932 . . . . 0.0 110.789 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 206' ' ' LEU . 0.9 OUTLIER -76.88 122.94 25.54 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 176.079 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.422 ' OG1' ' C ' ' A' ' 200' ' ' PHE . 2.8 t -136.41 148.57 47.86 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 50.3 tp -99.15 118.1 35.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -130.12 142.73 50.57 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -87.76 109.05 19.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.5 144.05 15.4 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.342 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -137.83 153.54 49.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.033 -0.583 . . . . 0.0 109.955 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.401 ' NH1' ' NE2' ' A' ' 215' ' ' HIS . 3.7 ppt_? -120.57 140.46 51.47 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -140.01 155.66 46.98 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.005 0.431 . . . . 0.0 111.437 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.401 ' NE2' ' NH1' ' A' ' 213' ' ' ARG . 13.9 m170 -99.17 142.19 30.97 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.758 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.169 -179.874 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.8 tp . . . . . 0 N--CA 1.468 0.469 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -100.05 162.94 19.18 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.307 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 39.4 t -126.13 128.98 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -134.09 147.07 50.83 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -110.83 99.69 8.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.136 175.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.698 ' CZ ' HH12 ' A' ' 66' ' ' ARG . 99.0 mtt180 -130.28 130.86 45.07 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.838 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.462 ' C ' ' O ' ' A' ' 237' ' ' ARG . 61.3 m-85 . . . . . 0 N--CA 1.474 0.732 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.834 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.479 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.57 167.99 25.9 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.382 2.055 . . . . 0.0 114.183 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -141.01 143.48 34.45 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.6 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.8 t -132.03 146.38 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -148.31 130.99 15.94 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.36 132.71 12.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.825 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -96.08 151.93 19.01 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.12 0.486 . . . . 0.0 111.859 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.8 tp -123.99 131.21 53.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.671 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.779 179.379 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 p -155.95 131.54 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.906 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 t -138.51 135.85 35.52 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -148.58 168.67 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.756 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.76 -153.3 12.99 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -121.43 143.33 49.3 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.144 0.497 . . . . 0.0 111.561 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -86.71 112.97 22.17 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.866 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -125.48 150.47 47.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.968 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.22 103.6 2.62 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.48 -68.32 0.52 Allowed Glycine 0 CA--C 1.52 0.391 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -148.05 160.77 42.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -113.73 162.01 16.8 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 120.897 0.38 . . . . 0.0 111.608 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.0 mm -104.14 126.71 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 102.11 -3.293 . . . . 0.0 102.11 172.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.47 125.25 9.76 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 119.149 -1.021 . . . . 0.0 111.946 -176.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.23 153.41 20.0 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.553 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -134.24 128.07 33.15 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -151.45 161.27 42.99 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.185 0.993 . . . . 0.0 113.188 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 113.224 -1.807 . . . . 0.0 107.418 178.946 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.475 HD23 ' N ' ' A' ' 117' ' ' LEU . 1.3 pt? . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -176.45 -138.14 2.82 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.051 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.873 ' H ' HD23 ' A' ' 119' ' ' LEU . 1.2 pt? -131.2 160.55 34.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.2 0.524 . . . . 0.0 111.992 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 m -148.74 147.62 29.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.423 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.01 135.98 53.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 123' ' ' TYR . 96.7 mt -118.96 158.06 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.556 0.693 . . . . 0.0 112.552 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.474 ' N ' HG22 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -106.07 101.49 10.98 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -104.72 122.71 46.26 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 123.67 0.606 . . . . 0.0 111.234 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -96.72 105.36 17.46 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.084 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.424 ' CD ' HH22 ' A' ' 237' ' ' ARG . 59.1 tt0 -87.83 -11.35 48.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.698 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 128' ' ' ASN . 21.4 tt -67.52 -40.67 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.947 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.461 ' N ' HG23 ' A' ' 127' ' ' ILE . 88.0 m-20 -78.68 -11.78 59.99 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.0 t0 59.7 -78.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.177 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -66.27 -46.26 77.67 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -105.58 117.52 34.24 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.439 ' HZ2' ' HA3' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -131.85 96.53 20.28 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.889 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.17 109.56 0.64 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.035 1.156 . . . . 0.0 109.387 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CZ ' ' HA3' ' A' ' 197' ' ' GLY . 21.9 p90 -78.66 129.9 35.25 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 118.712 -1.195 . . . . 0.0 109.78 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.17 142.51 40.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.646 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -171.79 -176.8 40.99 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 118.28 -1.914 . . . . 0.0 113.709 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.73 137.57 51.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -130.12 131.17 45.59 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.45 132.35 64.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.682 0.753 . . . . 0.0 109.125 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -113.54 150.44 32.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.121 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.1 p90 . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.297 -179.954 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 C--O 1.232 0.163 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -135.15 142.08 13.44 Favored Glycine 0 N--CA 1.466 0.67 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.821 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.2 pp -133.39 141.89 48.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.304 -0.948 . . . . 0.0 108.755 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -153.45 174.15 32.13 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.04 138.59 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.902 0.382 . . . . 0.0 110.988 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.8 mt -111.06 131.08 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.859 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.53 148.43 32.17 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.424 ' HA3' ' CZ ' ' A' ' 134' ' ' TYR . . . 158.05 -176.89 34.99 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.4 p -138.75 142.3 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 118.728 1.264 . . . . 0.0 113.346 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.439 ' HA3' ' HZ2' ' A' ' 132' ' ' LYS . . . -103.88 144.83 15.98 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.761 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.426 ' N ' ' OG1' ' A' ' 207' ' ' THR . 14.3 t80 -137.72 105.69 5.67 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -91.59 154.22 19.2 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -176.54 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.441 ' CG1' ' H ' ' A' ' 203' ' ' THR . 5.3 pt -95.15 -47.1 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.652 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.7 OUTLIER -122.76 115.25 29.53 Favored Pre-proline 0 N--CA 1.433 -1.296 0 N-CA-C 100.563 -3.865 . . . . 0.0 100.563 172.17 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -12.15 -40.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 124.069 3.179 . . . . 0.0 117.176 -174.11 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 203' ' ' THR . 11.7 pttm -84.72 -32.37 23.55 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 3.2 mm? -85.4 105.14 15.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 121.475 1.943 . . . . 0.0 107.751 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 235' ' ' ARG . 1.0 OUTLIER -131.75 140.23 49.18 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 75.9 mt -93.37 135.36 34.68 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 113.734 -1.576 . . . . 0.0 108.749 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.613 ' CG ' HH11 ' A' ' 235' ' ' ARG . 42.7 m-20 -118.22 145.91 44.64 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -135.49 113.02 10.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 114.059 -1.428 . . . . 0.0 107.292 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -162.22 -177.65 35.44 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.56 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.35 152.42 49.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.594 -0.803 . . . . 0.0 110.97 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -106.88 127.28 53.29 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -112.09 150.65 30.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.295 0.569 . . . . 0.0 112.271 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' A' ' 216' ' ' ASN . 77.3 t60 -129.1 128.96 44.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.723 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 215' ' ' HIS . 97.1 m-20 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.462 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.28 169.25 30.26 Favored Glycine 0 CA--C 1.517 0.203 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.95 136.28 57.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.449 0.643 . . . . 0.0 111.378 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.613 HH11 ' CG ' ' A' ' 209' ' ' ASP . 81.1 mtt85 -121.27 130.21 53.54 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.95 106.29 17.2 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.575 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.589 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 3.6 tmt_? -119.79 109.14 15.25 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.229 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.545 ' CB ' ' O ' ' A' ' 237' ' ' ARG . 28.5 t80 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.679 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.184 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.43 124.05 9.11 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 122.717 2.278 . . . . 0.0 112.822 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -144.95 148.29 33.65 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.507 ' H ' ' HB2' ' A' ' 236' ' ' TYR . 78.7 t -138.68 146.31 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.553 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -132.4 126.53 33.37 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.992 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.95 148.0 27.86 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 15' ' ' LEU . 57.2 t0 -162.6 134.58 5.36 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.581 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -173.48 -171.0 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.025 178.524 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.411 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.861 179.848 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.446 0.165 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.37 135.13 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.639 0.257 . . . . 0.0 110.949 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 m -118.47 125.9 50.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.85 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.17 137.98 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.871 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.82 172.06 36.29 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.666 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -109.91 144.8 37.88 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 65' ' ' TRP . 44.4 t0 -150.84 130.96 13.49 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.584 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 31.6 p90 -128.41 105.87 8.62 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.807 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . 6.95 95.46 0.0 OUTLIER Glycine 0 N--CA 1.481 1.692 0 O-C-N 123.251 0.345 . . . . 0.0 113.186 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.96 -110.77 0.46 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.417 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 10.2 p-90 -103.74 -177.67 3.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.73 ' NH1' ' HE ' ' A' ' 235' ' ' ARG . 75.3 ttt180 -153.42 151.42 29.88 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.27 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.5 tp -129.58 142.4 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.431 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.56 143.03 19.51 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.89 155.99 16.54 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 71' ' ' TYR . 48.2 t0 -146.25 133.11 20.1 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.573 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 49.0 p90 175.5 -172.06 0.07 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.755 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 71' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.268 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.238 0.479 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.538 ' C ' HD22 ' A' ' 119' ' ' LEU . . . -122.0 126.57 6.5 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.538 HD22 ' C ' ' A' ' 118' ' ' GLY . 3.4 mm? -113.17 140.35 47.99 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.8 m -120.26 124.54 45.9 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.68 122.37 42.59 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.529 HG22 ' N ' ' A' ' 123' ' ' TYR . 94.4 mt -126.45 160.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -175.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.529 ' N ' HG22 ' A' ' 122' ' ' ILE . 70.6 m-85 -128.38 103.15 6.98 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 177.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.464 ' HB2' HH22 ' A' ' 235' ' ' ARG . 67.6 t0 -138.83 129.94 26.78 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.494 ' CD1' ' NZ ' ' A' ' 132' ' ' LYS . 65.0 m-85 -120.86 133.26 55.31 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.439 177.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.41 HE21 ' HB2' ' A' ' 126' ' ' GLN . 0.0 OUTLIER -105.71 -13.75 15.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.269 0.557 . . . . 0.0 109.559 178.509 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 129' ' ' ASP . 65.9 mt -70.9 -40.51 76.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.777 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -55.6 89.64 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 127' ' ' ILE . 90.5 m-20 47.1 -114.25 0.54 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.865 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -131.2 22.73 4.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.086 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -167.28 127.3 1.45 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.492 -178.165 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.621 ' H ' HH22 ' A' ' 237' ' ' ARG . 12.8 tptm -134.63 129.56 19.47 Favored Pre-proline 0 C--O 1.238 0.5 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.497 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.38 129.96 28.56 Favored 'Trans proline' 0 N--CA 1.479 0.671 0 N-CA-C 107.404 -1.806 . . . . 0.0 107.404 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.622 ' CG ' ' NH1' ' A' ' 235' ' ' ARG . 52.0 p90 -122.64 148.6 45.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.525 0.602 . . . . 0.0 111.008 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.3 pt -141.05 163.62 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.555 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.34 173.78 41.82 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.188 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -117.26 159.78 22.12 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -127.79 130.99 49.62 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.939 0.4 . . . . 0.0 111.222 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 20.2 m -130.62 128.69 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.069 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.7 136.2 50.29 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.678 0.275 . . . . 0.0 110.931 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.7 p90 . . . . . 0 N--CA 1.467 0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.288 179.997 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.234 0.253 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -120.4 130.73 8.47 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.275 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.9 mp -135.83 148.62 48.76 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.631 0.729 . . . . 0.0 110.583 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.5 174.21 42.6 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.94 146.82 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 117.418 0.609 . . . . 0.0 110.2 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.9 tt -115.77 144.6 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.849 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.21 145.19 26.1 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -173.41 -179.32 44.0 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.124 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 57.8 t -132.54 135.95 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.596 0.236 . . . . 0.0 111.305 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -108.56 122.33 6.59 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.269 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.533 ' C ' HG23 ' A' ' 207' ' ' THR . 54.3 t80 -124.91 106.55 10.08 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.685 0.794 . . . . 0.0 109.166 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.617 ' OD1' ' O ' ' A' ' 203' ' ' THR . 32.5 t70 -61.88 151.31 34.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -177.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 206' ' ' LEU . 28.9 mm -117.79 -29.12 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 176.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.617 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 31.5 m -155.08 120.34 2.59 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 100.219 -3.993 . . . . 0.0 100.219 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.589 ' N ' ' OD2' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -6.54 -56.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 123.408 2.738 . . . . 0.0 115.336 -172.484 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.67 ' HA ' ' H ' ' A' ' 237' ' ' ARG . 37.0 pttt -83.94 -30.47 26.25 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 203' ' ' THR . 80.0 mt -78.62 110.92 14.17 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 119.62 1.1 . . . . 0.0 109.634 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.533 HG23 ' C ' ' A' ' 200' ' ' PHE . 2.1 m -125.99 145.81 50.14 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 209' ' ' ASP . 1.6 tm? -94.12 119.57 33.15 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.578 ' N ' HD13 ' A' ' 208' ' ' LEU . 45.7 t0 -106.21 145.81 31.08 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 209' ' ' ASP . . . -132.37 126.8 34.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.774 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -168.86 176.74 42.98 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 119.53 -1.319 . . . . 0.0 113.468 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -156.97 168.73 26.61 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.837 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.516 HH12 ' CD2' ' A' ' 215' ' ' HIS . 68.1 ttt-85 -108.11 124.73 50.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.038 0.447 . . . . 0.0 111.61 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' A' ' 216' ' ' ASN . 79.9 t80 -65.5 -49.65 68.22 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.266 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.516 ' CD2' HH12 ' A' ' 213' ' ' ARG . 20.6 t-160 58.84 112.97 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.411 ' O ' ' CE2' ' A' ' 214' ' ' TYR . 15.1 m120 . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 120.829 0.347 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -157.47 176.74 34.55 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.493 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 11.2 m -128.27 131.71 68.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.73 ' HE ' ' NH1' ' A' ' 66' ' ' ARG . 62.2 ttt180 -117.83 142.27 47.5 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.507 ' HB2' ' H ' ' A' ' 11' ' ' VAL . 15.8 m-85 -108.55 125.26 51.62 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.67 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 99.1 mtt180 -126.4 90.19 3.14 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 7.2 t80 . . . . . 0 C--O 1.219 -0.513 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.077 -177.866 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.52 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.85 111.28 2.47 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.98 1.787 . . . . 0.0 112.772 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -107.57 169.7 8.42 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.498 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 12' ' ' GLN . 61.0 t -126.04 157.72 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.464 0.65 . . . . 0.0 112.43 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.525 ' N ' HG12 ' A' ' 11' ' ' VAL . 30.7 mt-30 -130.94 130.98 44.14 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.281 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.86 135.12 29.24 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.452 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.99 144.47 25.88 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 tp -139.39 123.7 18.08 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.985 0.421 . . . . 0.0 110.617 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.852 179.801 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 . . . . . 0 CA--C 1.521 -0.154 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.13 161.81 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.376 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.5 t -148.23 133.24 18.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.982 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.14 157.51 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.615 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.57 -170.25 38.22 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.309 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -112.9 153.96 27.12 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 47.4 p-10 -141.47 129.2 21.62 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 121.634 0.73 . . . . 0.0 112.842 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 4.2 p90 -127.46 148.24 50.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.676 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -43.26 111.14 0.35 Allowed Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.34 -83.42 0.27 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.581 ' N ' ' CD1' ' A' ' 65' ' ' TRP . 1.4 p-90 -143.92 169.86 17.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.953 0.406 . . . . 0.0 111.5 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.476 HH21 ' NH1' ' A' ' 237' ' ' ARG . 54.8 mtt180 -129.39 172.61 11.34 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.578 0.704 . . . . 0.0 111.369 -178.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.4 mt -140.58 132.59 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.12 152.76 31.65 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.97 159.65 15.63 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 71' ' ' TYR . 41.3 t0 -157.2 167.21 31.04 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.424 -178.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.474 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 97.5 m-85 82.16 -126.08 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 125.08 1.488 . . . . 0.0 111.855 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 71' ' ' TYR . . . . . . . . 0 CA--C 1.532 0.272 0 O-C-N 123.676 0.61 . . . . 0.0 111.262 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -143.31 147.16 18.43 Favored Glycine 0 C--N 1.342 0.909 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.841 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.74 151.93 38.93 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.5 m -135.58 118.07 15.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.007 0.432 . . . . 0.0 111.559 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.77 131.15 43.77 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.491 HG22 ' N ' ' A' ' 123' ' ' TYR . 96.8 mt -125.29 158.71 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.414 0.626 . . . . 0.0 112.661 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.491 ' N ' HG22 ' A' ' 122' ' ' ILE . 63.3 m-85 -112.95 122.09 46.6 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.301 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -109.07 122.83 48.1 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.783 0.677 . . . . 0.0 110.095 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.478 ' O ' ' CB ' ' A' ' 126' ' ' GLN . 0.5 OUTLIER -111.51 177.67 4.58 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.214 0.53 . . . . 0.0 110.954 -179.447 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 131' ' ' PHE . 2.4 tp-100 88.24 128.16 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.933 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.8 tt -118.67 -3.97 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.749 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 40.3 p-10 -151.02 -45.13 0.12 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.326 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 73.9 m-20 -71.97 -158.41 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.59 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -128.27 25.98 5.77 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.66 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.1 OUTLIER -138.65 111.28 7.62 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.292 0.951 . . . . 0.0 113.119 -177.186 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.416 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -131.12 137.15 30.03 Favored Pre-proline 0 C--N 1.351 0.661 0 CA-C-N 118.145 0.43 . . . . 0.0 110.424 177.699 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.16 116.66 3.39 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 122.089 1.859 . . . . 0.0 110.033 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.416 ' CE1' ' C ' ' A' ' 197' ' ' GLY . 36.5 p90 -81.12 129.97 34.81 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.798 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 91.4 mt -133.96 140.13 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.974 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -173.17 -172.97 39.19 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.698 -1.239 . . . . 0.0 112.785 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.55 142.23 33.53 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.533 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -121.52 133.48 55.03 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.323 0.582 . . . . 0.0 110.161 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.6 m -129.25 131.63 67.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.005 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.48 130.92 55.83 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.558 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.6 t80 . . . . . 0 C--O 1.238 0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 111.946 -178.997 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.234 0.265 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.83 130.71 9.22 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mp -134.95 145.37 48.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.677 0.275 . . . . 0.0 110.662 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -163.44 -169.33 26.75 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.8 146.0 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.613 0.72 . . . . 0.0 112.243 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.444 HD11 HH11 ' A' ' 138' ' ' ARG . 34.1 mm -112.94 131.62 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.83 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -156.69 151.08 25.38 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.849 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.416 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . 160.39 -169.86 36.28 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.61 148.18 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.309 0.576 . . . . 0.0 111.327 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -145.9 158.79 27.79 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.602 ' N ' ' OG1' ' A' ' 207' ' ' THR . 1.6 p90 -137.96 153.41 49.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.658 0.742 . . . . 0.0 111.497 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 1.2 m-20 -56.75 142.45 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.945 -176.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 206' ' ' LEU . 72.0 mt -101.31 -23.63 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 123.065 1.412 . . . . 0.0 107.812 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.587 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.7 OUTLIER -165.13 -174.69 0.4 Allowed Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.587 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.2 OUTLIER -5.31 -93.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.144 0 CA-C-N 124.82 2.757 . . . . 0.0 114.454 -179.128 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -128.09 17.93 6.62 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 120.909 1.686 . . . . 0.0 113.297 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 206' ' ' LEU . 10.0 mp -74.46 127.32 32.76 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 176.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 5.2 t -139.34 152.74 47.41 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -177.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.0 tt -97.57 141.46 30.58 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.62 144.15 50.71 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -176.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.09 114.01 19.77 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -145.02 -179.84 21.64 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 119.426 -1.368 . . . . 0.0 113.816 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -129.03 159.34 36.24 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 113.955 -1.123 . . . . 0.0 109.331 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -141.72 148.51 39.15 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -142.34 160.55 40.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.646 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.531 ' ND1' ' N ' ' A' ' 215' ' ' HIS . 0.0 OUTLIER -122.56 147.58 46.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.357 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.349 -179.924 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 121.216 0.531 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -128.11 148.21 17.67 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.1 130.21 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 122.728 -0.277 . . . . 0.0 110.433 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -130.29 116.88 18.97 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -99.74 107.13 19.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.301 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.476 ' NH1' HH21 ' A' ' 66' ' ' ARG . 76.8 mtp180 -125.44 128.04 47.47 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.976 0.417 . . . . 0.0 110.893 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 . . . . . 0 C--O 1.218 -0.583 0 CA-C-O 117.938 -1.029 . . . . 0.0 111.13 179.853 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.328 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.03 116.2 3.37 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 CA-C-N 119.614 1.707 . . . . 0.0 113.829 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.629 ' CZ ' ' NE ' ' A' ' 66' ' ' ARG . 11.4 p90 -115.65 167.61 10.76 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.76 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.0 t -125.71 149.32 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-O 120.926 0.393 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -118.96 139.7 51.23 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.033 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.92 156.06 44.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.85 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 38.0 p30 -150.26 136.4 18.66 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.86 170.02 16.49 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.625 178.938 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? . . . . . 0 C--O 1.232 0.139 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 57' ' ' SER . 59.9 t -148.53 155.2 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.193 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.45 ' N ' HG12 ' A' ' 56' ' ' VAL . 38.5 m -135.17 148.11 49.6 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.842 0.353 . . . . 0.0 110.432 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.6 t -129.35 141.15 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.92 170.72 31.33 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 119.804 -1.189 . . . . 0.0 113.724 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -102.2 140.47 36.45 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-N 114.942 -0.629 . . . . 0.0 110.232 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.426 ' CG ' ' NH1' ' A' ' 237' ' ' ARG . 44.9 t0 -90.06 114.12 25.95 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 124.177 0.923 . . . . 0.0 113.252 -177.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' TRP . 34.3 m-85 -124.78 118.8 27.2 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.392 -1.277 . . . . 0.0 108.825 177.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.56 105.5 0.83 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.22 -52.36 0.83 Allowed Glycine 0 N--CA 1.466 0.64 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.417 ' O ' ' O ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -140.98 166.31 25.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.634 ' NH1' ' NH2' ' A' ' 237' ' ' ARG . 16.4 ttp180 -146.43 162.68 37.73 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.854 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.2 tp -135.24 134.1 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.631 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.15 137.87 23.63 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.299 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.79 137.45 40.07 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.577 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -99.0 125.67 44.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.505 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -129.09 139.56 51.94 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.175 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.349 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.277 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 167.61 -137.28 4.53 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.002 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.1 148.81 51.98 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.4 p -153.9 139.8 18.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.68 135.55 46.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.519 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.417 ' O ' ' CB ' ' A' ' 66' ' ' ARG . 99.1 mt -122.15 133.75 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -101.73 113.75 27.2 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -90.24 113.16 24.93 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.36 105.82 16.92 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -74.77 56.97 0.74 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.614 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.6 pt -76.27 -20.48 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -135.88 -102.16 0.21 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.155 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -178.44 -27.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.859 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -99.35 -19.6 16.94 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -161.55 137.67 8.04 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.376 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.59 149.43 73.03 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.238 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.38 104.61 1.36 Allowed 'Trans proline' 0 N--CA 1.485 1.003 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.601 ' CD2' ' NH2' ' A' ' 235' ' ' ARG . 36.4 p90 -86.14 133.09 33.89 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.616 0.722 . . . . 0.0 112.352 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 tp -133.84 138.52 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.835 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.38 167.01 31.3 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.81 157.97 37.85 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -137.0 134.51 36.7 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 37.1 t -128.63 123.87 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.56 141.61 35.21 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.693 0.759 . . . . 0.0 111.996 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 . . . . . 0 C--O 1.237 0.444 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.617 179.456 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 191' ' ' GLY . 3.5 p . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.403 ' N ' HG22 ' A' ' 190' ' ' VAL . . . -142.07 142.97 12.28 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 119.042 -1.551 . . . . 0.0 113.092 -177.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.87 146.03 35.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.362 -0.919 . . . . 0.0 110.005 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -165.55 175.47 41.26 Favored Glycine 0 C--N 1.314 -0.673 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.2 m -133.47 150.17 31.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.9 pt -119.96 151.82 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.74 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -167.75 158.7 11.16 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.931 0.872 . . . . 0.0 112.478 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.482 ' C ' ' CE2' ' A' ' 134' ' ' TYR . . . 174.12 -165.57 37.27 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.61 135.69 57.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.356 0.598 . . . . 0.0 110.037 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -102.91 136.72 13.01 Favored Glycine 0 C--O 1.224 -0.513 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.996 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.93 109.79 9.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 45.8 p30 -54.97 144.74 22.24 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -176.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.7 tt -125.98 2.05 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.809 1.29 . . . . 0.0 109.292 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.582 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -160.56 162.66 22.9 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 100.327 -3.953 . . . . 0.0 100.327 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.582 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.3 OUTLIER -10.57 -79.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.775 2.317 . . . . 0.0 113.771 -177.023 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 237' ' ' ARG . 12.8 mptt -129.03 25.4 5.56 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.472 0.578 . . . . 0.0 110.304 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 236' ' ' TYR . 3.4 tp -78.92 110.69 14.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 53.6 p -106.25 145.64 31.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 14.9 tp -106.25 122.18 45.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 111.991 -2.368 . . . . 0.0 106.03 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -110.09 136.37 49.44 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -175.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -108.68 112.69 25.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 173.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -145.88 179.41 22.94 Favored Glycine 0 N--CA 1.463 0.486 0 C-N-CA 119.28 -1.438 . . . . 0.0 113.938 -175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.22 157.26 43.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.244 -1.478 . . . . 0.0 109.742 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -107.97 133.05 52.85 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -114.67 108.05 16.29 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 216' ' ' ASN . 52.9 p-80 -106.93 132.04 53.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.082 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 215' ' ' HIS . 59.5 t30 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 121.123 0.487 . . . . 0.0 111.42 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 CA--C 1.512 -0.507 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -98.71 121.55 7.22 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.663 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 71.1 t -115.55 125.05 72.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.601 ' NH2' ' CD2' ' A' ' 134' ' ' TYR . 1.7 mtt180 -133.33 144.43 49.65 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.509 0.671 . . . . 0.0 111.515 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.473 ' HA ' HD12 ' A' ' 206' ' ' LEU . 6.9 t80 -103.09 103.3 13.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.378 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.634 ' NH2' ' NH1' ' A' ' 66' ' ' ARG . 55.9 ttm-85 -130.59 129.76 43.16 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.484 ' C ' ' O ' ' A' ' 237' ' ' ARG . 69.6 m-85 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 118.025 -0.988 . . . . 0.0 112.547 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.45 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.567 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 94.0 Cg_endo -84.35 119.68 2.4 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 122.962 2.441 . . . . 0.0 111.749 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.567 ' CG ' ' O ' ' A' ' 9' ' ' PRO . 71.9 m-85 -152.01 -175.94 5.45 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.639 HG22 ' N ' ' A' ' 12' ' ' GLN . 12.5 p -124.46 163.86 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -174.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.639 ' N ' HG22 ' A' ' 11' ' ' VAL . 10.7 tm0? -135.31 149.92 49.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.805 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.04 130.75 15.98 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -101.97 130.96 48.62 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.99 0.424 . . . . 0.0 111.957 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.83 155.44 47.79 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.526 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.392 179.521 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.56 139.5 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 p -141.88 153.49 44.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.02 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.17 147.44 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.362 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.46 -154.08 10.6 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -135.99 154.47 51.07 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 53.5 p30 -121.84 149.63 43.08 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -176.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -126.53 159.95 31.98 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 112.246 -2.252 . . . . 0.0 105.14 175.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.58 100.7 0.1 OUTLIER Glycine 0 CA--C 1.535 1.301 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.259 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.562 ' O ' ' CD1' ' A' ' 65' ' ' TRP . . . 61.84 48.52 83.34 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.771 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 64' ' ' GLY . 16.7 m95 -165.8 89.24 0.42 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.609 ' NH1' ' NH1' ' A' ' 235' ' ' ARG . 70.9 ttt180 -127.33 150.43 49.59 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -176.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.43 141.35 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.397 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.72 137.91 19.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.384 0.611 . . . . 0.0 112.488 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.88 156.13 16.81 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -151.39 159.03 44.45 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -160.64 165.99 29.65 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.46 -1.7 . . . . 0.0 108.902 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.13 -179.666 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.578 ' N ' HD22 ' A' ' 117' ' ' LEU . 3.0 mm? . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.69 138.81 14.47 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tp -149.45 140.01 22.53 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.7 p -157.12 155.64 31.38 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.365 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.91 137.34 52.09 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.474 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 123' ' ' TYR . 4.6 mp -126.31 156.13 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.348 0.594 . . . . 0.0 111.175 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.47 ' N ' HG22 ' A' ' 122' ' ' ILE . 57.6 m-85 -117.48 113.05 21.47 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.837 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -106.64 122.9 47.26 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.201 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -75.68 104.01 6.04 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.037 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -71.2 -29.7 65.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.136 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.8 -41.67 88.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.421 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -58.65 126.81 29.17 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.581 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.48 -21.87 59.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -128.1 -48.94 1.33 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.529 ' O ' ' CD2' ' A' ' 131' ' ' PHE . 52.9 p90 -115.65 132.59 56.59 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.14 110.77 41.03 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.319 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.14 109.63 1.58 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 N-CA-C 108.882 -1.238 . . . . 0.0 108.882 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 1.8 p90 -83.21 132.73 35.05 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.223 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 63.6 mt -134.33 154.87 38.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.75 -173.16 44.89 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 118.113 -1.994 . . . . 0.0 113.858 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.91 141.98 50.73 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -123.66 131.23 53.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.992 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.04 130.44 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.235 0.541 . . . . 0.0 111.477 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.26 117.8 34.92 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.961 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 78.1 t80 . . . . . 0 N--CA 1.469 0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.952 -178.242 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.466 0.356 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -102.05 111.66 4.12 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.1 pp -143.76 159.13 43.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 112.375 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -177.93 -155.66 14.67 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.68 157.0 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 117.247 0.523 . . . . 0.0 110.747 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.9 pt -130.08 145.41 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.874 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -156.19 150.52 25.57 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.086 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 175.9 -173.5 46.3 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.8 143.94 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 117.731 0.765 . . . . 0.0 111.066 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -143.41 160.72 27.66 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.14 152.38 49.9 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.45 0.643 . . . . 0.0 111.532 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 6.3 p30 -69.36 146.89 51.76 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 113.717 -1.583 . . . . 0.0 115.195 -175.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 43.8 mt -119.91 -1.17 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 123.335 1.54 . . . . 0.0 107.123 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.541 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.2 OUTLIER -165.15 147.98 6.96 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 100.5 -3.889 . . . . 0.0 100.5 178.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.541 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -6.62 -67.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 123.249 2.633 . . . . 0.0 114.191 -176.178 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 237' ' ' ARG . 58.8 mmtt -130.77 33.07 4.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.359 0.982 . . . . 0.0 112.292 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 0.9 OUTLIER -92.55 108.07 19.69 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 176.284 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.0 t -137.35 154.88 49.94 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -174.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.96 141.85 45.1 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 113.023 -1.899 . . . . 0.0 107.578 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -135.73 147.89 48.63 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.27 150.6 43.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -179.36 -172.89 44.04 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.612 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -123.55 167.98 13.2 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.843 -0.678 . . . . 0.0 109.837 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -140.85 141.66 34.64 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.599 0.238 . . . . 0.0 110.84 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -109.75 11.21 24.54 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.256 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 216' ' ' ASN . 50.0 p-80 -37.6 115.42 0.41 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 215' ' ' HIS . 7.7 t-20 . . . . . 0 N--CA 1.475 0.781 0 O-C-N 123.855 0.722 . . . . 0.0 112.643 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 121.287 0.565 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -102.1 151.14 18.35 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.724 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.86 129.76 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.609 ' NH1' ' NH1' ' A' ' 66' ' ' ARG . 93.7 mtt180 -133.41 140.92 47.6 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.421 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 26.2 t80 -113.52 102.06 9.94 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 102.203 -3.258 . . . . 0.0 102.203 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.572 ' O ' ' HB2' ' A' ' 205' ' ' LYS . 62.1 ttp85 -148.82 136.65 20.66 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.474 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.934 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.9 p -64.57 -23.66 67.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.533 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.26 141.94 47.16 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.247 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -62.39 -43.85 97.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.0 -135.93 48.76 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -131.77 23.81 4.16 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -74.97 136.43 41.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.29 -168.71 34.19 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.957 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.53 150.51 87.36 Favored 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 123.896 3.064 . . . . 0.0 115.153 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 44.2 p90 -149.45 161.65 41.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.259 -1.791 . . . . 0.0 106.77 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.9 t -130.5 135.51 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 118.385 0.539 . . . . 0.0 110.741 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -120.32 148.53 43.61 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.69 107.5 4.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.476 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -85.79 151.17 24.04 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.722 ' C ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -171.17 167.78 6.96 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.596 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 15' ' ' LEU . . . 144.43 -116.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.992 0.808 . . . . 0.0 109.868 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 16' ' ' ALA . 61.8 t80 58.23 147.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.893 0.378 . . . . 0.0 110.662 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.34 147.79 29.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.641 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -155.41 161.7 40.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.483 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -152.77 93.59 1.78 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.482 ' C ' ' H ' ' A' ' 23' ' ' THR . 61.9 m170 -103.51 -171.61 1.97 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.246 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 22' ' ' ILE . 18.4 tt -73.74 38.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.419 0.628 . . . . 0.0 109.884 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.581 HG23 ' N ' ' A' ' 24' ' ' HIS . 14.6 t -58.69 -45.8 88.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.16 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.581 ' N ' HG23 ' A' ' 23' ' ' THR . 77.3 t60 -124.73 101.61 7.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.939 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 51.0 t0 -81.11 162.35 23.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.52 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.481 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 64.8 m-85 -121.47 65.13 16.21 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.394 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.36 156.29 58.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.518 2.146 . . . . 0.0 112.313 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.427 ' H ' ' HD2' ' A' ' 29' ' ' PRO . 3.1 mt-10 -176.28 -55.66 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.17 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' H ' ' A' ' 28' ' ' GLU . 73.9 Cg_endo -75.51 -15.56 19.59 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.99 1.793 . . . . 0.0 112.312 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 p -101.07 7.53 43.32 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.048 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 59.26 156.01 0.1 OUTLIER Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.94 122.01 9.67 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.453 2.102 . . . . 0.0 112.032 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -129.32 12.58 6.02 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.611 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -106.73 150.84 25.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.93 0.395 . . . . 0.0 110.768 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.499 ' CG ' ' H ' ' A' ' 36' ' ' LYS . 63.2 t30 -78.32 -170.74 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.798 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.499 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 28.5 tptp -60.67 -47.23 87.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.26 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 tt -137.03 -15.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.345 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.6 m 54.79 88.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.739 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.1 m -65.42 132.63 49.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.502 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -79.34 136.07 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.551 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 m -142.84 -103.28 0.13 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.89 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -64.4 -33.9 76.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.236 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -58.73 -44.98 90.61 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.985 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -130.41 134.89 47.48 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.781 0.324 . . . . 0.0 110.373 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -63.72 -44.81 92.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.082 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 3.3 p-10 176.21 -77.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.532 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.505 ' H ' ' CG ' ' A' ' 46' ' ' ASN . 96.5 mt 56.84 151.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.583 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.485 ' C ' HG23 ' A' ' 49' ' ' THR . 55.4 ttm-85 60.14 167.75 0.08 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.134 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.485 HG23 ' C ' ' A' ' 48' ' ' ARG . 2.6 p 71.53 -44.14 0.58 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.382 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -99.78 136.14 40.16 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.879 0.371 . . . . 0.0 110.524 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.8 m 48.99 88.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.574 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.909 HG13 ' H ' ' A' ' 53' ' ' HIS . 2.3 p -73.02 -94.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.177 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.909 ' H ' HG13 ' A' ' 52' ' ' VAL . 2.2 p80 179.45 71.5 0.15 Allowed Pre-proline 0 CA--C 1.53 0.189 0 C-N-CA 121.239 -0.184 . . . . 0.0 111.088 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' ARG . 44.7 Cg_endo -69.46 -62.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.652 1.568 . . . . 0.0 111.461 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' PRO . 37.3 ttm180 32.94 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.204 0.315 . . . . 0.0 110.526 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.31 132.6 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.0 t -114.21 122.08 45.69 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.957 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 59' ' ' GLY . 3.9 p -135.01 153.92 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.405 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -175.8 -168.35 36.0 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.379 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -117.0 138.46 51.55 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.3 p30 -105.01 120.25 41.01 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 64' ' ' GLY . 74.9 m-85 -124.19 128.64 49.52 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.29 92.66 0.01 OUTLIER Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 62' ' ' PHE . . . 138.41 -94.1 0.21 Allowed Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -93.0 148.6 21.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.557 0.694 . . . . 0.0 111.444 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -132.17 135.66 46.51 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.963 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.66 128.86 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.75 143.83 47.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.036 0.446 . . . . 0.0 110.76 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.27 134.69 42.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.72 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -111.7 129.41 56.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.91 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -118.62 137.46 53.26 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.409 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.03 -43.09 4.72 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.737 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' A' ' 74' ' ' TYR . 78.2 ttt180 59.05 150.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.586 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.494 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 19.9 t80 95.52 105.38 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.069 0.855 . . . . 0.0 110.406 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -116.54 40.3 2.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.592 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.5 tttm 63.5 4.25 1.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.545 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -97.31 120.45 37.69 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.829 0.347 . . . . 0.0 110.107 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -97.55 90.6 5.09 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.328 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 80' ' ' ASN . 99.0 m-20 -64.38 -39.95 94.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.491 ' CG ' ' H ' ' A' ' 81' ' ' LYS . 18.9 t-20 49.51 179.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.346 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.491 ' H ' ' CG ' ' A' ' 80' ' ' ASN . 55.6 mtpt -63.41 138.4 58.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.883 0.373 . . . . 0.0 110.525 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -54.1 89.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.858 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 81' ' ' LYS . 47.5 t -158.78 155.45 27.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.092 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.8 m -107.69 144.72 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.518 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 57.4 38.65 28.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.912 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 87' ' ' GLU . 3.7 tp -64.38 -41.1 91.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.537 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' N ' HG23 ' A' ' 86' ' ' ILE . 22.4 pt-20 -109.06 142.19 40.13 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.599 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -84.5 123.56 30.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.4 t -64.37 -45.04 97.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.429 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -80.55 136.53 36.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.379 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.7 pt -130.35 149.74 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -80.4 -21.45 42.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.296 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -72.84 131.47 42.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.824 0.345 . . . . 0.0 110.811 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -70.14 -35.69 74.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -61.44 141.38 57.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.703 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -158.65 -96.39 0.11 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 83.9 mt 56.62 77.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.96 0.409 . . . . 0.0 109.993 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -66.6 -38.92 88.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.301 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 99' ' ' ILE . 19.5 tt -124.02 126.26 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.923 0.392 . . . . 0.0 111.053 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -99.72 5.05 45.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.612 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.454 ' H ' HG12 ' A' ' 99' ' ' ILE . 43.6 ttm180 -49.59 131.09 21.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.358 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -106.48 145.02 32.33 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.579 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.6 t -82.57 163.3 21.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.349 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 54.79 25.8 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.283 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -127.65 -51.47 1.36 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.259 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 45.33 70.11 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.369 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -65.45 145.1 56.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.55 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.462 ' OD1' ' NH2' ' A' ' 224' ' ' ARG . 16.4 m120 -78.8 148.75 32.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.846 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.8 -156.56 9.07 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 t -125.56 128.82 48.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.862 0.363 . . . . 0.0 110.44 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -152.14 -6.82 0.22 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.739 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -65.71 -41.1 92.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.696 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -153.16 123.75 7.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.55 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 115' ' ' SER . 80.2 t -129.56 131.92 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.953 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 114' ' ' VAL . 1.5 t 49.04 101.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.916 0.388 . . . . 0.0 110.33 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 91.1 p -150.69 162.97 39.66 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.966 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.2 mp -78.96 138.05 37.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.48 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -128.86 128.38 5.84 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.44 131.75 36.58 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.9 m -145.72 147.12 31.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.918 0.389 . . . . 0.0 110.428 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.28 113.3 26.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.477 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.684 ' N ' HD12 ' A' ' 122' ' ' ILE . 3.4 mp -111.55 146.59 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -112.77 127.21 56.09 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -98.92 125.17 44.28 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 176.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.46 ' C ' ' H ' ' A' ' 127' ' ' ILE . 39.0 m-85 -107.21 120.79 43.08 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -80.93 21.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.826 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 128' ' ' ASN . 21.4 tt -68.29 -39.35 80.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.689 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.49 ' N ' HG23 ' A' ' 127' ' ' ILE . 96.7 m-20 -93.39 -174.79 3.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.976 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -102.3 -52.55 3.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.266 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.75 -14.2 14.64 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.445 ' O ' ' CD2' ' A' ' 131' ' ' PHE . 48.9 p90 -144.77 125.95 14.67 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.109 0.868 . . . . 0.0 112.093 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.4 mtmm -107.59 129.72 23.82 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.48 140.87 33.9 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 120.975 1.117 . . . . 0.0 109.982 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -107.34 133.94 51.14 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.588 0.232 . . . . 0.0 110.858 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.3 tt -151.85 136.83 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.264 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -175.37 -168.15 35.45 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.224 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.31 156.16 49.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.845 0.355 . . . . 0.0 111.132 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.731 ' NH2' HH11 ' A' ' 213' ' ' ARG . 39.5 ttm180 -106.7 144.84 32.77 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.541 0.686 . . . . 0.0 112.837 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.6 t -130.87 112.7 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.93 126.94 52.97 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.439 ' CG ' ' N ' ' A' ' 142' ' ' GLY . 88.2 t80 -126.26 156.77 39.78 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.447 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.439 ' N ' ' CG ' ' A' ' 141' ' ' TYR . . . -159.34 169.67 35.51 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -65.91 119.39 11.22 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.981 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.53 -24.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.325 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -120.16 139.78 52.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.4 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -111.81 -65.49 1.17 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.813 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.9 m -75.18 152.66 38.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.986 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 148' ' ' ILE . 0.2 OUTLIER -65.29 -42.69 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.412 ' N ' ' CG2' ' A' ' 148' ' ' ILE . 42.4 t0 -159.56 160.79 34.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.78 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.9 m -83.63 -97.18 0.05 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.521 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 70.9 p -138.45 157.53 46.02 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.438 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -63.92 -41.67 97.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.608 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -79.47 143.11 35.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.776 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 81.7 p -111.95 10.22 20.57 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.583 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 21.8 mm -76.83 129.18 37.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.255 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -112.02 147.14 36.61 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.913 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.527 HG13 ' N ' ' A' ' 158' ' ' THR . 14.6 p -62.48 -43.03 97.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.527 ' N ' HG13 ' A' ' 157' ' ' VAL . 56.9 m -71.66 133.28 45.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.448 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.2 m -79.82 129.53 34.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.407 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 44.0 t -72.31 113.8 23.97 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.46 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.82 -10.01 16.92 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.967 1.778 . . . . 0.0 112.393 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.3 t -60.89 -44.44 97.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.354 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -141.48 79.19 1.67 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.667 0.27 . . . . 0.0 111.135 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.605 ' N ' ' CD ' ' A' ' 165' ' ' PRO . . . -84.99 -42.74 0.67 Allowed Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 164' ' ' ALA . 24.1 Cg_exo -62.24 144.93 96.15 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.532 2.154 . . . . 0.0 111.373 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -146.58 -5.66 0.55 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.661 0.267 . . . . 0.0 110.787 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 61.2 63.2 5.1 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.43 82.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.753 0.311 . . . . 0.0 110.342 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 170' ' ' THR . 8.9 p -128.24 129.48 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.155 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 171' ' ' THR . 77.0 p 50.58 174.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.613 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 170' ' ' THR . 82.7 p 52.09 111.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.059 0.456 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -142.46 159.35 42.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.548 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 56.7 35.67 26.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.141 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 46.4 p -67.75 -31.45 71.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.715 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -111.23 93.06 17.14 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 116.856 -0.156 . . . . 0.0 111.28 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.54 -6.17 8.0 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.678 2.252 . . . . 0.0 112.734 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.511 ' O ' ' NE2' ' A' ' 179' ' ' GLN . 71.4 mmtt -69.57 144.35 53.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.069 0.462 . . . . 0.0 110.769 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 60.2 p -68.05 139.2 56.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.964 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -124.4 120.34 31.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.043 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -63.6 -41.27 98.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.59 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 48.95 75.8 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -78.71 137.95 38.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.217 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -99.23 -96.19 0.24 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.701 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.2 m -72.73 144.14 47.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.916 0.389 . . . . 0.0 110.835 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -97.1 104.91 16.96 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.17 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 39.2 t -132.55 106.92 8.12 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.733 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.445 HG23 ' N ' ' A' ' 188' ' ' ARG . 21.0 tt -67.5 -39.85 83.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.135 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.445 ' N ' HG23 ' A' ' 187' ' ' ILE . 36.4 mmt180 -50.45 102.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.052 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -90.58 140.64 29.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.865 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.0 p -73.67 155.82 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -135.51 139.85 11.14 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.446 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.54 147.27 52.52 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 114.398 -0.901 . . . . 0.0 108.785 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -160.5 -172.6 27.99 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.92 153.75 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 111.438 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 95.3 mt -130.94 136.3 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.678 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.49 154.98 32.67 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.123 0.487 . . . . 0.0 111.41 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 173.93 178.92 44.22 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.6 m -136.89 135.73 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -114.78 136.83 13.5 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.429 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -121.07 104.91 10.14 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 0.3 OUTLIER -97.36 143.83 27.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.248 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 43.7 mm -75.54 -34.74 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 175.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.45 HG22 ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -165.79 164.32 11.85 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 101.183 -3.636 . . . . 0.0 101.183 177.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.504 ' C ' ' O ' ' A' ' 237' ' ' ARG . 8.2 Cg_endo -55.11 -15.82 11.31 Favored 'Trans proline' 0 C--N 1.288 -2.629 0 CA-C-N 121.801 1.679 . . . . 0.0 111.66 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.458 ' HA ' ' H ' ' A' ' 237' ' ' ARG . 0.9 OUTLIER -73.8 -39.45 64.11 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.5 mt -123.08 110.45 15.34 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.626 0.648 . . . . 0.0 111.381 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 t -134.56 138.27 44.46 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.615 ' N ' HD12 ' A' ' 208' ' ' LEU . 5.8 mp -89.78 128.38 36.13 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -133.95 124.8 26.97 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -84.59 111.5 19.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -109.51 139.6 15.38 Favored Glycine 0 N--CA 1.467 0.744 0 C-N-CA 121.272 -0.489 . . . . 0.0 112.655 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -129.95 125.71 36.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.95 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.731 HH11 ' NH2' ' A' ' 138' ' ' ARG . 60.7 ttm-85 -110.64 116.82 32.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 215' ' ' HIS . 60.8 t80 -132.69 156.0 47.79 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.406 0.622 . . . . 0.0 111.939 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.539 ' O ' ' CD2' ' A' ' 214' ' ' TYR . 84.5 t60 -87.34 168.34 13.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.652 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.465 ' N ' ' CG ' ' A' ' 215' ' ' HIS . 65.1 t30 -71.8 146.09 48.26 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.853 0.359 . . . . 0.0 110.636 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 35.8 t-105 -77.52 112.81 14.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.28 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -118.62 -146.71 8.07 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -66.18 99.37 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 0.0 110.516 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 220' ' ' LEU . 9.5 mp 53.34 174.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.535 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -81.34 76.86 8.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.553 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -104.76 7.71 34.73 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.721 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 21.1 m -64.19 134.22 54.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.914 0.388 . . . . 0.0 110.664 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.462 ' NH2' ' OD1' ' A' ' 108' ' ' ASN . 12.1 tpt180 -72.92 -72.17 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.789 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -74.26 144.07 44.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.932 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.22 -122.05 0.15 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.752 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 229' ' ' GLU . 59.4 p -66.96 -30.0 70.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.041 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 65.85 -69.02 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.563 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 227' ' ' THR . 80.6 tt0 -154.5 82.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.343 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 231' ' ' SER . . . -163.3 150.53 12.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.023 0.44 . . . . 0.0 111.137 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 230' ' ' ALA . 0.6 OUTLIER 163.8 -50.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.054 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 15' ' ' LEU . 12.1 tp -130.04 145.39 51.66 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.9 148.17 19.18 Favored Glycine 0 C--N 1.314 -0.672 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 68.5 t -122.16 128.83 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.693 HH12 ' NH2' ' A' ' 237' ' ' ARG . 45.7 ptt85 -133.29 143.01 48.77 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.77 0.795 . . . . 0.0 111.266 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 53.5 t80 -110.57 126.67 54.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 113.763 -1.562 . . . . 0.0 113.326 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.693 ' NH2' HH12 ' A' ' 235' ' ' ARG . 36.3 ttm180 -140.76 113.0 7.88 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.946 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' A' ' 237' ' ' ARG . 90.5 m-85 . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 117.852 -1.071 . . . . 0.0 111.954 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 t -72.27 133.48 45.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.822 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.453 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 46.2 mp0 -71.37 -39.03 71.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.085 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 6' ' ' GLY . 47.9 t0 -61.4 -45.0 96.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.304 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.54 -35.82 0.83 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 4' ' ' ASP . . . 81.88 7.5 87.89 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -140.67 141.82 34.98 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 122.553 -0.38 . . . . 0.0 110.261 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 10' ' ' TYR . . . -134.84 88.22 0.24 Allowed Glycine 0 CA--C 1.533 1.167 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 26.9 Cg_endo -74.48 141.32 28.15 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.607 1.538 . . . . 0.0 111.532 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 63.8 m-85 -147.23 -179.86 7.13 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.603 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 12' ' ' GLN . 2.3 p -128.6 160.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.556 ' OE1' ' NH2' ' A' ' 235' ' ' ARG . 57.2 tt0 -142.71 147.04 34.98 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.851 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.31 156.92 43.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.928 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -160.5 155.78 24.86 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.0 mt -134.15 146.2 49.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.584 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.53 -42.86 61.19 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' A' ' 17' ' ' TYR . 84.7 t80 56.28 25.89 9.86 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.909 0.385 . . . . 0.0 110.42 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.36 142.76 52.1 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 111.782 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -74.83 -111.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.232 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 41.77 76.38 0.07 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.799 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.506 ' CG ' ' N ' ' A' ' 22' ' ' ILE . 83.7 t60 -93.99 167.7 11.43 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.974 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.506 ' N ' ' CG ' ' A' ' 21' ' ' HIS . 97.5 mt -61.51 -88.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.164 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.483 HG23 HG22 ' A' ' 22' ' ' ILE . 45.7 p -134.4 161.31 35.37 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.852 0.358 . . . . 0.0 110.921 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 25' ' ' ASP . 96.4 m-70 -99.99 55.41 0.93 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.775 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 24' ' ' HIS . 98.7 m-20 56.39 118.7 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.871 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 27' ' ' PRO . 68.2 m-85 -58.57 155.23 30.22 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.403 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 26' ' ' TYR . 53.1 Cg_exo -53.0 -146.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.112 1.874 . . . . 0.0 112.942 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 65.58 65.72 0.88 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.308 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -90.46 -173.41 0.63 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.979 2.453 . . . . 0.0 111.843 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 p 59.74 113.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.017 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.84 56.48 17.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.542 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.69 60.48 5.19 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.585 2.19 . . . . 0.0 111.292 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -67.01 -20.84 65.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.522 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -74.81 100.42 4.04 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.962 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -104.67 8.16 35.09 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.208 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 38' ' ' SER . 8.2 mtmp? -84.44 -11.01 57.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.734 0.302 . . . . 0.0 110.526 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mm 42.32 -88.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 36' ' ' LYS . 33.8 p -155.4 163.45 40.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.791 0.329 . . . . 0.0 110.322 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 t -132.64 141.39 48.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.296 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 p -173.63 -12.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.474 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.0 p -153.87 167.19 30.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.667 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 43' ' ' TYR . 42.8 p-10 -64.73 -32.1 73.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.488 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 57.4 m-85 55.59 35.96 26.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.132 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -92.51 117.96 30.49 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.811 0.338 . . . . 0.0 110.475 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -168.48 22.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.446 0.641 . . . . 0.0 109.388 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -63.62 -39.89 95.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.692 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.5 mm -76.2 128.43 37.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.523 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -88.37 140.98 28.91 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.553 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.4 t -142.67 163.51 32.61 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.576 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 47.71 97.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.696 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.2 t -72.13 150.02 44.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.23 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.95 148.06 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.719 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.501 ' ND1' ' N ' ' A' ' 53' ' ' HIS . 5.1 p-80 -116.61 73.5 5.88 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.613 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -40.83 146.87 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.667 2.245 . . . . 0.0 113.487 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.68 138.07 41.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.161 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 57' ' ' SER . 13.7 p -140.64 162.23 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.639 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.511 ' N ' HG22 ' A' ' 56' ' ' VAL . 28.3 t -146.61 151.94 38.1 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.81 163.15 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.326 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.18 178.68 43.45 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.934 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -112.73 131.12 55.81 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.19 0.596 . . . . 0.0 109.813 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -102.08 127.24 49.06 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.545 ' O ' ' N ' ' A' ' 64' ' ' GLY . 90.5 m-85 -124.56 139.55 53.77 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.58 88.82 0.01 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.11 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 62' ' ' PHE . . . 129.77 -82.33 0.33 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -95.99 144.08 26.59 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.675 0.75 . . . . 0.0 111.501 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.782 HH11 HH21 ' A' ' 237' ' ' ARG . 51.2 ttp180 -136.27 137.93 41.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.377 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.93 128.68 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.58 139.32 26.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.08 145.46 50.32 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.107 0.48 . . . . 0.0 111.095 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -93.58 125.96 38.47 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -106.38 141.97 36.82 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.631 0.729 . . . . 0.0 111.789 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -166.06 101.51 0.65 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.489 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HG2' ' H ' ' A' ' 75' ' ' ARG . 73.6 ttt180 -83.65 155.81 22.99 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 111.111 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.46 ' O ' ' O ' ' A' ' 75' ' ' ARG . 69.1 m-85 -87.6 14.34 8.55 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 74' ' ' TYR . 40.9 ttm180 40.34 106.42 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.358 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 75' ' ' ARG . 22.3 tptm 55.21 114.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.142 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -88.17 133.33 34.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.007 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.65 163.19 14.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 47.5 p-10 -48.66 137.5 11.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.494 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -84.92 94.09 8.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.636 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -144.39 49.82 1.32 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.335 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 40.66 -101.05 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.862 0.363 . . . . 0.0 110.836 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 83' ' ' SER . 10.4 t 56.04 53.73 8.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.601 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 85' ' ' ASN . 32.6 m -64.04 -41.44 92.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.19 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.503 ' N ' HG23 ' A' ' 84' ' ' VAL . 61.1 t-20 -134.33 89.86 2.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.026 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 87' ' ' GLU . 10.1 tp -66.44 -40.85 87.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.781 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' N ' HG23 ' A' ' 86' ' ' ILE . 77.0 mm-40 -138.06 136.81 37.17 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.855 0.36 . . . . 0.0 110.251 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -99.09 136.72 38.65 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.556 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.7 m -78.94 -12.87 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.676 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 62.37 76.05 0.38 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.303 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.4 tt -87.52 134.72 27.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.6 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -130.89 140.04 50.17 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.647 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -148.18 125.77 11.76 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.94 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -111.23 124.66 52.67 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.472 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -94.96 172.78 7.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.432 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.45 -19.95 1.87 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.44 133.59 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.929 0.395 . . . . 0.0 110.287 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -40.96 130.32 2.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.797 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 99' ' ' ILE . 9.2 tp -97.71 125.95 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.303 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -132.68 103.83 6.32 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.076 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -70.4 81.67 0.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.444 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -66.24 -35.71 81.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.431 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -65.84 131.61 46.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.604 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -134.33 -0.27 3.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.326 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -91.34 104.48 17.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.462 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -80.06 133.26 36.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.712 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -76.83 131.91 38.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.371 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -91.5 119.89 31.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -150.33 -150.65 5.33 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.2 p -68.23 140.84 56.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.754 0.311 . . . . 0.0 110.631 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.531 ' O ' ' CG ' ' A' ' 112' ' ' HIS . 96.7 m-85 -60.85 -48.11 83.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.695 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 111' ' ' PHE . 99.0 m-70 -159.03 159.98 35.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.752 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.04 -11.47 59.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.255 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.62 111.65 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.876 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.8 t -62.9 -43.43 98.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.584 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 74.09 151.65 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.2 mp -95.74 140.52 30.43 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -135.1 142.2 13.58 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 120.468 -0.873 . . . . 0.0 113.392 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.3 mt -120.43 143.47 48.46 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.7 t -139.68 118.02 12.06 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.63 118.54 29.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.548 HG22 ' N ' ' A' ' 123' ' ' TYR . 46.3 mm -104.77 160.17 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.548 ' N ' HG22 ' A' ' 122' ' ' ILE . 62.8 t80 -128.02 99.48 5.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 64' ' ' GLY . 43.8 t0 -138.34 122.8 18.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.843 0.354 . . . . 0.0 110.33 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.504 ' H ' ' CG ' ' A' ' 132' ' ' LYS . 10.9 m-85 -113.19 121.56 44.85 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.823 0.821 . . . . 0.0 112.322 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 126' ' ' GLN . 1.3 mp0 -86.7 -10.51 53.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.915 -1.038 . . . . 0.0 108.841 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.571 ' C ' ' H ' ' A' ' 129' ' ' ASP . 96.4 mt -67.84 -41.2 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 95.4 m-20 -69.67 35.35 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.849 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' A' ' 127' ' ' ILE . 20.8 t0 92.62 -119.94 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.85 0.719 . . . . 0.0 110.491 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -127.34 23.3 6.42 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.574 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 11.0 p90 -151.13 126.39 9.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 119.568 -0.853 . . . . 0.0 113.287 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.504 ' CG ' ' H ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -135.87 135.71 22.09 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.413 177.623 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.65 98.34 1.14 Allowed 'Trans proline' 0 C--N 1.325 -0.661 0 N-CA-C 104.217 -3.032 . . . . 0.0 104.217 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -76.66 135.75 39.13 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 118.97 -1.092 . . . . 0.0 113.566 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.2 mt -120.54 134.17 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 CA-C-N 113.465 -1.698 . . . . 0.0 107.75 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.02 166.06 30.38 Favored Glycine 0 N--CA 1.46 0.288 0 C-N-CA 119.897 -1.145 . . . . 0.0 112.145 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.22 134.7 34.13 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -106.97 119.8 40.33 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.195 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 139' ' ' VAL . 9.8 p -136.3 123.12 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.77 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.84 129.44 34.48 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.95 136.95 46.79 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.081 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.22 -48.97 4.62 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.476 ' CG ' ' O ' ' A' ' 143' ' ' HIS . 16.9 p80 -154.96 119.3 4.72 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.957 0.408 . . . . 0.0 111.206 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.481 ' O ' ' ND1' ' A' ' 146' ' ' HIS . 9.8 p -86.56 -1.32 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.895 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.512 ' O ' ' CG ' ' A' ' 146' ' ' HIS . 95.6 mtt-85 -64.46 144.77 56.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.273 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' A' ' 145' ' ' ARG . 70.8 m80 -158.66 -128.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.879 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 148' ' ' ILE . 50.0 m -149.95 151.23 33.03 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.518 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 147' ' ' SER . 28.0 pt 31.78 51.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.822 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.24 -43.19 99.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.638 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.2 p -77.14 162.04 27.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.428 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 152' ' ' LYS . 98.0 m -131.07 -89.85 0.45 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.612 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 151' ' ' THR . 55.2 mtpt 44.58 -172.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.776 0.322 . . . . 0.0 110.694 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -79.18 139.76 37.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.455 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.7 t -152.64 175.71 12.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.748 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 95.0 mt -74.64 131.3 35.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.228 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -141.09 163.78 32.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.072 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.2 t 62.35 27.89 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-O 121.054 0.454 . . . . 0.0 110.454 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 98.4 m -116.21 121.15 41.21 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.1 m -65.89 133.9 51.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.311 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 160' ' ' VAL . 18.5 m -94.47 146.63 31.84 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.907 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.64 -34.26 7.36 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.096 1.864 . . . . 0.0 112.525 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 70.8 m -79.33 152.84 30.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.146 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.14 134.66 38.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.804 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.59 146.45 98.57 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.0 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.05 146.81 47.59 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.127 1.884 . . . . 0.0 111.795 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -79.92 124.83 29.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.229 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 62.21 -131.28 44.97 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.47 -50.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 0.0 110.393 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.43 132.03 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.039 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 170' ' ' THR . 8.9 t -87.6 129.54 35.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.229 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 62.1 m -108.91 124.38 50.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.593 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -174.66 -70.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.219 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.436 ' O ' ' OG1' ' A' ' 174' ' ' THR . 51.2 t-20 -156.31 -127.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.227 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 173' ' ' ASN . 78.7 p 52.06 -92.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.328 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.401 ' N ' ' OG1' ' A' ' 174' ' ' THR . 34.6 t70 -113.73 91.59 21.85 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.464 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 177' ' ' LYS . 51.7 Cg_endo -91.15 5.29 4.01 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.948 2.432 . . . . 0.0 111.92 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 176' ' ' PRO . 98.5 mttt 58.62 120.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.198 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.7 t -73.35 170.17 15.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.877 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -54.39 115.3 2.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.288 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -154.07 174.54 14.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.7 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -63.27 -37.04 85.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.852 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.08 133.24 44.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.421 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -151.59 -65.55 0.18 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.531 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.5 t -81.94 172.87 12.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.037 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -90.29 10.84 23.23 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.3 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 11.3 m -60.6 173.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.404 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 96.3 mt -73.85 128.02 36.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.993 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -85.47 142.8 28.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.296 0.57 . . . . 0.0 111.808 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? 47.12 77.25 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.431 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 190' ' ' VAL . 14.1 p -126.63 131.89 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -138.32 135.17 7.29 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 119.505 -1.331 . . . . 0.0 114.583 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.59 144.75 50.79 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 163.31 -148.83 15.74 Favored Glycine 0 C--N 1.322 -0.216 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.01 159.19 26.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.767 0.794 . . . . 0.0 112.004 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 19.5 tt -113.11 131.61 64.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.66 150.47 36.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 122.15 0.976 . . . . 0.0 112.769 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 171.58 177.4 41.25 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.68 136.22 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.623 0.725 . . . . 0.0 110.57 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -122.87 120.67 4.34 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -128.25 142.21 51.22 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.836 0.827 . . . . 0.0 109.59 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 13.6 p-10 -49.16 141.8 7.82 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 117.438 2.385 . . . . 0.0 117.438 -173.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.532 ' O ' HG22 ' A' ' 202' ' ' ILE . 49.7 mm -124.31 5.59 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 112.35 -2.204 . . . . 0.0 106.177 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.58 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER 176.15 173.83 0.29 Allowed Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 -178.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.58 ' C ' ' O ' ' A' ' 203' ' ' THR . 3.8 Cg_exo -14.36 -83.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 123.58 2.314 . . . . 0.0 113.687 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.435 ' O ' HG23 ' A' ' 207' ' ' THR . 58.7 mttp -129.61 29.6 5.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.689 0.757 . . . . 0.0 110.604 177.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 202' ' ' ILE . 4.2 tt -83.66 111.89 19.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 176.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 205' ' ' LYS . 3.2 p -120.31 152.73 37.41 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.16 131.77 48.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 112.728 -2.033 . . . . 0.0 105.623 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -108.06 146.82 32.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -145.59 129.51 17.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.531 -1.668 . . . . 0.0 106.673 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -167.68 -168.99 30.64 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 118.903 -1.617 . . . . 0.0 113.038 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -143.81 142.69 30.99 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.542 HH12 ' CD2' ' A' ' 215' ' ' HIS . 8.9 ptm180 -91.41 116.98 29.28 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.95 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -63.47 -46.35 86.59 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.542 ' CD2' HH12 ' A' ' 213' ' ' ARG . 86.3 t60 29.59 84.36 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.206 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.9 t30 43.27 94.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.38 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 34.82 -122.44 0.11 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.348 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -165.65 68.18 0.2 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 220' ' ' LEU . 15.1 tpt85 -67.33 -18.78 65.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.73 0.3 . . . . 0.0 110.449 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 220' ' ' LEU . 10.0 mp -43.4 -95.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.566 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 221' ' ' GLU . 9.2 tm-20 40.13 94.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.055 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -136.13 2.78 2.83 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.334 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 60.9 p -138.71 156.06 47.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.152 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -65.07 -40.77 95.16 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.878 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.532 ' CD2' ' N ' ' A' ' 226' ' ' LYS . 67.7 t80 -135.37 -101.37 0.22 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.892 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.532 ' N ' ' CD2' ' A' ' 225' ' ' PHE . 44.9 mmtm 40.73 34.88 0.28 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.338 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.5 m -64.95 119.53 10.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.42 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -149.78 -91.09 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.874 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 45.86 31.35 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.135 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.07 154.04 39.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.671 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.518 ' C ' HD12 ' A' ' 232' ' ' LEU . 71.8 p -137.75 131.29 31.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.787 0.327 . . . . 0.0 110.166 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 231' ' ' SER . 11.3 mp -110.3 136.72 49.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.789 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -141.58 153.08 23.87 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.011 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 14.2 p -133.44 134.18 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.652 ' NE ' HH12 ' A' ' 66' ' ' ARG . 52.6 ttm-85 -133.29 141.67 48.1 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 80.4 t80 -107.84 103.57 12.86 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.782 HH21 HH11 ' A' ' 66' ' ' ARG . 41.1 ttm180 -126.44 133.54 51.21 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 124.188 0.93 . . . . 0.0 111.413 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 10.2 t80 . . . . . 0 C--O 1.218 -0.554 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.308 179.493 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 1' ' ' ALA . 4.9 p 48.16 99.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.486 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -76.87 144.29 39.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.897 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.89 -39.65 95.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.34 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.76 -24.58 10.88 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.14 -39.78 3.08 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -71.82 137.11 47.33 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.83 -160.93 11.63 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.105 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.54 -174.59 2.0 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.308 2.672 . . . . 0.0 112.464 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.691 ' CZ ' ' NH2' ' A' ' 66' ' ' ARG . 3.4 t80 -159.47 141.02 13.06 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 120.904 0.383 . . . . 0.0 111.786 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 12' ' ' GLN . 58.0 t -132.21 159.39 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.451 ' N ' HG12 ' A' ' 11' ' ' VAL . 44.4 tt0 -157.44 151.79 24.94 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -176.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.7 121.59 10.64 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 113.172 -1.831 . . . . 0.0 107.825 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 38.4 p30 -92.65 133.77 35.66 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.1 mt -126.86 133.87 50.63 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.149 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.28 -31.22 0.32 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.768 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -82.43 142.93 31.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.032 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.92 -127.38 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.684 0.278 . . . . 0.0 110.704 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -60.16 -44.63 94.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.842 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.26 136.4 54.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.544 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 22' ' ' ILE . 78.7 t60 -122.34 -80.87 0.63 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.354 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' HIS . 2.6 tp 31.43 104.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.62 0.724 . . . . 0.0 112.114 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 25' ' ' ASP . 19.5 p -69.74 164.41 23.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.626 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 24' ' ' HIS . 80.0 t60 -79.99 26.36 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.389 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 23' ' ' THR . 32.8 t70 -88.26 109.74 20.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.91 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -162.21 64.89 1.72 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.283 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.13 -62.45 0.25 Allowed 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 122.736 2.29 . . . . 0.0 113.012 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 34.78 58.09 2.27 Favored Pre-proline 0 N--CA 1.467 0.406 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -75.43 -30.69 6.33 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.67 2.247 . . . . 0.0 111.98 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -64.55 -20.0 65.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.379 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -117.67 86.07 23.01 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.861 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.24 145.25 98.95 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.37 2.046 . . . . 0.0 111.594 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -132.13 134.4 45.4 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.568 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp 44.83 37.94 2.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.628 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -154.22 172.01 18.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.681 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -96.28 -170.51 2.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.553 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.64 -16.96 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.559 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 39' ' ' THR . 69.0 m -55.32 -41.53 72.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.607 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.595 HG22 ' N ' ' A' ' 40' ' ' VAL . 53.9 m 54.54 164.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.709 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.595 ' N ' HG22 ' A' ' 39' ' ' THR . 10.6 p -69.94 136.81 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.591 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 p -75.37 163.94 26.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 43' ' ' TYR . 43.6 t0 -62.68 -177.06 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.644 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.509 ' H ' ' CG ' ' A' ' 42' ' ' ASP . 16.5 t80 70.82 -35.02 0.31 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.573 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' A' ' 42' ' ' ASP . 78.4 t80 -59.95 -43.83 94.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -64.35 143.37 57.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.842 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -149.36 147.6 28.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.342 . . . . 0.0 110.665 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.67 ' N ' HD12 ' A' ' 47' ' ' ILE . 3.1 mp -76.55 130.52 36.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.021 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -120.62 141.55 50.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.14 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 98.4 m -126.56 130.43 50.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.178 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -127.9 133.62 49.31 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.784 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.4 p -168.85 -108.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.749 0.309 . . . . 0.0 110.596 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.5 m -112.67 132.16 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.06 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 55' ' ' ARG . 83.5 m-70 -146.55 72.52 12.83 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.85 76.57 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 120.961 1.107 . . . . 0.0 110.577 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 53' ' ' HIS . 43.9 ttm180 -72.41 146.48 46.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.952 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.07 139.3 44.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 121.154 0.502 . . . . 0.0 111.462 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.26 130.27 36.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.91 162.71 37.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.065 0.459 . . . . 0.0 111.155 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.85 -136.21 3.1 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -139.28 151.76 46.71 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 121.482 0.658 . . . . 0.0 112.344 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.563 ' OD2' ' NE ' ' A' ' 237' ' ' ARG . 12.1 t0 -92.39 104.79 17.08 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.125 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -126.33 148.07 49.62 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.256 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.47 125.77 8.07 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 123' ' ' TYR . . . 94.09 -10.73 71.56 Favored Glycine 0 C--N 1.33 0.247 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.539 ' CZ2' ' CG2' ' A' ' 67' ' ' ILE . 22.6 t90 -167.69 142.45 3.72 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.565 -0.817 . . . . 0.0 110.198 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.691 ' NH2' ' CZ ' ' A' ' 10' ' ' TYR . 69.4 mtp180 -144.01 144.34 31.62 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.539 ' CG2' ' CZ2' ' A' ' 65' ' ' TRP . 48.5 pt -120.17 138.34 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.639 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.65 110.16 8.53 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.786 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.07 119.52 29.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -100.14 128.42 46.22 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 112.146 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -153.92 155.23 35.27 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.675 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 73' ' ' ARG . . . -150.94 -63.04 0.19 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.475 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 72' ' ' ALA . 91.0 mtm180 56.28 125.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.507 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 71.0 t80 -147.23 31.67 0.91 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.123 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? -130.27 138.75 50.66 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.329 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -77.56 142.99 38.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.452 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -83.1 -116.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.538 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 79' ' ' ASN . 56.8 p30 -131.78 53.23 2.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.759 0.314 . . . . 0.0 110.412 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 78' ' ' ASN . 98.3 m-20 50.17 179.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.155 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 44.1 p30 -86.25 137.24 32.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.001 0.429 . . . . 0.0 110.351 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -143.16 158.76 43.32 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.452 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 83' ' ' SER . 55.2 p90 -111.07 145.19 38.96 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.342 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 82' ' ' TYR . 31.6 t 49.44 179.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.429 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.5 133.79 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.368 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -126.02 130.05 50.39 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.22 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.679 ' H ' ' CD1' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -102.39 3.48 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.573 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.96 -38.71 92.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.395 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 54.09 52.81 12.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.58 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 90' ' ' ARG . 8.3 p -61.79 -43.56 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.602 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.511 ' N ' HG13 ' A' ' 89' ' ' VAL . 17.6 ptm180 -76.61 135.72 39.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 110.245 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 92' ' ' ARG . 41.6 pt -132.82 161.86 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.012 0.434 . . . . 0.0 111.199 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 91' ' ' ILE . 80.0 mtp85 54.59 161.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.136 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -142.09 166.45 24.68 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.784 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -46.78 123.81 5.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.026 0.441 . . . . 0.0 110.954 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -158.37 170.96 21.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.513 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.56 -55.58 0.69 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.66 -43.45 98.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.664 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -122.39 141.51 51.51 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.002 0.43 . . . . 0.0 110.758 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.8 tt -146.64 1.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.037 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -61.44 -43.46 98.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.646 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.458 ' HG3' ' H ' ' A' ' 103' ' ' THR . 16.6 tpp180 -77.95 129.05 34.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.215 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.64 0.76 45.41 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.969 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.458 ' H ' ' HG3' ' A' ' 101' ' ' ARG . 93.9 m -86.84 128.4 35.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.789 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 106' ' ' GLN . 11.9 pm0 -70.92 -168.2 0.26 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.323 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 64.61 -64.75 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.818 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.505 ' C ' ' H ' ' A' ' 108' ' ' ASN . 14.9 mm100 53.56 -168.58 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.519 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 64.51 -38.18 0.22 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.801 0.688 . . . . 0.0 111.395 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.505 ' H ' ' C ' ' A' ' 106' ' ' GLN . 9.2 m120 -64.2 -39.88 94.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.786 0.327 . . . . 0.0 110.421 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.07 -103.33 2.88 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.5 p -80.37 166.34 21.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.754 0.311 . . . . 0.0 110.562 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -102.52 -162.74 0.94 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.322 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.586 ' CG ' ' H ' ' A' ' 113' ' ' ALA . 10.1 t-80 71.61 -149.72 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.294 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.586 ' H ' ' CG ' ' A' ' 112' ' ' HIS . . . 57.52 -149.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.573 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.4 t 53.16 -83.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.522 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 113' ' ' ALA . 42.9 t -118.04 99.67 7.04 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.107 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.0 m -160.99 -165.58 1.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.632 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 117' ' ' LEU . 2.8 mm? 58.92 -150.4 0.44 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 162.53 -105.4 0.26 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 118.875 -1.631 . . . . 0.0 112.916 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.28 151.74 33.43 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.4 0.619 . . . . 0.0 111.547 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.0 t -139.48 119.25 13.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.458 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.91 123.23 26.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.089 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.504 HD13 HH22 ' A' ' 235' ' ' ARG . 90.7 mt -101.23 135.95 35.25 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' A' ' 64' ' ' GLY . 12.2 m-85 -124.3 107.72 11.47 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.008 0.432 . . . . 0.0 110.301 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.666 ' CG ' HH11 ' A' ' 66' ' ' ARG . 9.5 m-20 -96.96 141.53 30.02 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.933 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.495 ' O ' ' CB ' ' A' ' 132' ' ' LYS . 93.5 m-85 -103.34 153.7 20.17 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -108.59 63.61 0.61 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.8 mp -67.43 -41.69 86.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -141.84 -85.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.011 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.4 t70 179.24 -44.22 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.332 0.587 . . . . 0.0 110.297 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.99 -43.31 88.15 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.629 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -142.93 110.73 5.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -175.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -130.58 139.93 37.13 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.353 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.46 152.18 70.84 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.323 1.348 . . . . 0.0 109.603 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 0.5 OUTLIER -138.45 133.95 33.42 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.612 -179.135 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.4 pt -130.4 154.8 41.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.441 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -155.88 163.27 31.72 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.93 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -102.35 122.61 44.59 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -92.66 128.22 38.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.111 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.13 119.22 46.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.32 153.53 46.47 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.419 ' CE1' ' O ' ' A' ' 117' ' ' LEU . 47.6 p90 -142.21 164.72 29.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.55 . . . . 0.0 110.927 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.52 -119.87 0.63 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -62.57 99.91 0.17 Allowed 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.2 p -142.87 141.04 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.906 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -108.99 127.31 53.97 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.6 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -164.01 -82.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.596 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 60.1 p -165.99 -144.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.572 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 149' ' ' ASP . 72.0 mt 57.55 74.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.15 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 148' ' ' ILE . 66.6 t0 35.91 95.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.264 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.4 t -128.82 152.76 48.13 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.603 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 152' ' ' LYS . 59.1 m -62.28 161.1 11.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.74 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.523 ' N ' HG22 ' A' ' 151' ' ' THR . 61.4 pttt -58.73 137.41 57.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.707 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.476 ' C ' ' H ' ' A' ' 155' ' ' ILE . 53.6 mtmt -102.58 -165.95 1.23 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.699 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.4 p -74.22 25.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.476 ' H ' ' C ' ' A' ' 153' ' ' LYS . 41.5 pt -90.51 -5.03 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.963 0.411 . . . . 0.0 110.288 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' A' ' 157' ' ' VAL . 0.0 OUTLIER -42.17 164.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.804 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.419 ' O ' ' OE1' ' A' ' 156' ' ' GLU . 31.1 m -57.44 160.12 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.624 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 67.3 p -61.04 137.19 58.24 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.7 t -142.71 156.69 45.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.918 0.39 . . . . 0.0 110.933 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 160' ' ' VAL . 7.3 p -58.61 129.96 84.85 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.567 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.08 131.75 8.58 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.302 1.334 . . . . 0.0 111.979 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 78.2 p -61.79 -42.51 99.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.293 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -150.95 129.97 12.58 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.931 0.396 . . . . 0.0 110.875 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.99 152.72 95.81 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.803 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.57 109.28 2.82 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.877 1.718 . . . . 0.0 111.806 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.87 4.11 49.68 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.241 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.48 149.24 2.84 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 179.59 -38.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.917 0.389 . . . . 0.0 110.169 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 95.6 t -75.77 133.53 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.363 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.5 t -137.73 161.25 37.01 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.655 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.5 m 65.22 165.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.591 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -74.69 -2.86 28.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.606 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 57.11 40.82 28.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.408 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.4 m -62.2 134.42 56.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.292 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -113.44 91.71 20.98 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.112 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -87.45 114.07 0.97 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.441 2.094 . . . . 0.0 111.446 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -75.44 -95.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.602 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.8 p -66.95 -35.26 79.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.876 0.369 . . . . 0.0 110.478 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -160.62 -47.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.183 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.479 ' CG ' ' H ' ' A' ' 181' ' ' ASP . 12.8 p-10 -150.12 -68.44 0.2 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.358 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 182' ' ' TYR . 32.8 t70 47.39 -177.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.512 ' H ' ' CG ' ' A' ' 181' ' ' ASP . 99.0 m-85 -113.11 146.17 39.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.456 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 185' ' ' ASN . 29.7 pt20 -63.46 -37.59 87.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.986 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 26.9 t 49.01 -94.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.661 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 183' ' ' GLN . 99.5 m-20 -81.83 107.74 14.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.362 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 26.6 t -74.43 -91.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.855 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 94.1 mt -130.06 128.56 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.945 0.402 . . . . 0.0 111.043 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -154.88 -24.51 0.12 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.03 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 51.25 72.5 0.36 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.67 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.4 p -133.04 154.87 40.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -119.33 117.96 3.8 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.22 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 7.8 tt -145.34 127.81 15.99 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -171.73 -163.16 25.21 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.305 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.79 138.37 49.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.47 0.653 . . . . 0.0 110.929 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 67.4 mt -113.51 130.63 67.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -138.16 154.46 49.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.743 0.782 . . . . 0.0 112.849 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 172.32 -171.93 44.55 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.66 135.67 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.213 0.53 . . . . 0.0 110.231 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -96.05 113.15 4.58 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -116.0 117.68 30.82 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 58.9 p30 -57.92 150.29 20.8 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 206' ' ' LEU . 21.5 mm -113.33 -60.63 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.567 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -106.42 176.88 1.49 Allowed Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 174.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.567 ' C ' ' O ' ' A' ' 203' ' ' THR . 15.9 Cg_exo -14.93 -81.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.485 0.974 0 CA-C-N 122.909 2.075 . . . . 0.0 113.746 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 237' ' ' ARG . 97.3 mttt -126.73 28.08 5.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.514 0.674 . . . . 0.0 110.761 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 202' ' ' ILE . 2.9 tt -85.8 112.67 21.31 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.4 p -103.93 149.8 24.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -172.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 208' ' ' LEU . 0.4 OUTLIER -104.36 106.07 16.44 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 101.695 -3.446 . . . . 0.0 101.695 173.064 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -104.09 130.37 51.79 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -174.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -122.14 144.19 49.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.348 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.44 -163.88 32.12 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.0 147.11 46.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -105.18 119.01 38.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.796 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -120.89 163.5 18.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.285 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -124.91 -172.76 2.64 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 216' ' ' ASN . 49.9 t-20 -56.39 -40.21 74.26 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.496 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -108.83 147.11 32.59 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.855 0.359 . . . . 0.0 110.61 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -66.78 -133.93 0.03 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -85.46 132.08 34.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.908 0.385 . . . . 0.0 110.474 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 220' ' ' LEU . 3.5 mm? -63.49 -42.96 98.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.909 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -144.11 124.77 14.09 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.744 0.307 . . . . 0.0 110.861 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -100.87 104.68 15.91 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.31 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.91 -17.85 1.22 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.83 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -138.6 151.12 46.98 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.89 0.376 . . . . 0.0 110.68 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -105.36 115.76 30.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.498 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -158.21 108.56 2.12 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.533 ' OG1' ' N ' ' A' ' 228' ' ' HIS . 1.6 t -165.28 -120.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.492 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.533 ' N ' ' OG1' ' A' ' 227' ' ' THR . 86.4 t60 52.97 6.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.758 0.314 . . . . 0.0 110.384 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 227' ' ' THR . 97.3 mt-10 -54.43 -176.14 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.207 0.527 . . . . 0.0 110.186 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -165.8 84.78 0.34 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.7 p -154.2 167.23 30.58 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 122.012 0.91 . . . . 0.0 112.442 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.61 -57.36 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.567 -1.651 . . . . 0.0 107.143 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 153.4 -166.8 31.79 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.869 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.25 130.64 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.681 ' NH1' HH22 ' A' ' 66' ' ' ARG . 71.2 mtp180 -128.59 142.85 50.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.287 0.565 . . . . 0.0 111.555 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.499 ' O ' ' CD2' ' A' ' 236' ' ' TYR . 5.5 t80 -106.28 106.49 17.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.764 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.563 ' NE ' ' OD2' ' A' ' 61' ' ' ASP . 71.7 ttt180 -133.75 128.63 35.26 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.0 t80 . . . . . 0 C--O 1.222 -0.381 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.847 179.733 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 p -156.6 163.58 39.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.48 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.44 129.83 42.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.532 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -155.22 175.16 14.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.402 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.23 -141.6 0.18 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.49 -109.5 2.82 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.04 154.02 39.03 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.84 -165.6 38.94 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 118.756 -1.687 . . . . 0.0 114.617 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.72 157.43 27.97 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 124.679 3.586 . . . . 0.0 115.354 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -150.62 165.6 32.85 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.831 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.18 139.27 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -124.81 145.65 49.65 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.58 0.705 . . . . 0.0 112.473 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.77 151.0 34.05 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.998 -1.455 . . . . 0.0 108.476 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 15' ' ' LEU . 38.4 t0 -142.33 144.06 33.04 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.577 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 92.0 mt -126.94 143.69 51.21 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.684 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.62 -89.89 0.43 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.055 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -148.89 157.93 43.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.539 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.48 151.21 37.01 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.259 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -142.17 140.67 32.47 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.973 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -79.8 106.32 11.74 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -74.98 -69.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.298 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.6 mt -122.03 133.2 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.779 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.0 m -111.73 130.6 55.74 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.999 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -58.22 -44.78 88.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.275 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 55.15 75.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.625 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 54.4 77.27 0.45 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.96 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.45 146.4 27.63 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.128 1.885 . . . . 0.0 111.734 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 13.5 pt-20 -177.8 54.73 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 28' ' ' GLU . 95.6 Cg_endo -74.08 152.88 46.27 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.797 2.331 . . . . 0.0 112.167 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.0 p -99.5 116.73 32.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.258 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -173.84 57.31 0.2 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.554 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.82 -20.55 58.57 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.477 2.118 . . . . 0.0 111.811 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 33' ' ' ASN . 43.6 p-10 -78.34 120.4 23.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -131.91 144.85 51.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.86 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.46 ' CG ' ' H ' ' A' ' 36' ' ' LYS . 19.3 t-20 -127.69 -124.07 0.23 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.575 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.46 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 88.7 tttt 57.68 90.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.803 0.335 . . . . 0.0 110.538 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mm -108.54 125.65 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.16 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.0 m -81.0 -95.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.518 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.4 m -158.11 -57.94 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.598 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 40' ' ' VAL . 33.7 m -89.51 130.22 39.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.484 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -78.46 -149.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.571 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 40.27 86.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -146.41 155.31 42.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.451 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.425 ' H ' ' H ' ' A' ' 45' ' ' ARG . 87.8 t80 -160.29 -12.6 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.379 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.425 ' H ' ' H ' ' A' ' 44' ' ' PHE . 99.9 mtt180 -76.73 136.62 39.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.272 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -157.36 120.15 3.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.78 0.324 . . . . 0.0 111.048 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 47' ' ' ILE . 9.7 tp -142.11 131.54 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.123 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.9 ttp85 -124.77 102.25 7.48 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.936 0.398 . . . . 0.0 110.305 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.1 m -133.81 132.58 40.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 51' ' ' SER . 42.2 ttm180 -142.0 87.02 2.01 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.069 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 50' ' ' ARG . 1.2 t 54.94 113.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.017 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -110.28 -5.4 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.204 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 55.54 64.42 5.49 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.003 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -95.9 84.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.087 2.525 . . . . 0.0 112.777 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.27 118.19 31.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.203 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 57' ' ' SER . 74.9 t -139.37 159.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.381 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.484 ' N ' HG12 ' A' ' 56' ' ' VAL . 5.1 m -141.7 141.66 33.32 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.486 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.62 137.49 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.094 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.22 -175.65 32.47 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.037 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -96.97 137.51 35.94 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.977 0.418 . . . . 0.0 111.73 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.531 ' OD1' ' NH2' ' A' ' 66' ' ' ARG . 34.3 t70 -101.37 115.07 29.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.37 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -124.56 120.69 32.66 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.497 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.0 107.24 0.44 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.32 -60.98 0.59 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.439 ' N ' ' CD1' ' A' ' 65' ' ' TRP . 8.7 p-90 -157.98 150.68 22.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.937 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.628 ' NH1' ' NH1' ' A' ' 235' ' ' ARG . 9.3 ptp85 -135.66 167.23 21.51 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.887 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.2 pt -145.22 143.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.193 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.86 145.51 29.88 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.15 0.5 . . . . 0.0 110.71 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.17 127.28 38.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.403 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -98.18 127.56 44.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.558 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 45.2 p90 -139.88 166.24 25.15 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.846 0.831 . . . . 0.0 112.848 -177.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 71' ' ' TYR . . . 145.59 42.17 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 113.001 -1.909 . . . . 0.0 108.6 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -78.95 172.35 13.92 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.578 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 76' ' ' LYS . 92.8 m-85 -62.08 -34.0 75.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.127 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 55.35 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 74' ' ' TYR . 58.2 tttm -134.77 126.18 28.43 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 110.51 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -77.34 -76.65 0.17 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.566 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -149.75 137.67 20.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.583 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 80' ' ' ASN . 20.6 p30 -68.08 -33.61 74.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.632 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 62.4 t-20 -85.37 109.36 18.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.342 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 82' ' ' TYR . 53.9 mtmt -88.17 109.54 19.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.885 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 81' ' ' LYS . 96.2 m-85 53.49 163.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.19 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.4 m -71.91 153.02 42.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.273 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 86' ' ' ILE . 96.9 t -88.58 114.85 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.114 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 42.59 -91.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.706 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 84' ' ' VAL . 44.4 pt -129.47 160.51 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 120.845 0.355 . . . . 0.0 110.791 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.51 -20.0 65.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.636 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 59.93 98.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -109.42 131.56 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.79 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -48.78 -76.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.297 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 91' ' ' ILE . 7.0 tp -149.54 105.39 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.981 0.42 . . . . 0.0 110.587 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -135.92 138.59 42.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.11 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -95.31 -50.41 5.04 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.267 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -171.36 115.25 0.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.809 0.338 . . . . 0.0 110.84 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -63.78 -41.05 98.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.693 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 97' ' ' ILE . . . 80.98 165.48 33.98 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 96' ' ' GLY . 9.7 mm 45.13 97.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 110.443 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -112.63 84.93 2.06 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.031 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.34 -43.88 94.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.273 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.8 t0 64.07 112.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.971 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 103' ' ' THR . 33.5 ttp180 -161.11 -140.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.827 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? 60.57 -70.36 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.678 0.275 . . . . 0.0 110.535 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.546 ' N ' ' O ' ' A' ' 101' ' ' ARG . 61.5 p -64.74 -30.89 71.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -51.95 136.54 28.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.204 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.55 -99.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.715 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 44.52 83.39 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.135 0.493 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -138.18 147.57 43.98 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.12 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.433 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 46.5 p30 -78.46 79.03 4.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.68 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.08 123.75 0.6 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.487 ' HG1' ' HD2' ' A' ' 111' ' ' PHE . 3.9 t -137.95 156.81 47.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.723 0.297 . . . . 0.0 110.204 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.487 ' HD2' ' HG1' ' A' ' 110' ' ' THR . 87.2 m-85 37.31 90.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.241 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 99.5 m-70 -85.33 55.79 3.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.402 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 112' ' ' HIS . . . 66.25 159.16 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.698 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.61 132.87 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.86 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.9 p -119.28 19.51 12.79 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.944 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.6 m 54.94 175.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp -139.99 162.51 35.02 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 170.32 -109.72 0.34 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 119.644 -1.265 . . . . 0.0 111.99 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.28 147.63 41.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.292 0.567 . . . . 0.0 110.748 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.3 p -150.81 141.38 22.58 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.68 149.05 32.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.815 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.463 ' O ' ' CG1' ' A' ' 122' ' ' ILE . 3.4 pt -144.36 114.45 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.587 ' CZ ' HG23 ' A' ' 135' ' ' ILE . 34.2 p90 -90.43 141.91 28.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.575 ' OD1' ' NH1' ' A' ' 66' ' ' ARG . 62.7 m-20 -89.84 115.84 27.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 113.387 -1.733 . . . . 0.0 108.143 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.476 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 87.8 t80 -118.13 121.8 41.44 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.464 ' CB ' ' O ' ' A' ' 125' ' ' PHE . 1.4 mm100 147.96 177.33 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.53 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.56 ' O ' HG22 ' A' ' 127' ' ' ILE . 93.0 mt -70.21 -1.46 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.753 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 70.9 36.55 1.46 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.632 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.46 -60.39 1.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.889 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -129.06 -48.31 1.22 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.572 ' CD2' ' CE1' ' A' ' 200' ' ' PHE . 1.0 OUTLIER -148.32 146.58 28.61 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.145 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.476 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -134.74 141.82 40.09 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.337 177.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.56 107.96 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 N-CA-C 108.007 -1.574 . . . . 0.0 108.007 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -81.85 131.02 35.25 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.981 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.587 HG23 ' CZ ' ' A' ' 123' ' ' TYR . 2.5 tt -161.83 149.51 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.832 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.69 -144.88 6.25 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.092 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -127.43 164.14 22.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.69 ' NH2' HH21 ' A' ' 213' ' ' ARG . 41.7 ttm180 -125.17 133.89 52.62 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.096 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.88 121.71 61.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.27 146.17 44.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.138 0.494 . . . . 0.0 110.98 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -131.27 160.97 33.35 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.698 0.761 . . . . 0.0 111.661 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.35 47.96 0.48 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -52.09 -13.18 0.28 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.011 -0.594 . . . . 0.0 112.145 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.3 t -71.04 157.94 6.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.171 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.529 ' O ' ' ND1' ' A' ' 146' ' ' HIS . 35.1 ttm180 65.3 154.25 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.276 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.529 ' ND1' ' O ' ' A' ' 145' ' ' ARG . 54.3 p-80 42.77 40.4 2.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.905 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.8 t -64.61 -17.67 64.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.093 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 31.5 pt -68.03 -131.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.691 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.6 t0 64.26 45.42 3.93 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.672 0.272 . . . . 0.0 111.201 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.8 p -64.11 -65.92 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.871 0.367 . . . . 0.0 110.145 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 60.5 p -138.75 155.97 47.75 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.395 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -139.83 151.22 45.54 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.632 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -75.06 146.92 41.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.297 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 92.4 m -121.02 127.27 51.59 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.915 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 155' ' ' ILE . 9.1 tp -140.62 131.48 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.081 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -174.27 -34.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.811 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.89 132.06 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.923 0.392 . . . . 0.0 110.257 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 2.9 t -132.22 153.58 50.46 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.282 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.1 t -63.1 133.44 54.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.984 0.421 . . . . 0.0 110.727 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 160' ' ' VAL . 4.1 m -84.39 153.89 62.43 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.877 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -39.23 139.25 0.6 Allowed 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 121.893 1.729 . . . . 0.0 111.999 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.3 p -81.68 -8.86 59.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.079 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -138.33 113.51 9.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.958 0.409 . . . . 0.0 110.884 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.684 ' HB1' ' CD ' ' A' ' 165' ' ' PRO . . . -172.01 -178.19 0.44 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.483 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.684 ' CD ' ' HB1' ' A' ' 164' ' ' ALA . 28.7 Cg_exo -60.61 142.24 97.35 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.104 1.869 . . . . 0.0 111.745 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -64.92 -40.33 94.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.795 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.67 -167.27 48.19 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -152.62 151.56 30.76 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.951 0.405 . . . . 0.0 110.751 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.42 141.08 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.335 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 171' ' ' THR . 1.9 m -147.51 -138.77 0.09 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.389 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.546 ' H ' HG22 ' A' ' 170' ' ' THR . 23.4 p 51.91 171.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.794 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -105.65 140.98 37.88 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.712 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 52.9 p30 -90.95 4.12 52.8 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.291 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 21.3 p 46.01 -119.51 0.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.032 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -111.36 154.38 43.74 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -40.57 125.38 2.01 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.645 1.563 . . . . 0.0 111.798 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.98 -42.02 94.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.162 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 86.9 m 45.07 79.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.384 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -117.86 -98.15 0.45 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.36 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 56.53 34.4 24.28 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.64 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -97.4 7.79 45.85 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.599 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -44.59 161.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.637 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -45.26 113.61 0.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.802 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 39.9 t -155.87 152.58 28.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.655 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -152.11 171.1 18.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.233 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 41.5 t -67.63 125.33 25.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 110.725 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.924 ' H ' HD12 ' A' ' 187' ' ' ILE . 3.1 mp -67.44 -45.03 86.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.747 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.82 140.77 29.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.807 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -81.4 84.43 6.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.331 0.586 . . . . 0.0 111.157 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 191' ' ' GLY . 54.9 t -121.35 162.4 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 190' ' ' VAL . . . -137.58 135.74 7.78 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.162 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.4 tp -142.61 131.05 22.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -164.02 -160.93 12.32 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.39 153.25 35.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.986 0.898 . . . . 0.0 111.228 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.6 tt -124.67 134.04 67.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 113.622 -1.626 . . . . 0.0 108.733 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -157.67 156.15 31.25 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 119.634 -0.827 . . . . 0.0 112.454 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 169.06 -171.41 42.96 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.16 135.54 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.517 0.659 . . . . 0.0 111.034 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -116.35 129.9 8.71 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.968 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.572 ' CE1' ' CD2' ' A' ' 131' ' ' PHE . 56.7 m-85 -104.29 109.52 21.39 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.704 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.26 121.6 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 124.662 1.226 . . . . 0.0 110.171 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.554 ' O ' HG22 ' A' ' 202' ' ' ILE . 42.7 mm -126.57 3.8 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 123.385 1.564 . . . . 0.0 108.635 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.778 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.2 OUTLIER -156.59 73.33 4.81 Favored Pre-proline 0 N--CA 1.425 -1.714 1 N-CA-C 98.664 -4.569 . . . . 0.0 98.664 178.138 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER 1.06 -41.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.826 1 C-N-CA 126.111 4.541 . . . . 0.0 116.747 -170.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.778 ' N ' ' O ' ' A' ' 203' ' ' THR . 61.9 pttt -96.73 0.08 49.01 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.623 HD23 ' C ' ' A' ' 206' ' ' LEU . 5.9 tt -109.07 106.67 16.69 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 8.4 t -141.61 140.73 33.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 119.257 -0.977 . . . . 0.0 113.011 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.26 116.67 30.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.422 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -97.22 123.3 40.96 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.371 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -117.31 124.43 48.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -170.15 -173.54 37.59 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 118.946 -1.597 . . . . 0.0 112.705 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -133.79 148.24 51.34 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.69 HH21 ' NH2' ' A' ' 138' ' ' ARG . 84.0 mtp180 -127.05 129.27 47.7 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -152.75 157.34 40.7 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.199 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.533 ' ND1' ' N ' ' A' ' 215' ' ' HIS . 0.0 OUTLIER -151.79 165.49 34.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.191 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.674 ' ND2' ' CD2' ' A' ' 217' ' ' TRP . 0.8 OUTLIER 44.55 17.99 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.022 0.439 . . . . 0.0 110.411 -179.453 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.674 ' CD2' ' ND2' ' A' ' 216' ' ' ASN . 1.9 m-90 -146.75 157.64 43.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.751 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 142.02 -13.92 2.6 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -102.26 144.69 30.47 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.929 0.395 . . . . 0.0 110.912 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 220' ' ' LEU . 10.0 mp -84.12 -0.27 51.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.244 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.69 -38.34 84.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.533 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 222' ' ' ASN . 44.0 p-10 -156.69 90.6 1.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 111.101 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 81.0 p -83.61 72.84 10.29 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.107 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -64.37 -44.04 92.64 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.446 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -164.13 136.34 4.85 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.694 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 228' ' ' HIS . 63.0 tttp -148.14 -79.28 0.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.317 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 226' ' ' LYS . 1.8 p 30.59 38.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.873 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 226' ' ' LYS . 43.5 t60 -70.22 122.79 20.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 110.42 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -86.68 160.11 18.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.534 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.14 140.74 58.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.388 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.413 ' C ' HD12 ' A' ' 232' ' ' LEU . 5.7 p -115.76 140.16 49.48 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 232' ' ' LEU . 10.9 mp -107.42 131.94 53.73 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -126.79 152.03 18.38 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.474 -0.393 . . . . 0.0 112.229 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.0 p -126.86 131.45 71.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.628 ' NH1' ' NH1' ' A' ' 66' ' ' ARG . 60.3 ttp180 -130.67 143.45 50.76 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -91.93 126.76 37.14 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 112.93 -1.941 . . . . 0.0 106.441 176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.574 ' H ' ' CA ' ' A' ' 205' ' ' LYS . 1.4 tmm_? -147.13 109.5 4.54 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 122.452 1.12 . . . . 0.0 111.701 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 C--O 1.22 -0.484 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.596 -179.712 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 2' ' ' SER . 8.8 p 59.08 101.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.566 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -132.76 -33.38 1.2 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.392 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.6 143.94 53.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.678 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.56 -135.59 4.0 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.67 -35.17 91.5 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -64.26 136.02 56.78 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.27 -94.94 0.9 Allowed Glycine 0 CA--C 1.537 1.459 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.78 129.2 22.78 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.806 1.671 . . . . 0.0 114.206 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -162.26 166.57 25.23 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.608 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 12' ' ' GLN . 40.9 t -128.86 157.24 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.473 ' N ' HG12 ' A' ' 11' ' ' VAL . 32.0 tp60 -135.32 143.79 46.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.775 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.89 149.2 29.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.128 0.489 . . . . 0.0 111.293 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 39.0 p-10 -105.17 120.57 41.85 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.995 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.2 mt -118.63 141.5 48.54 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.998 0.428 . . . . 0.0 111.07 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.89 -72.95 0.44 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.186 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.457 ' CD2' ' N ' ' A' ' 18' ' ' ALA . 85.7 t80 -163.67 -83.32 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.454 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.457 ' N ' ' CD2' ' A' ' 17' ' ' TYR . . . -172.34 158.11 4.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.566 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -95.08 132.86 39.51 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.4 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -85.34 -179.12 6.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.044 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 75.5 m80 39.86 -122.94 0.39 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.152 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.2 tt -140.68 145.65 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.53 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 p -76.62 170.21 16.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.684 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.442 ' O ' ' ND1' ' A' ' 24' ' ' HIS . 0.2 OUTLIER -58.17 133.49 55.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.526 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.99 -39.48 94.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.978 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.676 ' H ' ' CD ' ' A' ' 27' ' ' PRO . 1.5 t80 -168.7 -40.68 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.312 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.676 ' CD ' ' H ' ' A' ' 26' ' ' TYR . 22.3 Cg_exo -64.51 146.37 89.2 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.38 2.054 . . . . 0.0 111.823 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -176.93 76.21 0.25 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.931 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.45 141.33 97.32 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.374 2.049 . . . . 0.0 111.554 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.9 p -69.37 -35.26 75.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.795 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.549 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -179.15 -45.07 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.342 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 31' ' ' ALA . 35.4 Cg_exo -60.49 143.45 99.46 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.47 2.113 . . . . 0.0 111.861 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 11.3 p-10 -156.18 -58.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.67 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -101.73 150.01 23.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.842 0.353 . . . . 0.0 110.351 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.454 ' OD1' ' N ' ' A' ' 35' ' ' ASN . 11.4 p-10 -72.5 -10.61 60.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.639 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -78.15 142.33 38.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.172 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.9 mt -106.37 117.26 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.139 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.7 p -79.19 152.2 30.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.904 0.383 . . . . 0.0 110.89 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.6 m -98.58 -42.73 7.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.506 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.48 ' C ' ' H ' ' A' ' 42' ' ' ASP . 5.7 p -143.14 -22.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.496 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.43 ' C ' ' N ' ' A' ' 43' ' ' TYR . 1.9 m 62.51 -2.38 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.982 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 43' ' ' TYR . 98.9 m-20 50.48 13.96 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.607 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 42' ' ' ASP . 76.7 m-85 -158.67 85.79 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.385 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -75.2 -19.65 59.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.184 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 47' ' ' ILE . 35.1 ttm180 62.14 35.03 15.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.629 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 39.15 -96.2 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.738 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 45' ' ' ARG . 40.5 pt -113.94 -167.8 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.955 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -138.83 142.82 38.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 0.0 110.611 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.6 m -125.33 7.43 7.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.544 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -62.41 -40.42 96.46 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.529 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.8 t -154.01 99.16 2.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.178 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.4 m -101.52 2.29 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 61.57 109.77 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.745 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.12 130.53 35.56 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.119 1.213 . . . . 0.0 110.522 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -92.95 152.77 19.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.761 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 57' ' ' SER . 12.5 p -138.73 154.25 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.156 0.503 . . . . 0.0 111.75 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.475 ' N ' HG22 ' A' ' 56' ' ' VAL . 26.5 t -142.9 143.55 32.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.201 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 p -135.28 151.23 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.76 174.56 42.77 Favored Glycine 0 C--O 1.241 0.561 0 C-N-CA 118.302 -1.904 . . . . 0.0 114.191 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.99 138.44 34.52 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 113.446 -1.377 . . . . 0.0 108.161 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -116.72 102.82 9.75 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.41 ' O ' ' C ' ' A' ' 63' ' ' GLY . 78.3 m-85 -107.65 127.53 53.74 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 175.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -41.16 103.9 0.04 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 120.012 -1.089 . . . . 0.0 110.744 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.05 -83.92 0.19 Allowed Glycine 0 C--N 1.343 0.968 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.447 ' CD1' ' N ' ' A' ' 65' ' ' TRP . 2.1 p-90 -133.23 172.92 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.127 0.464 . . . . 0.0 111.433 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.855 HH21 HD13 ' A' ' 122' ' ' ILE . 50.6 ttp180 -125.1 151.61 45.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.452 ' N ' ' HG2' ' A' ' 66' ' ' ARG . 91.3 mt -108.37 129.7 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -141.62 145.64 35.26 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.63 149.5 49.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 113.606 -1.634 . . . . 0.0 106.667 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 4.1 p-10 -148.92 153.47 38.05 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 119.272 -0.971 . . . . 0.0 113.201 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -108.38 143.05 37.83 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 113.835 -1.529 . . . . 0.0 109.156 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -156.34 4.73 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.982 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -89.32 157.23 18.27 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 110.571 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -76.09 142.47 41.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.411 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -91.5 115.29 27.91 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.087 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.94 -42.99 89.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.963 0.411 . . . . 0.0 110.372 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 39.74 86.34 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.209 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.444 ' C ' ' H ' ' A' ' 80' ' ' ASN . 60.9 m-80 -63.49 -40.38 96.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.819 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 79' ' ' ASN . 3.5 t30 61.7 2.67 0.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.35 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' H ' ' C ' ' A' ' 78' ' ' ASN . 89.6 m-20 -109.22 114.89 28.99 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.691 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -77.42 142.6 39.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.098 0.475 . . . . 0.0 110.671 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 9.6 p90 -143.79 -134.86 0.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.028 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 0.8 OUTLIER 82.78 12.33 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.032 0.444 . . . . 0.0 109.955 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.71 -43.25 96.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.697 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.3 t30 67.31 87.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.957 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -110.53 104.03 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.048 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.38 -37.39 74.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.021 0.439 . . . . 0.0 109.962 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 56.84 40.07 29.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.731 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.54 -35.44 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.286 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' ILE . 94.1 mtt180 -72.88 146.04 46.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.442 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.451 ' O ' ' O ' ' A' ' 90' ' ' ARG . 88.7 mt 56.28 116.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.565 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 93' ' ' LYS . 83.3 mtp180 -64.88 -42.58 94.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.779 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 92' ' ' ARG . 87.2 tttt 53.22 105.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 96' ' ' GLY . 18.4 pt-20 -65.27 -41.83 93.81 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.578 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 52.09 40.02 27.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.676 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.406 ' H ' ' HG3' ' A' ' 94' ' ' GLU . . . 70.04 151.81 0.67 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.7 pt -77.92 -21.93 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.784 0.326 . . . . 0.0 110.678 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 99' ' ' ILE . 99.8 mtt180 -78.18 145.51 35.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.744 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 98' ' ' ARG . 17.5 mm 46.54 97.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.423 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -80.35 -87.19 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.698 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -97.17 133.48 41.75 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.395 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -134.7 27.23 3.66 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.556 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 59.1 p -65.06 -32.37 74.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.316 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 54.86 59.7 3.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.637 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -90.48 8.81 31.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.888 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.43 -40.64 91.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.786 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.65 150.81 27.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.998 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 56.56 42.25 27.48 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.291 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.86 -121.15 2.16 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 111' ' ' PHE . 67.3 p -82.15 165.05 20.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.07 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 110' ' ' THR . 89.3 m-85 56.73 147.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.23 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 60.4 m170 -83.34 137.4 33.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.638 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -147.44 134.63 20.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.1 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.73 160.5 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.661 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 116' ' ' SER . 66.1 m -116.28 97.37 6.01 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.658 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 115' ' ' SER . 1.4 m 57.73 140.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.67 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -142.72 124.69 15.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.868 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -102.09 124.59 8.25 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -143.01 135.65 27.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 117.6 0.7 . . . . 0.0 109.802 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.8 m -154.81 151.99 29.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.432 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.678 ' C ' HD12 ' A' ' 122' ' ' ILE . . . -118.18 125.89 51.11 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.855 HD13 HH21 ' A' ' 66' ' ' ARG . 1.7 mp -119.96 154.56 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.542 0.687 . . . . 0.0 112.232 -176.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -103.12 110.35 22.27 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.184 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -108.5 122.49 47.15 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -91.36 81.56 5.45 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.49 0.662 . . . . 0.0 109.417 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -67.71 -18.27 64.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.203 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.0 pt -67.91 -30.46 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.812 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 131' ' ' PHE . 89.2 m-20 -70.66 121.53 18.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 67.8 t0 -63.97 -41.85 97.42 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -105.37 -18.95 13.95 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 20.8 p90 -158.2 133.87 8.99 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.289 1.404 . . . . 0.0 114.368 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -118.09 103.64 49.54 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.0 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.602 ' HA ' HG22 ' A' ' 198' ' ' VAL . 24.8 Cg_exo -63.57 123.14 11.56 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 15.3 p90 -106.58 133.46 51.22 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.093 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.9 tt -145.76 147.53 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.109 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.45 -171.85 37.69 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 119.69 -1.243 . . . . 0.0 113.605 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.53 136.98 39.56 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 20.1 ttt-85 -124.98 120.89 32.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.38 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.17 135.6 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.942 0.877 . . . . 0.0 112.11 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.25 124.9 50.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.029 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -129.46 144.84 51.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.096 0.474 . . . . 0.0 111.933 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -178.24 -164.42 31.33 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 47.73 -139.76 0.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.61 149.35 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.725 0.297 . . . . 0.0 110.438 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 -59.9 -42.82 94.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.87 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -79.48 68.38 5.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.044 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.411 ' OG ' ' NE ' ' A' ' 189' ' ' ARG . 25.7 t -80.54 162.08 24.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.621 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 148' ' ' ILE . 21.2 tt -96.49 129.68 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.135 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -86.3 98.67 11.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.581 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.9 m -60.85 -42.19 97.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.402 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 93.4 m -123.61 129.36 51.05 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.341 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -75.77 139.45 41.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.614 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -95.53 -3.24 46.97 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.545 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 155' ' ' ILE . 8.7 m 58.08 163.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.838 0.351 . . . . 0.0 110.579 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.457 ' N ' HG22 ' A' ' 154' ' ' THR . 19.2 tt -130.42 134.54 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.525 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 58.21 102.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.671 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.17 161.57 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.385 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.73 123.94 44.99 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.215 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 24.1 m -66.92 135.14 53.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.871 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.9 t -56.33 132.21 75.97 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.705 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.12 156.69 46.94 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.078 1.852 . . . . 0.0 112.118 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.0 m -65.86 105.03 1.2 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.459 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 164' ' ' ALA . 52.9 t30 -160.74 -87.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.663 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . 59.21 150.19 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.41 147.9 59.68 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.052 1.835 . . . . 0.0 111.776 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -84.65 139.17 32.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.605 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -160.05 -94.59 0.1 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 169' ' ' VAL . . . -67.44 143.34 56.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.748 0.309 . . . . 0.0 110.538 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 168' ' ' ALA . 4.9 t 59.65 138.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.613 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 87.3 m -62.53 -45.67 91.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 95.8 m -121.4 129.1 52.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.49 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 172' ' ' TYR . 53.2 p90 -84.94 130.33 34.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.751 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -117.5 119.21 34.36 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.283 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 179.38 78.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.328 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -57.1 110.57 2.52 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.309 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.24 159.73 17.65 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.099 1.866 . . . . 0.0 111.755 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 178' ' ' THR . 98.6 mttt -142.71 -75.75 0.27 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.904 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 177' ' ' LYS . 2.6 p 36.77 51.21 0.91 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.275 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -69.73 138.6 52.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.566 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -82.47 136.02 35.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.788 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 181' ' ' ASP . 40.4 p30 -152.55 82.17 1.23 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.724 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 181' ' ' ASP . 63.0 t80 44.0 98.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.93 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -159.23 105.94 1.74 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.483 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.3 p -152.59 129.52 11.0 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.821 0.343 . . . . 0.0 110.776 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.488 ' O ' ' ND2' ' A' ' 185' ' ' ASN . 2.5 t30 53.64 41.13 32.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.612 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 188' ' ' ARG . 14.2 p -64.54 -89.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.762 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.7 mt 67.07 -36.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.725 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 186' ' ' SER . 61.9 ttt85 52.35 82.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.361 . . . . 0.0 111.954 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.411 ' NE ' ' OG ' ' A' ' 147' ' ' SER . 78.0 mtp85 -109.51 -2.15 17.82 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 33.5 m -135.96 161.49 37.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.375 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -130.93 150.58 19.4 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.929 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.4 pp -168.2 136.72 2.32 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.661 0.743 . . . . 0.0 112.618 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -169.41 -140.54 2.99 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.49 164.31 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.483 0.658 . . . . 0.0 111.763 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.7 tt -129.84 138.09 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.549 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.455 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . -152.74 164.23 38.17 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.477 ' O ' ' CD2' ' A' ' 134' ' ' TYR . . . 155.47 170.6 21.14 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.062 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 133' ' ' PRO . 59.8 t -131.29 138.41 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 117.274 0.537 . . . . 0.0 111.804 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -105.46 134.02 11.87 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -131.29 105.82 7.89 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.79 153.27 33.01 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -175.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 66.6 mt -113.18 -10.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 123.298 1.523 . . . . 0.0 107.888 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.699 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.5 m -166.75 103.5 0.65 Allowed Pre-proline 0 C--N 1.3 -1.562 1 N-CA-C 99.445 -4.28 . . . . 0.0 99.445 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.466 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -11.56 -42.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 123.557 2.838 . . . . 0.0 115.63 -172.527 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 203' ' ' THR . 13.6 pttm -77.87 -34.72 51.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 203' ' ' THR . 50.5 tp -83.93 105.76 15.07 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.2 m -128.61 131.28 48.12 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 208' ' ' LEU . 10.0 mp -96.8 141.57 29.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -134.67 144.77 48.0 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.012 0.911 . . . . 0.0 113.335 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -101.86 113.08 25.95 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -152.58 157.56 27.35 Favored Glycine 0 N--CA 1.462 0.387 0 C-N-CA 118.556 -1.783 . . . . 0.0 113.895 -176.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -169.31 163.91 10.79 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.645 ' N ' ' NE ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -124.48 154.15 40.96 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.932 0.396 . . . . 0.0 110.129 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -142.78 133.51 25.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.94 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -74.59 144.91 43.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.174 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -93.22 107.48 19.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.158 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -151.63 -18.1 0.19 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.178 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 219' ' ' ARG . . . 84.01 16.17 68.09 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 221' ' ' GLU . 25.8 ptt180 11.84 -110.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.5 mp 62.55 -65.91 0.09 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.46 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 219' ' ' ARG . 44.3 tt0 -46.68 -38.84 10.41 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.581 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 222' ' ' ASN . 1.9 p-10 -91.16 111.05 22.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.915 0.388 . . . . 0.0 110.858 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.4 p -85.75 169.43 13.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.856 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 57.74 -164.48 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.877 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 225' ' ' PHE . 72.1 t80 55.49 28.66 12.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.17 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.463 ' O ' ' ND1' ' A' ' 228' ' ' HIS . 69.0 mttm -76.49 -15.87 59.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.975 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 29.7 m -64.36 129.13 38.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.557 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 226' ' ' LYS . 81.0 m80 -113.8 130.45 56.46 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.198 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 230' ' ' ALA . 81.2 tt0 -67.55 -39.63 84.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.564 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 229' ' ' GLU . . . 62.17 152.81 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 26.9 p -155.24 162.53 40.88 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.164 -1.014 . . . . 0.0 112.326 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 71.1 mt -81.51 148.03 29.39 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.04 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -143.75 137.92 7.77 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.6 145.39 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 117.393 0.597 . . . . 0.0 110.621 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -124.55 142.77 51.09 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.328 0.585 . . . . 0.0 111.063 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -110.34 106.07 15.31 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.431 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.661 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 2.4 tmt_? -114.06 96.13 5.65 Favored 'General case' 0 C--O 1.255 1.37 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 237' ' ' ARG . 72.3 m-85 . . . . . 0 N--CA 1.472 0.661 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.447 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 t 53.96 93.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.658 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -143.17 154.93 44.39 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 110.988 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -71.41 149.31 46.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.276 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.71 111.68 0.51 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.892 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.463 ' C ' ' NH2' ' A' ' 237' ' ' ARG . . . 43.24 -115.49 1.08 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-O 121.101 0.278 . . . . 0.0 112.586 178.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.688 ' N ' ' NH2' ' A' ' 237' ' ' ARG . 84.9 mtm180 -60.46 159.14 10.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.043 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.92 -62.4 0.6 Allowed Glycine 0 CA--C 1.535 1.293 0 CA-C-O 119.699 -0.501 . . . . 0.0 112.118 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.461 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 58.6 Cg_endo -90.74 143.41 3.48 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.896 2.397 . . . . 0.0 113.477 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.608 ' CZ ' ' NH2' ' A' ' 66' ' ' ARG . 1.7 m-85 -159.63 146.59 16.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.21 0.528 . . . . 0.0 112.221 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.3 t -141.19 137.06 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.946 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -135.31 149.49 49.78 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.52 152.17 32.6 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.837 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -107.0 155.43 19.81 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.626 0.25 . . . . 0.0 111.003 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -139.29 128.93 24.55 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.624 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -96.02 76.18 3.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.728 0.299 . . . . 0.0 111.415 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 16' ' ' ALA . 76.3 t80 56.28 155.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.135 0.493 . . . . 0.0 111.405 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 49.63 -148.23 0.29 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.071 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 20' ' ' GLU . 82.6 t80 -153.69 107.38 2.99 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.527 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 19' ' ' TYR . 46.4 tp10 48.64 104.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.707 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -73.06 125.23 27.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.796 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.4 mt -67.27 -43.92 87.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.143 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.3 p -130.57 165.79 22.01 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.884 0.373 . . . . 0.0 110.903 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -70.52 129.48 39.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.674 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -80.14 160.08 25.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.397 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 52.88 73.39 0.95 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.3 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.09 -35.94 83.39 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.967 2.445 . . . . 0.0 112.274 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -121.99 79.11 41.91 Favored Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.937 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.48 9.86 3.94 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.75 2.3 . . . . 0.0 111.726 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.2 m 58.69 84.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.419 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -172.86 77.24 0.42 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.473 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.34 145.75 97.99 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.652 2.235 . . . . 0.0 111.703 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -134.07 80.11 1.85 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.23 -41.3 99.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.24 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 55.54 68.05 0.92 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.955 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -62.35 -43.41 98.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.39 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 38' ' ' SER . 96.7 mt -92.22 -86.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.469 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 37' ' ' ILE . 6.5 p 46.62 104.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.21 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 63.4 p -130.37 155.14 46.87 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.425 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.31 129.2 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.462 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.1 t -63.22 -44.4 95.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.805 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -102.61 132.52 48.65 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.822 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -112.32 10.16 19.94 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.49 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -74.87 145.26 42.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.76 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -71.46 142.17 50.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.378 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -154.39 24.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.671 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 47' ' ' ILE . 21.1 tt -91.9 121.28 42.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.994 0.426 . . . . 0.0 110.114 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.4 ttp-105 -170.77 -45.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.013 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 49' ' ' THR . 6.9 t -79.8 125.14 29.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.307 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -65.63 -41.93 92.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.699 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.523 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 37.1 t -135.27 154.16 51.65 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.841 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.496 ' C ' ' CG ' ' A' ' 53' ' ' HIS . 34.8 m -83.61 -0.29 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.182 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER 64.12 173.98 0.07 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.057 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.66 160.85 3.5 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 122.791 2.327 . . . . 0.0 112.365 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.6 mtm-85 -72.62 156.67 38.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.248 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.76 134.14 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.842 0.353 . . . . 0.0 111.034 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -133.37 143.39 48.91 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.514 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.71 160.33 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.052 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.56 177.04 40.33 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.415 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -121.13 155.65 34.03 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 47.4 t0 -137.72 124.08 20.65 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -177.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 63' ' ' GLY . 16.5 m-85 -116.67 104.83 11.77 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -24.85 97.2 0.01 OUTLIER Glycine 0 CA--C 1.533 1.203 0 CA-C-N 117.718 0.235 . . . . 0.0 113.097 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.18 -13.74 7.93 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 66' ' ' ARG . 15.6 t90 -165.88 136.56 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.012 0.406 . . . . 0.0 110.823 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.608 ' NH2' ' CZ ' ' A' ' 10' ' ' TYR . 14.8 ptp180 -148.17 148.44 30.55 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.843 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.6 pt -108.93 147.71 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.779 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.0 141.35 36.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 110.857 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.88 129.13 25.55 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.498 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 24.8 p30 -106.2 143.76 33.87 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.476 0.655 . . . . 0.0 111.906 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.09 146.2 50.02 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.992 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.83 -108.61 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.074 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -138.6 143.02 39.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.712 0.292 . . . . 0.0 110.258 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -73.85 -66.58 0.69 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 56.62 82.96 0.1 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.953 0.406 . . . . 0.0 109.938 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -125.68 146.62 49.66 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.89 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.498 ' CG ' ' O ' ' A' ' 77' ' ' TRP . 26.2 t90 -163.63 14.83 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.807 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -63.33 -41.65 98.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.011 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 39.66 -118.57 0.28 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.964 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.69 38.1 29.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.888 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -59.26 -83.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.178 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 82' ' ' TYR . 71.2 t80 -100.53 3.83 43.1 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.961 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 84' ' ' VAL . 38.8 t -62.0 -41.63 98.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.801 0.334 . . . . 0.0 110.444 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 85' ' ' ASN . 86.8 t 56.28 159.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.584 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.516 ' N ' HG12 ' A' ' 84' ' ' VAL . 59.4 t30 -86.38 109.34 18.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.624 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.8 pt -74.53 -20.11 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.779 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -79.17 6.17 10.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.158 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.489 ' N ' ' OD1' ' A' ' 88' ' ' ASN . 10.2 p-10 -44.71 -68.52 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 90' ' ' ARG . 22.9 t 38.33 81.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.934 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 89' ' ' VAL . 84.6 mtt85 55.27 111.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.97 0.414 . . . . 0.0 110.399 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.0 mm -78.01 130.81 35.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.664 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -91.95 141.78 28.26 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.105 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -160.74 125.97 3.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.507 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.44 ' O ' ' O ' ' A' ' 95' ' ' ASN . 8.0 pt-20 -175.21 101.19 0.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.051 0.453 . . . . 0.0 111.15 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 94' ' ' GLU . 99.6 m-20 41.92 -167.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.067 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.21 -81.82 1.29 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.0 mm -66.14 -26.37 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.342 . . . . 0.0 110.568 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 45.76 36.18 2.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.49 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 100' ' ' ASP . 21.7 mt 48.1 -121.65 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.979 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.436 ' N ' HG22 ' A' ' 99' ' ' ILE . 45.5 t0 52.86 168.47 0.01 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.951 0.405 . . . . 0.0 110.981 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.41 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 57.1 ttp180 -72.87 133.96 44.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.381 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -67.82 135.5 52.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.084 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.43 -36.4 8.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.21 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -72.89 -163.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.48 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 107' ' ' GLU . 54.7 t-20 59.46 42.65 17.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.557 ' H ' ' CD ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -65.95 3.69 0.78 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.431 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' A' ' 105' ' ' ASN . 80.0 mm-40 57.13 -92.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.954 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 110' ' ' THR . 18.4 t-20 -90.77 100.23 13.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.876 0.37 . . . . 0.0 110.789 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.65 -34.51 89.15 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 111' ' ' PHE . 69.0 p -75.3 168.9 19.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.805 0.336 . . . . 0.0 110.681 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.455 ' O ' ' O ' ' A' ' 110' ' ' THR . 83.8 m-85 43.12 -171.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.888 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -97.72 -6.12 33.62 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.401 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 62.61 -151.06 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.385 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 t -90.13 87.8 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.322 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.0 p -174.53 78.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.693 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -153.82 137.27 15.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.959 0.409 . . . . 0.0 111.104 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.1 mt -125.09 126.06 44.74 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.878 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 70' ' ' ASP . . . -133.01 115.45 1.57 Allowed Glycine 0 N--CA 1.469 0.847 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.787 ' H ' HD23 ' A' ' 119' ' ' LEU . 1.7 pt? -141.11 153.62 45.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.327 0.563 . . . . 0.0 111.498 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.3 m -146.42 153.58 40.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.065 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.43 125.03 46.66 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 97.3 mt -123.6 152.32 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -111.25 131.94 54.74 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.158 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 15.6 p-10 -132.9 125.25 29.48 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 123.801 0.688 . . . . 0.0 110.813 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.497 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 81.2 m-85 -115.69 80.63 1.47 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -105.07 7.32 33.87 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 110.003 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER -67.84 -28.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -62.08 -49.97 73.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.4 t0 179.16 -102.75 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.287 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -117.77 0.9 12.09 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 10.8 m-85 -113.25 111.28 21.78 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.497 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -133.31 142.7 45.24 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 117.93 0.332 . . . . 0.0 111.066 178.405 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -91.28 120.13 0.62 Allowed 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 122.36 2.04 . . . . 0.0 109.281 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.594 ' CE1' ' OD2' ' A' ' 209' ' ' ASP . 40.1 p90 -92.02 128.26 37.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.528 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 47.8 mm -134.78 131.99 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.777 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.76 174.84 38.31 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.611 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.37 131.06 55.38 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.95 125.42 50.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.186 0.517 . . . . 0.0 111.089 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.98 139.18 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.122 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.01 137.39 52.16 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.526 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -135.94 137.76 41.66 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.203 0.525 . . . . 0.0 111.19 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 144' ' ' VAL . . . -123.59 143.38 14.96 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -66.03 67.06 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.383 0.592 . . . . 0.0 110.783 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 142' ' ' GLY . 72.3 t -135.53 135.26 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.562 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 40.33 79.15 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.022 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -90.13 -6.99 54.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.433 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 87.6 p -71.34 150.37 45.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.009 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 40.5 pt -126.46 -13.86 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.497 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.33 143.51 48.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.971 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.1 m -84.49 61.2 6.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.377 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.5 m -61.95 -47.56 84.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.597 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -173.44 -2.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.722 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -68.71 -12.45 61.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.504 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 63.3 p -80.45 163.73 23.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.851 0.358 . . . . 0.0 110.576 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 92.3 mt 42.52 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.448 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.03 140.05 32.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.947 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.1 m -121.72 131.27 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.917 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 73.3 p -131.34 153.31 49.74 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.786 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.3 t -147.38 151.52 36.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.39 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.58 118.31 65.32 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.809 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.7 133.84 39.52 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 120.948 1.099 . . . . 0.0 111.599 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 26.3 m -98.15 155.0 17.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.902 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 56.52 43.13 26.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.217 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.407 ' N ' ' CD ' ' A' ' 165' ' ' PRO . . . -170.66 54.61 0.22 Allowed Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.209 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 164' ' ' ALA . 73.3 Cg_endo -72.63 145.21 41.28 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.634 2.223 . . . . 0.0 111.636 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.8 p30 -155.64 -1.82 0.14 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.781 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -82.14 -3.69 90.48 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 61.27 -168.65 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.739 0.304 . . . . 0.0 110.404 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.5 m -77.14 138.56 20.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.587 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.5 t -142.98 159.24 42.62 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.509 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.0 t -72.29 143.72 48.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.985 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -130.03 158.3 39.98 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.584 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 64.8 t30 61.65 24.11 14.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.722 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 20.2 m -64.56 -45.57 86.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.532 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.95 152.31 48.27 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.666 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.64 -156.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.426 2.084 . . . . 0.0 111.475 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.0 -41.1 95.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.704 0.288 . . . . 0.0 110.721 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 10.8 t -96.96 138.3 34.71 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.769 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.466 ' N ' ' CD ' ' A' ' 179' ' ' GLN . 1.5 pm0 -130.82 153.5 49.01 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -90.61 -168.89 2.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.065 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -78.27 -2.91 40.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.916 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.9 t80 70.04 -56.47 0.58 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.664 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -73.9 128.17 34.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.709 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 68.5 m -146.11 149.03 33.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.537 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.33 34.21 22.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.631 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 48.4 t -160.68 92.68 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.804 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.551 ' C ' ' H ' ' A' ' 189' ' ' ARG . 96.3 mt -135.24 -82.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.064 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 57.9 ttm-85 64.05 -19.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.584 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.551 ' H ' ' C ' ' A' ' 187' ' ' ILE . 10.3 mpt_? -54.46 -92.81 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.0 t -135.8 118.6 22.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.543 ' C ' HD22 ' A' ' 192' ' ' LEU . . . -146.92 159.32 27.98 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.329 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.842 HD22 ' N ' ' A' ' 192' ' ' LEU . 0.4 OUTLIER -117.46 146.89 43.19 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.641 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -168.19 -177.57 39.45 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.716 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.62 156.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.606 0.717 . . . . 0.0 111.636 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.2 tt -127.06 135.55 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.041 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.3 161.01 37.64 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . 157.81 -167.06 34.14 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.51 162.32 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 122.73 -0.277 . . . . 0.0 110.978 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.12 165.04 34.64 Favored Glycine 0 CA--C 1.545 1.916 0 C-N-CA 119.842 -1.17 . . . . 0.0 114.616 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -130.82 128.71 41.22 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.683 1.193 . . . . 0.0 109.004 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 4.6 p30 -89.88 151.18 21.87 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.488 HG22 ' OG1' ' A' ' 203' ' ' THR . 0.8 OUTLIER -67.98 -37.93 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 103.005 -2.961 . . . . 0.0 103.005 174.061 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.675 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.0 OUTLIER -176.31 148.97 0.91 Allowed Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 100.612 -3.847 . . . . 0.0 100.612 176.639 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.445 ' C ' ' O ' ' A' ' 237' ' ' ARG . 32.0 Cg_exo -35.86 -17.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.295 -2.25 0 C-N-CA 121.313 1.342 . . . . 0.0 113.419 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.675 ' N ' ' O ' ' A' ' 203' ' ' THR . 87.1 tttt -68.87 -44.52 73.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 119.309 -0.377 . . . . 0.0 111.868 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.98 114.65 14.86 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.941 0.401 . . . . 0.0 111.056 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 201' ' ' ASP . 4.8 t -127.87 133.79 49.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.818 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.0 123.03 32.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.594 ' OD2' ' CE1' ' A' ' 134' ' ' TYR . 13.4 t70 -109.52 110.94 22.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.878 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -102.75 134.72 45.67 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.14 36.98 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 119.97 -1.109 . . . . 0.0 112.199 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -133.61 134.39 43.18 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -89.45 108.56 19.71 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.998 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -102.65 127.87 49.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -125.25 161.54 26.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.024 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.5 m120 57.22 88.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.223 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -38.27 -75.41 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.933 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -98.81 146.6 18.2 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 221' ' ' GLU . 35.0 ptt180 -140.67 -39.09 0.43 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.666 0.27 . . . . 0.0 110.581 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 220' ' ' LEU . 8.0 mp 45.77 12.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.916 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 219' ' ' ARG . 83.7 tt0 -68.38 -34.7 76.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.404 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 65.6 t30 60.02 39.07 20.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.809 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 5.7 m -164.32 53.74 0.14 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.434 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -143.83 -19.23 0.59 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.685 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 43.98 -159.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.523 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.85 150.7 40.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.783 0.325 . . . . 0.0 110.704 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 85.5 m -119.47 129.06 54.55 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.197 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.447 ' CG ' ' N ' ' A' ' 229' ' ' GLU . 23.7 t-160 -61.92 -105.39 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.1 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.447 ' N ' ' CG ' ' A' ' 228' ' ' HIS . 80.1 mm-40 55.81 168.85 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.882 0.372 . . . . 0.0 110.892 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.491 ' O ' ' CB ' ' A' ' 231' ' ' SER . . . 47.49 -111.51 0.39 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.19 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 232' ' ' LEU . 4.1 p 84.86 -65.16 0.06 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.781 -0.19 . . . . 0.0 110.973 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.521 ' N ' ' OG ' ' A' ' 231' ' ' SER . 6.8 tt -130.48 119.17 22.22 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -115.06 172.51 14.24 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 62.1 t -139.68 131.56 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.588 0.233 . . . . 0.0 110.918 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.459 HH11 ' NH1' ' A' ' 66' ' ' ARG . 36.6 ttm180 -132.7 142.07 48.88 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 236' ' ' TYR . 1.1 t80 -118.72 137.68 53.17 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.688 ' NH2' ' N ' ' A' ' 7' ' ' ARG . 14.3 ttt-85 -150.38 112.5 4.6 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.626 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.398 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 p -76.92 162.6 27.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.659 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.66 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.1 pm0 -66.48 -40.36 89.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.225 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -71.71 140.66 49.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.356 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.63 -178.76 26.93 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.1 -127.82 21.3 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.434 ' HD2' ' H ' ' A' ' 7' ' ' ARG . 3.7 mpt_? -86.25 127.55 34.77 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.08 -175.24 13.69 Favored Glycine 0 N--CA 1.47 0.957 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.166 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.405 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 48.9 Cg_endo -92.74 165.08 2.73 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.558 2.838 . . . . 0.0 114.951 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.596 ' OH ' ' HB2' ' A' ' 68' ' ' ALA . 22.5 p90 -163.85 164.39 23.5 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.575 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 p -135.39 155.22 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-O 120.524 0.202 . . . . 0.0 111.088 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -134.81 147.76 50.02 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.2 152.6 34.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.742 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 31.7 p-10 -153.24 159.06 42.53 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -133.3 152.39 51.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.042 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.35 175.75 6.73 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.68 0.276 . . . . 0.0 110.73 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -70.21 139.84 52.35 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.955 0.407 . . . . 0.0 110.952 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 47.92 -168.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.281 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 20' ' ' GLU . 66.9 t80 -83.08 123.63 29.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.808 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 19' ' ' TYR . 82.0 tt0 55.35 154.37 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.067 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -66.69 -39.8 88.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.292 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.413 ' H ' ' HG2' ' A' ' 20' ' ' GLU . 41.4 pt -99.04 159.12 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.178 0.514 . . . . 0.0 111.311 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.0 p -65.51 -32.54 74.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.835 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' A' ' 24' ' ' HIS . 25.3 t-80 50.61 41.02 25.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 27.7 t70 -92.19 9.22 34.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.945 0.402 . . . . 0.0 110.184 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 25' ' ' ASP . 2.0 m-85 -149.06 55.5 2.03 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.037 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -33.69 -49.85 0.51 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.848 2.365 . . . . 0.0 112.755 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.418 ' OE1' ' ND2' ' A' ' 105' ' ' ASN . 4.0 pt-20 -179.74 150.44 0.56 Allowed Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.729 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -72.38 -53.06 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.323 2.016 . . . . 0.0 111.718 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 3.0 t -149.75 149.96 31.34 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.58 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 30' ' ' THR . . . 171.23 74.06 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.317 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.9 144.45 99.57 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.674 2.25 . . . . 0.0 111.729 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 33' ' ' ASN . 44.5 p-10 -100.75 107.07 18.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.957 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -82.11 148.24 28.64 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -68.18 121.09 15.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.89 0.376 . . . . 0.0 110.588 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -114.47 131.07 56.74 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.438 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 38' ' ' SER . 10.4 tp -86.42 -39.82 13.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.795 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.476 ' N ' HG23 ' A' ' 37' ' ' ILE . 32.2 p -155.55 163.94 39.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.646 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.7 p -71.36 124.23 24.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 41' ' ' SER . 14.0 p -90.27 -40.05 12.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.302 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.478 ' N ' HG13 ' A' ' 40' ' ' VAL . 41.9 p -161.49 86.35 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.513 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.405 ' OD1' ' NZ ' ' A' ' 102' ' ' LYS . 99.5 m-20 -71.17 142.53 50.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.717 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -85.55 165.56 16.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.19 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -56.37 -19.13 13.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.699 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 63.6 ttm-85 -59.72 -42.22 92.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.485 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -45.49 147.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.081 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.8 mt 61.39 69.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.824 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -147.22 -43.58 0.17 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.919 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 t -147.31 159.0 44.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.417 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -141.31 160.58 39.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.312 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' VAL . 45.7 t -67.81 139.8 56.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.528 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 53' ' ' HIS . 46.6 t 56.42 157.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.548 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.636 ' CD2' ' HE ' ' A' ' 73' ' ' ARG . 80.8 t60 56.67 83.44 0.22 Allowed Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.686 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -86.18 -100.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.844 2.363 . . . . 0.0 112.71 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -125.66 157.76 36.46 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.6 155.28 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.574 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -135.45 128.7 31.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.288 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 m -140.91 165.34 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.19 -152.25 12.58 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.552 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -113.98 139.12 49.5 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-O 120.762 0.315 . . . . 0.0 111.543 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.1 p30 -103.26 101.01 10.93 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 124.835 1.335 . . . . 0.0 112.874 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.545 ' CZ ' ' O ' ' A' ' 65' ' ' TRP . 23.9 p90 -125.37 125.26 43.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -39.51 131.61 2.22 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.98 -84.59 0.37 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.545 ' O ' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -117.32 153.73 32.47 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.361 0.6 . . . . 0.0 110.33 179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.622 ' NH1' ' NH2' ' A' ' 235' ' ' ARG . 0.6 OUTLIER -129.82 130.94 45.94 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.77 128.57 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.596 ' HB2' ' OH ' ' A' ' 10' ' ' TYR . . . -139.0 124.66 19.56 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 120.922 0.391 . . . . 0.0 110.571 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.31 138.59 39.87 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.02 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -100.56 128.72 46.53 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.302 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -129.13 156.94 43.1 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.757 0.789 . . . . 0.0 111.95 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.25 151.0 44.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 113.617 -1.628 . . . . 0.0 108.462 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.636 ' HE ' ' CD2' ' A' ' 53' ' ' HIS . 95.6 mtt-85 -62.96 -66.13 0.59 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.588 -0.445 . . . . 0.0 112.177 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.3 t80 69.64 -24.39 0.15 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.557 0.218 . . . . 0.0 111.026 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.542 ' H ' ' C ' ' A' ' 73' ' ' ARG . 85.8 mtm-85 59.53 60.97 2.11 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.859 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -94.79 -13.06 25.97 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.659 0.266 . . . . 0.0 111.017 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -61.71 -41.0 97.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 0.0 110.644 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 28.1 p-10 -54.1 129.74 35.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.423 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 78' ' ' ASN . 96.5 m-20 -145.65 -35.21 0.3 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.078 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 57.09 39.56 29.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.909 0.385 . . . . 0.0 110.567 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.97 -38.09 87.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.959 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -59.46 -47.49 85.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.13 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.1 p -68.45 144.46 54.66 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.638 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.3 t -126.67 130.49 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.228 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.554 ' O ' ' ND2' ' A' ' 85' ' ' ASN . 0.4 OUTLIER -153.97 94.31 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.399 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.8 mt -113.8 127.08 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.102 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 46.78 73.3 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.357 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -78.21 93.39 4.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.038 0.447 . . . . 0.0 110.693 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 91' ' ' ILE . 14.6 p -65.69 -22.88 31.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.59 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -53.67 -7.53 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.191 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.502 ' H ' ' C ' ' A' ' 89' ' ' VAL . 10.3 tp -62.11 134.55 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.531 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -130.83 153.25 49.29 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.63 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -67.42 134.91 52.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.089 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -163.26 131.83 3.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.651 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 39.09 -105.48 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.028 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.63 86.47 0.12 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.6 tt -132.55 134.94 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 110.131 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' NH1' ' OD1' ' A' ' 100' ' ' ASP . 9.2 ptm180 -69.78 134.81 48.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.094 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.6 pt -104.25 27.67 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.982 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.413 ' OD1' ' NH1' ' A' ' 98' ' ' ARG . 90.8 m-20 58.2 -91.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.922 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -134.24 132.9 40.23 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.913 0.387 . . . . 0.0 110.743 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.405 ' NZ ' ' OD1' ' A' ' 42' ' ' ASP . 38.3 ttmt -79.01 141.88 37.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.188 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.1 t -136.85 143.96 43.35 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.232 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -110.25 37.77 2.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.394 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.418 ' ND2' ' OE1' ' A' ' 28' ' ' GLU . 94.0 m-20 -62.48 -39.54 93.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.897 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -40.65 -66.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.796 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -69.53 -20.94 63.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.492 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.6 t30 60.23 50.55 6.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -48.66 175.24 0.03 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.4 m -69.1 119.67 13.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 0.0 110.66 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.21 -43.6 97.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.409 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.539 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 70.9 t60 -57.11 -39.09 74.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.115 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 112' ' ' HIS . . . 73.88 101.11 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.662 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.5 t -125.88 133.08 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.964 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 116' ' ' SER . 32.6 t -154.3 -151.81 0.38 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.891 0.377 . . . . 0.0 110.549 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.449 ' N ' ' OG ' ' A' ' 115' ' ' SER . 3.2 m 61.74 139.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.647 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -107.76 163.27 13.25 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.379 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.7 -157.96 20.94 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.233 -1.461 . . . . 0.0 112.373 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.1 mt -127.42 144.69 51.02 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.269 0.557 . . . . 0.0 110.571 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 84.0 p -147.47 140.44 25.02 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.63 127.75 53.6 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 87.9 mt -101.51 135.09 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.537 ' O ' ' CG ' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -128.77 102.88 6.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.255 0.934 . . . . 0.0 112.127 -176.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.547 ' CG ' HH21 ' A' ' 66' ' ' ARG . 3.4 m-20 -89.94 135.74 33.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.841 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 132' ' ' LYS . 41.9 t80 -113.22 81.36 1.49 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -70.32 85.8 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.038 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 128' ' ' ASN . 17.5 tt -70.21 -41.29 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.129 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.431 ' N ' HG23 ' A' ' 127' ' ' ILE . 40.3 t30 177.67 -47.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.384 0.428 . . . . 0.0 110.199 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -59.91 -169.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.088 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -100.48 -1.72 35.03 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.495 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 7.1 p90 -138.34 128.97 26.46 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.435 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -133.41 156.8 79.36 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 121.021 0.439 . . . . 0.0 111.059 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.7 146.3 21.05 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.922 1.748 . . . . 0.0 109.675 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 134' ' ' TYR . 6.8 p90 -138.25 138.13 38.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.207 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 136' ' ' GLY . 32.2 mt -136.56 164.43 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.86 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.488 ' N ' ' CG2' ' A' ' 135' ' ' ILE . . . -164.93 -176.67 36.83 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.669 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -133.2 155.46 49.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.24 -0.98 . . . . 0.0 108.753 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -135.56 128.1 30.65 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.33 121.75 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -124.75 124.3 41.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 110.506 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -136.44 165.5 25.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.564 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.81 91.57 2.23 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -149.65 -97.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.76 -0.259 . . . . 0.0 111.002 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.9 t -64.51 -45.68 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -82.27 153.3 25.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.938 0.399 . . . . 0.0 111.345 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.488 ' O ' ' ND1' ' A' ' 146' ' ' HIS . 11.0 p80 -147.12 144.41 29.0 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.34 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 91.0 p 44.18 -122.32 0.84 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.737 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 89.3 mt -99.98 128.56 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.343 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 151' ' ' THR . 92.2 m-20 -61.65 -42.73 99.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.13 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.9 p 43.74 17.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.881 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 149' ' ' ASP . 63.4 m -114.48 116.28 28.6 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.257 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -65.55 -45.75 82.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.724 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -178.24 26.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.053 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 156' ' ' GLU . 1.8 m -76.95 157.1 31.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.092 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.2 mt 57.75 -78.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.35 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 154' ' ' THR . 76.1 mt-10 -43.96 157.77 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.8 0.333 . . . . 0.0 111.026 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.9 t 65.68 61.06 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.671 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 90.7 m -125.26 128.39 48.2 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.991 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 54.4 p -73.86 134.61 43.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.681 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.7 m -109.8 158.46 34.8 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 162' ' ' SER . 31.8 Cg_exo -55.28 143.32 76.37 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.219 1.279 . . . . 0.0 111.852 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 161' ' ' PRO . 42.1 m 53.47 112.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.969 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.474 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 34.5 p-10 -80.38 20.33 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.723 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 163' ' ' ASN . . . 69.41 59.86 0.58 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.04 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -71.1 150.85 60.73 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.564 2.176 . . . . 0.0 111.664 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 166' ' ' ASN . 2.8 t30 56.92 36.45 27.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.081 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 55.43 -129.35 46.27 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.63 151.04 48.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.743 0.306 . . . . 0.0 110.349 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 73.1 t -60.89 -46.17 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.496 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 76.2 p -112.52 115.43 28.64 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.37 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 173' ' ' ASN . 10.6 p -111.97 -49.84 2.95 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.694 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 84.5 t80 44.37 -88.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.441 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.553 ' N ' ' O ' ' A' ' 171' ' ' THR . 52.2 p30 -97.32 149.3 22.24 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 99.3 m -65.44 -27.56 68.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.728 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -113.39 91.86 21.23 Favored Pre-proline 0 N--CA 1.469 0.498 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -88.57 166.12 6.31 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.868 2.378 . . . . 0.0 111.915 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 178' ' ' THR . 88.8 tttt -66.93 133.31 49.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.48 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.43 ' O ' ' O ' ' A' ' 177' ' ' LYS . 15.9 p 50.93 172.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.975 0.417 . . . . 0.0 111.017 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -156.68 96.75 1.66 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.337 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -156.7 -34.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.6 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.528 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 96.6 m-20 42.72 -122.38 0.66 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.641 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 181' ' ' ASP . 96.5 m-85 -159.07 -113.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.803 0.335 . . . . 0.0 110.538 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -66.49 -25.69 66.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.209 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 77.9 p -58.81 -38.6 78.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.641 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -132.41 113.29 12.98 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.447 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.8 t -169.43 73.53 0.08 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.621 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.582 ' C ' HD12 ' A' ' 187' ' ' ILE . 2.3 pp -95.42 -0.38 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.571 ' N ' HD12 ' A' ' 187' ' ' ILE . 59.2 ttp180 -70.5 -82.13 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.823 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 50.9 -87.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 188' ' ' ARG . 73.7 t -76.6 163.74 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 175.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.441 ' N ' HG12 ' A' ' 190' ' ' VAL . . . -141.16 140.43 10.34 Favored Glycine 0 N--CA 1.476 1.305 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.698 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 216' ' ' ASN . 47.1 tp -133.61 125.1 28.04 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -156.12 -169.78 20.68 Favored Glycine 0 C--N 1.32 -0.345 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.8 158.98 42.71 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 CA-C-O 122.306 1.051 . . . . 0.0 112.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.8 mm -109.57 130.48 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 112.639 -2.073 . . . . 0.0 107.312 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.3 156.86 42.32 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.514 -0.741 . . . . 0.0 111.834 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.408 ' C ' ' CE2' ' A' ' 134' ' ' TYR . . . 150.05 -176.98 28.46 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.42 159.68 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -136.84 140.74 11.7 Favored Glycine 0 N--CA 1.47 0.93 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.781 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -122.04 105.44 10.29 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -96.0 137.16 35.46 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 202' ' ' ILE . 1.2 mp -69.54 -39.16 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 173.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -155.25 156.08 30.66 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 101.284 -3.598 . . . . 0.0 101.284 175.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.509 ' C ' ' O ' ' A' ' 237' ' ' ARG . 32.3 Cg_exo -48.78 -17.51 1.17 Allowed 'Trans proline' 0 C--N 1.288 -2.622 0 CA-C-N 121.706 1.645 . . . . 0.0 111.267 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 203' ' ' THR . 60.4 tttp -67.82 -39.77 83.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.286 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 9.0 mt -124.05 107.79 11.67 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.123 0.874 . . . . 0.0 111.925 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.596 HG23 ' HG2' ' A' ' 235' ' ' ARG . 0.3 OUTLIER -136.81 141.03 42.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.63 0.728 . . . . 0.0 112.948 177.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.44 ' O ' ' OD1' ' A' ' 209' ' ' ASP . 84.0 mt -99.1 148.3 24.19 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 208' ' ' LEU . 28.3 m-20 -139.3 137.0 35.46 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -83.65 133.43 34.82 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.86 151.62 19.66 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 120.236 -0.983 . . . . 0.0 114.59 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -135.22 142.18 45.96 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.195 -1.002 . . . . 0.0 109.03 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 86.0 mmt-85 -110.75 125.04 53.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -127.83 161.39 29.14 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.604 0.716 . . . . 0.0 112.862 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.661 ' CG ' ' H ' ' A' ' 216' ' ' ASN . 69.1 t60 -126.97 -175.46 3.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.486 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.661 ' H ' ' CG ' ' A' ' 215' ' ' HIS . 45.4 t-20 -63.17 111.6 2.29 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.554 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -102.85 91.51 4.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.939 0.399 . . . . 0.0 110.328 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -88.43 -166.6 42.46 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -87.18 1.86 51.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.051 0.453 . . . . 0.0 110.177 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.78 -41.41 99.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.317 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 57.26 71.92 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.073 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -87.86 115.91 25.65 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 223' ' ' THR . 13.3 t -70.81 130.61 42.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.032 0.444 . . . . 0.0 111.127 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -146.47 168.51 21.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.087 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -61.68 135.68 57.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 0.0 110.701 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 35.21 -121.25 0.12 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.428 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.445 ' O ' HG22 ' A' ' 227' ' ' THR . 12.3 m -165.69 7.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.901 0.381 . . . . 0.0 110.296 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 70.4 m80 52.88 78.38 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.032 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.563 ' O ' ' HB3' ' A' ' 230' ' ' ALA . 15.7 pt-20 -127.49 -175.03 3.33 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.78 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 229' ' ' GLU . . . 76.5 84.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.826 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 57.7 m -131.75 152.61 50.81 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.314 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 25.4 mt -128.6 131.94 48.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.11 0.481 . . . . 0.0 111.12 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -131.77 148.2 18.94 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.306 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.6 p -131.39 137.83 54.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.622 ' NH2' ' NH1' ' A' ' 66' ' ' ARG . 10.8 ptm180 -136.55 146.74 46.51 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -101.99 113.07 25.99 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 113.254 -1.793 . . . . 0.0 108.967 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.611 HH11 ' NH2' ' A' ' 66' ' ' ARG . 75.0 ttt180 -139.23 115.55 10.46 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 122.354 1.073 . . . . 0.0 112.113 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.522 ' OXT' ' CD1' ' A' ' 238' ' ' PHE . 1.2 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.21 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 4' ' ' ASP . 39.5 t -146.74 109.88 4.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.508 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -66.58 -35.01 79.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.937 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 2' ' ' SER . 53.9 p30 -144.33 174.35 10.98 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.016 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -44.43 -90.8 0.01 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.46 9.46 85.97 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -138.69 125.25 20.67 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 110.58 -0.155 . . . . 0.0 110.58 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.448 ' C ' ' CE2' ' A' ' 10' ' ' TYR . . . -179.69 151.55 10.16 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.139 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 77.5 Cg_endo -80.82 127.19 6.15 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.877 2.384 . . . . 0.0 111.695 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 52.4 m-85 -141.24 -178.23 5.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.888 -0.142 . . . . 0.0 111.287 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 12' ' ' GLN . 6.2 t -138.62 162.6 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.476 ' N ' HG12 ' A' ' 11' ' ' VAL . 8.9 tm0? -130.51 131.62 45.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.972 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.88 140.14 22.23 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.967 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -161.05 168.83 23.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 230' ' ' ALA . 0.4 OUTLIER -172.12 179.88 2.52 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.499 179.63 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 230' ' ' ALA . . . -131.68 158.08 42.05 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.172 0.511 . . . . 0.0 111.946 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -106.65 134.43 49.81 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.353 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -159.41 156.2 28.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.858 0.361 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -148.63 162.79 39.0 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.205 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -158.32 49.4 0.38 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.908 0.385 . . . . 0.0 110.694 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.407 ' O ' ' C ' ' A' ' 22' ' ' ILE . 3.7 m80 -68.19 -43.28 78.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.872 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 23' ' ' THR . 20.4 pt 32.29 -123.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.796 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 22' ' ' ILE . 9.6 p 52.13 113.76 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.089 0.471 . . . . 0.0 111.026 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.573 ' ND1' ' CD2' ' A' ' 26' ' ' TYR . 56.6 t-80 -65.36 -44.37 87.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.711 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.58 50.71 12.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.218 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.573 ' CD2' ' ND1' ' A' ' 24' ' ' HIS . 1.9 m-85 -35.49 99.41 0.17 Allowed Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.488 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.48 145.55 94.03 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.622 1.548 . . . . 0.0 111.688 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -146.46 69.92 12.67 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.932 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -83.02 85.29 1.6 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.788 2.325 . . . . 0.0 111.933 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.6 p -104.91 -3.61 23.17 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.618 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.39 152.7 81.5 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.321 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.83 159.58 52.14 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.424 2.083 . . . . 0.0 111.627 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -55.61 123.62 14.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.417 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 36' ' ' LYS . 35.8 tttm -119.65 -143.22 0.35 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.02 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.9 t30 68.85 -38.53 0.39 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 34' ' ' LYS . 68.6 mttm -64.0 -44.16 93.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.512 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -128.18 128.72 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.373 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 40' ' ' VAL . 58.5 p -149.63 -23.36 0.27 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.642 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 m 61.16 -71.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.39 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 38' ' ' SER . 88.1 t -96.61 128.74 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.239 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 42' ' ' ASP . 34.0 t -77.5 -89.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.398 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 41' ' ' SER . 99.1 m-20 56.56 127.89 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.178 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -146.74 160.43 42.25 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.436 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 51.0 p90 -92.13 131.4 37.41 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.979 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -94.72 134.38 37.37 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.424 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -119.92 127.14 52.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.624 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.889 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -136.06 148.27 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.46 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -154.49 149.22 26.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.813 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.7 m -128.65 130.71 47.62 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.593 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -109.86 149.5 29.78 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.315 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.552 ' CB ' HH12 ' A' ' 75' ' ' ARG . 36.9 m -80.44 -93.21 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.515 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.469 ' O ' ' CG ' ' A' ' 53' ' ' HIS . 24.7 t 53.26 112.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.056 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.469 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 72.4 m80 -156.22 77.83 4.33 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.943 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.11 149.33 90.86 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 123.059 2.506 . . . . 0.0 112.292 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.425 ' HD3' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -73.31 162.26 29.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.485 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.0 t -131.09 155.49 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.249 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.9 m -137.33 151.85 49.09 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.982 0.42 . . . . 0.0 111.622 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.02 145.68 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.336 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 67' ' ' ILE . . . -164.72 -179.96 39.07 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 119.61 -1.281 . . . . 0.0 114.184 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -106.68 132.85 52.19 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -97.65 121.18 39.25 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -125.37 113.64 17.82 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.42 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -43.35 103.94 0.05 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 123' ' ' TYR . . . 136.88 -36.07 2.02 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.426 ' N ' ' CD1' ' A' ' 65' ' ' TRP . 0.3 OUTLIER -170.18 156.3 5.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.979 0.418 . . . . 0.0 110.879 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.487 HH21 HG21 ' A' ' 122' ' ' ILE . 17.3 ttp85 -134.55 135.38 42.26 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.404 ' O ' ' HA3' ' A' ' 59' ' ' GLY . 49.3 mm -99.98 127.92 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.38 130.93 14.86 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 119.454 -0.898 . . . . 0.0 112.169 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.49 144.2 26.84 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.989 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -104.28 128.01 52.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.129 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -134.35 162.02 33.37 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.012 0.435 . . . . 0.0 111.242 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.32 160.39 40.36 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.434 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -105.35 151.09 24.62 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.863 0.363 . . . . 0.0 111.092 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.497 ' O ' ' CD1' ' A' ' 77' ' ' TRP . 94.9 m-85 -102.01 101.41 11.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.235 0.54 . . . . 0.0 109.975 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.552 HH12 ' CB ' ' A' ' 51' ' ' SER . 84.5 mtp180 -55.9 -24.5 37.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.464 -178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 77' ' ' TRP . 52.7 mtpt -61.08 -44.89 96.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.536 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.497 ' CD1' ' O ' ' A' ' 74' ' ' TYR . 83.4 m95 37.94 -113.72 0.12 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.643 0.259 . . . . 0.0 110.889 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 54.21 67.08 1.06 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.749 0.309 . . . . 0.0 110.587 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -61.47 -41.4 97.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.223 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -105.28 133.25 50.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.441 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -122.74 121.4 36.24 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.296 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -61.73 -46.67 88.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.2 m -138.66 150.34 46.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 110.821 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.2 t -65.62 -68.7 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.415 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -152.14 -73.3 0.15 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.501 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.61 128.24 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.555 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -171.71 -116.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.055 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 90' ' ' ARG . 23.2 t-20 -148.0 -110.79 0.08 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.685 0.279 . . . . 0.0 110.475 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.405 ' N ' ' CG ' ' A' ' 88' ' ' ASN . 60.5 t 57.45 -76.17 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 88' ' ' ASN . 89.1 mtm180 47.33 -173.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.757 0.313 . . . . 0.0 110.446 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.0 pt -118.75 119.46 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.232 0.539 . . . . 0.0 110.594 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -68.96 -41.85 77.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.874 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 94' ' ' GLU . 64.7 mttp -70.22 140.84 52.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.777 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 93' ' ' LYS . 97.6 mt-10 45.6 95.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.627 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 95' ' ' ASN . 48.4 p-10 -85.8 137.61 32.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.498 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -79.55 130.88 10.16 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.41 ' O ' ' O ' ' A' ' 98' ' ' ARG . 7.4 tp -142.03 139.63 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.909 0.385 . . . . 0.0 110.642 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.41 ' O ' ' O ' ' A' ' 97' ' ' ILE . 77.2 ttt180 41.73 95.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.952 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 99' ' ' ILE . 9.3 tp -131.24 130.83 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.257 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 101' ' ' ARG . 52.7 t0 -145.68 -22.62 0.47 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.521 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 100' ' ' ASP . 23.9 mmm180 53.08 109.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.623 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -37.34 85.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.429 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 96.6 m -123.25 127.18 48.23 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.229 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 104' ' ' GLU . 58.2 mp0 -110.69 116.93 32.17 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.246 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -63.17 -40.92 98.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.326 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -81.37 138.09 35.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.728 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.54 37.1 3.87 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.364 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 56.96 78.32 0.23 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.664 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.39 116.17 0.89 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.521 ' C ' ' H ' ' A' ' 112' ' ' HIS . 49.1 m -127.81 136.89 52.08 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.728 0.299 . . . . 0.0 110.279 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 112' ' ' HIS . 71.5 t80 -57.14 -0.72 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.952 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.521 ' H ' ' C ' ' A' ' 110' ' ' THR . 86.5 t60 51.49 105.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.969 0.414 . . . . 0.0 110.718 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 53.37 -160.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.451 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 116' ' ' SER . 9.0 p -139.42 153.45 23.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.202 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 94.6 p -69.78 10.91 0.32 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.177 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 114' ' ' VAL . 1.0 OUTLIER 51.5 -151.6 0.24 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.839 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.51 173.07 14.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.33 -126.6 1.03 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.926 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 62.1 tp -135.52 149.47 49.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 120.993 0.425 . . . . 0.0 110.277 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.1 p -152.55 152.37 31.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.46 130.03 51.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.009 0.433 . . . . 0.0 110.767 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.612 ' N ' HD12 ' A' ' 122' ' ' ILE . 1.9 mp -97.72 148.17 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 177.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.541 ' CE1' ' O ' ' A' ' 64' ' ' GLY . 4.2 t80 -138.7 123.98 19.26 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 118.941 -1.104 . . . . 0.0 113.64 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.644 ' CB ' HH22 ' A' ' 237' ' ' ARG . 32.6 p-10 -110.36 120.29 41.97 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 113.489 -1.687 . . . . 0.0 106.588 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.473 ' CD2' ' OH ' ' A' ' 123' ' ' TYR . 5.1 t80 -70.26 129.32 39.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.248 0.546 . . . . 0.0 111.675 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.424 ' O ' ' O ' ' A' ' 125' ' ' PHE . 88.0 mt-30 39.98 -167.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.903 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.526 ' O ' ' C ' ' A' ' 128' ' ' ASN . 1.3 mp -105.0 20.83 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.656 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 127' ' ' ILE . 65.6 m-80 -11.46 -73.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.593 0.558 . . . . 0.0 111.828 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 128' ' ' ASN . 4.7 p30 153.89 -51.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.875 0.734 . . . . 0.0 111.441 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.81 -19.0 3.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -146.98 122.81 10.62 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.021 0.828 . . . . 0.0 113.146 -178.247 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.409 ' HB3' ' N ' ' A' ' 125' ' ' PHE . 1.3 mptt -134.24 133.0 21.37 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.045 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -51.12 133.62 41.71 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 CA-C-N 119.95 1.018 . . . . 0.0 110.325 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -96.76 130.0 44.08 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.463 ' N ' ' CD1' ' A' ' 134' ' ' TYR . 96.7 mt -136.62 136.51 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -129.27 139.28 10.84 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.984 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -118.38 128.79 54.97 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -129.99 131.44 45.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.247 0.546 . . . . 0.0 112.025 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.42 113.31 2.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.44 144.95 35.36 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.92 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -150.94 171.28 17.52 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.313 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.17 175.66 47.49 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -80.14 104.0 10.4 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.307 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 145' ' ' ARG . 93.8 t -128.31 127.81 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.733 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 144' ' ' VAL . 33.1 mmt180 40.21 -166.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.192 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -159.22 146.41 17.15 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.114 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 74.7 m -131.69 151.06 51.92 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.962 0.41 . . . . 0.0 110.854 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 148' ' ' ILE . 19.9 tt -135.17 131.42 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.071 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -91.38 106.66 18.66 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.039 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.1 m -80.77 147.73 30.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.247 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 t -148.35 155.14 40.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.875 0.369 . . . . 0.0 110.667 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -130.67 143.12 50.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.216 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 154' ' ' THR . 9.0 pttp -88.0 -93.15 0.1 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.24 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER 32.72 98.89 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.623 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.2 mt -104.58 127.8 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.196 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.64 115.72 15.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.38 -44.0 97.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 3.6 t -132.05 153.03 50.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.805 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 159' ' ' THR . 8.9 t -84.19 128.55 34.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.0 110.814 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.446 ' H ' HG22 ' A' ' 160' ' ' VAL . 3.2 m -65.76 157.3 80.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.665 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.85 -39.6 48.61 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.404 1.402 . . . . 0.0 111.949 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.2 m -72.4 149.59 44.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.689 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 56.86 44.94 22.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.426 ' N ' ' CD ' ' A' ' 165' ' ' PRO . . . -146.77 53.66 1.78 Allowed Pre-proline 0 N--CA 1.463 0.197 0 CA-C-O 120.691 0.282 . . . . 0.0 111.008 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 164' ' ' ALA . 84.0 Cg_endo -73.55 160.48 44.19 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.818 2.345 . . . . 0.0 111.82 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -62.23 -39.85 94.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.509 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.02 -155.55 21.53 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 62.82 120.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.683 0.277 . . . . 0.0 110.261 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 169' ' ' VAL . 12.1 p -122.66 130.09 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.51 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.8 m -132.13 -1.82 3.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.281 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 173' ' ' ASN . 77.5 m -112.12 125.77 54.47 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.672 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.02 8.47 32.39 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.384 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.446 ' H ' HG22 ' A' ' 171' ' ' THR . 98.7 m-20 -73.29 148.29 43.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.552 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 43.6 p 41.61 80.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.637 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.71 150.56 81.87 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.532 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.49 157.75 48.71 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.53 2.153 . . . . 0.0 111.988 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -74.51 -7.54 53.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.596 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.6 m 59.39 157.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.735 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -77.26 143.21 39.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.541 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -86.11 109.06 18.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -72.26 146.16 47.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.661 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -102.34 137.39 40.65 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.498 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 183' ' ' GLN . 2.3 pm0 -125.17 -120.68 0.26 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.373 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 183' ' ' GLN . 5.1 p 49.48 100.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.849 0.357 . . . . 0.0 110.517 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.483 ' OD1' ' N ' ' A' ' 186' ' ' SER . 57.6 p30 -158.65 -128.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.324 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.483 ' N ' ' OD1' ' A' ' 185' ' ' ASN . 1.9 m 63.92 87.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.893 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.0 tt -128.93 139.46 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.589 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.409 ' HD3' ' H ' ' A' ' 188' ' ' ARG . 0.0 OUTLIER -84.13 61.17 6.34 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.618 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -59.93 -38.88 83.66 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.09 154.66 31.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -123.55 147.83 16.69 Favored Glycine 0 N--CA 1.472 1.099 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.003 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 tt -144.49 127.51 16.51 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.783 -0.709 . . . . 0.0 109.236 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -150.3 170.34 30.26 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.09 140.73 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.837 0.827 . . . . 0.0 111.987 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.1 mt -118.64 134.56 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.476 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -148.42 153.27 38.3 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.503 0.668 . . . . 0.0 111.97 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 179.08 -140.59 4.47 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.611 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.43 140.82 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.83 0.315 . . . . 0.0 111.123 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -119.48 123.31 5.6 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.195 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -123.61 106.71 10.79 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 0.3 OUTLIER -74.54 152.58 39.31 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -176.165 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.54 HG23 ' N ' ' A' ' 203' ' ' THR . 8.1 tt -64.72 -36.91 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 113.068 -1.878 . . . . 0.0 108.208 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.827 ' O ' ' N ' ' A' ' 205' ' ' LYS . 29.7 m 178.62 100.26 0.15 Allowed Pre-proline 0 C--N 1.315 -0.93 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 238' ' ' PHE . 0.1 OUTLIER -14.55 58.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 124.02 3.146 . . . . 0.0 115.139 -173.575 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.827 ' N ' ' O ' ' A' ' 203' ' ' THR . 75.4 tttt -135.24 -44.81 0.7 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.063 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 26.5 tp -143.81 121.32 11.74 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.467 HG21 ' HE ' ' A' ' 235' ' ' ARG . 0.7 OUTLIER -95.67 145.26 25.41 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -176.221 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 209' ' ' ASP . 1.0 OUTLIER -107.63 117.65 34.67 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.561 ' N ' HD13 ' A' ' 208' ' ' LEU . 3.8 p30 -141.37 146.35 36.51 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -100.06 148.86 24.09 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.361 -1.745 . . . . 0.0 107.032 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -174.53 115.44 0.55 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 118.777 -1.678 . . . . 0.0 113.713 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -170.31 139.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -148.8 -86.09 0.09 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 215' ' ' HIS . 18.7 t80 -170.46 -178.46 2.7 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.394 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.545 ' O ' ' CE2' ' A' ' 214' ' ' TYR . 10.4 p-80 -149.34 165.91 30.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.233 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.63 95.94 1.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.13 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 49.0 t90 -154.61 121.46 5.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.57 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -85.38 -179.81 50.61 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 221' ' ' GLU . 42.3 ttm180 -100.58 118.0 35.86 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.881 0.372 . . . . 0.0 110.284 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.3 tp -90.42 -2.08 57.93 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.231 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 219' ' ' ARG . 97.5 mt-10 56.77 38.14 29.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.562 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.493 ' CG ' ' H ' ' A' ' 223' ' ' THR . 39.3 t-20 -150.78 -138.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.186 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 224' ' ' ARG . 1.3 t 32.5 -116.08 0.06 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.802 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.521 ' N ' ' OG1' ' A' ' 223' ' ' THR . 10.2 tpt180 -155.09 154.61 32.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.792 0.33 . . . . 0.0 110.343 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -80.6 -0.83 39.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.244 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.28 141.73 47.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.761 0.315 . . . . 0.0 110.664 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 228' ' ' HIS . 4.3 m -166.41 -126.06 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.645 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 227' ' ' THR . 96.7 m-70 59.45 134.14 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.845 0.355 . . . . 0.0 110.788 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -164.88 64.18 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.541 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 15' ' ' LEU . . . -175.92 -109.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.789 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.9 t 63.15 -82.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.098 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 232' ' ' LEU . 10.0 mp -86.38 130.34 34.54 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.127 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -146.36 143.71 11.88 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.575 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 234' ' ' VAL . 12.8 p -123.69 129.72 74.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.467 ' HE ' HG21 ' A' ' 207' ' ' THR . 52.9 mtm180 -133.54 144.33 49.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.32 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 3.1 m-85 -76.34 122.83 25.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.644 HH22 ' CB ' ' A' ' 124' ' ' ASP . 16.6 tpt180 -138.69 113.13 8.85 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 124.277 0.985 . . . . 0.0 111.86 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.446 ' OXT' ' CG ' ' A' ' 238' ' ' PHE . 78.5 t80 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.013 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 m -72.99 147.85 44.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.504 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -172.41 -130.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.913 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -146.86 107.57 4.12 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.76 0.314 . . . . 0.0 110.532 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.54 -3.25 90.67 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.29 7.49 76.46 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -102.23 126.85 49.33 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.443 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . -158.74 165.18 33.97 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.94 158.28 30.95 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.011 2.474 . . . . 0.0 112.776 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.43 ' CZ ' ' CG ' ' A' ' 66' ' ' ARG . 20.6 p90 -154.25 163.29 40.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.456 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.9 t -129.02 144.17 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 120.88 0.371 . . . . 0.0 111.813 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -123.1 131.54 53.73 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.112 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.68 142.74 24.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.072 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 51.4 p-10 -95.96 143.33 27.24 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.506 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.623 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 97.5 mt -143.67 162.34 36.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.186 0.517 . . . . 0.0 112.036 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . 86.7 142.99 0.05 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.343 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -127.01 131.31 51.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.779 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.94 144.68 55.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.448 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -72.61 -75.5 0.14 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.912 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 22' ' ' ILE . 19.0 pt-20 -66.58 -37.79 85.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.667 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 59.64 -73.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.512 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 20' ' ' GLU . 86.9 mt -108.03 126.97 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.151 0.5 . . . . 0.0 111.729 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.1 p -128.53 -38.09 1.75 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.168 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.516 ' CG ' ' N ' ' A' ' 25' ' ' ASP . 27.9 t-80 42.73 -111.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.929 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' N ' ' CG ' ' A' ' 24' ' ' HIS . 54.3 p-10 -83.75 173.77 11.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.733 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -38.35 106.19 0.36 Allowed Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.678 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -53.23 142.59 55.68 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.588 1.525 . . . . 0.0 112.589 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 57.71 63.9 4.38 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.507 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -92.46 -99.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.894 2.396 . . . . 0.0 111.694 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.7 p -142.15 35.16 1.53 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.026 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -154.16 57.74 1.92 Allowed Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.683 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.22 146.79 87.25 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.548 2.165 . . . . 0.0 111.877 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -135.6 119.05 16.85 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.699 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -166.49 -164.58 0.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.521 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 58.03 36.26 25.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.658 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -98.83 93.95 6.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.554 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 38' ' ' SER . 5.1 mp -133.29 132.03 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.543 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 37' ' ' ILE . 3.1 m 47.45 100.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.0 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.8 t -145.61 151.19 37.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.403 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.7 ' O ' HG22 ' A' ' 40' ' ' VAL . 7.1 p 35.61 27.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.22 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 39' ' ' THR . 9.4 t 52.44 91.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.641 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -121.24 155.53 34.41 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.913 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 55.12 96.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.061 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -66.01 -39.9 90.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.73 146.62 49.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.501 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -144.54 -44.68 0.24 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.044 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 47' ' ' ILE . 74.2 mt -88.5 13.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.5 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.443 ' C ' ' H ' ' A' ' 50' ' ' ARG . 90.0 mtm180 55.75 -101.04 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.679 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 48' ' ' ARG . 18.0 p 50.14 10.39 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.372 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.443 ' H ' ' C ' ' A' ' 48' ' ' ARG . 76.3 ttt180 -171.41 86.48 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 110.33 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.9 p -140.69 92.37 2.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.67 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.09 133.71 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.634 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.457 ' ND1' ' N ' ' A' ' 53' ' ' HIS . 10.0 p-80 -174.77 79.56 0.33 Allowed Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.819 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 55' ' ' ARG . 51.7 Cg_exo -53.48 -44.6 47.61 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.703 2.269 . . . . 0.0 112.928 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 54' ' ' PRO . 99.9 mtt180 42.28 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.538 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 57' ' ' SER . 9.4 p -155.25 161.5 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 119.386 -0.925 . . . . 0.0 112.709 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 56' ' ' VAL . 49.9 m -132.5 133.03 43.29 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.698 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.516 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 4.3 m -140.05 165.95 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 111.609 0.225 . . . . 0.0 111.609 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.52 -162.04 24.75 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 119.721 -1.228 . . . . 0.0 114.188 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -112.53 151.18 30.29 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.499 -0.851 . . . . 0.0 108.915 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 8' ' ' GLY . 3.6 p-10 -136.95 114.36 10.93 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.529 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 38.9 p90 -125.05 105.35 9.11 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.29 177.03 7.5 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 105.888 -2.885 . . . . 0.0 105.888 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.601 ' CA ' ' H ' ' A' ' 124' ' ' ASP . . . -47.05 -36.16 8.89 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 120.013 1.907 . . . . 0.0 111.305 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -48.48 97.42 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.69 ' HE ' ' CD1' ' A' ' 122' ' ' ILE . 26.5 ttp-105 -130.07 119.76 23.59 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.674 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.4 pt -126.88 137.79 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.956 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 58' ' ' VAL . . . -136.88 146.0 45.03 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.234 0.54 . . . . 0.0 111.661 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.1 140.53 29.91 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.218 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -102.25 127.4 49.23 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.299 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -112.4 136.77 51.48 Favored 'General case' 0 C--O 1.248 0.979 0 O-C-N 124.627 1.204 . . . . 0.0 110.394 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.37 -156.03 0.66 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.568 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.403 ' O ' ' CD1' ' A' ' 74' ' ' TYR . 74.3 mtp85 -104.96 150.81 24.6 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.812 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.2 m-85 -142.67 -71.06 0.33 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.824 0.345 . . . . 0.0 111.449 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -53.08 76.27 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.418 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 74' ' ' TYR . 88.8 tttt -68.78 -42.74 76.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.068 0.461 . . . . 0.0 110.148 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -94.19 144.93 25.08 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.945 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -101.78 13.01 36.12 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.463 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 57.06 34.11 24.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.713 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 46.1 69.32 0.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.632 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.22 -46.21 90.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.221 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -164.47 -59.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.38 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 85' ' ' ASN . 56.4 m -153.28 -164.93 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.21 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 t 61.11 -70.72 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.703 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 83' ' ' SER . 99.0 m-20 48.97 -102.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.725 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.541 HD13 ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -127.69 -46.96 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.809 0.338 . . . . 0.0 110.298 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 18.6 pt-20 -87.56 142.51 27.8 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.8 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -135.22 -67.63 0.54 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.627 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.8 t -125.37 132.84 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.546 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -99.6 136.11 40.01 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.19 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 95.9 mt -91.54 -86.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.747 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -145.71 91.41 2.1 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.623 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -126.34 130.35 50.63 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -172.59 111.98 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.345 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -98.09 98.54 9.84 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.383 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -93.12 -10.84 59.29 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 96.0 mt -117.23 127.89 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.917 0.389 . . . . 0.0 110.451 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -169.65 -17.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.666 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 76.2 mt -66.19 -25.51 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.422 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' A' ' 102' ' ' LYS . 54.9 t0 -63.2 143.99 57.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.871 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.488 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 62.1 ttp180 63.8 -28.61 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.859 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.55 ' H ' ' C ' ' A' ' 100' ' ' ASP . 74.8 tttt 68.53 -61.47 0.4 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.705 0.288 . . . . 0.0 110.734 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 101' ' ' ARG . 23.5 m -59.57 131.59 51.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.175 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -70.35 -119.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.572 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.751 HD21 HH22 ' A' ' 219' ' ' ARG . 22.3 t-20 -86.61 152.5 22.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.862 0.363 . . . . 0.0 110.577 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.43 ' N ' ' OD1' ' A' ' 105' ' ' ASN . 9.4 pt20 -77.9 166.62 22.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.663 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 58.29 -166.01 0.16 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.855 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.07 -40.44 97.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.79 170.53 44.37 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.1 p -74.35 96.85 2.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.869 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -156.31 79.89 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.111 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -163.37 129.12 3.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.457 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.62 142.54 51.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.536 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.4 ' H ' HG22 ' A' ' 114' ' ' VAL . 19.2 m -81.72 151.65 4.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.009 0.433 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.7 p -53.13 120.7 6.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.756 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.529 ' O ' ' CZ ' ' A' ' 74' ' ' TYR . 51.4 m -61.67 -44.29 97.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.328 0.585 . . . . 0.0 109.755 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.1 tp -156.01 140.63 16.94 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -149.43 178.27 27.06 Favored Glycine 0 N--CA 1.476 1.332 0 C-N-CA 118.901 -1.619 . . . . 0.0 112.6 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.753 ' N ' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -134.49 150.75 50.83 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.852 0.834 . . . . 0.0 111.519 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.1 t -134.29 102.47 5.37 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.24 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.32 122.56 39.32 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.69 ' CD1' ' HE ' ' A' ' 66' ' ' ARG . 3.4 pt -121.87 146.3 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -127.69 128.93 46.28 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.601 ' H ' ' CA ' ' A' ' 64' ' ' GLY . 13.7 t70 -112.51 134.38 54.07 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.788 0.804 . . . . 0.0 111.885 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.605 ' C ' ' H ' ' A' ' 127' ' ' ILE . 76.9 m-85 -93.4 85.47 4.97 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.752 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -60.34 16.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.059 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.605 ' H ' ' C ' ' A' ' 125' ' ' PHE . 38.4 mm -68.3 -42.0 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.477 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -75.59 143.63 42.25 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.136 0.494 . . . . 0.0 110.164 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.6 -40.65 97.6 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -127.35 -7.35 5.84 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 20.2 p90 -168.91 127.0 1.02 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.911 1.687 . . . . 0.0 115.291 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.56 ' NZ ' ' OD1' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -136.76 149.28 66.49 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -69.65 137.43 35.76 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.791 1.318 . . . . 0.0 111.798 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 28.3 p90 -105.95 130.86 53.81 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 106.617 -1.624 . . . . 0.0 106.617 175.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.5 pt -127.92 149.15 32.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.74 174.36 37.38 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.952 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.04 139.14 53.65 Favored 'General case' 0 CA--C 1.523 -0.062 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 193' ' ' GLY . 0.0 OUTLIER -126.32 126.13 43.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.767 0.318 . . . . 0.0 110.882 -178.418 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.18 146.21 33.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.81 0.814 . . . . 0.0 111.274 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.97 127.01 44.79 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.61 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -109.6 122.92 48.52 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -153.91 86.91 0.13 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -73.04 138.95 46.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.975 0.417 . . . . 0.0 110.562 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 144' ' ' VAL . 14.5 p -76.22 -3.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.178 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.419 ' CB ' ' O ' ' A' ' 144' ' ' VAL . 44.6 ttm-85 80.26 88.38 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.277 0.361 . . . . 0.0 110.352 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.51 ' CE1' ' O ' ' A' ' 148' ' ' ILE . 7.6 t60 -85.44 85.88 7.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.352 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.6 t -62.58 -44.16 97.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.977 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.51 ' O ' ' CE1' ' A' ' 146' ' ' HIS . 84.2 mt -108.39 125.72 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.552 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 150' ' ' SER . 41.8 p-10 -65.72 -37.88 87.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.748 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.535 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 47.8 t -73.98 149.68 41.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.645 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 153' ' ' LYS . 3.0 m 62.68 114.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.816 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -65.73 -5.13 7.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.512 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.454 ' H ' HG22 ' A' ' 151' ' ' THR . 75.6 tttt 67.63 56.44 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.076 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.6 m -62.25 -44.64 96.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.15 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 157' ' ' VAL . 69.7 mt -74.75 130.94 35.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -43.19 -20.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.28 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.502 ' H ' HG22 ' A' ' 155' ' ' ILE . 9.2 p -140.15 142.18 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.225 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 18.7 m -61.3 136.02 57.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.244 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 29.5 m -60.46 131.89 52.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.4 m -91.15 156.4 43.94 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.659 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.65 -38.29 16.73 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.649 1.566 . . . . 0.0 112.076 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 99.7 p -148.55 100.81 3.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 110.721 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -70.12 -104.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.47 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.672 ' HB1' ' CD ' ' A' ' 165' ' ' PRO . . . -174.41 -178.11 0.35 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.672 ' CD ' ' HB1' ' A' ' 164' ' ' ALA . 27.6 Cg_exo -60.68 144.25 99.52 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.969 1.779 . . . . 0.0 111.331 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 166' ' ' ASN . 40.4 p-10 -80.11 115.57 19.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.988 0.423 . . . . 0.0 110.725 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.65 -129.38 0.88 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.19 137.82 56.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.716 0.293 . . . . 0.0 110.419 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.4 131.12 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.325 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.512 ' C ' ' H ' ' A' ' 172' ' ' TYR . 81.0 p -129.62 -7.94 4.59 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.451 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 173' ' ' ASN . 41.7 p 47.55 10.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.135 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 170' ' ' THR . 28.5 p90 34.2 31.23 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 111.607 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 174' ' ' THR . 50.5 p30 -65.67 -17.52 64.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.7 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 173' ' ' ASN . 45.7 p -69.01 134.9 50.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.245 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 5.8 p-10 -113.55 92.15 22.91 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.873 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 177' ' ' LYS . 87.3 Cg_endo -86.81 116.91 1.35 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.457 2.105 . . . . 0.0 111.538 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 176' ' ' PRO . 17.9 ptpt 33.72 -141.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.256 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 69.3 m -105.64 117.36 33.83 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.717 0.294 . . . . 0.0 110.466 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -174.18 52.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.856 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.529 ' O ' ' NH1' ' A' ' 188' ' ' ARG . 25.3 m120 -89.52 103.6 16.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.782 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 24.4 p-10 -148.48 -56.18 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.418 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -63.24 -41.65 99.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.455 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.621 ' O ' HD11 ' A' ' 187' ' ' ILE . 99.2 mt-30 -55.99 171.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.333 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.0 m -89.21 -8.09 54.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.626 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 187' ' ' ILE . 82.7 m-20 -88.34 161.37 17.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.309 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 31.6 t 58.22 -76.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.178 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.621 HD11 ' O ' ' A' ' 183' ' ' GLN . 51.6 mm 55.79 78.68 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 180' ' ' ASN . 29.7 ptt-85 -90.37 31.3 1.03 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.459 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -60.38 -43.52 96.52 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 190' ' ' VAL . 3.8 t -67.2 163.98 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 176.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.434 ' C ' HD22 ' A' ' 192' ' ' LEU . . . -142.73 148.38 20.1 Favored Glycine 0 N--CA 1.473 1.127 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.845 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.434 HD22 ' C ' ' A' ' 191' ' ' GLY . 1.7 mm? -115.51 154.79 28.7 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 138' ' ' ARG . . . -170.14 -178.77 41.28 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.46 155.67 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.567 0.699 . . . . 0.0 111.34 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 195' ' ' ILE . 16.0 tt -131.95 130.49 61.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.94 161.58 42.37 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 119.956 -0.698 . . . . 0.0 112.084 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.68 -178.36 36.71 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.88 136.57 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 117.822 0.811 . . . . 0.0 110.612 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -97.69 137.52 13.35 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -121.58 100.23 6.9 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.596 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -100.46 152.85 19.89 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -172.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 28.2 mm -89.27 -67.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 103.776 -2.676 . . . . 0.0 103.776 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.5 p -103.89 -166.33 0.1 OUTLIER Pre-proline 0 CA--C 1.542 0.668 1 N-CA-C 100.1 -4.037 . . . . 0.0 100.1 172.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -81.03 -16.63 9.81 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 CA-C-N 126.373 3.312 . . . . 0.0 112.303 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.657 ' HA ' ' H ' ' A' ' 237' ' ' ARG . 47.7 pttt -81.86 -43.95 17.53 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -81.03 104.38 11.49 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.205 -178.497 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.79 131.55 24.23 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.728 0.694 . . . . 0.0 112.523 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 36.7 tp -94.79 130.3 41.39 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -110.81 123.41 50.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -107.44 118.27 36.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -157.11 -175.35 27.93 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 118.023 -2.037 . . . . 0.0 114.411 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.543 ' CE2' ' CD1' ' A' ' 214' ' ' TYR . 69.5 t80 -141.25 110.03 6.09 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 113.557 -1.322 . . . . 0.0 108.724 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -104.3 128.91 52.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.142 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.543 ' CD1' ' CE2' ' A' ' 212' ' ' TYR . 37.1 p90 -151.27 156.38 40.73 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.249 0.547 . . . . 0.0 111.361 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.633 ' NE2' ' CE3' ' A' ' 217' ' ' TRP . 3.2 p80 -154.45 165.99 34.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.417 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -101.0 110.88 22.96 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.913 0.387 . . . . 0.0 111.052 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.695 ' HE1' ' N ' ' A' ' 220' ' ' LEU . 18.5 p90 -138.41 -53.04 0.61 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.611 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.64 ' N ' ' CG ' ' A' ' 217' ' ' TRP . . . 88.55 106.74 1.03 Allowed Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.751 HH22 HD21 ' A' ' 105' ' ' ASN . 5.3 tpt180 51.13 88.17 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.861 0.363 . . . . 0.0 111.176 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.695 ' N ' ' HE1' ' A' ' 217' ' ' TRP . 11.8 tp -79.65 156.05 27.79 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.29 -0.413 . . . . 0.0 109.953 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.89 -37.9 86.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.827 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -69.22 146.12 52.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.62 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 3.7 t -145.04 174.16 11.28 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.102 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 65.52 -47.32 0.38 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.806 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -103.59 114.64 29.06 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.848 0.356 . . . . 0.0 110.319 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -145.3 74.94 1.42 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.351 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 229' ' ' GLU . 16.8 p -95.87 -0.95 50.39 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.929 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 228' ' ' HIS . 51.0 t-80 -80.02 18.67 0.8 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.095 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 227' ' ' THR . 83.6 tt0 -135.3 117.26 15.26 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.592 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 43.57 88.83 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 12.9 p -165.32 173.66 10.96 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.482 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 15' ' ' LEU . 87.9 mt -90.99 160.7 15.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.298 0.571 . . . . 0.0 110.337 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -154.48 164.97 31.78 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.13 150.94 17.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 CA-C-N 117.653 0.726 . . . . 0.0 110.917 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.473 ' NH2' ' CE1' ' A' ' 134' ' ' TYR . 99.7 mtt180 -132.6 142.54 49.18 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.467 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -107.28 110.4 22.41 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.657 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 76.2 ttt-85 -131.88 108.88 9.7 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-O 122.096 0.951 . . . . 0.0 113.422 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.438 ' C ' ' O ' ' A' ' 237' ' ' ARG . 2.6 t80 . . . . . 0 N--CA 1.47 0.54 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.182 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p 55.85 26.93 10.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.696 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 4' ' ' ASP . 81.0 tt0 -66.66 -37.69 85.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.577 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' GLU . 98.8 m-20 53.55 167.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.39 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.91 22.18 0.02 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.949 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.02 13.68 71.19 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.575 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -84.54 121.14 27.18 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -165.83 -166.86 25.56 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 118.896 -1.621 . . . . 0.0 114.15 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.71 159.79 19.58 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 124.359 3.373 . . . . 0.0 115.493 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -167.13 136.96 2.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.141 -1.845 . . . . 0.0 107.95 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 12' ' ' GLN . 3.5 p -134.81 156.84 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.465 ' N ' HG22 ' A' ' 11' ' ' VAL . 27.4 pt20 -154.21 148.39 25.87 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.91 122.3 7.87 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.646 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -86.42 116.46 24.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.89 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 232' ' ' LEU . 11.8 tp -84.85 128.59 34.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.492 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.44 153.82 23.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.533 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.525 ' CD2' ' N ' ' A' ' 18' ' ' ALA . 81.2 t80 -42.45 -90.42 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.275 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.525 ' N ' ' CD2' ' A' ' 17' ' ' TYR . . . -169.31 154.54 5.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.164 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 19' ' ' TYR . 44.8 p90 -69.64 129.79 40.62 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.223 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -97.69 116.45 29.93 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.497 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.542 ' O ' ' NE2' ' A' ' 24' ' ' HIS . 67.6 m80 -150.0 85.79 1.42 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.488 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.57 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -65.82 -40.02 86.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.544 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.6 t -63.31 126.61 28.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.626 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.542 ' NE2' ' O ' ' A' ' 21' ' ' HIS . 66.3 m-70 -147.1 93.61 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.261 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 68.4 t0 -64.78 132.92 50.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.26 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 12.4 m-85 -54.03 152.57 10.44 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.207 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.19 -89.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.182 1.921 . . . . 0.0 112.568 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -136.77 151.55 72.69 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.18 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.69 98.4 1.13 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.98 1.787 . . . . 0.0 111.726 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 86.9 m -63.74 -46.23 86.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.077 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.536 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . . . 177.31 -46.7 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.9 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 31' ' ' ALA . 53.9 Cg_exo -52.58 -39.17 76.0 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.214 1.943 . . . . 0.0 111.923 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -88.6 80.78 7.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.211 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.12 -46.17 90.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.435 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -150.18 101.11 2.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.253 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -100.69 131.55 46.53 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.072 0.463 . . . . 0.0 110.643 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.7 pt -80.63 -16.38 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.745 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.6 m -76.45 93.64 3.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.33 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -176.92 91.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.514 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.51 142.67 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.819 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.2 m 49.63 59.84 4.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.571 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 43' ' ' TYR . 79.3 m-20 -63.28 -132.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 42' ' ' ASP . 62.4 t80 54.36 110.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.826 0.346 . . . . 0.0 110.821 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -135.48 151.25 50.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.422 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HD2' ' H ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -83.94 154.74 23.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.031 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 48' ' ' ARG . 10.8 p30 -73.16 113.95 10.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.475 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 67.5 mt 47.86 -88.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.145 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 46' ' ' ASN . 37.7 ptt180 -149.32 168.26 23.84 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.726 0.298 . . . . 0.0 110.416 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.5 p -125.85 165.81 18.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.663 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 56.29 -179.49 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.311 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 51' ' ' SER . 5.1 t 51.5 35.61 14.82 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.163 0.506 . . . . 0.0 110.582 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.39 -45.94 94.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.627 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.483 ' CD2' ' H ' ' A' ' 53' ' ' HIS . 18.2 p80 -81.21 132.48 56.14 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.755 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.17 151.54 30.31 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.931 1.754 . . . . 0.0 111.739 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -88.43 128.7 35.53 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.15 161.38 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.832 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.3 t -144.35 146.16 32.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.002 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.43 153.47 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.3 179.49 39.1 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.893 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -111.51 140.7 45.89 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.851 -0.674 . . . . 0.0 110.331 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -89.27 107.56 19.12 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.49 1.119 . . . . 0.0 110.72 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -126.02 142.25 51.6 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.575 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.99 127.29 24.63 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.89 -61.11 0.71 Allowed Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -125.34 158.55 33.95 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.607 0.718 . . . . 0.0 111.967 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.492 HH21 ' NE ' ' A' ' 237' ' ' ARG . 70.7 mtt85 -133.18 147.38 52.04 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.8 mt -111.74 126.38 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.13 135.59 35.88 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.324 0.583 . . . . 0.0 111.949 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.62 122.67 47.89 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.862 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 42.5 p-10 -99.84 128.45 45.93 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -153.93 171.77 18.47 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 122.161 0.982 . . . . 0.0 112.342 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -177.55 101.66 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 113.294 -1.776 . . . . 0.0 108.048 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -142.71 157.79 44.3 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.059 0.457 . . . . 0.0 111.715 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -146.35 121.22 9.95 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.302 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -140.19 -76.45 0.33 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.875 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 77' ' ' TRP . 10.5 mtpm? 53.12 105.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.214 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.45 ' O ' ' O ' ' A' ' 76' ' ' LYS . 10.2 m-90 49.06 107.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.101 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -96.16 109.08 21.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.983 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 50.6 t30 57.66 68.66 0.82 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -78.04 155.76 30.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.005 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.33 39.82 30.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.223 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.407 ' O ' ' O ' ' A' ' 83' ' ' SER . 70.5 t80 -101.07 -42.38 6.4 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.319 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 82' ' ' TYR . 15.7 m 49.69 98.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.793 0.33 . . . . 0.0 110.523 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 85' ' ' ASN . 11.4 p -62.73 -46.8 95.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.974 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.573 ' N ' HG13 ' A' ' 84' ' ' VAL . 22.9 t-20 -104.74 99.32 8.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.549 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.642 HG23 ' N ' ' A' ' 87' ' ' GLU . 20.7 tt -121.26 -51.77 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.603 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.642 ' N ' HG23 ' A' ' 86' ' ' ILE . 83.3 tt0 -174.99 97.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.042 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -98.54 7.71 45.81 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.549 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 96.3 t -106.78 120.21 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.389 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -173.11 -52.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.213 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 93' ' ' LYS . 41.4 mm -89.82 -81.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.494 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 mmp_? 46.53 9.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.671 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 91' ' ' ILE . 51.7 mtpt -100.32 -109.81 0.2 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 95' ' ' ASN . 83.4 tt0 -80.04 151.61 29.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.313 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 94' ' ' GLU . 53.7 t-20 59.7 133.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.584 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.61 -173.83 5.72 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 98' ' ' ARG . 16.0 tt -64.86 -40.21 88.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.254 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.454 ' N ' HG23 ' A' ' 97' ' ' ILE . 16.3 tpp180 60.63 136.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.94 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.6 mm -64.13 -44.26 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.049 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 101' ' ' ARG . 47.7 t0 59.09 163.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.919 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.402 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 48.8 mmm-85 38.3 91.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.926 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -78.21 -13.71 59.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.473 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.9 m -64.37 131.25 46.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.45 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -75.77 157.19 33.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.599 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -71.61 137.52 48.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.715 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -127.29 121.59 31.54 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.426 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' A' ' 107' ' ' GLU . 56.0 mp0 -85.28 -112.87 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.741 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -64.32 -41.04 97.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.367 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.77 44.99 0.04 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.9 p -92.16 113.12 25.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.797 0.332 . . . . 0.0 110.342 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -148.85 140.46 23.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.463 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 43.11 93.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.44 151.78 31.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.307 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.54 132.49 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.65 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.4 p -156.47 163.68 39.13 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.148 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.7 p -154.51 157.87 39.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.345 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.93 160.06 44.16 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 177.31 -146.25 7.63 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.319 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 mp -137.38 148.83 46.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.19 0.519 . . . . 0.0 110.185 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 77.3 p -146.35 138.59 25.09 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.38 114.35 28.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.163 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 55.2 mt -88.87 129.83 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 135' ' ' ILE . 16.0 m-85 -100.98 116.53 33.05 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.256 0.551 . . . . 0.0 109.93 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.47 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 66.8 t0 -100.15 124.28 45.37 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.523 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.495 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 68.5 m-85 -110.03 82.6 1.62 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.693 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -58.6 -6.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 110.44 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 129' ' ' ASP . 66.7 mt -68.83 -40.45 81.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.792 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -73.2 27.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.649 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 127' ' ' ILE . 34.9 t0 68.53 -119.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.981 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -90.52 -12.26 37.71 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.42 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 4.1 p90 -118.2 102.49 9.03 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.359 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -109.6 130.58 22.62 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 179.086 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -76.94 120.15 5.35 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 120.728 0.952 . . . . 0.0 110.048 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' A' ' 207' ' ' THR . 24.4 m-85 -75.91 130.71 38.92 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.456 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.556 ' O ' ' CD2' ' A' ' 123' ' ' TYR . 28.6 mm -135.96 135.6 50.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.46 169.98 37.1 Favored Glycine 0 C--N 1.322 -0.25 0 C-N-CA 118.979 -1.582 . . . . 0.0 113.203 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -104.34 140.42 37.92 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -118.49 124.38 47.44 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.0 123.23 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -147.21 146.41 29.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.844 0.354 . . . . 0.0 110.377 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -130.8 155.65 46.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.947 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.41 -179.48 42.4 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 63.2 t60 -114.1 95.03 5.08 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.689 0.281 . . . . 0.0 111.184 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 99.0 t -100.95 -82.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.118 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -148.89 -123.76 0.05 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.064 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -147.7 85.06 1.55 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.655 0.264 . . . . 0.0 110.706 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 94.6 p -86.26 -16.53 37.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.964 0.412 . . . . 0.0 110.518 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 149' ' ' ASP . 16.8 tt -67.85 -39.75 82.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.795 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.463 ' N ' HG23 ' A' ' 148' ' ' ILE . 53.9 p30 -138.28 -176.49 4.47 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.695 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.0 p -154.14 162.74 40.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.628 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.7 p -143.61 -145.88 0.18 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.423 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -81.48 23.12 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.622 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -60.85 -46.45 90.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.275 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.04 101.97 2.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.305 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.73 -44.08 96.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.537 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -104.88 122.0 44.88 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.146 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 157' ' ' VAL . 9.9 p -129.6 133.32 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.804 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 2.6 t -132.24 148.75 52.46 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.901 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.8 m -122.5 127.74 49.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.951 0.405 . . . . 0.0 110.882 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 160' ' ' VAL . 22.9 t -49.1 111.61 2.03 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.578 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -51.39 138.66 46.76 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.356 1.371 . . . . 0.0 111.838 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.9 t -61.76 -44.51 96.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.179 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -167.95 -82.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.311 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.674 ' HB3' ' HD3' ' A' ' 165' ' ' PRO . . . -164.93 -63.9 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' A' ' 164' ' ' ALA . 72.8 Cg_endo -71.1 146.31 51.65 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.118 1.879 . . . . 0.0 111.191 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -138.33 109.31 6.75 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.883 0.373 . . . . 0.0 111.008 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 169' ' ' VAL . . . 54.17 -135.58 43.74 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 167' ' ' GLY . . . 70.18 -39.61 0.44 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.808 0.337 . . . . 0.0 110.728 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 167' ' ' GLY . 34.0 m -71.45 -32.95 48.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 34.88 76.35 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 58.7 p -67.04 -32.55 73.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.158 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 83.4 t80 45.64 93.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.914 0.388 . . . . 0.0 110.459 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -135.87 137.3 41.3 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.34 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.3 m -81.11 81.59 7.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.402 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -114.74 90.64 22.82 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.056 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -89.65 116.52 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.651 2.234 . . . . 0.0 111.457 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -147.09 -30.54 0.34 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.692 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.4 t -122.13 -22.88 5.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.72 0.295 . . . . 0.0 110.975 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 51.2 98.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.931 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 66.0 t30 49.77 96.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.152 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 181' ' ' ASP . 67.4 t0 -159.63 44.47 0.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.386 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.495 ' CD2' ' N ' ' A' ' 183' ' ' GLN . 53.2 p90 -61.73 -46.41 89.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.896 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.495 ' N ' ' CD2' ' A' ' 182' ' ' TYR . 58.5 tt0 -157.36 -24.22 0.09 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.824 0.345 . . . . 0.0 110.7 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.0 m -83.52 -174.93 5.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.756 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 57.21 38.16 28.67 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.409 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.3 t -61.51 164.89 5.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.563 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 38.4 pt -65.55 -40.76 89.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.172 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -164.31 84.39 0.43 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.21 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -137.23 -18.59 1.3 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.1 163.21 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 114.291 -1.322 . . . . 0.0 107.661 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.672 ' C ' HD12 ' A' ' 192' ' ' LEU . . . -130.59 102.87 0.54 Allowed Glycine 0 N--CA 1.468 0.771 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.672 HD12 ' C ' ' A' ' 191' ' ' GLY . 10.7 mp -127.75 133.89 49.51 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.068 0.461 . . . . 0.0 110.143 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -179.33 -140.17 3.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.33 152.47 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.442 0.639 . . . . 0.0 110.547 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.3 tp -111.96 142.1 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.59 174.66 13.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 111.81 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 155.91 -176.99 33.23 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.66 136.65 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -131.86 135.07 7.97 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 120.431 -0.89 . . . . 0.0 114.467 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -106.74 113.1 26.4 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 113.684 -1.258 . . . . 0.0 108.224 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 43.6 p30 -51.34 147.03 6.23 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.092 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.0 mm -108.9 -51.48 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.522 HG22 ' HD2' ' A' ' 204' ' ' PRO . 0.3 OUTLIER -106.79 -174.06 0.3 Allowed Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 176.038 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.522 ' HD2' HG22 ' A' ' 203' ' ' THR . 11.0 Cg_exo -32.87 -70.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 122.55 1.947 . . . . 0.0 114.311 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -126.8 20.72 7.06 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.171 0.986 . . . . 0.0 110.425 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.5 tt -88.24 127.62 35.45 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.425 HG21 ' OH ' ' A' ' 134' ' ' TYR . 6.0 t -137.09 152.75 50.38 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.1 tt -105.7 124.25 49.25 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.465 ' CG ' ' NH1' ' A' ' 235' ' ' ARG . 2.2 p30 -137.1 147.62 46.17 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -174.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -91.08 127.03 36.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -114.93 150.5 18.71 Favored Glycine 0 N--CA 1.471 0.977 0 C-N-CA 121.287 -0.482 . . . . 0.0 113.001 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.64 127.84 37.84 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -89.85 136.64 32.92 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.61 101.08 6.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.682 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.47 ' NE2' ' OD1' ' A' ' 216' ' ' ASN . 84.7 t60 -97.42 126.77 42.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.47 ' OD1' ' NE2' ' A' ' 215' ' ' HIS . 13.4 m120 42.62 -168.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 110.757 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -86.8 131.68 34.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.015 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -90.73 135.27 12.77 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -152.62 170.9 19.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.738 0.304 . . . . 0.0 110.571 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.601 HD22 ' N ' ' A' ' 220' ' ' LEU . 3.5 mm? -75.64 133.54 40.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.202 0.525 . . . . 0.0 111.145 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -173.82 118.16 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.583 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 223' ' ' THR . 55.4 t-20 58.65 34.63 23.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.093 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.41 ' C ' ' O ' ' A' ' 222' ' ' ASN . 69.2 p 29.98 82.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.141 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -86.61 149.47 24.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.972 0.415 . . . . 0.0 110.76 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -143.84 -160.36 1.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.747 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.1 tttp 60.53 77.08 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.848 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.0 m -139.59 73.82 1.44 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.804 0.335 . . . . 0.0 110.552 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.522 ' CD2' ' HG3' ' A' ' 229' ' ' GLU . 37.4 t60 -146.3 171.02 15.61 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.133 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.522 ' HG3' ' CD2' ' A' ' 228' ' ' HIS . 97.0 mt-10 55.98 38.65 30.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.384 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -41.23 -85.66 0.0 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.528 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 97.1 p -163.24 156.51 19.25 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.981 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 233' ' ' GLY . 5.8 tt -124.23 126.24 45.76 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 177.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.555 ' N ' HD23 ' A' ' 232' ' ' LEU . . . -115.36 171.28 13.63 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.278 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.31 129.73 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 113.708 -1.246 . . . . 0.0 108.32 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.465 ' NH1' ' CG ' ' A' ' 209' ' ' ASP . 83.8 mtt85 -132.48 141.79 48.95 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.805 0.335 . . . . 0.0 110.353 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -122.0 112.16 17.93 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.658 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.492 ' NE ' HH21 ' A' ' 66' ' ' ARG . 87.5 mtm-85 -134.06 126.65 30.59 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 . . . . . 0 C--O 1.218 -0.563 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.453 -178.915 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 4' ' ' ASP . 48.4 t -61.45 -177.52 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.518 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 59.13 -73.63 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.67 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 2' ' ' SER . 99.9 m-20 -62.5 -40.37 96.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.868 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.07 -143.53 22.14 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.17 -121.97 0.78 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.49 ' HD2' ' H ' ' A' ' 7' ' ' ARG . 3.2 mpt_? -75.68 152.53 37.52 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.448 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . 169.31 -78.55 0.1 Allowed Glycine 0 CA--C 1.541 1.68 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.487 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.464 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 71.4 Cg_endo -82.25 158.29 17.45 Favored 'Trans proline' 0 N--CA 1.507 2.277 0 C-N-CA 122.899 2.399 . . . . 0.0 111.989 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.623 ' CE2' ' NH1' ' A' ' 66' ' ' ARG . 3.4 t80 -148.1 137.71 22.34 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 236' ' ' TYR . 57.6 t -131.84 135.15 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -136.46 144.27 44.31 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -174.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.434 ' O ' ' OD1' ' A' ' 14' ' ' ASP . . . -152.99 149.43 28.18 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.304 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 13' ' ' ALA . 86.0 m-20 -144.44 125.71 14.71 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.175 -0.328 . . . . 0.0 110.661 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.401 HD12 ' C ' ' A' ' 14' ' ' ASP . 5.3 mp -140.66 163.46 32.81 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.353 0.596 . . . . 0.0 111.903 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 17' ' ' TYR . . . -131.32 -112.68 0.24 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.133 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' ALA . 67.2 t80 58.21 129.96 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.773 0.321 . . . . 0.0 111.124 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -157.88 43.72 0.32 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.183 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -134.98 127.29 30.23 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.157 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -100.79 175.59 5.58 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.985 0.421 . . . . 0.0 111.031 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.44 ' CG ' ' N ' ' A' ' 22' ' ' ILE . 70.5 t60 61.16 170.76 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.862 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.44 ' N ' ' CG ' ' A' ' 21' ' ' HIS . 19.8 tt -83.42 153.94 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.852 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 25' ' ' ASP . 14.9 m -72.15 99.93 2.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.504 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 24' ' ' HIS . 52.5 t-80 45.53 10.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.794 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 23' ' ' THR . 35.4 t70 58.03 -178.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.791 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.502 ' H ' ' CG ' ' A' ' 25' ' ' ASP . 43.5 m-85 57.39 68.25 2.09 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.67 -39.23 89.99 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 123.121 2.548 . . . . 0.0 113.38 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.76 152.44 32.12 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.106 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.65 -99.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.281 1.988 . . . . 0.0 111.793 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 47.2 p -110.88 -87.6 0.53 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.607 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.445 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -177.39 53.11 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.65 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 31' ' ' ALA . 37.5 Cg_endo -65.35 -24.23 57.81 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.721 2.281 . . . . 0.0 112.065 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 32' ' ' PRO . 89.9 m-20 -150.21 115.22 5.35 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.702 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -147.7 135.64 21.18 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.522 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.496 ' CG ' ' H ' ' A' ' 36' ' ' LYS . 62.6 t30 -162.47 -144.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.148 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.496 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 86.0 tttt -145.49 -79.34 0.18 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.3 mt -139.58 -54.73 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 t 40.81 -158.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER 71.69 -164.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.225 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.521 ' H ' HG22 ' A' ' 39' ' ' THR . 85.3 t -62.68 -45.39 98.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.804 0.335 . . . . 0.0 110.494 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.6 t -65.58 140.71 58.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.536 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 54.4 p-10 -154.18 76.85 1.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.264 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -107.72 130.78 54.91 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.662 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -71.72 -14.35 61.99 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -73.3 148.34 43.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.705 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -134.23 91.93 2.87 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.617 ' N ' HD12 ' A' ' 47' ' ' ILE . 2.4 mp -68.17 -21.54 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -60.08 143.59 51.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.209 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 t -144.83 173.21 12.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -42.97 -66.97 0.31 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.918 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 71.1 m -161.39 -123.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.044 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.537 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 14.8 p -63.92 -26.13 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.453 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.585 ' O ' ' CG ' ' A' ' 53' ' ' HIS . 20.2 p80 43.61 99.95 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.496 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.95 140.16 69.35 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.375 1.383 . . . . 0.0 112.775 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -139.11 -160.77 1.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.036 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.464 HG22 ' N ' ' A' ' 57' ' ' SER . 9.7 p -150.01 154.42 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 119.567 -0.853 . . . . 0.0 113.065 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 56' ' ' VAL . 15.2 t -135.67 134.49 39.24 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.009 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.36 163.34 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.295 0.569 . . . . 0.0 111.933 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.64 -160.35 25.52 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -128.9 143.67 50.96 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 120.84 0.352 . . . . 0.0 110.345 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 9' ' ' PRO . 18.1 p-10 -124.72 115.39 20.66 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -126.91 158.02 37.88 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.49 123.02 32.05 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.426 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.06 -89.07 0.28 Allowed Glycine 0 N--CA 1.474 1.184 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.3 p-90 -127.79 174.04 9.45 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.623 ' NH1' ' CE2' ' A' ' 10' ' ' TYR . 25.3 ttp85 -147.32 147.42 30.34 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.354 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.39 144.24 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.39 150.18 19.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.364 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.88 159.14 31.8 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 55.6 p30 -140.45 153.07 46.13 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.51 169.26 24.21 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.363 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.5 -155.13 0.67 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.946 0.403 . . . . 0.0 111.305 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -147.86 60.63 1.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.735 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -145.11 -1.21 0.85 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.999 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -71.03 -21.46 62.26 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.759 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' TRP . 65.4 tttm -139.89 -81.94 0.27 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.716 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.579 ' CG ' ' N ' ' A' ' 78' ' ' ASN . 25.4 t90 51.15 176.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.135 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.579 ' N ' ' CG ' ' A' ' 77' ' ' TRP . 99.0 m-20 55.27 36.29 26.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.909 0.385 . . . . 0.0 110.123 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -62.31 -40.04 95.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.68 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -80.97 107.5 13.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -78.71 155.37 29.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.641 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 82' ' ' TYR . 52.8 p90 -85.78 122.76 30.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.027 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.3 p -83.76 175.85 9.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.361 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.3 t 61.01 112.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.425 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -94.78 137.92 33.25 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.638 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.4 pt -127.02 121.94 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.59 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 87' ' ' GLU . 44.7 mp0 38.45 32.13 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.191 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -95.08 1.84 55.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.886 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 90' ' ' ARG . 13.5 p -122.94 -37.17 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 120.828 0.346 . . . . 0.0 110.6 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.431 ' N ' HG13 ' A' ' 89' ' ' VAL . 79.5 mtp85 -64.07 -36.88 85.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.636 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.3 pt -66.14 151.24 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.768 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -127.16 152.37 47.43 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.714 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.64 164.98 29.34 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.631 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -146.54 156.55 43.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.599 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -139.26 128.97 24.66 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.283 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -153.82 74.48 0.24 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 98' ' ' ARG . 96.1 mt -118.32 130.86 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.812 0.339 . . . . 0.0 110.203 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 97' ' ' ILE . 89.4 mtm180 -50.94 -104.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.7 pt -133.83 155.68 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.869 0.366 . . . . 0.0 110.763 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -86.94 177.07 7.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.597 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.594 HH11 HD22 ' A' ' 105' ' ' ASN . 85.0 mtp180 -52.63 -176.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.552 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -62.52 -43.52 98.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.44 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.6 p -140.1 163.48 32.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.377 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -62.47 160.8 12.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.066 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.594 HD22 HH11 ' A' ' 101' ' ' ARG . 30.6 p30 -141.97 176.2 9.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.728 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 76.13 21.85 1.45 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.915 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -147.18 -45.98 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.599 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -90.52 115.32 27.57 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.168 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 160.44 -92.9 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.517 HG22 ' CD2' ' A' ' 111' ' ' PHE . 5.8 m -63.79 144.03 57.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 0.0 110.787 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.517 ' CD2' HG22 ' A' ' 110' ' ' THR . 65.9 m-85 42.78 -165.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.866 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -66.39 133.18 49.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.641 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.53 -50.47 71.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.202 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 68.2 t -131.43 135.1 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.944 0.402 . . . . 0.0 111.033 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.5 m -161.95 87.63 0.66 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.019 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.447 ' OG ' ' N ' ' A' ' 117' ' ' LEU . 91.0 p -88.92 -79.39 0.32 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.543 ' N ' HD22 ' A' ' 117' ' ' LEU . 3.2 mm? -89.83 131.89 35.53 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.73 134.71 7.5 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.188 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.2 tt -123.94 140.76 52.66 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.9 t -133.27 123.01 24.74 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' A' ' 136' ' ' GLY . . . -94.39 130.72 40.62 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 123' ' ' TYR . 88.2 mt -129.73 159.36 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.499 ' N ' HG22 ' A' ' 122' ' ' ILE . 55.8 m-85 -118.42 118.15 30.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 237' ' ' ARG . 54.4 t0 -140.0 114.9 9.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.909 0.385 . . . . 0.0 111.478 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -122.11 96.18 4.95 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.574 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.564 ' NE2' ' OD1' ' A' ' 201' ' ' ASP . 47.9 tt0 -93.51 -0.62 56.27 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.397 0.618 . . . . 0.0 109.907 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.0 -23.56 29.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 12.7 t-20 -60.79 -42.63 97.94 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.165 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 128' ' ' ASN . 52.2 m-20 -175.21 -110.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.677 0.611 . . . . 0.0 109.366 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -118.22 1.05 11.86 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.665 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -128.81 131.67 47.78 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.485 0.491 . . . . 0.0 110.116 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.675 ' NZ ' HH22 ' A' ' 237' ' ' ARG . 0.5 OUTLIER -116.56 128.04 26.3 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.025 -178.055 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.13 129.55 29.02 Favored 'Trans proline' 0 N--CA 1.482 0.816 0 N-CA-C 107.187 -1.89 . . . . 0.0 107.187 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -115.16 129.15 56.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.368 0.604 . . . . 0.0 111.234 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.2 tt -162.2 148.77 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.509 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 121' ' ' ALA . . . -169.22 -177.23 39.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 119.637 -1.268 . . . . 0.0 113.157 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.48 144.03 30.76 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.044 0.45 . . . . 0.0 110.326 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -119.1 118.85 32.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.949 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.25 128.99 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.938 0.399 . . . . 0.0 110.657 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.31 128.06 43.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -142.38 165.77 26.5 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.783 0.802 . . . . 0.0 111.749 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.16 -6.78 0.08 OUTLIER Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 189' ' ' ARG . 79.5 m80 -88.75 166.68 13.88 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.872 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 98.5 t -80.38 131.71 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.068 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -95.66 132.82 40.43 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.952 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -153.89 -82.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.315 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 149' ' ' ASP . 26.4 m -80.75 -80.28 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.434 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 23.0 mm 65.85 -51.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.935 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 147' ' ' SER . 63.8 t0 -62.18 -41.44 98.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.661 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 149' ' ' ASP . 24.5 p 41.18 93.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.579 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 m -62.65 -45.39 93.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.799 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -151.07 -113.21 0.05 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.517 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 57.97 -168.74 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.005 0.431 . . . . 0.0 111.021 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 60.9 m 54.97 81.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.776 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.2 pt -131.09 161.88 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.284 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -73.47 107.67 5.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 111.229 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.2 m -108.55 -2.31 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 28.4 p -103.32 138.98 39.35 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.29 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.7 t -144.19 156.14 44.19 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.517 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.97 148.96 50.0 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.19 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 163' ' ' ASN . 94.5 Cg_endo -76.13 -96.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.134 1.889 . . . . 0.0 112.084 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.7 t 45.24 16.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 161' ' ' PRO . 64.9 t30 55.75 38.31 29.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.98 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . 58.14 152.21 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.258 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.59 137.55 27.87 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 121.984 1.79 . . . . 0.0 111.616 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -162.9 170.55 18.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.748 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 153.06 109.8 0.4 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.45 -4.29 58.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.058 0.456 . . . . 0.0 110.174 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.36 -17.2 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.717 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.7 t -132.95 155.52 48.97 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.023 0.44 . . . . 0.0 110.768 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.6 p -82.15 172.23 13.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.836 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -65.58 140.67 58.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.568 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -86.41 110.17 19.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.844 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 65.6 p -70.38 138.72 51.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.466 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -92.3 150.18 39.71 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.623 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.97 158.83 45.65 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.506 2.137 . . . . 0.0 111.901 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 45.43 -156.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.301 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 70.5 p -130.42 159.46 36.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 110.828 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 48.76 89.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.526 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -142.79 90.05 2.18 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.572 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 -117.2 12.77 14.52 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.578 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -78.55 139.12 38.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.896 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -154.79 -29.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.366 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 34.1 p -156.61 162.14 39.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.579 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -151.98 155.37 37.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.325 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 84.0 p -75.37 159.99 30.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.389 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.5 tt -87.38 126.25 41.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.163 0.506 . . . . 0.0 110.274 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.517 ' C ' ' H ' ' A' ' 190' ' ' VAL . 87.4 mtm180 -65.35 -35.47 81.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.224 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.524 ' O ' ' ND1' ' A' ' 143' ' ' HIS . 69.2 mtm180 67.15 -5.0 0.75 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.275 0.559 . . . . 0.0 109.67 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.517 ' H ' ' C ' ' A' ' 188' ' ' ARG . 14.9 p -137.85 153.97 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -136.04 151.34 20.7 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 119.904 -1.141 . . . . 0.0 112.973 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.8 pp -166.89 147.54 5.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.144 0.497 . . . . 0.0 111.273 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -172.86 -156.84 13.32 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.92 147.92 33.08 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-O 122.063 0.935 . . . . 0.0 113.041 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 7.5 tp -116.89 148.01 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.204 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.09 167.12 30.31 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.897 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 150.98 -168.31 30.66 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.5 m -140.53 159.7 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 117.317 0.558 . . . . 0.0 110.407 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -143.91 133.78 5.49 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.787 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -130.51 127.23 38.73 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.564 ' OD1' ' NE2' ' A' ' 126' ' ' GLN . 0.1 OUTLIER -79.19 152.02 30.91 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 -173.485 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 202' ' ' ILE . 1.2 mp -62.36 -42.85 97.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 174.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.1 OUTLIER -164.5 171.9 5.22 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 176.263 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.569 ' O ' ' C ' ' A' ' 238' ' ' PHE . 13.8 Cg_endo -65.91 63.72 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 CA-C-N 121.722 1.651 . . . . 0.0 110.598 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 203' ' ' THR . 16.3 ptpt -134.21 -46.4 0.77 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.12 0.568 . . . . 0.0 110.516 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.408 ' N ' ' HG3' ' A' ' 205' ' ' LYS . 7.5 tt -160.63 153.21 20.82 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.1 t -134.48 152.84 52.05 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.67 133.26 34.26 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 112.881 -1.963 . . . . 0.0 106.482 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.598 ' CG ' HH12 ' A' ' 235' ' ' ARG . 6.1 t70 -135.66 133.91 38.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.908 0.861 . . . . 0.0 112.564 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -101.94 117.99 35.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.06 143.89 15.12 Favored Glycine 0 N--CA 1.467 0.735 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.983 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -171.32 136.06 1.0 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.373 -0.913 . . . . 0.0 108.597 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.527 ' O ' ' CD1' ' A' ' 214' ' ' TYR . 0.0 OUTLIER -166.15 -139.84 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.251 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 213' ' ' ARG . 75.8 m-85 -155.48 -158.88 0.86 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.471 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -141.47 167.46 22.11 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.212 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 62.98 90.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.58 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -96.33 137.74 34.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.392 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 152.41 -117.95 0.85 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.426 ' O ' ' ND2' ' A' ' 222' ' ' ASN . 93.9 mtt-85 -70.4 147.13 49.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.787 0.327 . . . . 0.0 110.254 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 220' ' ' LEU . 3.4 mm? -62.21 -42.03 98.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -92.19 107.4 19.19 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.572 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 219' ' ' ARG . 10.3 p30 -162.08 117.47 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.559 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.69 HG22 ' H ' ' A' ' 224' ' ' ARG . 28.2 m 50.85 175.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.615 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.69 ' H ' HG22 ' A' ' 223' ' ' THR . 2.5 mpt_? -65.71 147.92 52.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.018 0.437 . . . . 0.0 110.356 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -63.78 -37.73 88.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.938 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 56.08 96.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.136 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 69.2 p -78.31 165.53 23.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.515 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.416 ' HD1' ' H ' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -151.52 164.17 37.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.293 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -82.56 -86.92 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.481 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -171.48 162.68 6.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.581 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 32.1 t -140.84 123.05 15.74 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.889 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.27 127.96 42.75 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -117.65 152.36 17.69 Favored Glycine 0 CA--C 1.517 0.2 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 234' ' ' VAL . 33.3 m -122.86 128.04 75.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.598 HH12 ' CG ' ' A' ' 209' ' ' ASP . 80.5 mtm-85 -126.24 141.16 52.03 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.397 0.618 . . . . 0.0 110.03 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.455 ' HB3' ' H ' ' A' ' 11' ' ' VAL . 41.1 t80 -90.62 115.57 27.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.121 -176.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.675 HH22 ' NZ ' ' A' ' 132' ' ' LYS . 31.3 ttm105 -124.04 87.88 2.81 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.569 ' C ' ' O ' ' A' ' 204' ' ' PRO . 33.3 t80 . . . . . 0 CA--C 1.512 -0.505 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.721 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.9 p -155.51 163.09 40.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.415 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 57.0 mp0 -80.76 127.19 32.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.36 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -72.28 -117.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.245 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.36 11.23 85.22 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.64 -143.54 8.51 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.602 HH22 HE22 ' A' ' 126' ' ' GLN . 95.9 mtt-85 -82.92 156.31 23.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.814 -0.193 . . . . 0.0 110.792 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.524 ' O ' ' CD2' ' A' ' 10' ' ' TYR . . . 120.54 -95.22 0.57 Allowed Glycine 0 CA--C 1.55 2.253 0 CA-C-O 119.716 -0.491 . . . . 0.0 113.394 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.576 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 71.8 Cg_exo -45.65 106.63 0.09 OUTLIER 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.232 2.621 . . . . 0.0 116.825 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 16.7 m-85 -146.51 157.2 43.71 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.97 154.66 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.077 -1.049 . . . . 0.0 112.703 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -120.24 149.67 41.9 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.307 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.7 125.87 23.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.209 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 53.1 p-10 -91.91 149.75 21.39 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 15' ' ' LEU . 1.0 OUTLIER 178.49 174.54 0.62 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.591 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.33 156.67 34.89 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.917 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 90.9 m-85 -107.15 136.28 47.25 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.952 0.406 . . . . 0.0 111.198 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 17' ' ' TYR . . . 68.81 104.07 0.06 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.673 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' A' ' 20' ' ' GLU . 86.2 t80 -142.36 155.95 45.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.37 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.543 ' O ' ' CD2' ' A' ' 19' ' ' TYR . 57.7 mp0 -81.7 148.3 29.05 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.929 0.395 . . . . 0.0 111.202 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -175.19 45.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.588 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.95 97.47 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.221 0.534 . . . . 0.0 111.044 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.3 m -66.66 -44.55 81.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.737 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 60.69 90.83 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.633 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 25' ' ' ASP . 40.4 p-10 -132.44 110.56 10.61 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.656 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.564 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.7 OUTLIER -165.83 44.97 0.11 Allowed Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 121.143 0.497 . . . . 0.0 110.255 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 26' ' ' TYR . 37.9 Cg_endo -64.31 -22.56 66.37 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.574 2.183 . . . . 0.0 112.074 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 27' ' ' PRO . 43.2 mt-10 56.91 150.6 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.103 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.57 87.19 1.57 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.25 1.966 . . . . 0.0 111.47 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.436 ' O ' ' C ' ' A' ' 31' ' ' ALA . 90.3 m -65.06 -86.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.05 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 30' ' ' THR . . . -26.63 91.77 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 O-C-N 123.611 0.57 . . . . 0.0 112.177 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.09 146.59 14.4 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 122.119 1.879 . . . . 0.0 111.978 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 55.01 35.0 23.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.852 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -62.27 -45.44 93.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.458 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -124.8 149.07 47.78 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.279 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -61.68 -44.99 95.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.268 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.22 128.16 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.245 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -155.97 76.86 0.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.596 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -159.22 28.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.643 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.38 162.97 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.914 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.2 p 51.68 175.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.945 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.9 t0 60.3 50.33 6.29 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.49 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -73.63 -126.12 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.947 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 45' ' ' ARG . 91.1 m-85 -65.11 -44.84 87.46 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.319 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 44' ' ' PHE . 28.3 mmt180 42.43 96.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.913 0.387 . . . . 0.0 110.856 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -78.89 143.98 35.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.677 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.451 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -103.91 132.1 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.308 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -77.15 148.49 35.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.744 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 t -146.33 160.67 41.71 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.659 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -137.66 90.0 2.46 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.538 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.8 t -155.88 123.62 5.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.279 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.97 162.89 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.264 0.555 . . . . 0.0 111.378 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -60.29 153.7 57.03 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.997 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.2 42.17 0.84 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.5 2.133 . . . . 0.0 111.541 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 53.58 -129.5 2.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.787 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 57' ' ' SER . 9.1 p -163.57 157.33 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 117.696 -1.602 . . . . 0.0 114.929 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.54 ' N ' HG22 ' A' ' 56' ' ' VAL . 21.8 t -117.7 121.6 41.3 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 113.946 -1.479 . . . . 0.0 107.783 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -132.97 148.72 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.64 0.257 . . . . 0.0 110.607 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -157.77 165.9 33.73 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.327 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -112.85 147.65 36.53 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 24.9 t70 -157.08 153.97 28.71 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -177.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 4.8 p90 -130.77 155.07 47.28 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 110.629 -2.987 . . . . 0.0 106.146 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -42.85 117.35 1.48 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.509 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 124' ' ' ASP . . . 144.82 -89.65 0.16 Allowed Glycine 0 CA--C 1.534 1.241 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 25.1 p-90 -152.86 173.27 15.55 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.7 HH22 ' NH1' ' A' ' 237' ' ' ARG . 0.2 OUTLIER -130.88 173.02 11.37 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.042 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.5 mt -116.7 125.38 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 171.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.4 111.78 13.16 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.31 126.53 32.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.723 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -90.82 127.81 36.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -119.13 113.03 20.27 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.91 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -170.47 122.83 0.65 Allowed 'General case' 0 C--N 1.339 0.116 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.786 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -147.56 135.33 21.07 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.922 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -139.89 -20.99 0.89 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.934 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -93.26 60.98 3.27 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.836 0.351 . . . . 0.0 111.147 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.68 -77.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.368 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -158.17 147.98 19.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.945 0.402 . . . . 0.0 110.61 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -147.6 145.0 28.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.006 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 81' ' ' LYS . 47.0 t30 48.47 -116.36 0.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.287 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.515 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 13.6 t-20 58.07 -75.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.686 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 79' ' ' ASN . 68.1 mttm -63.04 -43.68 98.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.46 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 84' ' ' VAL . 87.9 m-85 -63.34 -42.46 98.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.082 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.0 t 57.34 -77.76 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.853 0.359 . . . . 0.0 110.477 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 82' ' ' TYR . 35.9 m -126.62 160.61 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.661 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 87' ' ' GLU . 98.6 m-20 -83.35 72.75 10.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.319 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 85' ' ' ASN . 43.8 mm 31.36 -86.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.91 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 85' ' ' ASN . 74.1 mm-40 -63.68 143.65 57.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.916 0.388 . . . . 0.0 110.696 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -98.93 143.86 28.76 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.72 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 89' ' ' VAL . 13.0 p -79.73 131.53 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.297 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 91' ' ' ILE . 78.8 ttt-85 -165.2 -57.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.665 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 90' ' ' ARG . 18.5 pt 32.02 -121.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.915 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -93.12 35.7 1.06 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.68 0.276 . . . . 0.0 111.321 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.7 mttp 54.08 -170.57 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.626 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 53.59 94.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.785 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -63.55 -41.15 98.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.767 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.52 -135.33 4.09 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.9 pt -80.34 136.83 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.91 0.386 . . . . 0.0 110.464 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -144.76 -44.53 0.24 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.65 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.6 mm -63.83 -43.64 97.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.0 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -78.17 92.18 4.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.358 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -73.12 142.95 47.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.385 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -138.85 151.43 46.99 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.272 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.17 135.33 53.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.422 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -125.97 -22.14 4.2 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.779 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 59.39 46.89 11.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.105 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 107' ' ' GLU . 77.2 mt-30 -57.01 133.06 54.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.051 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 106' ' ' GLN . 97.0 mt-10 55.16 165.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -159.54 81.28 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.601 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.47 -3.83 57.89 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 112' ' ' HIS . 22.3 m -65.85 131.02 45.28 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.202 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -88.35 -3.6 58.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.301 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.689 ' H ' HG22 ' A' ' 110' ' ' THR . 27.7 t-80 69.39 -1.61 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.607 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.32 144.34 26.39 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.996 0.427 . . . . 0.0 110.782 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.34 162.85 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.826 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.6 p -45.56 115.24 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.076 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.2 m -81.77 -135.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.176 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.02 144.48 50.37 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 177.18 -141.63 5.42 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.101 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.2 130.57 53.32 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.53 0.681 . . . . 0.0 111.694 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.4 m -132.25 111.32 11.29 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.47 127.76 38.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 1.9 mp -90.34 161.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 176.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.447 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 2.4 t80 -139.76 108.0 5.79 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.548 ' CB ' HH12 ' A' ' 66' ' ' ARG . 18.3 t70 -123.7 132.44 53.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.36 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.508 ' C ' ' H ' ' A' ' 127' ' ' ILE . 27.6 m-85 -93.99 84.1 4.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.798 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.602 HE22 HH22 ' A' ' 7' ' ' ARG . 54.9 tt0 -52.14 -4.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.786 -0.571 . . . . 0.0 111.352 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.508 ' H ' ' C ' ' A' ' 125' ' ' PHE . 92.7 mt -66.59 -42.71 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 120.228 -0.589 . . . . 0.0 112.304 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 22.4 t-20 -68.02 -40.35 82.95 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.189 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 128' ' ' ASN . 11.4 t0 88.6 -55.15 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.031 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -79.33 -51.74 9.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 2.0 p90 -151.55 128.22 10.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -134.75 153.34 78.77 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.122 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.472 ' HA ' HG12 ' A' ' 198' ' ' VAL . 17.2 Cg_exo -64.56 136.01 48.27 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 120.514 0.81 . . . . 0.0 110.68 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.81 128.2 34.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.7 mt -141.55 139.77 31.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -171.2 175.01 44.93 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.231 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.69 152.81 48.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -124.86 130.8 53.09 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.0 t -130.71 118.52 42.61 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.23 130.2 42.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.024 0.44 . . . . 0.0 110.563 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -111.48 136.71 50.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.43 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -90.57 -70.44 1.21 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -154.44 130.53 10.28 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.707 0.289 . . . . 0.0 110.444 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.99 110.78 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.208 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -96.21 3.57 53.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.194 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 51.1 m170 -95.17 130.45 41.9 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.963 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 149' ' ' ASP . 22.7 t -139.14 140.21 37.83 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.426 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 150' ' ' SER . 90.6 mt 47.28 -86.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.543 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 147' ' ' SER . 97.8 m-20 57.01 45.27 21.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.195 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 152' ' ' LYS . 11.5 t -61.62 -43.54 98.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.002 0.43 . . . . 0.0 110.402 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 93.9 m 43.75 -89.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.767 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 150' ' ' SER . 25.4 pttm -72.95 133.35 44.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.727 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -114.56 -113.36 0.34 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.872 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 155' ' ' ILE . 77.3 p -73.2 -20.43 60.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.924 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 154' ' ' THR . 93.7 mt 55.11 109.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.468 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.41 -109.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.017 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.03 136.13 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.269 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 57.1 p -131.15 152.66 50.21 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.018 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 98.8 m -88.25 126.57 35.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.783 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.4 m -85.93 151.31 54.63 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.822 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -41.86 140.21 2.09 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.07 1.847 . . . . 0.0 112.591 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 163' ' ' ASN . 61.9 m -107.75 69.4 0.74 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.827 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 162' ' ' SER . 64.1 t30 60.54 128.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.487 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.51 79.28 4.4 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.186 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -60.79 147.77 94.14 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.49 2.127 . . . . 0.0 110.975 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -139.87 170.56 15.65 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.956 0.408 . . . . 0.0 111.058 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 168' ' ' ALA . . . 154.18 -52.39 0.46 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 167' ' ' GLY . . . 54.73 161.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.779 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -64.25 -29.35 47.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.443 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 69.0 p -74.31 169.77 16.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 81.1 p -76.52 165.04 25.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -142.68 10.0 1.8 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.647 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -63.0 -41.15 99.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.257 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 81.2 p -108.81 128.48 54.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.977 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -97.05 150.9 37.34 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.577 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -37.39 -54.77 1.1 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 122.404 2.07 . . . . 0.0 112.527 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -165.46 -29.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.073 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 36.2 m -66.76 133.51 50.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.826 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -151.17 81.14 1.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.835 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.6 t30 56.9 33.84 23.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.401 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -89.03 168.54 12.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.446 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -81.83 142.98 32.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.349 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.561 ' CD ' ' H ' ' A' ' 183' ' ' GLN . 1.7 mp0 -51.26 149.88 3.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.544 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.2 t 46.28 -159.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.808 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -129.19 139.93 51.7 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.799 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.1 t -68.72 -148.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.985 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 187' ' ' ILE . 3.5 mp -73.7 125.48 32.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.537 HH22 ' CZ ' ' A' ' 189' ' ' ARG . 9.5 ptm180 -81.17 157.91 25.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.306 0.575 . . . . 0.0 111.46 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.537 ' CZ ' HH22 ' A' ' 188' ' ' ARG . 99.7 mtt180 54.48 61.61 2.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.861 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.28 155.97 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -134.6 131.73 6.02 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.212 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.1 mp -136.7 132.62 35.15 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.583 0.706 . . . . 0.0 109.902 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -162.42 -170.5 27.31 Favored Glycine 0 C--N 1.321 -0.27 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.1 m -134.69 160.91 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.435 1.118 . . . . 0.0 113.653 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mt -110.12 136.26 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 113.032 -1.895 . . . . 0.0 110.251 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -160.67 147.0 15.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.693 0.758 . . . . 0.0 110.871 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 163.06 -172.44 39.07 Favored Glycine 0 C--O 1.221 -0.686 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 133' ' ' PRO . 33.8 m -136.93 155.05 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 118.303 1.051 . . . . 0.0 109.472 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -154.78 159.51 29.03 Favored Glycine 0 C--O 1.241 0.555 0 C-N-CA 119.452 -1.356 . . . . 0.0 112.181 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.84 153.15 37.68 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.541 0.686 . . . . 0.0 110.557 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -59.52 149.5 29.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.065 -1.425 . . . . 0.0 113.971 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 206' ' ' LEU . 47.0 mm -111.31 -46.13 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.55 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.2 OUTLIER -127.43 -172.93 0.28 Allowed Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 175.171 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.55 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.8 OUTLIER -14.06 -85.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.401 0 CA-C-N 124.04 2.478 . . . . 0.0 114.869 -178.763 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -126.7 21.39 7.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.007 0.908 . . . . 0.0 110.057 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 202' ' ' ILE . 1.0 OUTLIER -75.08 112.98 11.88 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.515 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.6 t -130.87 152.59 50.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.45 143.07 44.2 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 113.082 -1.872 . . . . 0.0 107.9 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.81 150.68 49.05 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -126.31 134.15 51.2 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 231' ' ' SER . . . -174.57 -164.13 28.95 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 119.431 -1.366 . . . . 0.0 113.419 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -156.28 151.23 26.22 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 115.221 -0.49 . . . . 0.0 109.795 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 80.2 mtm-85 -92.6 124.93 36.98 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -107.07 125.41 51.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 109.97 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -56.61 156.97 5.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.556 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -45.38 160.24 0.05 OUTLIER 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.578 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -78.45 143.67 36.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.547 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -170.77 84.23 0.08 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -71.92 -22.04 61.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.544 0.211 . . . . 0.0 111.458 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 220' ' ' LEU . 11.1 mp -62.13 -41.45 98.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.12 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -157.03 133.15 9.66 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.97 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.637 ' C ' HD21 ' A' ' 222' ' ' ASN . 0.3 OUTLIER -161.91 70.54 0.33 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.98 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 19.7 m -66.33 -43.24 86.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.76 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -56.44 149.49 16.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.244 0.545 . . . . 0.0 111.189 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -101.55 152.03 21.27 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.009 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -88.27 -178.59 5.95 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.947 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.4 m -144.8 157.94 43.98 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.129 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -117.11 123.98 48.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.196 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -139.76 151.2 45.61 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.923 0.392 . . . . 0.0 110.623 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -97.88 76.13 2.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 211' ' ' GLY . 29.6 t -157.87 158.34 34.91 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.565 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.419 ' C ' HD13 ' A' ' 232' ' ' LEU . 0.3 OUTLIER -178.05 -72.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 147.7 -166.83 28.75 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.71 144.98 33.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -118.21 136.63 53.53 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -101.32 107.88 19.35 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.017 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.7 ' NH1' HH22 ' A' ' 66' ' ' ARG . 81.8 mtp180 -113.93 113.58 25.04 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.431 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 93.3 m-85 . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.428 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.6 p -102.72 75.14 1.4 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.748 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 56.3 mp0 -82.81 22.7 0.88 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.215 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -64.78 141.53 58.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.001 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.62 177.3 46.79 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.89 16.64 50.51 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.131 -0.787 . . . . 0.0 111.131 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -129.06 157.99 40.19 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.47 124.77 6.83 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.21 160.05 33.05 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.902 1.734 . . . . 0.0 109.583 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.708 ' CD2' ' NH2' ' A' ' 66' ' ' ARG . 33.1 t80 -151.07 136.98 18.15 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.45 -0.9 . . . . 0.0 113.01 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 12' ' ' GLN . 52.0 t -141.49 160.41 21.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.457 ' N ' HG12 ' A' ' 11' ' ' VAL . 57.6 tt0 -147.78 140.02 24.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.882 0.765 . . . . 0.0 112.856 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.01 122.9 45.53 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.158 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -83.11 124.82 30.84 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.4 tp -116.52 132.37 56.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.998 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.88 47.5 0.78 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.28 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' CD2' ' N ' ' A' ' 18' ' ' ALA . 68.1 t80 47.85 -104.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.926 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.45 ' N ' ' CD2' ' A' ' 17' ' ' TYR . . . -157.4 -134.72 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.761 0.315 . . . . 0.0 110.701 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -146.71 161.96 39.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.577 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -120.53 137.72 54.23 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.516 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -153.08 164.16 38.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.745 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 22' ' ' ILE . 16.0 tt -128.48 126.3 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.956 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.454 ' C ' ' ND1' ' A' ' 24' ' ' HIS . 69.2 p -129.59 -11.6 4.45 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.547 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.454 ' ND1' ' C ' ' A' ' 23' ' ' THR . 46.3 p-80 36.22 46.75 0.41 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.598 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -97.45 114.37 26.21 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.174 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 7.3 m-85 -54.31 149.66 19.07 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.58 152.76 78.76 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.871 1.714 . . . . 0.0 111.297 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 28' ' ' GLU . 20.2 mp0 -124.9 78.95 65.11 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.607 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -89.88 115.73 0.62 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 123.016 2.477 . . . . 0.0 112.251 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -65.47 -45.98 81.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.068 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 59.09 60.73 4.85 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.175 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.52 151.51 53.14 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.701 2.268 . . . . 0.0 112.036 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -103.82 144.83 30.97 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.681 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.81 125.22 28.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.382 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -159.3 171.73 19.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.424 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -89.69 96.13 10.56 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.9 pt -69.24 -40.85 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 m 58.34 9.25 0.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.778 0.323 . . . . 0.0 110.861 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.7 p -135.1 157.21 47.5 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.657 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 t -89.26 131.08 37.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.357 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.1 m -113.79 146.33 40.09 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.936 0.398 . . . . 0.0 110.537 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -86.75 155.05 20.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.885 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -110.5 149.96 29.58 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.437 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -99.27 130.89 45.59 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.028 0.442 . . . . 0.0 110.818 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -63.75 -158.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.937 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 57.14 60.0 3.16 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.25 -48.59 88.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.429 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -161.41 160.39 29.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.602 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.4 p -134.86 155.79 50.05 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.938 0.399 . . . . 0.0 110.723 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -161.28 -48.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.075 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 52' ' ' VAL . 88.8 p 54.51 -162.52 0.13 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.828 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 51' ' ' SER . 4.5 t 60.93 127.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -153.04 94.01 3.12 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -80.78 118.35 3.44 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.824 1.683 . . . . 0.0 110.006 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' HG13 ' A' ' 56' ' ' VAL . 39.6 mmt180 -71.08 -122.61 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 55' ' ' ARG . 8.3 m -157.18 -176.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 119.206 -0.998 . . . . 0.0 112.961 -176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.89 136.4 54.93 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.875 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.2 p -141.85 148.98 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.017 0.437 . . . . 0.0 111.776 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.58 -155.61 20.26 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -131.83 154.15 49.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.47 ' HB3' ' HE ' ' A' ' 66' ' ' ARG . 2.5 p30 -130.01 133.17 46.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -175.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.73 123.51 33.22 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.945 -1.48 . . . . 0.0 107.479 175.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -34.77 134.73 0.4 Allowed Glycine 0 N--CA 1.472 1.038 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.522 ' O ' ' CD2' ' A' ' 123' ' ' TYR . . . 97.64 -63.45 0.93 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -131.23 136.02 47.87 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.342 0.591 . . . . 0.0 111.153 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.708 ' NH2' ' CD2' ' A' ' 10' ' ' TYR . 54.9 mtp180 -137.01 156.05 48.92 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.1 tt -139.64 140.68 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.377 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.18 147.22 10.97 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.83 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.85 149.49 26.35 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -115.99 145.63 42.8 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.596 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 80.3 m-85 67.41 -98.08 0.04 OUTLIER 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.192 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 71' ' ' TYR . . . 96.83 81.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.468 1.105 . . . . 0.0 110.3 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -151.59 144.72 24.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 111.198 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 75' ' ' ARG . 32.0 p90 -178.59 13.09 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.509 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 74' ' ' TYR . 83.6 mtp180 -54.06 -123.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.723 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.1 tptp 64.95 48.84 2.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.646 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -92.57 148.99 21.64 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.618 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.5 ' CG ' ' H ' ' A' ' 79' ' ' ASN . 41.4 t-20 47.73 -139.86 0.63 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.234 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.5 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 91.3 m-20 55.33 43.03 29.62 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.765 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -56.11 109.88 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 0.0 110.146 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.96 155.69 47.83 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.539 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -62.88 121.77 14.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.0 110.89 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.418 ' H ' ' H ' ' A' ' 84' ' ' VAL . 18.7 p -161.44 -12.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.974 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 85' ' ' ASN . 55.5 t -124.38 133.75 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.06 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.42 ' O ' ' O ' ' A' ' 84' ' ' VAL . 86.2 m-20 56.07 111.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.555 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.9 mt -80.61 128.42 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.596 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -132.81 142.71 49.12 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.212 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 90' ' ' ARG . 49.3 p-10 -68.57 -27.07 65.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.804 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 88' ' ' ASN . 40.2 t 45.7 -87.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.517 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.547 ' N ' ' O ' ' A' ' 88' ' ' ASN . 89.7 mtm-85 -78.62 142.58 37.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.844 0.354 . . . . 0.0 110.348 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.495 ' C ' ' H ' ' A' ' 93' ' ' LYS . 42.7 pt -104.77 -141.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.865 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 94' ' ' GLU . 69.7 ttt180 68.52 -11.84 0.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' A' ' 91' ' ' ILE . 54.3 mtmt 48.89 -87.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.94 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 92' ' ' ARG . 49.9 tp10 -67.58 91.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.534 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -64.7 -40.97 96.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.719 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.0 98.82 0.09 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.0 pt -129.93 160.54 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 120.794 0.331 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -78.78 147.28 33.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.845 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.2 mt -81.25 128.09 39.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.228 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 101' ' ' ARG . 34.2 t70 -124.39 42.39 3.27 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.701 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 100' ' ' ASP . 77.2 ttt-85 58.01 150.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.333 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 103' ' ' THR . 63.6 mttp -64.54 -45.42 87.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.619 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER 27.56 -107.37 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.459 0.475 . . . . 0.0 111.621 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.508 ' N ' ' OG1' ' A' ' 103' ' ' THR . 97.6 mt-10 -83.76 151.85 24.99 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 107' ' ' GLU . 55.6 p30 -150.76 171.09 17.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.922 0.391 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -55.08 90.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.355 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 105' ' ' ASN . 80.8 tt0 -78.06 141.1 39.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.436 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 56.95 46.9 18.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.607 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -71.09 48.64 0.86 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 t -137.42 160.09 40.09 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.771 0.32 . . . . 0.0 110.376 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -95.8 136.84 35.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.992 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -83.55 152.91 24.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.652 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -153.45 39.53 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.437 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 115' ' ' SER . 69.1 t -62.76 -46.76 95.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.986 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 114' ' ' VAL . 2.9 t 34.79 97.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.638 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.441 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 26.3 t -158.99 74.02 0.63 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.748 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.34 142.6 49.39 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 168.22 -151.76 19.12 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 118.931 -1.604 . . . . 0.0 113.768 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.8 mt -113.32 160.17 18.63 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 114.993 -0.604 . . . . 0.0 109.84 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 p -143.67 129.17 19.07 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 111.818 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.0 130.03 40.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 123' ' ' TYR . 73.0 mt -123.9 161.59 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -175.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.526 ' N ' HG22 ' A' ' 122' ' ' ILE . 50.5 t80 -140.65 141.16 35.08 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.407 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 24.1 p-10 -143.38 138.63 29.54 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.279 0.561 . . . . 0.0 111.598 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.5 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 14.8 m-85 -83.97 83.56 7.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.048 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.432 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 13.9 mm100 -85.33 6.09 27.84 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.28 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 128' ' ' ASN . 20.4 tt -69.21 -40.16 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.421 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.548 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 20.1 p30 -90.65 -40.53 11.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.749 0.309 . . . . 0.0 110.202 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 1.2 m-20 77.1 -30.43 0.17 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.277 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -65.34 -45.04 85.8 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.059 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -154.49 116.16 4.15 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.568 0.699 . . . . 0.0 110.928 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.5 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 1.1 ptpp? -115.54 119.66 37.51 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.233 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -53.14 118.16 4.53 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 CA-C-N 119.736 0.941 . . . . 0.0 110.066 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -76.28 127.82 33.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.8 tt -155.98 146.46 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 118.768 -1.173 . . . . 0.0 112.818 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -169.76 178.63 42.62 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.22 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -116.19 157.4 24.9 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -124.83 138.47 54.26 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.33 114.05 32.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.97 152.65 51.91 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -104.26 160.75 14.62 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.426 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -126.62 -54.59 0.15 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -119.94 109.78 15.93 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.9 m -89.69 3.32 6.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.241 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.468 ' O ' ' CG ' ' A' ' 146' ' ' HIS . 59.1 ttm-85 55.71 -120.64 1.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.468 ' CG ' ' O ' ' A' ' 145' ' ' ARG . 79.0 m80 -157.77 -56.09 0.08 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.807 0.337 . . . . 0.0 110.457 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 85.6 p -73.96 151.9 40.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 149' ' ' ASP . 21.4 tt -133.19 -37.94 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.097 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 148' ' ' ILE . 53.3 t0 -70.18 147.78 49.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.633 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.7 m 60.02 115.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.802 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.7 p -129.92 -49.2 1.13 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.589 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -147.86 135.79 21.12 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.389 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 154' ' ' THR . 60.2 tttp -136.98 133.2 35.34 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.711 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 153' ' ' LYS . 5.6 m 57.47 153.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 156' ' ' GLU . 20.3 mm -106.17 117.71 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.549 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 155' ' ' ILE . 80.1 mm-40 56.82 140.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.338 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.9 m -106.11 -12.47 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.521 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 15.4 p -86.2 155.01 20.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.241 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 86.5 m -119.06 128.37 54.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.216 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.6 m -73.87 146.65 85.56 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.251 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.3 161.03 43.79 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.463 2.109 . . . . 0.0 112.235 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 70.7 m -68.65 148.81 49.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.773 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 57.72 34.7 24.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.296 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.678 ' HB3' ' HD3' ' A' ' 165' ' ' PRO . . . -66.59 -60.7 6.11 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 164' ' ' ALA . 77.5 Cg_endo -74.25 -172.48 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.222 1.948 . . . . 0.0 110.967 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 166' ' ' ASN . 61.7 t-20 57.11 38.27 28.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.866 0.365 . . . . 0.0 110.421 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -115.9 17.63 15.18 Favored Glycine 0 N--CA 1.466 0.636 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 61.28 -153.41 0.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.332 . . . . 0.0 110.53 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.7 m -113.05 131.96 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.911 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.6 m -61.77 -46.44 89.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.702 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 5.3 m -162.21 -47.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.095 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -83.26 137.93 33.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.132 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -63.8 -40.24 96.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.601 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 85.4 m 48.68 90.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.503 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -87.02 135.75 34.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.72 67.05 8.76 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.096 1.864 . . . . 0.0 111.504 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -62.65 -41.0 98.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.382 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.8 t -144.31 154.99 43.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.987 0.422 . . . . 0.0 110.913 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -103.31 147.55 26.93 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.327 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -95.85 11.33 34.08 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.562 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.28 108.02 13.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.978 0.418 . . . . 0.0 110.613 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -147.41 136.1 21.96 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.101 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -49.96 110.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.535 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.9 m -73.13 145.41 46.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.739 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -163.81 32.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.161 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 187' ' ' ILE . 75.1 p -58.3 -88.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.029 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.407 ' N ' ' OG ' ' A' ' 186' ' ' SER . 37.6 mm 50.24 87.78 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 42.38 -135.34 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.356 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -106.35 122.3 45.97 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.453 0.644 . . . . 0.0 111.816 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.5 t -121.15 132.78 69.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.853 ' C ' HD13 ' A' ' 192' ' ' LEU . . . -137.84 136.38 8.14 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 119.177 -1.487 . . . . 0.0 113.756 -176.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 1.059 ' H ' HD22 ' A' ' 192' ' ' LEU . 0.0 OUTLIER -117.52 148.75 41.57 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.378 -0.911 . . . . 0.0 108.81 178.408 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -169.28 -169.63 32.85 Favored Glycine 0 C--N 1.32 -0.312 0 N-CA-C 107.906 -2.077 . . . . 0.0 107.906 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.0 m -137.98 155.08 29.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.981 0.896 . . . . 0.0 111.972 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.6 tp -113.86 131.69 65.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.015 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.76 149.19 33.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.119 0.485 . . . . 0.0 111.259 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.94 -167.17 37.26 Favored Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 p -145.13 140.13 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 117.284 0.542 . . . . 0.0 110.46 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.48 130.55 9.18 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.38 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.606 ' N ' ' OG1' ' A' ' 207' ' ' THR . 2.6 t80 -115.09 118.71 34.14 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -61.26 149.88 36.42 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 206' ' ' LEU . 51.4 mm -113.35 -61.13 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.515 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.7 OUTLIER -102.11 -173.14 0.28 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 175.46 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.515 ' C ' ' O ' ' A' ' 203' ' ' THR . 5.5 Cg_exo -22.76 -79.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.352 0 CA-C-N 123.281 2.208 . . . . 0.0 114.486 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -128.33 34.89 4.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.543 0.687 . . . . 0.0 111.181 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 202' ' ' ILE . 0.3 OUTLIER -90.31 111.7 23.01 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.207 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.606 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 0.9 OUTLIER -132.51 152.52 51.53 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.17 140.52 29.42 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.453 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 233' ' ' GLY . 4.4 m-20 -118.94 138.83 52.51 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -121.69 123.43 41.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 113.717 -1.583 . . . . 0.0 107.841 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -160.17 -175.81 31.56 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.365 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -141.96 154.21 44.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.78 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.533 ' N ' ' NE ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -83.5 139.1 33.12 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -128.38 89.96 2.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.72 0.295 . . . . 0.0 110.667 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -101.64 140.01 36.52 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.65 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.8 t30 60.29 70.47 0.62 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 111.16 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -59.65 -41.56 90.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.959 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -126.82 -142.9 5.72 Favored Glycine 0 N--CA 1.468 0.816 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 56.45 66.63 1.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.749 0.309 . . . . 0.0 110.261 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 40.9 tp 40.61 80.82 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.685 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -87.53 123.41 32.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.559 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -82.71 141.75 32.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.93 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 23.8 m -73.33 120.1 18.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.963 0.411 . . . . 0.0 110.996 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -160.31 152.84 20.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.854 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -148.94 152.26 36.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.87 0.367 . . . . 0.0 110.861 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -146.94 -69.56 0.25 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.508 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.9 p -62.77 -78.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.214 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 71.9 t60 38.71 78.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.949 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' A' ' 230' ' ' ALA . 84.0 tt0 -145.17 -92.01 0.1 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.324 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 229' ' ' GLU . . . 169.18 86.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 38.6 p -160.2 167.66 27.13 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.099 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 26.8 tp -177.72 -63.9 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.807 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.429 ' O ' ' OD2' ' A' ' 209' ' ' ASP . . . 160.57 -168.82 36.17 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 119.929 -1.129 . . . . 0.0 112.781 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.0 127.92 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.731 ' NH2' HH11 ' A' ' 237' ' ' ARG . 0.2 OUTLIER -104.95 141.95 35.64 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.05 0.453 . . . . 0.0 110.425 -179.028 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -107.62 108.68 20.06 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.053 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.731 HH11 ' NH2' ' A' ' 235' ' ' ARG . 82.4 mtp180 -129.38 120.11 25.0 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.407 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 1.6 m-85 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.707 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 4' ' ' ASP . 34.2 t -85.41 65.13 9.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.497 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 4' ' ' ASP . 83.1 tt0 47.42 -97.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.522 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 3' ' ' GLU . 6.8 p-10 41.43 -169.18 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.908 0.385 . . . . 0.0 111.029 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.51 14.56 50.47 Favored Glycine 0 N--CA 1.465 0.627 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.18 -57.81 15.35 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.031 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -139.76 148.12 41.81 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 117.03 0.415 . . . . 0.0 110.896 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.413 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . -166.35 -174.84 36.12 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.708 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.471 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 95.9 Cg_endo -82.69 176.65 7.59 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.884 3.056 . . . . 0.0 113.525 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.401 ' CE1' ' NH1' ' A' ' 66' ' ' ARG . 75.8 t80 -141.26 145.09 35.11 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 t -152.7 145.41 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 114.417 -1.265 . . . . 0.0 108.027 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.53 150.6 27.95 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.94 147.01 52.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 112.13 -2.304 . . . . 0.0 105.931 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -152.76 137.57 17.06 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.52 133.39 45.03 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.063 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.15 -87.55 0.48 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.522 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -120.81 122.99 41.51 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.463 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.2 162.37 16.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.845 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -148.4 160.21 43.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.32 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.89 119.62 39.44 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.448 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.633 ' CG ' ' H ' ' A' ' 22' ' ' ILE . 37.7 t-80 -87.63 178.55 6.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.429 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.633 ' H ' ' CG ' ' A' ' 21' ' ' HIS . 20.7 tt -118.43 140.02 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.538 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.3 p -129.79 164.32 24.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.287 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -81.5 112.77 19.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.624 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -76.29 145.05 39.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.653 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -43.52 163.49 0.16 Allowed Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.149 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.43 ' O ' ' OE1' ' A' ' 28' ' ' GLU . 25.5 Cg_exo -60.76 146.92 96.58 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.478 1.452 . . . . 0.0 111.975 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.536 ' H ' ' HD2' ' A' ' 29' ' ' PRO . 1.3 tp10 -179.01 -45.44 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.437 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.536 ' HD2' ' H ' ' A' ' 28' ' ' GLU . 51.8 Cg_exo -54.26 -37.29 88.19 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.333 2.022 . . . . 0.0 112.225 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 30' ' ' THR . 1.3 t -80.45 159.07 25.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.586 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . . . 177.82 -47.92 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.473 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 31' ' ' ALA . 50.8 Cg_exo -53.73 -41.08 77.09 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.251 1.967 . . . . 0.0 112.319 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' LYS . 20.4 t-20 -175.07 -93.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 0.0 110.455 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.479 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 45.3 mmtm 49.7 -177.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.075 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -152.3 58.28 0.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.595 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -72.67 -79.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.8 pt -75.18 -23.26 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.101 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -60.21 -42.35 94.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.089 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.4 m -124.59 132.3 53.44 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.9 0.381 . . . . 0.0 110.672 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.85 134.6 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.167 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 t -164.63 22.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.452 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -80.3 166.18 21.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.749 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -147.25 159.32 43.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -73.42 139.99 46.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.53 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -156.08 156.35 34.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.442 ' C ' ' H ' ' A' ' 48' ' ' ARG . 98.8 m-20 54.44 103.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.992 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -77.02 27.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.647 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 46' ' ' ASN . 11.6 ptp180 -44.62 -21.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.953 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.42 ' N ' ' C ' ' A' ' 47' ' ' ILE . 22.7 p -69.08 81.68 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.533 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -147.08 129.49 15.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 110.662 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 52' ' ' VAL . 47.1 t -139.79 -85.68 0.22 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.797 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 51' ' ' SER . 3.0 t 56.41 152.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.804 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.3 m170 55.18 79.1 0.35 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.245 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 55' ' ' ARG . 56.5 Cg_endo -90.22 79.67 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.011 2.474 . . . . 0.0 112.834 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 54' ' ' PRO . 56.8 ttp180 29.85 102.91 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 p -142.71 146.05 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.6 m -128.86 149.09 50.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.207 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.31 153.29 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.81 -148.73 7.53 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 61' ' ' ASP . 16.4 t80 -138.8 155.95 47.75 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 9' ' ' PRO . 7.4 p-10 -133.06 134.68 44.66 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -127.12 147.93 50.16 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 175.528 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.34 140.58 32.33 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.841 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.2 -35.21 2.98 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.11 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.454 ' O ' ' O ' ' A' ' 62' ' ' PHE . 84.6 m95 -139.4 131.13 27.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.406 0.603 . . . . 0.0 111.606 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.401 ' NH1' ' CE1' ' A' ' 10' ' ' TYR . 46.0 ttp180 -144.21 132.5 21.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.751 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.622 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -139.35 153.62 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.923 0.868 . . . . 0.0 112.358 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.39 140.0 8.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.934 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.98 146.01 24.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.698 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -93.31 128.74 39.46 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.515 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -109.24 140.14 43.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.498 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 73' ' ' ARG . . . -150.65 -75.49 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.486 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 72' ' ' ALA . 66.6 ttt180 56.73 136.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.162 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -145.21 149.88 35.71 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.149 0.5 . . . . 0.0 111.28 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -164.4 -174.41 3.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.829 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.4 tttm 67.19 47.85 1.28 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.833 0.349 . . . . 0.0 110.581 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.417 ' O ' ' O ' ' A' ' 78' ' ' ASN . 51.0 t90 -60.78 -46.47 90.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.816 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 77' ' ' TRP . 91.4 m-20 39.94 -161.94 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.793 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -65.0 141.74 58.67 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 82' ' ' TYR . 53.0 t-20 -101.0 -122.32 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.002 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 82' ' ' TYR . 17.8 ptpt -70.78 25.24 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.427 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.547 ' CG ' ' O ' ' A' ' 81' ' ' LYS . 53.9 p90 43.04 -170.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.02 0.438 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 84' ' ' VAL . 78.4 p -156.03 120.26 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.36 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 83' ' ' SER . 24.2 t 47.15 102.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.218 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -153.23 -85.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.572 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' GLU . 43.9 pt -91.47 -158.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.69 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 86' ' ' ILE . 83.0 tt0 59.59 124.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.332 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 87' ' ' GLU . 92.1 m-20 -145.72 178.9 7.81 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.713 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.8 p -91.33 136.78 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.39 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -120.2 131.85 55.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.751 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.536 HG22 ' N ' ' A' ' 92' ' ' ARG . 86.9 mt 35.17 -101.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.33 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.536 ' N ' HG22 ' A' ' 91' ' ' ILE . 62.0 ttp180 -171.57 92.25 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.037 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -84.13 153.92 23.44 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -41.26 110.01 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.867 0.365 . . . . 0.0 110.695 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -63.08 -40.79 98.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.931 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 99' ' ' ILE . . . 83.76 57.61 2.4 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.71 -42.95 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.762 0.315 . . . . 0.0 110.647 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.0 tpp85 -57.87 -46.36 84.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.848 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.444 ' O ' ' O ' ' A' ' 96' ' ' GLY . 42.1 pt -137.61 148.22 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.924 0.392 . . . . 0.0 110.772 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -79.85 152.63 29.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -69.83 148.58 48.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.36 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -143.24 156.5 44.76 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.73 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 t -144.41 156.28 44.14 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.438 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -124.92 -160.46 0.95 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.544 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 m120 57.74 36.53 26.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.861 0.362 . . . . 0.0 110.44 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.52 -12.7 61.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.347 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -70.18 -3.39 16.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.33 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -62.24 -41.19 98.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.582 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.37 145.93 31.1 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.7 p -116.4 130.71 56.91 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.833 0.349 . . . . 0.0 110.327 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -77.36 145.13 37.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.561 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -93.18 109.04 20.54 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.55 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.37 144.41 44.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.737 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.27 139.69 18.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.001 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.9 p -56.85 139.46 51.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.143 0.497 . . . . 0.0 111.769 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.8 m -161.45 147.84 14.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.365 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.1 mt -91.5 130.94 37.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -109.4 147.7 16.99 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.372 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.9 tp -128.3 133.0 48.65 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.3 m -137.27 116.42 12.54 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.555 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.98 134.14 55.44 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.168 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 123' ' ' TYR . 74.5 mt -119.73 158.94 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.522 ' N ' HG22 ' A' ' 122' ' ' ILE . 31.7 m-85 -113.73 109.71 19.0 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' OD2' ' NH1' ' A' ' 237' ' ' ARG . 20.9 t70 -107.36 138.64 43.19 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -116.87 152.37 34.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.677 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -147.37 44.22 1.13 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.7 mt -69.18 -42.46 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -96.0 -13.15 24.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.41 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 61.88 29.42 17.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.336 0.588 . . . . 0.0 109.984 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -125.64 -51.5 1.6 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.846 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 131' ' ' PHE . 43.1 p90 -175.16 131.78 0.3 Allowed 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.247 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -134.21 151.64 76.81 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.846 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.22 130.98 20.99 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.507 1.471 . . . . 0.0 109.899 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.474 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 2.4 p90 -120.55 133.32 55.4 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 39.9 pt -135.55 152.76 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.286 0.565 . . . . 0.0 111.424 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.84 174.89 39.24 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -117.2 143.08 46.25 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.935 0.398 . . . . 0.0 110.194 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -116.92 116.89 28.28 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.401 HG22 ' N ' ' A' ' 140' ' ' ALA . 12.6 p -124.65 158.95 31.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' ' 139' ' ' VAL . . . -135.71 142.97 45.14 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.647 0.737 . . . . 0.0 112.572 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -132.39 132.5 42.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.304 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -96.78 -133.85 7.89 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.842 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -142.17 165.9 26.17 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.5 m -133.35 158.57 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.07 0.462 . . . . 0.0 110.866 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -103.39 153.91 19.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.303 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -60.22 103.72 0.26 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.155 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.5 t -61.73 -42.19 98.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.325 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 92.2 mt -89.79 121.1 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.293 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 151' ' ' THR . 53.4 p30 -157.37 174.93 14.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.667 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 152' ' ' LYS . 10.3 m 53.49 -83.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.924 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.516 ' N ' ' O ' ' A' ' 149' ' ' ASP . 24.4 p -47.3 89.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 150' ' ' SER . 52.5 tptt -64.95 -45.26 86.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.46 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 55.96 168.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.486 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.2 t -149.24 171.21 16.84 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.908 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 34.2 pt -67.67 140.25 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.797 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -74.05 121.49 21.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.304 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.73 -42.7 93.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 58.9 p -120.55 153.49 36.67 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.49 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.7 m -99.14 126.08 44.82 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.999 0.428 . . . . 0.0 111.218 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 52.2 t -115.82 110.99 43.6 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.617 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -53.3 144.52 48.74 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.358 1.372 . . . . 0.0 112.149 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 85.9 p -73.81 154.36 39.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.804 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -107.56 6.86 28.38 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.704 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.13 62.46 0.76 Allowed Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.454 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.8 158.44 42.95 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.668 2.245 . . . . 0.0 111.536 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -77.64 106.55 9.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 0.0 110.481 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -69.21 149.0 48.37 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.55 -11.37 60.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.679 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.8 t -84.23 119.22 32.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.72 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 172' ' ' TYR . 5.2 m -158.88 -14.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.35 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 173' ' ' ASN . 51.2 p 47.53 11.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.035 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 172' ' ' TYR . 89.8 t80 49.61 9.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.029 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 171' ' ' THR . 57.3 t-20 -140.46 -0.12 1.61 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.03 0.443 . . . . 0.0 110.172 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 93.7 m -63.67 -45.18 91.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.929 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -86.86 132.5 41.91 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.853 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.66 116.46 3.51 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.084 1.856 . . . . 0.0 111.856 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -87.64 118.47 27.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.831 0.348 . . . . 0.0 110.618 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 180' ' ' ASN . 3.0 t -147.86 146.29 29.02 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.437 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 44.31 14.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.078 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 178' ' ' THR . 85.4 m-20 -137.25 27.24 2.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.442 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.51 143.66 57.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.849 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -146.53 158.07 43.84 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.433 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -73.78 -89.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.286 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.8 m -140.41 67.2 1.37 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.073 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 43.15 -105.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.575 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.4 t 53.69 73.72 0.36 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 65.8 mt -62.91 -45.17 99.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.031 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -70.66 140.78 51.63 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -80.57 151.89 28.88 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.81 148.83 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 114.029 -1.442 . . . . 0.0 108.855 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -130.34 126.2 4.89 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 7.4 tt -120.57 123.52 43.08 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 122.066 0.936 . . . . 0.0 111.415 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -138.06 157.37 24.31 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.59 139.63 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 117.41 0.605 . . . . 0.0 111.463 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 tt -116.42 132.98 64.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.472 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.52 34.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.04 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 162.5 -165.88 36.35 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.3 p -136.41 146.57 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 120.975 0.417 . . . . 0.0 109.974 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -117.67 137.37 13.18 Favored Glycine 0 C--O 1.244 0.754 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.977 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.634 ' N ' ' OG1' ' A' ' 207' ' ' THR . 10.7 t80 -122.16 120.0 32.94 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.689 0.876 . . . . 0.0 109.301 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 22.6 p30 -61.94 139.38 58.4 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.528 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 202' ' ' ILE . 63.9 mt -125.18 -5.59 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-O 122.523 1.154 . . . . 0.0 109.499 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.581 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -160.35 -178.64 0.92 Allowed Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 101.271 -3.603 . . . . 0.0 101.271 177.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.581 ' C ' ' O ' ' A' ' 203' ' ' THR . 13.8 Cg_exo -18.95 -83.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 CA-C-N 123.965 2.452 . . . . 0.0 114.089 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -128.92 20.2 5.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.661 0.743 . . . . 0.0 109.884 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.408 ' HB3' ' OG1' ' A' ' 203' ' ' THR . 5.9 tt -78.98 124.18 28.01 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 1.8 t -143.42 154.08 43.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.411 HD23 ' C ' ' A' ' 208' ' ' LEU . 7.7 tt -91.55 126.65 36.71 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 112.92 -1.945 . . . . 0.0 105.797 175.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 210' ' ' ALA . 41.5 t0 -102.12 144.49 30.61 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -175.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.517 ' N ' ' OD1' ' A' ' 209' ' ' ASP . . . -125.17 113.68 18.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.346 -1.752 . . . . 0.0 107.538 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -175.38 -165.27 31.25 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -147.07 161.36 41.0 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.951 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.2 ttp-105 -129.57 103.24 6.76 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.432 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.529 ' CD1' ' NE2' ' A' ' 228' ' ' HIS . 84.6 t80 -174.68 148.69 1.15 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.064 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -159.1 -84.61 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.66 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -84.49 153.12 23.51 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.907 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -59.41 -47.78 84.17 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.446 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 79.29 152.91 7.23 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 45.97 -172.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.982 0.42 . . . . 0.0 111.292 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 222' ' ' ASN . 2.1 mm? -76.1 142.69 41.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.672 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -70.83 31.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.141 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 220' ' ' LEU . 8.6 p30 -68.52 102.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER 34.57 -103.87 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.78 -179.067 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.55 ' N ' ' OG1' ' A' ' 223' ' ' THR . 34.4 mmt180 28.07 98.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.336 0.398 . . . . 0.0 111.918 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 225' ' ' PHE . 52.1 p90 -105.91 129.72 54.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.51 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -111.41 -177.83 3.29 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.339 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.9 t -145.11 154.55 42.58 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.254 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.529 ' NE2' ' CD1' ' A' ' 214' ' ' TYR . 28.1 m170 -106.97 -63.48 1.28 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.039 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 52.04 44.18 29.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.987 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 51.48 -177.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.362 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.1 t -149.26 143.42 25.86 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 120.989 0.423 . . . . 0.0 110.543 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 59.4 mt -112.78 137.68 50.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -148.63 165.75 29.17 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.339 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.19 127.4 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.77 145.58 44.74 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.083 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -112.91 116.35 29.85 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.405 ' NH1' ' OD2' ' A' ' 124' ' ' ASP . 81.4 mtm180 -124.34 133.05 53.55 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.904 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.548 ' OXT' ' CG ' ' A' ' 238' ' ' PHE . 85.1 t80 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.546 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 t -69.78 143.29 53.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.552 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -163.95 97.98 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.915 0.388 . . . . 0.0 110.643 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -91.84 106.22 18.3 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.403 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.91 168.65 37.69 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.535 ' O ' ' CZ ' ' A' ' 238' ' ' PHE . . . 168.24 -82.81 0.1 OUTLIER Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.931 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -78.74 142.34 37.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 111.62 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.29 178.56 40.15 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.159 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.66 152.71 25.99 Favored 'Trans proline' 0 N--CA 1.507 2.291 0 C-N-CA 124.153 3.236 . . . . 0.0 116.397 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.53 ' CD2' ' NH2' ' A' ' 66' ' ' ARG . 6.7 p90 -148.69 164.67 33.66 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.442 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 p -131.99 153.99 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.402 0.62 . . . . 0.0 112.527 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -120.95 142.61 49.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.032 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 14' ' ' ASP . . . -142.87 149.86 39.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.471 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 13' ' ' ALA . 92.4 m-20 -140.52 147.26 39.26 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.491 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -168.16 -175.77 2.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.721 177.841 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.89 -60.79 0.77 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.897 0.38 . . . . 0.0 110.179 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.0 t80 58.96 119.76 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.774 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -165.45 -80.9 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.342 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -144.63 93.29 2.4 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.327 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -82.12 142.56 32.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.749 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -111.74 131.0 55.61 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.399 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 22' ' ' ILE . 1.6 pp -130.17 164.62 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.561 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.7 m -62.33 134.56 56.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.228 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -64.97 106.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.212 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.05 -45.48 92.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.568 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -38.67 101.35 0.23 Allowed Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.817 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.52 -38.96 75.78 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.807 1.671 . . . . 0.0 112.518 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -124.14 85.78 54.61 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.003 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.56 162.41 30.38 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.177 1.918 . . . . 0.0 111.643 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 76.7 p -48.38 130.35 16.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 110.586 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 30' ' ' THR . . . 177.06 74.63 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.268 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.96 -40.61 75.53 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.691 2.261 . . . . 0.0 112.206 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -149.43 93.31 2.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.744 0.307 . . . . 0.0 111.064 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -141.14 119.26 12.01 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -103.31 6.97 38.32 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.364 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -65.33 -27.88 68.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.913 0.387 . . . . 0.0 110.553 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.6 mm -60.67 -43.91 95.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.723 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.7 t -59.61 141.99 53.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.612 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 60.7 m 49.29 97.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.577 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.6 t -100.96 114.27 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.545 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.5 m -89.74 -12.15 40.21 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -88.63 116.06 26.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.732 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.31 137.22 35.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.556 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -83.22 129.47 35.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.655 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -129.47 152.32 49.14 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.242 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 50.9 p-10 -146.45 88.62 1.79 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.351 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.8 tt -65.63 -40.04 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.803 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -78.37 88.75 4.37 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.57 -61.38 1.39 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.593 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -71.51 130.57 41.6 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.282 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 p -83.25 146.79 28.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.124 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 52' ' ' VAL . 3.2 p -161.67 78.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.524 0.678 . . . . 0.0 109.624 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.622 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 25.0 m170 -91.89 -26.66 0.29 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 53' ' ' HIS . 84.4 Cg_exo -47.65 -71.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.565 1.51 . . . . 0.0 111.942 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.573 HH12 ' CD2' ' A' ' 228' ' ' HIS . 86.8 mtm180 31.63 97.59 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.552 0.532 . . . . 0.0 111.277 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 57' ' ' SER . 29.6 t -142.69 159.06 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.83 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.501 ' N ' HG12 ' A' ' 56' ' ' VAL . 42.5 t -146.75 138.16 24.32 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.626 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -138.22 157.56 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.63 -178.63 38.17 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 119.844 -1.169 . . . . 0.0 113.605 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -104.93 129.64 53.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.395 -0.902 . . . . 0.0 109.224 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB2' HH21 ' A' ' 66' ' ' ARG . 61.1 t0 -100.41 121.5 41.63 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -175.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -125.4 121.64 34.45 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -50.54 113.88 2.31 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' A' ' 65' ' ' TRP . . . 120.01 -49.38 0.88 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 64' ' ' GLY . 8.3 m0 -146.46 136.09 23.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 117.136 0.468 . . . . 0.0 109.986 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.698 HH12 ' CZ ' ' A' ' 237' ' ' ARG . 26.7 mtp180 -133.8 147.13 51.22 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.988 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.2 126.36 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 120' ' ' SER . . . -128.44 113.4 15.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.006 0.431 . . . . 0.0 110.024 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.78 127.08 34.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.893 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -101.8 128.9 47.95 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -149.68 159.15 44.57 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.92 0.867 . . . . 0.0 111.892 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -156.97 -160.63 0.98 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.528 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -96.9 139.35 33.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.408 . . . . 0.0 111.09 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 75' ' ' ARG . 41.6 t80 -111.21 -43.51 3.71 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.371 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 74' ' ' TYR . 6.6 mmp_? 40.56 111.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.748 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.443 ' HG2' ' H ' ' A' ' 78' ' ' ASN . 78.5 tttt -135.87 138.3 42.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.454 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -48.81 -14.37 0.07 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.281 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.443 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 66.1 t30 59.14 58.73 2.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.556 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -84.93 102.27 13.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.619 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.57 -40.81 96.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.525 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -136.22 139.53 42.84 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.001 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.48 140.77 46.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.994 0.426 . . . . 0.0 110.913 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.4 t -96.63 96.88 8.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.124 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.433 HG22 ' H ' ' A' ' 86' ' ' ILE . 14.4 p -140.91 137.78 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.485 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -121.47 44.34 2.58 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.986 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.813 HG23 ' H ' ' A' ' 87' ' ' GLU . 13.7 tt -62.04 -63.97 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.757 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.813 ' H ' HG23 ' A' ' 86' ' ' ILE . 97.6 mt-10 37.9 22.92 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.732 0.301 . . . . 0.0 111.245 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.558 ' N ' ' O ' ' A' ' 86' ' ' ILE . 99.0 m-20 -71.31 -70.69 0.3 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.739 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.712 ' O ' HG22 ' A' ' 89' ' ' VAL . 7.1 p 36.65 25.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.322 0.582 . . . . 0.0 110.876 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 88' ' ' ASN . 34.0 ptt180 -119.96 12.76 12.08 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.675 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 95.5 mt -90.29 122.84 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.232 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -63.41 -43.97 96.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.234 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -173.75 130.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.37 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' OE1' ' OD1' ' A' ' 95' ' ' ASN . 6.5 tm-20 -172.61 -43.63 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.467 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.486 ' C ' ' H ' ' A' ' 97' ' ' ILE . 99.1 m-20 -96.16 14.28 24.49 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.656 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.79 37.89 0.5 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.486 ' H ' ' C ' ' A' ' 95' ' ' ASN . 97.0 mt -63.88 -43.6 97.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.622 0.249 . . . . 0.0 111.182 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 100' ' ' ASP . 31.3 mmt180 55.03 96.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 0.0 110.346 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' A' ' 102' ' ' LYS . 82.4 mt 45.68 -94.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.375 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 102' ' ' LYS . 56.2 t0 42.53 63.48 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.359 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 102' ' ' LYS . 67.2 ttp85 62.67 -3.41 0.3 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.634 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 100' ' ' ASP . 99.7 mttt 54.0 169.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.15 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.1 p -100.74 1.61 40.54 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 55.43 46.44 23.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.445 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 49.71 -95.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.446 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -91.33 122.72 34.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.316 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -85.2 -178.83 6.87 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.83 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.0 m120 53.7 -92.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.991 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.18 161.95 32.98 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.5 t -135.27 148.38 49.53 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.876 0.369 . . . . 0.0 110.206 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -107.56 127.11 53.34 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.274 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -72.57 134.93 45.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.27 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.15 122.94 18.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.993 0.425 . . . . 0.0 110.669 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.97 133.36 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.779 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.6 t -162.94 54.1 0.19 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.731 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 97.3 p -87.02 104.75 16.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.45 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.435 HD23 ' C ' ' A' ' 117' ' ' LEU . 6.4 tt -136.34 121.67 19.27 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 178.87 -145.53 6.79 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.124 -1.512 . . . . 0.0 113.083 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 95.5 mt -117.69 154.35 31.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.608 0.718 . . . . 0.0 110.91 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 69.6 m -144.96 98.73 3.22 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.42 114.66 11.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.311 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.1 mt -110.81 134.02 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.452 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 29.4 p90 -132.6 120.45 21.82 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.408 -177.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -97.74 143.22 28.6 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 112.904 -1.953 . . . . 0.0 108.328 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.579 ' C ' ' H ' ' A' ' 127' ' ' ILE . 15.0 m-85 -102.45 113.01 25.98 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.631 0.729 . . . . 0.0 111.376 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -65.37 11.88 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.253 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.579 ' H ' ' C ' ' A' ' 125' ' ' PHE . 8.3 tp -68.06 -40.31 82.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.19 0.519 . . . . 0.0 110.484 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.495 ' N ' HG23 ' A' ' 127' ' ' ILE . 24.4 m120 -99.77 141.3 32.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.301 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -79.45 -60.81 2.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -66.33 -41.89 88.96 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 131' ' ' PHE . 48.0 p90 -145.61 143.16 29.71 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 119.194 -0.432 . . . . 0.0 111.472 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.62 132.82 23.68 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 118.254 0.479 . . . . 0.0 110.267 178.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.62 136.68 21.6 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 N-CA-C 108.05 -1.558 . . . . 0.0 108.05 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 199' ' ' GLY . 0.8 OUTLIER -132.41 144.24 50.36 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 122.329 1.062 . . . . 0.0 112.312 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 136' ' ' GLY . 94.2 mt -135.04 161.48 40.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 113.338 -1.756 . . . . 0.0 107.895 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 135' ' ' ILE . . . -161.22 160.03 31.73 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 118.929 -1.605 . . . . 0.0 114.185 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -107.94 135.45 49.3 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -118.43 125.79 50.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 139' ' ' VAL . 18.4 m -117.89 113.92 43.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.09 125.53 51.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.36 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -112.26 153.18 27.54 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.716 0.77 . . . . 0.0 112.522 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -123.95 -102.51 1.52 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.429 ' N ' ' ND1' ' A' ' 143' ' ' HIS . 0.0 OUTLIER -157.17 150.49 23.96 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.092 0.473 . . . . 0.0 111.834 178.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 50.7 t -126.58 135.08 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.225 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 121.49 26.15 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.475 ' CG ' ' N ' ' A' ' 147' ' ' SER . 56.3 p-80 -149.64 -45.45 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.407 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.475 ' N ' ' CG ' ' A' ' 146' ' ' HIS . 6.5 p 58.93 134.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.707 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 82.5 mt -104.28 116.39 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.188 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 150' ' ' SER . 52.4 t0 -155.76 78.82 1.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 149' ' ' ASP . 15.7 t 57.32 153.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.011 0.434 . . . . 0.0 110.758 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.4 m -63.68 -31.9 73.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.821 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.4 -42.64 96.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.79 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.523 ' CD ' ' H ' ' A' ' 154' ' ' THR . 1.6 tmtm? 63.81 -162.29 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.988 0.423 . . . . 0.0 110.472 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.523 ' H ' ' CD ' ' A' ' 153' ' ' LYS . 44.6 p 52.87 -136.01 1.43 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.54 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 91.6 mt 49.92 -87.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.609 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 154' ' ' THR . 73.0 mm-40 -65.09 132.98 50.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.734 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.612 HG12 ' N ' ' A' ' 158' ' ' THR . 38.5 t 52.02 168.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.826 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.612 ' N ' HG12 ' A' ' 157' ' ' VAL . 71.4 p -76.57 153.77 35.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.004 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 13.7 t -114.06 157.25 22.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.922 0.391 . . . . 0.0 110.719 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.8 t -59.67 125.23 79.36 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.957 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -42.18 145.25 0.89 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.936 1.757 . . . . 0.0 112.93 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.7 t -61.55 -43.54 98.67 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.515 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 55.53 50.95 13.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.669 0.271 . . . . 0.0 110.665 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.87 149.64 0.8 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.425 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -73.02 150.41 48.47 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.232 1.954 . . . . 0.0 111.854 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -144.04 130.22 19.68 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 110.849 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.43 66.35 2.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 169' ' ' VAL . . . -63.57 141.83 58.62 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.156 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 168' ' ' ALA . 46.9 t 54.07 106.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.569 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.73 114.03 13.67 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.399 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 42.0 p -69.24 -33.31 73.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.114 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -94.75 134.37 37.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.044 0.449 . . . . 0.0 111.262 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -154.47 45.0 0.54 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.001 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.2 t -109.31 19.93 18.83 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.486 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 32.0 p-10 -66.73 137.77 95.11 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.723 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.69 31.56 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.199 1.933 . . . . 0.0 111.834 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 178' ' ' THR . 22.6 pttm -157.32 134.7 10.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.927 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 177' ' ' LYS . 59.3 p 45.67 -173.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.887 0.375 . . . . 0.0 110.685 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 56.18 96.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.343 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 62.0 t30 58.85 32.65 22.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.769 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 181' ' ' ASP . 65.2 t0 -70.95 -39.36 72.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.911 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -141.82 157.7 44.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.782 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 43.81 -99.37 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.145 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 t -145.74 -90.04 0.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -130.59 -6.11 4.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.753 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 42.7 t -150.86 147.63 27.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.447 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.598 ' C ' HD12 ' A' ' 187' ' ' ILE . 2.3 pp -97.73 9.14 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.27 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.416 ' N ' HD12 ' A' ' 187' ' ' ILE . 39.4 ptt180 -48.92 135.29 15.81 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -98.2 97.67 9.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.502 0.668 . . . . 0.0 112.248 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.56 160.6 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.35 130.35 4.57 Favored Glycine 0 N--CA 1.47 0.935 0 C-N-CA 119.888 -1.149 . . . . 0.0 113.425 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.83 137.09 53.14 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -164.26 -168.75 26.81 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.84 145.52 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.539 0.685 . . . . 0.0 111.847 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.0 mm -112.53 128.92 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.79 162.61 38.23 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.385 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.489 ' O ' ' CD1' ' A' ' 134' ' ' TYR . . . 157.99 178.87 32.43 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.16 139.82 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 134' ' ' TYR . . . -120.83 137.85 12.29 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 120.169 -1.015 . . . . 0.0 114.475 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.422 ' C ' ' OG1' ' A' ' 207' ' ' THR . 90.6 m-85 -104.62 106.67 17.26 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 114.131 -1.034 . . . . 0.0 108.593 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 201' ' ' ASP . 9.9 p30 -63.31 149.79 44.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.463 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.8 mm -102.98 -74.73 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.462 ' O ' ' C ' ' A' ' 204' ' ' PRO . 1.4 p -80.18 -167.85 0.15 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.462 ' C ' ' O ' ' A' ' 203' ' ' THR . 1.5 Cg_exo -33.76 -74.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 CA-C-N 122.69 1.996 . . . . 0.0 114.678 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 237' ' ' ARG . 10.0 mptt -125.19 20.19 8.19 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.251 0.932 . . . . 0.0 110.789 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 206' ' ' LEU . 0.9 OUTLIER -76.88 122.94 25.54 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 176.079 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.422 ' OG1' ' C ' ' A' ' 200' ' ' PHE . 2.8 t -136.41 148.57 47.86 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 50.3 tp -99.15 118.1 35.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -130.12 142.73 50.57 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -87.76 109.05 19.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 231' ' ' SER . . . -130.5 144.05 15.4 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.342 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -137.83 153.54 49.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.033 -0.583 . . . . 0.0 109.955 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.401 ' NH1' ' NE2' ' A' ' 215' ' ' HIS . 3.7 ppt_? -120.57 140.46 51.47 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -140.01 155.66 46.98 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.005 0.431 . . . . 0.0 111.437 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.401 ' NE2' ' NH1' ' A' ' 213' ' ' ARG . 13.9 m170 -99.17 142.19 30.97 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.758 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 217' ' ' TRP . 38.0 p-10 -64.12 -41.75 97.11 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.169 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.479 ' N ' ' OD1' ' A' ' 216' ' ' ASN . 57.4 t-105 -118.53 137.49 53.18 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -77.0 91.57 1.01 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -110.14 6.41 22.76 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.759 0.314 . . . . 0.0 110.545 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 220' ' ' LEU . 10.2 mp -74.02 145.26 44.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.534 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -56.11 -172.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.494 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 224' ' ' ARG . 23.6 t-20 -63.86 -39.51 94.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 2.1 m -67.49 35.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.41 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.521 ' H ' ' C ' ' A' ' 222' ' ' ASN . 54.3 ptt85 -77.16 -5.22 48.28 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.488 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -59.97 -46.34 89.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.68 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -132.4 125.04 29.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.962 0.41 . . . . 0.0 110.927 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.5 t -152.1 158.43 42.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.245 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.573 ' CD2' HH12 ' A' ' 55' ' ' ARG . 86.3 t60 -75.85 127.11 32.32 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.413 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -152.18 160.47 43.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.905 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -52.95 -177.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.92 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 211' ' ' GLY . 1.7 t 174.44 -53.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.8 tp -136.57 110.65 8.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -100.05 162.94 19.18 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.307 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 39.4 t -126.13 128.98 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -134.09 147.07 50.83 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -110.83 99.69 8.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.136 175.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.698 ' CZ ' HH12 ' A' ' 66' ' ' ARG . 99.0 mtt180 -130.28 130.86 45.07 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.838 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.535 ' CZ ' ' O ' ' A' ' 6' ' ' GLY . 61.3 m-85 . . . . . 0 N--CA 1.474 0.732 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.834 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.5 m -71.04 148.64 47.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.613 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 42.15 -123.23 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.572 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -94.79 1.77 55.44 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.875 0.369 . . . . 0.0 110.492 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.94 122.82 3.5 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.08 -75.5 0.28 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -87.53 152.25 22.35 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.73 -152.03 6.72 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.33 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.57 167.99 25.9 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.382 2.055 . . . . 0.0 114.183 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -141.01 143.48 34.45 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.6 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.8 t -132.03 146.38 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -148.31 130.99 15.94 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.36 132.71 12.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.825 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -96.08 151.93 19.01 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.12 0.486 . . . . 0.0 111.859 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.8 tp -123.99 131.21 53.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.671 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.46 -123.29 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.779 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.449 ' CG ' ' O ' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -137.77 125.86 22.9 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.278 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 179.22 114.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.36 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -151.31 132.1 14.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.751 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -160.7 -92.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.472 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.4 ' O ' ' ND1' ' A' ' 21' ' ' HIS . 57.8 t-80 38.91 58.8 1.72 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.849 0.357 . . . . 0.0 110.551 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.9 108.58 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.247 0.546 . . . . 0.0 110.544 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.6 p -141.37 173.16 11.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.984 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -148.44 156.55 42.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.892 0.377 . . . . 0.0 110.616 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -76.67 162.47 27.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.596 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -147.79 80.62 8.81 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.678 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.86 159.73 34.42 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.438 2.092 . . . . 0.0 112.012 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -139.01 81.2 22.02 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.203 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.46 159.2 22.56 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.534 2.156 . . . . 0.0 112.139 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -63.5 137.22 58.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.646 ' HB1' ' HD2' ' A' ' 32' ' ' PRO . . . -138.21 176.36 2.74 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.353 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.646 ' HD2' ' HB1' ' A' ' 31' ' ' ALA . 52.8 Cg_exo -54.21 -39.49 86.15 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.375 2.05 . . . . 0.0 112.384 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -96.39 143.31 27.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.741 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -90.08 155.64 18.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.416 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -72.77 141.7 48.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.601 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -76.83 138.48 39.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.0 pt -128.23 149.92 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.553 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.2 m -136.63 150.54 48.59 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.551 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.7 m -153.11 94.95 1.9 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.378 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -172.12 -18.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.78 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -65.28 136.17 56.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.858 0.361 . . . . 0.0 110.616 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -89.11 179.92 6.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.623 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -101.35 132.1 47.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.132 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -158.73 3.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.804 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -68.93 135.22 50.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.624 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -89.49 -64.71 1.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.374 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.2 tp -162.0 139.34 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.416 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.2 mtp85 -138.28 89.87 2.42 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.423 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -86.23 165.32 16.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.489 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 31.3 ptt85 -121.4 -46.89 2.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.45 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 73' ' ' ARG . 10.9 t 49.01 92.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.786 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.37 53.15 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.534 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -161.91 67.59 2.13 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.506 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -91.17 -166.42 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.375 2.717 . . . . 0.0 113.477 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 58.7 82.81 0.13 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.498 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 p -155.95 131.54 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.906 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 t -138.51 135.85 35.52 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -148.58 168.67 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.756 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.76 -153.3 12.99 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -121.43 143.33 49.3 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.144 0.497 . . . . 0.0 111.561 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -86.71 112.97 22.17 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.866 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -125.48 150.47 47.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.968 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.22 103.6 2.62 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.48 -68.32 0.52 Allowed Glycine 0 CA--C 1.52 0.391 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -148.05 160.77 42.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -113.73 162.01 16.8 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 120.897 0.38 . . . . 0.0 111.608 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.0 mm -104.14 126.71 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 102.11 -3.293 . . . . 0.0 102.11 172.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.47 125.25 9.76 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 119.149 -1.021 . . . . 0.0 111.946 -176.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.23 153.41 20.0 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.553 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -134.24 128.07 33.15 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -151.45 161.27 42.99 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.185 0.993 . . . . 0.0 113.188 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.48 151.3 15.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.224 -1.807 . . . . 0.0 107.418 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.435 ' O ' ' OG ' ' A' ' 51' ' ' SER . 9.1 ptm180 -141.79 135.5 29.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.281 0.562 . . . . 0.0 111.669 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 44.9 p90 -172.83 107.63 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.602 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -101.63 136.77 40.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.635 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 78' ' ' ASN . 40.6 tttm 43.96 39.67 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.5 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 49.35 -93.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.927 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 76' ' ' LYS . 62.9 t-20 -175.67 -60.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.374 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -64.34 125.82 25.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.802 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.429 ' ND2' ' NZ ' ' A' ' 76' ' ' LYS . 61.1 t-20 -141.86 88.21 2.1 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.623 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -83.76 -11.63 56.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.936 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.04 142.0 30.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.1 t -155.84 156.69 35.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.176 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.4 t -118.14 130.83 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.949 0.404 . . . . 0.0 110.252 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 87' ' ' GLU . 51.4 p30 -162.8 61.39 0.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.512 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.2 mt 44.75 -88.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.68 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 85' ' ' ASN . 97.5 mt-10 -64.61 131.01 45.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.436 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 88' ' ' ASN . 43.1 p-10 -163.66 91.18 0.65 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.859 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.4 m -123.8 130.5 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.511 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -86.58 151.2 23.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.358 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 mm -87.39 91.78 3.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.173 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -133.28 150.38 51.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.594 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -78.08 147.68 34.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.24 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 95' ' ' ASN . 46.8 tp10 -72.52 111.25 7.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.848 0.356 . . . . 0.0 110.276 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 94' ' ' GLU . 82.1 m-20 -158.8 162.21 37.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.413 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.2 146.28 42.46 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 97' ' ' ILE . 19.1 tt -131.54 129.56 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.908 0.385 . . . . 0.0 110.633 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.6 ptt-85 -149.21 155.03 40.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.466 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.2 pt -82.31 135.78 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.175 0.512 . . . . 0.0 110.619 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -144.54 -33.72 0.38 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.085 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -151.57 154.14 35.89 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.485 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.415 ' C ' ' HG1' ' A' ' 103' ' ' THR . 98.8 mttt -79.9 -2.12 42.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.728 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.438 ' HG1' ' H ' ' A' ' 104' ' ' GLU . 56.4 p 50.3 -100.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.266 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.438 ' H ' ' HG1' ' A' ' 103' ' ' THR . 80.1 mm-40 -76.22 130.95 38.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.16 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -94.09 168.84 10.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.644 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -126.77 98.92 5.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.907 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -67.05 -40.35 87.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.692 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -87.26 101.69 13.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.632 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' A' ' 111' ' ' PHE . . . -90.73 179.15 42.89 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.7 p -71.95 135.72 46.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 0.0 110.539 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 109' ' ' GLY . 92.3 m-85 -136.0 -45.72 0.65 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.665 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.442 ' CE1' ' H ' ' A' ' 114' ' ' VAL . 51.4 t-80 -151.99 -93.87 0.05 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.515 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' N ' ' ND1' ' A' ' 112' ' ' HIS . . . 47.05 31.93 1.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.832 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.442 ' H ' ' CE1' ' A' ' 112' ' ' HIS . 58.6 t -69.44 -26.77 32.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.655 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 115' ' ' SER . 5.0 p 69.51 103.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.426 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.6 p -167.24 163.79 15.42 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.037 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.475 HD23 ' N ' ' A' ' 117' ' ' LEU . 1.3 pt? -156.89 157.4 34.81 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.877 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -176.45 -138.14 2.82 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.051 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.873 ' H ' HD23 ' A' ' 119' ' ' LEU . 1.2 pt? -131.2 160.55 34.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.2 0.524 . . . . 0.0 111.992 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 m -148.74 147.62 29.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.423 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.01 135.98 53.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 123' ' ' TYR . 96.7 mt -118.96 158.06 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.556 0.693 . . . . 0.0 112.552 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.474 ' N ' HG22 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -106.07 101.49 10.98 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -104.72 122.71 46.26 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 123.67 0.606 . . . . 0.0 111.234 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -96.72 105.36 17.46 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.084 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.424 ' CD ' HH22 ' A' ' 237' ' ' ARG . 59.1 tt0 -87.83 -11.35 48.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.698 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 128' ' ' ASN . 21.4 tt -67.52 -40.67 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.947 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.461 ' N ' HG23 ' A' ' 127' ' ' ILE . 88.0 m-20 -78.68 -11.78 59.99 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.0 t0 59.7 -78.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.177 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -66.27 -46.26 77.67 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -105.58 117.52 34.24 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.439 ' HZ2' ' HA3' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -131.85 96.53 20.28 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.17 109.56 0.64 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.035 1.156 . . . . 0.0 109.387 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CZ ' ' HA3' ' A' ' 197' ' ' GLY . 21.9 p90 -78.66 129.9 35.25 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 118.712 -1.195 . . . . 0.0 109.78 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.17 142.51 40.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.646 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -171.79 -176.8 40.99 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 118.28 -1.914 . . . . 0.0 113.709 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.73 137.57 51.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -130.12 131.17 45.59 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.45 132.35 64.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.682 0.753 . . . . 0.0 109.125 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -113.54 150.44 32.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.121 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -156.72 168.15 28.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.297 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -117.15 134.01 10.97 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 144' ' ' VAL . 77.4 t60 -55.12 -76.37 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 143' ' ' HIS . 5.4 t 53.22 121.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.625 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 146' ' ' HIS . 23.7 mmt85 -62.55 -36.24 82.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.259 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 145' ' ' ARG . 85.8 t60 49.42 96.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 146' ' ' HIS . 7.8 t 61.34 131.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.317 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 15.6 tt -154.51 -16.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.348 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -61.32 -49.15 78.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.521 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.7 t -160.04 152.92 21.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.705 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.4 p -149.47 101.85 3.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.256 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -155.1 -34.09 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.627 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -73.3 130.95 41.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.611 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.39 -12.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.223 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 155' ' ' ILE . 20.3 tt -129.12 131.35 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.159 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 158' ' ' THR . 43.4 tp10 -99.4 71.91 1.79 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.604 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.05 -34.12 66.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.405 ' O ' ' OE2' ' A' ' 156' ' ' GLU . 5.0 t -132.59 153.1 51.35 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.863 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 159' ' ' THR . 1.4 t -95.25 144.83 25.52 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.281 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.2 t -59.51 130.01 87.46 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.08 -42.31 21.08 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.502 1.468 . . . . 0.0 112.975 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 78.1 p -63.83 -39.66 94.74 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.039 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -105.22 75.88 1.19 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.884 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.604 ' HB1' ' CD ' ' A' ' 165' ' ' PRO . . . -56.0 179.62 0.1 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.604 ' CD ' ' HB1' ' A' ' 164' ' ' ALA . 28.0 Cg_exo -60.44 142.58 98.39 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.709 1.606 . . . . 0.0 111.304 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -100.97 8.12 43.21 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.482 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 158.27 -154.78 25.84 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -156.46 -117.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.28 131.23 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.919 0.39 . . . . 0.0 110.256 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 91.5 m -118.41 126.22 51.61 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.068 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.12 -36.34 18.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.877 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -153.77 -73.28 0.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.766 0.317 . . . . 0.0 110.673 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 174' ' ' THR . 28.3 t-20 42.79 -109.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.618 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 173' ' ' ASN . 63.8 p -120.99 133.06 55.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.156 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -113.45 91.7 21.0 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.808 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -87.49 -17.96 2.69 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.684 2.256 . . . . 0.0 112.874 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -80.83 126.32 31.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.019 0.438 . . . . 0.0 111.546 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.35 -41.39 56.68 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.449 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -103.15 129.4 50.02 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.265 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 181' ' ' ASP . 93.0 m-20 -89.4 93.9 9.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.901 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 180' ' ' ASN . 6.6 p-10 42.59 -173.52 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.58 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.627 ' CG ' ' N ' ' A' ' 183' ' ' GLN . 60.9 t80 -174.13 177.0 2.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.969 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.627 ' N ' ' CG ' ' A' ' 182' ' ' TYR . 94.3 mt-30 -59.86 -31.4 69.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.886 0.374 . . . . 0.0 110.484 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.411 ' O ' ' O ' ' A' ' 183' ' ' GLN . 12.9 p 47.19 96.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.319 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 55.3 p30 -87.46 -175.37 5.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.558 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 60.0 m -57.92 132.3 53.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.728 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 188' ' ' ARG . 42.4 pt -88.43 -15.27 9.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.137 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 187' ' ' ILE . 81.5 mtp180 -60.03 -149.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.876 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -126.71 118.44 24.73 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.326 0.584 . . . . 0.0 111.57 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.21 153.66 37.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -135.15 142.08 13.44 Favored Glycine 0 N--CA 1.466 0.67 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.821 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.2 pp -133.39 141.89 48.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.304 -0.948 . . . . 0.0 108.755 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -153.45 174.15 32.13 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.04 138.59 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.902 0.382 . . . . 0.0 110.988 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.8 mt -111.06 131.08 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.859 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.53 148.43 32.17 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.424 ' HA3' ' CZ ' ' A' ' 134' ' ' TYR . . . 158.05 -176.89 34.99 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.4 p -138.75 142.3 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 118.728 1.264 . . . . 0.0 113.346 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.439 ' HA3' ' HZ2' ' A' ' 132' ' ' LYS . . . -103.88 144.83 15.98 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.761 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.426 ' N ' ' OG1' ' A' ' 207' ' ' THR . 14.3 t80 -137.72 105.69 5.67 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -91.59 154.22 19.2 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -176.54 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.441 ' CG1' ' H ' ' A' ' 203' ' ' THR . 5.3 pt -95.15 -47.1 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.652 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.7 OUTLIER -122.76 115.25 29.53 Favored Pre-proline 0 N--CA 1.433 -1.296 0 N-CA-C 100.563 -3.865 . . . . 0.0 100.563 172.17 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -12.15 -40.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 124.069 3.179 . . . . 0.0 117.176 -174.11 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 203' ' ' THR . 11.7 pttm -84.72 -32.37 23.55 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 3.2 mm? -85.4 105.14 15.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 121.475 1.943 . . . . 0.0 107.751 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 235' ' ' ARG . 1.0 OUTLIER -131.75 140.23 49.18 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 75.9 mt -93.37 135.36 34.68 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 113.734 -1.576 . . . . 0.0 108.749 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.613 ' CG ' HH11 ' A' ' 235' ' ' ARG . 42.7 m-20 -118.22 145.91 44.64 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -135.49 113.02 10.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 114.059 -1.428 . . . . 0.0 107.292 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -162.22 -177.65 35.44 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.56 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.35 152.42 49.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.594 -0.803 . . . . 0.0 110.97 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -106.88 127.28 53.29 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -112.09 150.65 30.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.295 0.569 . . . . 0.0 112.271 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' A' ' 216' ' ' ASN . 77.3 t60 -129.1 128.96 44.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.723 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 215' ' ' HIS . 97.1 m-20 51.41 107.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.462 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -143.38 99.85 3.51 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.825 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -159.84 -116.93 0.45 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 220' ' ' LEU . 18.2 tpp180 -63.61 144.98 56.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.855 0.359 . . . . 0.0 110.246 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.94 HD22 ' H ' ' A' ' 220' ' ' LEU . 1.9 mm? -57.28 -159.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.195 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 66.19 61.68 0.6 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.378 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 222' ' ' ASN . 0.7 OUTLIER -98.52 123.9 42.95 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.001 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.7 m -63.77 -47.95 78.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.184 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -114.14 150.85 33.54 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.996 0.427 . . . . 0.0 110.78 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -161.47 21.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.886 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -97.57 40.97 1.14 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.872 0.367 . . . . 0.0 110.488 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 73.1 m -116.39 123.59 47.95 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.271 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -173.55 86.38 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.652 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -139.51 132.38 29.24 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.598 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -86.08 162.28 18.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.391 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 46.9 t -151.96 154.21 35.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.675 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.0 tt -111.02 140.12 45.82 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.28 169.25 30.26 Favored Glycine 0 CA--C 1.517 0.203 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.95 136.28 57.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.449 0.643 . . . . 0.0 111.378 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.613 HH11 ' CG ' ' A' ' 209' ' ' ASP . 81.1 mtt85 -121.27 130.21 53.54 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.95 106.29 17.2 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.575 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.589 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 3.6 tmt_? -119.79 109.14 15.25 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.229 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.545 ' CB ' ' O ' ' A' ' 237' ' ' ARG . 28.5 t80 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.679 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 3' ' ' GLU . 86.7 p -75.86 164.41 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.601 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 2' ' ' SER . 43.5 tp10 59.88 129.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.48 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 55.73 28.41 12.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.477 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 46.55 -131.21 11.86 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 129.56 -150.66 19.02 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -68.79 159.79 31.71 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.52 -73.07 0.4 Allowed Glycine 0 CA--C 1.533 1.184 0 C-N-CA 120.961 -0.637 . . . . 0.0 111.923 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.43 124.05 9.11 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 122.717 2.278 . . . . 0.0 112.822 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -144.95 148.29 33.65 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.507 ' H ' ' HB2' ' A' ' 236' ' ' TYR . 78.7 t -138.68 146.31 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.553 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -132.4 126.53 33.37 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.992 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.95 148.0 27.86 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 15' ' ' LEU . 57.2 t0 -162.6 134.58 5.36 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.581 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -173.48 -171.0 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.025 178.524 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.73 71.57 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.861 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' O ' ' O ' ' A' ' 18' ' ' ALA . 78.9 t80 -62.94 -49.65 73.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 17' ' ' TYR . . . 57.03 162.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.513 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -87.88 163.29 16.47 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.721 0.296 . . . . 0.0 110.954 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.53 ' OE2' ' N ' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -124.39 -30.72 3.36 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.667 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.53 ' N ' ' OE2' ' A' ' 20' ' ' GLU . 59.4 t-80 -166.78 -22.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 110.635 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.411 ' O ' ' O ' ' A' ' 21' ' ' HIS . 43.2 mt 58.3 118.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.581 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 24' ' ' HIS . 1.3 t -172.9 -117.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.593 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.524 ' N ' ' OG1' ' A' ' 23' ' ' THR . 15.9 m80 63.43 123.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.842 0.353 . . . . 0.0 110.502 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -135.76 94.03 3.02 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.623 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.608 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 91.7 t80 -99.08 -33.31 0.24 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.546 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 26' ' ' TYR . 89.0 Cg_endo -83.2 156.84 14.88 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.773 1.648 . . . . 0.0 111.904 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -68.14 148.11 98.32 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.883 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 31' ' ' ALA . 72.8 Cg_endo -73.2 86.75 1.1 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.18 1.92 . . . . 0.0 111.898 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 p 39.9 -96.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.335 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -57.94 151.4 44.5 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.309 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.44 -83.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.263 1.976 . . . . 0.0 111.725 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 36' ' ' LYS . 52.0 p-10 -103.06 6.01 38.41 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.442 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 36' ' ' LYS . 6.2 tmtt? 42.3 37.07 0.83 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.697 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 64.28 -4.86 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.759 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 33' ' ' ASN . 63.3 pttt -172.44 146.48 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.346 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 37' ' ' ILE . 19.6 tt -125.63 126.11 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.884 0.373 . . . . 0.0 110.389 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.2 p -102.24 -6.65 22.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.578 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.5 p -87.84 132.54 34.15 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.331 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG23 ' H ' ' A' ' 41' ' ' SER . 0.4 OUTLIER -96.98 -96.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.581 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.491 ' H ' HG23 ' A' ' 40' ' ' VAL . 86.0 p -159.37 177.66 10.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t0 72.3 -56.71 0.64 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.857 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -61.36 -44.92 96.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.969 0.414 . . . . 0.0 110.006 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.4 ' CG ' ' N ' ' A' ' 45' ' ' ARG . 88.7 t80 -60.83 155.81 18.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.149 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 25.1 ttm180 61.13 -133.66 0.67 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.6 t30 50.73 38.64 19.92 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.105 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.3 pt -90.36 45.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -76.33 97.57 4.26 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.088 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.3 p -149.19 24.8 0.91 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.024 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -74.37 137.77 42.98 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.575 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 52' ' ' VAL . 37.0 p -88.91 -35.78 16.3 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.516 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 51' ' ' SER . 35.6 t 48.79 101.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.908 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -173.1 60.95 0.26 Allowed Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.102 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.18 148.65 44.59 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.714 2.276 . . . . 0.0 112.309 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -167.19 111.51 0.72 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.702 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.37 135.13 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.639 0.257 . . . . 0.0 110.949 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 m -118.47 125.9 50.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.85 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.17 137.98 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.871 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.82 172.06 36.29 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.666 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -109.91 144.8 37.88 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 65' ' ' TRP . 44.4 t0 -150.84 130.96 13.49 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.584 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 31.6 p90 -128.41 105.87 8.62 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.807 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . 6.95 95.46 0.0 OUTLIER Glycine 0 N--CA 1.481 1.692 0 O-C-N 123.251 0.345 . . . . 0.0 113.186 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.96 -110.77 0.46 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.417 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 10.2 p-90 -103.74 -177.67 3.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.73 ' NH1' ' HE ' ' A' ' 235' ' ' ARG . 75.3 ttt180 -153.42 151.42 29.88 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.27 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.5 tp -129.58 142.4 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.431 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.56 143.03 19.51 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.89 155.99 16.54 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 71' ' ' TYR . 48.2 t0 -146.25 133.11 20.1 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.573 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 49.0 p90 175.5 -172.06 0.07 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.755 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 71' ' ' TYR . . . 166.58 68.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -151.26 146.62 26.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.641 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -150.75 -127.65 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.461 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 60.23 73.43 0.48 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.556 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.08 -176.9 4.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.593 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -59.7 -40.11 86.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.151 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.58 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 57.8 t30 -90.57 102.71 15.45 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.771 0.32 . . . . 0.0 110.639 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.58 ' ND2' ' O ' ' A' ' 78' ' ' ASN . 17.8 m120 -159.21 176.88 11.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.457 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 48.55 -169.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.073 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt 56.28 60.94 2.91 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -61.94 -42.12 98.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.366 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.4 p -71.46 161.9 30.3 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.717 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.66 148.34 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.043 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -97.33 144.57 26.96 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.582 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.1 mm -63.45 -44.37 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.728 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -143.26 -62.56 0.41 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.494 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -165.73 54.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.84 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.3 t -99.41 119.68 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.401 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -172.8 -68.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.908 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.709 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.0 mp 46.96 94.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.324 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -80.23 -22.88 41.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.78 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.3 tptt 73.69 164.21 0.28 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.116 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -62.41 136.24 57.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.873 0.368 . . . . 0.0 110.775 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 95' ' ' ASN . 38.4 t-20 -153.12 -22.57 0.15 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.736 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.28 173.8 52.61 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 98' ' ' ARG . 2.5 mt -119.01 -145.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.585 ' H ' HG22 ' A' ' 97' ' ' ILE . 85.0 mtt85 -105.55 1.59 27.61 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.973 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.6 tt -106.21 144.26 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 57.31 98.54 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.05 0.452 . . . . 0.0 109.834 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -62.81 -40.3 96.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.524 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -125.75 145.47 50.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.935 0.398 . . . . 0.0 110.946 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.0 p -83.1 -139.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.488 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 55.23 40.61 31.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 110.233 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 105' ' ' ASN . 5.7 p-10 -86.06 103.31 14.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.765 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -68.76 -21.36 64.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.137 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 62.3 -101.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.418 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -87.55 116.94 26.01 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.82 0.343 . . . . 0.0 110.804 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.58 156.06 27.78 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.1 m -69.35 135.95 51.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.732 0.301 . . . . 0.0 110.68 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -104.7 41.05 1.38 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.662 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -153.71 48.76 0.66 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.023 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 112' ' ' HIS . . . 57.43 150.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.098 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 115' ' ' SER . 27.0 m -139.45 167.2 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.809 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 114' ' ' VAL . 4.8 p 89.28 125.13 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.779 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.4 t -155.66 149.32 25.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.738 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.5 mp -86.23 141.61 29.18 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.84 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.538 ' C ' HD22 ' A' ' 119' ' ' LEU . . . -122.0 126.57 6.5 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.538 HD22 ' C ' ' A' ' 118' ' ' GLY . 3.4 mm? -113.17 140.35 47.99 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.8 m -120.26 124.54 45.9 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.68 122.37 42.59 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.529 HG22 ' N ' ' A' ' 123' ' ' TYR . 94.4 mt -126.45 160.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -175.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.529 ' N ' HG22 ' A' ' 122' ' ' ILE . 70.6 m-85 -128.38 103.15 6.98 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 177.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.464 ' HB2' HH22 ' A' ' 235' ' ' ARG . 67.6 t0 -138.83 129.94 26.78 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.494 ' CD1' ' NZ ' ' A' ' 132' ' ' LYS . 65.0 m-85 -120.86 133.26 55.31 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.439 177.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.41 HE21 ' HB2' ' A' ' 126' ' ' GLN . 0.0 OUTLIER -105.71 -13.75 15.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.269 0.557 . . . . 0.0 109.559 178.509 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 129' ' ' ASP . 65.9 mt -70.9 -40.51 76.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.777 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -55.6 89.64 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 127' ' ' ILE . 90.5 m-20 47.1 -114.25 0.54 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.865 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -131.2 22.73 4.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.086 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -167.28 127.3 1.45 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.492 -178.165 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.621 ' H ' HH22 ' A' ' 237' ' ' ARG . 12.8 tptm -134.63 129.56 19.47 Favored Pre-proline 0 C--O 1.238 0.5 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.497 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.38 129.96 28.56 Favored 'Trans proline' 0 N--CA 1.479 0.671 0 N-CA-C 107.404 -1.806 . . . . 0.0 107.404 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.622 ' CG ' ' NH1' ' A' ' 235' ' ' ARG . 52.0 p90 -122.64 148.6 45.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.525 0.602 . . . . 0.0 111.008 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.3 pt -141.05 163.62 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.555 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.34 173.78 41.82 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.188 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -117.26 159.78 22.12 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -127.79 130.99 49.62 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.939 0.4 . . . . 0.0 111.222 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 20.2 m -130.62 128.69 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.069 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.7 136.2 50.29 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.678 0.275 . . . . 0.0 110.931 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -147.95 158.16 43.9 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.288 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -110.85 -168.73 19.15 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 143' ' ' HIS . 4.5 p-80 -92.52 156.95 16.81 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.023 0.439 . . . . 0.0 110.807 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 39.6 t 58.04 114.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.395 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -94.64 -109.61 0.13 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.745 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -153.52 141.67 20.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.216 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 p -153.21 130.48 11.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.909 0.385 . . . . 0.0 110.517 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 96.2 mt -124.12 129.42 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.205 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -86.55 110.62 19.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.43 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.4 m -60.24 -42.13 94.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.362 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.7 p -83.63 165.21 19.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.468 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 153' ' ' LYS . 30.6 mmtp -107.55 11.58 28.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.214 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 152' ' ' LYS . 51.9 tttp 59.6 136.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.905 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.0 m 63.5 106.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.584 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 19.8 tt -131.08 142.28 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.385 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 158' ' ' THR . 97.2 mt-10 -71.74 52.5 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.505 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 63.3 t 49.81 -86.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.39 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 156' ' ' GLU . 24.7 m -66.85 133.6 50.4 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 52.4 p -67.91 137.01 54.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.84 0.352 . . . . 0.0 110.747 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 160' ' ' VAL . 7.6 p -61.76 122.93 74.83 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.11 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.65 -40.27 46.65 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.317 1.345 . . . . 0.0 112.123 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.0 m -81.77 103.14 11.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.634 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 164' ' ' ALA . 54.7 p30 -155.38 -19.73 0.11 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.637 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.525 ' N ' ' OD1' ' A' ' 163' ' ' ASN . . . 178.36 151.84 0.45 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.077 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.93 152.51 57.7 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.305 2.003 . . . . 0.0 112.072 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -91.52 35.75 0.95 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.317 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 170' ' ' THR . . . 82.08 18.48 67.16 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 58.94 -147.68 0.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 110.454 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.5 m -92.4 24.26 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.654 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 167' ' ' GLY . 2.9 t -144.92 157.09 44.26 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.822 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.9 t -82.23 173.22 12.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.326 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -81.99 132.39 35.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.345 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -103.75 105.99 16.36 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.851 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 63.7 p 41.2 -137.91 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.067 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -85.52 150.06 53.15 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.115 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.56 158.6 39.94 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.699 2.266 . . . . 0.0 111.974 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -69.26 -76.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.448 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.5 p -81.17 166.89 20.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -80.39 94.92 6.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.473 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 181' ' ' ASP . 50.1 p30 -69.16 -19.0 64.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.733 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 180' ' ' ASN . 98.3 m-20 -90.22 110.73 21.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.021 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -103.6 6.84 37.47 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.085 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -87.11 49.23 1.78 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.521 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.3 t -138.69 134.22 33.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.595 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -143.15 106.55 4.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.225 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 27.9 p -75.98 160.41 29.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.302 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.656 HG23 ' N ' ' A' ' 188' ' ' ARG . 18.8 tt -155.95 -54.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.584 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.656 ' N ' HG23 ' A' ' 187' ' ' ILE . 79.4 mtp85 39.96 84.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.223 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.413 HH11 HG13 ' A' ' 187' ' ' ILE . 76.0 mtt85 -143.21 77.95 1.58 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.663 0.744 . . . . 0.0 111.417 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.45 156.85 33.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -120.4 130.73 8.47 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.275 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.9 mp -135.83 148.62 48.76 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.631 0.729 . . . . 0.0 110.583 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.5 174.21 42.6 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.94 146.82 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 117.418 0.609 . . . . 0.0 110.2 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.9 tt -115.77 144.6 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.849 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.21 145.19 26.1 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -173.41 -179.32 44.0 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.124 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 57.8 t -132.54 135.95 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.596 0.236 . . . . 0.0 111.305 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -108.56 122.33 6.59 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.269 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.533 ' C ' HG23 ' A' ' 207' ' ' THR . 54.3 t80 -124.91 106.55 10.08 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.685 0.794 . . . . 0.0 109.166 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.617 ' OD1' ' O ' ' A' ' 203' ' ' THR . 32.5 t70 -61.88 151.31 34.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -177.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 206' ' ' LEU . 28.9 mm -117.79 -29.12 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 176.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.617 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 31.5 m -155.08 120.34 2.59 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 100.219 -3.993 . . . . 0.0 100.219 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.589 ' N ' ' OD2' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -6.54 -56.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 123.408 2.738 . . . . 0.0 115.336 -172.484 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.67 ' HA ' ' H ' ' A' ' 237' ' ' ARG . 37.0 pttt -83.94 -30.47 26.25 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 203' ' ' THR . 80.0 mt -78.62 110.92 14.17 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 119.62 1.1 . . . . 0.0 109.634 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.533 HG23 ' C ' ' A' ' 200' ' ' PHE . 2.1 m -125.99 145.81 50.14 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 209' ' ' ASP . 1.6 tm? -94.12 119.57 33.15 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.578 ' N ' HD13 ' A' ' 208' ' ' LEU . 45.7 t0 -106.21 145.81 31.08 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 209' ' ' ASP . . . -132.37 126.8 34.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.774 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -168.86 176.74 42.98 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 119.53 -1.319 . . . . 0.0 113.468 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -156.97 168.73 26.61 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.837 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.516 HH12 ' CD2' ' A' ' 215' ' ' HIS . 68.1 ttt-85 -108.11 124.73 50.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.038 0.447 . . . . 0.0 111.61 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.472 ' OH ' ' NH2' ' A' ' 219' ' ' ARG . 79.9 t80 -65.5 -49.65 68.22 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.266 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.516 ' CD2' HH12 ' A' ' 213' ' ' ARG . 20.6 t-160 58.84 112.97 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.411 ' O ' ' CE2' ' A' ' 214' ' ' TYR . 15.1 m120 33.53 -156.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 177.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.56 ' CB ' HH11 ' A' ' 219' ' ' ARG . 55.3 p-90 -131.67 169.26 16.41 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.091 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -140.39 24.13 2.66 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.56 HH11 ' CB ' ' A' ' 217' ' ' TRP . 7.8 mpt_? -65.19 179.85 0.67 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.037 0.446 . . . . 0.0 110.751 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' A' ' 222' ' ' ASN . 11.1 mp 58.91 151.32 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.007 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 66.94 -26.19 0.12 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.315 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.542 ' H ' ' C ' ' A' ' 220' ' ' LEU . 98.0 m-20 54.68 51.56 13.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.569 0.223 . . . . 0.0 111.507 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 77.1 m -123.65 130.27 52.4 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.792 0.33 . . . . 0.0 110.433 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.432 ' HD3' ' H ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -102.38 138.42 39.33 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.219 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 225' ' ' PHE . 88.8 t80 -152.16 8.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.688 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -143.37 151.76 40.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 110.832 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.5 p -131.95 171.5 13.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.131 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -143.96 155.87 44.2 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 110.888 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -139.48 159.97 40.93 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.646 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -75.82 155.88 34.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.429 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 60.8 m -134.33 153.62 51.78 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.357 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 90.0 mt -97.7 149.35 22.38 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.829 0.347 . . . . 0.0 110.129 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -157.47 176.74 34.55 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.493 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 11.2 m -128.27 131.71 68.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.73 ' HE ' ' NH1' ' A' ' 66' ' ' ARG . 62.2 ttt180 -117.83 142.27 47.5 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.507 ' HB2' ' H ' ' A' ' 11' ' ' VAL . 15.8 m-85 -108.55 125.26 51.62 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.67 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 99.1 mtt180 -126.4 90.19 3.14 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 7.2 t80 . . . . . 0 C--O 1.219 -0.513 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.077 -177.866 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.5 m -70.67 139.91 51.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.762 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -111.23 -8.11 14.39 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.258 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' GLY . 47.4 p-10 -89.7 2.82 54.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.592 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' ASP . . . -56.53 -157.38 0.01 OUTLIER Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.55 133.65 9.29 Favored Glycine 0 N--CA 1.468 0.787 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -130.97 138.04 49.53 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.69 142.86 14.27 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.85 111.28 2.47 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.98 1.787 . . . . 0.0 112.772 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -107.57 169.7 8.42 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.498 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 12' ' ' GLN . 61.0 t -126.04 157.72 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.464 0.65 . . . . 0.0 112.43 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.525 ' N ' HG12 ' A' ' 11' ' ' VAL . 30.7 mt-30 -130.94 130.98 44.14 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.281 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.86 135.12 29.24 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.452 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.99 144.47 25.88 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 tp -139.39 123.7 18.08 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.985 0.421 . . . . 0.0 110.617 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -170.6 -42.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.852 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -85.12 141.4 30.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.319 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.61 144.08 48.95 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.342 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.526 ' O ' ' CD2' ' A' ' 19' ' ' TYR . 28.8 p90 -107.2 105.97 16.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.287 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -139.91 122.9 16.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.0 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -170.04 84.97 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.761 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.4 mt -117.39 100.86 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.843 0.354 . . . . 0.0 110.487 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' ' 24' ' ' HIS . 44.2 p -145.8 164.86 30.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.493 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 23' ' ' THR . 19.5 m80 59.65 128.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.003 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -68.56 136.83 53.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.43 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.95 165.0 2.81 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.988 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.57 149.39 87.22 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.728 1.618 . . . . 0.0 112.087 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.527 ' H ' ' HD2' ' A' ' 29' ' ' PRO . 2.0 mt-10 -171.98 -52.49 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.628 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HD2' ' H ' ' A' ' 28' ' ' GLU . 89.8 Cg_endo -82.43 -165.28 0.32 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.258 1.972 . . . . 0.0 112.578 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.6 m 61.97 151.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.085 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 60.54 69.87 1.08 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.058 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 33' ' ' ASN . 23.6 Cg_exo -62.27 144.51 95.49 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.518 2.145 . . . . 0.0 111.655 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 32' ' ' PRO . 82.3 m-20 47.12 -178.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.802 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -162.78 12.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.767 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.92 -46.46 84.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.441 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 38' ' ' SER . 63.0 mttp -151.89 -173.71 4.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.016 0.436 . . . . 0.0 111.034 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.1 mt 47.02 -87.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.694 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' LYS . 4.6 m -87.78 112.1 22.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.176 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.8 t -152.14 152.49 32.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.65 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.77 -23.49 25.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.216 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m 49.37 -112.57 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.702 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -148.69 129.3 14.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.986 0.422 . . . . 0.0 110.927 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -134.99 83.54 2.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.914 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 38.23 -103.82 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.992 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -138.62 -161.61 1.2 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.038 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -71.06 175.92 4.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.273 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.1 pt -69.99 -13.54 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.651 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 61.41 133.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.529 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.6 t -139.68 161.98 36.22 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.417 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -69.91 141.37 53.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.686 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 52' ' ' VAL . 11.7 t -109.05 -0.45 19.48 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.096 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 53' ' ' HIS . 59.9 t 55.25 164.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.572 ' N ' HG12 ' A' ' 52' ' ' VAL . 70.6 t60 -153.96 90.78 3.26 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.76 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.26 144.87 99.24 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.71 1.607 . . . . 0.0 110.84 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -70.55 161.26 30.98 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.226 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.13 161.81 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.376 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.5 t -148.23 133.24 18.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.982 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.14 157.51 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.615 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.57 -170.25 38.22 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.309 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -112.9 153.96 27.12 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 47.4 p-10 -141.47 129.2 21.62 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 121.634 0.73 . . . . 0.0 112.842 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 4.2 p90 -127.46 148.24 50.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.676 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -43.26 111.14 0.35 Allowed Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.34 -83.42 0.27 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.581 ' N ' ' CD1' ' A' ' 65' ' ' TRP . 1.4 p-90 -143.92 169.86 17.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.953 0.406 . . . . 0.0 111.5 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.476 HH21 ' NH1' ' A' ' 237' ' ' ARG . 54.8 mtt180 -129.39 172.61 11.34 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.578 0.704 . . . . 0.0 111.369 -178.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.4 mt -140.58 132.59 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.12 152.76 31.65 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.97 159.65 15.63 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 71' ' ' TYR . 41.3 t0 -157.2 167.21 31.04 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.424 -178.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.474 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 97.5 m-85 82.16 -126.08 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 125.08 1.488 . . . . 0.0 111.855 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 71' ' ' TYR . . . 71.32 101.96 0.06 Allowed 'General case' 0 CA--C 1.532 0.272 0 O-C-N 123.676 0.61 . . . . 0.0 111.262 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -160.19 107.09 1.59 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.918 0.39 . . . . 0.0 110.962 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -125.36 133.15 52.66 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.42 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -165.4 23.23 0.05 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.304 -0.559 . . . . 0.0 111.211 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -63.21 -42.9 99.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.65 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -157.29 132.6 9.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.834 0.35 . . . . 0.0 111.011 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -108.55 145.61 34.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.24 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 57.5 p30 -83.78 163.2 20.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.76 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -145.27 138.12 26.2 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.641 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -103.42 155.26 18.62 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.266 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 82' ' ' TYR . 49.3 p90 -119.95 131.11 55.08 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.583 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.3 m -76.27 -68.64 0.57 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.611 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.28 162.94 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.372 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -67.6 139.22 56.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.336 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 88' ' ' ASN . 86.7 mt -108.1 126.44 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.473 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -91.45 -0.81 57.67 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.507 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.667 ' H ' HG22 ' A' ' 86' ' ' ILE . 91.1 m-20 -88.5 9.25 24.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.494 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.56 131.31 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.913 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -136.53 -139.27 0.15 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.099 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.8 mm 59.38 42.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.261 0.553 . . . . 0.0 109.707 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 94' ' ' GLU . 60.0 ttm-85 -62.26 -43.1 99.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.635 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp 51.2 -88.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.373 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 92' ' ' ARG . 14.6 tm-20 -68.54 125.29 26.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.303 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -149.17 18.34 0.96 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.981 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.82 11.66 0.03 OUTLIER Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.365 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.0 pt -127.28 154.19 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.787 0.327 . . . . 0.0 110.543 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -144.09 65.12 1.3 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.702 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 100' ' ' ASP . 10.4 tp -67.34 -41.17 86.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.565 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.499 ' N ' HG23 ' A' ' 99' ' ' ILE . 99.5 m-20 53.24 -99.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.527 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 38.11 66.31 0.5 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.022 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -145.34 152.26 39.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.305 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 85.5 m -61.32 -44.93 96.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.34 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' A' ' 106' ' ' GLN . 41.6 tt0 -81.88 119.7 24.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.158 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.405 ' O ' ' O ' ' A' ' 106' ' ' GLN . 99.3 m-20 -99.34 33.76 2.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.45 ' H ' ' HG2' ' A' ' 104' ' ' GLU . 88.6 mt-30 56.5 160.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.99 0.424 . . . . 0.0 110.867 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.59 -31.12 71.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.871 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -84.52 9.84 12.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.699 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.37 -33.36 87.03 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.9 p -128.33 163.0 25.75 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.055 0.455 . . . . 0.0 110.75 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -73.18 148.17 44.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.873 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -134.18 136.79 44.0 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.747 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -175.33 -110.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.335 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.5 t 45.44 81.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.404 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.3 m -81.89 148.44 28.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.13 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.9 m -143.29 152.26 41.47 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.943 0.401 . . . . 0.0 111.718 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.46 165.71 32.35 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.963 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -143.31 147.16 18.43 Favored Glycine 0 C--N 1.342 0.909 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.841 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.74 151.93 38.93 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.5 m -135.58 118.07 15.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.007 0.432 . . . . 0.0 111.559 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.77 131.15 43.77 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.491 HG22 ' N ' ' A' ' 123' ' ' TYR . 96.8 mt -125.29 158.71 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.414 0.626 . . . . 0.0 112.661 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.491 ' N ' HG22 ' A' ' 122' ' ' ILE . 63.3 m-85 -112.95 122.09 46.6 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.301 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -109.07 122.83 48.1 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.783 0.677 . . . . 0.0 110.095 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.478 ' O ' ' CB ' ' A' ' 126' ' ' GLN . 0.5 OUTLIER -111.51 177.67 4.58 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.214 0.53 . . . . 0.0 110.954 -179.447 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 131' ' ' PHE . 2.4 tp-100 88.24 128.16 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.933 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.8 tt -118.67 -3.97 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.749 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 40.3 p-10 -151.02 -45.13 0.12 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.326 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 73.9 m-20 -71.97 -158.41 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.59 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -128.27 25.98 5.77 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.66 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.1 OUTLIER -138.65 111.28 7.62 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.292 0.951 . . . . 0.0 113.119 -177.186 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.416 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -131.12 137.15 30.03 Favored Pre-proline 0 C--N 1.351 0.661 0 CA-C-N 118.145 0.43 . . . . 0.0 110.424 177.699 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.16 116.66 3.39 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 122.089 1.859 . . . . 0.0 110.033 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.416 ' CE1' ' C ' ' A' ' 197' ' ' GLY . 36.5 p90 -81.12 129.97 34.81 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.798 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 91.4 mt -133.96 140.13 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.974 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -173.17 -172.97 39.19 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.698 -1.239 . . . . 0.0 112.785 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.55 142.23 33.53 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.533 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -121.52 133.48 55.03 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.323 0.582 . . . . 0.0 110.161 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.6 m -129.25 131.63 67.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.005 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.48 130.92 55.83 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.558 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 142' ' ' GLY . 90.6 t80 -134.1 161.63 34.33 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 111.946 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.512 ' N ' ' CG ' ' A' ' 141' ' ' TYR . . . -168.21 174.91 43.05 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -101.76 126.98 48.73 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 117.231 0.515 . . . . 0.0 111.081 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.9 m -124.49 131.98 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.2 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -115.36 102.54 9.94 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.93 0.395 . . . . 0.0 110.963 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 147' ' ' SER . 77.9 m80 -141.74 89.61 2.21 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.692 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 146' ' ' HIS . 2.8 p 61.03 133.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.1 mm -101.32 120.8 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.885 0.374 . . . . 0.0 110.808 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.4 t0 42.51 -106.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.041 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.8 t 55.59 87.85 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.495 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.5 p -81.56 165.91 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.44 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -91.67 93.32 8.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.474 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -95.73 -7.22 37.9 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.915 0.388 . . . . 0.0 110.447 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.0 m -62.25 -46.33 89.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.646 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 41.7 pt -94.26 140.53 16.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.658 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -149.29 75.53 1.29 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.409 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.17 -43.0 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.984 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 5.7 t -117.16 145.5 43.8 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.214 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.9 p -78.41 165.88 23.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.375 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 162' ' ' SER . 33.9 m -72.17 149.14 91.8 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.256 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -38.75 89.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.036 1.824 . . . . 0.0 112.068 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 160' ' ' VAL . 69.1 m -60.48 -43.81 96.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.912 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -170.48 25.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.826 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 61.27 82.94 0.21 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -60.15 146.6 95.88 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.538 2.159 . . . . 0.0 111.903 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -60.37 -179.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.287 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -62.7 131.45 43.62 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -90.59 -7.14 53.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.709 0.29 . . . . 0.0 110.391 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 170' ' ' THR . 83.7 t -65.45 -46.64 89.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 169' ' ' VAL . 0.7 OUTLIER 31.08 51.24 0.12 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.542 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.44 ' O ' ' OG1' ' A' ' 171' ' ' THR . 0.3 OUTLIER 34.26 41.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.076 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -63.72 -76.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.025 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -151.72 110.19 3.78 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 65.8 p 44.79 -156.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 18.9 p-10 -83.83 150.24 58.56 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.656 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.58 -99.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.348 2.032 . . . . 0.0 112.191 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -88.3 141.05 28.86 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.704 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.7 m -129.98 127.09 39.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.813 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 36.77 89.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.554 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -63.53 -41.86 98.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.411 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 39.74 82.5 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.189 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -71.06 137.1 48.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.163 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 184' ' ' SER . 54.8 tt0 -48.54 -67.65 0.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.265 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 183' ' ' GLN . 7.6 t 60.04 139.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.78 0.324 . . . . 0.0 110.332 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -150.4 32.25 0.65 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.007 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 43.0 t -150.38 91.61 1.77 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.889 0.376 . . . . 0.0 111.027 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 187' ' ' ILE . 17.5 mt -143.36 51.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 190' ' ' VAL . 15.3 mmt85 -108.54 -111.79 0.31 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.475 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 42.04 -86.2 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.206 0.317 . . . . 0.0 110.28 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 188' ' ' ARG . 13.5 t -69.92 133.66 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.83 130.71 9.22 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mp -134.95 145.37 48.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.677 0.275 . . . . 0.0 110.662 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -163.44 -169.33 26.75 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.8 146.0 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.613 0.72 . . . . 0.0 112.243 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.444 HD11 HH11 ' A' ' 138' ' ' ARG . 34.1 mm -112.94 131.62 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.83 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -156.69 151.08 25.38 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.849 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.416 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . 160.39 -169.86 36.28 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.61 148.18 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.309 0.576 . . . . 0.0 111.327 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -145.9 158.79 27.79 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.602 ' N ' ' OG1' ' A' ' 207' ' ' THR . 1.6 p90 -137.96 153.41 49.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.658 0.742 . . . . 0.0 111.497 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 1.2 m-20 -56.75 142.45 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.945 -176.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 206' ' ' LEU . 72.0 mt -101.31 -23.63 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 123.065 1.412 . . . . 0.0 107.812 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.587 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.7 OUTLIER -165.13 -174.69 0.4 Allowed Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.587 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.2 OUTLIER -5.31 -93.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.144 0 CA-C-N 124.82 2.757 . . . . 0.0 114.454 -179.128 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -128.09 17.93 6.62 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 120.909 1.686 . . . . 0.0 113.297 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 206' ' ' LEU . 10.0 mp -74.46 127.32 32.76 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 176.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 5.2 t -139.34 152.74 47.41 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -177.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.0 tt -97.57 141.46 30.58 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.62 144.15 50.71 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -176.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.09 114.01 19.77 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -145.02 -179.84 21.64 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 119.426 -1.368 . . . . 0.0 113.816 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -129.03 159.34 36.24 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 113.955 -1.123 . . . . 0.0 109.331 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -141.72 148.51 39.15 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -142.34 160.55 40.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.646 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.531 ' ND1' ' N ' ' A' ' 215' ' ' HIS . 0.0 OUTLIER -122.56 147.58 46.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.357 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 51.66 77.38 0.14 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.349 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -78.24 142.84 37.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.972 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 158.56 -111.54 0.49 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -128.69 143.52 50.95 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.629 HD22 ' N ' ' A' ' 220' ' ' LEU . 3.3 mm? -75.58 139.49 42.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.217 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -141.43 -173.05 3.65 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.538 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -52.59 165.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.753 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 72.3 p 49.23 82.03 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.634 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -78.9 144.28 35.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.589 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -103.62 145.92 29.33 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.603 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -139.85 137.05 34.61 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.291 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 7.7 m -147.26 -59.82 0.27 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.74 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.485 ' N ' ' ND1' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -153.96 158.58 40.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.447 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -120.47 -126.76 0.27 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.543 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.48 144.33 57.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 110.978 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 49.6 m -153.89 167.49 29.54 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.451 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 92.1 mt -86.12 143.99 27.75 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.924 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -128.11 148.21 17.67 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.1 130.21 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 122.728 -0.277 . . . . 0.0 110.433 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -130.29 116.88 18.97 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -99.74 107.13 19.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.301 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.476 ' NH1' HH21 ' A' ' 66' ' ' ARG . 76.8 mtp180 -125.44 128.04 47.47 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.976 0.417 . . . . 0.0 110.893 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 . . . . . 0 C--O 1.218 -0.583 0 CA-C-O 117.938 -1.029 . . . . 0.0 111.13 179.853 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -60.33 -41.93 94.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.585 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -150.85 128.72 11.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.262 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -89.62 112.33 23.53 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.729 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.74 -133.64 52.66 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.53 25.12 68.62 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -68.16 131.97 46.35 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.33 108.03 3.16 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.023 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.03 116.2 3.37 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 CA-C-N 119.614 1.707 . . . . 0.0 113.829 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.629 ' CZ ' ' NE ' ' A' ' 66' ' ' ARG . 11.4 p90 -115.65 167.61 10.76 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.76 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.0 t -125.71 149.32 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-O 120.926 0.393 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -118.96 139.7 51.23 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.033 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.92 156.06 44.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.85 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 38.0 p30 -150.26 136.4 18.66 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.86 170.02 16.49 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.47 -120.8 0.11 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.625 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -113.05 142.29 45.89 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.03 -163.51 1.75 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.852 0.358 . . . . 0.0 111.051 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -142.6 159.95 41.24 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.525 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -73.64 150.98 40.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.331 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -77.31 136.23 38.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.543 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 tt -95.72 133.78 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.946 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.7 m -103.68 125.71 50.35 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.488 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -78.86 -65.48 0.99 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.72 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -159.05 176.84 11.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.492 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 26' ' ' TYR . 18.8 p90 -161.88 60.79 1.18 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.847 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.69 141.6 79.93 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.052 1.835 . . . . 0.0 111.94 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.76 ' H ' ' CD ' ' A' ' 29' ' ' PRO . 3.6 mt-10 -126.11 -38.34 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.588 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.063 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.76 ' CD ' ' H ' ' A' ' 28' ' ' GLU . 91.5 Cg_endo -90.95 10.2 2.88 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.527 2.151 . . . . 0.0 112.693 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.5 p -129.23 160.16 33.82 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.833 0.349 . . . . 0.0 110.645 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 32' ' ' PRO . . . -163.0 75.99 1.91 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.932 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 31' ' ' ALA . 32.3 Cg_exo -56.94 -143.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.736 2.29 . . . . 0.0 111.821 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 58.56 40.88 23.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -124.22 110.77 15.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.658 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -149.36 -57.9 0.2 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.429 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.7 pttm -158.45 163.82 36.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.795 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -79.22 131.57 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.148 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.1 p -149.27 -136.78 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.038 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.9 m -61.75 135.93 57.8 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.089 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.37 155.23 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.965 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.6 p -151.75 163.51 38.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.399 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -65.62 136.32 56.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.596 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -62.6 -46.57 87.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.818 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -76.35 42.81 0.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.524 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -58.48 -67.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.482 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.451 ' CG ' ' H ' ' A' ' 47' ' ' ILE . 63.3 t30 -171.92 -179.56 2.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.434 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.451 ' H ' ' CG ' ' A' ' 46' ' ' ASN . 14.3 tt -86.55 135.25 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.591 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -63.3 -41.98 99.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.784 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.5 t -92.25 168.19 11.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.012 0.434 . . . . 0.0 110.814 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -167.42 34.62 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.803 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.2 p -78.57 111.76 14.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.631 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.5 m -136.87 163.02 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.557 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.7 m170 71.24 57.36 0.42 Allowed Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.508 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.78 148.86 65.87 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.388 2.058 . . . . 0.0 110.982 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -56.63 100.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 57' ' ' SER . 59.9 t -148.53 155.2 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.193 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.45 ' N ' HG12 ' A' ' 56' ' ' VAL . 38.5 m -135.17 148.11 49.6 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.842 0.353 . . . . 0.0 110.432 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.6 t -129.35 141.15 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.92 170.72 31.33 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 119.804 -1.189 . . . . 0.0 113.724 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -102.2 140.47 36.45 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-N 114.942 -0.629 . . . . 0.0 110.232 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' CG ' ' NH1' ' A' ' 237' ' ' ARG . 44.9 t0 -90.06 114.12 25.95 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 124.177 0.923 . . . . 0.0 113.252 -177.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' TRP . 34.3 m-85 -124.78 118.8 27.2 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.392 -1.277 . . . . 0.0 108.825 177.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.56 105.5 0.83 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.22 -52.36 0.83 Allowed Glycine 0 N--CA 1.466 0.64 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.417 ' O ' ' O ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -140.98 166.31 25.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.634 ' NH1' ' NH2' ' A' ' 237' ' ' ARG . 16.4 ttp180 -146.43 162.68 37.73 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.854 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.2 tp -135.24 134.1 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.631 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.15 137.87 23.63 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.299 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.79 137.45 40.07 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.577 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -99.0 125.67 44.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.505 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -129.09 139.56 51.94 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 73' ' ' ARG . . . -172.81 133.4 0.57 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.349 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.662 ' HE ' ' NH2' ' A' ' 75' ' ' ARG . 81.0 mtp85 38.8 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.975 0.417 . . . . 0.0 111.307 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -66.94 -39.34 87.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.145 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.662 ' NH2' ' HE ' ' A' ' 73' ' ' ARG . 84.6 mtt85 59.73 88.32 0.07 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.766 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.528 ' O ' ' CD1' ' A' ' 77' ' ' TRP . 62.3 tttm -173.39 95.25 0.11 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.675 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.528 ' CD1' ' O ' ' A' ' 76' ' ' LYS . 4.7 m-90 -148.12 121.39 8.97 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.533 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -64.74 -40.83 95.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.771 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -126.28 81.02 1.96 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.632 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -63.15 -42.17 99.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.643 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -144.54 -15.04 0.56 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.597 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 82' ' ' TYR . 31.9 p90 -114.4 108.16 16.51 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.962 0.41 . . . . 0.0 110.879 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.5 t -62.28 -44.9 95.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.295 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.7 m -149.42 3.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.187 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.5 t30 60.38 93.83 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.643 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.31 -43.41 98.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.473 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.04 102.57 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.524 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.489 HD21 HG13 ' A' ' 89' ' ' VAL . 6.9 p-10 -65.16 -35.71 81.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.355 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.489 HG13 HD21 ' A' ' 88' ' ' ASN . 35.5 m -130.51 157.43 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.355 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -70.72 -96.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.8 pt -129.13 162.02 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.628 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.522 ' N ' ' CD ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -146.17 10.05 1.13 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.371 -179.653 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -76.73 -8.77 57.92 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.599 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 93' ' ' LYS . 97.9 mt-10 56.51 116.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.018 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 94' ' ' GLU . 63.3 m-20 57.11 117.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.887 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -155.67 152.37 23.84 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 96.1 mt -122.54 126.99 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.848 0.356 . . . . 0.0 110.423 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -165.12 50.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.761 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 102' ' ' LYS . 84.0 mt -103.3 113.95 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.846 0.355 . . . . 0.0 110.482 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -94.26 -22.73 18.21 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.137 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -63.79 -39.16 93.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.115 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.426 ' H ' HG22 ' A' ' 99' ' ' ILE . 52.8 mtmt 45.37 -113.0 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.554 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 105' ' ' ASN . 81.1 p -116.24 9.6 14.63 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.187 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 104' ' ' GLU . 1.1 tm-20 -72.51 20.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.553 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 103' ' ' THR . 90.3 m-20 55.45 169.51 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.97 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -79.59 -163.82 0.57 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.225 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.44 129.55 42.54 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.239 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -91.44 117.29 29.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.687 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.32 -168.48 26.47 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 110' ' ' THR . 2.4 t -75.83 174.75 9.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.436 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -72.96 142.46 47.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.715 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -84.33 129.31 34.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.449 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.45 146.16 54.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.398 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.3 t -70.93 131.44 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.415 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.7 t -72.34 124.7 25.65 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.1 t -171.04 133.78 0.91 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.881 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER -148.95 158.89 44.52 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.255 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 167.61 -137.28 4.53 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.002 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.1 148.81 51.98 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.4 p -153.9 139.8 18.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.68 135.55 46.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.519 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.417 ' O ' ' CB ' ' A' ' 66' ' ' ARG . 99.1 mt -122.15 133.75 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -101.73 113.75 27.2 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -90.24 113.16 24.93 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.36 105.82 16.92 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -74.77 56.97 0.74 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.614 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.6 pt -76.27 -20.48 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -135.88 -102.16 0.21 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.155 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -178.44 -27.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.859 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -99.35 -19.6 16.94 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -161.55 137.67 8.04 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.376 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.59 149.43 73.03 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.238 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.38 104.61 1.36 Allowed 'Trans proline' 0 N--CA 1.485 1.003 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.601 ' CD2' ' NH2' ' A' ' 235' ' ' ARG . 36.4 p90 -86.14 133.09 33.89 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.616 0.722 . . . . 0.0 112.352 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 tp -133.84 138.52 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.835 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.38 167.01 31.3 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.81 157.97 37.85 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -137.0 134.51 36.7 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 37.1 t -128.63 123.87 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.56 141.61 35.21 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.693 0.759 . . . . 0.0 111.996 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -103.79 157.13 17.29 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.617 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -131.0 141.42 12.7 Favored Glycine 0 N--CA 1.466 0.678 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 52.7 m170 42.65 92.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.993 0.425 . . . . 0.0 110.728 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.81 142.19 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.479 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.512 ' C ' ' H ' ' A' ' 147' ' ' SER . 87.4 mtm180 56.51 -97.26 0.07 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.169 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 69.42 -37.71 0.38 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.705 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 145' ' ' ARG . 11.3 p -77.82 168.67 19.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.43 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 96.1 mt -67.48 135.14 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.488 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -79.47 107.38 12.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.1 m -139.54 150.24 44.85 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.385 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 76.3 p -108.93 61.61 0.6 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.158 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -61.91 -44.87 95.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.49 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.401 ' CD ' ' O ' ' A' ' 155' ' ' ILE . 18.1 ptpt -147.32 146.2 29.61 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.943 0.401 . . . . 0.0 110.476 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 37.0 p -67.72 -34.97 77.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.542 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.601 HG22 ' H ' ' A' ' 156' ' ' GLU . 3.1 mt -141.21 -141.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.694 0.283 . . . . 0.0 110.262 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.601 ' H ' HG22 ' A' ' 155' ' ' ILE . 17.6 pt-20 -157.79 -8.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.378 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.47 HG23 ' N ' ' A' ' 158' ' ' THR . 32.6 m -63.03 -40.1 87.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.47 ' N ' HG23 ' A' ' 157' ' ' VAL . 24.7 m -63.9 134.39 55.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.801 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 159' ' ' THR . 10.4 t -96.18 125.46 40.72 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.004 0.43 . . . . 0.0 110.824 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.3 m -95.48 152.82 39.51 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.72 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -39.42 136.46 1.03 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.888 1.726 . . . . 0.0 112.304 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 163' ' ' ASN . 26.7 t -79.97 -115.03 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.426 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.448 ' N ' ' OG ' ' A' ' 162' ' ' SER . 53.2 p-10 -151.0 19.04 0.78 Allowed 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.28 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.666 ' HB3' ' CD ' ' A' ' 165' ' ' PRO . . . -60.72 -66.59 1.44 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.506 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.666 ' CD ' ' HB3' ' A' ' 164' ' ' ALA . 56.9 Cg_endo -67.16 143.68 65.93 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.09 1.86 . . . . 0.0 110.969 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 50.84 50.9 18.1 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.556 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -144.8 159.8 27.89 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.9 89.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.65 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 t 48.12 94.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.475 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.573 ' C ' ' H ' ' A' ' 172' ' ' TYR . 99.2 m -69.1 -73.66 0.15 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.713 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 5.1 m 64.9 -19.82 0.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.522 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.573 ' H ' ' C ' ' A' ' 170' ' ' THR . 87.9 t80 -63.84 -25.01 67.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.641 0.258 . . . . 0.0 110.78 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -65.88 101.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.527 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.6 m -63.44 -46.31 86.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.89 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -65.49 113.67 12.59 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.859 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 178' ' ' THR . 92.3 Cg_endo -83.14 116.17 2.39 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 121.714 1.609 . . . . 0.0 111.758 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 179' ' ' GLN . 32.4 mmtp 40.33 -89.21 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.757 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 176' ' ' PRO . 21.3 m 58.68 -78.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.708 0.289 . . . . 0.0 110.609 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.514 ' N ' ' O ' ' A' ' 177' ' ' LYS . 11.7 tp-100 -90.55 104.36 16.95 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.21 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -63.56 -40.96 98.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.817 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -83.6 98.39 9.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.092 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -99.31 -47.93 4.99 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.503 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -157.44 142.17 16.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.112 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 18.9 m 38.16 88.14 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.112 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -126.14 93.87 3.93 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.442 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 27.3 t -155.14 131.51 10.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.025 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 187' ' ' ILE . 20.2 tt -142.63 127.58 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.713 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -165.94 23.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.834 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.57 ' HE ' ' HA ' ' A' ' 189' ' ' ARG . 2.2 tpm_? -64.79 -14.23 58.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 191' ' ' GLY . 3.5 p -119.22 158.54 20.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 177.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.403 ' N ' HG22 ' A' ' 190' ' ' VAL . . . -142.07 142.97 12.28 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 119.042 -1.551 . . . . 0.0 113.092 -177.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.87 146.03 35.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.362 -0.919 . . . . 0.0 110.005 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -165.55 175.47 41.26 Favored Glycine 0 C--N 1.314 -0.673 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.2 m -133.47 150.17 31.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.9 pt -119.96 151.82 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.74 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -167.75 158.7 11.16 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.931 0.872 . . . . 0.0 112.478 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.482 ' C ' ' CE2' ' A' ' 134' ' ' TYR . . . 174.12 -165.57 37.27 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.61 135.69 57.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.356 0.598 . . . . 0.0 110.037 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -102.91 136.72 13.01 Favored Glycine 0 C--O 1.224 -0.513 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.996 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.93 109.79 9.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 45.8 p30 -54.97 144.74 22.24 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -176.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.7 tt -125.98 2.05 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.809 1.29 . . . . 0.0 109.292 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.582 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -160.56 162.66 22.9 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 100.327 -3.953 . . . . 0.0 100.327 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.582 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.3 OUTLIER -10.57 -79.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.775 2.317 . . . . 0.0 113.771 -177.023 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 237' ' ' ARG . 12.8 mptt -129.03 25.4 5.56 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.472 0.578 . . . . 0.0 110.304 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 236' ' ' TYR . 3.4 tp -78.92 110.69 14.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 53.6 p -106.25 145.64 31.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 14.9 tp -106.25 122.18 45.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 111.991 -2.368 . . . . 0.0 106.03 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -110.09 136.37 49.44 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -175.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -108.68 112.69 25.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 173.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -145.88 179.41 22.94 Favored Glycine 0 N--CA 1.463 0.486 0 C-N-CA 119.28 -1.438 . . . . 0.0 113.938 -175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.22 157.26 43.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.244 -1.478 . . . . 0.0 109.742 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -107.97 133.05 52.85 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' A' ' 217' ' ' TRP . 74.3 t80 -114.67 108.05 16.29 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 216' ' ' ASN . 52.9 p-80 -106.93 132.04 53.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.082 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 215' ' ' HIS . 59.5 t30 57.67 148.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.123 0.487 . . . . 0.0 111.42 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.422 ' O ' ' OH ' ' A' ' 214' ' ' TYR . 14.0 m-90 -63.68 -42.12 98.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.598 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 121.69 -90.11 0.44 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 34.6 -148.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.764 0.316 . . . . 0.0 111.483 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 220' ' ' LEU . 2.2 mm? -74.75 159.37 32.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.247 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 220' ' ' LEU . 97.4 mt-10 59.46 127.48 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.844 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 55.6 51.75 12.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.672 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 21.1 p -70.08 137.94 51.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.55 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.52 ' HD3' ' H ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -84.63 158.49 20.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.845 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 227' ' ' THR . 33.8 t80 -134.56 130.04 35.94 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.83 0.348 . . . . 0.0 110.695 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.4 tttt 37.42 -95.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.39 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 225' ' ' PHE . 6.0 m 39.87 83.9 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.761 0.315 . . . . 0.0 110.999 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.614 ' CG ' ' H ' ' A' ' 229' ' ' GLU . 30.7 t-80 -102.47 -119.02 0.19 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.581 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.614 ' H ' ' CG ' ' A' ' 228' ' ' HIS . 43.5 tt0 -68.34 130.47 42.98 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.98 0.419 . . . . 0.0 110.584 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -168.49 29.49 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.438 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.2 t -139.89 125.79 19.6 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.863 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 86.2 mt -108.65 104.49 13.8 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -98.71 121.55 7.22 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.663 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 71.1 t -115.55 125.05 72.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.601 ' NH2' ' CD2' ' A' ' 134' ' ' TYR . 1.7 mtt180 -133.33 144.43 49.65 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.509 0.671 . . . . 0.0 111.515 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.473 ' HA ' HD12 ' A' ' 206' ' ' LEU . 6.9 t80 -103.09 103.3 13.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.378 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.634 ' NH2' ' NH1' ' A' ' 66' ' ' ARG . 55.9 ttm-85 -130.59 129.76 43.16 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.484 ' C ' ' O ' ' A' ' 237' ' ' ARG . 69.6 m-85 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 118.025 -0.988 . . . . 0.0 112.547 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 3' ' ' GLU . 11.6 m 45.18 -92.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.564 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 1' ' ' ALA . 32.8 tp10 57.71 156.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.08 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -76.98 117.08 18.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.448 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.66 169.49 37.65 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.92 -143.72 0.41 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -92.18 136.38 33.23 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 110.605 -0.146 . . . . 0.0 110.605 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -110.11 96.2 0.92 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.204 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.567 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 94.0 Cg_endo -84.35 119.68 2.4 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 122.962 2.441 . . . . 0.0 111.749 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.567 ' CG ' ' O ' ' A' ' 9' ' ' PRO . 71.9 m-85 -152.01 -175.94 5.45 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.639 HG22 ' N ' ' A' ' 12' ' ' GLN . 12.5 p -124.46 163.86 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -174.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.639 ' N ' HG22 ' A' ' 11' ' ' VAL . 10.7 tm0? -135.31 149.92 49.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.805 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.04 130.75 15.98 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -101.97 130.96 48.62 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.99 0.424 . . . . 0.0 111.957 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.83 155.44 47.79 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.526 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.61 124.19 7.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.392 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -102.15 3.62 38.67 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 110.375 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.75 -30.17 71.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.085 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -75.31 135.72 40.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.735 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.36 -78.02 0.56 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.836 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -145.32 132.8 20.77 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.678 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -127.33 129.96 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.521 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.09 -62.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.272 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 25' ' ' ASP . 70.2 m80 -66.53 -41.78 88.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.682 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 42.2 t0 56.48 159.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.115 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -54.0 110.21 1.96 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.76 -23.19 14.59 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.642 1.561 . . . . 0.0 112.567 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -156.27 91.21 2.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.449 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.05 147.79 72.8 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.068 1.845 . . . . 0.0 111.668 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.1 p -57.61 -40.41 79.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.553 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 43.28 80.43 0.29 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.553 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.86 144.35 98.74 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.366 2.044 . . . . 0.0 112.004 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 58.12 36.72 26.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.065 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HG3' ' H ' ' A' ' 36' ' ' LYS . 26.1 pttm -64.22 -36.52 84.35 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.369 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 36' ' ' LYS . 46.1 m-20 56.88 39.63 29.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.282 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 35' ' ' ASN . 54.1 mtmt 55.17 112.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.864 0.364 . . . . 0.0 110.748 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.62 126.22 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.495 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -162.5 -63.46 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.691 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.7 p -132.64 109.74 9.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.617 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 41' ' ' SER . 20.0 m -133.92 135.45 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.349 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 40' ' ' VAL . 33.7 m -55.25 -165.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.736 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -79.72 55.82 2.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.372 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -82.19 142.65 32.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.804 0.335 . . . . 0.0 110.478 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -72.6 140.27 47.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.18 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -144.6 -35.3 0.34 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.364 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 54.02 80.74 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.444 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.447 ' C ' ' H ' ' A' ' 49' ' ' THR . 19.8 tt -123.6 161.93 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.987 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 67.27 -2.55 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.475 ' O ' HG22 ' A' ' 49' ' ' THR . 35.4 m -92.36 -4.0 54.5 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.04 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -58.91 -4.8 0.51 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.066 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.478 ' OG ' ' N ' ' A' ' 52' ' ' VAL . 40.4 t -60.83 -170.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.592 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.478 ' N ' ' OG ' ' A' ' 51' ' ' SER . 4.6 t 61.52 117.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.329 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -131.77 87.91 43.91 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.055 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HG2' HH21 ' A' ' 138' ' ' ARG . 36.9 Cg_exo -57.69 144.88 92.03 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.443 2.095 . . . . 0.0 110.638 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -148.23 -43.09 0.16 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.56 139.5 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 p -141.88 153.49 44.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.02 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.17 147.44 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.362 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.46 -154.08 10.6 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -135.99 154.47 51.07 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 53.5 p30 -121.84 149.63 43.08 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -176.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -126.53 159.95 31.98 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 112.246 -2.252 . . . . 0.0 105.14 175.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.58 100.7 0.1 OUTLIER Glycine 0 CA--C 1.535 1.301 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.259 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.562 ' O ' ' CD1' ' A' ' 65' ' ' TRP . . . 61.84 48.52 83.34 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.771 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 64' ' ' GLY . 16.7 m95 -165.8 89.24 0.42 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.609 ' NH1' ' NH1' ' A' ' 235' ' ' ARG . 70.9 ttt180 -127.33 150.43 49.59 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -176.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.43 141.35 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.397 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.72 137.91 19.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.384 0.611 . . . . 0.0 112.488 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.88 156.13 16.81 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -151.39 159.03 44.45 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -160.64 165.99 29.65 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.46 -1.7 . . . . 0.0 108.902 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.73 -165.16 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.13 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.42 ' NH1' ' HE ' ' A' ' 75' ' ' ARG . 15.7 tpt180 -126.12 124.16 39.94 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.898 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -174.03 -10.69 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.524 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.42 ' HE ' ' NH1' ' A' ' 73' ' ' ARG . 37.7 ptt180 -71.79 141.99 49.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.167 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -87.12 137.0 32.72 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -114.54 128.95 56.6 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.895 0.379 . . . . 0.0 110.559 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -147.8 95.82 2.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.334 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -96.71 9.09 42.7 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.246 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -150.02 170.41 18.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.054 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -88.79 -170.98 3.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.926 0.394 . . . . 0.0 110.758 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -62.38 -36.33 81.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.387 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.5 p -134.88 156.71 48.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.982 0.42 . . . . 0.0 110.904 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.6 t -76.86 133.59 30.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.607 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ILE . 62.7 t30 64.74 94.84 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.695 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.407 ' O ' ' O ' ' A' ' 85' ' ' ASN . 23.9 mm 60.34 140.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.687 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -65.49 140.44 58.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.766 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 89' ' ' VAL . 59.8 t-20 -77.44 150.79 34.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.177 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.534 ' N ' ' OD1' ' A' ' 88' ' ' ASN . 5.9 t -82.68 100.92 6.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.366 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.9 mtp180 -84.36 -59.92 2.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.664 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.9 tt -152.61 145.24 15.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.459 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -73.2 136.49 44.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 110.902 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -156.23 138.28 14.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.281 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 95' ' ' ASN . 80.8 tt0 -154.13 133.1 12.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.785 0.326 . . . . 0.0 110.706 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 94' ' ' GLU . 88.7 m-20 -152.77 170.19 20.9 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.493 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 97' ' ' ILE . . . -81.17 -172.1 45.92 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 96' ' ' GLY . 1.6 tp 35.32 96.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.481 0.658 . . . . 0.0 111.186 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -53.18 118.82 4.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.945 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 100' ' ' ASP . 17.2 tt -68.64 -37.64 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.34 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.429 ' N ' HG23 ' A' ' 99' ' ' ILE . 98.6 m-20 57.42 152.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.729 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -70.71 -167.34 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.399 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -73.5 -15.45 61.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.81 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.4 p -104.08 118.84 37.62 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.582 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -83.94 -80.26 0.19 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.408 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 106' ' ' GLN . 28.2 t-20 -141.21 97.09 3.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.393 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 105' ' ' ASN . 50.7 tt0 46.16 98.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.756 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -161.39 100.25 1.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.486 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 56.51 35.77 26.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.487 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.61 7.68 65.81 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.2 p -133.58 160.89 36.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.966 0.412 . . . . 0.0 110.972 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 42.85 -123.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.93 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -75.41 141.79 43.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.913 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -158.39 -79.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.314 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.69 -34.36 69.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.7 m -70.35 145.69 50.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.856 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.8 m -139.57 154.56 47.65 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.578 ' N ' HD22 ' A' ' 117' ' ' LEU . 3.0 mm? -87.2 132.12 33.98 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.364 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.69 138.81 14.47 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tp -149.45 140.01 22.53 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.7 p -157.12 155.64 31.38 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.365 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.91 137.34 52.09 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.474 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 123' ' ' TYR . 4.6 mp -126.31 156.13 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.348 0.594 . . . . 0.0 111.175 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.47 ' N ' HG22 ' A' ' 122' ' ' ILE . 57.6 m-85 -117.48 113.05 21.47 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.837 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -106.64 122.9 47.26 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.201 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -75.68 104.01 6.04 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.037 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -71.2 -29.7 65.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.136 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.8 -41.67 88.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.421 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -58.65 126.81 29.17 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.581 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.48 -21.87 59.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -128.1 -48.94 1.33 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.529 ' O ' ' CD2' ' A' ' 131' ' ' PHE . 52.9 p90 -115.65 132.59 56.59 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.14 110.77 41.03 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.319 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.14 109.63 1.58 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 N-CA-C 108.882 -1.238 . . . . 0.0 108.882 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 1.8 p90 -83.21 132.73 35.05 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.223 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 63.6 mt -134.33 154.87 38.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.75 -173.16 44.89 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 118.113 -1.994 . . . . 0.0 113.858 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.91 141.98 50.73 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.434 HH21 ' HG2' ' A' ' 54' ' ' PRO . 78.7 ttt180 -123.66 131.23 53.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.992 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.04 130.44 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.235 0.541 . . . . 0.0 111.477 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.26 117.8 34.92 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.961 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -120.31 140.97 50.47 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.952 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.99 -144.19 4.65 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -83.86 109.6 17.69 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.811 0.339 . . . . 0.0 110.438 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.3 p -143.94 156.37 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.008 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 56.9 79.07 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.813 0.339 . . . . 0.0 110.407 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.515 ' O ' ' ND1' ' A' ' 146' ' ' HIS . 64.3 t-80 -169.24 59.33 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.599 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 78.4 p -65.88 -55.62 16.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.029 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 21.1 tt -155.53 147.32 12.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.441 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 150' ' ' SER . 32.1 t0 -144.71 -143.03 0.14 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.187 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.519 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 22.1 m -68.84 138.26 54.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.748 0.309 . . . . 0.0 110.446 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.7 p -90.54 162.32 15.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.76 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.83 -37.9 89.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.971 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 64.5 mttp 59.73 20.59 9.33 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.615 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 156' ' ' GLU . 74.5 p -136.44 161.89 34.59 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.023 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 94.8 mt 54.0 -87.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.389 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 154' ' ' THR . 18.2 pt-20 -133.58 161.81 33.61 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.041 0.448 . . . . 0.0 111.11 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.3 m -118.78 132.84 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.184 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 5.7 p -78.84 154.26 29.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.564 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 21.7 p -79.88 164.83 23.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.35 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.37 149.69 97.24 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.122 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -40.25 -55.68 1.75 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.173 1.915 . . . . 0.0 112.69 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.1 p -159.09 164.02 35.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.701 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 164' ' ' ALA . 51.5 p-10 -84.09 -32.32 24.83 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.694 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.524 ' N ' ' OD1' ' A' ' 163' ' ' ASN . . . -179.04 78.87 0.21 Allowed Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.365 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 166' ' ' ASN . 90.2 Cg_endo -80.22 151.85 20.8 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.372 2.048 . . . . 0.0 111.731 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 165' ' ' PRO . 71.4 m-20 58.45 141.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.949 0.405 . . . . 0.0 110.835 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -85.65 174.7 48.54 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.93 111.53 20.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.762 0.315 . . . . 0.0 110.533 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.3 t 38.34 84.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.098 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 50.7 p -82.06 -100.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.494 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.6 m -166.96 97.68 0.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.795 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 173' ' ' ASN . 98.7 m-85 -74.37 -107.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.232 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.495 ' CG ' ' H ' ' A' ' 174' ' ' THR . 60.8 t30 43.92 -171.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.944 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.495 ' H ' ' CG ' ' A' ' 173' ' ' ASN . 2.5 m 66.75 0.08 1.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.63 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.14 147.34 79.81 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.527 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.45 154.44 45.34 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.28 1.987 . . . . 0.0 111.984 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -92.31 80.39 4.98 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.777 0.322 . . . . 0.0 110.277 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 65.5 p -85.1 167.4 15.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -55.03 174.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.803 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 65.7 t30 57.46 53.28 7.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -61.37 -42.04 98.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.628 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 184' ' ' SER . 93.7 t80 -144.87 -69.26 0.3 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.518 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 49.2 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 182' ' ' TYR . 12.3 p -155.42 161.9 40.89 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.897 0.38 . . . . 0.0 110.804 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -99.68 118.73 36.83 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.713 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.3 t -146.99 -156.22 0.7 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.414 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 96.0 mt 54.63 90.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.09 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -115.71 42.95 2.19 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.649 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 49.72 26.62 1.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.155 0.502 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.46 136.69 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -102.05 111.66 4.12 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.1 pp -143.76 159.13 43.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 112.375 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -177.93 -155.66 14.67 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.68 157.0 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 117.247 0.523 . . . . 0.0 110.747 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.9 pt -130.08 145.41 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.874 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -156.19 150.52 25.57 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.086 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 175.9 -173.5 46.3 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.8 143.94 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 117.731 0.765 . . . . 0.0 111.066 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -143.41 160.72 27.66 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.14 152.38 49.9 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.45 0.643 . . . . 0.0 111.532 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 6.3 p30 -69.36 146.89 51.76 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 113.717 -1.583 . . . . 0.0 115.195 -175.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 43.8 mt -119.91 -1.17 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 123.335 1.54 . . . . 0.0 107.123 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.541 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.2 OUTLIER -165.15 147.98 6.96 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 100.5 -3.889 . . . . 0.0 100.5 178.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.541 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -6.62 -67.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 123.249 2.633 . . . . 0.0 114.191 -176.178 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 237' ' ' ARG . 58.8 mmtt -130.77 33.07 4.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.359 0.982 . . . . 0.0 112.292 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 0.9 OUTLIER -92.55 108.07 19.69 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 176.284 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.0 t -137.35 154.88 49.94 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -174.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.96 141.85 45.1 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 113.023 -1.899 . . . . 0.0 107.578 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -135.73 147.89 48.63 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.27 150.6 43.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -179.36 -172.89 44.04 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.612 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -123.55 167.98 13.2 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.843 -0.678 . . . . 0.0 109.837 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -140.85 141.66 34.64 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.599 0.238 . . . . 0.0 110.84 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.417 ' HB3' ' HE1' ' A' ' 217' ' ' TRP . 2.3 m-85 -109.75 11.21 24.54 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.256 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 216' ' ' ASN . 50.0 p-80 -37.6 115.42 0.41 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 215' ' ' HIS . 7.7 t-20 24.33 105.86 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.855 0.722 . . . . 0.0 112.643 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.417 ' HE1' ' HB3' ' A' ' 214' ' ' TYR . 0.5 OUTLIER -71.4 152.96 42.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.815 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 102.44 -21.03 42.53 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.33 -41.21 94.2 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.528 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 90.4 mt -129.53 113.97 15.51 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.769 0.318 . . . . 0.0 110.715 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -71.03 -38.62 72.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.786 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 50.3 -99.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.516 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.3 m 58.09 98.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.291 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -141.67 154.51 45.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.501 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.14 -47.24 87.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.88 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -143.55 128.2 18.14 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.645 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 88.3 m -127.43 129.79 48.13 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.39 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -100.58 139.37 36.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.603 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 55.65 -178.22 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.169 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -155.59 -88.62 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.326 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 50.5 m -132.74 124.19 27.66 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.12 135.83 54.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.287 0.565 . . . . 0.0 111.578 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -102.1 151.14 18.35 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.724 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.86 129.76 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.609 ' NH1' ' NH1' ' A' ' 66' ' ' ARG . 93.7 mtt180 -133.41 140.92 47.6 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.421 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 26.2 t80 -113.52 102.06 9.94 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 102.203 -3.258 . . . . 0.0 102.203 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.572 ' O ' ' HB2' ' A' ' 205' ' ' LYS . 62.1 ttp85 -148.82 136.65 20.66 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.474 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.934 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.148 0 CA-C-O 121.233 0.352 . . . . 0.0 112.957 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.53 150.51 87.36 Favored 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 123.896 3.064 . . . . 0.0 115.153 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 44.2 p90 -149.45 161.65 41.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.259 -1.791 . . . . 0.0 106.77 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.9 t -130.5 135.51 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 118.385 0.539 . . . . 0.0 110.741 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -120.32 148.53 43.61 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.69 107.5 4.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.476 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -85.79 151.17 24.04 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.722 HD22 ' C ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -171.17 167.78 6.96 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.596 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.476 0.826 0 O-C-N 123.992 0.808 . . . . 0.0 109.868 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 110.526 -0.176 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.31 132.6 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.0 t -114.21 122.08 45.69 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.957 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 59' ' ' GLY . 3.9 p -135.01 153.92 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.405 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -175.8 -168.35 36.0 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.379 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -117.0 138.46 51.55 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.3 p30 -105.01 120.25 41.01 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 64' ' ' GLY . 74.9 m-85 -124.19 128.64 49.52 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.29 92.66 0.01 OUTLIER Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 62' ' ' PHE . . . 138.41 -94.1 0.21 Allowed Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -93.0 148.6 21.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.557 0.694 . . . . 0.0 111.444 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -132.17 135.66 46.51 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.963 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.66 128.86 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.75 143.83 47.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.036 0.446 . . . . 0.0 110.76 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.27 134.69 42.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.72 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -111.7 129.41 56.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.91 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -118.62 137.46 53.26 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.409 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.219 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.737 179.635 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.2 mp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.84 0.352 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -128.86 128.38 5.84 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.44 131.75 36.58 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.9 m -145.72 147.12 31.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.918 0.389 . . . . 0.0 110.428 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.28 113.3 26.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.477 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.684 HD12 ' N ' ' A' ' 122' ' ' ILE . 3.4 mp -111.55 146.59 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -112.77 127.21 56.09 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -98.92 125.17 44.28 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 176.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.46 ' C ' ' H ' ' A' ' 127' ' ' ILE . 39.0 m-85 -107.21 120.79 43.08 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -80.93 21.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.826 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 128' ' ' ASN . 21.4 tt -68.29 -39.35 80.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.689 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.49 ' N ' HG23 ' A' ' 127' ' ' ILE . 11.2 m120 -93.39 -174.79 3.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.976 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -102.3 -52.55 3.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.266 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.75 -14.2 14.64 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.445 ' O ' ' CD2' ' A' ' 131' ' ' PHE . 48.9 p90 -144.77 125.95 14.67 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.109 0.868 . . . . 0.0 112.093 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.4 mtmm -107.59 129.72 23.82 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.48 140.87 33.9 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 120.975 1.117 . . . . 0.0 109.982 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -107.34 133.94 51.14 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.588 0.232 . . . . 0.0 110.858 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.3 tt -151.85 136.83 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.264 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -175.37 -168.15 35.45 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.224 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.31 156.16 49.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.845 0.355 . . . . 0.0 111.132 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.731 ' NH2' HH11 ' A' ' 213' ' ' ARG . 39.5 ttm180 -106.7 144.84 32.77 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.541 0.686 . . . . 0.0 112.837 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.6 t -130.87 112.7 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.93 126.94 52.97 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 88.2 t80 . . . . . 0 N--CA 1.461 0.116 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.447 178.584 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 CA--C 1.52 -0.203 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -135.51 139.85 11.14 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.446 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.54 147.27 52.52 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 114.398 -0.901 . . . . 0.0 108.785 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -160.5 -172.6 27.99 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.92 153.75 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 111.438 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 95.3 mt -130.94 136.3 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.678 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.49 154.98 32.67 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.123 0.487 . . . . 0.0 111.41 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 173.93 178.92 44.22 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.6 m -136.89 135.73 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -114.78 136.83 13.5 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.429 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -121.07 104.91 10.14 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 201' ' ' ASP . 0.3 OUTLIER -97.36 143.83 27.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 43.7 mm -75.54 -34.74 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 175.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.45 HG22 ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -165.79 164.32 11.85 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 101.183 -3.636 . . . . 0.0 101.183 177.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.504 ' C ' ' O ' ' A' ' 237' ' ' ARG . 8.2 Cg_endo -55.11 -15.82 11.31 Favored 'Trans proline' 0 C--N 1.288 -2.629 0 CA-C-N 121.801 1.679 . . . . 0.0 111.66 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.458 ' HA ' ' H ' ' A' ' 237' ' ' ARG . 0.9 OUTLIER -73.8 -39.45 64.11 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.5 mt -123.08 110.45 15.34 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.626 0.648 . . . . 0.0 111.381 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 t -134.56 138.27 44.46 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.615 HD12 ' N ' ' A' ' 208' ' ' LEU . 5.8 mp -89.78 128.38 36.13 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -133.95 124.8 26.97 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -84.59 111.5 19.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -109.51 139.6 15.38 Favored Glycine 0 N--CA 1.467 0.744 0 C-N-CA 121.272 -0.489 . . . . 0.0 112.655 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -129.95 125.71 36.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.95 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.731 HH11 ' NH2' ' A' ' 138' ' ' ARG . 60.7 ttm-85 -110.64 116.82 32.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 215' ' ' HIS . 60.8 t80 -132.69 156.0 47.79 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.406 0.622 . . . . 0.0 111.939 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.539 ' O ' ' CD2' ' A' ' 214' ' ' TYR . 84.5 t60 -87.34 168.34 13.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.652 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.465 ' N ' ' CG ' ' A' ' 215' ' ' HIS . 65.1 t30 . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.853 0.359 . . . . 0.0 110.636 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 15' ' ' LEU . 12.1 tp . . . . . 0 CA--C 1.514 -0.427 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.9 148.17 19.18 Favored Glycine 0 C--N 1.314 -0.672 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 68.5 t -122.16 128.83 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.693 HH12 ' NH2' ' A' ' 237' ' ' ARG . 45.7 ptt85 -133.29 143.01 48.77 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.77 0.795 . . . . 0.0 111.266 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 53.5 t80 -110.57 126.67 54.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 113.763 -1.562 . . . . 0.0 113.326 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.693 ' NH2' HH12 ' A' ' 235' ' ' ARG . 36.3 ttm180 -140.76 113.0 7.88 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.946 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' A' ' 237' ' ' ARG . 90.5 m-85 . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 117.852 -1.071 . . . . 0.0 111.954 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 10' ' ' TYR . . . . . . . . 0 CA--C 1.533 1.167 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 26.9 Cg_endo -74.48 141.32 28.15 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.607 1.538 . . . . 0.0 111.532 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 63.8 m-85 -147.23 -179.86 7.13 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.603 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 12' ' ' GLN . 2.3 p -128.6 160.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.556 ' OE1' ' NH2' ' A' ' 235' ' ' ARG . 57.2 tt0 -142.71 147.04 34.98 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.851 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.31 156.92 43.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.928 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -160.5 155.78 24.86 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.0 mt -134.15 146.2 49.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.584 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.174 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 57' ' ' SER . 13.7 p -140.64 162.23 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.639 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.511 ' N ' HG22 ' A' ' 56' ' ' VAL . 28.3 t -146.61 151.94 38.1 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.81 163.15 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.326 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.18 178.68 43.45 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.934 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -112.73 131.12 55.81 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.19 0.596 . . . . 0.0 109.813 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -102.08 127.24 49.06 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.545 ' O ' ' N ' ' A' ' 64' ' ' GLY . 90.5 m-85 -124.56 139.55 53.77 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.58 88.82 0.01 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.11 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 62' ' ' PHE . . . 129.77 -82.33 0.33 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -95.99 144.08 26.59 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.675 0.75 . . . . 0.0 111.501 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.782 HH11 HH21 ' A' ' 237' ' ' ARG . 51.2 ttp180 -136.27 137.93 41.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.377 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.93 128.68 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.58 139.32 26.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.08 145.46 50.32 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.107 0.48 . . . . 0.0 111.095 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -93.58 125.96 38.47 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -106.38 141.97 36.82 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.631 0.729 . . . . 0.0 111.789 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.489 -179.837 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.2 mp . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -135.1 142.2 13.58 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 120.468 -0.873 . . . . 0.0 113.392 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.3 mt -120.43 143.47 48.46 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.7 t -139.68 118.02 12.06 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.63 118.54 29.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.548 HG22 ' N ' ' A' ' 123' ' ' TYR . 46.3 mm -104.77 160.17 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.548 ' N ' HG22 ' A' ' 122' ' ' ILE . 62.8 t80 -128.02 99.48 5.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 64' ' ' GLY . 43.8 t0 -138.34 122.8 18.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.843 0.354 . . . . 0.0 110.33 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.504 ' H ' ' CG ' ' A' ' 132' ' ' LYS . 10.9 m-85 -113.19 121.56 44.85 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.823 0.821 . . . . 0.0 112.322 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 126' ' ' GLN . 1.3 mp0 -86.7 -10.51 53.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.915 -1.038 . . . . 0.0 108.841 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.571 ' C ' ' H ' ' A' ' 129' ' ' ASP . 96.4 mt -67.84 -41.2 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 95.4 m-20 -69.67 35.35 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.849 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' A' ' 127' ' ' ILE . 20.8 t0 92.62 -119.94 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.85 0.719 . . . . 0.0 110.491 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -127.34 23.3 6.42 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.574 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 11.0 p90 -151.13 126.39 9.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 119.568 -0.853 . . . . 0.0 113.287 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.504 ' CG ' ' H ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -135.87 135.71 22.09 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.413 177.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.65 98.34 1.14 Allowed 'Trans proline' 0 C--N 1.325 -0.661 0 N-CA-C 104.217 -3.032 . . . . 0.0 104.217 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -76.66 135.75 39.13 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 118.97 -1.092 . . . . 0.0 113.566 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.2 mt -120.54 134.17 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 CA-C-N 113.465 -1.698 . . . . 0.0 107.75 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.02 166.06 30.38 Favored Glycine 0 N--CA 1.46 0.288 0 C-N-CA 119.897 -1.145 . . . . 0.0 112.145 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.22 134.7 34.13 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -106.97 119.8 40.33 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.195 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 139' ' ' VAL . 9.8 p -136.3 123.12 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.77 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.84 129.44 34.48 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 . . . . . 0 C--O 1.237 0.442 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.081 -179.15 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 190' ' ' VAL . 14.1 p . . . . . 0 N--CA 1.465 0.279 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -138.32 135.17 7.29 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 119.505 -1.331 . . . . 0.0 114.583 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.59 144.75 50.79 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 163.31 -148.83 15.74 Favored Glycine 0 C--N 1.322 -0.216 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.01 159.19 26.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.767 0.794 . . . . 0.0 112.004 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 19.5 tt -113.11 131.61 64.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.66 150.47 36.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 122.15 0.976 . . . . 0.0 112.769 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 171.58 177.4 41.25 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.68 136.22 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.623 0.725 . . . . 0.0 110.57 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -122.87 120.67 4.34 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -128.25 142.21 51.22 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.836 0.827 . . . . 0.0 109.59 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 201' ' ' ASP . 13.6 p-10 -49.16 141.8 7.82 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 117.438 2.385 . . . . 0.0 117.438 -173.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 202' ' ' ILE . 49.7 mm -124.31 5.59 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 112.35 -2.204 . . . . 0.0 106.177 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.58 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER 176.15 173.83 0.29 Allowed Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 -178.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.58 ' C ' ' O ' ' A' ' 203' ' ' THR . 3.8 Cg_exo -14.36 -83.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 123.58 2.314 . . . . 0.0 113.687 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.435 ' O ' HG23 ' A' ' 207' ' ' THR . 58.7 mttp -129.61 29.6 5.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.689 0.757 . . . . 0.0 110.604 177.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 202' ' ' ILE . 4.2 tt -83.66 111.89 19.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 176.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 205' ' ' LYS . 3.2 p -120.31 152.73 37.41 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.16 131.77 48.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 112.728 -2.033 . . . . 0.0 105.623 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -108.06 146.82 32.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -145.59 129.51 17.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.531 -1.668 . . . . 0.0 106.673 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -167.68 -168.99 30.64 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 118.903 -1.617 . . . . 0.0 113.038 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -143.81 142.69 30.99 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.542 HH12 ' CD2' ' A' ' 215' ' ' HIS . 8.9 ptm180 -91.41 116.98 29.28 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.95 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -63.47 -46.35 86.59 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.542 ' CD2' HH12 ' A' ' 213' ' ' ARG . 86.3 t60 29.59 84.36 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.206 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.9 t30 . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.38 179.287 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 232' ' ' LEU . 11.3 mp . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 121.107 0.48 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -141.58 153.08 23.87 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.011 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 14.2 p -133.44 134.18 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.652 ' NE ' HH12 ' A' ' 66' ' ' ARG . 52.6 ttm-85 -133.29 141.67 48.1 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 80.4 t80 -107.84 103.57 12.86 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.782 HH21 HH11 ' A' ' 66' ' ' ARG . 41.1 ttm180 -126.44 133.54 51.21 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 124.188 0.93 . . . . 0.0 111.413 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 10.2 t80 . . . . . 0 C--O 1.218 -0.554 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.308 179.493 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.062 0 CA-C-O 120.967 0.204 . . . . 0.0 113.105 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.54 -174.59 2.0 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.308 2.672 . . . . 0.0 112.464 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.691 ' CZ ' ' NH2' ' A' ' 66' ' ' ARG . 3.4 t80 -159.47 141.02 13.06 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 120.904 0.383 . . . . 0.0 111.786 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 12' ' ' GLN . 58.0 t -132.21 159.39 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.571 ' NE2' ' NE ' ' A' ' 235' ' ' ARG . 7.4 tt0 -157.44 151.79 24.94 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -176.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.7 121.59 10.64 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 113.172 -1.831 . . . . 0.0 107.825 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 38.4 p30 -92.65 133.77 35.66 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.1 mt -126.86 133.87 50.63 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.149 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.768 179.408 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 . . . . . 0 CA--C 1.518 -0.287 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.07 139.3 44.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 121.154 0.502 . . . . 0.0 111.462 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.26 130.27 36.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.91 162.71 37.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.065 0.459 . . . . 0.0 111.155 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.85 -136.21 3.1 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -139.28 151.76 46.71 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 121.482 0.658 . . . . 0.0 112.344 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.563 ' OD2' ' NE ' ' A' ' 237' ' ' ARG . 12.1 t0 -92.39 104.79 17.08 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.125 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -126.33 148.07 49.62 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.256 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.47 125.77 8.07 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 123' ' ' TYR . . . 94.09 -10.73 71.56 Favored Glycine 0 C--N 1.33 0.247 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.539 ' CZ2' ' CG2' ' A' ' 67' ' ' ILE . 22.6 t90 -167.69 142.45 3.72 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.565 -0.817 . . . . 0.0 110.198 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.691 ' NH2' ' CZ ' ' A' ' 10' ' ' TYR . 69.4 mtp180 -144.01 144.34 31.62 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.539 ' CG2' ' CZ2' ' A' ' 65' ' ' TRP . 48.5 pt -120.17 138.34 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.639 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.65 110.16 8.53 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.786 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.07 119.52 29.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -100.14 128.42 46.22 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 112.146 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -153.92 155.23 35.27 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.675 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.475 -179.381 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 117' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.466 0.35 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 162.53 -105.4 0.26 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 118.875 -1.631 . . . . 0.0 112.916 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.28 151.74 33.43 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.4 0.619 . . . . 0.0 111.547 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.0 t -139.48 119.25 13.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.458 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.91 123.23 26.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.089 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.504 HD13 HH22 ' A' ' 235' ' ' ARG . 90.7 mt -101.23 135.95 35.25 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' A' ' 64' ' ' GLY . 12.2 m-85 -124.3 107.72 11.47 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.008 0.432 . . . . 0.0 110.301 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.666 ' CG ' HH11 ' A' ' 66' ' ' ARG . 9.5 m-20 -96.96 141.53 30.02 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.933 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.495 ' O ' ' CB ' ' A' ' 132' ' ' LYS . 93.5 m-85 -103.34 153.7 20.17 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -108.59 63.61 0.61 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.8 mp -67.43 -41.69 86.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -141.84 -85.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.011 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.4 t70 179.24 -44.22 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.332 0.587 . . . . 0.0 110.297 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.99 -43.31 88.15 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -142.93 110.73 5.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -175.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -130.58 139.93 37.13 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.46 152.18 70.84 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.323 1.348 . . . . 0.0 109.603 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 0.5 OUTLIER -138.45 133.95 33.42 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.612 -179.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.4 pt -130.4 154.8 41.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.441 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -155.88 163.27 31.72 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.93 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -102.35 122.61 44.59 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -92.66 128.22 38.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.111 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.13 119.22 46.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.32 153.53 46.47 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.419 ' CE1' ' O ' ' A' ' 117' ' ' LEU . 47.6 p90 . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.55 . . . . 0.0 110.927 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -119.33 117.96 3.8 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.22 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 7.8 tt -145.34 127.81 15.99 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -171.73 -163.16 25.21 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.305 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.79 138.37 49.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.47 0.653 . . . . 0.0 110.929 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 67.4 mt -113.51 130.63 67.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -138.16 154.46 49.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.743 0.782 . . . . 0.0 112.849 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 172.32 -171.93 44.55 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.66 135.67 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.213 0.53 . . . . 0.0 110.231 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -96.05 113.15 4.58 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -116.0 117.68 30.82 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 201' ' ' ASP . 58.9 p30 -57.92 150.29 20.8 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 206' ' ' LEU . 21.5 mm -113.33 -60.63 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.567 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -106.42 176.88 1.49 Allowed Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 174.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.567 ' C ' ' O ' ' A' ' 203' ' ' THR . 15.9 Cg_exo -14.93 -81.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.485 0.974 0 CA-C-N 122.909 2.075 . . . . 0.0 113.746 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 237' ' ' ARG . 97.3 mttt -126.73 28.08 5.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.514 0.674 . . . . 0.0 110.761 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 202' ' ' ILE . 2.9 tt -85.8 112.67 21.31 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.4 p -103.93 149.8 24.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -172.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 208' ' ' LEU . 0.4 OUTLIER -104.36 106.07 16.44 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 101.695 -3.446 . . . . 0.0 101.695 173.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -104.09 130.37 51.79 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -174.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -122.14 144.19 49.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.348 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.44 -163.88 32.12 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.0 147.11 46.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -105.18 119.01 38.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.796 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -120.89 163.5 18.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.285 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -124.91 -172.76 2.64 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 216' ' ' ASN . 49.9 t-20 . . . . . 0 C--N 1.33 -0.272 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.496 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 153.4 -166.8 31.79 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.869 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.25 130.64 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.681 ' NH1' HH22 ' A' ' 66' ' ' ARG . 71.2 mtp180 -128.59 142.85 50.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.287 0.565 . . . . 0.0 111.555 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.499 ' O ' ' CD2' ' A' ' 236' ' ' TYR . 5.5 t80 -106.28 106.49 17.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.764 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.563 ' NE ' ' OD2' ' A' ' 61' ' ' ASP . 71.7 ttt180 -133.75 128.63 35.26 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.0 t80 . . . . . 0 C--O 1.222 -0.381 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.847 179.733 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.69 0 N-CA-C 114.617 0.607 . . . . 0.0 114.617 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.72 157.43 27.97 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 124.679 3.586 . . . . 0.0 115.354 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -150.62 165.6 32.85 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.831 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.18 139.27 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -124.81 145.65 49.65 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.58 0.705 . . . . 0.0 112.473 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.77 151.0 34.05 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.998 -1.455 . . . . 0.0 108.476 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 15' ' ' LEU . 38.4 t0 -142.33 144.06 33.04 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.577 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 92.0 mt -126.94 143.69 51.21 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.684 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.428 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.055 179.011 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 57' ' ' SER . 74.9 t -139.37 159.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.381 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.484 ' N ' HG12 ' A' ' 56' ' ' VAL . 5.1 m -141.7 141.66 33.32 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.486 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.62 137.49 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.094 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.22 -175.65 32.47 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.037 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -96.97 137.51 35.94 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.977 0.418 . . . . 0.0 111.73 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.531 ' OD1' ' NH2' ' A' ' 66' ' ' ARG . 34.3 t70 -101.37 115.07 29.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.37 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -124.56 120.69 32.66 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.497 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.0 107.24 0.44 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.32 -60.98 0.59 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 65' ' ' TRP . 8.7 p-90 -157.98 150.68 22.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.937 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.628 ' NH1' ' NH1' ' A' ' 235' ' ' ARG . 9.3 ptp85 -135.66 167.23 21.51 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.887 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.2 pt -145.22 143.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.193 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.86 145.51 29.88 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.15 0.5 . . . . 0.0 110.71 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.17 127.28 38.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.403 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -98.18 127.56 44.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.558 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 45.2 p90 -139.88 166.24 25.15 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.846 0.831 . . . . 0.0 112.848 -177.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 71' ' ' TYR . . . . . . . . 0 N--CA 1.462 0.173 0 CA-C-N 113.001 -1.909 . . . . 0.0 108.6 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 170.32 -109.72 0.34 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 119.644 -1.265 . . . . 0.0 111.99 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.28 147.63 41.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.292 0.567 . . . . 0.0 110.748 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.3 p -150.81 141.38 22.58 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.68 149.05 32.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.815 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 3.4 pt -144.36 114.45 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.587 ' CZ ' HG23 ' A' ' 135' ' ' ILE . 34.2 p90 -90.43 141.91 28.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.575 ' OD1' ' NH1' ' A' ' 66' ' ' ARG . 62.7 m-20 -89.84 115.84 27.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 113.387 -1.733 . . . . 0.0 108.143 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.476 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 87.8 t80 -118.13 121.8 41.44 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.464 ' CB ' ' O ' ' A' ' 125' ' ' PHE . 1.4 mm100 147.96 177.33 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.53 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 127' ' ' ILE . 93.0 mt -70.21 -1.46 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.753 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 70.9 36.55 1.46 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.632 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.46 -60.39 1.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.889 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -129.06 -48.31 1.22 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.572 ' CD2' ' CE1' ' A' ' 200' ' ' PHE . 1.0 OUTLIER -148.32 146.58 28.61 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.145 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.476 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -134.74 141.82 40.09 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.337 177.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.56 107.96 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 N-CA-C 108.007 -1.574 . . . . 0.0 108.007 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -81.85 131.02 35.25 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.981 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.587 HG23 ' CZ ' ' A' ' 123' ' ' TYR . 2.5 tt -161.83 149.51 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.832 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.69 -144.88 6.25 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.092 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -127.43 164.14 22.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.69 ' NH2' HH21 ' A' ' 213' ' ' ARG . 41.7 ttm180 -125.17 133.89 52.62 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.096 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.88 121.71 61.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.27 146.17 44.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.138 0.494 . . . . 0.0 110.98 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 . . . . . 0 C--O 1.238 0.481 0 CA-C-O 121.698 0.761 . . . . 0.0 111.661 -179.516 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 191' ' ' GLY . 54.9 t . . . . . 0 C--O 1.234 0.283 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 190' ' ' VAL . . . -137.58 135.74 7.78 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.162 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.4 tp -142.61 131.05 22.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -164.02 -160.93 12.32 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.39 153.25 35.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.986 0.898 . . . . 0.0 111.228 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.6 tt -124.67 134.04 67.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 113.622 -1.626 . . . . 0.0 108.733 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -157.67 156.15 31.25 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 119.634 -0.827 . . . . 0.0 112.454 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 169.06 -171.41 42.96 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.16 135.54 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.517 0.659 . . . . 0.0 111.034 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -116.35 129.9 8.71 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.968 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.572 ' CE1' ' CD2' ' A' ' 131' ' ' PHE . 56.7 m-85 -104.29 109.52 21.39 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.704 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.26 121.6 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 124.662 1.226 . . . . 0.0 110.171 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 202' ' ' ILE . 42.7 mm -126.57 3.8 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 123.385 1.564 . . . . 0.0 108.635 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.778 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.2 OUTLIER -156.59 73.33 4.81 Favored Pre-proline 0 N--CA 1.425 -1.714 1 N-CA-C 98.664 -4.569 . . . . 0.0 98.664 178.138 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER 1.06 -41.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.826 1 C-N-CA 126.111 4.541 . . . . 0.0 116.747 -170.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.778 ' N ' ' O ' ' A' ' 203' ' ' THR . 61.9 pttt -96.73 0.08 49.01 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.623 HD23 ' C ' ' A' ' 206' ' ' LEU . 5.9 tt -109.07 106.67 16.69 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 8.4 t -141.61 140.73 33.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 119.257 -0.977 . . . . 0.0 113.011 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.26 116.67 30.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.422 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -97.22 123.3 40.96 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.371 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -117.31 124.43 48.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -170.15 -173.54 37.59 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 118.946 -1.597 . . . . 0.0 112.705 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -133.79 148.24 51.34 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.69 HH21 ' NH2' ' A' ' 138' ' ' ARG . 84.0 mtp180 -127.05 129.27 47.7 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -152.75 157.34 40.7 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.199 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.533 ' ND1' ' N ' ' A' ' 215' ' ' HIS . 0.0 OUTLIER -151.79 165.49 34.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.191 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.4 ' CG ' ' O ' ' A' ' 215' ' ' HIS . 14.5 p30 . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 121.022 0.439 . . . . 0.0 110.411 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 232' ' ' LEU . 10.9 mp . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -126.79 152.03 18.38 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.474 -0.393 . . . . 0.0 112.229 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.0 p -126.86 131.45 71.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.628 ' NH1' ' NH1' ' A' ' 66' ' ' ARG . 60.3 ttp180 -130.67 143.45 50.76 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -91.93 126.76 37.14 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 112.93 -1.941 . . . . 0.0 106.441 176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.574 ' H ' ' CA ' ' A' ' 205' ' ' LYS . 1.4 tmm_? -147.13 109.5 4.54 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 122.452 1.12 . . . . 0.0 111.701 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 C--O 1.22 -0.484 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.596 -179.712 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.459 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.78 129.2 22.78 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.806 1.671 . . . . 0.0 114.206 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -162.26 166.57 25.23 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.608 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 12' ' ' GLN . 40.9 t -128.86 157.24 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.473 ' N ' HG12 ' A' ' 11' ' ' VAL . 32.0 tp60 -135.32 143.79 46.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.775 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.89 149.2 29.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.128 0.489 . . . . 0.0 111.293 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 39.0 p-10 -105.17 120.57 41.85 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.995 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.2 mt -118.63 141.5 48.54 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.998 0.428 . . . . 0.0 111.07 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.186 179.544 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.604 0.24 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 57' ' ' SER . 12.5 p -138.73 154.25 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.156 0.503 . . . . 0.0 111.75 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.475 ' N ' HG22 ' A' ' 56' ' ' VAL . 26.5 t -142.9 143.55 32.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.201 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 p -135.28 151.23 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.76 174.56 42.77 Favored Glycine 0 C--O 1.241 0.561 0 C-N-CA 118.302 -1.904 . . . . 0.0 114.191 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.99 138.44 34.52 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 113.446 -1.377 . . . . 0.0 108.161 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -116.72 102.82 9.75 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.41 ' O ' ' C ' ' A' ' 63' ' ' GLY . 78.3 m-85 -107.65 127.53 53.74 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 175.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -41.16 103.9 0.04 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 120.012 -1.089 . . . . 0.0 110.744 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.05 -83.92 0.19 Allowed Glycine 0 C--N 1.343 0.968 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.447 ' CD1' ' N ' ' A' ' 65' ' ' TRP . 2.1 p-90 -133.23 172.92 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.127 0.464 . . . . 0.0 111.433 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.855 HH21 HD13 ' A' ' 122' ' ' ILE . 50.6 ttp180 -125.1 151.61 45.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.452 ' N ' ' HG2' ' A' ' 66' ' ' ARG . 91.3 mt -108.37 129.7 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -141.62 145.64 35.26 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.63 149.5 49.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 113.606 -1.634 . . . . 0.0 106.667 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 4.1 p-10 -148.92 153.47 38.05 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 119.272 -0.971 . . . . 0.0 113.201 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -108.38 143.05 37.83 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 113.835 -1.529 . . . . 0.0 109.156 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.982 -179.838 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -102.09 124.59 8.25 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -143.01 135.65 27.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 117.6 0.7 . . . . 0.0 109.802 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.8 m -154.81 151.99 29.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.432 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.678 ' C ' HD12 ' A' ' 122' ' ' ILE . . . -118.18 125.89 51.11 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.855 HD13 HH21 ' A' ' 66' ' ' ARG . 1.7 mp -119.96 154.56 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.542 0.687 . . . . 0.0 112.232 -176.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -103.12 110.35 22.27 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.184 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -108.5 122.49 47.15 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -91.36 81.56 5.45 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.49 0.662 . . . . 0.0 109.417 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -67.71 -18.27 64.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.203 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.0 pt -67.91 -30.46 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.812 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 131' ' ' PHE . 11.5 m120 -70.66 121.53 18.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 129' ' ' ASP . 67.8 t0 -63.97 -41.85 97.42 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -105.37 -18.95 13.95 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 20.8 p90 -158.2 133.87 8.99 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.289 1.404 . . . . 0.0 114.368 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -118.09 103.64 49.54 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.0 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.602 ' HA ' HG22 ' A' ' 198' ' ' VAL . 24.8 Cg_exo -63.57 123.14 11.56 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 15.3 p90 -106.58 133.46 51.22 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.093 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.9 tt -145.76 147.53 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.109 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.45 -171.85 37.69 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 119.69 -1.243 . . . . 0.0 113.605 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.53 136.98 39.56 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 20.1 ttt-85 -124.98 120.89 32.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.38 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.17 135.6 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.942 0.877 . . . . 0.0 112.11 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.25 124.9 50.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.029 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.4 t80 . . . . . 0 C--N 1.325 -0.479 0 CA-C-O 121.096 0.474 . . . . 0.0 111.933 -177.82 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.233 0.188 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -130.93 150.58 19.4 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.929 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.4 pp -168.2 136.72 2.32 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.661 0.743 . . . . 0.0 112.618 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -169.41 -140.54 2.99 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.49 164.31 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.483 0.658 . . . . 0.0 111.763 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.7 tt -129.84 138.09 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.549 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.455 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . -152.74 164.23 38.17 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.477 ' O ' ' CD2' ' A' ' 134' ' ' TYR . . . 155.47 170.6 21.14 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.062 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 133' ' ' PRO . 59.8 t -131.29 138.41 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 117.274 0.537 . . . . 0.0 111.804 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -105.46 134.02 11.87 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -131.29 105.82 7.89 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.79 153.27 33.01 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -175.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 66.6 mt -113.18 -10.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 123.298 1.523 . . . . 0.0 107.888 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.699 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.5 m -166.75 103.5 0.65 Allowed Pre-proline 0 C--N 1.3 -1.562 1 N-CA-C 99.445 -4.28 . . . . 0.0 99.445 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.466 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -11.56 -42.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 123.557 2.838 . . . . 0.0 115.63 -172.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 203' ' ' THR . 13.6 pttm -77.87 -34.72 51.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 203' ' ' THR . 50.5 tp -83.93 105.76 15.07 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.2 m -128.61 131.28 48.12 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 208' ' ' LEU . 10.0 mp -96.8 141.57 29.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -134.67 144.77 48.0 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.012 0.911 . . . . 0.0 113.335 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -101.86 113.08 25.95 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -152.58 157.56 27.35 Favored Glycine 0 N--CA 1.462 0.387 0 C-N-CA 118.556 -1.783 . . . . 0.0 113.895 -176.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -169.31 163.91 10.79 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.645 ' N ' ' NE ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -124.48 154.15 40.96 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.932 0.396 . . . . 0.0 110.129 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -142.78 133.51 25.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.94 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -74.59 144.91 43.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.174 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.4 t30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.158 179.429 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 71.1 mt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.507 0.67 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -143.75 137.92 7.77 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.6 145.39 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 117.393 0.597 . . . . 0.0 110.621 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -124.55 142.77 51.09 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.328 0.585 . . . . 0.0 111.063 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -110.34 106.07 15.31 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.431 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.661 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 2.4 tmt_? -114.06 96.13 5.65 Favored 'General case' 0 C--O 1.255 1.37 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 237' ' ' ARG . 72.3 m-85 . . . . . 0 N--CA 1.472 0.661 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.447 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.293 0 CA-C-O 119.699 -0.501 . . . . 0.0 112.118 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.461 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 58.6 Cg_endo -90.74 143.41 3.48 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.896 2.397 . . . . 0.0 113.477 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.608 ' CZ ' ' NH2' ' A' ' 66' ' ' ARG . 1.7 m-85 -159.63 146.59 16.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.21 0.528 . . . . 0.0 112.221 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.3 t -141.19 137.06 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.946 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -135.31 149.49 49.78 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.52 152.17 32.6 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.837 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -107.0 155.43 19.81 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.626 0.25 . . . . 0.0 111.003 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -139.29 128.93 24.55 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.624 ' N ' HD13 ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 120.728 0.299 . . . . 0.0 111.415 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.6 mtm-85 . . . . . 0 C--O 1.232 0.158 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.76 134.14 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.842 0.353 . . . . 0.0 111.034 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -133.37 143.39 48.91 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.514 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.71 160.33 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.052 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.56 177.04 40.33 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.415 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -121.13 155.65 34.03 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 47.4 t0 -137.72 124.08 20.65 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -177.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 63' ' ' GLY . 16.5 m-85 -116.67 104.83 11.77 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -24.85 97.2 0.01 OUTLIER Glycine 0 CA--C 1.533 1.203 0 CA-C-N 117.718 0.235 . . . . 0.0 113.097 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.18 -13.74 7.93 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 66' ' ' ARG . 15.6 t90 -165.88 136.56 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.012 0.406 . . . . 0.0 110.823 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.608 ' NH2' ' CZ ' ' A' ' 10' ' ' TYR . 14.8 ptp180 -148.17 148.44 30.55 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.843 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.6 pt -108.93 147.71 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.779 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.0 141.35 36.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 110.857 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.88 129.13 25.55 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 24.8 p30 -106.2 143.76 33.87 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.476 0.655 . . . . 0.0 111.906 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.09 146.2 50.02 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.992 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.142 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.074 179.475 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 N--CA 1.463 0.222 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 70' ' ' ASP . . . -133.01 115.45 1.57 Allowed Glycine 0 N--CA 1.469 0.847 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.787 ' H ' HD23 ' A' ' 119' ' ' LEU . 1.7 pt? -141.11 153.62 45.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.327 0.563 . . . . 0.0 111.498 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.3 m -146.42 153.58 40.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.065 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.43 125.03 46.66 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 97.3 mt -123.6 152.32 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -111.25 131.94 54.74 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.158 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 15.6 p-10 -132.9 125.25 29.48 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 123.801 0.688 . . . . 0.0 110.813 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.497 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 81.2 m-85 -115.69 80.63 1.47 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -105.07 7.32 33.87 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 110.003 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.591 ' O ' HD13 ' A' ' 127' ' ' ILE . 0.3 OUTLIER -67.84 -28.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -62.08 -49.97 73.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.4 t0 179.16 -102.75 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.287 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -117.77 0.9 12.09 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 10.8 m-85 -113.25 111.28 21.78 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.497 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -133.31 142.7 45.24 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 117.93 0.332 . . . . 0.0 111.066 178.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -91.28 120.13 0.62 Allowed 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 122.36 2.04 . . . . 0.0 109.281 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.594 ' CE1' ' OD2' ' A' ' 209' ' ' ASP . 40.1 p90 -92.02 128.26 37.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.528 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 47.8 mm -134.78 131.99 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.777 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.76 174.84 38.31 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.611 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.37 131.06 55.38 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.95 125.42 50.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.186 0.517 . . . . 0.0 111.089 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.98 139.18 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.122 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.01 137.39 52.16 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.526 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 121.203 0.525 . . . . 0.0 111.19 179.446 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.236 0.375 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.543 ' C ' HD22 ' A' ' 192' ' ' LEU . . . -146.92 159.32 27.98 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.329 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.842 HD22 ' N ' ' A' ' 192' ' ' LEU . 0.4 OUTLIER -117.46 146.89 43.19 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.641 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -168.19 -177.57 39.45 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.716 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.62 156.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.606 0.717 . . . . 0.0 111.636 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.2 tt -127.06 135.55 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.041 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.3 161.01 37.64 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . 157.81 -167.06 34.14 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.51 162.32 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 122.73 -0.277 . . . . 0.0 110.978 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.12 165.04 34.64 Favored Glycine 0 CA--C 1.545 1.916 0 C-N-CA 119.842 -1.17 . . . . 0.0 114.616 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -130.82 128.71 41.22 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.683 1.193 . . . . 0.0 109.004 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 201' ' ' ASP . 4.6 p30 -89.88 151.18 21.87 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.488 HG22 ' OG1' ' A' ' 203' ' ' THR . 0.8 OUTLIER -67.98 -37.93 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 103.005 -2.961 . . . . 0.0 103.005 174.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.675 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.0 OUTLIER -176.31 148.97 0.91 Allowed Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 100.612 -3.847 . . . . 0.0 100.612 176.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.445 ' C ' ' O ' ' A' ' 237' ' ' ARG . 32.0 Cg_exo -35.86 -17.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.295 -2.25 0 C-N-CA 121.313 1.342 . . . . 0.0 113.419 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.675 ' N ' ' O ' ' A' ' 203' ' ' THR . 87.1 tttt -68.87 -44.52 73.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 119.309 -0.377 . . . . 0.0 111.868 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.98 114.65 14.86 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.941 0.401 . . . . 0.0 111.056 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 201' ' ' ASP . 4.8 t -127.87 133.79 49.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.818 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.0 123.03 32.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.594 ' OD2' ' CE1' ' A' ' 134' ' ' TYR . 13.4 t70 -109.52 110.94 22.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.878 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -102.75 134.72 45.67 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.14 36.98 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 119.97 -1.109 . . . . 0.0 112.199 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -133.61 134.39 43.18 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -89.45 108.56 19.71 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.998 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -102.65 127.87 49.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -125.25 161.54 26.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.024 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.5 m120 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.223 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 15' ' ' LEU . 6.8 tt . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -115.06 172.51 14.24 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 62.1 t -139.68 131.56 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.588 0.233 . . . . 0.0 110.918 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.459 HH11 ' NH1' ' A' ' 66' ' ' ARG . 36.6 ttm180 -132.7 142.07 48.88 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 236' ' ' TYR . 1.1 t80 -118.72 137.68 53.17 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 204' ' ' PRO . 14.3 ttt-85 -150.38 112.5 4.6 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.626 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.398 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.957 0 N-CA-C 112.166 -0.374 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.405 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 48.9 Cg_endo -92.74 165.08 2.73 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.558 2.838 . . . . 0.0 114.951 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.596 ' OH ' ' HB2' ' A' ' 68' ' ' ALA . 22.5 p90 -163.85 164.39 23.5 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.575 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 p -135.39 155.22 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-O 120.524 0.202 . . . . 0.0 111.088 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.542 HE22 HD11 ' A' ' 122' ' ' ILE . 30.6 mt-30 -134.81 147.76 50.02 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.2 152.6 34.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.742 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 31.7 p-10 -153.24 159.06 42.53 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -133.3 152.39 51.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.042 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.68 0.276 . . . . 0.0 110.73 179.639 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.6 155.28 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.574 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -135.45 128.7 31.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.288 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 m -140.91 165.34 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.19 -152.25 12.58 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.552 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -113.98 139.12 49.5 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-O 120.762 0.315 . . . . 0.0 111.543 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.1 p30 -103.26 101.01 10.93 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 124.835 1.335 . . . . 0.0 112.874 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.545 ' CZ ' ' O ' ' A' ' 65' ' ' TRP . 23.9 p90 -125.37 125.26 43.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -39.51 131.61 2.22 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.98 -84.59 0.37 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.545 ' O ' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -117.32 153.73 32.47 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.361 0.6 . . . . 0.0 110.33 179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.622 ' NH1' ' NH2' ' A' ' 235' ' ' ARG . 0.6 OUTLIER -129.82 130.94 45.94 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.77 128.57 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.596 ' HB2' ' OH ' ' A' ' 10' ' ' TYR . . . -139.0 124.66 19.56 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 120.922 0.391 . . . . 0.0 110.571 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.31 138.59 39.87 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.02 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -100.56 128.72 46.53 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.302 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -129.13 156.94 43.1 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.757 0.789 . . . . 0.0 111.95 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.202 0 CA-C-N 113.617 -1.628 . . . . 0.0 108.462 178.612 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.429 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.7 -157.96 20.94 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.233 -1.461 . . . . 0.0 112.373 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.1 mt -127.42 144.69 51.02 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.269 0.557 . . . . 0.0 110.571 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 84.0 p -147.47 140.44 25.02 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.63 127.75 53.6 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.542 HD11 HE22 ' A' ' 12' ' ' GLN . 87.9 mt -101.51 135.09 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -128.77 102.88 6.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.255 0.934 . . . . 0.0 112.127 -176.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.547 ' CG ' HH21 ' A' ' 66' ' ' ARG . 3.4 m-20 -89.94 135.74 33.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.841 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 132' ' ' LYS . 41.9 t80 -113.22 81.36 1.49 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -70.32 85.8 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.038 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 128' ' ' ASN . 17.5 tt -70.21 -41.29 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.129 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.431 ' N ' HG23 ' A' ' 127' ' ' ILE . 40.3 t30 177.67 -47.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.384 0.428 . . . . 0.0 110.199 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -59.91 -169.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.088 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -100.48 -1.72 35.03 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.495 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 7.1 p90 -138.34 128.97 26.46 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.435 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -133.41 156.8 79.36 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 121.021 0.439 . . . . 0.0 111.059 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.7 146.3 21.05 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.922 1.748 . . . . 0.0 109.675 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 134' ' ' TYR . 6.8 p90 -138.25 138.13 38.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.207 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 136' ' ' GLY . 32.2 mt -136.56 164.43 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.86 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.488 ' N ' ' CG2' ' A' ' 135' ' ' ILE . . . -164.93 -176.67 36.83 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.669 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -133.2 155.46 49.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.24 -0.98 . . . . 0.0 108.753 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -135.56 128.1 30.65 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.33 121.75 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -124.75 124.3 41.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 110.506 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 . . . . . 0 N--CA 1.464 0.246 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.564 -179.754 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 191' ' ' GLY . 73.7 t . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.441 ' N ' HG12 ' A' ' 190' ' ' VAL . . . -141.16 140.43 10.34 Favored Glycine 0 N--CA 1.476 1.305 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.698 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 216' ' ' ASN . 47.1 tp -133.61 125.1 28.04 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -156.12 -169.78 20.68 Favored Glycine 0 C--N 1.32 -0.345 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.8 158.98 42.71 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 CA-C-O 122.306 1.051 . . . . 0.0 112.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.8 mm -109.57 130.48 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 112.639 -2.073 . . . . 0.0 107.312 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.3 156.86 42.32 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.514 -0.741 . . . . 0.0 111.834 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.408 ' C ' ' CE2' ' A' ' 134' ' ' TYR . . . 150.05 -176.98 28.46 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.42 159.68 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -136.84 140.74 11.7 Favored Glycine 0 N--CA 1.47 0.93 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.781 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -122.04 105.44 10.29 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -96.0 137.16 35.46 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 202' ' ' ILE . 1.2 mp -69.54 -39.16 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 173.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -155.25 156.08 30.66 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 101.284 -3.598 . . . . 0.0 101.284 175.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.509 ' C ' ' O ' ' A' ' 237' ' ' ARG . 32.3 Cg_exo -48.78 -17.51 1.17 Allowed 'Trans proline' 0 C--N 1.288 -2.622 0 CA-C-N 121.706 1.645 . . . . 0.0 111.267 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 203' ' ' THR . 60.4 tttp -67.82 -39.77 83.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.286 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 9.0 mt -124.05 107.79 11.67 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.123 0.874 . . . . 0.0 111.925 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.596 HG23 ' HG2' ' A' ' 235' ' ' ARG . 0.3 OUTLIER -136.81 141.03 42.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.63 0.728 . . . . 0.0 112.948 177.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.44 ' O ' ' OD1' ' A' ' 209' ' ' ASP . 84.0 mt -99.1 148.3 24.19 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 208' ' ' LEU . 28.3 m-20 -139.3 137.0 35.46 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -83.65 133.43 34.82 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.86 151.62 19.66 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 120.236 -0.983 . . . . 0.0 114.59 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -135.22 142.18 45.96 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.195 -1.002 . . . . 0.0 109.03 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 86.0 mmt-85 -110.75 125.04 53.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -127.83 161.39 29.14 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.604 0.716 . . . . 0.0 112.862 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.661 ' CG ' ' H ' ' A' ' 216' ' ' ASN . 69.1 t60 -126.97 -175.46 3.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.486 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.661 ' H ' ' CG ' ' A' ' 215' ' ' HIS . 45.4 t-20 . . . . . 0 C--N 1.328 -0.346 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.554 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 25.4 mt . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 121.11 0.481 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -131.77 148.2 18.94 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.306 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.6 p -131.39 137.83 54.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.622 ' NH2' ' NH1' ' A' ' 66' ' ' ARG . 10.8 ptm180 -136.55 146.74 46.51 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -101.99 113.07 25.99 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 113.254 -1.793 . . . . 0.0 108.967 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.611 HH11 ' NH2' ' A' ' 66' ' ' ARG . 75.0 ttt180 -139.23 115.55 10.46 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 122.354 1.073 . . . . 0.0 112.113 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.522 ' OXT' ' CD1' ' A' ' 238' ' ' PHE . 1.2 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.21 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.448 ' C ' ' CE2' ' A' ' 10' ' ' TYR . . . . . . . . 0 CA--C 1.539 1.561 0 N-CA-C 112.139 -0.385 . . . . 0.0 112.139 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 77.5 Cg_endo -80.82 127.19 6.15 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.877 2.384 . . . . 0.0 111.695 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 52.4 m-85 -141.24 -178.23 5.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.888 -0.142 . . . . 0.0 111.287 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 12' ' ' GLN . 6.2 t -138.62 162.6 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.476 ' N ' HG12 ' A' ' 11' ' ' VAL . 8.9 tm0? -130.51 131.62 45.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.972 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.88 140.14 22.23 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.967 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -161.05 168.83 23.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 232' ' ' LEU . 0.4 OUTLIER -172.12 179.88 2.52 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.499 179.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 121.172 0.511 . . . . 0.0 111.946 -179.613 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.696 0.284 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.0 t -131.09 155.49 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.249 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.9 m -137.33 151.85 49.09 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.982 0.42 . . . . 0.0 111.622 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.02 145.68 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.336 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 67' ' ' ILE . . . -164.72 -179.96 39.07 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 119.61 -1.281 . . . . 0.0 114.184 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -106.68 132.85 52.19 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -97.65 121.18 39.25 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -125.37 113.64 17.82 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.42 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -43.35 103.94 0.05 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 123' ' ' TYR . . . 136.88 -36.07 2.02 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.426 ' CD1' ' N ' ' A' ' 65' ' ' TRP . 0.3 OUTLIER -170.18 156.3 5.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.979 0.418 . . . . 0.0 110.879 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.487 HH21 HG21 ' A' ' 122' ' ' ILE . 17.3 ttp85 -134.55 135.38 42.26 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.404 ' O ' ' HA3' ' A' ' 59' ' ' GLY . 49.3 mm -99.98 127.92 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.38 130.93 14.86 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 119.454 -0.898 . . . . 0.0 112.169 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.49 144.2 26.84 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.989 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -104.28 128.01 52.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.129 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -134.35 162.02 33.37 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.012 0.435 . . . . 0.0 111.242 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.37 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.434 179.718 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.521 -0.164 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.33 -126.6 1.03 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.926 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 62.1 tp -135.52 149.47 49.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 120.993 0.425 . . . . 0.0 110.277 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.1 p -152.55 152.37 31.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.46 130.03 51.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.009 0.433 . . . . 0.0 110.767 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.612 HD12 ' N ' ' A' ' 122' ' ' ILE . 1.9 mp -97.72 148.17 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 177.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.541 ' CE1' ' O ' ' A' ' 64' ' ' GLY . 4.2 t80 -138.7 123.98 19.26 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 118.941 -1.104 . . . . 0.0 113.64 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.644 ' CB ' HH22 ' A' ' 237' ' ' ARG . 32.6 p-10 -110.36 120.29 41.97 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 113.489 -1.687 . . . . 0.0 106.588 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.473 ' CD2' ' OH ' ' A' ' 123' ' ' TYR . 5.1 t80 -70.26 129.32 39.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.248 0.546 . . . . 0.0 111.675 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.424 ' O ' ' O ' ' A' ' 125' ' ' PHE . 88.0 mt-30 39.98 -167.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.903 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.526 ' O ' ' C ' ' A' ' 128' ' ' ASN . 1.3 mp -105.0 20.83 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.656 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 127' ' ' ILE . 65.6 m-80 -11.46 -73.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.593 0.558 . . . . 0.0 111.828 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 128' ' ' ASN . 4.7 p30 153.89 -51.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.875 0.734 . . . . 0.0 111.441 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.81 -19.0 3.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -146.98 122.81 10.62 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.021 0.828 . . . . 0.0 113.146 -178.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.409 ' HB3' ' N ' ' A' ' 125' ' ' PHE . 1.3 mptt -134.24 133.0 21.37 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.045 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -51.12 133.62 41.71 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 CA-C-N 119.95 1.018 . . . . 0.0 110.325 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -96.76 130.0 44.08 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.463 ' N ' ' CD1' ' A' ' 134' ' ' TYR . 96.7 mt -136.62 136.51 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -129.27 139.28 10.84 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.984 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -118.38 128.79 54.97 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -129.99 131.44 45.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.247 0.546 . . . . 0.0 112.025 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.42 113.31 2.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.44 144.95 35.36 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.92 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.4 p90 . . . . . 0 C--O 1.236 0.356 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.313 -179.93 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.234 0.254 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -123.55 147.83 16.69 Favored Glycine 0 N--CA 1.472 1.099 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.003 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 tt -144.49 127.51 16.51 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.783 -0.709 . . . . 0.0 109.236 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -150.3 170.34 30.26 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.09 140.73 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.837 0.827 . . . . 0.0 111.987 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.1 mt -118.64 134.56 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.476 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -148.42 153.27 38.3 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.503 0.668 . . . . 0.0 111.97 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 179.08 -140.59 4.47 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.611 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.43 140.82 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.83 0.315 . . . . 0.0 111.123 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -119.48 123.31 5.6 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.195 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -123.61 106.71 10.79 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 201' ' ' ASP . 0.3 OUTLIER -74.54 152.58 39.31 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -176.165 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.54 HG23 ' N ' ' A' ' 203' ' ' THR . 8.1 tt -64.72 -36.91 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 113.068 -1.878 . . . . 0.0 108.208 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.827 ' O ' ' N ' ' A' ' 205' ' ' LYS . 29.7 m 178.62 100.26 0.15 Allowed Pre-proline 0 C--N 1.315 -0.93 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 238' ' ' PHE . 0.1 OUTLIER -14.55 58.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 124.02 3.146 . . . . 0.0 115.139 -173.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.827 ' N ' ' O ' ' A' ' 203' ' ' THR . 75.4 tttt -135.24 -44.81 0.7 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.063 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 26.5 tp -143.81 121.32 11.74 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.467 HG21 ' HE ' ' A' ' 235' ' ' ARG . 0.7 OUTLIER -95.67 145.26 25.41 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -176.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 209' ' ' ASP . 1.0 OUTLIER -107.63 117.65 34.67 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.561 ' N ' HD13 ' A' ' 208' ' ' LEU . 3.8 p30 -141.37 146.35 36.51 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -100.06 148.86 24.09 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.361 -1.745 . . . . 0.0 107.032 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -174.53 115.44 0.55 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 118.777 -1.678 . . . . 0.0 113.713 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -170.31 139.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -148.8 -86.09 0.09 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 215' ' ' HIS . 18.7 t80 -170.46 -178.46 2.7 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.394 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.545 ' O ' ' CE2' ' A' ' 214' ' ' TYR . 10.4 p-80 -149.34 165.91 30.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.233 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 . . . . . 0 C--N 1.33 -0.274 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.13 179.917 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 232' ' ' LEU . 10.0 mp . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 120.781 0.324 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -146.36 143.71 11.88 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.575 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 234' ' ' VAL . 12.8 p -123.69 129.72 74.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.467 ' HE ' HG21 ' A' ' 207' ' ' THR . 52.9 mtm180 -133.54 144.33 49.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.32 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 3.1 m-85 -76.34 122.83 25.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.644 HH22 ' CB ' ' A' ' 124' ' ' ASP . 16.6 tpt180 -138.69 113.13 8.85 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 124.277 0.985 . . . . 0.0 111.86 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.446 ' OXT' ' CG ' ' A' ' 238' ' ' PHE . 78.5 t80 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.013 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.443 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . . . . . . 0 CA--C 1.53 1.016 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.94 158.28 30.95 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.011 2.474 . . . . 0.0 112.776 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.43 ' CZ ' ' CG ' ' A' ' 66' ' ' ARG . 20.6 p90 -154.25 163.29 40.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.456 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.9 t -129.02 144.17 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 120.88 0.371 . . . . 0.0 111.813 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -123.1 131.54 53.73 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.112 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.68 142.74 24.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.072 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 51.4 p-10 -95.96 143.33 27.24 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.506 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.623 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 97.5 mt -143.67 162.34 36.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.186 0.517 . . . . 0.0 112.036 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.471 0.585 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.343 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 119.739 -0.172 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 57' ' ' SER . 9.4 p -155.25 161.5 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 119.386 -0.925 . . . . 0.0 112.709 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 56' ' ' VAL . 49.9 m -132.5 133.03 43.29 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.698 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.516 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 4.3 m -140.05 165.95 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 111.609 0.225 . . . . 0.0 111.609 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.52 -162.04 24.75 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 119.721 -1.228 . . . . 0.0 114.188 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -112.53 151.18 30.29 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.499 -0.851 . . . . 0.0 108.915 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 8' ' ' GLY . 3.6 p-10 -136.95 114.36 10.93 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 62' ' ' PHE . 38.9 p90 -125.05 105.35 9.11 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.29 177.03 7.5 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 105.888 -2.885 . . . . 0.0 105.888 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.601 ' CA ' ' H ' ' A' ' 124' ' ' ASP . . . -47.05 -36.16 8.89 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 120.013 1.907 . . . . 0.0 111.305 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -48.48 97.42 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.69 ' HE ' ' CD1' ' A' ' 122' ' ' ILE . 26.5 ttp-105 -130.07 119.76 23.59 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.674 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.4 pt -126.88 137.79 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.956 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 58' ' ' VAL . . . -136.88 146.0 45.03 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.234 0.54 . . . . 0.0 111.661 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.1 140.53 29.91 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.218 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -102.25 127.4 49.23 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.299 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -112.4 136.77 51.48 Favored 'General case' 0 C--O 1.248 0.979 0 O-C-N 124.627 1.204 . . . . 0.0 110.394 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.325 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.568 179.813 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.1 tp . . . . . 0 CA--C 1.524 -0.027 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -149.43 178.27 27.06 Favored Glycine 0 N--CA 1.476 1.332 0 C-N-CA 118.901 -1.619 . . . . 0.0 112.6 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.753 HD13 ' N ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -134.49 150.75 50.83 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.852 0.834 . . . . 0.0 111.519 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.1 t -134.29 102.47 5.37 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.24 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.32 122.56 39.32 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.69 ' CD1' ' HE ' ' A' ' 66' ' ' ARG . 3.4 pt -121.87 146.3 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -127.69 128.93 46.28 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.601 ' H ' ' CA ' ' A' ' 64' ' ' GLY . 13.7 t70 -112.51 134.38 54.07 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.788 0.804 . . . . 0.0 111.885 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.605 ' C ' ' H ' ' A' ' 127' ' ' ILE . 76.9 m-85 -93.4 85.47 4.97 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.752 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.587 ' NE2' HH12 ' A' ' 237' ' ' ARG . 97.7 mt-30 -60.34 16.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.059 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.605 ' H ' ' C ' ' A' ' 125' ' ' PHE . 38.4 mm -68.3 -42.0 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.477 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -75.59 143.63 42.25 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.136 0.494 . . . . 0.0 110.164 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.6 -40.65 97.6 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -127.35 -7.35 5.84 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 20.2 p90 -168.91 127.0 1.02 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.911 1.687 . . . . 0.0 115.291 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.56 ' NZ ' ' OD1' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -136.76 149.28 66.49 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -69.65 137.43 35.76 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.791 1.318 . . . . 0.0 111.798 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 28.3 p90 -105.95 130.86 53.81 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 106.617 -1.624 . . . . 0.0 106.617 175.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.5 pt -127.92 149.15 32.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.74 174.36 37.38 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.952 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.04 139.14 53.65 Favored 'General case' 0 CA--C 1.523 -0.062 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 193' ' ' GLY . 0.0 OUTLIER -126.32 126.13 43.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.767 0.318 . . . . 0.0 110.882 -178.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.18 146.21 33.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.81 0.814 . . . . 0.0 111.274 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.97 127.01 44.79 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.61 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.1 t80 . . . . . 0 C--O 1.237 0.426 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.865 179.883 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.434 ' C ' HD22 ' A' ' 192' ' ' LEU . . . -142.73 148.38 20.1 Favored Glycine 0 N--CA 1.473 1.127 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.845 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.434 HD22 ' C ' ' A' ' 191' ' ' GLY . 1.7 mm? -115.51 154.79 28.7 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 138' ' ' ARG . . . -170.14 -178.77 41.28 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.46 155.67 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.567 0.699 . . . . 0.0 111.34 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 195' ' ' ILE . 16.0 tt -131.95 130.49 61.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.94 161.58 42.37 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 119.956 -0.698 . . . . 0.0 112.084 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.68 -178.36 36.71 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.88 136.57 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 117.822 0.811 . . . . 0.0 110.612 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -97.69 137.52 13.35 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -121.58 100.23 6.9 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.596 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -100.46 152.85 19.89 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -172.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 28.2 mm -89.27 -67.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 103.776 -2.676 . . . . 0.0 103.776 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.5 p -103.89 -166.33 0.1 OUTLIER Pre-proline 0 CA--C 1.542 0.668 1 N-CA-C 100.1 -4.037 . . . . 0.0 100.1 172.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -81.03 -16.63 9.81 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 CA-C-N 126.373 3.312 . . . . 0.0 112.303 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.657 ' HA ' ' H ' ' A' ' 237' ' ' ARG . 47.7 pttt -81.86 -43.95 17.53 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -81.03 104.38 11.49 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.205 -178.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.79 131.55 24.23 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.728 0.694 . . . . 0.0 112.523 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 36.7 tp -94.79 130.3 41.39 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -110.81 123.41 50.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -107.44 118.27 36.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -157.11 -175.35 27.93 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 118.023 -2.037 . . . . 0.0 114.411 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.543 ' CE2' ' CD1' ' A' ' 214' ' ' TYR . 69.5 t80 -141.25 110.03 6.09 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 113.557 -1.322 . . . . 0.0 108.724 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -104.3 128.91 52.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.142 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.543 ' CD1' ' CE2' ' A' ' 212' ' ' TYR . 37.1 p90 -151.27 156.38 40.73 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.249 0.547 . . . . 0.0 111.361 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -154.45 165.99 34.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.417 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 62.1 t30 . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 120.913 0.387 . . . . 0.0 111.052 -178.976 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 15' ' ' LEU . 87.9 mt . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 121.298 0.571 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -154.48 164.97 31.78 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.13 150.94 17.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 CA-C-N 117.653 0.726 . . . . 0.0 110.917 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.473 ' NH2' ' CE1' ' A' ' 134' ' ' TYR . 99.7 mtt180 -132.6 142.54 49.18 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.467 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -107.28 110.4 22.41 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.657 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 76.2 ttt-85 -131.88 108.88 9.7 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-O 122.096 0.951 . . . . 0.0 113.422 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.438 ' C ' ' O ' ' A' ' 237' ' ' ARG . 2.6 t80 . . . . . 0 N--CA 1.47 0.54 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.182 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.261 0 N-CA-C 114.15 0.42 . . . . 0.0 114.15 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.71 159.79 19.58 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 124.359 3.373 . . . . 0.0 115.493 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -167.13 136.96 2.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.141 -1.845 . . . . 0.0 107.95 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 12' ' ' GLN . 3.5 p -134.81 156.84 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.465 ' N ' HG22 ' A' ' 11' ' ' VAL . 27.4 pt20 -154.21 148.39 25.87 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.91 122.3 7.87 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.646 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -86.42 116.46 24.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.89 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 232' ' ' LEU . 11.8 tp -84.85 128.59 34.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.492 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.533 179.62 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.15 161.38 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.832 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.3 t -144.35 146.16 32.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.002 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.43 153.47 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.3 179.49 39.1 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.893 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -111.51 140.7 45.89 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.851 -0.674 . . . . 0.0 110.331 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -89.27 107.56 19.12 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.49 1.119 . . . . 0.0 110.72 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -126.02 142.25 51.6 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.575 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.99 127.29 24.63 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.89 -61.11 0.71 Allowed Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -125.34 158.55 33.95 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.607 0.718 . . . . 0.0 111.967 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.492 HH21 ' NE ' ' A' ' 237' ' ' ARG . 70.7 mtt85 -133.18 147.38 52.04 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.8 mt -111.74 126.38 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.13 135.59 35.88 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.324 0.583 . . . . 0.0 111.949 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.62 122.67 47.89 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.862 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 42.5 p-10 -99.84 128.45 45.93 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -153.93 171.77 18.47 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 122.161 0.982 . . . . 0.0 112.342 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.298 0 CA-C-N 113.294 -1.776 . . . . 0.0 108.048 179.91 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.461 0.122 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 177.31 -146.25 7.63 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.319 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 mp -137.38 148.83 46.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.19 0.519 . . . . 0.0 110.185 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 77.3 p -146.35 138.59 25.09 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.38 114.35 28.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.163 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 55.2 mt -88.87 129.83 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 135' ' ' ILE . 16.0 m-85 -100.98 116.53 33.05 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.256 0.551 . . . . 0.0 109.93 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.47 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 66.8 t0 -100.15 124.28 45.37 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.523 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.495 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 68.5 m-85 -110.03 82.6 1.62 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.693 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -58.6 -6.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 110.44 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 129' ' ' ASP . 66.7 mt -68.83 -40.45 81.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.792 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -73.2 27.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.649 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 127' ' ' ILE . 34.9 t0 68.53 -119.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.981 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -90.52 -12.26 37.71 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.1 p90 -118.2 102.49 9.03 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.359 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -109.6 130.58 22.62 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 179.086 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -76.94 120.15 5.35 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 120.728 0.952 . . . . 0.0 110.048 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' A' ' 207' ' ' THR . 24.4 m-85 -75.91 130.71 38.92 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.456 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.556 ' O ' ' CD2' ' A' ' 123' ' ' TYR . 28.6 mm -135.96 135.6 50.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.46 169.98 37.1 Favored Glycine 0 C--N 1.322 -0.25 0 C-N-CA 118.979 -1.582 . . . . 0.0 113.203 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -104.34 140.42 37.92 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -118.49 124.38 47.44 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.0 123.23 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -147.21 146.41 29.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.844 0.354 . . . . 0.0 110.377 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 . . . . . 0 C--O 1.235 0.305 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.947 -179.366 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.232 0.146 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.672 ' C ' HD12 ' A' ' 192' ' ' LEU . . . -130.59 102.87 0.54 Allowed Glycine 0 N--CA 1.468 0.771 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.672 HD12 ' C ' ' A' ' 191' ' ' GLY . 10.7 mp -127.75 133.89 49.51 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.068 0.461 . . . . 0.0 110.143 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -179.33 -140.17 3.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.33 152.47 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.442 0.639 . . . . 0.0 110.547 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.3 tp -111.96 142.1 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.59 174.66 13.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 111.81 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 155.91 -176.99 33.23 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.66 136.65 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -131.86 135.07 7.97 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 120.431 -0.89 . . . . 0.0 114.467 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -106.74 113.1 26.4 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 113.684 -1.258 . . . . 0.0 108.224 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 201' ' ' ASP . 43.6 p30 -51.34 147.03 6.23 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.092 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.0 mm -108.9 -51.48 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.522 HG22 ' HD2' ' A' ' 204' ' ' PRO . 0.3 OUTLIER -106.79 -174.06 0.3 Allowed Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 176.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.522 ' HD2' HG22 ' A' ' 203' ' ' THR . 11.0 Cg_exo -32.87 -70.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 122.55 1.947 . . . . 0.0 114.311 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -126.8 20.72 7.06 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.171 0.986 . . . . 0.0 110.425 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.5 tt -88.24 127.62 35.45 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.425 HG21 ' OH ' ' A' ' 134' ' ' TYR . 6.0 t -137.09 152.75 50.38 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.1 tt -105.7 124.25 49.25 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.465 ' CG ' ' NH1' ' A' ' 235' ' ' ARG . 2.2 p30 -137.1 147.62 46.17 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -174.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -91.08 127.03 36.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -114.93 150.5 18.71 Favored Glycine 0 N--CA 1.471 0.977 0 C-N-CA 121.287 -0.482 . . . . 0.0 113.001 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.64 127.84 37.84 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -89.85 136.64 32.92 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.61 101.08 6.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.682 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.613 ' NE2' ' ND2' ' A' ' 216' ' ' ASN . 84.7 t60 -97.42 126.77 42.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.613 ' ND2' ' NE2' ' A' ' 215' ' ' HIS . 94.4 m-20 . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 110.757 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 233' ' ' GLY . 5.8 tt . . . . . 0 C--O 1.225 -0.196 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.555 ' N ' HD23 ' A' ' 232' ' ' LEU . . . -115.36 171.28 13.63 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.278 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.31 129.73 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 113.708 -1.246 . . . . 0.0 108.32 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.465 ' NH1' ' CG ' ' A' ' 209' ' ' ASP . 83.8 mtt85 -132.48 141.79 48.95 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.805 0.335 . . . . 0.0 110.353 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -122.0 112.16 17.93 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.658 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.492 ' NE ' HH21 ' A' ' 66' ' ' ARG . 87.5 mtm-85 -134.06 126.65 30.59 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 . . . . . 0 C--O 1.218 -0.563 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.453 -178.915 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.448 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . . . . . . 0 CA--C 1.541 1.68 0 CA-C-O 119.995 -0.336 . . . . 0.0 113.487 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.464 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 71.4 Cg_endo -82.25 158.29 17.45 Favored 'Trans proline' 0 N--CA 1.507 2.277 0 C-N-CA 122.899 2.399 . . . . 0.0 111.989 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.623 ' CE2' ' NH1' ' A' ' 66' ' ' ARG . 3.4 t80 -148.1 137.71 22.34 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 236' ' ' TYR . 57.6 t -131.84 135.15 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -136.46 144.27 44.31 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -174.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.434 ' O ' ' OD1' ' A' ' 14' ' ' ASP . . . -152.99 149.43 28.18 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.304 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 13' ' ' ALA . 86.0 m-20 -144.44 125.71 14.71 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.175 -0.328 . . . . 0.0 110.661 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.401 HD12 ' C ' ' A' ' 14' ' ' ASP . 5.3 mp -140.66 163.46 32.81 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.353 0.596 . . . . 0.0 111.903 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.467 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.133 179.591 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 . . . . . 0 N--CA 1.462 0.139 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.464 HG22 ' N ' ' A' ' 57' ' ' SER . 9.7 p -150.01 154.42 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 119.567 -0.853 . . . . 0.0 113.065 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 56' ' ' VAL . 15.2 t -135.67 134.49 39.24 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.009 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.36 163.34 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.295 0.569 . . . . 0.0 111.933 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.64 -160.35 25.52 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -128.9 143.67 50.96 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 120.84 0.352 . . . . 0.0 110.345 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 9' ' ' PRO . 18.1 p-10 -124.72 115.39 20.66 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -126.91 158.02 37.88 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.49 123.02 32.05 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.426 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.06 -89.07 0.28 Allowed Glycine 0 N--CA 1.474 1.184 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.3 p-90 -127.79 174.04 9.45 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.623 ' NH1' ' CE2' ' A' ' 10' ' ' TYR . 25.3 ttp85 -147.32 147.42 30.34 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.354 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.39 144.24 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.39 150.18 19.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.364 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.88 159.14 31.8 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 55.6 p30 -140.45 153.07 46.13 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.51 169.26 24.21 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.363 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 120.946 0.403 . . . . 0.0 111.305 -179.124 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' ' 117' ' ' LEU . 3.2 mm? . . . . . 0 N--CA 1.464 0.243 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.73 134.71 7.5 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.188 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.2 tt -123.94 140.76 52.66 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.9 t -133.27 123.01 24.74 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' A' ' 136' ' ' GLY . . . -94.39 130.72 40.62 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 123' ' ' TYR . 88.2 mt -129.73 159.36 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.499 ' N ' HG22 ' A' ' 122' ' ' ILE . 55.8 m-85 -118.42 118.15 30.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 237' ' ' ARG . 54.4 t0 -140.0 114.9 9.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.909 0.385 . . . . 0.0 111.478 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -122.11 96.18 4.95 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.574 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.564 ' NE2' ' OD1' ' A' ' 201' ' ' ASP . 47.9 tt0 -93.51 -0.62 56.27 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.397 0.618 . . . . 0.0 109.907 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.0 -23.56 29.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 12.7 t-20 -60.79 -42.63 97.94 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.165 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 128' ' ' ASN . 52.2 m-20 -175.21 -110.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.677 0.611 . . . . 0.0 109.366 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -118.22 1.05 11.86 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.665 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -128.81 131.67 47.78 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.485 0.491 . . . . 0.0 110.116 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.675 ' NZ ' HH22 ' A' ' 237' ' ' ARG . 0.5 OUTLIER -116.56 128.04 26.3 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.025 -178.055 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.13 129.55 29.02 Favored 'Trans proline' 0 N--CA 1.482 0.816 0 N-CA-C 107.187 -1.89 . . . . 0.0 107.187 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -115.16 129.15 56.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.368 0.604 . . . . 0.0 111.234 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.2 tt -162.2 148.77 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.509 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 121' ' ' ALA . . . -169.22 -177.23 39.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 119.637 -1.268 . . . . 0.0 113.157 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.48 144.03 30.76 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.044 0.45 . . . . 0.0 110.326 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -119.1 118.85 32.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.949 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.25 128.99 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.938 0.399 . . . . 0.0 110.657 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.31 128.06 43.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.1 p90 . . . . . 0 C--O 1.239 0.512 0 CA-C-O 121.783 0.802 . . . . 0.0 111.749 -178.905 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.231 0.115 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -136.04 151.34 20.7 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 119.904 -1.141 . . . . 0.0 112.973 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.8 pp -166.89 147.54 5.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.144 0.497 . . . . 0.0 111.273 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -172.86 -156.84 13.32 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.92 147.92 33.08 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-O 122.063 0.935 . . . . 0.0 113.041 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 7.5 tp -116.89 148.01 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.204 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.09 167.12 30.31 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.897 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 150.98 -168.31 30.66 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.5 m -140.53 159.7 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 117.317 0.558 . . . . 0.0 110.407 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -143.91 133.78 5.49 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.787 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -130.51 127.23 38.73 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.564 ' OD1' ' NE2' ' A' ' 126' ' ' GLN . 0.1 OUTLIER -79.19 152.02 30.91 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 -173.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 202' ' ' ILE . 1.2 mp -62.36 -42.85 97.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 174.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.1 OUTLIER -164.5 171.9 5.22 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 176.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.569 ' O ' ' C ' ' A' ' 238' ' ' PHE . 13.8 Cg_endo -65.91 63.72 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 CA-C-N 121.722 1.651 . . . . 0.0 110.598 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 203' ' ' THR . 16.3 ptpt -134.21 -46.4 0.77 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.12 0.568 . . . . 0.0 110.516 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.408 ' N ' ' HG3' ' A' ' 205' ' ' LYS . 7.5 tt -160.63 153.21 20.82 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.1 t -134.48 152.84 52.05 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.67 133.26 34.26 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 112.881 -1.963 . . . . 0.0 106.482 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.598 ' CG ' HH12 ' A' ' 235' ' ' ARG . 6.1 t70 -135.66 133.91 38.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.908 0.861 . . . . 0.0 112.564 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -101.94 117.99 35.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.06 143.89 15.12 Favored Glycine 0 N--CA 1.467 0.735 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.983 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -171.32 136.06 1.0 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.373 -0.913 . . . . 0.0 108.597 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.527 ' O ' ' CD1' ' A' ' 214' ' ' TYR . 0.0 OUTLIER -166.15 -139.84 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.251 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 213' ' ' ARG . 75.8 m-85 -155.48 -158.88 0.86 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.471 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -141.47 167.46 22.11 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.212 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.58 -179.577 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.273 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -117.65 152.36 17.69 Favored Glycine 0 CA--C 1.517 0.2 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 234' ' ' VAL . 33.3 m -122.86 128.04 75.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.598 HH12 ' CG ' ' A' ' 209' ' ' ASP . 80.5 mtm-85 -126.24 141.16 52.03 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.397 0.618 . . . . 0.0 110.03 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.455 ' HB3' ' H ' ' A' ' 11' ' ' VAL . 41.1 t80 -90.62 115.57 27.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.121 -176.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.675 HH22 ' NZ ' ' A' ' 132' ' ' LYS . 31.3 ttm105 -124.04 87.88 2.81 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.569 ' C ' ' O ' ' A' ' 204' ' ' PRO . 33.3 t80 . . . . . 0 CA--C 1.512 -0.505 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.721 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.524 ' O ' ' CD2' ' A' ' 10' ' ' TYR . . . . . . . . 0 CA--C 1.55 2.253 0 CA-C-O 119.716 -0.491 . . . . 0.0 113.394 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.576 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 71.8 Cg_exo -45.65 106.63 0.09 OUTLIER 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.232 2.621 . . . . 0.0 116.825 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 16.7 m-85 -146.51 157.2 43.71 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.97 154.66 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.077 -1.049 . . . . 0.0 112.703 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.574 HE21 ' C ' ' A' ' 13' ' ' ALA . 46.9 tp60 -120.24 149.67 41.9 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.307 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.574 ' C ' HE21 ' A' ' 12' ' ' GLN . . . -137.7 125.87 23.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.209 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 53.1 p-10 -91.91 149.75 21.39 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 15' ' ' LEU . 1.0 OUTLIER 178.49 174.54 0.62 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.591 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.917 179.183 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 57' ' ' SER . 9.1 p -163.57 157.33 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 117.696 -1.602 . . . . 0.0 114.929 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.54 ' N ' HG22 ' A' ' 56' ' ' VAL . 21.8 t -117.7 121.6 41.3 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 113.946 -1.479 . . . . 0.0 107.783 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -132.97 148.72 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.64 0.257 . . . . 0.0 110.607 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -157.77 165.9 33.73 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.327 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -112.85 147.65 36.53 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 24.9 t70 -157.08 153.97 28.71 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -177.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 62' ' ' PHE . 4.8 p90 -130.77 155.07 47.28 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 110.629 -2.987 . . . . 0.0 106.146 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -42.85 117.35 1.48 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.509 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 124' ' ' ASP . . . 144.82 -89.65 0.16 Allowed Glycine 0 CA--C 1.534 1.241 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 25.1 p-90 -152.86 173.27 15.55 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.7 HH22 ' NH1' ' A' ' 237' ' ' ARG . 0.2 OUTLIER -130.88 173.02 11.37 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.042 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.5 mt -116.7 125.38 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 171.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.4 111.78 13.16 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.31 126.53 32.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.723 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -90.82 127.81 36.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -119.13 113.03 20.27 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.91 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.116 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.786 179.691 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 177.18 -141.63 5.42 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.101 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.2 130.57 53.32 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.53 0.681 . . . . 0.0 111.694 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.4 m -132.25 111.32 11.29 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.47 127.76 38.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 1.9 mp -90.34 161.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 176.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.447 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 2.4 t80 -139.76 108.0 5.79 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.548 ' CB ' HH12 ' A' ' 66' ' ' ARG . 18.3 t70 -123.7 132.44 53.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.36 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.508 ' C ' ' H ' ' A' ' 127' ' ' ILE . 27.6 m-85 -93.99 84.1 4.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.798 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -52.14 -4.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.786 -0.571 . . . . 0.0 111.352 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.508 ' H ' ' C ' ' A' ' 125' ' ' PHE . 92.7 mt -66.59 -42.71 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 120.228 -0.589 . . . . 0.0 112.304 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 22.4 t-20 -68.02 -40.35 82.95 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.189 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 128' ' ' ASN . 11.4 t0 88.6 -55.15 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.031 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -79.33 -51.74 9.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 2.0 p90 -151.55 128.22 10.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -134.75 153.34 78.77 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.122 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.472 ' HA ' HG12 ' A' ' 198' ' ' VAL . 17.2 Cg_exo -64.56 136.01 48.27 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 120.514 0.81 . . . . 0.0 110.68 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.81 128.2 34.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.7 mt -141.55 139.77 31.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -171.2 175.01 44.93 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.231 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.69 152.81 48.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -124.86 130.8 53.09 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.0 t -130.71 118.52 42.61 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.23 130.2 42.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.024 0.44 . . . . 0.0 110.563 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 . . . . . 0 C--O 1.236 0.388 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.43 -179.94 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.52 -0.187 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -134.6 131.73 6.02 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.212 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.1 mp -136.7 132.62 35.15 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.583 0.706 . . . . 0.0 109.902 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -162.42 -170.5 27.31 Favored Glycine 0 C--N 1.321 -0.27 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.1 m -134.69 160.91 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.435 1.118 . . . . 0.0 113.653 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mt -110.12 136.26 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 113.032 -1.895 . . . . 0.0 110.251 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -160.67 147.0 15.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.693 0.758 . . . . 0.0 110.871 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 163.06 -172.44 39.07 Favored Glycine 0 C--O 1.221 -0.686 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 133' ' ' PRO . 33.8 m -136.93 155.05 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 118.303 1.051 . . . . 0.0 109.472 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -154.78 159.51 29.03 Favored Glycine 0 C--O 1.241 0.555 0 C-N-CA 119.452 -1.356 . . . . 0.0 112.181 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.84 153.15 37.68 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.541 0.686 . . . . 0.0 110.557 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -59.52 149.5 29.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.065 -1.425 . . . . 0.0 113.971 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 206' ' ' LEU . 47.0 mm -111.31 -46.13 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.55 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.2 OUTLIER -127.43 -172.93 0.28 Allowed Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 175.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.55 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.8 OUTLIER -14.06 -85.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.401 0 CA-C-N 124.04 2.478 . . . . 0.0 114.869 -178.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -126.7 21.39 7.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.007 0.908 . . . . 0.0 110.057 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 202' ' ' ILE . 1.0 OUTLIER -75.08 112.98 11.88 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.6 t -130.87 152.59 50.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.45 143.07 44.2 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 113.082 -1.872 . . . . 0.0 107.9 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.81 150.68 49.05 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -126.31 134.15 51.2 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -174.57 -164.13 28.95 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 119.431 -1.366 . . . . 0.0 113.419 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -156.28 151.23 26.22 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 115.221 -0.49 . . . . 0.0 109.795 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 80.2 mtm-85 -92.6 124.93 36.98 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -107.07 125.41 51.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 109.97 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -56.61 156.97 5.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.556 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 . . . . . 0 C--O 1.233 0.187 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.578 179.883 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.419 ' C ' HD13 ' A' ' 232' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.517 -0.293 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 147.7 -166.83 28.75 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.5 ' N ' HE22 ' A' ' 12' ' ' GLN . 3.0 m -134.71 144.98 33.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -118.21 136.63 53.53 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -101.32 107.88 19.35 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.017 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.7 ' NH1' HH22 ' A' ' 66' ' ' ARG . 81.8 mtp180 -113.93 113.58 25.04 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.431 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 93.3 m-85 . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.428 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.409 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.21 160.05 33.05 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.902 1.734 . . . . 0.0 109.583 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.708 ' CD2' ' NH2' ' A' ' 66' ' ' ARG . 33.1 t80 -151.07 136.98 18.15 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.45 -0.9 . . . . 0.0 113.01 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 12' ' ' GLN . 52.0 t -141.49 160.41 21.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.457 ' N ' HG12 ' A' ' 11' ' ' VAL . 57.6 tt0 -147.78 140.02 24.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.882 0.765 . . . . 0.0 112.856 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.01 122.9 45.53 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.158 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -83.11 124.82 30.84 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.4 tp -116.52 132.37 56.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.998 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.28 179.928 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' HG13 ' A' ' 56' ' ' VAL . 39.6 mmt180 . . . . . 0 CA--C 1.522 -0.117 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 55' ' ' ARG . 8.3 m -157.18 -176.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 119.206 -0.998 . . . . 0.0 112.961 -176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.89 136.4 54.93 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.875 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.2 p -141.85 148.98 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.017 0.437 . . . . 0.0 111.776 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.58 -155.61 20.26 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -131.83 154.15 49.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.47 ' HB3' ' HE ' ' A' ' 66' ' ' ARG . 2.5 p30 -130.01 133.17 46.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -175.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.73 123.51 33.22 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.945 -1.48 . . . . 0.0 107.479 175.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -34.77 134.73 0.4 Allowed Glycine 0 N--CA 1.472 1.038 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.522 ' O ' ' CD2' ' A' ' 123' ' ' TYR . . . 97.64 -63.45 0.93 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -131.23 136.02 47.87 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.342 0.591 . . . . 0.0 111.153 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.708 ' NH2' ' CD2' ' A' ' 10' ' ' TYR . 54.9 mtp180 -137.01 156.05 48.92 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.1 tt -139.64 140.68 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.377 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.18 147.22 10.97 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.83 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.85 149.49 26.35 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -115.99 145.63 42.8 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.596 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 80.3 m-85 67.41 -98.08 0.04 OUTLIER 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.192 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 71' ' ' TYR . . . . . . . . 0 N--CA 1.472 0.644 0 O-C-N 124.468 1.105 . . . . 0.0 110.3 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 168.22 -151.76 19.12 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 118.931 -1.604 . . . . 0.0 113.768 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.8 mt -113.32 160.17 18.63 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 114.993 -0.604 . . . . 0.0 109.84 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 p -143.67 129.17 19.07 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 111.818 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.0 130.03 40.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 123' ' ' TYR . 73.0 mt -123.9 161.59 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -175.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.526 ' N ' HG22 ' A' ' 122' ' ' ILE . 50.5 t80 -140.65 141.16 35.08 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.407 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 24.1 p-10 -143.38 138.63 29.54 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.279 0.561 . . . . 0.0 111.598 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.5 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 14.8 m-85 -83.97 83.56 7.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.048 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.464 HE21 HH12 ' A' ' 237' ' ' ARG . 70.2 mm-40 -85.33 6.09 27.84 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.28 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 128' ' ' ASN . 20.4 tt -69.21 -40.16 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.421 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.548 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 20.1 p30 -90.65 -40.53 11.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.749 0.309 . . . . 0.0 110.202 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 1.2 m-20 77.1 -30.43 0.17 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.277 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -65.34 -45.04 85.8 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.059 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -154.49 116.16 4.15 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.568 0.699 . . . . 0.0 110.928 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.5 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 1.1 ptpp? -115.54 119.66 37.51 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.233 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -53.14 118.16 4.53 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 CA-C-N 119.736 0.941 . . . . 0.0 110.066 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -76.28 127.82 33.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.8 tt -155.98 146.46 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 118.768 -1.173 . . . . 0.0 112.818 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -169.76 178.63 42.62 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.22 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -116.19 157.4 24.9 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -124.83 138.47 54.26 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.33 114.05 32.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.97 152.65 51.91 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.24 0.555 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.426 177.765 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 N--CA 1.463 0.181 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.853 ' C ' HD13 ' A' ' 192' ' ' LEU . . . -137.84 136.38 8.14 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 119.177 -1.487 . . . . 0.0 113.756 -176.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 1.059 HD22 ' H ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -117.52 148.75 41.57 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.378 -0.911 . . . . 0.0 108.81 178.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -169.28 -169.63 32.85 Favored Glycine 0 C--N 1.32 -0.312 0 N-CA-C 107.906 -2.077 . . . . 0.0 107.906 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.0 m -137.98 155.08 29.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.981 0.896 . . . . 0.0 111.972 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.6 tp -113.86 131.69 65.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.015 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.76 149.19 33.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.119 0.485 . . . . 0.0 111.259 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.94 -167.17 37.26 Favored Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 p -145.13 140.13 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 117.284 0.542 . . . . 0.0 110.46 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.48 130.55 9.18 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.38 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.606 ' N ' ' OG1' ' A' ' 207' ' ' THR . 2.6 t80 -115.09 118.71 34.14 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -61.26 149.88 36.42 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 206' ' ' LEU . 51.4 mm -113.35 -61.13 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.515 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.7 OUTLIER -102.11 -173.14 0.28 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 175.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.515 ' C ' ' O ' ' A' ' 203' ' ' THR . 5.5 Cg_exo -22.76 -79.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.352 0 CA-C-N 123.281 2.208 . . . . 0.0 114.486 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -128.33 34.89 4.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.543 0.687 . . . . 0.0 111.181 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 202' ' ' ILE . 0.3 OUTLIER -90.31 111.7 23.01 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.606 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 0.9 OUTLIER -132.51 152.52 51.53 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.17 140.52 29.42 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.453 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 233' ' ' GLY . 4.4 m-20 -118.94 138.83 52.51 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -121.69 123.43 41.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 113.717 -1.583 . . . . 0.0 107.841 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -160.17 -175.81 31.56 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.365 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -141.96 154.21 44.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.78 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.533 ' N ' ' NE ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -83.5 139.1 33.12 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -128.38 89.96 2.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.72 0.295 . . . . 0.0 110.667 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -101.64 140.01 36.52 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.65 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.8 t30 . . . . . 0 N--CA 1.465 0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 111.16 179.041 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 26.8 tp . . . . . 0 N--CA 1.461 0.08 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.429 ' O ' ' OD2' ' A' ' 209' ' ' ASP . . . 160.57 -168.82 36.17 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 119.929 -1.129 . . . . 0.0 112.781 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.0 127.92 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.731 ' NH2' HH11 ' A' ' 237' ' ' ARG . 0.2 OUTLIER -104.95 141.95 35.64 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.05 0.453 . . . . 0.0 110.425 -179.028 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -107.62 108.68 20.06 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.053 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.731 HH11 ' NH2' ' A' ' 235' ' ' ARG . 82.4 mtp180 -129.38 120.11 25.0 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.407 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 1.6 m-85 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.707 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.413 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . . . . . . 0 CA--C 1.536 1.403 0 CA-C-O 121.005 0.225 . . . . 0.0 112.708 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.471 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 95.9 Cg_endo -82.69 176.65 7.59 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.884 3.056 . . . . 0.0 113.525 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.401 ' CE1' ' NH1' ' A' ' 66' ' ' ARG . 75.8 t80 -141.26 145.09 35.11 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 t -152.7 145.41 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 114.417 -1.265 . . . . 0.0 108.027 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.53 150.6 27.95 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.94 147.01 52.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 112.13 -2.304 . . . . 0.0 105.931 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -152.76 137.57 17.06 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.52 133.39 45.03 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.063 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.268 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.522 179.636 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 p -142.71 146.05 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.6 m -128.86 149.09 50.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.207 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.31 153.29 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.81 -148.73 7.53 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 61' ' ' ASP . 16.4 t80 -138.8 155.95 47.75 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 9' ' ' PRO . 7.4 p-10 -133.06 134.68 44.66 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -127.12 147.93 50.16 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 175.528 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.34 140.58 32.33 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.841 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.2 -35.21 2.98 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.11 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.454 ' O ' ' O ' ' A' ' 62' ' ' PHE . 84.6 m95 -139.4 131.13 27.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.406 0.603 . . . . 0.0 111.606 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.401 ' NH1' ' CE1' ' A' ' 10' ' ' TYR . 46.0 ttp180 -144.21 132.5 21.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.751 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.622 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -139.35 153.62 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.923 0.868 . . . . 0.0 112.358 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.39 140.0 8.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.934 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.98 146.01 24.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.698 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -93.31 128.74 39.46 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.515 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -109.24 140.14 43.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.498 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.486 178.868 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -109.4 147.7 16.99 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.372 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.9 tp -128.3 133.0 48.65 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.3 m -137.27 116.42 12.54 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.555 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.98 134.14 55.44 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.168 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 123' ' ' TYR . 74.5 mt -119.73 158.94 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.522 ' N ' HG22 ' A' ' 122' ' ' ILE . 31.7 m-85 -113.73 109.71 19.0 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' OD2' ' NH1' ' A' ' 237' ' ' ARG . 20.9 t70 -107.36 138.64 43.19 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -116.87 152.37 34.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.677 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -147.37 44.22 1.13 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.7 mt -69.18 -42.46 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -96.0 -13.15 24.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.41 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 61.88 29.42 17.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.336 0.588 . . . . 0.0 109.984 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -125.64 -51.5 1.6 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.846 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 131' ' ' PHE . 43.1 p90 -175.16 131.78 0.3 Allowed 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.247 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -134.21 151.64 76.81 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.846 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.22 130.98 20.99 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.507 1.471 . . . . 0.0 109.899 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.474 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 2.4 p90 -120.55 133.32 55.4 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 39.9 pt -135.55 152.76 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.286 0.565 . . . . 0.0 111.424 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.84 174.89 39.24 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -117.2 143.08 46.25 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.935 0.398 . . . . 0.0 110.194 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -116.92 116.89 28.28 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.401 HG22 ' N ' ' A' ' 140' ' ' ALA . 12.6 p -124.65 158.95 31.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' ' 139' ' ' VAL . . . -135.71 142.97 45.14 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.647 0.737 . . . . 0.0 112.572 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.304 178.31 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -130.34 126.2 4.89 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 7.4 tt -120.57 123.52 43.08 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 122.066 0.936 . . . . 0.0 111.415 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -138.06 157.37 24.31 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.59 139.63 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 117.41 0.605 . . . . 0.0 111.463 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 tt -116.42 132.98 64.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.472 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.52 34.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.04 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 162.5 -165.88 36.35 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.3 p -136.41 146.57 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 120.975 0.417 . . . . 0.0 109.974 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -117.67 137.37 13.18 Favored Glycine 0 C--O 1.244 0.754 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.977 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.634 ' N ' ' OG1' ' A' ' 207' ' ' THR . 10.7 t80 -122.16 120.0 32.94 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.689 0.876 . . . . 0.0 109.301 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 201' ' ' ASP . 22.6 p30 -61.94 139.38 58.4 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.528 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 202' ' ' ILE . 63.9 mt -125.18 -5.59 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-O 122.523 1.154 . . . . 0.0 109.499 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.581 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -160.35 -178.64 0.92 Allowed Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 101.271 -3.603 . . . . 0.0 101.271 177.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.581 ' C ' ' O ' ' A' ' 203' ' ' THR . 13.8 Cg_exo -18.95 -83.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 CA-C-N 123.965 2.452 . . . . 0.0 114.089 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -128.92 20.2 5.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.661 0.743 . . . . 0.0 109.884 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.408 ' HB3' ' OG1' ' A' ' 203' ' ' THR . 5.9 tt -78.98 124.18 28.01 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 1.8 t -143.42 154.08 43.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -175.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.411 ' C ' HD23 ' A' ' 208' ' ' LEU . 7.7 tt -91.55 126.65 36.71 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 112.92 -1.945 . . . . 0.0 105.797 175.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 210' ' ' ALA . 41.5 t0 -102.12 144.49 30.61 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -175.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 0.517 ' N ' ' OD1' ' A' ' 209' ' ' ASP . . . -125.17 113.68 18.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.346 -1.752 . . . . 0.0 107.538 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -175.38 -165.27 31.25 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -147.07 161.36 41.0 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.951 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.2 ttp-105 -129.57 103.24 6.76 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.432 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -174.68 148.69 1.15 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.064 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -159.1 -84.61 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.66 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.469 0.505 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.907 -179.08 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 59.4 mt . . . . . 0 C--O 1.233 0.193 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -148.63 165.75 29.17 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.339 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.19 127.4 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.77 145.58 44.74 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.083 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -112.91 116.35 29.85 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.405 ' NH1' ' OD2' ' A' ' 124' ' ' ASP . 81.4 mtm180 -124.34 133.05 53.55 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.904 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.548 ' OXT' ' CG ' ' A' ' 238' ' ' PHE . 85.1 t80 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.546 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.476 0 N-CA-C 112.159 -0.376 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.66 152.71 25.99 Favored 'Trans proline' 0 N--CA 1.507 2.291 0 C-N-CA 124.153 3.236 . . . . 0.0 116.397 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.53 ' CD2' ' NH2' ' A' ' 66' ' ' ARG . 6.7 p90 -148.69 164.67 33.66 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.442 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 p -131.99 153.99 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.402 0.62 . . . . 0.0 112.527 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.555 ' NE2' HH22 ' A' ' 235' ' ' ARG . 63.8 tt0 -120.95 142.61 49.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.032 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 14' ' ' ASP . . . -142.87 149.86 39.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.471 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 13' ' ' ALA . 92.4 m-20 -140.52 147.26 39.26 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.491 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -168.16 -175.77 2.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.721 177.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 120.897 0.38 . . . . 0.0 110.179 179.166 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 111.277 0.103 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 57' ' ' SER . 29.6 t -142.69 159.06 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.83 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.501 ' N ' HG12 ' A' ' 56' ' ' VAL . 42.5 t -146.75 138.16 24.32 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.626 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -138.22 157.56 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.63 -178.63 38.17 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 119.844 -1.169 . . . . 0.0 113.605 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -104.93 129.64 53.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.395 -0.902 . . . . 0.0 109.224 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB2' HH21 ' A' ' 66' ' ' ARG . 61.1 t0 -100.41 121.5 41.63 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -175.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -125.4 121.64 34.45 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -50.54 113.88 2.31 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' A' ' 65' ' ' TRP . . . 120.01 -49.38 0.88 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 64' ' ' GLY . 8.3 m0 -146.46 136.09 23.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 117.136 0.468 . . . . 0.0 109.986 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.698 HH12 ' CZ ' ' A' ' 237' ' ' ARG . 26.7 mtp180 -133.8 147.13 51.22 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.988 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.2 126.36 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 120' ' ' SER . . . -128.44 113.4 15.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.006 0.431 . . . . 0.0 110.024 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.78 127.08 34.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.893 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -101.8 128.9 47.95 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -149.68 159.15 44.57 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.92 0.867 . . . . 0.0 111.892 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.455 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.528 179.159 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.435 ' C ' HD23 ' A' ' 117' ' ' LEU . 6.4 tt . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 178.87 -145.53 6.79 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.124 -1.512 . . . . 0.0 113.083 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 95.5 mt -117.69 154.35 31.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.608 0.718 . . . . 0.0 110.91 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 69.6 m -144.96 98.73 3.22 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.42 114.66 11.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.311 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.1 mt -110.81 134.02 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.452 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 29.4 p90 -132.6 120.45 21.82 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.408 -177.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -97.74 143.22 28.6 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 112.904 -1.953 . . . . 0.0 108.328 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.579 ' C ' ' H ' ' A' ' 127' ' ' ILE . 15.0 m-85 -102.45 113.01 25.98 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.631 0.729 . . . . 0.0 111.376 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -65.37 11.88 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.253 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.579 ' H ' ' C ' ' A' ' 125' ' ' PHE . 8.3 tp -68.06 -40.31 82.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.19 0.519 . . . . 0.0 110.484 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.495 ' N ' HG23 ' A' ' 127' ' ' ILE . 72.8 m-20 -99.77 141.3 32.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.301 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -79.45 -60.81 2.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -66.33 -41.89 88.96 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.484 ' O ' ' CD1' ' A' ' 131' ' ' PHE . 48.0 p90 -145.61 143.16 29.71 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 119.194 -0.432 . . . . 0.0 111.472 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.62 132.82 23.68 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 118.254 0.479 . . . . 0.0 110.267 178.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.62 136.68 21.6 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 N-CA-C 108.05 -1.558 . . . . 0.0 108.05 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 199' ' ' GLY . 0.8 OUTLIER -132.41 144.24 50.36 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 122.329 1.062 . . . . 0.0 112.312 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 136' ' ' GLY . 94.2 mt -135.04 161.48 40.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 113.338 -1.756 . . . . 0.0 107.895 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 135' ' ' ILE . . . -161.22 160.03 31.73 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 118.929 -1.605 . . . . 0.0 114.185 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -107.94 135.45 49.3 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -118.43 125.79 50.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 139' ' ' VAL . 18.4 m -117.89 113.92 43.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.09 125.53 51.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.36 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 C--O 1.238 0.46 0 CA-C-O 121.716 0.77 . . . . 0.0 112.522 -178.636 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.233 0.197 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.35 130.35 4.57 Favored Glycine 0 N--CA 1.47 0.935 0 C-N-CA 119.888 -1.149 . . . . 0.0 113.425 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.83 137.09 53.14 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -164.26 -168.75 26.81 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.84 145.52 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.539 0.685 . . . . 0.0 111.847 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.0 mm -112.53 128.92 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.79 162.61 38.23 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.385 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.489 ' O ' ' CD1' ' A' ' 134' ' ' TYR . . . 157.99 178.87 32.43 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.16 139.82 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 134' ' ' TYR . . . -120.83 137.85 12.29 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 120.169 -1.015 . . . . 0.0 114.475 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.422 ' C ' ' OG1' ' A' ' 207' ' ' THR . 90.6 m-85 -104.62 106.67 17.26 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 114.131 -1.034 . . . . 0.0 108.593 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 201' ' ' ASP . 9.9 p30 -63.31 149.79 44.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.463 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.8 mm -102.98 -74.73 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.462 ' O ' ' C ' ' A' ' 204' ' ' PRO . 1.4 p -80.18 -167.85 0.15 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.462 ' C ' ' O ' ' A' ' 203' ' ' THR . 1.5 Cg_exo -33.76 -74.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 CA-C-N 122.69 1.996 . . . . 0.0 114.678 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 237' ' ' ARG . 10.0 mptt -125.19 20.19 8.19 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.251 0.932 . . . . 0.0 110.789 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 206' ' ' LEU . 0.9 OUTLIER -76.88 122.94 25.54 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 176.079 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.422 ' OG1' ' C ' ' A' ' 200' ' ' PHE . 2.8 t -136.41 148.57 47.86 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 50.3 tp -99.15 118.1 35.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -130.12 142.73 50.57 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -87.76 109.05 19.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.5 144.05 15.4 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.342 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -137.83 153.54 49.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.033 -0.583 . . . . 0.0 109.955 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.401 ' NH1' ' NE2' ' A' ' 215' ' ' HIS . 3.7 ppt_? -120.57 140.46 51.47 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -140.01 155.66 46.98 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.005 0.431 . . . . 0.0 111.437 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.401 ' NE2' ' NH1' ' A' ' 213' ' ' ARG . 13.9 m170 -99.17 142.19 30.97 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.758 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.169 -179.874 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.8 tp . . . . . 0 N--CA 1.468 0.469 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -100.05 162.94 19.18 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.307 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 39.4 t -126.13 128.98 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.555 HH22 ' NE2' ' A' ' 12' ' ' GLN . 90.4 mtt-85 -134.09 147.07 50.83 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -174.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -110.83 99.69 8.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.136 175.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.698 ' CZ ' HH12 ' A' ' 66' ' ' ARG . 99.0 mtt180 -130.28 130.86 45.07 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.838 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.462 ' C ' ' O ' ' A' ' 237' ' ' ARG . 61.3 m-85 . . . . . 0 N--CA 1.474 0.732 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.834 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.479 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.57 167.99 25.9 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.382 2.055 . . . . 0.0 114.183 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -141.01 143.48 34.45 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.6 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.8 t -132.03 146.38 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -148.31 130.99 15.94 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.36 132.71 12.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.825 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -96.08 151.93 19.01 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.12 0.486 . . . . 0.0 111.859 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.8 tp -123.99 131.21 53.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.671 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.779 179.379 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 p -155.95 131.54 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.906 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 t -138.51 135.85 35.52 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -148.58 168.67 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.756 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.76 -153.3 12.99 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -121.43 143.33 49.3 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.144 0.497 . . . . 0.0 111.561 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -86.71 112.97 22.17 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.866 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -125.48 150.47 47.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.968 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.22 103.6 2.62 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.48 -68.32 0.52 Allowed Glycine 0 CA--C 1.52 0.391 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -148.05 160.77 42.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -113.73 162.01 16.8 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 120.897 0.38 . . . . 0.0 111.608 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.0 mm -104.14 126.71 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 102.11 -3.293 . . . . 0.0 102.11 172.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.47 125.25 9.76 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 119.149 -1.021 . . . . 0.0 111.946 -176.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.23 153.41 20.0 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.553 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -134.24 128.07 33.15 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -151.45 161.27 42.99 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.185 0.993 . . . . 0.0 113.188 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 113.224 -1.807 . . . . 0.0 107.418 178.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.475 ' N ' HD23 ' A' ' 117' ' ' LEU . 1.3 pt? . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -176.45 -138.14 2.82 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.051 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.873 ' H ' HD23 ' A' ' 119' ' ' LEU . 1.2 pt? -131.2 160.55 34.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.2 0.524 . . . . 0.0 111.992 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 m -148.74 147.62 29.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.423 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.01 135.98 53.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 123' ' ' TYR . 96.7 mt -118.96 158.06 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.556 0.693 . . . . 0.0 112.552 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.474 ' N ' HG22 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -106.07 101.49 10.98 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -104.72 122.71 46.26 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 123.67 0.606 . . . . 0.0 111.234 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -96.72 105.36 17.46 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.084 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.424 ' CD ' HH22 ' A' ' 237' ' ' ARG . 59.1 tt0 -87.83 -11.35 48.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.698 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 128' ' ' ASN . 21.4 tt -67.52 -40.67 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.947 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.461 ' N ' HG23 ' A' ' 127' ' ' ILE . 88.0 m-20 -78.68 -11.78 59.99 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.0 t0 59.7 -78.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.177 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -66.27 -46.26 77.67 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -105.58 117.52 34.24 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.439 ' HZ2' ' HA3' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -131.85 96.53 20.28 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.17 109.56 0.64 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.035 1.156 . . . . 0.0 109.387 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CZ ' ' HA3' ' A' ' 197' ' ' GLY . 21.9 p90 -78.66 129.9 35.25 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 118.712 -1.195 . . . . 0.0 109.78 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.17 142.51 40.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.646 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -171.79 -176.8 40.99 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 118.28 -1.914 . . . . 0.0 113.709 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.73 137.57 51.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -130.12 131.17 45.59 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.45 132.35 64.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.682 0.753 . . . . 0.0 109.125 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -113.54 150.44 32.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.121 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.1 p90 . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.297 -179.954 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 C--O 1.232 0.163 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -135.15 142.08 13.44 Favored Glycine 0 N--CA 1.466 0.67 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.821 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.2 pp -133.39 141.89 48.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.304 -0.948 . . . . 0.0 108.755 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -153.45 174.15 32.13 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.04 138.59 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.902 0.382 . . . . 0.0 110.988 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.8 mt -111.06 131.08 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.859 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.53 148.43 32.17 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.424 ' HA3' ' CZ ' ' A' ' 134' ' ' TYR . . . 158.05 -176.89 34.99 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.4 p -138.75 142.3 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 118.728 1.264 . . . . 0.0 113.346 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.439 ' HA3' ' HZ2' ' A' ' 132' ' ' LYS . . . -103.88 144.83 15.98 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.761 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.426 ' N ' ' OG1' ' A' ' 207' ' ' THR . 14.3 t80 -137.72 105.69 5.67 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -91.59 154.22 19.2 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -176.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.441 ' CG1' ' H ' ' A' ' 203' ' ' THR . 5.3 pt -95.15 -47.1 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.652 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.7 OUTLIER -122.76 115.25 29.53 Favored Pre-proline 0 N--CA 1.433 -1.296 0 N-CA-C 100.563 -3.865 . . . . 0.0 100.563 172.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -12.15 -40.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 124.069 3.179 . . . . 0.0 117.176 -174.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 203' ' ' THR . 11.7 pttm -84.72 -32.37 23.55 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 3.2 mm? -85.4 105.14 15.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 121.475 1.943 . . . . 0.0 107.751 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 235' ' ' ARG . 1.0 OUTLIER -131.75 140.23 49.18 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 75.9 mt -93.37 135.36 34.68 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 113.734 -1.576 . . . . 0.0 108.749 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.613 ' CG ' HH11 ' A' ' 235' ' ' ARG . 42.7 m-20 -118.22 145.91 44.64 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -135.49 113.02 10.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 114.059 -1.428 . . . . 0.0 107.292 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -162.22 -177.65 35.44 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.56 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.35 152.42 49.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.594 -0.803 . . . . 0.0 110.97 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -106.88 127.28 53.29 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -112.09 150.65 30.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.295 0.569 . . . . 0.0 112.271 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' A' ' 216' ' ' ASN . 77.3 t60 -129.1 128.96 44.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.723 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 215' ' ' HIS . 97.1 m-20 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.462 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.28 169.25 30.26 Favored Glycine 0 CA--C 1.517 0.203 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.95 136.28 57.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.449 0.643 . . . . 0.0 111.378 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.613 HH11 ' CG ' ' A' ' 209' ' ' ASP . 81.1 mtt85 -121.27 130.21 53.54 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.95 106.29 17.2 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.575 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.589 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 3.6 tmt_? -119.79 109.14 15.25 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.229 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.545 ' CB ' ' O ' ' A' ' 237' ' ' ARG . 28.5 t80 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.679 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.184 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.43 124.05 9.11 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 122.717 2.278 . . . . 0.0 112.822 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -144.95 148.29 33.65 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.507 ' H ' ' HB2' ' A' ' 236' ' ' TYR . 78.7 t -138.68 146.31 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.553 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -132.4 126.53 33.37 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.992 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.95 148.0 27.86 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 15' ' ' LEU . 57.2 t0 -162.6 134.58 5.36 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.581 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -173.48 -171.0 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.025 178.524 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.411 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.861 179.848 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.446 0.165 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.37 135.13 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.639 0.257 . . . . 0.0 110.949 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 m -118.47 125.9 50.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.85 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.17 137.98 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.871 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.82 172.06 36.29 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.666 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -109.91 144.8 37.88 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 65' ' ' TRP . 44.4 t0 -150.84 130.96 13.49 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 62' ' ' PHE . 31.6 p90 -128.41 105.87 8.62 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.807 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . 6.95 95.46 0.0 OUTLIER Glycine 0 N--CA 1.481 1.692 0 O-C-N 123.251 0.345 . . . . 0.0 113.186 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.96 -110.77 0.46 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.417 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 10.2 p-90 -103.74 -177.67 3.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.73 ' NH1' ' HE ' ' A' ' 235' ' ' ARG . 75.3 ttt180 -153.42 151.42 29.88 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.27 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.5 tp -129.58 142.4 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.431 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.56 143.03 19.51 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.89 155.99 16.54 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 71' ' ' TYR . 48.2 t0 -146.25 133.11 20.1 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.573 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 49.0 p90 175.5 -172.06 0.07 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.755 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 71' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.268 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.238 0.479 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.538 ' C ' HD22 ' A' ' 119' ' ' LEU . . . -122.0 126.57 6.5 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.538 HD22 ' C ' ' A' ' 118' ' ' GLY . 3.4 mm? -113.17 140.35 47.99 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.8 m -120.26 124.54 45.9 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.68 122.37 42.59 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.529 HG22 ' N ' ' A' ' 123' ' ' TYR . 94.4 mt -126.45 160.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -175.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.529 ' N ' HG22 ' A' ' 122' ' ' ILE . 70.6 m-85 -128.38 103.15 6.98 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 177.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.464 ' HB2' HH22 ' A' ' 235' ' ' ARG . 67.6 t0 -138.83 129.94 26.78 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.494 ' CD1' ' NZ ' ' A' ' 132' ' ' LYS . 65.0 m-85 -120.86 133.26 55.31 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.439 177.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.5 pp0? -105.71 -13.75 15.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.269 0.557 . . . . 0.0 109.559 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 129' ' ' ASP . 65.9 mt -70.9 -40.51 76.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.777 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -55.6 89.64 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 127' ' ' ILE . 90.5 m-20 47.1 -114.25 0.54 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.865 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -131.2 22.73 4.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.086 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.549 ' O ' ' CD1' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -167.28 127.3 1.45 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.492 -178.165 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.621 ' H ' HH22 ' A' ' 237' ' ' ARG . 12.8 tptm -134.63 129.56 19.47 Favored Pre-proline 0 C--O 1.238 0.5 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.497 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.38 129.96 28.56 Favored 'Trans proline' 0 N--CA 1.479 0.671 0 N-CA-C 107.404 -1.806 . . . . 0.0 107.404 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.622 ' CG ' ' NH1' ' A' ' 235' ' ' ARG . 52.0 p90 -122.64 148.6 45.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.525 0.602 . . . . 0.0 111.008 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.3 pt -141.05 163.62 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.555 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.34 173.78 41.82 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.188 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -117.26 159.78 22.12 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -127.79 130.99 49.62 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.939 0.4 . . . . 0.0 111.222 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 20.2 m -130.62 128.69 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.069 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.7 136.2 50.29 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.678 0.275 . . . . 0.0 110.931 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.7 p90 . . . . . 0 N--CA 1.467 0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.288 179.997 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.234 0.253 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -120.4 130.73 8.47 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.275 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.9 mp -135.83 148.62 48.76 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.631 0.729 . . . . 0.0 110.583 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.5 174.21 42.6 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.94 146.82 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 117.418 0.609 . . . . 0.0 110.2 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.9 tt -115.77 144.6 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.849 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.21 145.19 26.1 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -173.41 -179.32 44.0 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.124 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 57.8 t -132.54 135.95 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.596 0.236 . . . . 0.0 111.305 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -108.56 122.33 6.59 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.269 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.533 ' C ' HG23 ' A' ' 207' ' ' THR . 54.3 t80 -124.91 106.55 10.08 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.685 0.794 . . . . 0.0 109.166 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.617 ' OD1' ' O ' ' A' ' 203' ' ' THR . 32.5 t70 -61.88 151.31 34.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -177.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 206' ' ' LEU . 28.9 mm -117.79 -29.12 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 176.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.617 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 31.5 m -155.08 120.34 2.59 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 100.219 -3.993 . . . . 0.0 100.219 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.589 ' N ' ' OD2' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -6.54 -56.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 123.408 2.738 . . . . 0.0 115.336 -172.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.67 ' HA ' ' H ' ' A' ' 237' ' ' ARG . 37.0 pttt -83.94 -30.47 26.25 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 203' ' ' THR . 80.0 mt -78.62 110.92 14.17 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 119.62 1.1 . . . . 0.0 109.634 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.533 HG23 ' C ' ' A' ' 200' ' ' PHE . 2.1 m -125.99 145.81 50.14 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 209' ' ' ASP . 1.6 tm? -94.12 119.57 33.15 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.578 ' N ' HD13 ' A' ' 208' ' ' LEU . 45.7 t0 -106.21 145.81 31.08 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 209' ' ' ASP . . . -132.37 126.8 34.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.774 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -168.86 176.74 42.98 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 119.53 -1.319 . . . . 0.0 113.468 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -156.97 168.73 26.61 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.837 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.516 HH12 ' CD2' ' A' ' 215' ' ' HIS . 68.1 ttt-85 -108.11 124.73 50.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.038 0.447 . . . . 0.0 111.61 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' A' ' 216' ' ' ASN . 79.9 t80 -65.5 -49.65 68.22 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.266 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.516 ' CD2' HH12 ' A' ' 213' ' ' ARG . 20.6 t-160 58.84 112.97 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.411 ' O ' ' CE2' ' A' ' 214' ' ' TYR . 15.1 m120 . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 120.829 0.347 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -157.47 176.74 34.55 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.493 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 11.2 m -128.27 131.71 68.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.73 ' HE ' ' NH1' ' A' ' 66' ' ' ARG . 62.2 ttt180 -117.83 142.27 47.5 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.507 ' HB2' ' H ' ' A' ' 11' ' ' VAL . 15.8 m-85 -108.55 125.26 51.62 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.67 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 99.1 mtt180 -126.4 90.19 3.14 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 7.2 t80 . . . . . 0 C--O 1.219 -0.513 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.077 -177.866 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.52 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.85 111.28 2.47 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.98 1.787 . . . . 0.0 112.772 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -107.57 169.7 8.42 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.498 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 12' ' ' GLN . 61.0 t -126.04 157.72 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.464 0.65 . . . . 0.0 112.43 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.525 ' N ' HG12 ' A' ' 11' ' ' VAL . 53.9 mt-30 -130.94 130.98 44.14 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.281 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.86 135.12 29.24 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.452 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.99 144.47 25.88 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 tp -139.39 123.7 18.08 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.985 0.421 . . . . 0.0 110.617 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.852 179.801 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 . . . . . 0 CA--C 1.521 -0.154 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.13 161.81 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.376 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.5 t -148.23 133.24 18.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.982 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.14 157.51 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.615 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.57 -170.25 38.22 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.309 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -112.9 153.96 27.12 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 47.4 p-10 -141.47 129.2 21.62 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 121.634 0.73 . . . . 0.0 112.842 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 62' ' ' PHE . 4.2 p90 -127.46 148.24 50.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.676 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -43.26 111.14 0.35 Allowed Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.34 -83.42 0.27 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.581 ' CD1' ' N ' ' A' ' 65' ' ' TRP . 1.4 p-90 -143.92 169.86 17.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.953 0.406 . . . . 0.0 111.5 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.476 HH21 ' NH1' ' A' ' 237' ' ' ARG . 54.8 mtt180 -129.39 172.61 11.34 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.578 0.704 . . . . 0.0 111.369 -178.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.4 mt -140.58 132.59 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.12 152.76 31.65 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.97 159.65 15.63 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 71' ' ' TYR . 41.3 t0 -157.2 167.21 31.04 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.424 -178.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.474 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 97.5 m-85 82.16 -126.08 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 125.08 1.488 . . . . 0.0 111.855 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 71' ' ' TYR . . . . . . . . 0 CA--C 1.532 0.272 0 O-C-N 123.676 0.61 . . . . 0.0 111.262 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -143.31 147.16 18.43 Favored Glycine 0 C--N 1.342 0.909 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.841 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.74 151.93 38.93 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.5 m -135.58 118.07 15.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.007 0.432 . . . . 0.0 111.559 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.77 131.15 43.77 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.506 HD11 HE22 ' A' ' 12' ' ' GLN . 96.8 mt -125.29 158.71 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.414 0.626 . . . . 0.0 112.661 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.491 ' N ' HG22 ' A' ' 122' ' ' ILE . 63.3 m-85 -112.95 122.09 46.6 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.301 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -109.07 122.83 48.1 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.783 0.677 . . . . 0.0 110.095 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.478 ' O ' ' CB ' ' A' ' 126' ' ' GLN . 0.5 OUTLIER -111.51 177.67 4.58 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.214 0.53 . . . . 0.0 110.954 -179.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 131' ' ' PHE . 2.4 tp-100 88.24 128.16 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.933 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.8 tt -118.67 -3.97 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.749 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 40.3 p-10 -151.02 -45.13 0.12 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.326 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 73.9 m-20 -71.97 -158.41 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.59 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -128.27 25.98 5.77 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.66 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 0.1 OUTLIER -138.65 111.28 7.62 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.292 0.951 . . . . 0.0 113.119 -177.186 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.416 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -131.12 137.15 30.03 Favored Pre-proline 0 C--N 1.351 0.661 0 CA-C-N 118.145 0.43 . . . . 0.0 110.424 177.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.16 116.66 3.39 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 122.089 1.859 . . . . 0.0 110.033 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.416 ' CE1' ' C ' ' A' ' 197' ' ' GLY . 36.5 p90 -81.12 129.97 34.81 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.798 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 91.4 mt -133.96 140.13 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.974 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -173.17 -172.97 39.19 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.698 -1.239 . . . . 0.0 112.785 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.55 142.23 33.53 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.533 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -121.52 133.48 55.03 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.323 0.582 . . . . 0.0 110.161 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.6 m -129.25 131.63 67.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.005 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.48 130.92 55.83 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.558 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.6 t80 . . . . . 0 C--O 1.238 0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 111.946 -178.997 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.234 0.265 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.83 130.71 9.22 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mp -134.95 145.37 48.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.677 0.275 . . . . 0.0 110.662 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -163.44 -169.33 26.75 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.8 146.0 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.613 0.72 . . . . 0.0 112.243 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.444 HD11 HH11 ' A' ' 138' ' ' ARG . 34.1 mm -112.94 131.62 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.83 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -156.69 151.08 25.38 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.849 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.416 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . 160.39 -169.86 36.28 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.61 148.18 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.309 0.576 . . . . 0.0 111.327 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -145.9 158.79 27.79 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.602 ' N ' ' OG1' ' A' ' 207' ' ' THR . 1.6 p90 -137.96 153.41 49.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.658 0.742 . . . . 0.0 111.497 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' A' ' 201' ' ' ASP . 1.2 m-20 -56.75 142.45 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.945 -176.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 206' ' ' LEU . 72.0 mt -101.31 -23.63 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 123.065 1.412 . . . . 0.0 107.812 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.587 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.7 OUTLIER -165.13 -174.69 0.4 Allowed Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.587 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.2 OUTLIER -5.31 -93.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.144 0 CA-C-N 124.82 2.757 . . . . 0.0 114.454 -179.128 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -128.09 17.93 6.62 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 120.909 1.686 . . . . 0.0 113.297 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 206' ' ' LEU . 10.0 mp -74.46 127.32 32.76 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 176.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 5.2 t -139.34 152.74 47.41 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -177.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.0 tt -97.57 141.46 30.58 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.62 144.15 50.71 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -176.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.09 114.01 19.77 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -145.02 -179.84 21.64 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 119.426 -1.368 . . . . 0.0 113.816 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -129.03 159.34 36.24 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 113.955 -1.123 . . . . 0.0 109.331 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -141.72 148.51 39.15 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -142.34 160.55 40.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.646 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.531 ' ND1' ' N ' ' A' ' 215' ' ' HIS . 0.0 OUTLIER -122.56 147.58 46.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.357 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.349 -179.924 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 121.216 0.531 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -128.11 148.21 17.67 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.1 130.21 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 122.728 -0.277 . . . . 0.0 110.433 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -130.29 116.88 18.97 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -99.74 107.13 19.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.301 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.476 ' NH1' HH21 ' A' ' 66' ' ' ARG . 76.8 mtp180 -125.44 128.04 47.47 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.976 0.417 . . . . 0.0 110.893 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 . . . . . 0 C--O 1.218 -0.583 0 CA-C-O 117.938 -1.029 . . . . 0.0 111.13 179.853 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.328 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.03 116.2 3.37 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 CA-C-N 119.614 1.707 . . . . 0.0 113.829 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.629 ' CZ ' ' NE ' ' A' ' 66' ' ' ARG . 11.4 p90 -115.65 167.61 10.76 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.76 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.0 t -125.71 149.32 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-O 120.926 0.393 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -118.96 139.7 51.23 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.033 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.92 156.06 44.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.85 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 38.0 p30 -150.26 136.4 18.66 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.86 170.02 16.49 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.625 178.938 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? . . . . . 0 C--O 1.232 0.139 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 57' ' ' SER . 59.9 t -148.53 155.2 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.193 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.45 ' N ' HG12 ' A' ' 56' ' ' VAL . 38.5 m -135.17 148.11 49.6 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.842 0.353 . . . . 0.0 110.432 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.6 t -129.35 141.15 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.92 170.72 31.33 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 119.804 -1.189 . . . . 0.0 113.724 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -102.2 140.47 36.45 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-N 114.942 -0.629 . . . . 0.0 110.232 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.426 ' CG ' ' NH1' ' A' ' 237' ' ' ARG . 44.9 t0 -90.06 114.12 25.95 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 124.177 0.923 . . . . 0.0 113.252 -177.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' TRP . 34.3 m-85 -124.78 118.8 27.2 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.392 -1.277 . . . . 0.0 108.825 177.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.56 105.5 0.83 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.22 -52.36 0.83 Allowed Glycine 0 N--CA 1.466 0.64 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.417 ' O ' ' O ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -140.98 166.31 25.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.634 ' NH1' ' NH2' ' A' ' 237' ' ' ARG . 16.4 ttp180 -146.43 162.68 37.73 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.854 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.2 tp -135.24 134.1 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.631 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.15 137.87 23.63 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.299 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.79 137.45 40.07 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.577 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -99.0 125.67 44.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.505 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -129.09 139.56 51.94 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.175 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.349 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.477 ' O ' HD12 ' A' ' 117' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.277 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 167.61 -137.28 4.53 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.002 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.1 148.81 51.98 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.4 p -153.9 139.8 18.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.68 135.55 46.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.519 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.417 ' O ' ' CB ' ' A' ' 66' ' ' ARG . 99.1 mt -122.15 133.75 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -101.73 113.75 27.2 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -90.24 113.16 24.93 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.36 105.82 16.92 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -74.77 56.97 0.74 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.614 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.6 pt -76.27 -20.48 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -135.88 -102.16 0.21 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.155 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -178.44 -27.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.859 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -99.35 -19.6 16.94 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -161.55 137.67 8.04 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.376 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.59 149.43 73.03 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.238 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.38 104.61 1.36 Allowed 'Trans proline' 0 N--CA 1.485 1.003 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.601 ' CD2' ' NH2' ' A' ' 235' ' ' ARG . 36.4 p90 -86.14 133.09 33.89 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.616 0.722 . . . . 0.0 112.352 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 tp -133.84 138.52 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.835 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.38 167.01 31.3 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.81 157.97 37.85 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -137.0 134.51 36.7 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 37.1 t -128.63 123.87 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.56 141.61 35.21 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.693 0.759 . . . . 0.0 111.996 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 . . . . . 0 C--O 1.237 0.444 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.617 179.456 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 191' ' ' GLY . 3.5 p . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.403 ' N ' HG22 ' A' ' 190' ' ' VAL . . . -142.07 142.97 12.28 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 119.042 -1.551 . . . . 0.0 113.092 -177.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.87 146.03 35.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.362 -0.919 . . . . 0.0 110.005 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -165.55 175.47 41.26 Favored Glycine 0 C--N 1.314 -0.673 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.2 m -133.47 150.17 31.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.9 pt -119.96 151.82 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.74 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -167.75 158.7 11.16 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.931 0.872 . . . . 0.0 112.478 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.482 ' C ' ' CE2' ' A' ' 134' ' ' TYR . . . 174.12 -165.57 37.27 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.61 135.69 57.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.356 0.598 . . . . 0.0 110.037 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -102.91 136.72 13.01 Favored Glycine 0 C--O 1.224 -0.513 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.996 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.93 109.79 9.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 45.8 p30 -54.97 144.74 22.24 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -176.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.7 tt -125.98 2.05 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.809 1.29 . . . . 0.0 109.292 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.582 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -160.56 162.66 22.9 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 100.327 -3.953 . . . . 0.0 100.327 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.582 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.3 OUTLIER -10.57 -79.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.775 2.317 . . . . 0.0 113.771 -177.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 237' ' ' ARG . 12.8 mptt -129.03 25.4 5.56 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.472 0.578 . . . . 0.0 110.304 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 236' ' ' TYR . 3.4 tp -78.92 110.69 14.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 53.6 p -106.25 145.64 31.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 14.9 tp -106.25 122.18 45.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 111.991 -2.368 . . . . 0.0 106.03 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -110.09 136.37 49.44 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -175.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -108.68 112.69 25.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 173.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -145.88 179.41 22.94 Favored Glycine 0 N--CA 1.463 0.486 0 C-N-CA 119.28 -1.438 . . . . 0.0 113.938 -175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.22 157.26 43.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.244 -1.478 . . . . 0.0 109.742 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -107.97 133.05 52.85 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -114.67 108.05 16.29 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 216' ' ' ASN . 52.9 p-80 -106.93 132.04 53.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.082 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 215' ' ' HIS . 59.5 t30 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 121.123 0.487 . . . . 0.0 111.42 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 CA--C 1.512 -0.507 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -98.71 121.55 7.22 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.663 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 71.1 t -115.55 125.05 72.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.601 ' NH2' ' CD2' ' A' ' 134' ' ' TYR . 1.7 mtt180 -133.33 144.43 49.65 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.509 0.671 . . . . 0.0 111.515 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.473 ' HA ' HD12 ' A' ' 206' ' ' LEU . 6.9 t80 -103.09 103.3 13.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.378 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.634 ' NH2' ' NH1' ' A' ' 66' ' ' ARG . 55.9 ttm-85 -130.59 129.76 43.16 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.484 ' C ' ' O ' ' A' ' 237' ' ' ARG . 69.6 m-85 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 118.025 -0.988 . . . . 0.0 112.547 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.45 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.567 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 94.0 Cg_endo -84.35 119.68 2.4 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 122.962 2.441 . . . . 0.0 111.749 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.567 ' CG ' ' O ' ' A' ' 9' ' ' PRO . 71.9 m-85 -152.01 -175.94 5.45 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.639 HG22 ' N ' ' A' ' 12' ' ' GLN . 12.5 p -124.46 163.86 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -174.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.639 ' N ' HG22 ' A' ' 11' ' ' VAL . 10.7 tm0? -135.31 149.92 49.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.805 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.04 130.75 15.98 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -101.97 130.96 48.62 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.99 0.424 . . . . 0.0 111.957 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.83 155.44 47.79 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.526 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.392 179.521 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.56 139.5 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 p -141.88 153.49 44.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.02 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.17 147.44 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.362 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.46 -154.08 10.6 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -135.99 154.47 51.07 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 53.5 p30 -121.84 149.63 43.08 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -176.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -126.53 159.95 31.98 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 112.246 -2.252 . . . . 0.0 105.14 175.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.58 100.7 0.1 OUTLIER Glycine 0 CA--C 1.535 1.301 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.259 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.562 ' O ' ' CD1' ' A' ' 65' ' ' TRP . . . 61.84 48.52 83.34 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.771 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 64' ' ' GLY . 16.7 m95 -165.8 89.24 0.42 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.609 ' NH1' ' NH1' ' A' ' 235' ' ' ARG . 70.9 ttt180 -127.33 150.43 49.59 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -176.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.43 141.35 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.397 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.72 137.91 19.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.384 0.611 . . . . 0.0 112.488 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.88 156.13 16.81 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -151.39 159.03 44.45 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -160.64 165.99 29.65 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.46 -1.7 . . . . 0.0 108.902 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.13 -179.666 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.578 HD22 ' N ' ' A' ' 117' ' ' LEU . 3.0 mm? . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.69 138.81 14.47 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tp -149.45 140.01 22.53 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.7 p -157.12 155.64 31.38 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.365 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.91 137.34 52.09 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.474 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 123' ' ' TYR . 4.6 mp -126.31 156.13 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.348 0.594 . . . . 0.0 111.175 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.47 ' N ' HG22 ' A' ' 122' ' ' ILE . 57.6 m-85 -117.48 113.05 21.47 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.837 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -106.64 122.9 47.26 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.201 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -75.68 104.01 6.04 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.037 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -71.2 -29.7 65.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.136 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.8 -41.67 88.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.421 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -58.65 126.81 29.17 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.581 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.48 -21.87 59.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -128.1 -48.94 1.33 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.529 ' O ' ' CD2' ' A' ' 131' ' ' PHE . 52.9 p90 -115.65 132.59 56.59 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.14 110.77 41.03 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.319 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.14 109.63 1.58 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 N-CA-C 108.882 -1.238 . . . . 0.0 108.882 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 1.8 p90 -83.21 132.73 35.05 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.223 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 63.6 mt -134.33 154.87 38.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.75 -173.16 44.89 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 118.113 -1.994 . . . . 0.0 113.858 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.91 141.98 50.73 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -123.66 131.23 53.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.992 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.04 130.44 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.235 0.541 . . . . 0.0 111.477 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.26 117.8 34.92 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.961 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 78.1 t80 . . . . . 0 N--CA 1.469 0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.952 -178.242 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.466 0.356 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -102.05 111.66 4.12 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.1 pp -143.76 159.13 43.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 112.375 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -177.93 -155.66 14.67 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.68 157.0 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 117.247 0.523 . . . . 0.0 110.747 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.9 pt -130.08 145.41 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.874 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -156.19 150.52 25.57 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.086 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 175.9 -173.5 46.3 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.8 143.94 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 117.731 0.765 . . . . 0.0 111.066 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -143.41 160.72 27.66 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.14 152.38 49.9 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.45 0.643 . . . . 0.0 111.532 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 6.3 p30 -69.36 146.89 51.76 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 113.717 -1.583 . . . . 0.0 115.195 -175.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 43.8 mt -119.91 -1.17 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 123.335 1.54 . . . . 0.0 107.123 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.541 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.2 OUTLIER -165.15 147.98 6.96 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 100.5 -3.889 . . . . 0.0 100.5 178.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.541 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -6.62 -67.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 123.249 2.633 . . . . 0.0 114.191 -176.178 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 237' ' ' ARG . 58.8 mmtt -130.77 33.07 4.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.359 0.982 . . . . 0.0 112.292 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 0.9 OUTLIER -92.55 108.07 19.69 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 176.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.0 t -137.35 154.88 49.94 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -174.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.96 141.85 45.1 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 113.023 -1.899 . . . . 0.0 107.578 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -135.73 147.89 48.63 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.27 150.6 43.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -179.36 -172.89 44.04 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.612 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -123.55 167.98 13.2 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.843 -0.678 . . . . 0.0 109.837 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -140.85 141.66 34.64 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.599 0.238 . . . . 0.0 110.84 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -109.75 11.21 24.54 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.256 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 216' ' ' ASN . 50.0 p-80 -37.6 115.42 0.41 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 215' ' ' HIS . 7.7 t-20 . . . . . 0 N--CA 1.475 0.781 0 O-C-N 123.855 0.722 . . . . 0.0 112.643 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 121.287 0.565 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -102.1 151.14 18.35 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.724 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.86 129.76 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.609 ' NH1' ' NH1' ' A' ' 66' ' ' ARG . 93.7 mtt180 -133.41 140.92 47.6 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.421 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 26.2 t80 -113.52 102.06 9.94 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 102.203 -3.258 . . . . 0.0 102.203 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.572 ' O ' ' HB2' ' A' ' 205' ' ' LYS . 62.1 ttp85 -148.82 136.65 20.66 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.474 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.934 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.9 p -64.57 -23.66 67.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.533 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.26 141.94 47.16 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.247 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -62.39 -43.85 97.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.0 -135.93 48.76 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -131.77 23.81 4.16 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -74.97 136.43 41.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.29 -168.71 34.19 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.957 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.53 150.51 87.36 Favored 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 123.896 3.064 . . . . 0.0 115.153 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 44.2 p90 -149.45 161.65 41.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.259 -1.791 . . . . 0.0 106.77 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.9 t -130.5 135.51 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 118.385 0.539 . . . . 0.0 110.741 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -120.32 148.53 43.61 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.69 107.5 4.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.476 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -85.79 151.17 24.04 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.722 HD22 ' C ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -171.17 167.78 6.96 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.596 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 15' ' ' LEU . . . 144.43 -116.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.992 0.808 . . . . 0.0 109.868 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 16' ' ' ALA . 61.8 t80 58.23 147.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.893 0.378 . . . . 0.0 110.662 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.34 147.79 29.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.641 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -155.41 161.7 40.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.483 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -152.77 93.59 1.78 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.482 ' C ' ' H ' ' A' ' 23' ' ' THR . 61.9 m170 -103.51 -171.61 1.97 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.246 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 22' ' ' ILE . 18.4 tt -73.74 38.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.419 0.628 . . . . 0.0 109.884 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.581 HG23 ' N ' ' A' ' 24' ' ' HIS . 14.6 t -58.69 -45.8 88.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.16 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.581 ' N ' HG23 ' A' ' 23' ' ' THR . 77.3 t60 -124.73 101.61 7.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.939 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 51.0 t0 -81.11 162.35 23.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.52 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.481 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 64.8 m-85 -121.47 65.13 16.21 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.394 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.36 156.29 58.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.518 2.146 . . . . 0.0 112.313 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.427 ' H ' ' HD2' ' A' ' 29' ' ' PRO . 3.1 mt-10 -176.28 -55.66 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.17 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' H ' ' A' ' 28' ' ' GLU . 73.9 Cg_endo -75.51 -15.56 19.59 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.99 1.793 . . . . 0.0 112.312 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 p -101.07 7.53 43.32 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.048 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 59.26 156.01 0.1 OUTLIER Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.94 122.01 9.67 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.453 2.102 . . . . 0.0 112.032 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -129.32 12.58 6.02 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.611 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -106.73 150.84 25.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.93 0.395 . . . . 0.0 110.768 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.499 ' CG ' ' H ' ' A' ' 36' ' ' LYS . 63.2 t30 -78.32 -170.74 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.798 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.499 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 28.5 tptp -60.67 -47.23 87.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.26 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 tt -137.03 -15.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.345 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.6 m 54.79 88.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.739 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.1 m -65.42 132.63 49.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.502 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -79.34 136.07 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.551 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 m -142.84 -103.28 0.13 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.89 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -64.4 -33.9 76.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.236 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -58.73 -44.98 90.61 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.985 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -130.41 134.89 47.48 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.781 0.324 . . . . 0.0 110.373 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -63.72 -44.81 92.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.082 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 3.3 p-10 176.21 -77.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.532 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.505 ' H ' ' CG ' ' A' ' 46' ' ' ASN . 96.5 mt 56.84 151.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.583 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.485 ' C ' HG23 ' A' ' 49' ' ' THR . 55.4 ttm-85 60.14 167.75 0.08 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.134 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.485 HG23 ' C ' ' A' ' 48' ' ' ARG . 2.6 p 71.53 -44.14 0.58 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.382 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -99.78 136.14 40.16 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.879 0.371 . . . . 0.0 110.524 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.8 m 48.99 88.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.574 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.909 HG13 ' H ' ' A' ' 53' ' ' HIS . 2.3 p -73.02 -94.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.177 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.909 ' H ' HG13 ' A' ' 52' ' ' VAL . 2.2 p80 179.45 71.5 0.15 Allowed Pre-proline 0 CA--C 1.53 0.189 0 C-N-CA 121.239 -0.184 . . . . 0.0 111.088 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' ARG . 44.7 Cg_endo -69.46 -62.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.652 1.568 . . . . 0.0 111.461 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.448 HH22 ' CD2' ' A' ' 228' ' ' HIS . 37.3 ttm180 32.94 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.204 0.315 . . . . 0.0 110.526 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.31 132.6 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.0 t -114.21 122.08 45.69 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.957 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 59' ' ' GLY . 3.9 p -135.01 153.92 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.405 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -175.8 -168.35 36.0 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.379 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -117.0 138.46 51.55 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.3 p30 -105.01 120.25 41.01 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 64' ' ' GLY . 74.9 m-85 -124.19 128.64 49.52 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.29 92.66 0.01 OUTLIER Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 62' ' ' PHE . . . 138.41 -94.1 0.21 Allowed Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -93.0 148.6 21.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.557 0.694 . . . . 0.0 111.444 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -132.17 135.66 46.51 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.963 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.66 128.86 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.75 143.83 47.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.036 0.446 . . . . 0.0 110.76 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.27 134.69 42.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.72 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -111.7 129.41 56.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.91 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -118.62 137.46 53.26 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.409 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.03 -43.09 4.72 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.737 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' A' ' 74' ' ' TYR . 78.2 ttt180 59.05 150.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.586 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.494 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 19.9 t80 95.52 105.38 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.069 0.855 . . . . 0.0 110.406 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -116.54 40.3 2.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.592 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.5 tttm 63.5 4.25 1.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.545 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -97.31 120.45 37.69 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.829 0.347 . . . . 0.0 110.107 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -97.55 90.6 5.09 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.328 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 80' ' ' ASN . 99.0 m-20 -64.38 -39.95 94.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.491 ' CG ' ' H ' ' A' ' 81' ' ' LYS . 18.9 t-20 49.51 179.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.346 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.491 ' H ' ' CG ' ' A' ' 80' ' ' ASN . 55.6 mtpt -63.41 138.4 58.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.883 0.373 . . . . 0.0 110.525 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -54.1 89.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.858 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 81' ' ' LYS . 47.5 t -158.78 155.45 27.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.092 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.8 m -107.69 144.72 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.518 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 57.4 38.65 28.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.912 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 87' ' ' GLU . 3.7 tp -64.38 -41.1 91.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.537 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' N ' HG23 ' A' ' 86' ' ' ILE . 22.4 pt-20 -109.06 142.19 40.13 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.599 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -84.5 123.56 30.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.4 t -64.37 -45.04 97.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.429 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -80.55 136.53 36.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.379 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.7 pt -130.35 149.74 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -80.4 -21.45 42.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.296 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -72.84 131.47 42.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.824 0.345 . . . . 0.0 110.811 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -70.14 -35.69 74.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -61.44 141.38 57.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.703 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -158.65 -96.39 0.11 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 83.9 mt 56.62 77.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.96 0.409 . . . . 0.0 109.993 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -66.6 -38.92 88.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.301 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 99' ' ' ILE . 19.5 tt -124.02 126.26 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.923 0.392 . . . . 0.0 111.053 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -99.72 5.05 45.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.612 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.454 ' H ' HG12 ' A' ' 99' ' ' ILE . 43.6 ttm180 -49.59 131.09 21.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.358 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -106.48 145.02 32.33 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.579 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.6 t -82.57 163.3 21.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.349 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 54.79 25.8 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.283 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -127.65 -51.47 1.36 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.259 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 45.33 70.11 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.369 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -65.45 145.1 56.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.55 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.462 ' OD1' ' NH2' ' A' ' 224' ' ' ARG . 16.4 m120 -78.8 148.75 32.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.846 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.8 -156.56 9.07 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 t -125.56 128.82 48.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.862 0.363 . . . . 0.0 110.44 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -152.14 -6.82 0.22 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.739 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -65.71 -41.1 92.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.696 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -153.16 123.75 7.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.55 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 115' ' ' SER . 80.2 t -129.56 131.92 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.953 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 114' ' ' VAL . 1.5 t 49.04 101.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.916 0.388 . . . . 0.0 110.33 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 91.1 p -150.69 162.97 39.66 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.966 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.2 mp -78.96 138.05 37.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.48 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -128.86 128.38 5.84 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.44 131.75 36.58 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.9 m -145.72 147.12 31.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.918 0.389 . . . . 0.0 110.428 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -102.28 113.3 26.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.477 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.684 HD12 ' N ' ' A' ' 122' ' ' ILE . 3.4 mp -111.55 146.59 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -112.77 127.21 56.09 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -98.92 125.17 44.28 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 176.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.46 ' C ' ' H ' ' A' ' 127' ' ' ILE . 39.0 m-85 -107.21 120.79 43.08 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -80.93 21.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.826 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 128' ' ' ASN . 21.4 tt -68.29 -39.35 80.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.689 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.49 ' N ' HG23 ' A' ' 127' ' ' ILE . 11.2 m120 -93.39 -174.79 3.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.976 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -102.3 -52.55 3.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.266 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.75 -14.2 14.64 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.445 ' O ' ' CD2' ' A' ' 131' ' ' PHE . 48.9 p90 -144.77 125.95 14.67 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.109 0.868 . . . . 0.0 112.093 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.4 mtmm -107.59 129.72 23.82 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.48 140.87 33.9 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 120.975 1.117 . . . . 0.0 109.982 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -107.34 133.94 51.14 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.588 0.232 . . . . 0.0 110.858 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.3 tt -151.85 136.83 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.264 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -175.37 -168.15 35.45 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.224 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.31 156.16 49.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.845 0.355 . . . . 0.0 111.132 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.731 ' NH2' HH11 ' A' ' 213' ' ' ARG . 39.5 ttm180 -106.7 144.84 32.77 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.541 0.686 . . . . 0.0 112.837 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.6 t -130.87 112.7 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.93 126.94 52.97 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.439 ' CG ' ' N ' ' A' ' 142' ' ' GLY . 88.2 t80 -126.26 156.77 39.78 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.447 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.439 ' N ' ' CG ' ' A' ' 141' ' ' TYR . . . -159.34 169.67 35.51 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -65.91 119.39 11.22 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.981 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.53 -24.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.325 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -120.16 139.78 52.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.4 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -111.81 -65.49 1.17 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.813 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.9 m -75.18 152.66 38.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.986 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.563 ' O ' HD13 ' A' ' 148' ' ' ILE . 0.2 OUTLIER -65.29 -42.69 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.412 ' N ' ' CG2' ' A' ' 148' ' ' ILE . 42.4 t0 -159.56 160.79 34.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.78 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.9 m -83.63 -97.18 0.05 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.521 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 70.9 p -138.45 157.53 46.02 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.438 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -63.92 -41.67 97.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.608 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -79.47 143.11 35.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.776 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 81.7 p -111.95 10.22 20.57 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.583 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 21.8 mm -76.83 129.18 37.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.255 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -112.02 147.14 36.61 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.913 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.527 HG13 ' N ' ' A' ' 158' ' ' THR . 14.6 p -62.48 -43.03 97.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.527 ' N ' HG13 ' A' ' 157' ' ' VAL . 56.9 m -71.66 133.28 45.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.448 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.2 m -79.82 129.53 34.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.407 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 44.0 t -72.31 113.8 23.97 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.46 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.82 -10.01 16.92 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.967 1.778 . . . . 0.0 112.393 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.3 t -60.89 -44.44 97.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.354 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -141.48 79.19 1.67 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.667 0.27 . . . . 0.0 111.135 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.605 ' N ' ' CD ' ' A' ' 165' ' ' PRO . . . -84.99 -42.74 0.67 Allowed Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 164' ' ' ALA . 24.1 Cg_exo -62.24 144.93 96.15 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.532 2.154 . . . . 0.0 111.373 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -146.58 -5.66 0.55 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.661 0.267 . . . . 0.0 110.787 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 61.2 63.2 5.1 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.43 82.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.753 0.311 . . . . 0.0 110.342 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 170' ' ' THR . 8.9 p -128.24 129.48 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.155 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 171' ' ' THR . 77.0 p 50.58 174.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.613 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 170' ' ' THR . 82.7 p 52.09 111.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.059 0.456 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -142.46 159.35 42.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.548 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 56.7 35.67 26.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.141 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 46.4 p -67.75 -31.45 71.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.715 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -111.23 93.06 17.14 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 116.856 -0.156 . . . . 0.0 111.28 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.54 -6.17 8.0 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.678 2.252 . . . . 0.0 112.734 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.511 ' O ' ' NE2' ' A' ' 179' ' ' GLN . 71.4 mmtt -69.57 144.35 53.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.069 0.462 . . . . 0.0 110.769 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 60.2 p -68.05 139.2 56.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.964 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -124.4 120.34 31.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.043 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -63.6 -41.27 98.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.59 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 48.95 75.8 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -78.71 137.95 38.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.217 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -99.23 -96.19 0.24 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.701 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.2 m -72.73 144.14 47.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.916 0.389 . . . . 0.0 110.835 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -97.1 104.91 16.96 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.17 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 39.2 t -132.55 106.92 8.12 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.733 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.445 HG23 ' N ' ' A' ' 188' ' ' ARG . 21.0 tt -67.5 -39.85 83.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.135 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.445 ' N ' HG23 ' A' ' 187' ' ' ILE . 36.4 mmt180 -50.45 102.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.052 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -90.58 140.64 29.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.865 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.0 p -73.67 155.82 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -135.51 139.85 11.14 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.446 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.54 147.27 52.52 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 114.398 -0.901 . . . . 0.0 108.785 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -160.5 -172.6 27.99 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.92 153.75 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 111.438 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 95.3 mt -130.94 136.3 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.678 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.49 154.98 32.67 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.123 0.487 . . . . 0.0 111.41 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 173.93 178.92 44.22 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.6 m -136.89 135.73 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -114.78 136.83 13.5 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.429 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -121.07 104.91 10.14 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 201' ' ' ASP . 0.3 OUTLIER -97.36 143.83 27.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 43.7 mm -75.54 -34.74 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 175.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.45 HG22 ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -165.79 164.32 11.85 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 101.183 -3.636 . . . . 0.0 101.183 177.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.504 ' C ' ' O ' ' A' ' 237' ' ' ARG . 8.2 Cg_endo -55.11 -15.82 11.31 Favored 'Trans proline' 0 C--N 1.288 -2.629 0 CA-C-N 121.801 1.679 . . . . 0.0 111.66 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.458 ' HA ' ' H ' ' A' ' 237' ' ' ARG . 0.9 OUTLIER -73.8 -39.45 64.11 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.5 mt -123.08 110.45 15.34 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.626 0.648 . . . . 0.0 111.381 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 t -134.56 138.27 44.46 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.615 HD12 ' N ' ' A' ' 208' ' ' LEU . 5.8 mp -89.78 128.38 36.13 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -133.95 124.8 26.97 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -84.59 111.5 19.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -109.51 139.6 15.38 Favored Glycine 0 N--CA 1.467 0.744 0 C-N-CA 121.272 -0.489 . . . . 0.0 112.655 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -129.95 125.71 36.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.95 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.731 HH11 ' NH2' ' A' ' 138' ' ' ARG . 60.7 ttm-85 -110.64 116.82 32.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 215' ' ' HIS . 60.8 t80 -132.69 156.0 47.79 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.406 0.622 . . . . 0.0 111.939 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.539 ' O ' ' CD2' ' A' ' 214' ' ' TYR . 84.5 t60 -87.34 168.34 13.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.652 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.465 ' N ' ' CG ' ' A' ' 215' ' ' HIS . 65.1 t30 -71.8 146.09 48.26 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.853 0.359 . . . . 0.0 110.636 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 35.8 t-105 -77.52 112.81 14.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.28 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -118.62 -146.71 8.07 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -66.18 99.37 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 0.0 110.516 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 220' ' ' LEU . 9.5 mp 53.34 174.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.535 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -81.34 76.86 8.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.553 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -104.76 7.71 34.73 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.721 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 21.1 m -64.19 134.22 54.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.914 0.388 . . . . 0.0 110.664 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.462 ' NH2' ' OD1' ' A' ' 108' ' ' ASN . 12.1 tpt180 -72.92 -72.17 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.789 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -74.26 144.07 44.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.932 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.22 -122.05 0.15 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.752 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 229' ' ' GLU . 59.4 p -66.96 -30.0 70.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.041 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.448 ' CD2' HH22 ' A' ' 55' ' ' ARG . 13.2 t60 65.85 -69.02 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.563 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 227' ' ' THR . 80.6 tt0 -154.5 82.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.343 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 231' ' ' SER . . . -163.3 150.53 12.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.023 0.44 . . . . 0.0 111.137 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 230' ' ' ALA . 0.6 OUTLIER 163.8 -50.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.054 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 15' ' ' LEU . 12.1 tp -130.04 145.39 51.66 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.9 148.17 19.18 Favored Glycine 0 C--N 1.314 -0.672 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 68.5 t -122.16 128.83 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.693 HH12 ' NH2' ' A' ' 237' ' ' ARG . 45.7 ptt85 -133.29 143.01 48.77 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.77 0.795 . . . . 0.0 111.266 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 53.5 t80 -110.57 126.67 54.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 113.763 -1.562 . . . . 0.0 113.326 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.693 ' NH2' HH12 ' A' ' 235' ' ' ARG . 36.3 ttm180 -140.76 113.0 7.88 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.946 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' A' ' 237' ' ' ARG . 90.5 m-85 . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 117.852 -1.071 . . . . 0.0 111.954 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 t -72.27 133.48 45.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.822 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.453 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 46.2 mp0 -71.37 -39.03 71.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.085 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 6' ' ' GLY . 47.9 t0 -61.4 -45.0 96.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.304 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.54 -35.82 0.83 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 4' ' ' ASP . . . 81.88 7.5 87.89 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -140.67 141.82 34.98 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 122.553 -0.38 . . . . 0.0 110.261 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 10' ' ' TYR . . . -134.84 88.22 0.24 Allowed Glycine 0 CA--C 1.533 1.167 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 26.9 Cg_endo -74.48 141.32 28.15 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.607 1.538 . . . . 0.0 111.532 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 63.8 m-85 -147.23 -179.86 7.13 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.603 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 12' ' ' GLN . 2.3 p -128.6 160.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.556 ' OE1' ' NH2' ' A' ' 235' ' ' ARG . 57.2 tt0 -142.71 147.04 34.98 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.851 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.31 156.92 43.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.928 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -160.5 155.78 24.86 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.0 mt -134.15 146.2 49.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.584 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.53 -42.86 61.19 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' A' ' 17' ' ' TYR . 84.7 t80 56.28 25.89 9.86 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.909 0.385 . . . . 0.0 110.42 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.36 142.76 52.1 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 111.782 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -74.83 -111.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.232 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 41.77 76.38 0.07 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.799 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.506 ' CG ' ' N ' ' A' ' 22' ' ' ILE . 83.7 t60 -93.99 167.7 11.43 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.974 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.506 ' N ' ' CG ' ' A' ' 21' ' ' HIS . 97.5 mt -61.51 -88.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.164 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.483 HG23 HG22 ' A' ' 22' ' ' ILE . 45.7 p -134.4 161.31 35.37 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.852 0.358 . . . . 0.0 110.921 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 25' ' ' ASP . 96.4 m-70 -99.99 55.41 0.93 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.775 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 24' ' ' HIS . 98.7 m-20 56.39 118.7 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.871 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 27' ' ' PRO . 68.2 m-85 -58.57 155.23 30.22 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.403 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 26' ' ' TYR . 53.1 Cg_exo -53.0 -146.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.112 1.874 . . . . 0.0 112.942 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 65.58 65.72 0.88 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.308 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -90.46 -173.41 0.63 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.979 2.453 . . . . 0.0 111.843 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 p 59.74 113.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.017 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.84 56.48 17.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.542 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.69 60.48 5.19 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.585 2.19 . . . . 0.0 111.292 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -67.01 -20.84 65.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.522 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -74.81 100.42 4.04 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.962 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -104.67 8.16 35.09 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.208 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 38' ' ' SER . 8.2 mtmp? -84.44 -11.01 57.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.734 0.302 . . . . 0.0 110.526 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mm 42.32 -88.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 36' ' ' LYS . 33.8 p -155.4 163.45 40.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.791 0.329 . . . . 0.0 110.322 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 t -132.64 141.39 48.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.296 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 p -173.63 -12.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.474 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.0 p -153.87 167.19 30.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.667 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 43' ' ' TYR . 42.8 p-10 -64.73 -32.1 73.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.488 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 57.4 m-85 55.59 35.96 26.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.132 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -92.51 117.96 30.49 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.811 0.338 . . . . 0.0 110.475 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -168.48 22.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.446 0.641 . . . . 0.0 109.388 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -63.62 -39.89 95.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.692 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.5 mm -76.2 128.43 37.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.523 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -88.37 140.98 28.91 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.553 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.4 t -142.67 163.51 32.61 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.576 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 47.71 97.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.696 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.2 t -72.13 150.02 44.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.23 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.95 148.06 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.719 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.501 ' ND1' ' N ' ' A' ' 53' ' ' HIS . 5.1 p-80 -116.61 73.5 5.88 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.613 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -40.83 146.87 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.667 2.245 . . . . 0.0 113.487 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.68 138.07 41.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.161 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 57' ' ' SER . 13.7 p -140.64 162.23 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.639 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.511 ' N ' HG22 ' A' ' 56' ' ' VAL . 28.3 t -146.61 151.94 38.1 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.81 163.15 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.326 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.18 178.68 43.45 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.934 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -112.73 131.12 55.81 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.19 0.596 . . . . 0.0 109.813 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -102.08 127.24 49.06 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.545 ' O ' ' N ' ' A' ' 64' ' ' GLY . 90.5 m-85 -124.56 139.55 53.77 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.58 88.82 0.01 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.11 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 62' ' ' PHE . . . 129.77 -82.33 0.33 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -95.99 144.08 26.59 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.675 0.75 . . . . 0.0 111.501 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.782 HH11 HH21 ' A' ' 237' ' ' ARG . 51.2 ttp180 -136.27 137.93 41.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.377 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.93 128.68 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.58 139.32 26.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.08 145.46 50.32 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.107 0.48 . . . . 0.0 111.095 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -93.58 125.96 38.47 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -106.38 141.97 36.82 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.631 0.729 . . . . 0.0 111.789 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -166.06 101.51 0.65 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.489 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HG2' ' H ' ' A' ' 75' ' ' ARG . 73.6 ttt180 -83.65 155.81 22.99 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 111.111 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.46 ' O ' ' O ' ' A' ' 75' ' ' ARG . 69.1 m-85 -87.6 14.34 8.55 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 74' ' ' TYR . 40.9 ttm180 40.34 106.42 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.358 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 75' ' ' ARG . 22.3 tptm 55.21 114.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.142 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -88.17 133.33 34.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.007 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.65 163.19 14.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 79' ' ' ASN . 47.5 p-10 -48.66 137.5 11.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.494 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -84.92 94.09 8.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.636 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -144.39 49.82 1.32 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.335 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 40.66 -101.05 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.862 0.363 . . . . 0.0 110.836 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 83' ' ' SER . 10.4 t 56.04 53.73 8.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.601 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 85' ' ' ASN . 32.6 m -64.04 -41.44 92.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.19 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.503 ' N ' HG23 ' A' ' 84' ' ' VAL . 61.1 t-20 -134.33 89.86 2.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.026 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 87' ' ' GLU . 10.1 tp -66.44 -40.85 87.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.781 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' N ' HG23 ' A' ' 86' ' ' ILE . 77.0 mm-40 -138.06 136.81 37.17 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.855 0.36 . . . . 0.0 110.251 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -99.09 136.72 38.65 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.556 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.7 m -78.94 -12.87 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.676 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 62.37 76.05 0.38 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.303 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.4 tt -87.52 134.72 27.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.6 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -130.89 140.04 50.17 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.647 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -148.18 125.77 11.76 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.94 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -111.23 124.66 52.67 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.472 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -94.96 172.78 7.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.432 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.45 -19.95 1.87 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.44 133.59 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.929 0.395 . . . . 0.0 110.287 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -40.96 130.32 2.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.797 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.486 ' O ' HG23 ' A' ' 99' ' ' ILE . 9.2 tp -97.71 125.95 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.303 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -132.68 103.83 6.32 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.076 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -70.4 81.67 0.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.444 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -66.24 -35.71 81.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.431 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -65.84 131.61 46.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.604 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -134.33 -0.27 3.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.326 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -91.34 104.48 17.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.462 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -80.06 133.26 36.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.712 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -76.83 131.91 38.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.371 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -91.5 119.89 31.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -150.33 -150.65 5.33 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.2 p -68.23 140.84 56.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.754 0.311 . . . . 0.0 110.631 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.531 ' O ' ' CG ' ' A' ' 112' ' ' HIS . 96.7 m-85 -60.85 -48.11 83.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.695 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 111' ' ' PHE . 99.0 m-70 -159.03 159.98 35.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.752 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.04 -11.47 59.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.255 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.62 111.65 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.876 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.8 t -62.9 -43.43 98.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.584 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 74.09 151.65 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.2 mp -95.74 140.52 30.43 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -135.1 142.2 13.58 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 120.468 -0.873 . . . . 0.0 113.392 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.3 mt -120.43 143.47 48.46 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.7 t -139.68 118.02 12.06 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.63 118.54 29.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.548 HG22 ' N ' ' A' ' 123' ' ' TYR . 46.3 mm -104.77 160.17 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.548 ' N ' HG22 ' A' ' 122' ' ' ILE . 62.8 t80 -128.02 99.48 5.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 64' ' ' GLY . 43.8 t0 -138.34 122.8 18.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.843 0.354 . . . . 0.0 110.33 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.504 ' H ' ' CG ' ' A' ' 132' ' ' LYS . 10.9 m-85 -113.19 121.56 44.85 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.823 0.821 . . . . 0.0 112.322 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 126' ' ' GLN . 1.3 mp0 -86.7 -10.51 53.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.915 -1.038 . . . . 0.0 108.841 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.571 ' C ' ' H ' ' A' ' 129' ' ' ASP . 96.4 mt -67.84 -41.2 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 95.4 m-20 -69.67 35.35 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.849 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' A' ' 127' ' ' ILE . 20.8 t0 92.62 -119.94 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.85 0.719 . . . . 0.0 110.491 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -127.34 23.3 6.42 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.574 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 11.0 p90 -151.13 126.39 9.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 119.568 -0.853 . . . . 0.0 113.287 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.504 ' CG ' ' H ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -135.87 135.71 22.09 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.413 177.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.65 98.34 1.14 Allowed 'Trans proline' 0 C--N 1.325 -0.661 0 N-CA-C 104.217 -3.032 . . . . 0.0 104.217 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -76.66 135.75 39.13 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 118.97 -1.092 . . . . 0.0 113.566 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.2 mt -120.54 134.17 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 CA-C-N 113.465 -1.698 . . . . 0.0 107.75 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.02 166.06 30.38 Favored Glycine 0 N--CA 1.46 0.288 0 C-N-CA 119.897 -1.145 . . . . 0.0 112.145 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.22 134.7 34.13 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -106.97 119.8 40.33 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.195 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 139' ' ' VAL . 9.8 p -136.3 123.12 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.77 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.84 129.44 34.48 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.95 136.95 46.79 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.081 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.22 -48.97 4.62 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.476 ' CG ' ' O ' ' A' ' 143' ' ' HIS . 47.3 p-80 -154.96 119.3 4.72 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.957 0.408 . . . . 0.0 111.206 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.481 ' O ' ' ND1' ' A' ' 146' ' ' HIS . 9.8 p -86.56 -1.32 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.895 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.512 ' O ' ' CG ' ' A' ' 146' ' ' HIS . 95.6 mtt-85 -64.46 144.77 56.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.273 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' A' ' 145' ' ' ARG . 70.8 m80 -158.66 -128.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.879 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 148' ' ' ILE . 50.0 m -149.95 151.23 33.03 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.518 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 147' ' ' SER . 28.0 pt 31.78 51.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.822 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.24 -43.19 99.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.638 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.2 p -77.14 162.04 27.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.428 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 152' ' ' LYS . 98.0 m -131.07 -89.85 0.45 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.612 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 151' ' ' THR . 55.2 mtpt 44.58 -172.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.776 0.322 . . . . 0.0 110.694 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -79.18 139.76 37.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.455 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.7 t -152.64 175.71 12.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.748 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 95.0 mt -74.64 131.3 35.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.228 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -141.09 163.78 32.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.072 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.2 t 62.35 27.89 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-O 121.054 0.454 . . . . 0.0 110.454 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 98.4 m -116.21 121.15 41.21 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.1 m -65.89 133.9 51.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.311 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 160' ' ' VAL . 18.5 m -94.47 146.63 31.84 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.907 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.64 -34.26 7.36 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.096 1.864 . . . . 0.0 112.525 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 70.8 m -79.33 152.84 30.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.146 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.14 134.66 38.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.804 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.59 146.45 98.57 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.0 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.05 146.81 47.59 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.127 1.884 . . . . 0.0 111.795 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -79.92 124.83 29.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.229 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 62.21 -131.28 44.97 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.47 -50.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 0.0 110.393 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.43 132.03 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.039 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 170' ' ' THR . 8.9 t -87.6 129.54 35.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.229 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 62.1 m -108.91 124.38 50.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.593 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -174.66 -70.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.219 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.436 ' O ' ' OG1' ' A' ' 174' ' ' THR . 51.2 t-20 -156.31 -127.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.227 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 173' ' ' ASN . 78.7 p 52.06 -92.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.328 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.401 ' N ' ' OG1' ' A' ' 174' ' ' THR . 34.6 t70 -113.73 91.59 21.85 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.464 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 177' ' ' LYS . 51.7 Cg_endo -91.15 5.29 4.01 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.948 2.432 . . . . 0.0 111.92 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 176' ' ' PRO . 98.5 mttt 58.62 120.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.198 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.7 t -73.35 170.17 15.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.877 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -54.39 115.3 2.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.288 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -154.07 174.54 14.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.7 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -63.27 -37.04 85.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.852 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.08 133.24 44.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.421 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -151.59 -65.55 0.18 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.531 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.5 t -81.94 172.87 12.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.037 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -90.29 10.84 23.23 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.3 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 11.3 m -60.6 173.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.404 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 96.3 mt -73.85 128.02 36.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.993 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -85.47 142.8 28.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.296 0.57 . . . . 0.0 111.808 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? 47.12 77.25 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.431 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 190' ' ' VAL . 14.1 p -126.63 131.89 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -138.32 135.17 7.29 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 119.505 -1.331 . . . . 0.0 114.583 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.59 144.75 50.79 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 163.31 -148.83 15.74 Favored Glycine 0 C--N 1.322 -0.216 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.01 159.19 26.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.767 0.794 . . . . 0.0 112.004 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 19.5 tt -113.11 131.61 64.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.66 150.47 36.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 122.15 0.976 . . . . 0.0 112.769 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 171.58 177.4 41.25 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.68 136.22 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.623 0.725 . . . . 0.0 110.57 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -122.87 120.67 4.34 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -128.25 142.21 51.22 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.836 0.827 . . . . 0.0 109.59 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 201' ' ' ASP . 13.6 p-10 -49.16 141.8 7.82 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 117.438 2.385 . . . . 0.0 117.438 -173.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 202' ' ' ILE . 49.7 mm -124.31 5.59 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 112.35 -2.204 . . . . 0.0 106.177 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.58 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER 176.15 173.83 0.29 Allowed Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 -178.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.58 ' C ' ' O ' ' A' ' 203' ' ' THR . 3.8 Cg_exo -14.36 -83.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 123.58 2.314 . . . . 0.0 113.687 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.435 ' O ' HG23 ' A' ' 207' ' ' THR . 58.7 mttp -129.61 29.6 5.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.689 0.757 . . . . 0.0 110.604 177.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 202' ' ' ILE . 4.2 tt -83.66 111.89 19.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 176.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 205' ' ' LYS . 3.2 p -120.31 152.73 37.41 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.16 131.77 48.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 112.728 -2.033 . . . . 0.0 105.623 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -108.06 146.82 32.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -145.59 129.51 17.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.531 -1.668 . . . . 0.0 106.673 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -167.68 -168.99 30.64 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 118.903 -1.617 . . . . 0.0 113.038 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -143.81 142.69 30.99 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.542 HH12 ' CD2' ' A' ' 215' ' ' HIS . 8.9 ptm180 -91.41 116.98 29.28 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.95 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -63.47 -46.35 86.59 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.542 ' CD2' HH12 ' A' ' 213' ' ' ARG . 86.3 t60 29.59 84.36 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.206 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.9 t30 43.27 94.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.38 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 34.82 -122.44 0.11 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.348 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -165.65 68.18 0.2 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 220' ' ' LEU . 15.1 tpt85 -67.33 -18.78 65.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.73 0.3 . . . . 0.0 110.449 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 220' ' ' LEU . 10.0 mp -43.4 -95.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.566 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.436 ' O ' ' OE1' ' A' ' 221' ' ' GLU . 9.2 tm-20 40.13 94.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.055 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.436 ' N ' ' ND2' ' A' ' 222' ' ' ASN . 0.3 OUTLIER -136.13 2.78 2.83 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.334 179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 60.9 p -138.71 156.06 47.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.152 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -65.07 -40.77 95.16 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.878 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.532 ' CD2' ' N ' ' A' ' 226' ' ' LYS . 67.7 t80 -135.37 -101.37 0.22 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.892 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.532 ' N ' ' CD2' ' A' ' 225' ' ' PHE . 44.9 mmtm 40.73 34.88 0.28 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.338 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.5 m -64.95 119.53 10.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.42 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -149.78 -91.09 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.874 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 45.86 31.35 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.135 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.07 154.04 39.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.671 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.518 ' C ' HD12 ' A' ' 232' ' ' LEU . 71.8 p -137.75 131.29 31.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.787 0.327 . . . . 0.0 110.166 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 231' ' ' SER . 11.3 mp -110.3 136.72 49.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.789 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -141.58 153.08 23.87 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.011 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 14.2 p -133.44 134.18 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.652 ' NE ' HH12 ' A' ' 66' ' ' ARG . 52.6 ttm-85 -133.29 141.67 48.1 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 80.4 t80 -107.84 103.57 12.86 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.782 HH21 HH11 ' A' ' 66' ' ' ARG . 41.1 ttm180 -126.44 133.54 51.21 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 124.188 0.93 . . . . 0.0 111.413 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 10.2 t80 . . . . . 0 C--O 1.218 -0.554 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.308 179.493 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 1' ' ' ALA . 4.9 p 48.16 99.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.486 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -76.87 144.29 39.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.897 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.89 -39.65 95.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.34 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.76 -24.58 10.88 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.14 -39.78 3.08 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -71.82 137.11 47.33 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.83 -160.93 11.63 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.105 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.54 -174.59 2.0 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.308 2.672 . . . . 0.0 112.464 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.691 ' CZ ' ' NH2' ' A' ' 66' ' ' ARG . 3.4 t80 -159.47 141.02 13.06 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 120.904 0.383 . . . . 0.0 111.786 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 12' ' ' GLN . 58.0 t -132.21 159.39 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.571 ' NE2' ' NE ' ' A' ' 235' ' ' ARG . 7.4 tt0 -157.44 151.79 24.94 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -176.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.7 121.59 10.64 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 113.172 -1.831 . . . . 0.0 107.825 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 38.4 p30 -92.65 133.77 35.66 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.1 mt -126.86 133.87 50.63 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.149 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.28 -31.22 0.32 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.768 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -82.43 142.93 31.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.032 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.92 -127.38 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.684 0.278 . . . . 0.0 110.704 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -60.16 -44.63 94.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.842 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.26 136.4 54.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.544 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 22' ' ' ILE . 25.9 t-80 -122.34 -80.87 0.63 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.354 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' HIS . 2.6 tp 31.43 104.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.62 0.724 . . . . 0.0 112.114 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 25' ' ' ASP . 19.5 p -69.74 164.41 23.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.626 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 24' ' ' HIS . 80.0 t60 -79.99 26.36 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.389 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 23' ' ' THR . 32.8 t70 -88.26 109.74 20.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.91 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -162.21 64.89 1.72 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.283 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.13 -62.45 0.25 Allowed 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 122.736 2.29 . . . . 0.0 113.012 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 34.78 58.09 2.27 Favored Pre-proline 0 N--CA 1.467 0.406 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -75.43 -30.69 6.33 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.67 2.247 . . . . 0.0 111.98 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -64.55 -20.0 65.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.379 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -117.67 86.07 23.01 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.861 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.61 ' CB ' HD21 ' A' ' 35' ' ' ASN . 27.3 Cg_exo -60.24 145.25 98.95 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.37 2.046 . . . . 0.0 111.594 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.461 ' N ' ' ND2' ' A' ' 35' ' ' ASN . 17.1 p30 -132.13 134.4 45.4 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.568 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp 44.83 37.94 2.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.628 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.713 HD22 ' H ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -154.22 172.01 18.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.681 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -96.28 -170.51 2.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.553 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.64 -16.96 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.559 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 39' ' ' THR . 69.0 m -55.32 -41.53 72.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.607 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.595 HG22 ' N ' ' A' ' 40' ' ' VAL . 53.9 m 54.54 164.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.709 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.595 ' N ' HG22 ' A' ' 39' ' ' THR . 10.6 p -69.94 136.81 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.591 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 p -75.37 163.94 26.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 43' ' ' TYR . 43.6 t0 -62.68 -177.06 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.644 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.509 ' H ' ' CG ' ' A' ' 42' ' ' ASP . 16.5 t80 70.82 -35.02 0.31 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.573 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' A' ' 42' ' ' ASP . 78.4 t80 -59.95 -43.83 94.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -64.35 143.37 57.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.842 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -149.36 147.6 28.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.342 . . . . 0.0 110.665 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.67 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.1 mp -76.55 130.52 36.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.021 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -120.62 141.55 50.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.14 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 98.4 m -126.56 130.43 50.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.178 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -127.9 133.62 49.31 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.784 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.4 p -168.85 -108.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.749 0.309 . . . . 0.0 110.596 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.5 m -112.67 132.16 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.06 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 55' ' ' ARG . 83.5 m-70 -146.55 72.52 12.83 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.85 76.57 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 120.961 1.107 . . . . 0.0 110.577 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 53' ' ' HIS . 43.9 ttm180 -72.41 146.48 46.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.952 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.07 139.3 44.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 121.154 0.502 . . . . 0.0 111.462 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.26 130.27 36.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.91 162.71 37.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.065 0.459 . . . . 0.0 111.155 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.85 -136.21 3.1 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -139.28 151.76 46.71 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 121.482 0.658 . . . . 0.0 112.344 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.563 ' OD2' ' NE ' ' A' ' 237' ' ' ARG . 12.1 t0 -92.39 104.79 17.08 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.125 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -126.33 148.07 49.62 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.256 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.47 125.77 8.07 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 123' ' ' TYR . . . 94.09 -10.73 71.56 Favored Glycine 0 C--N 1.33 0.247 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.539 ' CZ2' ' CG2' ' A' ' 67' ' ' ILE . 22.6 t90 -167.69 142.45 3.72 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.565 -0.817 . . . . 0.0 110.198 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.691 ' NH2' ' CZ ' ' A' ' 10' ' ' TYR . 69.4 mtp180 -144.01 144.34 31.62 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.539 ' CG2' ' CZ2' ' A' ' 65' ' ' TRP . 48.5 pt -120.17 138.34 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.639 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.65 110.16 8.53 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.786 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.07 119.52 29.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -100.14 128.42 46.22 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 112.146 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -153.92 155.23 35.27 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.675 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 73' ' ' ARG . . . -150.94 -63.04 0.19 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.475 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 72' ' ' ALA . 91.0 mtm180 56.28 125.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.507 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 71.0 t80 -147.23 31.67 0.91 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.123 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? -130.27 138.75 50.66 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.329 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -77.56 142.99 38.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.452 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -83.1 -116.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.538 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 79' ' ' ASN . 56.8 p30 -131.78 53.23 2.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.759 0.314 . . . . 0.0 110.412 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 78' ' ' ASN . 98.3 m-20 50.17 179.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.155 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 80' ' ' ASN . 44.1 p30 -86.25 137.24 32.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.001 0.429 . . . . 0.0 110.351 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -143.16 158.76 43.32 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.452 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 83' ' ' SER . 55.2 p90 -111.07 145.19 38.96 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.342 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 82' ' ' TYR . 31.6 t 49.44 179.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.429 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.5 133.79 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.368 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -126.02 130.05 50.39 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.22 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.679 ' CD1' ' H ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -102.39 3.48 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.573 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.96 -38.71 92.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.395 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.6 m120 54.09 52.81 12.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.58 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 90' ' ' ARG . 8.3 p -61.79 -43.56 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.602 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.511 ' N ' HG13 ' A' ' 89' ' ' VAL . 17.6 ptm180 -76.61 135.72 39.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 110.245 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 92' ' ' ARG . 41.6 pt -132.82 161.86 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.012 0.434 . . . . 0.0 111.199 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 91' ' ' ILE . 80.0 mtp85 54.59 161.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.136 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -142.09 166.45 24.68 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.784 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -46.78 123.81 5.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.026 0.441 . . . . 0.0 110.954 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -158.37 170.96 21.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.513 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.56 -55.58 0.69 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.66 -43.45 98.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.664 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -122.39 141.51 51.51 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.002 0.43 . . . . 0.0 110.758 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.8 tt -146.64 1.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.037 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -61.44 -43.46 98.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.646 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.458 ' HG3' ' H ' ' A' ' 103' ' ' THR . 16.6 tpp180 -77.95 129.05 34.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.215 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.64 0.76 45.41 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.969 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.458 ' H ' ' HG3' ' A' ' 101' ' ' ARG . 93.9 m -86.84 128.4 35.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.789 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 106' ' ' GLN . 11.9 pm0 -70.92 -168.2 0.26 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.323 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.449 ' ND2' ' ND2' ' A' ' 108' ' ' ASN . 45.8 t-20 64.61 -64.75 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.818 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.505 ' C ' ' H ' ' A' ' 108' ' ' ASN . 14.9 mm100 53.56 -168.58 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.519 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 64.51 -38.18 0.22 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.801 0.688 . . . . 0.0 111.395 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.505 ' H ' ' C ' ' A' ' 106' ' ' GLN . 99.0 m-20 -64.2 -39.88 94.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.786 0.327 . . . . 0.0 110.421 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.07 -103.33 2.88 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.5 p -80.37 166.34 21.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.754 0.311 . . . . 0.0 110.562 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -102.52 -162.74 0.94 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.322 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.586 ' CG ' ' H ' ' A' ' 113' ' ' ALA . 10.1 t-80 71.61 -149.72 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.294 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.586 ' H ' ' CG ' ' A' ' 112' ' ' HIS . . . 57.52 -149.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.573 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.4 t 53.16 -83.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.522 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 113' ' ' ALA . 42.9 t -118.04 99.67 7.04 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.107 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.0 m -160.99 -165.58 1.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.632 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 117' ' ' LEU . 2.8 mm? 58.92 -150.4 0.44 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 162.53 -105.4 0.26 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 118.875 -1.631 . . . . 0.0 112.916 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.28 151.74 33.43 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.4 0.619 . . . . 0.0 111.547 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.0 t -139.48 119.25 13.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.458 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.91 123.23 26.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.089 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.504 HD13 HH22 ' A' ' 235' ' ' ARG . 90.7 mt -101.23 135.95 35.25 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' A' ' 64' ' ' GLY . 12.2 m-85 -124.3 107.72 11.47 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.008 0.432 . . . . 0.0 110.301 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.666 ' CG ' HH11 ' A' ' 66' ' ' ARG . 9.5 m-20 -96.96 141.53 30.02 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.933 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.495 ' O ' ' CB ' ' A' ' 132' ' ' LYS . 93.5 m-85 -103.34 153.7 20.17 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -108.59 63.61 0.61 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.8 mp -67.43 -41.69 86.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -141.84 -85.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.011 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.4 t70 179.24 -44.22 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.332 0.587 . . . . 0.0 110.297 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.99 -43.31 88.15 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -142.93 110.73 5.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -175.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -130.58 139.93 37.13 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.46 152.18 70.84 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.323 1.348 . . . . 0.0 109.603 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 0.5 OUTLIER -138.45 133.95 33.42 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.612 -179.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.4 pt -130.4 154.8 41.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.441 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -155.88 163.27 31.72 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.93 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -102.35 122.61 44.59 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -92.66 128.22 38.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.111 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.13 119.22 46.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.32 153.53 46.47 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.419 ' CE1' ' O ' ' A' ' 117' ' ' LEU . 47.6 p90 -142.21 164.72 29.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.55 . . . . 0.0 110.927 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.52 -119.87 0.63 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -62.57 99.91 0.17 Allowed 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.2 p -142.87 141.04 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.906 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -108.99 127.31 53.97 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.6 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -164.01 -82.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.596 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 60.1 p -165.99 -144.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.572 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 149' ' ' ASP . 72.0 mt 57.55 74.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.15 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 148' ' ' ILE . 66.6 t0 35.91 95.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.264 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.4 t -128.82 152.76 48.13 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.603 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 152' ' ' LYS . 59.1 m -62.28 161.1 11.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.74 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.523 ' N ' HG22 ' A' ' 151' ' ' THR . 61.4 pttt -58.73 137.41 57.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.707 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.476 ' C ' ' H ' ' A' ' 155' ' ' ILE . 53.6 mtmt -102.58 -165.95 1.23 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.699 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.4 p -74.22 25.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.476 ' H ' ' C ' ' A' ' 153' ' ' LYS . 41.5 pt -90.51 -5.03 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.963 0.411 . . . . 0.0 110.288 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' A' ' 157' ' ' VAL . 0.0 OUTLIER -42.17 164.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.804 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.419 ' O ' ' OE1' ' A' ' 156' ' ' GLU . 31.1 m -57.44 160.12 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.624 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 67.3 p -61.04 137.19 58.24 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.7 t -142.71 156.69 45.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.918 0.39 . . . . 0.0 110.933 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 160' ' ' VAL . 7.3 p -58.61 129.96 84.85 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.567 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.08 131.75 8.58 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.302 1.334 . . . . 0.0 111.979 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 78.2 p -61.79 -42.51 99.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.293 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -150.95 129.97 12.58 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.931 0.396 . . . . 0.0 110.875 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.99 152.72 95.81 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.803 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.57 109.28 2.82 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.877 1.718 . . . . 0.0 111.806 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.87 4.11 49.68 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.241 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.48 149.24 2.84 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 179.59 -38.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.917 0.389 . . . . 0.0 110.169 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 95.6 t -75.77 133.53 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.363 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.5 t -137.73 161.25 37.01 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.655 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.5 m 65.22 165.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.591 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -74.69 -2.86 28.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.606 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 57.11 40.82 28.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.408 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.4 m -62.2 134.42 56.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.292 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -113.44 91.71 20.98 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.112 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -87.45 114.07 0.97 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.441 2.094 . . . . 0.0 111.446 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -75.44 -95.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.602 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.8 p -66.95 -35.26 79.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.876 0.369 . . . . 0.0 110.478 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -160.62 -47.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.183 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.479 ' CG ' ' H ' ' A' ' 181' ' ' ASP . 12.8 p-10 -150.12 -68.44 0.2 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.358 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 182' ' ' TYR . 32.8 t70 47.39 -177.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.512 ' H ' ' CG ' ' A' ' 181' ' ' ASP . 99.0 m-85 -113.11 146.17 39.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.456 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 185' ' ' ASN . 29.7 pt20 -63.46 -37.59 87.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.986 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 26.9 t 49.01 -94.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.661 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 183' ' ' GLN . 99.5 m-20 -81.83 107.74 14.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.362 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 26.6 t -74.43 -91.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.855 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 94.1 mt -130.06 128.56 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.945 0.402 . . . . 0.0 111.043 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -154.88 -24.51 0.12 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.03 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 51.25 72.5 0.36 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.67 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.4 p -133.04 154.87 40.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -119.33 117.96 3.8 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.22 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 7.8 tt -145.34 127.81 15.99 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -171.73 -163.16 25.21 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.305 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.79 138.37 49.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.47 0.653 . . . . 0.0 110.929 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 67.4 mt -113.51 130.63 67.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -138.16 154.46 49.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.743 0.782 . . . . 0.0 112.849 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 172.32 -171.93 44.55 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.66 135.67 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.213 0.53 . . . . 0.0 110.231 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -96.05 113.15 4.58 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -116.0 117.68 30.82 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 201' ' ' ASP . 58.9 p30 -57.92 150.29 20.8 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 206' ' ' LEU . 21.5 mm -113.33 -60.63 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.567 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -106.42 176.88 1.49 Allowed Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 174.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.567 ' C ' ' O ' ' A' ' 203' ' ' THR . 15.9 Cg_exo -14.93 -81.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.485 0.974 0 CA-C-N 122.909 2.075 . . . . 0.0 113.746 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 237' ' ' ARG . 97.3 mttt -126.73 28.08 5.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.514 0.674 . . . . 0.0 110.761 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 202' ' ' ILE . 2.9 tt -85.8 112.67 21.31 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.4 p -103.93 149.8 24.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -172.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 208' ' ' LEU . 0.4 OUTLIER -104.36 106.07 16.44 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 101.695 -3.446 . . . . 0.0 101.695 173.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -104.09 130.37 51.79 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -174.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -122.14 144.19 49.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.348 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.44 -163.88 32.12 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.0 147.11 46.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -105.18 119.01 38.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.796 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -120.89 163.5 18.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.285 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -124.91 -172.76 2.64 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 216' ' ' ASN . 49.9 t-20 -56.39 -40.21 74.26 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.496 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -108.83 147.11 32.59 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.855 0.359 . . . . 0.0 110.61 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -66.78 -133.93 0.03 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -85.46 132.08 34.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.908 0.385 . . . . 0.0 110.474 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 220' ' ' LEU . 3.5 mm? -63.49 -42.96 98.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.909 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -144.11 124.77 14.09 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.744 0.307 . . . . 0.0 110.861 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -100.87 104.68 15.91 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.31 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.91 -17.85 1.22 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.83 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -138.6 151.12 46.98 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.89 0.376 . . . . 0.0 110.68 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -105.36 115.76 30.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.498 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -158.21 108.56 2.12 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.533 ' OG1' ' N ' ' A' ' 228' ' ' HIS . 1.6 t -165.28 -120.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.492 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.533 ' N ' ' OG1' ' A' ' 227' ' ' THR . 86.4 t60 52.97 6.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.758 0.314 . . . . 0.0 110.384 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 227' ' ' THR . 97.3 mt-10 -54.43 -176.14 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.207 0.527 . . . . 0.0 110.186 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -165.8 84.78 0.34 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.7 p -154.2 167.23 30.58 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 122.012 0.91 . . . . 0.0 112.442 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.61 -57.36 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.567 -1.651 . . . . 0.0 107.143 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 153.4 -166.8 31.79 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.869 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.25 130.64 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.681 ' NH1' HH22 ' A' ' 66' ' ' ARG . 71.2 mtp180 -128.59 142.85 50.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.287 0.565 . . . . 0.0 111.555 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.499 ' O ' ' CD2' ' A' ' 236' ' ' TYR . 5.5 t80 -106.28 106.49 17.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.764 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.563 ' NE ' ' OD2' ' A' ' 61' ' ' ASP . 71.7 ttt180 -133.75 128.63 35.26 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.0 t80 . . . . . 0 C--O 1.222 -0.381 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.847 179.733 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 p -156.6 163.58 39.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.48 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.44 129.83 42.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.532 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -155.22 175.16 14.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.402 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.23 -141.6 0.18 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.49 -109.5 2.82 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.04 154.02 39.03 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.84 -165.6 38.94 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 118.756 -1.687 . . . . 0.0 114.617 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.72 157.43 27.97 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 124.679 3.586 . . . . 0.0 115.354 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -150.62 165.6 32.85 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.831 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.18 139.27 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -124.81 145.65 49.65 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.58 0.705 . . . . 0.0 112.473 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.77 151.0 34.05 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.998 -1.455 . . . . 0.0 108.476 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 15' ' ' LEU . 38.4 t0 -142.33 144.06 33.04 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.577 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 92.0 mt -126.94 143.69 51.21 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.684 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.62 -89.89 0.43 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.055 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -148.89 157.93 43.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.539 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.48 151.21 37.01 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.259 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -142.17 140.67 32.47 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.973 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -79.8 106.32 11.74 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -74.98 -69.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.298 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.6 mt -122.03 133.2 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.779 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.0 m -111.73 130.6 55.74 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.999 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -58.22 -44.78 88.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.275 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 55.15 75.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.625 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 54.4 77.27 0.45 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.96 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.45 146.4 27.63 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.128 1.885 . . . . 0.0 111.734 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 13.5 pt-20 -177.8 54.73 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 28' ' ' GLU . 95.6 Cg_endo -74.08 152.88 46.27 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.797 2.331 . . . . 0.0 112.167 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.0 p -99.5 116.73 32.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.258 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -173.84 57.31 0.2 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.554 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.82 -20.55 58.57 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.477 2.118 . . . . 0.0 111.811 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 33' ' ' ASN . 43.6 p-10 -78.34 120.4 23.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -131.91 144.85 51.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.86 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.46 ' CG ' ' H ' ' A' ' 36' ' ' LYS . 19.3 t-20 -127.69 -124.07 0.23 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.575 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.46 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 88.7 tttt 57.68 90.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.803 0.335 . . . . 0.0 110.538 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mm -108.54 125.65 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.16 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.0 m -81.0 -95.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.518 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.4 m -158.11 -57.94 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.598 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 40' ' ' VAL . 33.7 m -89.51 130.22 39.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.484 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -78.46 -149.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.571 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 40.27 86.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -146.41 155.31 42.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.451 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.425 ' H ' ' H ' ' A' ' 45' ' ' ARG . 87.8 t80 -160.29 -12.6 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.379 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.447 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 99.9 mtt180 -76.73 136.62 39.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.272 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 28.8 m120 -157.36 120.15 3.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.78 0.324 . . . . 0.0 111.048 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 47' ' ' ILE . 9.7 tp -142.11 131.54 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.123 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.9 ttp85 -124.77 102.25 7.48 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.936 0.398 . . . . 0.0 110.305 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.1 m -133.81 132.58 40.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 51' ' ' SER . 42.2 ttm180 -142.0 87.02 2.01 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.069 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 50' ' ' ARG . 1.2 t 54.94 113.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.017 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -110.28 -5.4 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.204 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.0 m80 55.54 64.42 5.49 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.003 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -95.9 84.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.087 2.525 . . . . 0.0 112.777 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.27 118.19 31.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.203 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 57' ' ' SER . 74.9 t -139.37 159.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.381 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.484 ' N ' HG12 ' A' ' 56' ' ' VAL . 5.1 m -141.7 141.66 33.32 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.486 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.62 137.49 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.094 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.22 -175.65 32.47 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.037 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -96.97 137.51 35.94 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.977 0.418 . . . . 0.0 111.73 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.531 ' OD1' ' NH2' ' A' ' 66' ' ' ARG . 34.3 t70 -101.37 115.07 29.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.37 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -124.56 120.69 32.66 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.497 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.0 107.24 0.44 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.32 -60.98 0.59 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 65' ' ' TRP . 8.7 p-90 -157.98 150.68 22.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.937 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.628 ' NH1' ' NH1' ' A' ' 235' ' ' ARG . 9.3 ptp85 -135.66 167.23 21.51 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.887 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.2 pt -145.22 143.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.193 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.86 145.51 29.88 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.15 0.5 . . . . 0.0 110.71 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.17 127.28 38.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.403 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -98.18 127.56 44.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.558 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 45.2 p90 -139.88 166.24 25.15 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.846 0.831 . . . . 0.0 112.848 -177.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 71' ' ' TYR . . . 145.59 42.17 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 113.001 -1.909 . . . . 0.0 108.6 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -78.95 172.35 13.92 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.578 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 76' ' ' LYS . 92.8 m-85 -62.08 -34.0 75.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.127 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 55.35 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 74' ' ' TYR . 58.2 tttm -134.77 126.18 28.43 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 110.51 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.524 ' O ' ' ND2' ' A' ' 78' ' ' ASN . 21.0 t-105 -77.34 -76.65 0.17 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.566 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 77' ' ' TRP . 14.3 m120 -149.75 137.67 20.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.583 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 80' ' ' ASN . 20.6 p30 -68.08 -33.61 74.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.632 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 62.4 t-20 -85.37 109.36 18.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.342 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 82' ' ' TYR . 53.9 mtmt -88.17 109.54 19.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.885 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 81' ' ' LYS . 96.2 m-85 53.49 163.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.19 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.4 m -71.91 153.02 42.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.273 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 86' ' ' ILE . 96.9 t -88.58 114.85 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.114 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 42.59 -91.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.706 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 84' ' ' VAL . 44.4 pt -129.47 160.51 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 120.845 0.355 . . . . 0.0 110.791 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.51 -20.0 65.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.636 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 59.93 98.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -109.42 131.56 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.79 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -48.78 -76.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.297 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 91' ' ' ILE . 7.0 tp -149.54 105.39 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.981 0.42 . . . . 0.0 110.587 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -135.92 138.59 42.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.11 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -95.31 -50.41 5.04 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.267 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -171.36 115.25 0.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.809 0.338 . . . . 0.0 110.84 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -63.78 -41.05 98.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.693 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 97' ' ' ILE . . . 80.98 165.48 33.98 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 96' ' ' GLY . 9.7 mm 45.13 97.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 110.443 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -112.63 84.93 2.06 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.031 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.34 -43.88 94.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.273 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.8 t0 64.07 112.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.971 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 103' ' ' THR . 33.5 ttp180 -161.11 -140.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.827 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? 60.57 -70.36 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.678 0.275 . . . . 0.0 110.535 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.546 ' N ' ' O ' ' A' ' 101' ' ' ARG . 61.5 p -64.74 -30.89 71.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -51.95 136.54 28.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.204 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -71.55 -99.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.715 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 44.52 83.39 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.135 0.493 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -138.18 147.57 43.98 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.12 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.433 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 46.5 p30 -78.46 79.03 4.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.68 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.08 123.75 0.6 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.487 ' HG1' ' HD2' ' A' ' 111' ' ' PHE . 3.9 t -137.95 156.81 47.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.723 0.297 . . . . 0.0 110.204 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.487 ' HD2' ' HG1' ' A' ' 110' ' ' THR . 87.2 m-85 37.31 90.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.241 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 99.5 m-70 -85.33 55.79 3.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.402 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 112' ' ' HIS . . . 66.25 159.16 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.698 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.61 132.87 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.86 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.9 p -119.28 19.51 12.79 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.944 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.6 m 54.94 175.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp -139.99 162.51 35.02 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 170.32 -109.72 0.34 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 119.644 -1.265 . . . . 0.0 111.99 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.28 147.63 41.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.292 0.567 . . . . 0.0 110.748 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.3 p -150.81 141.38 22.58 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.68 149.05 32.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.815 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 3.4 pt -144.36 114.45 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.587 ' CZ ' HG23 ' A' ' 135' ' ' ILE . 34.2 p90 -90.43 141.91 28.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.575 ' OD1' ' NH1' ' A' ' 66' ' ' ARG . 62.7 m-20 -89.84 115.84 27.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 113.387 -1.733 . . . . 0.0 108.143 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.476 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 87.8 t80 -118.13 121.8 41.44 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.464 ' CB ' ' O ' ' A' ' 125' ' ' PHE . 1.4 mm100 147.96 177.33 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.53 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 127' ' ' ILE . 93.0 mt -70.21 -1.46 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.753 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 70.9 36.55 1.46 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.632 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.46 -60.39 1.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.889 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -129.06 -48.31 1.22 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.572 ' CD2' ' CE1' ' A' ' 200' ' ' PHE . 1.0 OUTLIER -148.32 146.58 28.61 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.145 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.476 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -134.74 141.82 40.09 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.337 177.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.56 107.96 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 N-CA-C 108.007 -1.574 . . . . 0.0 108.007 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -81.85 131.02 35.25 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.981 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.587 HG23 ' CZ ' ' A' ' 123' ' ' TYR . 2.5 tt -161.83 149.51 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.832 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.69 -144.88 6.25 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.092 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -127.43 164.14 22.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.69 ' NH2' HH21 ' A' ' 213' ' ' ARG . 41.7 ttm180 -125.17 133.89 52.62 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.096 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.88 121.71 61.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.27 146.17 44.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.138 0.494 . . . . 0.0 110.98 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -131.27 160.97 33.35 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.698 0.761 . . . . 0.0 111.661 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.35 47.96 0.48 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -52.09 -13.18 0.28 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.011 -0.594 . . . . 0.0 112.145 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.3 t -71.04 157.94 6.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.171 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.529 ' O ' ' ND1' ' A' ' 146' ' ' HIS . 35.1 ttm180 65.3 154.25 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.276 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.529 ' ND1' ' O ' ' A' ' 145' ' ' ARG . 54.3 p-80 42.77 40.4 2.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.905 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.8 t -64.61 -17.67 64.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.093 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 31.5 pt -68.03 -131.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.691 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.6 t0 64.26 45.42 3.93 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.672 0.272 . . . . 0.0 111.201 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.8 p -64.11 -65.92 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.871 0.367 . . . . 0.0 110.145 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 60.5 p -138.75 155.97 47.75 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.395 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -139.83 151.22 45.54 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.632 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -75.06 146.92 41.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.297 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 92.4 m -121.02 127.27 51.59 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.915 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 155' ' ' ILE . 9.1 tp -140.62 131.48 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.081 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -174.27 -34.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.811 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.89 132.06 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.923 0.392 . . . . 0.0 110.257 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 2.9 t -132.22 153.58 50.46 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.282 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.1 t -63.1 133.44 54.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.984 0.421 . . . . 0.0 110.727 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 160' ' ' VAL . 4.1 m -84.39 153.89 62.43 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.877 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -39.23 139.25 0.6 Allowed 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 121.893 1.729 . . . . 0.0 111.999 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.3 p -81.68 -8.86 59.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.079 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -138.33 113.51 9.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.958 0.409 . . . . 0.0 110.884 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.684 ' HB1' ' CD ' ' A' ' 165' ' ' PRO . . . -172.01 -178.19 0.44 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.483 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.684 ' CD ' ' HB1' ' A' ' 164' ' ' ALA . 28.7 Cg_exo -60.61 142.24 97.35 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.104 1.869 . . . . 0.0 111.745 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -64.92 -40.33 94.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.795 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.67 -167.27 48.19 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -152.62 151.56 30.76 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.951 0.405 . . . . 0.0 110.751 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.42 141.08 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.335 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 171' ' ' THR . 1.9 m -147.51 -138.77 0.09 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.389 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.546 ' H ' HG22 ' A' ' 170' ' ' THR . 23.4 p 51.91 171.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.794 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -105.65 140.98 37.88 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.712 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 52.9 p30 -90.95 4.12 52.8 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.291 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 21.3 p 46.01 -119.51 0.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.032 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -111.36 154.38 43.74 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -40.57 125.38 2.01 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.645 1.563 . . . . 0.0 111.798 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.98 -42.02 94.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.162 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 86.9 m 45.07 79.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.384 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -117.86 -98.15 0.45 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.36 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 56.53 34.4 24.28 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.64 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -97.4 7.79 45.85 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.599 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -44.59 161.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.637 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -45.26 113.61 0.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.802 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 39.9 t -155.87 152.58 28.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.655 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.661 HD22 ' N ' ' A' ' 185' ' ' ASN . 0.0 OUTLIER -152.11 171.1 18.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.233 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 41.5 t -67.63 125.33 25.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 110.725 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.924 ' H ' HD12 ' A' ' 187' ' ' ILE . 3.1 mp -67.44 -45.03 86.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.747 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.82 140.77 29.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.807 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -81.4 84.43 6.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.331 0.586 . . . . 0.0 111.157 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 191' ' ' GLY . 54.9 t -121.35 162.4 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 190' ' ' VAL . . . -137.58 135.74 7.78 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.162 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.4 tp -142.61 131.05 22.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -164.02 -160.93 12.32 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.39 153.25 35.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.986 0.898 . . . . 0.0 111.228 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.6 tt -124.67 134.04 67.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 113.622 -1.626 . . . . 0.0 108.733 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -157.67 156.15 31.25 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 119.634 -0.827 . . . . 0.0 112.454 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 169.06 -171.41 42.96 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.16 135.54 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.517 0.659 . . . . 0.0 111.034 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -116.35 129.9 8.71 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.968 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.572 ' CE1' ' CD2' ' A' ' 131' ' ' PHE . 56.7 m-85 -104.29 109.52 21.39 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.704 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.26 121.6 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 124.662 1.226 . . . . 0.0 110.171 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 202' ' ' ILE . 42.7 mm -126.57 3.8 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 123.385 1.564 . . . . 0.0 108.635 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.778 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.2 OUTLIER -156.59 73.33 4.81 Favored Pre-proline 0 N--CA 1.425 -1.714 1 N-CA-C 98.664 -4.569 . . . . 0.0 98.664 178.138 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER 1.06 -41.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.826 1 C-N-CA 126.111 4.541 . . . . 0.0 116.747 -170.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.778 ' N ' ' O ' ' A' ' 203' ' ' THR . 61.9 pttt -96.73 0.08 49.01 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.623 HD23 ' C ' ' A' ' 206' ' ' LEU . 5.9 tt -109.07 106.67 16.69 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 8.4 t -141.61 140.73 33.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 119.257 -0.977 . . . . 0.0 113.011 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.26 116.67 30.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.422 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -97.22 123.3 40.96 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.371 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -117.31 124.43 48.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -170.15 -173.54 37.59 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 118.946 -1.597 . . . . 0.0 112.705 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -133.79 148.24 51.34 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.69 HH21 ' NH2' ' A' ' 138' ' ' ARG . 84.0 mtp180 -127.05 129.27 47.7 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -152.75 157.34 40.7 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.199 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.533 ' ND1' ' N ' ' A' ' 215' ' ' HIS . 0.0 OUTLIER -151.79 165.49 34.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.191 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.528 ' OD1' ' CD2' ' A' ' 217' ' ' TRP . 14.5 p30 44.55 17.99 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.022 0.439 . . . . 0.0 110.411 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.528 ' CD2' ' OD1' ' A' ' 216' ' ' ASN . 1.9 m-90 -146.75 157.64 43.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.751 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 142.02 -13.92 2.6 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -102.26 144.69 30.47 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.929 0.395 . . . . 0.0 110.912 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 220' ' ' LEU . 10.0 mp -84.12 -0.27 51.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.244 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.69 -38.34 84.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.533 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 222' ' ' ASN . 44.0 p-10 -156.69 90.6 1.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 111.101 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 81.0 p -83.61 72.84 10.29 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.107 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -64.37 -44.04 92.64 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.446 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -164.13 136.34 4.85 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.694 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 228' ' ' HIS . 63.0 tttp -148.14 -79.28 0.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.317 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 226' ' ' LYS . 1.8 p 30.59 38.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.873 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.505 ' CE1' ' H ' ' A' ' 213' ' ' ARG . 51.4 t-80 -70.22 122.79 20.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 110.42 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -86.68 160.11 18.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.534 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.14 140.74 58.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.388 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.413 ' C ' HD12 ' A' ' 232' ' ' LEU . 5.7 p -115.76 140.16 49.48 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 232' ' ' LEU . 10.9 mp -107.42 131.94 53.73 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -126.79 152.03 18.38 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.474 -0.393 . . . . 0.0 112.229 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.0 p -126.86 131.45 71.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.628 ' NH1' ' NH1' ' A' ' 66' ' ' ARG . 60.3 ttp180 -130.67 143.45 50.76 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -91.93 126.76 37.14 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 112.93 -1.941 . . . . 0.0 106.441 176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.574 ' H ' ' CA ' ' A' ' 205' ' ' LYS . 1.4 tmm_? -147.13 109.5 4.54 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 122.452 1.12 . . . . 0.0 111.701 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 C--O 1.22 -0.484 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.596 -179.712 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 2' ' ' SER . 8.8 p 59.08 101.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.566 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -132.76 -33.38 1.2 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.392 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.6 143.94 53.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.678 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.56 -135.59 4.0 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.67 -35.17 91.5 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -64.26 136.02 56.78 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.27 -94.94 0.9 Allowed Glycine 0 CA--C 1.537 1.459 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.78 129.2 22.78 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.806 1.671 . . . . 0.0 114.206 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -162.26 166.57 25.23 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.608 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 12' ' ' GLN . 40.9 t -128.86 157.24 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.473 ' N ' HG12 ' A' ' 11' ' ' VAL . 32.0 tp60 -135.32 143.79 46.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.775 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.89 149.2 29.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.128 0.489 . . . . 0.0 111.293 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 39.0 p-10 -105.17 120.57 41.85 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.995 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.2 mt -118.63 141.5 48.54 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.998 0.428 . . . . 0.0 111.07 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.89 -72.95 0.44 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.186 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.457 ' CD2' ' N ' ' A' ' 18' ' ' ALA . 85.7 t80 -163.67 -83.32 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.454 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.457 ' N ' ' CD2' ' A' ' 17' ' ' TYR . . . -172.34 158.11 4.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.566 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -95.08 132.86 39.51 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.4 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -85.34 -179.12 6.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.044 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 75.5 m80 39.86 -122.94 0.39 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.152 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.2 tt -140.68 145.65 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.53 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 p -76.62 170.21 16.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.684 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.442 ' O ' ' ND1' ' A' ' 24' ' ' HIS . 0.2 OUTLIER -58.17 133.49 55.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.526 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.99 -39.48 94.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.978 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.676 ' H ' ' CD ' ' A' ' 27' ' ' PRO . 1.5 t80 -168.7 -40.68 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.312 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.676 ' CD ' ' H ' ' A' ' 26' ' ' TYR . 22.3 Cg_exo -64.51 146.37 89.2 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.38 2.054 . . . . 0.0 111.823 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -176.93 76.21 0.25 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.931 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.45 141.33 97.32 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.374 2.049 . . . . 0.0 111.554 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.9 p -69.37 -35.26 75.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.795 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.549 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -179.15 -45.07 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.342 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 31' ' ' ALA . 35.4 Cg_exo -60.49 143.45 99.46 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.47 2.113 . . . . 0.0 111.861 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 11.3 p-10 -156.18 -58.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.67 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -101.73 150.01 23.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.842 0.353 . . . . 0.0 110.351 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.454 ' OD1' ' N ' ' A' ' 35' ' ' ASN . 11.4 p-10 -72.5 -10.61 60.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.639 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -78.15 142.33 38.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.172 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.9 mt -106.37 117.26 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.139 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.7 p -79.19 152.2 30.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.904 0.383 . . . . 0.0 110.89 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.6 m -98.58 -42.73 7.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.506 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.48 ' C ' ' H ' ' A' ' 42' ' ' ASP . 5.7 p -143.14 -22.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.496 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.43 ' C ' ' N ' ' A' ' 43' ' ' TYR . 1.9 m 62.51 -2.38 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.982 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 43' ' ' TYR . 98.9 m-20 50.48 13.96 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.607 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 42' ' ' ASP . 76.7 m-85 -158.67 85.79 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.385 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -75.2 -19.65 59.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.184 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 47' ' ' ILE . 35.1 ttm180 62.14 35.03 15.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.629 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 39.15 -96.2 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.738 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 45' ' ' ARG . 40.5 pt -113.94 -167.8 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.955 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -138.83 142.82 38.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 0.0 110.611 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.6 m -125.33 7.43 7.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.544 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -62.41 -40.42 96.46 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.529 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.8 t -154.01 99.16 2.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.178 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.4 m -101.52 2.29 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 61.57 109.77 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.745 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.12 130.53 35.56 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.119 1.213 . . . . 0.0 110.522 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -92.95 152.77 19.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.761 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 57' ' ' SER . 12.5 p -138.73 154.25 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.156 0.503 . . . . 0.0 111.75 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.475 ' N ' HG22 ' A' ' 56' ' ' VAL . 26.5 t -142.9 143.55 32.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.201 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 p -135.28 151.23 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.76 174.56 42.77 Favored Glycine 0 C--O 1.241 0.561 0 C-N-CA 118.302 -1.904 . . . . 0.0 114.191 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.99 138.44 34.52 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 113.446 -1.377 . . . . 0.0 108.161 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -116.72 102.82 9.75 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.41 ' O ' ' C ' ' A' ' 63' ' ' GLY . 78.3 m-85 -107.65 127.53 53.74 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 175.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -41.16 103.9 0.04 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 120.012 -1.089 . . . . 0.0 110.744 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.05 -83.92 0.19 Allowed Glycine 0 C--N 1.343 0.968 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.447 ' CD1' ' N ' ' A' ' 65' ' ' TRP . 2.1 p-90 -133.23 172.92 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.127 0.464 . . . . 0.0 111.433 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.855 HH21 HD13 ' A' ' 122' ' ' ILE . 50.6 ttp180 -125.1 151.61 45.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.452 ' N ' ' HG2' ' A' ' 66' ' ' ARG . 91.3 mt -108.37 129.7 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -141.62 145.64 35.26 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.63 149.5 49.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 113.606 -1.634 . . . . 0.0 106.667 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 4.1 p-10 -148.92 153.47 38.05 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 119.272 -0.971 . . . . 0.0 113.201 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -108.38 143.05 37.83 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 113.835 -1.529 . . . . 0.0 109.156 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -156.34 4.73 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.982 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -89.32 157.23 18.27 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 110.571 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -76.09 142.47 41.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.411 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -91.5 115.29 27.91 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.087 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.94 -42.99 89.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.963 0.411 . . . . 0.0 110.372 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.731 ' HE1' HD22 ' A' ' 79' ' ' ASN . 56.0 t-105 39.74 86.34 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.209 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.444 ' C ' ' H ' ' A' ' 80' ' ' ASN . 60.9 m-80 -63.49 -40.38 96.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.819 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.731 HD22 ' HE1' ' A' ' 77' ' ' TRP . 17.3 t-20 61.7 2.67 0.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.35 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' H ' ' C ' ' A' ' 78' ' ' ASN . 11.1 m120 -109.22 114.89 28.99 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.691 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -77.42 142.6 39.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.098 0.475 . . . . 0.0 110.671 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 9.6 p90 -143.79 -134.86 0.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.028 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 0.8 OUTLIER 82.78 12.33 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.032 0.444 . . . . 0.0 109.955 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.71 -43.25 96.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.697 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.3 t30 67.31 87.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.957 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -110.53 104.03 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.048 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.38 -37.39 74.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.021 0.439 . . . . 0.0 109.962 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 56.84 40.07 29.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.731 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.54 -35.44 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.286 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' ILE . 94.1 mtt180 -72.88 146.04 46.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.442 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.451 ' O ' ' O ' ' A' ' 90' ' ' ARG . 88.7 mt 56.28 116.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.565 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 93' ' ' LYS . 83.3 mtp180 -64.88 -42.58 94.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.779 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 92' ' ' ARG . 87.2 tttt 53.22 105.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 96' ' ' GLY . 18.4 pt-20 -65.27 -41.83 93.81 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.578 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 52.09 40.02 27.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.676 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.406 ' H ' ' HG3' ' A' ' 94' ' ' GLU . . . 70.04 151.81 0.67 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.7 pt -77.92 -21.93 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.784 0.326 . . . . 0.0 110.678 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 99' ' ' ILE . 99.8 mtt180 -78.18 145.51 35.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.744 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 98' ' ' ARG . 17.5 mm 46.54 97.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.423 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -80.35 -87.19 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.698 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -97.17 133.48 41.75 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.395 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -134.7 27.23 3.66 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.556 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 59.1 p -65.06 -32.37 74.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.316 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 54.86 59.7 3.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.637 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -90.48 8.81 31.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.888 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.43 -40.64 91.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.786 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.65 150.81 27.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.998 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 56.56 42.25 27.48 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.291 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.86 -121.15 2.16 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 111' ' ' PHE . 67.3 p -82.15 165.05 20.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.07 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 110' ' ' THR . 89.3 m-85 56.73 147.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.23 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 60.4 m170 -83.34 137.4 33.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.638 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -147.44 134.63 20.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.1 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.73 160.5 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.661 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 116' ' ' SER . 66.1 m -116.28 97.37 6.01 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.658 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 115' ' ' SER . 1.4 m 57.73 140.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.67 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -142.72 124.69 15.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.868 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -102.09 124.59 8.25 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -143.01 135.65 27.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 117.6 0.7 . . . . 0.0 109.802 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.8 m -154.81 151.99 29.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.432 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.678 ' C ' HD12 ' A' ' 122' ' ' ILE . . . -118.18 125.89 51.11 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.855 HD13 HH21 ' A' ' 66' ' ' ARG . 1.7 mp -119.96 154.56 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.542 0.687 . . . . 0.0 112.232 -176.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -103.12 110.35 22.27 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.184 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -108.5 122.49 47.15 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -91.36 81.56 5.45 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.49 0.662 . . . . 0.0 109.417 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -67.71 -18.27 64.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.203 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.0 pt -67.91 -30.46 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.812 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 131' ' ' PHE . 11.5 m120 -70.66 121.53 18.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 129' ' ' ASP . 67.8 t0 -63.97 -41.85 97.42 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -105.37 -18.95 13.95 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 20.8 p90 -158.2 133.87 8.99 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.289 1.404 . . . . 0.0 114.368 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -118.09 103.64 49.54 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.0 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.602 ' HA ' HG22 ' A' ' 198' ' ' VAL . 24.8 Cg_exo -63.57 123.14 11.56 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 15.3 p90 -106.58 133.46 51.22 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.093 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.9 tt -145.76 147.53 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.109 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.45 -171.85 37.69 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 119.69 -1.243 . . . . 0.0 113.605 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.53 136.98 39.56 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 20.1 ttt-85 -124.98 120.89 32.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.38 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.17 135.6 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.942 0.877 . . . . 0.0 112.11 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.25 124.9 50.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.029 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -129.46 144.84 51.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.096 0.474 . . . . 0.0 111.933 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -178.24 -164.42 31.33 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 47.73 -139.76 0.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.61 149.35 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.725 0.297 . . . . 0.0 110.438 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 -59.9 -42.82 94.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.87 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -79.48 68.38 5.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.044 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.411 ' OG ' ' NE ' ' A' ' 189' ' ' ARG . 25.7 t -80.54 162.08 24.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.621 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 148' ' ' ILE . 21.2 tt -96.49 129.68 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.135 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -86.3 98.67 11.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.581 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.9 m -60.85 -42.19 97.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.402 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 93.4 m -123.61 129.36 51.05 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.341 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -75.77 139.45 41.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.614 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -95.53 -3.24 46.97 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.545 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 155' ' ' ILE . 8.7 m 58.08 163.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.838 0.351 . . . . 0.0 110.579 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.457 ' N ' HG22 ' A' ' 154' ' ' THR . 19.2 tt -130.42 134.54 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.525 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 58.21 102.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.671 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.17 161.57 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.385 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.73 123.94 44.99 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.215 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 24.1 m -66.92 135.14 53.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.871 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.9 t -56.33 132.21 75.97 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.705 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.12 156.69 46.94 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.078 1.852 . . . . 0.0 112.118 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.0 m -65.86 105.03 1.2 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.459 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 164' ' ' ALA . 52.9 t30 -160.74 -87.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.663 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . 59.21 150.19 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.41 147.9 59.68 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.052 1.835 . . . . 0.0 111.776 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -84.65 139.17 32.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.605 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -160.05 -94.59 0.1 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 169' ' ' VAL . . . -67.44 143.34 56.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.748 0.309 . . . . 0.0 110.538 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 168' ' ' ALA . 4.9 t 59.65 138.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.613 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 87.3 m -62.53 -45.67 91.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 95.8 m -121.4 129.1 52.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.49 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 172' ' ' TYR . 53.2 p90 -84.94 130.33 34.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.751 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -117.5 119.21 34.36 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.283 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 179.38 78.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.328 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -57.1 110.57 2.52 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.309 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.24 159.73 17.65 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.099 1.866 . . . . 0.0 111.755 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 178' ' ' THR . 98.6 mttt -142.71 -75.75 0.27 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.904 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 177' ' ' LYS . 2.6 p 36.77 51.21 0.91 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.275 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -69.73 138.6 52.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.566 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -82.47 136.02 35.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.788 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 181' ' ' ASP . 40.4 p30 -152.55 82.17 1.23 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.724 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 181' ' ' ASP . 63.0 t80 44.0 98.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.93 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -159.23 105.94 1.74 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.483 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.3 p -152.59 129.52 11.0 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.821 0.343 . . . . 0.0 110.776 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 53.64 41.13 32.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.612 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 188' ' ' ARG . 14.2 p -64.54 -89.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.762 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.7 mt 67.07 -36.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.725 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 186' ' ' SER . 61.9 ttt85 52.35 82.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.361 . . . . 0.0 111.954 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.411 ' NE ' ' OG ' ' A' ' 147' ' ' SER . 78.0 mtp85 -109.51 -2.15 17.82 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 33.5 m -135.96 161.49 37.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.375 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -130.93 150.58 19.4 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.929 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.4 pp -168.2 136.72 2.32 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.661 0.743 . . . . 0.0 112.618 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -169.41 -140.54 2.99 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.49 164.31 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.483 0.658 . . . . 0.0 111.763 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.7 tt -129.84 138.09 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.549 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.455 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . -152.74 164.23 38.17 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.477 ' O ' ' CD2' ' A' ' 134' ' ' TYR . . . 155.47 170.6 21.14 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.062 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 133' ' ' PRO . 59.8 t -131.29 138.41 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 117.274 0.537 . . . . 0.0 111.804 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -105.46 134.02 11.87 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -131.29 105.82 7.89 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.79 153.27 33.01 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -175.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 66.6 mt -113.18 -10.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 123.298 1.523 . . . . 0.0 107.888 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.699 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.5 m -166.75 103.5 0.65 Allowed Pre-proline 0 C--N 1.3 -1.562 1 N-CA-C 99.445 -4.28 . . . . 0.0 99.445 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.466 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -11.56 -42.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 123.557 2.838 . . . . 0.0 115.63 -172.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 203' ' ' THR . 13.6 pttm -77.87 -34.72 51.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 203' ' ' THR . 50.5 tp -83.93 105.76 15.07 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.2 m -128.61 131.28 48.12 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 208' ' ' LEU . 10.0 mp -96.8 141.57 29.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -134.67 144.77 48.0 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.012 0.911 . . . . 0.0 113.335 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -101.86 113.08 25.95 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -152.58 157.56 27.35 Favored Glycine 0 N--CA 1.462 0.387 0 C-N-CA 118.556 -1.783 . . . . 0.0 113.895 -176.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -169.31 163.91 10.79 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.645 ' N ' ' NE ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -124.48 154.15 40.96 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.932 0.396 . . . . 0.0 110.129 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -142.78 133.51 25.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.94 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -74.59 144.91 43.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.174 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -93.22 107.48 19.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.158 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -151.63 -18.1 0.19 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.178 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 219' ' ' ARG . . . 84.01 16.17 68.09 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 221' ' ' GLU . 25.8 ptt180 11.84 -110.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.5 mp 62.55 -65.91 0.09 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.46 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 219' ' ' ARG . 44.3 tt0 -46.68 -38.84 10.41 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.581 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.47 HD21 ' CB ' ' A' ' 219' ' ' ARG . 10.1 p30 -91.16 111.05 22.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.915 0.388 . . . . 0.0 110.858 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.4 p -85.75 169.43 13.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.856 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 57.74 -164.48 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.877 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.531 ' O ' ' CD2' ' A' ' 225' ' ' PHE . 72.1 t80 55.49 28.66 12.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.17 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.463 ' O ' ' ND1' ' A' ' 228' ' ' HIS . 69.0 mttm -76.49 -15.87 59.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.975 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 29.7 m -64.36 129.13 38.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.557 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 226' ' ' LYS . 81.0 m80 -113.8 130.45 56.46 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.198 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 230' ' ' ALA . 81.2 tt0 -67.55 -39.63 84.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.564 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 229' ' ' GLU . . . 62.17 152.81 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 26.9 p -155.24 162.53 40.88 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.164 -1.014 . . . . 0.0 112.326 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 71.1 mt -81.51 148.03 29.39 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.04 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -143.75 137.92 7.77 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.6 145.39 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 117.393 0.597 . . . . 0.0 110.621 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -124.55 142.77 51.09 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.328 0.585 . . . . 0.0 111.063 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -110.34 106.07 15.31 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.431 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.661 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 2.4 tmt_? -114.06 96.13 5.65 Favored 'General case' 0 C--O 1.255 1.37 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 237' ' ' ARG . 72.3 m-85 . . . . . 0 N--CA 1.472 0.661 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.447 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 t 53.96 93.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.658 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -143.17 154.93 44.39 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 110.988 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -71.41 149.31 46.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.276 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.71 111.68 0.51 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.892 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.463 ' C ' ' NH2' ' A' ' 237' ' ' ARG . . . 43.24 -115.49 1.08 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-O 121.101 0.278 . . . . 0.0 112.586 178.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.688 ' N ' ' NH2' ' A' ' 237' ' ' ARG . 84.9 mtm180 -60.46 159.14 10.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.043 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.92 -62.4 0.6 Allowed Glycine 0 CA--C 1.535 1.293 0 CA-C-O 119.699 -0.501 . . . . 0.0 112.118 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.461 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 58.6 Cg_endo -90.74 143.41 3.48 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.896 2.397 . . . . 0.0 113.477 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.608 ' CZ ' ' NH2' ' A' ' 66' ' ' ARG . 1.7 m-85 -159.63 146.59 16.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.21 0.528 . . . . 0.0 112.221 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.3 t -141.19 137.06 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.946 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -135.31 149.49 49.78 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.52 152.17 32.6 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.837 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -107.0 155.43 19.81 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.626 0.25 . . . . 0.0 111.003 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -139.29 128.93 24.55 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.624 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -96.02 76.18 3.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.728 0.299 . . . . 0.0 111.415 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 16' ' ' ALA . 76.3 t80 56.28 155.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.135 0.493 . . . . 0.0 111.405 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 49.63 -148.23 0.29 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.071 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 20' ' ' GLU . 82.6 t80 -153.69 107.38 2.99 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.527 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 19' ' ' TYR . 46.4 tp10 48.64 104.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.707 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -73.06 125.23 27.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.796 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.4 mt -67.27 -43.92 87.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.143 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.3 p -130.57 165.79 22.01 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.884 0.373 . . . . 0.0 110.903 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -70.52 129.48 39.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.674 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -80.14 160.08 25.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.397 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 52.88 73.39 0.95 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.3 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.09 -35.94 83.39 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.967 2.445 . . . . 0.0 112.274 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -121.99 79.11 41.91 Favored Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.937 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.48 9.86 3.94 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.75 2.3 . . . . 0.0 111.726 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.2 m 58.69 84.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.419 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -172.86 77.24 0.42 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.473 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.34 145.75 97.99 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.652 2.235 . . . . 0.0 111.703 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -134.07 80.11 1.85 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.23 -41.3 99.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.24 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 m120 55.54 68.05 0.92 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.955 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -62.35 -43.41 98.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.39 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 38' ' ' SER . 96.7 mt -92.22 -86.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.469 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 37' ' ' ILE . 6.5 p 46.62 104.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.21 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 63.4 p -130.37 155.14 46.87 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.425 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.31 129.2 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.462 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.1 t -63.22 -44.4 95.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.805 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -102.61 132.52 48.65 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.822 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -112.32 10.16 19.94 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.49 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -74.87 145.26 42.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.76 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -71.46 142.17 50.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.378 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -154.39 24.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.671 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.53 ' O ' HG23 ' A' ' 47' ' ' ILE . 21.1 tt -91.9 121.28 42.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.994 0.426 . . . . 0.0 110.114 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.4 ttp-105 -170.77 -45.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.013 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 49' ' ' THR . 6.9 t -79.8 125.14 29.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.307 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -65.63 -41.93 92.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.699 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.523 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 37.1 t -135.27 154.16 51.65 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.841 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.496 ' C ' ' CG ' ' A' ' 53' ' ' HIS . 34.8 m -83.61 -0.29 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.182 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER 64.12 173.98 0.07 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.057 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.66 160.85 3.5 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 122.791 2.327 . . . . 0.0 112.365 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.6 mtm-85 -72.62 156.67 38.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.248 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.76 134.14 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.842 0.353 . . . . 0.0 111.034 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -133.37 143.39 48.91 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.514 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.71 160.33 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.052 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.56 177.04 40.33 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.415 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -121.13 155.65 34.03 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 47.4 t0 -137.72 124.08 20.65 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -177.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 63' ' ' GLY . 16.5 m-85 -116.67 104.83 11.77 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -24.85 97.2 0.01 OUTLIER Glycine 0 CA--C 1.533 1.203 0 CA-C-N 117.718 0.235 . . . . 0.0 113.097 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.18 -13.74 7.93 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 66' ' ' ARG . 15.6 t90 -165.88 136.56 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.012 0.406 . . . . 0.0 110.823 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.608 ' NH2' ' CZ ' ' A' ' 10' ' ' TYR . 14.8 ptp180 -148.17 148.44 30.55 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.843 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.6 pt -108.93 147.71 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.779 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.0 141.35 36.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 110.857 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.88 129.13 25.55 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 24.8 p30 -106.2 143.76 33.87 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.476 0.655 . . . . 0.0 111.906 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.09 146.2 50.02 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.992 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.83 -108.61 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.074 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -138.6 143.02 39.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.712 0.292 . . . . 0.0 110.258 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -73.85 -66.58 0.69 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 56.62 82.96 0.1 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.953 0.406 . . . . 0.0 109.938 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -125.68 146.62 49.66 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.89 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.498 ' CG ' ' O ' ' A' ' 77' ' ' TRP . 26.2 t90 -163.63 14.83 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.807 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -63.33 -41.65 98.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.011 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 39.66 -118.57 0.28 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.964 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.69 38.1 29.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.888 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -59.26 -83.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.178 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.515 ' O ' ' CD2' ' A' ' 82' ' ' TYR . 71.2 t80 -100.53 3.83 43.1 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.961 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 84' ' ' VAL . 38.8 t -62.0 -41.63 98.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.801 0.334 . . . . 0.0 110.444 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 85' ' ' ASN . 86.8 t 56.28 159.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.584 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.516 ' N ' HG12 ' A' ' 84' ' ' VAL . 59.4 t30 -86.38 109.34 18.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.624 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.8 pt -74.53 -20.11 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.779 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -79.17 6.17 10.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.158 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.489 ' N ' ' OD1' ' A' ' 88' ' ' ASN . 10.2 p-10 -44.71 -68.52 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 90' ' ' ARG . 22.9 t 38.33 81.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.934 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 89' ' ' VAL . 84.6 mtt85 55.27 111.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.97 0.414 . . . . 0.0 110.399 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.0 mm -78.01 130.81 35.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.664 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -91.95 141.78 28.26 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.105 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -160.74 125.97 3.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.507 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.44 ' O ' ' O ' ' A' ' 95' ' ' ASN . 8.0 pt-20 -175.21 101.19 0.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.051 0.453 . . . . 0.0 111.15 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 94' ' ' GLU . 99.6 m-20 41.92 -167.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.067 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.21 -81.82 1.29 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.0 mm -66.14 -26.37 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.342 . . . . 0.0 110.568 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 45.76 36.18 2.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.49 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 100' ' ' ASP . 21.7 mt 48.1 -121.65 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.979 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.436 ' N ' HG22 ' A' ' 99' ' ' ILE . 45.5 t0 52.86 168.47 0.01 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.951 0.405 . . . . 0.0 110.981 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.41 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 57.1 ttp180 -72.87 133.96 44.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.381 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -67.82 135.5 52.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.084 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.43 -36.4 8.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.21 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -72.89 -163.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.48 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 107' ' ' GLU . 54.7 t-20 59.46 42.65 17.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.557 ' H ' ' CD ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -65.95 3.69 0.78 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.431 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' A' ' 105' ' ' ASN . 80.0 mm-40 57.13 -92.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.954 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 110' ' ' THR . 18.4 t-20 -90.77 100.23 13.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.876 0.37 . . . . 0.0 110.789 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.65 -34.51 89.15 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 111' ' ' PHE . 69.0 p -75.3 168.9 19.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.805 0.336 . . . . 0.0 110.681 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.455 ' O ' ' O ' ' A' ' 110' ' ' THR . 83.8 m-85 43.12 -171.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.888 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -97.72 -6.12 33.62 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.401 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 62.61 -151.06 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.385 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 t -90.13 87.8 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.322 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.0 p -174.53 78.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.693 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -153.82 137.27 15.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.959 0.409 . . . . 0.0 111.104 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.1 mt -125.09 126.06 44.74 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.878 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 70' ' ' ASP . . . -133.01 115.45 1.57 Allowed Glycine 0 N--CA 1.469 0.847 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.787 ' H ' HD23 ' A' ' 119' ' ' LEU . 1.7 pt? -141.11 153.62 45.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.327 0.563 . . . . 0.0 111.498 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.3 m -146.42 153.58 40.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.065 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.43 125.03 46.66 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 97.3 mt -123.6 152.32 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -111.25 131.94 54.74 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.158 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 15.6 p-10 -132.9 125.25 29.48 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 123.801 0.688 . . . . 0.0 110.813 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.497 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 81.2 m-85 -115.69 80.63 1.47 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -105.07 7.32 33.87 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 110.003 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.591 ' O ' HD13 ' A' ' 127' ' ' ILE . 0.3 OUTLIER -67.84 -28.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -62.08 -49.97 73.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.4 t0 179.16 -102.75 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.287 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -117.77 0.9 12.09 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 10.8 m-85 -113.25 111.28 21.78 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.497 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -133.31 142.7 45.24 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 117.93 0.332 . . . . 0.0 111.066 178.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -91.28 120.13 0.62 Allowed 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 122.36 2.04 . . . . 0.0 109.281 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.594 ' CE1' ' OD2' ' A' ' 209' ' ' ASP . 40.1 p90 -92.02 128.26 37.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.528 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 47.8 mm -134.78 131.99 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.777 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.76 174.84 38.31 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.611 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.37 131.06 55.38 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.95 125.42 50.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.186 0.517 . . . . 0.0 111.089 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.98 139.18 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.122 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.01 137.39 52.16 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.526 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -135.94 137.76 41.66 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.203 0.525 . . . . 0.0 111.19 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 144' ' ' VAL . . . -123.59 143.38 14.96 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -66.03 67.06 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.383 0.592 . . . . 0.0 110.783 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 142' ' ' GLY . 72.3 t -135.53 135.26 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.562 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 40.33 79.15 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.022 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -90.13 -6.99 54.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.433 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 87.6 p -71.34 150.37 45.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.009 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 40.5 pt -126.46 -13.86 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.497 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.33 143.51 48.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.971 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.1 m -84.49 61.2 6.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.377 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.5 m -61.95 -47.56 84.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.597 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -173.44 -2.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.722 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -68.71 -12.45 61.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.504 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 63.3 p -80.45 163.73 23.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.851 0.358 . . . . 0.0 110.576 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 92.3 mt 42.52 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.448 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.03 140.05 32.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.947 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.1 m -121.72 131.27 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.917 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 73.3 p -131.34 153.31 49.74 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.786 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.3 t -147.38 151.52 36.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.39 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.58 118.31 65.32 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.809 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.7 133.84 39.52 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 120.948 1.099 . . . . 0.0 111.599 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 26.3 m -98.15 155.0 17.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.902 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 56.52 43.13 26.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.217 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.407 ' N ' ' CD ' ' A' ' 165' ' ' PRO . . . -170.66 54.61 0.22 Allowed Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.209 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 164' ' ' ALA . 73.3 Cg_endo -72.63 145.21 41.28 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.634 2.223 . . . . 0.0 111.636 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.8 p30 -155.64 -1.82 0.14 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.781 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -82.14 -3.69 90.48 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 61.27 -168.65 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.739 0.304 . . . . 0.0 110.404 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.5 m -77.14 138.56 20.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.587 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.5 t -142.98 159.24 42.62 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.509 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.0 t -72.29 143.72 48.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.985 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -130.03 158.3 39.98 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.584 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 64.8 t30 61.65 24.11 14.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.722 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 20.2 m -64.56 -45.57 86.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.532 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.95 152.31 48.27 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.666 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.64 -156.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.426 2.084 . . . . 0.0 111.475 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.0 -41.1 95.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.704 0.288 . . . . 0.0 110.721 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 10.8 t -96.96 138.3 34.71 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.769 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.466 ' CD ' ' N ' ' A' ' 179' ' ' GLN . 1.5 pm0 -130.82 153.5 49.01 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -90.61 -168.89 2.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.065 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -78.27 -2.91 40.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.916 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.9 t80 70.04 -56.47 0.58 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.664 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -73.9 128.17 34.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.709 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 68.5 m -146.11 149.03 33.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.537 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.33 34.21 22.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.631 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 48.4 t -160.68 92.68 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.804 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.551 ' C ' ' H ' ' A' ' 189' ' ' ARG . 96.3 mt -135.24 -82.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.064 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 57.9 ttm-85 64.05 -19.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.584 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.551 ' H ' ' C ' ' A' ' 187' ' ' ILE . 10.3 mpt_? -54.46 -92.81 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.0 t -135.8 118.6 22.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.543 ' C ' HD22 ' A' ' 192' ' ' LEU . . . -146.92 159.32 27.98 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.329 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.842 HD22 ' N ' ' A' ' 192' ' ' LEU . 0.4 OUTLIER -117.46 146.89 43.19 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.641 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -168.19 -177.57 39.45 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.716 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.62 156.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.606 0.717 . . . . 0.0 111.636 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.2 tt -127.06 135.55 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.041 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.3 161.01 37.64 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . 157.81 -167.06 34.14 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.51 162.32 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 122.73 -0.277 . . . . 0.0 110.978 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.12 165.04 34.64 Favored Glycine 0 CA--C 1.545 1.916 0 C-N-CA 119.842 -1.17 . . . . 0.0 114.616 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -130.82 128.71 41.22 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.683 1.193 . . . . 0.0 109.004 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 201' ' ' ASP . 4.6 p30 -89.88 151.18 21.87 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.488 HG22 ' OG1' ' A' ' 203' ' ' THR . 0.8 OUTLIER -67.98 -37.93 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 103.005 -2.961 . . . . 0.0 103.005 174.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.675 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.0 OUTLIER -176.31 148.97 0.91 Allowed Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 100.612 -3.847 . . . . 0.0 100.612 176.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.445 ' C ' ' O ' ' A' ' 237' ' ' ARG . 32.0 Cg_exo -35.86 -17.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.295 -2.25 0 C-N-CA 121.313 1.342 . . . . 0.0 113.419 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.675 ' N ' ' O ' ' A' ' 203' ' ' THR . 87.1 tttt -68.87 -44.52 73.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 119.309 -0.377 . . . . 0.0 111.868 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.98 114.65 14.86 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.941 0.401 . . . . 0.0 111.056 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 201' ' ' ASP . 4.8 t -127.87 133.79 49.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.818 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.0 123.03 32.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.594 ' OD2' ' CE1' ' A' ' 134' ' ' TYR . 13.4 t70 -109.52 110.94 22.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.878 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -102.75 134.72 45.67 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.14 36.98 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 119.97 -1.109 . . . . 0.0 112.199 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -133.61 134.39 43.18 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -89.45 108.56 19.71 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.998 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -102.65 127.87 49.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -125.25 161.54 26.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.024 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.5 m120 57.22 88.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.223 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -38.27 -75.41 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.933 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -98.81 146.6 18.2 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 221' ' ' GLU . 35.0 ptt180 -140.67 -39.09 0.43 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.666 0.27 . . . . 0.0 110.581 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 220' ' ' LEU . 8.0 mp 45.77 12.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.916 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 219' ' ' ARG . 83.7 tt0 -68.38 -34.7 76.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.404 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 65.6 t30 60.02 39.07 20.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.809 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 5.7 m -164.32 53.74 0.14 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.434 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -143.83 -19.23 0.59 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.685 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 43.98 -159.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.523 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.85 150.7 40.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.783 0.325 . . . . 0.0 110.704 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 85.5 m -119.47 129.06 54.55 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.197 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.447 ' CG ' ' N ' ' A' ' 229' ' ' GLU . 23.7 t-160 -61.92 -105.39 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.1 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.447 ' N ' ' CG ' ' A' ' 228' ' ' HIS . 80.1 mm-40 55.81 168.85 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.882 0.372 . . . . 0.0 110.892 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.491 ' O ' ' CB ' ' A' ' 231' ' ' SER . . . 47.49 -111.51 0.39 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.19 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 232' ' ' LEU . 4.1 p 84.86 -65.16 0.06 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.781 -0.19 . . . . 0.0 110.973 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.521 ' N ' ' OG ' ' A' ' 231' ' ' SER . 6.8 tt -130.48 119.17 22.22 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -115.06 172.51 14.24 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 62.1 t -139.68 131.56 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.588 0.233 . . . . 0.0 110.918 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.459 HH11 ' NH1' ' A' ' 66' ' ' ARG . 36.6 ttm180 -132.7 142.07 48.88 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 236' ' ' TYR . 1.1 t80 -118.72 137.68 53.17 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.688 ' NH2' ' N ' ' A' ' 7' ' ' ARG . 14.3 ttt-85 -150.38 112.5 4.6 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.626 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.398 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 p -76.92 162.6 27.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.659 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.66 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.1 pm0 -66.48 -40.36 89.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.225 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -71.71 140.66 49.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.356 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.63 -178.76 26.93 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.1 -127.82 21.3 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.434 ' H ' ' HD2' ' A' ' 7' ' ' ARG . 3.7 mpt_? -86.25 127.55 34.77 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.08 -175.24 13.69 Favored Glycine 0 N--CA 1.47 0.957 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.166 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.405 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 48.9 Cg_endo -92.74 165.08 2.73 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.558 2.838 . . . . 0.0 114.951 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.596 ' OH ' ' HB2' ' A' ' 68' ' ' ALA . 22.5 p90 -163.85 164.39 23.5 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.575 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 p -135.39 155.22 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-O 120.524 0.202 . . . . 0.0 111.088 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.542 HE22 HD11 ' A' ' 122' ' ' ILE . 30.6 mt-30 -134.81 147.76 50.02 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.2 152.6 34.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.742 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 31.7 p-10 -153.24 159.06 42.53 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -133.3 152.39 51.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.042 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.35 175.75 6.73 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.68 0.276 . . . . 0.0 110.73 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -70.21 139.84 52.35 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.955 0.407 . . . . 0.0 110.952 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 47.92 -168.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.281 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 20' ' ' GLU . 66.9 t80 -83.08 123.63 29.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.808 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 19' ' ' TYR . 82.0 tt0 55.35 154.37 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.067 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -66.69 -39.8 88.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.292 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.413 ' H ' ' HG2' ' A' ' 20' ' ' GLU . 41.4 pt -99.04 159.12 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.178 0.514 . . . . 0.0 111.311 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.0 p -65.51 -32.54 74.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.835 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' A' ' 24' ' ' HIS . 25.3 t-80 50.61 41.02 25.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 27.7 t70 -92.19 9.22 34.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.945 0.402 . . . . 0.0 110.184 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 25' ' ' ASP . 2.0 m-85 -149.06 55.5 2.03 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.037 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -33.69 -49.85 0.51 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.848 2.365 . . . . 0.0 112.755 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.418 ' OE1' ' ND2' ' A' ' 105' ' ' ASN . 4.0 pt-20 -179.74 150.44 0.56 Allowed Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.729 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -72.38 -53.06 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.323 2.016 . . . . 0.0 111.718 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 3.0 t -149.75 149.96 31.34 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.58 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 30' ' ' THR . . . 171.23 74.06 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.317 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.9 144.45 99.57 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.674 2.25 . . . . 0.0 111.729 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 33' ' ' ASN . 44.5 p-10 -100.75 107.07 18.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.957 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -82.11 148.24 28.64 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -68.18 121.09 15.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.89 0.376 . . . . 0.0 110.588 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -114.47 131.07 56.74 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.438 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 38' ' ' SER . 10.4 tp -86.42 -39.82 13.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.795 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.476 ' N ' HG23 ' A' ' 37' ' ' ILE . 32.2 p -155.55 163.94 39.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.646 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.7 p -71.36 124.23 24.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 41' ' ' SER . 14.0 p -90.27 -40.05 12.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.302 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.478 ' N ' HG13 ' A' ' 40' ' ' VAL . 41.9 p -161.49 86.35 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.513 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.405 ' OD1' ' NZ ' ' A' ' 102' ' ' LYS . 99.5 m-20 -71.17 142.53 50.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.717 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -85.55 165.56 16.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.19 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -56.37 -19.13 13.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.699 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 63.6 ttm-85 -59.72 -42.22 92.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.485 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -45.49 147.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.081 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.8 mt 61.39 69.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.824 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -147.22 -43.58 0.17 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.919 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 t -147.31 159.0 44.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.417 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -141.31 160.58 39.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.312 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' VAL . 45.7 t -67.81 139.8 56.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.528 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 53' ' ' HIS . 46.6 t 56.42 157.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.548 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.636 ' CD2' ' HE ' ' A' ' 73' ' ' ARG . 80.8 t60 56.67 83.44 0.22 Allowed Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.686 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -86.18 -100.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.844 2.363 . . . . 0.0 112.71 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -125.66 157.76 36.46 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.6 155.28 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.574 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -135.45 128.7 31.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.288 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 m -140.91 165.34 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.19 -152.25 12.58 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.552 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -113.98 139.12 49.5 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-O 120.762 0.315 . . . . 0.0 111.543 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.1 p30 -103.26 101.01 10.93 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 124.835 1.335 . . . . 0.0 112.874 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.545 ' CZ ' ' O ' ' A' ' 65' ' ' TRP . 23.9 p90 -125.37 125.26 43.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -39.51 131.61 2.22 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.98 -84.59 0.37 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.545 ' O ' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -117.32 153.73 32.47 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.361 0.6 . . . . 0.0 110.33 179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.622 ' NH1' ' NH2' ' A' ' 235' ' ' ARG . 0.6 OUTLIER -129.82 130.94 45.94 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.77 128.57 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.596 ' HB2' ' OH ' ' A' ' 10' ' ' TYR . . . -139.0 124.66 19.56 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 120.922 0.391 . . . . 0.0 110.571 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.31 138.59 39.87 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.02 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -100.56 128.72 46.53 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.302 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -129.13 156.94 43.1 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.757 0.789 . . . . 0.0 111.95 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.25 151.0 44.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 113.617 -1.628 . . . . 0.0 108.462 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.636 ' HE ' ' CD2' ' A' ' 53' ' ' HIS . 95.6 mtt-85 -62.96 -66.13 0.59 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.588 -0.445 . . . . 0.0 112.177 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.3 t80 69.64 -24.39 0.15 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.557 0.218 . . . . 0.0 111.026 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.542 ' H ' ' C ' ' A' ' 73' ' ' ARG . 85.8 mtm-85 59.53 60.97 2.11 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.859 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -94.79 -13.06 25.97 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.659 0.266 . . . . 0.0 111.017 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -61.71 -41.0 97.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 0.0 110.644 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.657 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.1 OUTLIER -54.1 129.74 35.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.423 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 78' ' ' ASN . 96.5 m-20 -145.65 -35.21 0.3 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.078 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.3 m120 57.09 39.56 29.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.909 0.385 . . . . 0.0 110.567 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.97 -38.09 87.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.959 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -59.46 -47.49 85.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.13 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.1 p -68.45 144.46 54.66 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.638 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.3 t -126.67 130.49 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.228 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 85' ' ' ASN . 10.2 p30 -153.97 94.31 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.399 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.8 mt -113.8 127.08 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.102 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 46.78 73.3 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.357 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -78.21 93.39 4.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.038 0.447 . . . . 0.0 110.693 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 91' ' ' ILE . 14.6 p -65.69 -22.88 31.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.59 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -53.67 -7.53 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.191 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.502 ' H ' ' C ' ' A' ' 89' ' ' VAL . 10.3 tp -62.11 134.55 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.531 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -130.83 153.25 49.29 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.63 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -67.42 134.91 52.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.089 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -163.26 131.83 3.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.651 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 39.09 -105.48 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.028 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.63 86.47 0.12 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.6 tt -132.55 134.94 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 110.131 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' NH1' ' OD1' ' A' ' 100' ' ' ASP . 9.2 ptm180 -69.78 134.81 48.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.094 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.6 pt -104.25 27.67 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.982 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.413 ' OD1' ' NH1' ' A' ' 98' ' ' ARG . 90.8 m-20 58.2 -91.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.922 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -134.24 132.9 40.23 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.913 0.387 . . . . 0.0 110.743 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.405 ' NZ ' ' OD1' ' A' ' 42' ' ' ASP . 38.3 ttmt -79.01 141.88 37.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.188 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.1 t -136.85 143.96 43.35 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.232 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -110.25 37.77 2.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.394 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.418 ' ND2' ' OE1' ' A' ' 28' ' ' GLU . 94.0 m-20 -62.48 -39.54 93.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.897 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -40.65 -66.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.796 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -69.53 -20.94 63.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.492 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.6 t30 60.23 50.55 6.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -48.66 175.24 0.03 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.4 m -69.1 119.67 13.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 0.0 110.66 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.21 -43.6 97.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.409 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.539 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 70.9 t60 -57.11 -39.09 74.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.115 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 112' ' ' HIS . . . 73.88 101.11 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.662 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.5 t -125.88 133.08 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.964 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 116' ' ' SER . 32.6 t -154.3 -151.81 0.38 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.891 0.377 . . . . 0.0 110.549 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.449 ' N ' ' OG ' ' A' ' 115' ' ' SER . 3.2 m 61.74 139.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.647 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.429 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -107.76 163.27 13.25 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.379 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.7 -157.96 20.94 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.233 -1.461 . . . . 0.0 112.373 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.1 mt -127.42 144.69 51.02 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.269 0.557 . . . . 0.0 110.571 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 84.0 p -147.47 140.44 25.02 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.63 127.75 53.6 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.542 HD11 HE22 ' A' ' 12' ' ' GLN . 87.9 mt -101.51 135.09 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -128.77 102.88 6.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.255 0.934 . . . . 0.0 112.127 -176.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.547 ' CG ' HH21 ' A' ' 66' ' ' ARG . 3.4 m-20 -89.94 135.74 33.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.841 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 132' ' ' LYS . 41.9 t80 -113.22 81.36 1.49 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -70.32 85.8 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.038 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 128' ' ' ASN . 17.5 tt -70.21 -41.29 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.129 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.431 ' N ' HG23 ' A' ' 127' ' ' ILE . 40.3 t30 177.67 -47.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.384 0.428 . . . . 0.0 110.199 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -59.91 -169.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.088 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -100.48 -1.72 35.03 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.495 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 7.1 p90 -138.34 128.97 26.46 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.435 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -133.41 156.8 79.36 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 121.021 0.439 . . . . 0.0 111.059 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.7 146.3 21.05 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.922 1.748 . . . . 0.0 109.675 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 134' ' ' TYR . 6.8 p90 -138.25 138.13 38.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.207 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 136' ' ' GLY . 32.2 mt -136.56 164.43 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.86 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.488 ' N ' ' CG2' ' A' ' 135' ' ' ILE . . . -164.93 -176.67 36.83 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.669 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -133.2 155.46 49.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.24 -0.98 . . . . 0.0 108.753 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -135.56 128.1 30.65 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.33 121.75 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -124.75 124.3 41.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 110.506 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -136.44 165.5 25.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.564 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.81 91.57 2.23 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -149.65 -97.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.76 -0.259 . . . . 0.0 111.002 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.9 t -64.51 -45.68 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -82.27 153.3 25.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.938 0.399 . . . . 0.0 111.345 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' A' ' 146' ' ' HIS . 11.0 p80 -147.12 144.41 29.0 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.34 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 91.0 p 44.18 -122.32 0.84 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.737 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 89.3 mt -99.98 128.56 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.343 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 151' ' ' THR . 92.2 m-20 -61.65 -42.73 99.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.13 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.9 p 43.74 17.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.881 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 149' ' ' ASP . 63.4 m -114.48 116.28 28.6 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.257 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -65.55 -45.75 82.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.724 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -178.24 26.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.053 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 156' ' ' GLU . 1.8 m -76.95 157.1 31.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.092 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.2 mt 57.75 -78.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.35 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 154' ' ' THR . 76.1 mt-10 -43.96 157.77 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.8 0.333 . . . . 0.0 111.026 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.9 t 65.68 61.06 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.671 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 90.7 m -125.26 128.39 48.2 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.991 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 54.4 p -73.86 134.61 43.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.681 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.7 m -109.8 158.46 34.8 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 162' ' ' SER . 31.8 Cg_exo -55.28 143.32 76.37 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.219 1.279 . . . . 0.0 111.852 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 161' ' ' PRO . 42.1 m 53.47 112.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.969 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.581 HD22 ' N ' ' A' ' 163' ' ' ASN . 0.1 OUTLIER -80.38 20.33 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.723 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 163' ' ' ASN . . . 69.41 59.86 0.58 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.04 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -71.1 150.85 60.73 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.564 2.176 . . . . 0.0 111.664 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 166' ' ' ASN . 19.7 t-20 56.92 36.45 27.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.081 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 55.43 -129.35 46.27 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.63 151.04 48.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.743 0.306 . . . . 0.0 110.349 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 73.1 t -60.89 -46.17 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.496 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 76.2 p -112.52 115.43 28.64 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.37 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 173' ' ' ASN . 10.6 p -111.97 -49.84 2.95 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.694 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 84.5 t80 44.37 -88.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.441 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.553 ' N ' ' O ' ' A' ' 171' ' ' THR . 52.2 p30 -97.32 149.3 22.24 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 99.3 m -65.44 -27.56 68.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.728 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -113.39 91.86 21.23 Favored Pre-proline 0 N--CA 1.469 0.498 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -88.57 166.12 6.31 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.868 2.378 . . . . 0.0 111.915 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 178' ' ' THR . 88.8 tttt -66.93 133.31 49.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.48 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.43 ' O ' ' O ' ' A' ' 177' ' ' LYS . 15.9 p 50.93 172.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.975 0.417 . . . . 0.0 111.017 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -156.68 96.75 1.66 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.337 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -156.7 -34.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.6 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.528 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 96.6 m-20 42.72 -122.38 0.66 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.641 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 181' ' ' ASP . 96.5 m-85 -159.07 -113.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.803 0.335 . . . . 0.0 110.538 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -66.49 -25.69 66.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.209 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 77.9 p -58.81 -38.6 78.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.641 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -132.41 113.29 12.98 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.447 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.8 t -169.43 73.53 0.08 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.621 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.582 HD12 ' C ' ' A' ' 187' ' ' ILE . 2.3 pp -95.42 -0.38 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.571 ' N ' HD12 ' A' ' 187' ' ' ILE . 59.2 ttp180 -70.5 -82.13 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.823 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 50.9 -87.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 188' ' ' ARG . 73.7 t -76.6 163.74 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 175.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.441 ' N ' HG12 ' A' ' 190' ' ' VAL . . . -141.16 140.43 10.34 Favored Glycine 0 N--CA 1.476 1.305 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.698 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 216' ' ' ASN . 47.1 tp -133.61 125.1 28.04 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -156.12 -169.78 20.68 Favored Glycine 0 C--N 1.32 -0.345 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.8 158.98 42.71 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 CA-C-O 122.306 1.051 . . . . 0.0 112.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.8 mm -109.57 130.48 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 112.639 -2.073 . . . . 0.0 107.312 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.3 156.86 42.32 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.514 -0.741 . . . . 0.0 111.834 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.408 ' C ' ' CE2' ' A' ' 134' ' ' TYR . . . 150.05 -176.98 28.46 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.42 159.68 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -136.84 140.74 11.7 Favored Glycine 0 N--CA 1.47 0.93 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.781 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -122.04 105.44 10.29 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -96.0 137.16 35.46 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 202' ' ' ILE . 1.2 mp -69.54 -39.16 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 173.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -155.25 156.08 30.66 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 101.284 -3.598 . . . . 0.0 101.284 175.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.509 ' C ' ' O ' ' A' ' 237' ' ' ARG . 32.3 Cg_exo -48.78 -17.51 1.17 Allowed 'Trans proline' 0 C--N 1.288 -2.622 0 CA-C-N 121.706 1.645 . . . . 0.0 111.267 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 203' ' ' THR . 60.4 tttp -67.82 -39.77 83.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.286 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 9.0 mt -124.05 107.79 11.67 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.123 0.874 . . . . 0.0 111.925 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.596 HG23 ' HG2' ' A' ' 235' ' ' ARG . 0.3 OUTLIER -136.81 141.03 42.88 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.63 0.728 . . . . 0.0 112.948 177.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.44 ' O ' ' OD1' ' A' ' 209' ' ' ASP . 84.0 mt -99.1 148.3 24.19 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 208' ' ' LEU . 28.3 m-20 -139.3 137.0 35.46 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -83.65 133.43 34.82 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.86 151.62 19.66 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 120.236 -0.983 . . . . 0.0 114.59 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -135.22 142.18 45.96 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.195 -1.002 . . . . 0.0 109.03 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 86.0 mmt-85 -110.75 125.04 53.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -127.83 161.39 29.14 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.604 0.716 . . . . 0.0 112.862 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.661 ' CG ' ' H ' ' A' ' 216' ' ' ASN . 69.1 t60 -126.97 -175.46 3.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.486 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.661 ' H ' ' CG ' ' A' ' 215' ' ' HIS . 45.4 t-20 -63.17 111.6 2.29 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.554 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -102.85 91.51 4.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.939 0.399 . . . . 0.0 110.328 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -88.43 -166.6 42.46 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -87.18 1.86 51.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.051 0.453 . . . . 0.0 110.177 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.78 -41.41 99.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.317 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 57.26 71.92 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.073 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -87.86 115.91 25.65 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 223' ' ' THR . 13.3 t -70.81 130.61 42.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.032 0.444 . . . . 0.0 111.127 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -146.47 168.51 21.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.087 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -61.68 135.68 57.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 0.0 110.701 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 35.21 -121.25 0.12 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.428 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.445 ' O ' HG22 ' A' ' 227' ' ' THR . 12.3 m -165.69 7.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.901 0.381 . . . . 0.0 110.296 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 70.4 m80 52.88 78.38 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.032 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.563 ' O ' ' HB3' ' A' ' 230' ' ' ALA . 15.7 pt-20 -127.49 -175.03 3.33 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.78 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 229' ' ' GLU . . . 76.5 84.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.826 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 57.7 m -131.75 152.61 50.81 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.314 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 25.4 mt -128.6 131.94 48.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.11 0.481 . . . . 0.0 111.12 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -131.77 148.2 18.94 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.306 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.6 p -131.39 137.83 54.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.622 ' NH2' ' NH1' ' A' ' 66' ' ' ARG . 10.8 ptm180 -136.55 146.74 46.51 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -101.99 113.07 25.99 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 113.254 -1.793 . . . . 0.0 108.967 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.611 HH11 ' NH2' ' A' ' 66' ' ' ARG . 75.0 ttt180 -139.23 115.55 10.46 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 122.354 1.073 . . . . 0.0 112.113 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.522 ' OXT' ' CD1' ' A' ' 238' ' ' PHE . 1.2 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.21 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 4' ' ' ASP . 39.5 t -146.74 109.88 4.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.508 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -66.58 -35.01 79.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.937 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 2' ' ' SER . 53.9 p30 -144.33 174.35 10.98 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.016 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -44.43 -90.8 0.01 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.46 9.46 85.97 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -138.69 125.25 20.67 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 110.58 -0.155 . . . . 0.0 110.58 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.448 ' C ' ' CE2' ' A' ' 10' ' ' TYR . . . -179.69 151.55 10.16 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.139 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 77.5 Cg_endo -80.82 127.19 6.15 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.877 2.384 . . . . 0.0 111.695 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 52.4 m-85 -141.24 -178.23 5.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.888 -0.142 . . . . 0.0 111.287 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 12' ' ' GLN . 6.2 t -138.62 162.6 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.476 ' N ' HG12 ' A' ' 11' ' ' VAL . 8.9 tm0? -130.51 131.62 45.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.972 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.88 140.14 22.23 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.967 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -161.05 168.83 23.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 230' ' ' ALA . 0.4 OUTLIER -172.12 179.88 2.52 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.499 179.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 230' ' ' ALA . . . -131.68 158.08 42.05 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.172 0.511 . . . . 0.0 111.946 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -106.65 134.43 49.81 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.353 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -159.41 156.2 28.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.858 0.361 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -148.63 162.79 39.0 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.205 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -158.32 49.4 0.38 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.908 0.385 . . . . 0.0 110.694 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.407 ' O ' ' C ' ' A' ' 22' ' ' ILE . 3.7 m80 -68.19 -43.28 78.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.872 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 23' ' ' THR . 20.4 pt 32.29 -123.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.796 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 22' ' ' ILE . 9.6 p 52.13 113.76 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.089 0.471 . . . . 0.0 111.026 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.573 ' ND1' ' CD2' ' A' ' 26' ' ' TYR . 56.6 t-80 -65.36 -44.37 87.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.711 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.58 50.71 12.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.218 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.573 ' CD2' ' ND1' ' A' ' 24' ' ' HIS . 1.9 m-85 -35.49 99.41 0.17 Allowed Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.488 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.48 145.55 94.03 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.622 1.548 . . . . 0.0 111.688 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -146.46 69.92 12.67 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.932 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -83.02 85.29 1.6 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.788 2.325 . . . . 0.0 111.933 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.6 p -104.91 -3.61 23.17 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.618 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.39 152.7 81.5 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.321 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.83 159.58 52.14 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.424 2.083 . . . . 0.0 111.627 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -55.61 123.62 14.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.417 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 36' ' ' LYS . 35.8 tttm -119.65 -143.22 0.35 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.02 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.9 t30 68.85 -38.53 0.39 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 34' ' ' LYS . 68.6 mttm -64.0 -44.16 93.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.512 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -128.18 128.72 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.373 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 40' ' ' VAL . 58.5 p -149.63 -23.36 0.27 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.642 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 m 61.16 -71.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.39 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 38' ' ' SER . 88.1 t -96.61 128.74 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.239 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 42' ' ' ASP . 34.0 t -77.5 -89.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.398 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 41' ' ' SER . 99.1 m-20 56.56 127.89 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.178 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -146.74 160.43 42.25 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.436 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 51.0 p90 -92.13 131.4 37.41 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.979 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -94.72 134.38 37.37 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.424 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -119.92 127.14 52.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.624 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.889 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -136.06 148.27 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.46 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -154.49 149.22 26.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.813 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.7 m -128.65 130.71 47.62 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.593 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -109.86 149.5 29.78 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.315 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.552 ' CB ' HH12 ' A' ' 75' ' ' ARG . 36.9 m -80.44 -93.21 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.515 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.469 ' O ' ' CG ' ' A' ' 53' ' ' HIS . 24.7 t 53.26 112.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.056 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.469 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 93.4 m-70 -156.22 77.83 4.33 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.943 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.11 149.33 90.86 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 123.059 2.506 . . . . 0.0 112.292 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.425 ' HD3' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -73.31 162.26 29.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.485 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.0 t -131.09 155.49 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.249 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.9 m -137.33 151.85 49.09 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.982 0.42 . . . . 0.0 111.622 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.02 145.68 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.336 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 67' ' ' ILE . . . -164.72 -179.96 39.07 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 119.61 -1.281 . . . . 0.0 114.184 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -106.68 132.85 52.19 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -97.65 121.18 39.25 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -125.37 113.64 17.82 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.42 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -43.35 103.94 0.05 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 123' ' ' TYR . . . 136.88 -36.07 2.02 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.426 ' CD1' ' N ' ' A' ' 65' ' ' TRP . 0.3 OUTLIER -170.18 156.3 5.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.979 0.418 . . . . 0.0 110.879 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.487 HH21 HG21 ' A' ' 122' ' ' ILE . 17.3 ttp85 -134.55 135.38 42.26 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.404 ' O ' ' HA3' ' A' ' 59' ' ' GLY . 49.3 mm -99.98 127.92 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.38 130.93 14.86 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 119.454 -0.898 . . . . 0.0 112.169 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.49 144.2 26.84 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.989 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -104.28 128.01 52.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.129 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -134.35 162.02 33.37 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.012 0.435 . . . . 0.0 111.242 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.32 160.39 40.36 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.434 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -105.35 151.09 24.62 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.863 0.363 . . . . 0.0 111.092 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.497 ' O ' ' CD1' ' A' ' 77' ' ' TRP . 94.9 m-85 -102.01 101.41 11.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.235 0.54 . . . . 0.0 109.975 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.552 HH12 ' CB ' ' A' ' 51' ' ' SER . 84.5 mtp180 -55.9 -24.5 37.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.464 -178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 77' ' ' TRP . 52.7 mtpt -61.08 -44.89 96.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.536 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.497 ' CD1' ' O ' ' A' ' 74' ' ' TYR . 83.4 m95 37.94 -113.72 0.12 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.643 0.259 . . . . 0.0 110.889 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 m120 54.21 67.08 1.06 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.749 0.309 . . . . 0.0 110.587 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -61.47 -41.4 97.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.223 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -105.28 133.25 50.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.441 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -122.74 121.4 36.24 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.296 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -61.73 -46.67 88.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.2 m -138.66 150.34 46.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 110.821 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.413 ' O ' ' ND2' ' A' ' 85' ' ' ASN . 96.2 t -65.62 -68.7 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.415 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 84' ' ' VAL . 23.5 m120 -152.14 -73.3 0.15 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.501 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.61 128.24 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.555 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -171.71 -116.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.055 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 90' ' ' ARG . 23.2 t-20 -148.0 -110.79 0.08 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.685 0.279 . . . . 0.0 110.475 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.405 ' N ' ' CG ' ' A' ' 88' ' ' ASN . 60.5 t 57.45 -76.17 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 88' ' ' ASN . 89.1 mtm180 47.33 -173.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.757 0.313 . . . . 0.0 110.446 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.0 pt -118.75 119.46 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.232 0.539 . . . . 0.0 110.594 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -68.96 -41.85 77.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.874 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 94' ' ' GLU . 64.7 mttp -70.22 140.84 52.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.777 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 93' ' ' LYS . 97.6 mt-10 45.6 95.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.627 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 95' ' ' ASN . 48.4 p-10 -85.8 137.61 32.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.498 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -79.55 130.88 10.16 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.41 ' O ' ' O ' ' A' ' 98' ' ' ARG . 7.4 tp -142.03 139.63 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.909 0.385 . . . . 0.0 110.642 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.41 ' O ' ' O ' ' A' ' 97' ' ' ILE . 77.2 ttt180 41.73 95.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.952 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 99' ' ' ILE . 9.3 tp -131.24 130.83 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.257 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 101' ' ' ARG . 52.7 t0 -145.68 -22.62 0.47 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.521 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 100' ' ' ASP . 23.9 mmm180 53.08 109.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.623 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -37.34 85.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.429 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 96.6 m -123.25 127.18 48.23 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.229 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 104' ' ' GLU . 58.2 mp0 -110.69 116.93 32.17 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.246 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -63.17 -40.92 98.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.326 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -81.37 138.09 35.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.728 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.54 37.1 3.87 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.364 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.2 m120 56.96 78.32 0.23 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.664 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.39 116.17 0.89 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.521 ' C ' ' H ' ' A' ' 112' ' ' HIS . 49.1 m -127.81 136.89 52.08 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.728 0.299 . . . . 0.0 110.279 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 112' ' ' HIS . 71.5 t80 -57.14 -0.72 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.952 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.521 ' H ' ' C ' ' A' ' 110' ' ' THR . 86.5 t60 51.49 105.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.969 0.414 . . . . 0.0 110.718 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 53.37 -160.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.451 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 116' ' ' SER . 9.0 p -139.42 153.45 23.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.202 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 94.6 p -69.78 10.91 0.32 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.177 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 114' ' ' VAL . 1.0 OUTLIER 51.5 -151.6 0.24 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.839 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.51 173.07 14.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.33 -126.6 1.03 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.926 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 62.1 tp -135.52 149.47 49.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 120.993 0.425 . . . . 0.0 110.277 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.1 p -152.55 152.37 31.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.46 130.03 51.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.009 0.433 . . . . 0.0 110.767 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.612 HD12 ' N ' ' A' ' 122' ' ' ILE . 1.9 mp -97.72 148.17 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 177.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.541 ' CE1' ' O ' ' A' ' 64' ' ' GLY . 4.2 t80 -138.7 123.98 19.26 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 118.941 -1.104 . . . . 0.0 113.64 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.644 ' CB ' HH22 ' A' ' 237' ' ' ARG . 32.6 p-10 -110.36 120.29 41.97 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 113.489 -1.687 . . . . 0.0 106.588 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.473 ' CD2' ' OH ' ' A' ' 123' ' ' TYR . 5.1 t80 -70.26 129.32 39.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.248 0.546 . . . . 0.0 111.675 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.424 ' O ' ' O ' ' A' ' 125' ' ' PHE . 88.0 mt-30 39.98 -167.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.903 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.526 ' O ' ' C ' ' A' ' 128' ' ' ASN . 1.3 mp -105.0 20.83 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.656 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 127' ' ' ILE . 65.6 m-80 -11.46 -73.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.593 0.558 . . . . 0.0 111.828 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 128' ' ' ASN . 4.7 p30 153.89 -51.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.875 0.734 . . . . 0.0 111.441 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.81 -19.0 3.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -146.98 122.81 10.62 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.021 0.828 . . . . 0.0 113.146 -178.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.409 ' HB3' ' N ' ' A' ' 125' ' ' PHE . 1.3 mptt -134.24 133.0 21.37 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.045 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -51.12 133.62 41.71 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 CA-C-N 119.95 1.018 . . . . 0.0 110.325 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -96.76 130.0 44.08 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.463 ' N ' ' CD1' ' A' ' 134' ' ' TYR . 96.7 mt -136.62 136.51 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -129.27 139.28 10.84 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.984 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -118.38 128.79 54.97 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -129.99 131.44 45.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.247 0.546 . . . . 0.0 112.025 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.42 113.31 2.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.44 144.95 35.36 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.92 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -150.94 171.28 17.52 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.313 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.17 175.66 47.49 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -80.14 104.0 10.4 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.307 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 145' ' ' ARG . 93.8 t -128.31 127.81 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.733 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 144' ' ' VAL . 33.1 mmt180 40.21 -166.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.192 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -159.22 146.41 17.15 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.114 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 74.7 m -131.69 151.06 51.92 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.962 0.41 . . . . 0.0 110.854 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 148' ' ' ILE . 19.9 tt -135.17 131.42 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.071 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -91.38 106.66 18.66 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.039 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.1 m -80.77 147.73 30.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.247 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 t -148.35 155.14 40.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.875 0.369 . . . . 0.0 110.667 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -130.67 143.12 50.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.216 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 154' ' ' THR . 9.0 pttp -88.0 -93.15 0.1 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.24 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER 32.72 98.89 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.623 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.2 mt -104.58 127.8 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.196 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.64 115.72 15.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.38 -44.0 97.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 3.6 t -132.05 153.03 50.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.805 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 159' ' ' THR . 8.9 t -84.19 128.55 34.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.0 110.814 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.446 ' H ' HG22 ' A' ' 160' ' ' VAL . 3.2 m -65.76 157.3 80.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.665 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.85 -39.6 48.61 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.404 1.402 . . . . 0.0 111.949 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.2 m -72.4 149.59 44.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.689 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 56.86 44.94 22.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.426 ' N ' ' CD ' ' A' ' 165' ' ' PRO . . . -146.77 53.66 1.78 Allowed Pre-proline 0 N--CA 1.463 0.197 0 CA-C-O 120.691 0.282 . . . . 0.0 111.008 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 164' ' ' ALA . 84.0 Cg_endo -73.55 160.48 44.19 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.818 2.345 . . . . 0.0 111.82 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -62.23 -39.85 94.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.509 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.02 -155.55 21.53 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 62.82 120.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.683 0.277 . . . . 0.0 110.261 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 169' ' ' VAL . 12.1 p -122.66 130.09 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.51 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.8 m -132.13 -1.82 3.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.281 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 173' ' ' ASN . 77.5 m -112.12 125.77 54.47 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.672 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.02 8.47 32.39 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.384 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.446 ' H ' HG22 ' A' ' 171' ' ' THR . 98.7 m-20 -73.29 148.29 43.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.552 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 43.6 p 41.61 80.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.637 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.71 150.56 81.87 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.532 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.49 157.75 48.71 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.53 2.153 . . . . 0.0 111.988 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -74.51 -7.54 53.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.596 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.6 m 59.39 157.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.735 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -77.26 143.21 39.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.541 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -86.11 109.06 18.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -72.26 146.16 47.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.661 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -102.34 137.39 40.65 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.498 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 183' ' ' GLN . 2.3 pm0 -125.17 -120.68 0.26 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.373 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 183' ' ' GLN . 5.1 p 49.48 100.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.849 0.357 . . . . 0.0 110.517 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.483 ' OD1' ' N ' ' A' ' 186' ' ' SER . 57.6 p30 -158.65 -128.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.324 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.483 ' N ' ' OD1' ' A' ' 185' ' ' ASN . 1.9 m 63.92 87.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.893 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.0 tt -128.93 139.46 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.589 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.409 ' HD3' ' H ' ' A' ' 188' ' ' ARG . 0.0 OUTLIER -84.13 61.17 6.34 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -59.93 -38.88 83.66 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.09 154.66 31.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -123.55 147.83 16.69 Favored Glycine 0 N--CA 1.472 1.099 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.003 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 tt -144.49 127.51 16.51 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.783 -0.709 . . . . 0.0 109.236 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -150.3 170.34 30.26 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.09 140.73 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.837 0.827 . . . . 0.0 111.987 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.1 mt -118.64 134.56 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.476 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -148.42 153.27 38.3 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.503 0.668 . . . . 0.0 111.97 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 179.08 -140.59 4.47 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.611 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.43 140.82 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.83 0.315 . . . . 0.0 111.123 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -119.48 123.31 5.6 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.195 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -123.61 106.71 10.79 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 201' ' ' ASP . 0.3 OUTLIER -74.54 152.58 39.31 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -176.165 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.54 HG23 ' N ' ' A' ' 203' ' ' THR . 8.1 tt -64.72 -36.91 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 113.068 -1.878 . . . . 0.0 108.208 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.827 ' O ' ' N ' ' A' ' 205' ' ' LYS . 29.7 m 178.62 100.26 0.15 Allowed Pre-proline 0 C--N 1.315 -0.93 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 238' ' ' PHE . 0.1 OUTLIER -14.55 58.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 124.02 3.146 . . . . 0.0 115.139 -173.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.827 ' N ' ' O ' ' A' ' 203' ' ' THR . 75.4 tttt -135.24 -44.81 0.7 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.063 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 26.5 tp -143.81 121.32 11.74 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.467 HG21 ' HE ' ' A' ' 235' ' ' ARG . 0.7 OUTLIER -95.67 145.26 25.41 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -176.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 209' ' ' ASP . 1.0 OUTLIER -107.63 117.65 34.67 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.561 ' N ' HD13 ' A' ' 208' ' ' LEU . 3.8 p30 -141.37 146.35 36.51 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -100.06 148.86 24.09 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.361 -1.745 . . . . 0.0 107.032 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -174.53 115.44 0.55 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 118.777 -1.678 . . . . 0.0 113.713 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -170.31 139.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -148.8 -86.09 0.09 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 215' ' ' HIS . 18.7 t80 -170.46 -178.46 2.7 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.394 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.545 ' O ' ' CE2' ' A' ' 214' ' ' TYR . 10.4 p-80 -149.34 165.91 30.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.233 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.63 95.94 1.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.13 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 49.0 t90 -154.61 121.46 5.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.57 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -85.38 -179.81 50.61 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 221' ' ' GLU . 42.3 ttm180 -100.58 118.0 35.86 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.881 0.372 . . . . 0.0 110.284 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.3 tp -90.42 -2.08 57.93 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.231 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 219' ' ' ARG . 97.5 mt-10 56.77 38.14 29.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.562 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.493 ' CG ' ' H ' ' A' ' 223' ' ' THR . 0.5 OUTLIER -150.78 -138.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.186 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 224' ' ' ARG . 1.3 t 32.5 -116.08 0.06 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.802 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.521 ' N ' ' OG1' ' A' ' 223' ' ' THR . 10.2 tpt180 -155.09 154.61 32.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.792 0.33 . . . . 0.0 110.343 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -80.6 -0.83 39.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.244 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.28 141.73 47.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.761 0.315 . . . . 0.0 110.664 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 228' ' ' HIS . 4.3 m -166.41 -126.06 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.645 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 227' ' ' THR . 96.7 m-70 59.45 134.14 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.845 0.355 . . . . 0.0 110.788 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -164.88 64.18 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.541 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 15' ' ' LEU . . . -175.92 -109.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.789 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.9 t 63.15 -82.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.098 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 232' ' ' LEU . 10.0 mp -86.38 130.34 34.54 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.127 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -146.36 143.71 11.88 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.575 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 234' ' ' VAL . 12.8 p -123.69 129.72 74.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.467 ' HE ' HG21 ' A' ' 207' ' ' THR . 52.9 mtm180 -133.54 144.33 49.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.32 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 3.1 m-85 -76.34 122.83 25.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.644 HH22 ' CB ' ' A' ' 124' ' ' ASP . 16.6 tpt180 -138.69 113.13 8.85 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 124.277 0.985 . . . . 0.0 111.86 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.446 ' OXT' ' CG ' ' A' ' 238' ' ' PHE . 78.5 t80 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.013 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 m -72.99 147.85 44.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.504 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -172.41 -130.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.913 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -146.86 107.57 4.12 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.76 0.314 . . . . 0.0 110.532 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.54 -3.25 90.67 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.29 7.49 76.46 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -102.23 126.85 49.33 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.443 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . -158.74 165.18 33.97 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.94 158.28 30.95 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.011 2.474 . . . . 0.0 112.776 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.43 ' CZ ' ' CG ' ' A' ' 66' ' ' ARG . 20.6 p90 -154.25 163.29 40.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.456 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.9 t -129.02 144.17 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 120.88 0.371 . . . . 0.0 111.813 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -123.1 131.54 53.73 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.112 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.68 142.74 24.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.072 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 51.4 p-10 -95.96 143.33 27.24 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.506 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.623 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 97.5 mt -143.67 162.34 36.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.186 0.517 . . . . 0.0 112.036 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . 86.7 142.99 0.05 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.343 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -127.01 131.31 51.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.779 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.94 144.68 55.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.448 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -72.61 -75.5 0.14 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.912 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 22' ' ' ILE . 19.0 pt-20 -66.58 -37.79 85.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.667 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 59.64 -73.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.512 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 20' ' ' GLU . 86.9 mt -108.03 126.97 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.151 0.5 . . . . 0.0 111.729 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.1 p -128.53 -38.09 1.75 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.168 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.516 ' CG ' ' N ' ' A' ' 25' ' ' ASP . 82.3 t60 42.73 -111.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.929 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' N ' ' CG ' ' A' ' 24' ' ' HIS . 54.3 p-10 -83.75 173.77 11.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.733 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -38.35 106.19 0.36 Allowed Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.678 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -53.23 142.59 55.68 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.588 1.525 . . . . 0.0 112.589 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 57.71 63.9 4.38 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.507 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -92.46 -99.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.894 2.396 . . . . 0.0 111.694 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.7 p -142.15 35.16 1.53 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.026 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -154.16 57.74 1.92 Allowed Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.683 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.22 146.79 87.25 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.548 2.165 . . . . 0.0 111.877 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -135.6 119.05 16.85 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.699 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -166.49 -164.58 0.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.521 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 58.03 36.26 25.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.658 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -98.83 93.95 6.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.554 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 38' ' ' SER . 5.1 mp -133.29 132.03 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.543 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 37' ' ' ILE . 3.1 m 47.45 100.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.0 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.8 t -145.61 151.19 37.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.403 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.7 HG22 ' O ' ' A' ' 40' ' ' VAL . 7.1 p 35.61 27.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.22 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 39' ' ' THR . 9.4 t 52.44 91.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.641 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -121.24 155.53 34.41 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.913 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 55.12 96.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.061 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -66.01 -39.9 90.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.73 146.62 49.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.501 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -144.54 -44.68 0.24 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.044 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 47' ' ' ILE . 74.2 mt -88.5 13.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.5 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.443 ' C ' ' H ' ' A' ' 50' ' ' ARG . 90.0 mtm180 55.75 -101.04 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.679 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 48' ' ' ARG . 18.0 p 50.14 10.39 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.372 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.443 ' H ' ' C ' ' A' ' 48' ' ' ARG . 76.3 ttt180 -171.41 86.48 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 110.33 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.9 p -140.69 92.37 2.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.67 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.09 133.71 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.634 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.457 ' ND1' ' N ' ' A' ' 53' ' ' HIS . 10.0 p-80 -174.77 79.56 0.33 Allowed Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.819 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 55' ' ' ARG . 51.7 Cg_exo -53.48 -44.6 47.61 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.703 2.269 . . . . 0.0 112.928 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 54' ' ' PRO . 99.9 mtt180 42.28 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.538 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 57' ' ' SER . 9.4 p -155.25 161.5 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 119.386 -0.925 . . . . 0.0 112.709 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 56' ' ' VAL . 49.9 m -132.5 133.03 43.29 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.698 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.516 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 4.3 m -140.05 165.95 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 111.609 0.225 . . . . 0.0 111.609 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.52 -162.04 24.75 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 119.721 -1.228 . . . . 0.0 114.188 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -112.53 151.18 30.29 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.499 -0.851 . . . . 0.0 108.915 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 8' ' ' GLY . 3.6 p-10 -136.95 114.36 10.93 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 62' ' ' PHE . 38.9 p90 -125.05 105.35 9.11 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.29 177.03 7.5 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 105.888 -2.885 . . . . 0.0 105.888 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.601 ' CA ' ' H ' ' A' ' 124' ' ' ASP . . . -47.05 -36.16 8.89 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 120.013 1.907 . . . . 0.0 111.305 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -48.48 97.42 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.69 ' HE ' ' CD1' ' A' ' 122' ' ' ILE . 26.5 ttp-105 -130.07 119.76 23.59 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.674 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.4 pt -126.88 137.79 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.956 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 58' ' ' VAL . . . -136.88 146.0 45.03 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.234 0.54 . . . . 0.0 111.661 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.1 140.53 29.91 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.218 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -102.25 127.4 49.23 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.299 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -112.4 136.77 51.48 Favored 'General case' 0 C--O 1.248 0.979 0 O-C-N 124.627 1.204 . . . . 0.0 110.394 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.37 -156.03 0.66 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.568 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.403 ' O ' ' CD1' ' A' ' 74' ' ' TYR . 74.3 mtp85 -104.96 150.81 24.6 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.812 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.2 m-85 -142.67 -71.06 0.33 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.824 0.345 . . . . 0.0 111.449 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -53.08 76.27 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.418 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 74' ' ' TYR . 88.8 tttt -68.78 -42.74 76.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.068 0.461 . . . . 0.0 110.148 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -94.19 144.93 25.08 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.945 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -101.78 13.01 36.12 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.463 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.3 m120 57.06 34.11 24.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.713 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.632 HD22 ' ND2' ' A' ' 85' ' ' ASN . 12.4 m120 46.1 69.32 0.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.632 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.22 -46.21 90.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.221 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -164.47 -59.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.38 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 85' ' ' ASN . 56.4 m -153.28 -164.93 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.21 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 t 61.11 -70.72 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.703 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.632 ' ND2' HD22 ' A' ' 80' ' ' ASN . 99.0 m-20 48.97 -102.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.725 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.541 HD13 ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -127.69 -46.96 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.809 0.338 . . . . 0.0 110.298 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 18.6 pt-20 -87.56 142.51 27.8 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.8 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -135.22 -67.63 0.54 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.627 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.8 t -125.37 132.84 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.546 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -99.6 136.11 40.01 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.19 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 95.9 mt -91.54 -86.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.747 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -145.71 91.41 2.1 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.623 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -126.34 130.35 50.63 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -172.59 111.98 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.345 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -98.09 98.54 9.84 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.383 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -93.12 -10.84 59.29 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 96.0 mt -117.23 127.89 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.917 0.389 . . . . 0.0 110.451 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -169.65 -17.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.666 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 76.2 mt -66.19 -25.51 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.422 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' A' ' 102' ' ' LYS . 54.9 t0 -63.2 143.99 57.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.871 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.488 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 62.1 ttp180 63.8 -28.61 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.859 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.55 ' H ' ' C ' ' A' ' 100' ' ' ASP . 74.8 tttt 68.53 -61.47 0.4 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.705 0.288 . . . . 0.0 110.734 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 101' ' ' ARG . 23.5 m -59.57 131.59 51.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.175 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -70.35 -119.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.572 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.751 HD21 HH22 ' A' ' 219' ' ' ARG . 22.3 t-20 -86.61 152.5 22.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.862 0.363 . . . . 0.0 110.577 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.43 ' N ' ' OD1' ' A' ' 105' ' ' ASN . 9.4 pt20 -77.9 166.62 22.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.663 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 58.29 -166.01 0.16 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.855 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.07 -40.44 97.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.79 170.53 44.37 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.1 p -74.35 96.85 2.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.869 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -156.31 79.89 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.111 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -163.37 129.12 3.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.457 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.62 142.54 51.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.536 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.4 ' H ' HG22 ' A' ' 114' ' ' VAL . 19.2 m -81.72 151.65 4.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.009 0.433 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.7 p -53.13 120.7 6.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.756 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.529 ' O ' ' CZ ' ' A' ' 74' ' ' TYR . 51.4 m -61.67 -44.29 97.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.328 0.585 . . . . 0.0 109.755 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.1 tp -156.01 140.63 16.94 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -149.43 178.27 27.06 Favored Glycine 0 N--CA 1.476 1.332 0 C-N-CA 118.901 -1.619 . . . . 0.0 112.6 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.753 HD13 ' N ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -134.49 150.75 50.83 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.852 0.834 . . . . 0.0 111.519 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.1 t -134.29 102.47 5.37 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.24 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.32 122.56 39.32 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.69 ' CD1' ' HE ' ' A' ' 66' ' ' ARG . 3.4 pt -121.87 146.3 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -127.69 128.93 46.28 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.601 ' H ' ' CA ' ' A' ' 64' ' ' GLY . 13.7 t70 -112.51 134.38 54.07 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.788 0.804 . . . . 0.0 111.885 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.605 ' C ' ' H ' ' A' ' 127' ' ' ILE . 76.9 m-85 -93.4 85.47 4.97 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.752 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.587 ' NE2' HH12 ' A' ' 237' ' ' ARG . 97.7 mt-30 -60.34 16.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.059 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.605 ' H ' ' C ' ' A' ' 125' ' ' PHE . 38.4 mm -68.3 -42.0 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.477 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -75.59 143.63 42.25 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.136 0.494 . . . . 0.0 110.164 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.6 -40.65 97.6 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -127.35 -7.35 5.84 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 20.2 p90 -168.91 127.0 1.02 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.911 1.687 . . . . 0.0 115.291 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.56 ' NZ ' ' OD1' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -136.76 149.28 66.49 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -69.65 137.43 35.76 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.791 1.318 . . . . 0.0 111.798 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 28.3 p90 -105.95 130.86 53.81 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 106.617 -1.624 . . . . 0.0 106.617 175.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.5 pt -127.92 149.15 32.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.74 174.36 37.38 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.952 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.04 139.14 53.65 Favored 'General case' 0 CA--C 1.523 -0.062 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 193' ' ' GLY . 0.0 OUTLIER -126.32 126.13 43.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.767 0.318 . . . . 0.0 110.882 -178.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.18 146.21 33.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.81 0.814 . . . . 0.0 111.274 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.97 127.01 44.79 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.61 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -109.6 122.92 48.52 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -153.91 86.91 0.13 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -73.04 138.95 46.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.975 0.417 . . . . 0.0 110.562 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.518 ' O ' HG22 ' A' ' 144' ' ' VAL . 14.5 p -76.22 -3.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.178 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.419 ' CB ' ' O ' ' A' ' 144' ' ' VAL . 44.6 ttm-85 80.26 88.38 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.277 0.361 . . . . 0.0 110.352 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.51 ' CE1' ' O ' ' A' ' 148' ' ' ILE . 7.6 t60 -85.44 85.88 7.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.352 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.6 t -62.58 -44.16 97.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.977 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.51 ' O ' ' CE1' ' A' ' 146' ' ' HIS . 84.2 mt -108.39 125.72 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.552 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 150' ' ' SER . 41.8 p-10 -65.72 -37.88 87.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.748 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.535 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 47.8 t -73.98 149.68 41.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.645 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 153' ' ' LYS . 3.0 m 62.68 114.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.816 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -65.73 -5.13 7.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.512 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.454 ' H ' HG22 ' A' ' 151' ' ' THR . 75.6 tttt 67.63 56.44 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.076 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.6 m -62.25 -44.64 96.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.15 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 157' ' ' VAL . 69.7 mt -74.75 130.94 35.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -43.19 -20.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.28 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.502 ' H ' HG22 ' A' ' 155' ' ' ILE . 9.2 p -140.15 142.18 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.225 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 18.7 m -61.3 136.02 57.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.244 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 29.5 m -60.46 131.89 52.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.4 m -91.15 156.4 43.94 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.659 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.65 -38.29 16.73 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.649 1.566 . . . . 0.0 112.076 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 99.7 p -148.55 100.81 3.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 110.721 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -70.12 -104.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.47 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.672 ' HB1' ' CD ' ' A' ' 165' ' ' PRO . . . -174.41 -178.11 0.35 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.672 ' CD ' ' HB1' ' A' ' 164' ' ' ALA . 27.6 Cg_exo -60.68 144.25 99.52 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.969 1.779 . . . . 0.0 111.331 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 166' ' ' ASN . 40.4 p-10 -80.11 115.57 19.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.988 0.423 . . . . 0.0 110.725 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.65 -129.38 0.88 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.19 137.82 56.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.716 0.293 . . . . 0.0 110.419 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.4 131.12 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.325 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.512 ' C ' ' H ' ' A' ' 172' ' ' TYR . 81.0 p -129.62 -7.94 4.59 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.451 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 173' ' ' ASN . 41.7 p 47.55 10.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.135 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 170' ' ' THR . 28.5 p90 34.2 31.23 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 111.607 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 174' ' ' THR . 50.5 p30 -65.67 -17.52 64.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.7 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 173' ' ' ASN . 45.7 p -69.01 134.9 50.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.245 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 5.8 p-10 -113.55 92.15 22.91 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.873 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 177' ' ' LYS . 87.3 Cg_endo -86.81 116.91 1.35 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.457 2.105 . . . . 0.0 111.538 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 176' ' ' PRO . 17.9 ptpt 33.72 -141.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.256 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 69.3 m -105.64 117.36 33.83 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.717 0.294 . . . . 0.0 110.466 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -174.18 52.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.856 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.529 ' O ' ' NH1' ' A' ' 188' ' ' ARG . 25.3 m120 -89.52 103.6 16.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.782 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 24.4 p-10 -148.48 -56.18 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.418 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -63.24 -41.65 99.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.455 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.621 ' O ' HD11 ' A' ' 187' ' ' ILE . 99.2 mt-30 -55.99 171.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.333 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.0 m -89.21 -8.09 54.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.626 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 187' ' ' ILE . 82.7 m-20 -88.34 161.37 17.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.309 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 31.6 t 58.22 -76.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.178 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.621 HD11 ' O ' ' A' ' 183' ' ' GLN . 51.6 mm 55.79 78.68 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 180' ' ' ASN . 29.7 ptt-85 -90.37 31.3 1.03 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.459 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -60.38 -43.52 96.52 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 190' ' ' VAL . 3.8 t -67.2 163.98 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 176.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.434 ' C ' HD22 ' A' ' 192' ' ' LEU . . . -142.73 148.38 20.1 Favored Glycine 0 N--CA 1.473 1.127 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.845 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.434 HD22 ' C ' ' A' ' 191' ' ' GLY . 1.7 mm? -115.51 154.79 28.7 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 138' ' ' ARG . . . -170.14 -178.77 41.28 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.46 155.67 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.567 0.699 . . . . 0.0 111.34 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 195' ' ' ILE . 16.0 tt -131.95 130.49 61.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.94 161.58 42.37 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 119.956 -0.698 . . . . 0.0 112.084 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.68 -178.36 36.71 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.88 136.57 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 117.822 0.811 . . . . 0.0 110.612 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -97.69 137.52 13.35 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -121.58 100.23 6.9 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.596 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -100.46 152.85 19.89 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -172.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 28.2 mm -89.27 -67.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 103.776 -2.676 . . . . 0.0 103.776 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.5 p -103.89 -166.33 0.1 OUTLIER Pre-proline 0 CA--C 1.542 0.668 1 N-CA-C 100.1 -4.037 . . . . 0.0 100.1 172.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -81.03 -16.63 9.81 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 CA-C-N 126.373 3.312 . . . . 0.0 112.303 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.657 ' HA ' ' H ' ' A' ' 237' ' ' ARG . 47.7 pttt -81.86 -43.95 17.53 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -81.03 104.38 11.49 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.205 -178.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.79 131.55 24.23 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.728 0.694 . . . . 0.0 112.523 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 36.7 tp -94.79 130.3 41.39 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -110.81 123.41 50.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -107.44 118.27 36.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -157.11 -175.35 27.93 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 118.023 -2.037 . . . . 0.0 114.411 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.543 ' CE2' ' CD1' ' A' ' 214' ' ' TYR . 69.5 t80 -141.25 110.03 6.09 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 113.557 -1.322 . . . . 0.0 108.724 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -104.3 128.91 52.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.142 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.543 ' CD1' ' CE2' ' A' ' 212' ' ' TYR . 37.1 p90 -151.27 156.38 40.73 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.249 0.547 . . . . 0.0 111.361 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.633 ' NE2' ' CE3' ' A' ' 217' ' ' TRP . 3.2 p80 -154.45 165.99 34.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.417 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -101.0 110.88 22.96 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.913 0.387 . . . . 0.0 111.052 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.695 ' HE1' ' N ' ' A' ' 220' ' ' LEU . 18.5 p90 -138.41 -53.04 0.61 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.611 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.64 ' N ' ' CG ' ' A' ' 217' ' ' TRP . . . 88.55 106.74 1.03 Allowed Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.751 HH22 HD21 ' A' ' 105' ' ' ASN . 5.3 tpt180 51.13 88.17 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.861 0.363 . . . . 0.0 111.176 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.695 ' N ' ' HE1' ' A' ' 217' ' ' TRP . 11.8 tp -79.65 156.05 27.79 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.29 -0.413 . . . . 0.0 109.953 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.89 -37.9 86.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.827 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -69.22 146.12 52.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.62 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 3.7 t -145.04 174.16 11.28 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.102 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 65.52 -47.32 0.38 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.806 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -103.59 114.64 29.06 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.848 0.356 . . . . 0.0 110.319 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -145.3 74.94 1.42 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.351 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 229' ' ' GLU . 16.8 p -95.87 -0.95 50.39 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.929 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 228' ' ' HIS . 51.0 t-80 -80.02 18.67 0.8 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.095 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 227' ' ' THR . 83.6 tt0 -135.3 117.26 15.26 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.592 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 43.57 88.83 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 12.9 p -165.32 173.66 10.96 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.482 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 15' ' ' LEU . 87.9 mt -90.99 160.7 15.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.298 0.571 . . . . 0.0 110.337 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -154.48 164.97 31.78 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.13 150.94 17.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 CA-C-N 117.653 0.726 . . . . 0.0 110.917 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.473 ' NH2' ' CE1' ' A' ' 134' ' ' TYR . 99.7 mtt180 -132.6 142.54 49.18 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.467 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -107.28 110.4 22.41 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.657 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 76.2 ttt-85 -131.88 108.88 9.7 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-O 122.096 0.951 . . . . 0.0 113.422 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.438 ' C ' ' O ' ' A' ' 237' ' ' ARG . 2.6 t80 . . . . . 0 N--CA 1.47 0.54 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.182 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p 55.85 26.93 10.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.696 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 4' ' ' ASP . 81.0 tt0 -66.66 -37.69 85.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.577 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' GLU . 98.8 m-20 53.55 167.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.39 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.91 22.18 0.02 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.949 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.02 13.68 71.19 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.575 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -84.54 121.14 27.18 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -165.83 -166.86 25.56 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 118.896 -1.621 . . . . 0.0 114.15 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.71 159.79 19.58 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 124.359 3.373 . . . . 0.0 115.493 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -167.13 136.96 2.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.141 -1.845 . . . . 0.0 107.95 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 12' ' ' GLN . 3.5 p -134.81 156.84 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.465 ' N ' HG22 ' A' ' 11' ' ' VAL . 27.4 pt20 -154.21 148.39 25.87 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.91 122.3 7.87 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.646 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -86.42 116.46 24.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.89 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 232' ' ' LEU . 11.8 tp -84.85 128.59 34.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.492 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.44 153.82 23.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.533 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.525 ' CD2' ' N ' ' A' ' 18' ' ' ALA . 81.2 t80 -42.45 -90.42 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.275 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.525 ' N ' ' CD2' ' A' ' 17' ' ' TYR . . . -169.31 154.54 5.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.164 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 19' ' ' TYR . 44.8 p90 -69.64 129.79 40.62 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.223 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -97.69 116.45 29.93 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.497 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.542 ' O ' ' NE2' ' A' ' 24' ' ' HIS . 67.6 m80 -150.0 85.79 1.42 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.488 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.57 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -65.82 -40.02 86.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.6 t -63.31 126.61 28.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.626 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.542 ' NE2' ' O ' ' A' ' 21' ' ' HIS . 66.3 m-70 -147.1 93.61 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.261 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 68.4 t0 -64.78 132.92 50.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.26 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 12.4 m-85 -54.03 152.57 10.44 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.207 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.19 -89.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.182 1.921 . . . . 0.0 112.568 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -136.77 151.55 72.69 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.18 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.69 98.4 1.13 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.98 1.787 . . . . 0.0 111.726 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 86.9 m -63.74 -46.23 86.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.077 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.536 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . . . 177.31 -46.7 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.9 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 31' ' ' ALA . 53.9 Cg_exo -52.58 -39.17 76.0 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.214 1.943 . . . . 0.0 111.923 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -88.6 80.78 7.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.211 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.12 -46.17 90.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.435 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -150.18 101.11 2.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.253 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -100.69 131.55 46.53 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.072 0.463 . . . . 0.0 110.643 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.7 pt -80.63 -16.38 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.745 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.6 m -76.45 93.64 3.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.33 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -176.92 91.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.514 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.51 142.67 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.819 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.2 m 49.63 59.84 4.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.571 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 43' ' ' TYR . 79.3 m-20 -63.28 -132.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 42' ' ' ASP . 62.4 t80 54.36 110.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.826 0.346 . . . . 0.0 110.821 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -135.48 151.25 50.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.422 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.41 ' H ' ' HD2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -83.94 154.74 23.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.031 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 48' ' ' ARG . 10.8 p30 -73.16 113.95 10.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.475 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 67.5 mt 47.86 -88.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.145 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 46' ' ' ASN . 37.7 ptt180 -149.32 168.26 23.84 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.726 0.298 . . . . 0.0 110.416 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.5 p -125.85 165.81 18.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.663 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 56.29 -179.49 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.311 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 51' ' ' SER . 5.1 t 51.5 35.61 14.82 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.163 0.506 . . . . 0.0 110.582 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.39 -45.94 94.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.627 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.483 ' H ' ' CD2' ' A' ' 53' ' ' HIS . 18.2 p80 -81.21 132.48 56.14 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.755 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.17 151.54 30.31 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.931 1.754 . . . . 0.0 111.739 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -88.43 128.7 35.53 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.15 161.38 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.832 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.3 t -144.35 146.16 32.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.002 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.43 153.47 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.3 179.49 39.1 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.893 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -111.51 140.7 45.89 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.851 -0.674 . . . . 0.0 110.331 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -89.27 107.56 19.12 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.49 1.119 . . . . 0.0 110.72 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -126.02 142.25 51.6 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.575 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.99 127.29 24.63 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.89 -61.11 0.71 Allowed Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -125.34 158.55 33.95 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.607 0.718 . . . . 0.0 111.967 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.492 HH21 ' NE ' ' A' ' 237' ' ' ARG . 70.7 mtt85 -133.18 147.38 52.04 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.8 mt -111.74 126.38 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.13 135.59 35.88 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.324 0.583 . . . . 0.0 111.949 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.62 122.67 47.89 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.862 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 42.5 p-10 -99.84 128.45 45.93 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -153.93 171.77 18.47 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 122.161 0.982 . . . . 0.0 112.342 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -177.55 101.66 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 113.294 -1.776 . . . . 0.0 108.048 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -142.71 157.79 44.3 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.059 0.457 . . . . 0.0 111.715 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -146.35 121.22 9.95 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.302 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -140.19 -76.45 0.33 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.875 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 77' ' ' TRP . 10.5 mtpm? 53.12 105.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.214 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.45 ' O ' ' O ' ' A' ' 76' ' ' LYS . 10.2 m-90 49.06 107.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.101 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -96.16 109.08 21.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.983 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 50.6 t30 57.66 68.66 0.82 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -78.04 155.76 30.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.005 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.33 39.82 30.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.223 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.407 ' O ' ' O ' ' A' ' 83' ' ' SER . 70.5 t80 -101.07 -42.38 6.4 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.319 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 82' ' ' TYR . 15.7 m 49.69 98.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.793 0.33 . . . . 0.0 110.523 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 85' ' ' ASN . 11.4 p -62.73 -46.8 95.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.974 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.573 ' N ' HG13 ' A' ' 84' ' ' VAL . 22.9 t-20 -104.74 99.32 8.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.549 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.642 HG23 ' N ' ' A' ' 87' ' ' GLU . 20.7 tt -121.26 -51.77 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.603 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.642 ' N ' HG23 ' A' ' 86' ' ' ILE . 83.3 tt0 -174.99 97.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.042 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -98.54 7.71 45.81 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.549 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 96.3 t -106.78 120.21 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.389 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -173.11 -52.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.213 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 93' ' ' LYS . 41.4 mm -89.82 -81.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.494 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 mmp_? 46.53 9.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.671 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 91' ' ' ILE . 51.7 mtpt -100.32 -109.81 0.2 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 95' ' ' ASN . 83.4 tt0 -80.04 151.61 29.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.313 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 94' ' ' GLU . 53.7 t-20 59.7 133.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.584 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.61 -173.83 5.72 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 98' ' ' ARG . 16.0 tt -64.86 -40.21 88.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.254 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.454 ' N ' HG23 ' A' ' 97' ' ' ILE . 16.3 tpp180 60.63 136.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.94 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.6 mm -64.13 -44.26 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.049 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 101' ' ' ARG . 47.7 t0 59.09 163.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.919 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.402 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 48.8 mmm-85 38.3 91.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.926 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -78.21 -13.71 59.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.473 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.9 m -64.37 131.25 46.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.45 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -75.77 157.19 33.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.599 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -71.61 137.52 48.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.715 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -127.29 121.59 31.54 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.426 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' A' ' 107' ' ' GLU . 56.0 mp0 -85.28 -112.87 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.741 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -64.32 -41.04 97.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.367 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.77 44.99 0.04 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.9 p -92.16 113.12 25.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.797 0.332 . . . . 0.0 110.342 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -148.85 140.46 23.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.463 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 43.11 93.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.44 151.78 31.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.307 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.54 132.49 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.65 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.4 p -156.47 163.68 39.13 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.148 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.7 p -154.51 157.87 39.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.345 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.93 160.06 44.16 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 177.31 -146.25 7.63 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.319 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 mp -137.38 148.83 46.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.19 0.519 . . . . 0.0 110.185 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 77.3 p -146.35 138.59 25.09 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.38 114.35 28.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.163 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 55.2 mt -88.87 129.83 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 135' ' ' ILE . 16.0 m-85 -100.98 116.53 33.05 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.256 0.551 . . . . 0.0 109.93 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.47 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 66.8 t0 -100.15 124.28 45.37 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.523 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.495 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 68.5 m-85 -110.03 82.6 1.62 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.693 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -58.6 -6.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 110.44 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 129' ' ' ASP . 66.7 mt -68.83 -40.45 81.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.792 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -73.2 27.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.649 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 127' ' ' ILE . 34.9 t0 68.53 -119.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.981 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -90.52 -12.26 37.71 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.1 p90 -118.2 102.49 9.03 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.359 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -109.6 130.58 22.62 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 179.086 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -76.94 120.15 5.35 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 120.728 0.952 . . . . 0.0 110.048 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' A' ' 207' ' ' THR . 24.4 m-85 -75.91 130.71 38.92 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.456 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.556 ' O ' ' CD2' ' A' ' 123' ' ' TYR . 28.6 mm -135.96 135.6 50.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.46 169.98 37.1 Favored Glycine 0 C--N 1.322 -0.25 0 C-N-CA 118.979 -1.582 . . . . 0.0 113.203 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -104.34 140.42 37.92 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -118.49 124.38 47.44 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.0 123.23 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -147.21 146.41 29.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.844 0.354 . . . . 0.0 110.377 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -130.8 155.65 46.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.947 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.41 -179.48 42.4 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 63.2 t60 -114.1 95.03 5.08 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.689 0.281 . . . . 0.0 111.184 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 99.0 t -100.95 -82.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.118 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -148.89 -123.76 0.05 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.064 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -147.7 85.06 1.55 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.655 0.264 . . . . 0.0 110.706 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 94.6 p -86.26 -16.53 37.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.964 0.412 . . . . 0.0 110.518 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 149' ' ' ASP . 16.8 tt -67.85 -39.75 82.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.795 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.463 ' N ' HG23 ' A' ' 148' ' ' ILE . 53.9 p30 -138.28 -176.49 4.47 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.695 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.0 p -154.14 162.74 40.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.628 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.7 p -143.61 -145.88 0.18 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.423 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -81.48 23.12 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.622 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -60.85 -46.45 90.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.275 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.04 101.97 2.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.305 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.73 -44.08 96.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.537 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -104.88 122.0 44.88 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.146 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 157' ' ' VAL . 9.9 p -129.6 133.32 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.804 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 2.6 t -132.24 148.75 52.46 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.901 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.8 m -122.5 127.74 49.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.951 0.405 . . . . 0.0 110.882 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 160' ' ' VAL . 22.9 t -49.1 111.61 2.03 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.578 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -51.39 138.66 46.76 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.356 1.371 . . . . 0.0 111.838 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.9 t -61.76 -44.51 96.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.179 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -167.95 -82.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.311 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.674 ' HB3' ' HD3' ' A' ' 165' ' ' PRO . . . -164.93 -63.9 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' A' ' 164' ' ' ALA . 72.8 Cg_endo -71.1 146.31 51.65 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.118 1.879 . . . . 0.0 111.191 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -138.33 109.31 6.75 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.883 0.373 . . . . 0.0 111.008 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 169' ' ' VAL . . . 54.17 -135.58 43.74 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 167' ' ' GLY . . . 70.18 -39.61 0.44 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.808 0.337 . . . . 0.0 110.728 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 167' ' ' GLY . 34.0 m -71.45 -32.95 48.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 34.88 76.35 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 58.7 p -67.04 -32.55 73.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.158 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 83.4 t80 45.64 93.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.914 0.388 . . . . 0.0 110.459 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -135.87 137.3 41.3 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.34 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.3 m -81.11 81.59 7.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.402 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -114.74 90.64 22.82 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.056 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -89.65 116.52 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.651 2.234 . . . . 0.0 111.457 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -147.09 -30.54 0.34 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.692 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.4 t -122.13 -22.88 5.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.72 0.295 . . . . 0.0 110.975 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 51.2 98.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.931 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 66.0 t30 49.77 96.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.152 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 181' ' ' ASP . 67.4 t0 -159.63 44.47 0.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.386 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.495 ' CD2' ' N ' ' A' ' 183' ' ' GLN . 53.2 p90 -61.73 -46.41 89.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.896 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.495 ' N ' ' CD2' ' A' ' 182' ' ' TYR . 58.5 tt0 -157.36 -24.22 0.09 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.824 0.345 . . . . 0.0 110.7 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.0 m -83.52 -174.93 5.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.756 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 57.21 38.16 28.67 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.409 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.3 t -61.51 164.89 5.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.563 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 38.4 pt -65.55 -40.76 89.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.172 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -164.31 84.39 0.43 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.21 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -137.23 -18.59 1.3 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.1 163.21 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 114.291 -1.322 . . . . 0.0 107.661 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.672 ' C ' HD12 ' A' ' 192' ' ' LEU . . . -130.59 102.87 0.54 Allowed Glycine 0 N--CA 1.468 0.771 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.672 HD12 ' C ' ' A' ' 191' ' ' GLY . 10.7 mp -127.75 133.89 49.51 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.068 0.461 . . . . 0.0 110.143 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -179.33 -140.17 3.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.33 152.47 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.442 0.639 . . . . 0.0 110.547 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.3 tp -111.96 142.1 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.59 174.66 13.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 111.81 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 155.91 -176.99 33.23 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.66 136.65 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -131.86 135.07 7.97 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 120.431 -0.89 . . . . 0.0 114.467 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -106.74 113.1 26.4 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 113.684 -1.258 . . . . 0.0 108.224 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 201' ' ' ASP . 43.6 p30 -51.34 147.03 6.23 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.092 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.0 mm -108.9 -51.48 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.522 HG22 ' HD2' ' A' ' 204' ' ' PRO . 0.3 OUTLIER -106.79 -174.06 0.3 Allowed Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 176.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.522 ' HD2' HG22 ' A' ' 203' ' ' THR . 11.0 Cg_exo -32.87 -70.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 122.55 1.947 . . . . 0.0 114.311 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -126.8 20.72 7.06 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.171 0.986 . . . . 0.0 110.425 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.5 tt -88.24 127.62 35.45 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.425 HG21 ' OH ' ' A' ' 134' ' ' TYR . 6.0 t -137.09 152.75 50.38 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.1 tt -105.7 124.25 49.25 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.465 ' CG ' ' NH1' ' A' ' 235' ' ' ARG . 2.2 p30 -137.1 147.62 46.17 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -174.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -91.08 127.03 36.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -114.93 150.5 18.71 Favored Glycine 0 N--CA 1.471 0.977 0 C-N-CA 121.287 -0.482 . . . . 0.0 113.001 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.64 127.84 37.84 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -89.85 136.64 32.92 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.61 101.08 6.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.682 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.613 ' NE2' ' ND2' ' A' ' 216' ' ' ASN . 84.7 t60 -97.42 126.77 42.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.613 ' ND2' ' NE2' ' A' ' 215' ' ' HIS . 94.4 m-20 42.62 -168.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 110.757 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -86.8 131.68 34.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.015 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -90.73 135.27 12.77 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -152.62 170.9 19.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.738 0.304 . . . . 0.0 110.571 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.601 HD22 ' N ' ' A' ' 220' ' ' LEU . 3.5 mm? -75.64 133.54 40.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.202 0.525 . . . . 0.0 111.145 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -173.82 118.16 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.583 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 223' ' ' THR . 55.4 t-20 58.65 34.63 23.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.093 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.41 ' C ' ' O ' ' A' ' 222' ' ' ASN . 69.2 p 29.98 82.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.141 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -86.61 149.47 24.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.972 0.415 . . . . 0.0 110.76 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -143.84 -160.36 1.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.747 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.1 tttp 60.53 77.08 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.848 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.0 m -139.59 73.82 1.44 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.804 0.335 . . . . 0.0 110.552 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.575 ' CD2' ' H ' ' A' ' 229' ' ' GLU . 11.2 t-80 -146.3 171.02 15.61 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.133 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.575 ' H ' ' CD2' ' A' ' 228' ' ' HIS . 97.0 mt-10 55.98 38.65 30.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.384 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -41.23 -85.66 0.0 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.528 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 97.1 p -163.24 156.51 19.25 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.981 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 233' ' ' GLY . 5.8 tt -124.23 126.24 45.76 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 177.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.555 ' N ' HD23 ' A' ' 232' ' ' LEU . . . -115.36 171.28 13.63 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.278 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.31 129.73 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 113.708 -1.246 . . . . 0.0 108.32 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.465 ' NH1' ' CG ' ' A' ' 209' ' ' ASP . 83.8 mtt85 -132.48 141.79 48.95 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.805 0.335 . . . . 0.0 110.353 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -122.0 112.16 17.93 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.658 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.492 ' NE ' HH21 ' A' ' 66' ' ' ARG . 87.5 mtm-85 -134.06 126.65 30.59 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 . . . . . 0 C--O 1.218 -0.563 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.453 -178.915 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 4' ' ' ASP . 48.4 t -61.45 -177.52 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.518 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 59.13 -73.63 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.67 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 2' ' ' SER . 99.9 m-20 -62.5 -40.37 96.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.868 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.07 -143.53 22.14 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.17 -121.97 0.78 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.49 ' H ' ' HD2' ' A' ' 7' ' ' ARG . 3.2 mpt_? -75.68 152.53 37.52 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.448 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . 169.31 -78.55 0.1 Allowed Glycine 0 CA--C 1.541 1.68 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.487 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.464 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 71.4 Cg_endo -82.25 158.29 17.45 Favored 'Trans proline' 0 N--CA 1.507 2.277 0 C-N-CA 122.899 2.399 . . . . 0.0 111.989 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.623 ' CE2' ' NH1' ' A' ' 66' ' ' ARG . 3.4 t80 -148.1 137.71 22.34 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 236' ' ' TYR . 57.6 t -131.84 135.15 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -136.46 144.27 44.31 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -174.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.434 ' O ' ' OD1' ' A' ' 14' ' ' ASP . . . -152.99 149.43 28.18 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.304 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 13' ' ' ALA . 86.0 m-20 -144.44 125.71 14.71 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.175 -0.328 . . . . 0.0 110.661 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.401 HD12 ' C ' ' A' ' 14' ' ' ASP . 5.3 mp -140.66 163.46 32.81 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.353 0.596 . . . . 0.0 111.903 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 17' ' ' TYR . . . -131.32 -112.68 0.24 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.133 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' ALA . 67.2 t80 58.21 129.96 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.773 0.321 . . . . 0.0 111.124 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -157.88 43.72 0.32 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.183 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -134.98 127.29 30.23 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.157 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -100.79 175.59 5.58 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.985 0.421 . . . . 0.0 111.031 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.44 ' CG ' ' N ' ' A' ' 22' ' ' ILE . 70.5 t60 61.16 170.76 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.862 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.44 ' N ' ' CG ' ' A' ' 21' ' ' HIS . 19.8 tt -83.42 153.94 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.852 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 25' ' ' ASP . 14.9 m -72.15 99.93 2.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.504 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 24' ' ' HIS . 85.0 t60 45.53 10.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.794 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 23' ' ' THR . 35.4 t70 58.03 -178.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.791 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.502 ' H ' ' CG ' ' A' ' 25' ' ' ASP . 43.5 m-85 57.39 68.25 2.09 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.67 -39.23 89.99 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 123.121 2.548 . . . . 0.0 113.38 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.76 152.44 32.12 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.106 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.65 -99.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.281 1.988 . . . . 0.0 111.793 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 47.2 p -110.88 -87.6 0.53 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.607 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.445 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -177.39 53.11 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.65 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 31' ' ' ALA . 37.5 Cg_endo -65.35 -24.23 57.81 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.721 2.281 . . . . 0.0 112.065 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 32' ' ' PRO . 89.9 m-20 -150.21 115.22 5.35 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.702 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -147.7 135.64 21.18 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.522 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.496 ' CG ' ' H ' ' A' ' 36' ' ' LYS . 62.6 t30 -162.47 -144.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.148 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.496 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 86.0 tttt -145.49 -79.34 0.18 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.3 mt -139.58 -54.73 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 t 40.81 -158.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER 71.69 -164.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.225 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.521 ' H ' HG22 ' A' ' 39' ' ' THR . 85.3 t -62.68 -45.39 98.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.804 0.335 . . . . 0.0 110.494 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.6 t -65.58 140.71 58.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.536 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 54.4 p-10 -154.18 76.85 1.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.264 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -107.72 130.78 54.91 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.662 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -71.72 -14.35 61.99 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -73.3 148.34 43.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.705 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -134.23 91.93 2.87 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 47' ' ' ILE . 2.4 mp -68.17 -21.54 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -60.08 143.59 51.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.209 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 t -144.83 173.21 12.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -42.97 -66.97 0.31 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.918 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 71.1 m -161.39 -123.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.044 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.537 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 14.8 p -63.92 -26.13 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.453 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' A' ' 53' ' ' HIS . 20.2 p80 43.61 99.95 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.496 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.95 140.16 69.35 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.375 1.383 . . . . 0.0 112.775 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -139.11 -160.77 1.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.036 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.464 HG22 ' N ' ' A' ' 57' ' ' SER . 9.7 p -150.01 154.42 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 119.567 -0.853 . . . . 0.0 113.065 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 56' ' ' VAL . 15.2 t -135.67 134.49 39.24 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.009 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.36 163.34 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.295 0.569 . . . . 0.0 111.933 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.64 -160.35 25.52 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -128.9 143.67 50.96 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 120.84 0.352 . . . . 0.0 110.345 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 9' ' ' PRO . 18.1 p-10 -124.72 115.39 20.66 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -126.91 158.02 37.88 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.49 123.02 32.05 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.426 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.06 -89.07 0.28 Allowed Glycine 0 N--CA 1.474 1.184 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.3 p-90 -127.79 174.04 9.45 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.623 ' NH1' ' CE2' ' A' ' 10' ' ' TYR . 25.3 ttp85 -147.32 147.42 30.34 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.354 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.39 144.24 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.39 150.18 19.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.364 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.88 159.14 31.8 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 55.6 p30 -140.45 153.07 46.13 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.51 169.26 24.21 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.363 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.5 -155.13 0.67 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.946 0.403 . . . . 0.0 111.305 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -147.86 60.63 1.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.735 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -145.11 -1.21 0.85 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.999 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -71.03 -21.46 62.26 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.759 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' TRP . 65.4 tttm -139.89 -81.94 0.27 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.716 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.579 ' CG ' ' N ' ' A' ' 78' ' ' ASN . 25.4 t90 51.15 176.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.135 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.579 ' N ' ' CG ' ' A' ' 77' ' ' TRP . 99.0 m-20 55.27 36.29 26.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.909 0.385 . . . . 0.0 110.123 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -62.31 -40.04 95.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.68 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -80.97 107.5 13.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -78.71 155.37 29.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.641 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.521 ' O ' ' CD2' ' A' ' 82' ' ' TYR . 52.8 p90 -85.78 122.76 30.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.027 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.3 p -83.76 175.85 9.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.361 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.3 t 61.01 112.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.425 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -94.78 137.92 33.25 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.638 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.4 pt -127.02 121.94 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.59 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 87' ' ' GLU . 44.7 mp0 38.45 32.13 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.191 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -95.08 1.84 55.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.886 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 90' ' ' ARG . 13.5 p -122.94 -37.17 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 120.828 0.346 . . . . 0.0 110.6 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.431 ' N ' HG13 ' A' ' 89' ' ' VAL . 79.5 mtp85 -64.07 -36.88 85.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.636 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.3 pt -66.14 151.24 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.768 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -127.16 152.37 47.43 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.714 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.64 164.98 29.34 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.631 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -146.54 156.55 43.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.599 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -139.26 128.97 24.66 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.283 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -153.82 74.48 0.24 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 98' ' ' ARG . 96.1 mt -118.32 130.86 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.812 0.339 . . . . 0.0 110.203 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 97' ' ' ILE . 89.4 mtm180 -50.94 -104.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.7 pt -133.83 155.68 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.869 0.366 . . . . 0.0 110.763 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -86.94 177.07 7.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.597 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.594 HH11 HD22 ' A' ' 105' ' ' ASN . 85.0 mtp180 -52.63 -176.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.552 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -62.52 -43.52 98.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.44 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.6 p -140.1 163.48 32.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.377 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -62.47 160.8 12.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.066 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.594 HD22 HH11 ' A' ' 101' ' ' ARG . 30.6 p30 -141.97 176.2 9.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.728 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 76.13 21.85 1.45 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.915 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -147.18 -45.98 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.599 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -90.52 115.32 27.57 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.168 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 160.44 -92.9 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.517 HG22 ' CD2' ' A' ' 111' ' ' PHE . 5.8 m -63.79 144.03 57.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 0.0 110.787 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.517 ' CD2' HG22 ' A' ' 110' ' ' THR . 65.9 m-85 42.78 -165.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.866 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -66.39 133.18 49.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.641 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.53 -50.47 71.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.202 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 68.2 t -131.43 135.1 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.944 0.402 . . . . 0.0 111.033 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.5 m -161.95 87.63 0.66 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.019 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.447 ' OG ' ' N ' ' A' ' 117' ' ' LEU . 91.0 p -88.92 -79.39 0.32 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' ' 117' ' ' LEU . 3.2 mm? -89.83 131.89 35.53 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.73 134.71 7.5 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.188 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.2 tt -123.94 140.76 52.66 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.9 t -133.27 123.01 24.74 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' A' ' 136' ' ' GLY . . . -94.39 130.72 40.62 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 123' ' ' TYR . 88.2 mt -129.73 159.36 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.499 ' N ' HG22 ' A' ' 122' ' ' ILE . 55.8 m-85 -118.42 118.15 30.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 237' ' ' ARG . 54.4 t0 -140.0 114.9 9.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.909 0.385 . . . . 0.0 111.478 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -122.11 96.18 4.95 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.574 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.564 ' NE2' ' OD1' ' A' ' 201' ' ' ASP . 47.9 tt0 -93.51 -0.62 56.27 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.397 0.618 . . . . 0.0 109.907 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.0 -23.56 29.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 12.7 t-20 -60.79 -42.63 97.94 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.165 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 128' ' ' ASN . 52.2 m-20 -175.21 -110.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.677 0.611 . . . . 0.0 109.366 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -118.22 1.05 11.86 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.665 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -128.81 131.67 47.78 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.485 0.491 . . . . 0.0 110.116 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.675 ' NZ ' HH22 ' A' ' 237' ' ' ARG . 0.5 OUTLIER -116.56 128.04 26.3 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.025 -178.055 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.13 129.55 29.02 Favored 'Trans proline' 0 N--CA 1.482 0.816 0 N-CA-C 107.187 -1.89 . . . . 0.0 107.187 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -115.16 129.15 56.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.368 0.604 . . . . 0.0 111.234 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.2 tt -162.2 148.77 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.509 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 121' ' ' ALA . . . -169.22 -177.23 39.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 119.637 -1.268 . . . . 0.0 113.157 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.48 144.03 30.76 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.044 0.45 . . . . 0.0 110.326 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -119.1 118.85 32.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.949 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.25 128.99 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.938 0.399 . . . . 0.0 110.657 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.31 128.06 43.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -142.38 165.77 26.5 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.783 0.802 . . . . 0.0 111.749 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.16 -6.78 0.08 OUTLIER Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 189' ' ' ARG . 79.5 m80 -88.75 166.68 13.88 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.872 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 98.5 t -80.38 131.71 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.068 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -95.66 132.82 40.43 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.952 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -153.89 -82.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.315 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 149' ' ' ASP . 26.4 m -80.75 -80.28 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.434 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 23.0 mm 65.85 -51.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.935 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 147' ' ' SER . 63.8 t0 -62.18 -41.44 98.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.661 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 149' ' ' ASP . 24.5 p 41.18 93.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.579 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 m -62.65 -45.39 93.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.799 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -151.07 -113.21 0.05 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.517 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 57.97 -168.74 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.005 0.431 . . . . 0.0 111.021 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 60.9 m 54.97 81.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.776 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.2 pt -131.09 161.88 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.284 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -73.47 107.67 5.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 111.229 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.2 m -108.55 -2.31 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 28.4 p -103.32 138.98 39.35 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.29 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.7 t -144.19 156.14 44.19 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.517 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.97 148.96 50.0 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.19 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 163' ' ' ASN . 94.5 Cg_endo -76.13 -96.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.134 1.889 . . . . 0.0 112.084 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.7 t 45.24 16.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 161' ' ' PRO . 64.9 t30 55.75 38.31 29.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.98 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . 58.14 152.21 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.258 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.59 137.55 27.87 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 121.984 1.79 . . . . 0.0 111.616 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -162.9 170.55 18.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.748 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 153.06 109.8 0.4 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.45 -4.29 58.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.058 0.456 . . . . 0.0 110.174 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.36 -17.2 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.717 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.7 t -132.95 155.52 48.97 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.023 0.44 . . . . 0.0 110.768 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.6 p -82.15 172.23 13.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.836 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -65.58 140.67 58.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.568 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -86.41 110.17 19.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.844 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 65.6 p -70.38 138.72 51.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.466 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -92.3 150.18 39.71 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.623 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.97 158.83 45.65 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.506 2.137 . . . . 0.0 111.901 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 45.43 -156.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.301 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 70.5 p -130.42 159.46 36.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 110.828 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 48.76 89.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.526 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -142.79 90.05 2.18 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.572 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 -117.2 12.77 14.52 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.578 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -78.55 139.12 38.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.896 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -154.79 -29.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.366 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 34.1 p -156.61 162.14 39.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.579 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -151.98 155.37 37.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.325 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 84.0 p -75.37 159.99 30.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.389 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.5 tt -87.38 126.25 41.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.163 0.506 . . . . 0.0 110.274 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.517 ' C ' ' H ' ' A' ' 190' ' ' VAL . 87.4 mtm180 -65.35 -35.47 81.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.224 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.524 ' O ' ' ND1' ' A' ' 143' ' ' HIS . 69.2 mtm180 67.15 -5.0 0.75 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.275 0.559 . . . . 0.0 109.67 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.517 ' H ' ' C ' ' A' ' 188' ' ' ARG . 14.9 p -137.85 153.97 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -136.04 151.34 20.7 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 119.904 -1.141 . . . . 0.0 112.973 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.8 pp -166.89 147.54 5.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.144 0.497 . . . . 0.0 111.273 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -172.86 -156.84 13.32 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.92 147.92 33.08 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-O 122.063 0.935 . . . . 0.0 113.041 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 7.5 tp -116.89 148.01 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.204 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.09 167.12 30.31 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.897 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 150.98 -168.31 30.66 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.5 m -140.53 159.7 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 117.317 0.558 . . . . 0.0 110.407 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -143.91 133.78 5.49 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.787 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -130.51 127.23 38.73 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.564 ' OD1' ' NE2' ' A' ' 126' ' ' GLN . 0.1 OUTLIER -79.19 152.02 30.91 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 -173.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 202' ' ' ILE . 1.2 mp -62.36 -42.85 97.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 174.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.1 OUTLIER -164.5 171.9 5.22 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 176.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.569 ' O ' ' C ' ' A' ' 238' ' ' PHE . 13.8 Cg_endo -65.91 63.72 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 CA-C-N 121.722 1.651 . . . . 0.0 110.598 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 203' ' ' THR . 16.3 ptpt -134.21 -46.4 0.77 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.12 0.568 . . . . 0.0 110.516 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.408 ' N ' ' HG3' ' A' ' 205' ' ' LYS . 7.5 tt -160.63 153.21 20.82 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.1 t -134.48 152.84 52.05 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.67 133.26 34.26 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 112.881 -1.963 . . . . 0.0 106.482 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.598 ' CG ' HH12 ' A' ' 235' ' ' ARG . 6.1 t70 -135.66 133.91 38.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.908 0.861 . . . . 0.0 112.564 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -101.94 117.99 35.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.06 143.89 15.12 Favored Glycine 0 N--CA 1.467 0.735 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.983 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -171.32 136.06 1.0 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.373 -0.913 . . . . 0.0 108.597 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.527 ' O ' ' CD1' ' A' ' 214' ' ' TYR . 0.0 OUTLIER -166.15 -139.84 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.251 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 213' ' ' ARG . 75.8 m-85 -155.48 -158.88 0.86 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.471 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -141.47 167.46 22.11 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.212 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 62.98 90.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.58 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -96.33 137.74 34.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.392 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 152.41 -117.95 0.85 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.426 ' O ' ' ND2' ' A' ' 222' ' ' ASN . 93.9 mtt-85 -70.4 147.13 49.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.787 0.327 . . . . 0.0 110.254 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 220' ' ' LEU . 3.4 mm? -62.21 -42.03 98.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -92.19 107.4 19.19 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.572 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 219' ' ' ARG . 10.3 p30 -162.08 117.47 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.559 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.69 HG22 ' H ' ' A' ' 224' ' ' ARG . 28.2 m 50.85 175.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.615 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.69 ' H ' HG22 ' A' ' 223' ' ' THR . 2.5 mpt_? -65.71 147.92 52.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.018 0.437 . . . . 0.0 110.356 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -63.78 -37.73 88.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.938 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 56.08 96.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.136 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 69.2 p -78.31 165.53 23.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.515 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.416 ' HD1' ' H ' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -151.52 164.17 37.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.293 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -82.56 -86.92 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.481 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -171.48 162.68 6.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.581 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 32.1 t -140.84 123.05 15.74 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.889 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.27 127.96 42.75 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -117.65 152.36 17.69 Favored Glycine 0 CA--C 1.517 0.2 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 234' ' ' VAL . 33.3 m -122.86 128.04 75.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.598 HH12 ' CG ' ' A' ' 209' ' ' ASP . 80.5 mtm-85 -126.24 141.16 52.03 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.397 0.618 . . . . 0.0 110.03 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.455 ' HB3' ' H ' ' A' ' 11' ' ' VAL . 41.1 t80 -90.62 115.57 27.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.121 -176.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.675 HH22 ' NZ ' ' A' ' 132' ' ' LYS . 31.3 ttm105 -124.04 87.88 2.81 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.569 ' C ' ' O ' ' A' ' 204' ' ' PRO . 33.3 t80 . . . . . 0 CA--C 1.512 -0.505 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.721 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.9 p -155.51 163.09 40.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.415 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 57.0 mp0 -80.76 127.19 32.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.36 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -72.28 -117.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.245 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.36 11.23 85.22 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.64 -143.54 8.51 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.602 HH22 HE22 ' A' ' 126' ' ' GLN . 95.9 mtt-85 -82.92 156.31 23.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.814 -0.193 . . . . 0.0 110.792 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.524 ' O ' ' CD2' ' A' ' 10' ' ' TYR . . . 120.54 -95.22 0.57 Allowed Glycine 0 CA--C 1.55 2.253 0 CA-C-O 119.716 -0.491 . . . . 0.0 113.394 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.576 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 71.8 Cg_exo -45.65 106.63 0.09 OUTLIER 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.232 2.621 . . . . 0.0 116.825 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 16.7 m-85 -146.51 157.2 43.71 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.97 154.66 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.077 -1.049 . . . . 0.0 112.703 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.574 HE21 ' C ' ' A' ' 13' ' ' ALA . 46.9 tp60 -120.24 149.67 41.9 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.307 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.574 ' C ' HE21 ' A' ' 12' ' ' GLN . . . -137.7 125.87 23.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.209 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 53.1 p-10 -91.91 149.75 21.39 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 15' ' ' LEU . 1.0 OUTLIER 178.49 174.54 0.62 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.591 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.33 156.67 34.89 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.917 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 90.9 m-85 -107.15 136.28 47.25 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.952 0.406 . . . . 0.0 111.198 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 17' ' ' TYR . . . 68.81 104.07 0.06 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.673 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' A' ' 20' ' ' GLU . 86.2 t80 -142.36 155.95 45.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.37 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.543 ' O ' ' CD2' ' A' ' 19' ' ' TYR . 57.7 mp0 -81.7 148.3 29.05 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.929 0.395 . . . . 0.0 111.202 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -175.19 45.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.588 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.95 97.47 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.221 0.534 . . . . 0.0 111.044 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.3 m -66.66 -44.55 81.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.737 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 60.69 90.83 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.633 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 25' ' ' ASP . 40.4 p-10 -132.44 110.56 10.61 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.656 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.564 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.7 OUTLIER -165.83 44.97 0.11 Allowed Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 121.143 0.497 . . . . 0.0 110.255 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 26' ' ' TYR . 37.9 Cg_endo -64.31 -22.56 66.37 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.574 2.183 . . . . 0.0 112.074 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 27' ' ' PRO . 43.2 mt-10 56.91 150.6 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.103 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.57 87.19 1.57 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.25 1.966 . . . . 0.0 111.47 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.436 ' O ' ' C ' ' A' ' 31' ' ' ALA . 90.3 m -65.06 -86.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.05 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 30' ' ' THR . . . -26.63 91.77 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 O-C-N 123.611 0.57 . . . . 0.0 112.177 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.09 146.59 14.4 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 122.119 1.879 . . . . 0.0 111.978 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 55.01 35.0 23.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.852 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -62.27 -45.44 93.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.458 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -124.8 149.07 47.78 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.279 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -61.68 -44.99 95.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.268 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.22 128.16 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.245 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -155.97 76.86 0.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.596 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -159.22 28.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.643 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.38 162.97 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.914 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.2 p 51.68 175.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.945 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.9 t0 60.3 50.33 6.29 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.49 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -73.63 -126.12 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.947 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 45' ' ' ARG . 91.1 m-85 -65.11 -44.84 87.46 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.319 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 44' ' ' PHE . 28.3 mmt180 42.43 96.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.913 0.387 . . . . 0.0 110.856 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -78.89 143.98 35.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.677 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.451 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -103.91 132.1 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.308 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -77.15 148.49 35.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.744 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 t -146.33 160.67 41.71 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.659 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -137.66 90.0 2.46 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.538 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.8 t -155.88 123.62 5.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.279 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.97 162.89 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.264 0.555 . . . . 0.0 111.378 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -60.29 153.7 57.03 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.997 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.2 42.17 0.84 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.5 2.133 . . . . 0.0 111.541 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 53.58 -129.5 2.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.787 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 57' ' ' SER . 9.1 p -163.57 157.33 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 117.696 -1.602 . . . . 0.0 114.929 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.54 ' N ' HG22 ' A' ' 56' ' ' VAL . 21.8 t -117.7 121.6 41.3 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 113.946 -1.479 . . . . 0.0 107.783 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -132.97 148.72 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.64 0.257 . . . . 0.0 110.607 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -157.77 165.9 33.73 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.327 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -112.85 147.65 36.53 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 66' ' ' ARG . 24.9 t70 -157.08 153.97 28.71 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -177.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 62' ' ' PHE . 4.8 p90 -130.77 155.07 47.28 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 110.629 -2.987 . . . . 0.0 106.146 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . -42.85 117.35 1.48 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.509 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 124' ' ' ASP . . . 144.82 -89.65 0.16 Allowed Glycine 0 CA--C 1.534 1.241 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 25.1 p-90 -152.86 173.27 15.55 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.7 HH22 ' NH1' ' A' ' 237' ' ' ARG . 0.2 OUTLIER -130.88 173.02 11.37 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.042 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.5 mt -116.7 125.38 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 171.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.4 111.78 13.16 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.31 126.53 32.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.723 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -90.82 127.81 36.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -119.13 113.03 20.27 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.91 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -170.47 122.83 0.65 Allowed 'General case' 0 C--N 1.339 0.116 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.786 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -147.56 135.33 21.07 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.922 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -139.89 -20.99 0.89 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.934 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -93.26 60.98 3.27 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.836 0.351 . . . . 0.0 111.147 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.68 -77.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.368 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -158.17 147.98 19.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.945 0.402 . . . . 0.0 110.61 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -147.6 145.0 28.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.006 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 81' ' ' LYS . 47.0 t30 48.47 -116.36 0.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.287 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.515 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 13.6 t-20 58.07 -75.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.686 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 79' ' ' ASN . 68.1 mttm -63.04 -43.68 98.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.46 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 84' ' ' VAL . 87.9 m-85 -63.34 -42.46 98.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.082 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.0 t 57.34 -77.76 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.853 0.359 . . . . 0.0 110.477 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 82' ' ' TYR . 35.9 m -126.62 160.61 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.661 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 87' ' ' GLU . 98.6 m-20 -83.35 72.75 10.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.319 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 85' ' ' ASN . 43.8 mm 31.36 -86.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.91 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 85' ' ' ASN . 74.1 mm-40 -63.68 143.65 57.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.916 0.388 . . . . 0.0 110.696 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -98.93 143.86 28.76 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.72 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 89' ' ' VAL . 13.0 p -79.73 131.53 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.297 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 91' ' ' ILE . 78.8 ttt-85 -165.2 -57.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.665 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 90' ' ' ARG . 18.5 pt 32.02 -121.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.915 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -93.12 35.7 1.06 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.68 0.276 . . . . 0.0 111.321 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.7 mttp 54.08 -170.57 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.626 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 53.59 94.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.785 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -63.55 -41.15 98.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.767 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.52 -135.33 4.09 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.9 pt -80.34 136.83 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.91 0.386 . . . . 0.0 110.464 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -144.76 -44.53 0.24 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.65 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.6 mm -63.83 -43.64 97.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.0 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -78.17 92.18 4.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.358 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -73.12 142.95 47.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.385 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -138.85 151.43 46.99 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.272 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.17 135.33 53.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.422 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -125.97 -22.14 4.2 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.779 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 59.39 46.89 11.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.105 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 107' ' ' GLU . 77.2 mt-30 -57.01 133.06 54.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.051 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 106' ' ' GLN . 97.0 mt-10 55.16 165.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -159.54 81.28 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.601 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.47 -3.83 57.89 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 112' ' ' HIS . 22.3 m -65.85 131.02 45.28 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.202 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -88.35 -3.6 58.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.301 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.689 ' H ' HG22 ' A' ' 110' ' ' THR . 27.7 t-80 69.39 -1.61 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.607 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.32 144.34 26.39 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.996 0.427 . . . . 0.0 110.782 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.34 162.85 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.826 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.6 p -45.56 115.24 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.076 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.2 m -81.77 -135.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.176 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.02 144.48 50.37 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 177.18 -141.63 5.42 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.101 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.2 130.57 53.32 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.53 0.681 . . . . 0.0 111.694 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.4 m -132.25 111.32 11.29 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.47 127.76 38.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 123' ' ' TYR . 1.9 mp -90.34 161.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 176.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.447 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 2.4 t80 -139.76 108.0 5.79 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.548 ' CB ' HH12 ' A' ' 66' ' ' ARG . 18.3 t70 -123.7 132.44 53.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.36 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.508 ' C ' ' H ' ' A' ' 127' ' ' ILE . 27.6 m-85 -93.99 84.1 4.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.798 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.602 HE22 HH22 ' A' ' 7' ' ' ARG . 54.9 tt0 -52.14 -4.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.786 -0.571 . . . . 0.0 111.352 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.508 ' H ' ' C ' ' A' ' 125' ' ' PHE . 92.7 mt -66.59 -42.71 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 120.228 -0.589 . . . . 0.0 112.304 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 22.4 t-20 -68.02 -40.35 82.95 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.189 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 128' ' ' ASN . 11.4 t0 88.6 -55.15 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.031 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -79.33 -51.74 9.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 131' ' ' PHE . 2.0 p90 -151.55 128.22 10.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -134.75 153.34 78.77 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.122 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.472 ' HA ' HG12 ' A' ' 198' ' ' VAL . 17.2 Cg_exo -64.56 136.01 48.27 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 120.514 0.81 . . . . 0.0 110.68 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.81 128.2 34.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.7 mt -141.55 139.77 31.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -171.2 175.01 44.93 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.231 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.69 152.81 48.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -124.86 130.8 53.09 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.0 t -130.71 118.52 42.61 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.23 130.2 42.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.024 0.44 . . . . 0.0 110.563 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -111.48 136.71 50.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.43 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -90.57 -70.44 1.21 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -154.44 130.53 10.28 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.707 0.289 . . . . 0.0 110.444 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.99 110.78 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.208 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -96.21 3.57 53.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.194 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 51.1 m170 -95.17 130.45 41.9 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.963 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 149' ' ' ASP . 22.7 t -139.14 140.21 37.83 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.426 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 150' ' ' SER . 90.6 mt 47.28 -86.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.543 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 147' ' ' SER . 97.8 m-20 57.01 45.27 21.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.195 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 152' ' ' LYS . 11.5 t -61.62 -43.54 98.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.002 0.43 . . . . 0.0 110.402 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 93.9 m 43.75 -89.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.767 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 150' ' ' SER . 25.4 pttm -72.95 133.35 44.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.727 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -114.56 -113.36 0.34 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.872 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 155' ' ' ILE . 77.3 p -73.2 -20.43 60.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.924 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 154' ' ' THR . 93.7 mt 55.11 109.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.468 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.41 -109.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.017 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.03 136.13 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.269 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 57.1 p -131.15 152.66 50.21 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.018 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 98.8 m -88.25 126.57 35.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.783 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.4 m -85.93 151.31 54.63 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.822 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -41.86 140.21 2.09 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.07 1.847 . . . . 0.0 112.591 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 163' ' ' ASN . 61.9 m -107.75 69.4 0.74 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.827 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 162' ' ' SER . 64.1 t30 60.54 128.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.487 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.51 79.28 4.4 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.186 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -60.79 147.77 94.14 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.49 2.127 . . . . 0.0 110.975 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -139.87 170.56 15.65 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.956 0.408 . . . . 0.0 111.058 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 168' ' ' ALA . . . 154.18 -52.39 0.46 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 167' ' ' GLY . . . 54.73 161.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.779 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -64.25 -29.35 47.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.443 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 69.0 p -74.31 169.77 16.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 81.1 p -76.52 165.04 25.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -142.68 10.0 1.8 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.647 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -63.0 -41.15 99.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.257 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 81.2 p -108.81 128.48 54.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.977 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -97.05 150.9 37.34 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.577 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -37.39 -54.77 1.1 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 122.404 2.07 . . . . 0.0 112.527 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -165.46 -29.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.073 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 36.2 m -66.76 133.51 50.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.826 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -151.17 81.14 1.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.835 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.6 t30 56.9 33.84 23.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.401 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -89.03 168.54 12.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.446 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -81.83 142.98 32.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.349 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.561 ' CD ' ' H ' ' A' ' 183' ' ' GLN . 1.7 mp0 -51.26 149.88 3.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.544 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.2 t 46.28 -159.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.808 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -129.19 139.93 51.7 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.799 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.1 t -68.72 -148.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.985 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 187' ' ' ILE . 3.5 mp -73.7 125.48 32.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.537 HH22 ' CZ ' ' A' ' 189' ' ' ARG . 9.5 ptm180 -81.17 157.91 25.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.306 0.575 . . . . 0.0 111.46 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.537 ' CZ ' HH22 ' A' ' 188' ' ' ARG . 99.7 mtt180 54.48 61.61 2.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.861 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.28 155.97 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -134.6 131.73 6.02 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.212 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.1 mp -136.7 132.62 35.15 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.583 0.706 . . . . 0.0 109.902 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -162.42 -170.5 27.31 Favored Glycine 0 C--N 1.321 -0.27 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.1 m -134.69 160.91 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.435 1.118 . . . . 0.0 113.653 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mt -110.12 136.26 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 113.032 -1.895 . . . . 0.0 110.251 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -160.67 147.0 15.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.693 0.758 . . . . 0.0 110.871 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 163.06 -172.44 39.07 Favored Glycine 0 C--O 1.221 -0.686 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 133' ' ' PRO . 33.8 m -136.93 155.05 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 118.303 1.051 . . . . 0.0 109.472 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -154.78 159.51 29.03 Favored Glycine 0 C--O 1.241 0.555 0 C-N-CA 119.452 -1.356 . . . . 0.0 112.181 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.84 153.15 37.68 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.541 0.686 . . . . 0.0 110.557 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -59.52 149.5 29.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.065 -1.425 . . . . 0.0 113.971 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 206' ' ' LEU . 47.0 mm -111.31 -46.13 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.55 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.2 OUTLIER -127.43 -172.93 0.28 Allowed Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 175.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.55 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.8 OUTLIER -14.06 -85.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.401 0 CA-C-N 124.04 2.478 . . . . 0.0 114.869 -178.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -126.7 21.39 7.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.007 0.908 . . . . 0.0 110.057 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 202' ' ' ILE . 1.0 OUTLIER -75.08 112.98 11.88 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.6 t -130.87 152.59 50.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.45 143.07 44.2 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 113.082 -1.872 . . . . 0.0 107.9 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.81 150.68 49.05 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -126.31 134.15 51.2 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 231' ' ' SER . . . -174.57 -164.13 28.95 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 119.431 -1.366 . . . . 0.0 113.419 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -156.28 151.23 26.22 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 115.221 -0.49 . . . . 0.0 109.795 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 80.2 mtm-85 -92.6 124.93 36.98 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -107.07 125.41 51.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 109.97 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -56.61 156.97 5.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.556 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -45.38 160.24 0.05 OUTLIER 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.578 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -78.45 143.67 36.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.547 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -170.77 84.23 0.08 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -71.92 -22.04 61.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.544 0.211 . . . . 0.0 111.458 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 220' ' ' LEU . 11.1 mp -62.13 -41.45 98.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.12 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -157.03 133.15 9.66 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.97 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -161.91 70.54 0.33 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.98 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 19.7 m -66.33 -43.24 86.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.76 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -56.44 149.49 16.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.244 0.545 . . . . 0.0 111.189 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -101.55 152.03 21.27 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.009 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -88.27 -178.59 5.95 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.947 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.4 m -144.8 157.94 43.98 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.129 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -117.11 123.98 48.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.196 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -139.76 151.2 45.61 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.923 0.392 . . . . 0.0 110.623 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -97.88 76.13 2.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 211' ' ' GLY . 29.6 t -157.87 158.34 34.91 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.565 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.419 ' C ' HD13 ' A' ' 232' ' ' LEU . 0.3 OUTLIER -178.05 -72.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 147.7 -166.83 28.75 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.5 ' N ' HE22 ' A' ' 12' ' ' GLN . 3.0 m -134.71 144.98 33.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -118.21 136.63 53.53 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -101.32 107.88 19.35 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.017 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.7 ' NH1' HH22 ' A' ' 66' ' ' ARG . 81.8 mtp180 -113.93 113.58 25.04 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.431 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 93.3 m-85 . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.428 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.6 p -102.72 75.14 1.4 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.748 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.509 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 56.3 mp0 -82.81 22.7 0.88 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.215 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -64.78 141.53 58.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.001 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.62 177.3 46.79 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.89 16.64 50.51 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.131 -0.787 . . . . 0.0 111.131 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -129.06 157.99 40.19 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.47 124.77 6.83 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.21 160.05 33.05 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.902 1.734 . . . . 0.0 109.583 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.708 ' CD2' ' NH2' ' A' ' 66' ' ' ARG . 33.1 t80 -151.07 136.98 18.15 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.45 -0.9 . . . . 0.0 113.01 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 12' ' ' GLN . 52.0 t -141.49 160.41 21.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.457 ' N ' HG12 ' A' ' 11' ' ' VAL . 57.6 tt0 -147.78 140.02 24.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.882 0.765 . . . . 0.0 112.856 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.01 122.9 45.53 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.158 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -83.11 124.82 30.84 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.4 tp -116.52 132.37 56.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.998 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.88 47.5 0.78 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.28 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' CD2' ' N ' ' A' ' 18' ' ' ALA . 68.1 t80 47.85 -104.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.926 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.45 ' N ' ' CD2' ' A' ' 17' ' ' TYR . . . -157.4 -134.72 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.761 0.315 . . . . 0.0 110.701 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -146.71 161.96 39.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.577 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -120.53 137.72 54.23 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.516 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -153.08 164.16 38.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.745 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 22' ' ' ILE . 16.0 tt -128.48 126.3 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.956 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.454 ' C ' ' ND1' ' A' ' 24' ' ' HIS . 69.2 p -129.59 -11.6 4.45 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.547 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.454 ' ND1' ' C ' ' A' ' 23' ' ' THR . 46.3 p-80 36.22 46.75 0.41 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.598 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -97.45 114.37 26.21 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.174 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 7.3 m-85 -54.31 149.66 19.07 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.58 152.76 78.76 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.871 1.714 . . . . 0.0 111.297 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 28' ' ' GLU . 20.2 mp0 -124.9 78.95 65.11 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.607 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -89.88 115.73 0.62 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 123.016 2.477 . . . . 0.0 112.251 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -65.47 -45.98 81.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.068 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 59.09 60.73 4.85 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.175 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.52 151.51 53.14 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.701 2.268 . . . . 0.0 112.036 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -103.82 144.83 30.97 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.681 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.81 125.22 28.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.382 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -159.3 171.73 19.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.424 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -89.69 96.13 10.56 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.9 pt -69.24 -40.85 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 m 58.34 9.25 0.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.778 0.323 . . . . 0.0 110.861 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.7 p -135.1 157.21 47.5 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.657 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 t -89.26 131.08 37.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.357 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.1 m -113.79 146.33 40.09 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.936 0.398 . . . . 0.0 110.537 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -86.75 155.05 20.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.885 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -110.5 149.96 29.58 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.437 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -99.27 130.89 45.59 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.028 0.442 . . . . 0.0 110.818 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -63.75 -158.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.937 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.1 m120 57.14 60.0 3.16 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.25 -48.59 88.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.429 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -161.41 160.39 29.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.602 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.4 p -134.86 155.79 50.05 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.938 0.399 . . . . 0.0 110.723 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -161.28 -48.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.075 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 52' ' ' VAL . 88.8 p 54.51 -162.52 0.13 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.828 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 51' ' ' SER . 4.5 t 60.93 127.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 52' ' ' VAL . 49.7 m80 -153.04 94.01 3.12 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -80.78 118.35 3.44 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.824 1.683 . . . . 0.0 110.006 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' HG13 ' A' ' 56' ' ' VAL . 39.6 mmt180 -71.08 -122.61 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 55' ' ' ARG . 8.3 m -157.18 -176.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 119.206 -0.998 . . . . 0.0 112.961 -176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.89 136.4 54.93 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.875 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.2 p -141.85 148.98 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.017 0.437 . . . . 0.0 111.776 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.58 -155.61 20.26 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -131.83 154.15 49.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.47 ' HB3' ' HE ' ' A' ' 66' ' ' ARG . 2.5 p30 -130.01 133.17 46.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -175.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.73 123.51 33.22 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.945 -1.48 . . . . 0.0 107.479 175.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -34.77 134.73 0.4 Allowed Glycine 0 N--CA 1.472 1.038 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.522 ' O ' ' CD2' ' A' ' 123' ' ' TYR . . . 97.64 -63.45 0.93 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -131.23 136.02 47.87 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.342 0.591 . . . . 0.0 111.153 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.708 ' NH2' ' CD2' ' A' ' 10' ' ' TYR . 54.9 mtp180 -137.01 156.05 48.92 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.1 tt -139.64 140.68 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.377 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.18 147.22 10.97 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.83 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.85 149.49 26.35 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -115.99 145.63 42.8 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.596 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 80.3 m-85 67.41 -98.08 0.04 OUTLIER 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.192 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 71' ' ' TYR . . . 96.83 81.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.468 1.105 . . . . 0.0 110.3 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -151.59 144.72 24.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 111.198 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 75' ' ' ARG . 32.0 p90 -178.59 13.09 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.509 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 74' ' ' TYR . 83.6 mtp180 -54.06 -123.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.723 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.1 tptp 64.95 48.84 2.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.646 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -92.57 148.99 21.64 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.618 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.5 ' CG ' ' H ' ' A' ' 79' ' ' ASN . 41.4 t-20 47.73 -139.86 0.63 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.234 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.5 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 13.6 m120 55.33 43.03 29.62 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.765 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -56.11 109.88 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 0.0 110.146 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.96 155.69 47.83 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.539 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -62.88 121.77 14.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.0 110.89 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.418 ' H ' ' H ' ' A' ' 84' ' ' VAL . 18.7 p -161.44 -12.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.974 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 85' ' ' ASN . 55.5 t -124.38 133.75 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.06 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.42 ' O ' ' O ' ' A' ' 84' ' ' VAL . 12.8 m120 56.07 111.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.555 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.9 mt -80.61 128.42 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.596 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -132.81 142.71 49.12 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.212 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 90' ' ' ARG . 49.3 p-10 -68.57 -27.07 65.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.804 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 88' ' ' ASN . 40.2 t 45.7 -87.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.517 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.547 ' N ' ' O ' ' A' ' 88' ' ' ASN . 89.7 mtm-85 -78.62 142.58 37.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.844 0.354 . . . . 0.0 110.348 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.495 ' C ' ' H ' ' A' ' 93' ' ' LYS . 42.7 pt -104.77 -141.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.865 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 94' ' ' GLU . 69.7 ttt180 68.52 -11.84 0.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' A' ' 91' ' ' ILE . 54.3 mtmt 48.89 -87.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.94 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 92' ' ' ARG . 49.9 tp10 -67.58 91.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.534 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -64.7 -40.97 96.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.719 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.0 98.82 0.09 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.0 pt -129.93 160.54 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 120.794 0.331 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -78.78 147.28 33.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.845 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.2 mt -81.25 128.09 39.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.228 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 101' ' ' ARG . 34.2 t70 -124.39 42.39 3.27 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.701 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 100' ' ' ASP . 77.2 ttt-85 58.01 150.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.333 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 103' ' ' THR . 63.6 mttp -64.54 -45.42 87.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.619 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER 27.56 -107.37 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.459 0.475 . . . . 0.0 111.621 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.508 ' N ' ' OG1' ' A' ' 103' ' ' THR . 97.6 mt-10 -83.76 151.85 24.99 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 107' ' ' GLU . 55.6 p30 -150.76 171.09 17.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.922 0.391 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -55.08 90.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.355 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 105' ' ' ASN . 80.8 tt0 -78.06 141.1 39.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.436 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.602 HD21 ' CE1' ' A' ' 112' ' ' HIS . 64.9 t30 56.95 46.9 18.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.607 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -71.09 48.64 0.86 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 t -137.42 160.09 40.09 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.771 0.32 . . . . 0.0 110.376 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -95.8 136.84 35.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.992 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.602 ' CE1' HD21 ' A' ' 108' ' ' ASN . 70.6 m80 -83.55 152.91 24.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.652 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -153.45 39.53 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.437 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 115' ' ' SER . 69.1 t -62.76 -46.76 95.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.986 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 114' ' ' VAL . 2.9 t 34.79 97.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.638 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.441 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 26.3 t -158.99 74.02 0.63 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.748 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.34 142.6 49.39 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 168.22 -151.76 19.12 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 118.931 -1.604 . . . . 0.0 113.768 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.8 mt -113.32 160.17 18.63 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 114.993 -0.604 . . . . 0.0 109.84 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 p -143.67 129.17 19.07 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 111.818 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.0 130.03 40.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 123' ' ' TYR . 73.0 mt -123.9 161.59 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -175.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.526 ' N ' HG22 ' A' ' 122' ' ' ILE . 50.5 t80 -140.65 141.16 35.08 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.407 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 24.1 p-10 -143.38 138.63 29.54 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.279 0.561 . . . . 0.0 111.598 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.5 ' H ' ' HB2' ' A' ' 132' ' ' LYS . 14.8 m-85 -83.97 83.56 7.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.048 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.464 HE21 HH12 ' A' ' 237' ' ' ARG . 70.2 mm-40 -85.33 6.09 27.84 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.28 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 128' ' ' ASN . 20.4 tt -69.21 -40.16 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.421 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.548 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 20.1 p30 -90.65 -40.53 11.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.749 0.309 . . . . 0.0 110.202 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 1.2 m-20 77.1 -30.43 0.17 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.277 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -65.34 -45.04 85.8 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.059 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -154.49 116.16 4.15 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.568 0.699 . . . . 0.0 110.928 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.5 ' HB2' ' H ' ' A' ' 125' ' ' PHE . 1.1 ptpp? -115.54 119.66 37.51 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.233 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -53.14 118.16 4.53 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 CA-C-N 119.736 0.941 . . . . 0.0 110.066 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -76.28 127.82 33.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.8 tt -155.98 146.46 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 118.768 -1.173 . . . . 0.0 112.818 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -169.76 178.63 42.62 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.22 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -116.19 157.4 24.9 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -124.83 138.47 54.26 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.33 114.05 32.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.97 152.65 51.91 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -104.26 160.75 14.62 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.426 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -126.62 -54.59 0.15 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -119.94 109.78 15.93 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.9 m -89.69 3.32 6.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.241 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.468 ' O ' ' CG ' ' A' ' 146' ' ' HIS . 59.1 ttm-85 55.71 -120.64 1.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.468 ' CG ' ' O ' ' A' ' 145' ' ' ARG . 79.0 m80 -157.77 -56.09 0.08 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.807 0.337 . . . . 0.0 110.457 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 85.6 p -73.96 151.9 40.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 149' ' ' ASP . 21.4 tt -133.19 -37.94 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.097 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 148' ' ' ILE . 53.3 t0 -70.18 147.78 49.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.633 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.7 m 60.02 115.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.802 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.7 p -129.92 -49.2 1.13 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.589 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -147.86 135.79 21.12 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.389 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 154' ' ' THR . 60.2 tttp -136.98 133.2 35.34 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.711 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 153' ' ' LYS . 5.6 m 57.47 153.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 156' ' ' GLU . 20.3 mm -106.17 117.71 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.549 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 155' ' ' ILE . 80.1 mm-40 56.82 140.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.338 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.9 m -106.11 -12.47 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.521 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 15.4 p -86.2 155.01 20.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.241 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 86.5 m -119.06 128.37 54.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.216 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.6 m -73.87 146.65 85.56 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.251 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.3 161.03 43.79 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.463 2.109 . . . . 0.0 112.235 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 70.7 m -68.65 148.81 49.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.773 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 57.72 34.7 24.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.296 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.678 ' HB3' ' HD3' ' A' ' 165' ' ' PRO . . . -66.59 -60.7 6.11 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 164' ' ' ALA . 77.5 Cg_endo -74.25 -172.48 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.222 1.948 . . . . 0.0 110.967 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 166' ' ' ASN . 61.7 t-20 57.11 38.27 28.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.866 0.365 . . . . 0.0 110.421 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -115.9 17.63 15.18 Favored Glycine 0 N--CA 1.466 0.636 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 61.28 -153.41 0.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.332 . . . . 0.0 110.53 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.7 m -113.05 131.96 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.911 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.6 m -61.77 -46.44 89.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.702 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 5.3 m -162.21 -47.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.095 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -83.26 137.93 33.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.132 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -63.8 -40.24 96.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.601 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 85.4 m 48.68 90.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.503 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -87.02 135.75 34.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.72 67.05 8.76 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.096 1.864 . . . . 0.0 111.504 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -62.65 -41.0 98.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.382 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.8 t -144.31 154.99 43.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.987 0.422 . . . . 0.0 110.913 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -103.31 147.55 26.93 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.327 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -95.85 11.33 34.08 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.562 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.28 108.02 13.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.978 0.418 . . . . 0.0 110.613 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -147.41 136.1 21.96 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.101 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -49.96 110.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.535 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.9 m -73.13 145.41 46.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.739 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -163.81 32.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.161 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 187' ' ' ILE . 75.1 p -58.3 -88.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.029 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.407 ' N ' ' OG ' ' A' ' 186' ' ' SER . 37.6 mm 50.24 87.78 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 42.38 -135.34 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.356 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -106.35 122.3 45.97 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.453 0.644 . . . . 0.0 111.816 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.5 t -121.15 132.78 69.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.853 ' C ' HD13 ' A' ' 192' ' ' LEU . . . -137.84 136.38 8.14 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 119.177 -1.487 . . . . 0.0 113.756 -176.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 1.059 HD22 ' H ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -117.52 148.75 41.57 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.378 -0.911 . . . . 0.0 108.81 178.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -169.28 -169.63 32.85 Favored Glycine 0 C--N 1.32 -0.312 0 N-CA-C 107.906 -2.077 . . . . 0.0 107.906 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.0 m -137.98 155.08 29.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.981 0.896 . . . . 0.0 111.972 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.6 tp -113.86 131.69 65.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.015 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.76 149.19 33.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.119 0.485 . . . . 0.0 111.259 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.94 -167.17 37.26 Favored Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 p -145.13 140.13 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 117.284 0.542 . . . . 0.0 110.46 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.48 130.55 9.18 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.38 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.606 ' N ' ' OG1' ' A' ' 207' ' ' THR . 2.6 t80 -115.09 118.71 34.14 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -61.26 149.88 36.42 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 206' ' ' LEU . 51.4 mm -113.35 -61.13 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.515 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.7 OUTLIER -102.11 -173.14 0.28 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 175.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.515 ' C ' ' O ' ' A' ' 203' ' ' THR . 5.5 Cg_exo -22.76 -79.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.352 0 CA-C-N 123.281 2.208 . . . . 0.0 114.486 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -128.33 34.89 4.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.543 0.687 . . . . 0.0 111.181 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 202' ' ' ILE . 0.3 OUTLIER -90.31 111.7 23.01 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.606 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 0.9 OUTLIER -132.51 152.52 51.53 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.17 140.52 29.42 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.453 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 233' ' ' GLY . 4.4 m-20 -118.94 138.83 52.51 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -121.69 123.43 41.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 113.717 -1.583 . . . . 0.0 107.841 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -160.17 -175.81 31.56 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.365 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -141.96 154.21 44.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.78 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.533 ' N ' ' NE ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -83.5 139.1 33.12 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -128.38 89.96 2.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.72 0.295 . . . . 0.0 110.667 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -101.64 140.01 36.52 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.65 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.8 t30 60.29 70.47 0.62 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 111.16 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -59.65 -41.56 90.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.959 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -126.82 -142.9 5.72 Favored Glycine 0 N--CA 1.468 0.816 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 56.45 66.63 1.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.749 0.309 . . . . 0.0 110.261 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 40.9 tp 40.61 80.82 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.685 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -87.53 123.41 32.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.559 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -82.71 141.75 32.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.93 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 23.8 m -73.33 120.1 18.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.963 0.411 . . . . 0.0 110.996 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -160.31 152.84 20.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.854 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -148.94 152.26 36.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.87 0.367 . . . . 0.0 110.861 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -146.94 -69.56 0.25 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.508 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.9 p -62.77 -78.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.214 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 71.9 t60 38.71 78.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.949 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' A' ' 230' ' ' ALA . 84.0 tt0 -145.17 -92.01 0.1 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.324 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 229' ' ' GLU . . . 169.18 86.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 38.6 p -160.2 167.66 27.13 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.099 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 26.8 tp -177.72 -63.9 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.807 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.429 ' O ' ' OD2' ' A' ' 209' ' ' ASP . . . 160.57 -168.82 36.17 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 119.929 -1.129 . . . . 0.0 112.781 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.0 127.92 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.731 ' NH2' HH11 ' A' ' 237' ' ' ARG . 0.2 OUTLIER -104.95 141.95 35.64 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.05 0.453 . . . . 0.0 110.425 -179.028 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -107.62 108.68 20.06 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.053 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.731 HH11 ' NH2' ' A' ' 235' ' ' ARG . 82.4 mtp180 -129.38 120.11 25.0 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.407 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 1.6 m-85 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.707 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 4' ' ' ASP . 34.2 t -85.41 65.13 9.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.497 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 4' ' ' ASP . 83.1 tt0 47.42 -97.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.522 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 3' ' ' GLU . 6.8 p-10 41.43 -169.18 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.908 0.385 . . . . 0.0 111.029 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.51 14.56 50.47 Favored Glycine 0 N--CA 1.465 0.627 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.18 -57.81 15.35 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.031 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -139.76 148.12 41.81 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 117.03 0.415 . . . . 0.0 110.896 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.413 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . -166.35 -174.84 36.12 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.708 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.471 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 95.9 Cg_endo -82.69 176.65 7.59 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.884 3.056 . . . . 0.0 113.525 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.401 ' CE1' ' NH1' ' A' ' 66' ' ' ARG . 75.8 t80 -141.26 145.09 35.11 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 t -152.7 145.41 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 114.417 -1.265 . . . . 0.0 108.027 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.53 150.6 27.95 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.94 147.01 52.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 112.13 -2.304 . . . . 0.0 105.931 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -152.76 137.57 17.06 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.52 133.39 45.03 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.063 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.15 -87.55 0.48 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.522 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -120.81 122.99 41.51 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.463 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.2 162.37 16.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.845 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -148.4 160.21 43.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.32 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.89 119.62 39.44 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.448 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.633 ' CG ' ' H ' ' A' ' 22' ' ' ILE . 81.3 t60 -87.63 178.55 6.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.429 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.633 ' H ' ' CG ' ' A' ' 21' ' ' HIS . 20.7 tt -118.43 140.02 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.538 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.3 p -129.79 164.32 24.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.287 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -81.5 112.77 19.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.624 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -76.29 145.05 39.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.653 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -43.52 163.49 0.16 Allowed Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.149 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.43 ' O ' ' OE1' ' A' ' 28' ' ' GLU . 25.5 Cg_exo -60.76 146.92 96.58 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.478 1.452 . . . . 0.0 111.975 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.536 ' H ' ' HD2' ' A' ' 29' ' ' PRO . 1.3 tp10 -179.01 -45.44 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.437 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.536 ' HD2' ' H ' ' A' ' 28' ' ' GLU . 51.8 Cg_exo -54.26 -37.29 88.19 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.333 2.022 . . . . 0.0 112.225 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 30' ' ' THR . 1.3 t -80.45 159.07 25.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.586 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . . . 177.82 -47.92 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.473 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 31' ' ' ALA . 50.8 Cg_exo -53.73 -41.08 77.09 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.251 1.967 . . . . 0.0 112.319 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' LYS . 20.4 t-20 -175.07 -93.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 0.0 110.455 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.479 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 45.3 mmtm 49.7 -177.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.075 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -152.3 58.28 0.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.595 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -72.67 -79.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.8 pt -75.18 -23.26 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.101 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -60.21 -42.35 94.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.089 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.4 m -124.59 132.3 53.44 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.9 0.381 . . . . 0.0 110.672 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.85 134.6 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.167 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 t -164.63 22.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.452 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -80.3 166.18 21.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.749 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -147.25 159.32 43.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -73.42 139.99 46.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.53 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -156.08 156.35 34.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.442 ' C ' ' H ' ' A' ' 48' ' ' ARG . 98.8 m-20 54.44 103.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.992 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -77.02 27.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.647 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 46' ' ' ASN . 11.6 ptp180 -44.62 -21.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.953 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.42 ' N ' ' C ' ' A' ' 47' ' ' ILE . 22.7 p -69.08 81.68 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.533 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -147.08 129.49 15.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 110.662 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 52' ' ' VAL . 47.1 t -139.79 -85.68 0.22 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.797 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 51' ' ' SER . 3.0 t 56.41 152.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.804 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.3 m170 55.18 79.1 0.35 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.245 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 55' ' ' ARG . 56.5 Cg_endo -90.22 79.67 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.011 2.474 . . . . 0.0 112.834 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 54' ' ' PRO . 56.8 ttp180 29.85 102.91 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 p -142.71 146.05 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.6 m -128.86 149.09 50.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.207 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.31 153.29 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.81 -148.73 7.53 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 61' ' ' ASP . 16.4 t80 -138.8 155.95 47.75 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 9' ' ' PRO . 7.4 p-10 -133.06 134.68 44.66 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -127.12 147.93 50.16 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 175.528 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.34 140.58 32.33 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.841 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.2 -35.21 2.98 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.11 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.454 ' O ' ' O ' ' A' ' 62' ' ' PHE . 84.6 m95 -139.4 131.13 27.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.406 0.603 . . . . 0.0 111.606 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.401 ' NH1' ' CE1' ' A' ' 10' ' ' TYR . 46.0 ttp180 -144.21 132.5 21.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.751 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.622 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -139.35 153.62 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.923 0.868 . . . . 0.0 112.358 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.39 140.0 8.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.934 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.98 146.01 24.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.698 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -93.31 128.74 39.46 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.515 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -109.24 140.14 43.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.498 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 73' ' ' ARG . . . -150.65 -75.49 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.486 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 72' ' ' ALA . 66.6 ttt180 56.73 136.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.162 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -145.21 149.88 35.71 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.149 0.5 . . . . 0.0 111.28 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -164.4 -174.41 3.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.829 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.4 tttm 67.19 47.85 1.28 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.833 0.349 . . . . 0.0 110.581 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.417 ' O ' ' O ' ' A' ' 78' ' ' ASN . 51.0 t90 -60.78 -46.47 90.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.816 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 77' ' ' TRP . 91.4 m-20 39.94 -161.94 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.793 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -65.0 141.74 58.67 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 82' ' ' TYR . 53.0 t-20 -101.0 -122.32 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.002 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 82' ' ' TYR . 17.8 ptpt -70.78 25.24 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.427 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.547 ' CG ' ' O ' ' A' ' 81' ' ' LYS . 53.9 p90 43.04 -170.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.02 0.438 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 84' ' ' VAL . 78.4 p -156.03 120.26 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.36 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 83' ' ' SER . 24.2 t 47.15 102.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.218 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -153.23 -85.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.572 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' GLU . 43.9 pt -91.47 -158.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.69 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 86' ' ' ILE . 83.0 tt0 59.59 124.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.332 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 87' ' ' GLU . 92.1 m-20 -145.72 178.9 7.81 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.713 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.8 p -91.33 136.78 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.39 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -120.2 131.85 55.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.751 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.536 HG22 ' N ' ' A' ' 92' ' ' ARG . 86.9 mt 35.17 -101.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.33 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.536 ' N ' HG22 ' A' ' 91' ' ' ILE . 62.0 ttp180 -171.57 92.25 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.037 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -84.13 153.92 23.44 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -41.26 110.01 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.867 0.365 . . . . 0.0 110.695 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -63.08 -40.79 98.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.931 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 99' ' ' ILE . . . 83.76 57.61 2.4 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.71 -42.95 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.762 0.315 . . . . 0.0 110.647 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.0 tpp85 -57.87 -46.36 84.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.848 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.444 ' O ' ' O ' ' A' ' 96' ' ' GLY . 42.1 pt -137.61 148.22 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.924 0.392 . . . . 0.0 110.772 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -79.85 152.63 29.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -69.83 148.58 48.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.36 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -143.24 156.5 44.76 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.73 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 t -144.41 156.28 44.14 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.438 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -124.92 -160.46 0.95 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.544 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 m120 57.74 36.53 26.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.861 0.362 . . . . 0.0 110.44 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.52 -12.7 61.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.347 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -70.18 -3.39 16.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.33 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -62.24 -41.19 98.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.582 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.37 145.93 31.1 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.7 p -116.4 130.71 56.91 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.833 0.349 . . . . 0.0 110.327 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -77.36 145.13 37.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.561 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -93.18 109.04 20.54 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.55 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.37 144.41 44.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.737 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.27 139.69 18.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.001 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.9 p -56.85 139.46 51.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.143 0.497 . . . . 0.0 111.769 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.8 m -161.45 147.84 14.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.365 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.1 mt -91.5 130.94 37.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -109.4 147.7 16.99 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.372 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.9 tp -128.3 133.0 48.65 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.3 m -137.27 116.42 12.54 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.555 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.98 134.14 55.44 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.168 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 123' ' ' TYR . 74.5 mt -119.73 158.94 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.522 ' N ' HG22 ' A' ' 122' ' ' ILE . 31.7 m-85 -113.73 109.71 19.0 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' OD2' ' NH1' ' A' ' 237' ' ' ARG . 20.9 t70 -107.36 138.64 43.19 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -116.87 152.37 34.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.677 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -147.37 44.22 1.13 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.7 mt -69.18 -42.46 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -96.0 -13.15 24.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.41 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 61.88 29.42 17.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.336 0.588 . . . . 0.0 109.984 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -125.64 -51.5 1.6 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.846 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 131' ' ' PHE . 43.1 p90 -175.16 131.78 0.3 Allowed 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.247 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -134.21 151.64 76.81 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.846 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.22 130.98 20.99 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.507 1.471 . . . . 0.0 109.899 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.474 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 2.4 p90 -120.55 133.32 55.4 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 39.9 pt -135.55 152.76 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.286 0.565 . . . . 0.0 111.424 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.84 174.89 39.24 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -117.2 143.08 46.25 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.935 0.398 . . . . 0.0 110.194 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -116.92 116.89 28.28 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.401 HG22 ' N ' ' A' ' 140' ' ' ALA . 12.6 p -124.65 158.95 31.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' ' 139' ' ' VAL . . . -135.71 142.97 45.14 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.647 0.737 . . . . 0.0 112.572 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -132.39 132.5 42.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.304 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -96.78 -133.85 7.89 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.842 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -142.17 165.9 26.17 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.5 m -133.35 158.57 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.07 0.462 . . . . 0.0 110.866 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -103.39 153.91 19.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.303 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -60.22 103.72 0.26 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.155 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.5 t -61.73 -42.19 98.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.325 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 92.2 mt -89.79 121.1 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.293 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 151' ' ' THR . 53.4 p30 -157.37 174.93 14.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.667 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 152' ' ' LYS . 10.3 m 53.49 -83.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.924 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.516 ' N ' ' O ' ' A' ' 149' ' ' ASP . 24.4 p -47.3 89.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 150' ' ' SER . 52.5 tptt -64.95 -45.26 86.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.46 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 55.96 168.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.486 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.2 t -149.24 171.21 16.84 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.908 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 34.2 pt -67.67 140.25 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.797 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -74.05 121.49 21.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.304 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.73 -42.7 93.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 58.9 p -120.55 153.49 36.67 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.49 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.7 m -99.14 126.08 44.82 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.999 0.428 . . . . 0.0 111.218 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 52.2 t -115.82 110.99 43.6 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.617 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -53.3 144.52 48.74 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.358 1.372 . . . . 0.0 112.149 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 85.9 p -73.81 154.36 39.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.804 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -107.56 6.86 28.38 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.704 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.13 62.46 0.76 Allowed Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.454 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.8 158.44 42.95 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.668 2.245 . . . . 0.0 111.536 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -77.64 106.55 9.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 0.0 110.481 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -69.21 149.0 48.37 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.55 -11.37 60.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.679 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.8 t -84.23 119.22 32.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.72 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 172' ' ' TYR . 5.2 m -158.88 -14.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.35 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 173' ' ' ASN . 51.2 p 47.53 11.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.035 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.522 ' O ' ' CD2' ' A' ' 172' ' ' TYR . 89.8 t80 49.61 9.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.029 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 171' ' ' THR . 57.3 t-20 -140.46 -0.12 1.61 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.03 0.443 . . . . 0.0 110.172 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 93.7 m -63.67 -45.18 91.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.929 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -86.86 132.5 41.91 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.853 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.66 116.46 3.51 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.084 1.856 . . . . 0.0 111.856 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -87.64 118.47 27.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.831 0.348 . . . . 0.0 110.618 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 180' ' ' ASN . 3.0 t -147.86 146.29 29.02 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.437 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.419 ' O ' ' ND2' ' A' ' 180' ' ' ASN . 88.5 mt-30 44.31 14.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.078 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 178' ' ' THR . 15.9 m120 -137.25 27.24 2.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.442 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.51 143.66 57.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.849 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -146.53 158.07 43.84 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.433 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -73.78 -89.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.286 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.8 m -140.41 67.2 1.37 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.073 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 43.15 -105.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.575 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.4 t 53.69 73.72 0.36 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 65.8 mt -62.91 -45.17 99.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.031 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -70.66 140.78 51.63 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -80.57 151.89 28.88 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.81 148.83 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 114.029 -1.442 . . . . 0.0 108.855 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -130.34 126.2 4.89 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 7.4 tt -120.57 123.52 43.08 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 122.066 0.936 . . . . 0.0 111.415 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -138.06 157.37 24.31 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.59 139.63 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 117.41 0.605 . . . . 0.0 111.463 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 tt -116.42 132.98 64.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.472 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.52 34.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.04 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 162.5 -165.88 36.35 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.3 p -136.41 146.57 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 120.975 0.417 . . . . 0.0 109.974 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -117.67 137.37 13.18 Favored Glycine 0 C--O 1.244 0.754 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.977 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.634 ' N ' ' OG1' ' A' ' 207' ' ' THR . 10.7 t80 -122.16 120.0 32.94 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.689 0.876 . . . . 0.0 109.301 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 201' ' ' ASP . 22.6 p30 -61.94 139.38 58.4 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.528 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 202' ' ' ILE . 63.9 mt -125.18 -5.59 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-O 122.523 1.154 . . . . 0.0 109.499 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.581 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -160.35 -178.64 0.92 Allowed Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 101.271 -3.603 . . . . 0.0 101.271 177.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.581 ' C ' ' O ' ' A' ' 203' ' ' THR . 13.8 Cg_exo -18.95 -83.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 CA-C-N 123.965 2.452 . . . . 0.0 114.089 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -128.92 20.2 5.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.661 0.743 . . . . 0.0 109.884 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.408 ' HB3' ' OG1' ' A' ' 203' ' ' THR . 5.9 tt -78.98 124.18 28.01 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 1.8 t -143.42 154.08 43.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -175.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.411 ' C ' HD23 ' A' ' 208' ' ' LEU . 7.7 tt -91.55 126.65 36.71 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 112.92 -1.945 . . . . 0.0 105.797 175.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 210' ' ' ALA . 41.5 t0 -102.12 144.49 30.61 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -175.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.517 ' N ' ' OD1' ' A' ' 209' ' ' ASP . . . -125.17 113.68 18.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.346 -1.752 . . . . 0.0 107.538 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -175.38 -165.27 31.25 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -147.07 161.36 41.0 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.951 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.2 ttp-105 -129.57 103.24 6.76 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.432 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.529 ' CD1' ' NE2' ' A' ' 228' ' ' HIS . 84.6 t80 -174.68 148.69 1.15 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.064 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -159.1 -84.61 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.66 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -84.49 153.12 23.51 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.907 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -59.41 -47.78 84.17 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.446 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 79.29 152.91 7.23 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 45.97 -172.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.982 0.42 . . . . 0.0 111.292 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 222' ' ' ASN . 2.1 mm? -76.1 142.69 41.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.672 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -70.83 31.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.141 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 220' ' ' LEU . 8.6 p30 -68.52 102.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER 34.57 -103.87 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.78 -179.067 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.55 ' N ' ' OG1' ' A' ' 223' ' ' THR . 34.4 mmt180 28.07 98.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.336 0.398 . . . . 0.0 111.918 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.412 ' O ' ' CD2' ' A' ' 225' ' ' PHE . 52.1 p90 -105.91 129.72 54.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.51 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -111.41 -177.83 3.29 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.339 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.9 t -145.11 154.55 42.58 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.254 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.529 ' NE2' ' CD1' ' A' ' 214' ' ' TYR . 28.1 m170 -106.97 -63.48 1.28 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.039 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 52.04 44.18 29.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.987 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 51.48 -177.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.362 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.1 t -149.26 143.42 25.86 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 120.989 0.423 . . . . 0.0 110.543 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 59.4 mt -112.78 137.68 50.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -148.63 165.75 29.17 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.339 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.19 127.4 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.77 145.58 44.74 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.083 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -112.91 116.35 29.85 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.405 ' NH1' ' OD2' ' A' ' 124' ' ' ASP . 81.4 mtm180 -124.34 133.05 53.55 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.904 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.548 ' OXT' ' CG ' ' A' ' 238' ' ' PHE . 85.1 t80 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.546 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 t -69.78 143.29 53.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.552 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -163.95 97.98 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.915 0.388 . . . . 0.0 110.643 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -91.84 106.22 18.3 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.403 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.91 168.65 37.69 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.535 ' O ' ' CZ ' ' A' ' 238' ' ' PHE . . . 168.24 -82.81 0.1 OUTLIER Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.931 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -78.74 142.34 37.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 111.62 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.29 178.56 40.15 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.159 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.66 152.71 25.99 Favored 'Trans proline' 0 N--CA 1.507 2.291 0 C-N-CA 124.153 3.236 . . . . 0.0 116.397 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.53 ' CD2' ' NH2' ' A' ' 66' ' ' ARG . 6.7 p90 -148.69 164.67 33.66 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.442 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 p -131.99 153.99 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.402 0.62 . . . . 0.0 112.527 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.555 ' NE2' HH22 ' A' ' 235' ' ' ARG . 63.8 tt0 -120.95 142.61 49.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.032 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 14' ' ' ASP . . . -142.87 149.86 39.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.471 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 13' ' ' ALA . 92.4 m-20 -140.52 147.26 39.26 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.491 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -168.16 -175.77 2.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.721 177.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.89 -60.79 0.77 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.897 0.38 . . . . 0.0 110.179 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.0 t80 58.96 119.76 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.774 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -165.45 -80.9 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.342 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -144.63 93.29 2.4 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.327 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -82.12 142.56 32.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.749 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -111.74 131.0 55.61 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.399 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.62 ' O ' HD12 ' A' ' 22' ' ' ILE . 1.6 pp -130.17 164.62 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.561 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.7 m -62.33 134.56 56.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.228 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -64.97 106.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.212 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.05 -45.48 92.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.568 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -38.67 101.35 0.23 Allowed Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.817 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.52 -38.96 75.78 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.807 1.671 . . . . 0.0 112.518 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -124.14 85.78 54.61 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.003 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.56 162.41 30.38 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.177 1.918 . . . . 0.0 111.643 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 76.7 p -48.38 130.35 16.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 110.586 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 30' ' ' THR . . . 177.06 74.63 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.268 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.96 -40.61 75.53 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.691 2.261 . . . . 0.0 112.206 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -149.43 93.31 2.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.744 0.307 . . . . 0.0 111.064 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -141.14 119.26 12.01 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -103.31 6.97 38.32 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.364 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -65.33 -27.88 68.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.913 0.387 . . . . 0.0 110.553 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.6 mm -60.67 -43.91 95.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.723 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.7 t -59.61 141.99 53.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.612 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 60.7 m 49.29 97.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.577 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.6 t -100.96 114.27 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.545 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.5 m -89.74 -12.15 40.21 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -88.63 116.06 26.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.732 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.31 137.22 35.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.556 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -83.22 129.47 35.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.655 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -129.47 152.32 49.14 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.242 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 50.9 p-10 -146.45 88.62 1.79 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.351 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.8 tt -65.63 -40.04 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.803 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -78.37 88.75 4.37 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.57 -61.38 1.39 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.593 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -71.51 130.57 41.6 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.282 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 p -83.25 146.79 28.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.124 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 52' ' ' VAL . 3.2 p -161.67 78.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.524 0.678 . . . . 0.0 109.624 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.622 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 25.0 m170 -91.89 -26.66 0.29 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 53' ' ' HIS . 84.4 Cg_exo -47.65 -71.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.565 1.51 . . . . 0.0 111.942 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.573 HH12 ' CD2' ' A' ' 228' ' ' HIS . 86.8 mtm180 31.63 97.59 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.552 0.532 . . . . 0.0 111.277 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 57' ' ' SER . 29.6 t -142.69 159.06 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.83 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.501 ' N ' HG12 ' A' ' 56' ' ' VAL . 42.5 t -146.75 138.16 24.32 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.626 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -138.22 157.56 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.63 -178.63 38.17 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 119.844 -1.169 . . . . 0.0 113.605 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -104.93 129.64 53.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.395 -0.902 . . . . 0.0 109.224 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB2' HH21 ' A' ' 66' ' ' ARG . 61.1 t0 -100.41 121.5 41.63 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -175.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -125.4 121.64 34.45 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -50.54 113.88 2.31 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' A' ' 65' ' ' TRP . . . 120.01 -49.38 0.88 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 64' ' ' GLY . 8.3 m0 -146.46 136.09 23.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 117.136 0.468 . . . . 0.0 109.986 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.698 HH12 ' CZ ' ' A' ' 237' ' ' ARG . 26.7 mtp180 -133.8 147.13 51.22 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.988 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.2 126.36 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 120' ' ' SER . . . -128.44 113.4 15.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.006 0.431 . . . . 0.0 110.024 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.78 127.08 34.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.893 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -101.8 128.9 47.95 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -149.68 159.15 44.57 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.92 0.867 . . . . 0.0 111.892 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -156.97 -160.63 0.98 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.528 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -96.9 139.35 33.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.408 . . . . 0.0 111.09 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 75' ' ' ARG . 41.6 t80 -111.21 -43.51 3.71 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.371 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 74' ' ' TYR . 6.6 mmp_? 40.56 111.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.748 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.443 ' HG2' ' H ' ' A' ' 78' ' ' ASN . 78.5 tttt -135.87 138.3 42.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.454 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -48.81 -14.37 0.07 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.281 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.443 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 66.1 t30 59.14 58.73 2.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.556 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -84.93 102.27 13.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.619 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.57 -40.81 96.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.525 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -136.22 139.53 42.84 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.001 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.48 140.77 46.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.994 0.426 . . . . 0.0 110.913 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.4 t -96.63 96.88 8.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.124 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.433 HG22 ' H ' ' A' ' 86' ' ' ILE . 14.4 p -140.91 137.78 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.485 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -121.47 44.34 2.58 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.986 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.813 HG23 ' H ' ' A' ' 87' ' ' GLU . 13.7 tt -62.04 -63.97 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.757 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.813 ' H ' HG23 ' A' ' 86' ' ' ILE . 97.6 mt-10 37.9 22.92 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.732 0.301 . . . . 0.0 111.245 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.558 ' N ' ' O ' ' A' ' 86' ' ' ILE . 99.0 m-20 -71.31 -70.69 0.3 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.739 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 89' ' ' VAL . 7.1 p 36.65 25.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.322 0.582 . . . . 0.0 110.876 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 88' ' ' ASN . 34.0 ptt180 -119.96 12.76 12.08 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.675 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 95.5 mt -90.29 122.84 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.232 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -63.41 -43.97 96.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.234 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -173.75 130.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.37 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' OE1' ' OD1' ' A' ' 95' ' ' ASN . 6.5 tm-20 -172.61 -43.63 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.467 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.486 ' C ' ' H ' ' A' ' 97' ' ' ILE . 99.1 m-20 -96.16 14.28 24.49 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.656 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.79 37.89 0.5 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.486 ' H ' ' C ' ' A' ' 95' ' ' ASN . 97.0 mt -63.88 -43.6 97.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.622 0.249 . . . . 0.0 111.182 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 100' ' ' ASP . 31.3 mmt180 55.03 96.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 0.0 110.346 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' A' ' 102' ' ' LYS . 82.4 mt 45.68 -94.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.375 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 102' ' ' LYS . 56.2 t0 42.53 63.48 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.359 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 102' ' ' LYS . 67.2 ttp85 62.67 -3.41 0.3 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.634 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 100' ' ' ASP . 99.7 mttt 54.0 169.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.15 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.1 p -100.74 1.61 40.54 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 55.43 46.44 23.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.445 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 49.71 -95.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.446 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -91.33 122.72 34.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.316 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -85.2 -178.83 6.87 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.83 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.0 m120 53.7 -92.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.991 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.18 161.95 32.98 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.5 t -135.27 148.38 49.53 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.876 0.369 . . . . 0.0 110.206 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -107.56 127.11 53.34 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.274 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -72.57 134.93 45.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.27 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.15 122.94 18.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.993 0.425 . . . . 0.0 110.669 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.97 133.36 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.779 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.6 t -162.94 54.1 0.19 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.731 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 97.3 p -87.02 104.75 16.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.45 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.435 ' C ' HD23 ' A' ' 117' ' ' LEU . 6.4 tt -136.34 121.67 19.27 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 178.87 -145.53 6.79 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.124 -1.512 . . . . 0.0 113.083 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 95.5 mt -117.69 154.35 31.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.608 0.718 . . . . 0.0 110.91 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 69.6 m -144.96 98.73 3.22 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.42 114.66 11.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.311 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.1 mt -110.81 134.02 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.452 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 29.4 p90 -132.6 120.45 21.82 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.408 -177.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -97.74 143.22 28.6 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 112.904 -1.953 . . . . 0.0 108.328 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.579 ' C ' ' H ' ' A' ' 127' ' ' ILE . 15.0 m-85 -102.45 113.01 25.98 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.631 0.729 . . . . 0.0 111.376 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -65.37 11.88 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.253 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.579 ' H ' ' C ' ' A' ' 125' ' ' PHE . 8.3 tp -68.06 -40.31 82.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.19 0.519 . . . . 0.0 110.484 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.495 ' N ' HG23 ' A' ' 127' ' ' ILE . 72.8 m-20 -99.77 141.3 32.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.301 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -79.45 -60.81 2.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -66.33 -41.89 88.96 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.484 ' O ' ' CD1' ' A' ' 131' ' ' PHE . 48.0 p90 -145.61 143.16 29.71 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 119.194 -0.432 . . . . 0.0 111.472 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.62 132.82 23.68 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 118.254 0.479 . . . . 0.0 110.267 178.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.62 136.68 21.6 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 N-CA-C 108.05 -1.558 . . . . 0.0 108.05 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 199' ' ' GLY . 0.8 OUTLIER -132.41 144.24 50.36 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 122.329 1.062 . . . . 0.0 112.312 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 136' ' ' GLY . 94.2 mt -135.04 161.48 40.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 113.338 -1.756 . . . . 0.0 107.895 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 135' ' ' ILE . . . -161.22 160.03 31.73 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 118.929 -1.605 . . . . 0.0 114.185 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -107.94 135.45 49.3 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -118.43 125.79 50.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 139' ' ' VAL . 18.4 m -117.89 113.92 43.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.09 125.53 51.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.36 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -112.26 153.18 27.54 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.716 0.77 . . . . 0.0 112.522 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -123.95 -102.51 1.52 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.429 ' ND1' ' N ' ' A' ' 143' ' ' HIS . 0.0 OUTLIER -157.17 150.49 23.96 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.092 0.473 . . . . 0.0 111.834 178.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 50.7 t -126.58 135.08 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.225 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 121.49 26.15 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.475 ' CG ' ' N ' ' A' ' 147' ' ' SER . 56.3 p-80 -149.64 -45.45 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.407 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.475 ' N ' ' CG ' ' A' ' 146' ' ' HIS . 6.5 p 58.93 134.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.707 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 82.5 mt -104.28 116.39 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.188 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 150' ' ' SER . 52.4 t0 -155.76 78.82 1.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 149' ' ' ASP . 15.7 t 57.32 153.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.011 0.434 . . . . 0.0 110.758 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.4 m -63.68 -31.9 73.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.821 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.4 -42.64 96.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.79 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.523 ' CD ' ' H ' ' A' ' 154' ' ' THR . 1.6 tmtm? 63.81 -162.29 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.988 0.423 . . . . 0.0 110.472 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.523 ' H ' ' CD ' ' A' ' 153' ' ' LYS . 44.6 p 52.87 -136.01 1.43 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.54 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 91.6 mt 49.92 -87.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.609 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 154' ' ' THR . 73.0 mm-40 -65.09 132.98 50.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.734 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.612 HG12 ' N ' ' A' ' 158' ' ' THR . 38.5 t 52.02 168.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.826 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.612 ' N ' HG12 ' A' ' 157' ' ' VAL . 71.4 p -76.57 153.77 35.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.004 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 13.7 t -114.06 157.25 22.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.922 0.391 . . . . 0.0 110.719 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.8 t -59.67 125.23 79.36 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.957 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -42.18 145.25 0.89 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.936 1.757 . . . . 0.0 112.93 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.7 t -61.55 -43.54 98.67 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.515 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 55.53 50.95 13.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.669 0.271 . . . . 0.0 110.665 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -44.87 149.64 0.8 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.425 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -73.02 150.41 48.47 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.232 1.954 . . . . 0.0 111.854 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -144.04 130.22 19.68 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 110.849 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.43 66.35 2.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 169' ' ' VAL . . . -63.57 141.83 58.62 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.156 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 168' ' ' ALA . 46.9 t 54.07 106.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.569 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.73 114.03 13.67 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.399 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 42.0 p -69.24 -33.31 73.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.114 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -94.75 134.37 37.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.044 0.449 . . . . 0.0 111.262 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.523 ' CB ' ' NE2' ' A' ' 179' ' ' GLN . 50.6 p-10 -154.47 45.0 0.54 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.001 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.2 t -109.31 19.93 18.83 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.486 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 32.0 p-10 -66.73 137.77 95.11 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.723 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.69 31.56 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.199 1.933 . . . . 0.0 111.834 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 178' ' ' THR . 22.6 pttm -157.32 134.7 10.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.927 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 177' ' ' LYS . 59.3 p 45.67 -173.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.887 0.375 . . . . 0.0 110.685 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.523 ' NE2' ' CB ' ' A' ' 173' ' ' ASN . 58.3 tt0 56.18 96.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.343 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 62.0 t30 58.85 32.65 22.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.769 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 181' ' ' ASP . 65.2 t0 -70.95 -39.36 72.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.911 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -141.82 157.7 44.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.782 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 43.81 -99.37 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.145 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 t -145.74 -90.04 0.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -130.59 -6.11 4.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.753 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 42.7 t -150.86 147.63 27.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.447 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.598 HD12 ' C ' ' A' ' 187' ' ' ILE . 2.3 pp -97.73 9.14 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.27 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.416 ' N ' HD12 ' A' ' 187' ' ' ILE . 39.4 ptt180 -48.92 135.29 15.81 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -98.2 97.67 9.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.502 0.668 . . . . 0.0 112.248 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.56 160.6 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.35 130.35 4.57 Favored Glycine 0 N--CA 1.47 0.935 0 C-N-CA 119.888 -1.149 . . . . 0.0 113.425 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.83 137.09 53.14 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -164.26 -168.75 26.81 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.84 145.52 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.539 0.685 . . . . 0.0 111.847 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.0 mm -112.53 128.92 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.79 162.61 38.23 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.385 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.489 ' O ' ' CD1' ' A' ' 134' ' ' TYR . . . 157.99 178.87 32.43 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.16 139.82 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 134' ' ' TYR . . . -120.83 137.85 12.29 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 120.169 -1.015 . . . . 0.0 114.475 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.422 ' C ' ' OG1' ' A' ' 207' ' ' THR . 90.6 m-85 -104.62 106.67 17.26 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 114.131 -1.034 . . . . 0.0 108.593 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 201' ' ' ASP . 9.9 p30 -63.31 149.79 44.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.463 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.8 mm -102.98 -74.73 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.462 ' O ' ' C ' ' A' ' 204' ' ' PRO . 1.4 p -80.18 -167.85 0.15 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.462 ' C ' ' O ' ' A' ' 203' ' ' THR . 1.5 Cg_exo -33.76 -74.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 CA-C-N 122.69 1.996 . . . . 0.0 114.678 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 237' ' ' ARG . 10.0 mptt -125.19 20.19 8.19 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.251 0.932 . . . . 0.0 110.789 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 206' ' ' LEU . 0.9 OUTLIER -76.88 122.94 25.54 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 176.079 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.422 ' OG1' ' C ' ' A' ' 200' ' ' PHE . 2.8 t -136.41 148.57 47.86 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 50.3 tp -99.15 118.1 35.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -130.12 142.73 50.57 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -87.76 109.05 19.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 231' ' ' SER . . . -130.5 144.05 15.4 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.342 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -137.83 153.54 49.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.033 -0.583 . . . . 0.0 109.955 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.401 ' NH1' ' NE2' ' A' ' 215' ' ' HIS . 3.7 ppt_? -120.57 140.46 51.47 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -140.01 155.66 46.98 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.005 0.431 . . . . 0.0 111.437 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.401 ' NE2' ' NH1' ' A' ' 213' ' ' ARG . 13.9 m170 -99.17 142.19 30.97 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.758 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 217' ' ' TRP . 38.0 p-10 -64.12 -41.75 97.11 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.169 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.479 ' N ' ' OD1' ' A' ' 216' ' ' ASN . 57.4 t-105 -118.53 137.49 53.18 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -77.0 91.57 1.01 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -110.14 6.41 22.76 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.759 0.314 . . . . 0.0 110.545 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 220' ' ' LEU . 10.2 mp -74.02 145.26 44.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.534 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -56.11 -172.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.494 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 224' ' ' ARG . 23.6 t-20 -63.86 -39.51 94.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 2.1 m -67.49 35.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.41 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.521 ' H ' ' C ' ' A' ' 222' ' ' ASN . 54.3 ptt85 -77.16 -5.22 48.28 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.488 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -59.97 -46.34 89.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.68 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -132.4 125.04 29.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.962 0.41 . . . . 0.0 110.927 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.5 t -152.1 158.43 42.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.245 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.573 ' CD2' HH12 ' A' ' 55' ' ' ARG . 86.3 t60 -75.85 127.11 32.32 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.413 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -152.18 160.47 43.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.905 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -52.95 -177.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.92 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 211' ' ' GLY . 1.7 t 174.44 -53.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.8 tp -136.57 110.65 8.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -100.05 162.94 19.18 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.307 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 39.4 t -126.13 128.98 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.555 HH22 ' NE2' ' A' ' 12' ' ' GLN . 90.4 mtt-85 -134.09 147.07 50.83 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -174.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -110.83 99.69 8.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.136 175.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.698 ' CZ ' HH12 ' A' ' 66' ' ' ARG . 99.0 mtt180 -130.28 130.86 45.07 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.838 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.535 ' CZ ' ' O ' ' A' ' 6' ' ' GLY . 61.3 m-85 . . . . . 0 N--CA 1.474 0.732 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.834 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.5 m -71.04 148.64 47.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.613 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 42.15 -123.23 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.572 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -94.79 1.77 55.44 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.875 0.369 . . . . 0.0 110.492 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.94 122.82 3.5 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.08 -75.5 0.28 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -87.53 152.25 22.35 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.73 -152.03 6.72 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.33 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.57 167.99 25.9 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.382 2.055 . . . . 0.0 114.183 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -141.01 143.48 34.45 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.6 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.8 t -132.03 146.38 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -148.31 130.99 15.94 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.36 132.71 12.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.825 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -96.08 151.93 19.01 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.12 0.486 . . . . 0.0 111.859 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.8 tp -123.99 131.21 53.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.671 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.46 -123.29 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.779 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.449 ' CG ' ' O ' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -137.77 125.86 22.9 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.278 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 179.22 114.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.36 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -151.31 132.1 14.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.751 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -160.7 -92.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.472 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.4 ' O ' ' ND1' ' A' ' 21' ' ' HIS . 57.8 t-80 38.91 58.8 1.72 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.849 0.357 . . . . 0.0 110.551 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.9 108.58 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.247 0.546 . . . . 0.0 110.544 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.6 p -141.37 173.16 11.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.984 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -148.44 156.55 42.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.892 0.377 . . . . 0.0 110.616 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -76.67 162.47 27.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.596 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -147.79 80.62 8.81 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.678 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.86 159.73 34.42 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.438 2.092 . . . . 0.0 112.012 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.521 ' OE2' ' ND2' ' A' ' 35' ' ' ASN . 45.7 tt0 -139.01 81.2 22.02 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.203 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.46 159.2 22.56 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.534 2.156 . . . . 0.0 112.139 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -63.5 137.22 58.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.646 ' HB1' ' HD2' ' A' ' 32' ' ' PRO . . . -138.21 176.36 2.74 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.353 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.646 ' HD2' ' HB1' ' A' ' 31' ' ' ALA . 52.8 Cg_exo -54.21 -39.49 86.15 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.375 2.05 . . . . 0.0 112.384 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -96.39 143.31 27.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.741 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -90.08 155.64 18.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.416 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.521 ' ND2' ' OE2' ' A' ' 28' ' ' GLU . 98.1 m-20 -72.77 141.7 48.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.601 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -76.83 138.48 39.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.0 pt -128.23 149.92 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.553 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.2 m -136.63 150.54 48.59 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.551 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.7 m -153.11 94.95 1.9 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.378 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -172.12 -18.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.78 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -65.28 136.17 56.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.858 0.361 . . . . 0.0 110.616 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -89.11 179.92 6.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.623 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -101.35 132.1 47.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.132 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -158.73 3.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.804 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -68.93 135.22 50.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.624 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -89.49 -64.71 1.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.374 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.2 tp -162.0 139.34 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.416 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.2 mtp85 -138.28 89.87 2.42 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.423 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -86.23 165.32 16.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.489 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 31.3 ptt85 -121.4 -46.89 2.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.45 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 73' ' ' ARG . 10.9 t 49.01 92.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.786 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.37 53.15 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.534 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -161.91 67.59 2.13 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.506 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -91.17 -166.42 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.375 2.717 . . . . 0.0 113.477 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 58.7 82.81 0.13 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.498 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 p -155.95 131.54 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.906 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 t -138.51 135.85 35.52 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -148.58 168.67 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.756 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.76 -153.3 12.99 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -121.43 143.33 49.3 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.144 0.497 . . . . 0.0 111.561 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -86.71 112.97 22.17 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.866 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -125.48 150.47 47.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.968 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.22 103.6 2.62 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.48 -68.32 0.52 Allowed Glycine 0 CA--C 1.52 0.391 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -148.05 160.77 42.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -113.73 162.01 16.8 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 120.897 0.38 . . . . 0.0 111.608 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.0 mm -104.14 126.71 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 102.11 -3.293 . . . . 0.0 102.11 172.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.47 125.25 9.76 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 119.149 -1.021 . . . . 0.0 111.946 -176.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.23 153.41 20.0 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.553 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -134.24 128.07 33.15 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -151.45 161.27 42.99 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.185 0.993 . . . . 0.0 113.188 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.48 151.3 15.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.224 -1.807 . . . . 0.0 107.418 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.435 ' O ' ' OG ' ' A' ' 51' ' ' SER . 9.1 ptm180 -141.79 135.5 29.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.281 0.562 . . . . 0.0 111.669 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 44.9 p90 -172.83 107.63 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.602 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -101.63 136.77 40.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.635 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 78' ' ' ASN . 40.6 tttm 43.96 39.67 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.5 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 49.35 -93.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.927 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 76' ' ' LYS . 62.9 t-20 -175.67 -60.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.374 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -64.34 125.82 25.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.802 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.429 ' ND2' ' NZ ' ' A' ' 76' ' ' LYS . 61.1 t-20 -141.86 88.21 2.1 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.623 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -83.76 -11.63 56.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.936 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.04 142.0 30.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.1 t -155.84 156.69 35.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.176 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.4 t -118.14 130.83 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.949 0.404 . . . . 0.0 110.252 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 87' ' ' GLU . 51.4 p30 -162.8 61.39 0.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.512 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.2 mt 44.75 -88.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.68 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 85' ' ' ASN . 97.5 mt-10 -64.61 131.01 45.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.436 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 88' ' ' ASN . 43.1 p-10 -163.66 91.18 0.65 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.859 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.4 m -123.8 130.5 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.511 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -86.58 151.2 23.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.358 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 mm -87.39 91.78 3.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.173 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -133.28 150.38 51.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.594 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -78.08 147.68 34.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.24 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 95' ' ' ASN . 46.8 tp10 -72.52 111.25 7.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.848 0.356 . . . . 0.0 110.276 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 94' ' ' GLU . 82.1 m-20 -158.8 162.21 37.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.413 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.2 146.28 42.46 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 97' ' ' ILE . 19.1 tt -131.54 129.56 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.908 0.385 . . . . 0.0 110.633 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.6 ptt-85 -149.21 155.03 40.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.466 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.2 pt -82.31 135.78 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.175 0.512 . . . . 0.0 110.619 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -144.54 -33.72 0.38 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.085 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -151.57 154.14 35.89 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.485 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.415 ' C ' ' HG1' ' A' ' 103' ' ' THR . 98.8 mttt -79.9 -2.12 42.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.728 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.438 ' HG1' ' H ' ' A' ' 104' ' ' GLU . 56.4 p 50.3 -100.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.266 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.438 ' H ' ' HG1' ' A' ' 103' ' ' THR . 80.1 mm-40 -76.22 130.95 38.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.16 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -94.09 168.84 10.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.644 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -126.77 98.92 5.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.907 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -67.05 -40.35 87.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.692 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -87.26 101.69 13.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.632 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' A' ' 111' ' ' PHE . . . -90.73 179.15 42.89 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.7 p -71.95 135.72 46.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 0.0 110.539 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 109' ' ' GLY . 92.3 m-85 -136.0 -45.72 0.65 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.665 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.442 ' CE1' ' H ' ' A' ' 114' ' ' VAL . 51.4 t-80 -151.99 -93.87 0.05 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.515 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' N ' ' ND1' ' A' ' 112' ' ' HIS . . . 47.05 31.93 1.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.832 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.442 ' H ' ' CE1' ' A' ' 112' ' ' HIS . 58.6 t -69.44 -26.77 32.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.655 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 115' ' ' SER . 5.0 p 69.51 103.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.426 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.6 p -167.24 163.79 15.42 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.037 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.475 ' N ' HD23 ' A' ' 117' ' ' LEU . 1.3 pt? -156.89 157.4 34.81 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.877 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -176.45 -138.14 2.82 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.051 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.873 ' H ' HD23 ' A' ' 119' ' ' LEU . 1.2 pt? -131.2 160.55 34.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.2 0.524 . . . . 0.0 111.992 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 m -148.74 147.62 29.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.423 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.01 135.98 53.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 123' ' ' TYR . 96.7 mt -118.96 158.06 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.556 0.693 . . . . 0.0 112.552 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.474 ' N ' HG22 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -106.07 101.49 10.98 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -104.72 122.71 46.26 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 123.67 0.606 . . . . 0.0 111.234 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -96.72 105.36 17.46 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.084 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.424 ' CD ' HH22 ' A' ' 237' ' ' ARG . 59.1 tt0 -87.83 -11.35 48.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.698 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 128' ' ' ASN . 21.4 tt -67.52 -40.67 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.947 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.461 ' N ' HG23 ' A' ' 127' ' ' ILE . 88.0 m-20 -78.68 -11.78 59.99 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.0 t0 59.7 -78.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.177 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -66.27 -46.26 77.67 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -105.58 117.52 34.24 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.439 ' HZ2' ' HA3' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -131.85 96.53 20.28 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.17 109.56 0.64 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.035 1.156 . . . . 0.0 109.387 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CZ ' ' HA3' ' A' ' 197' ' ' GLY . 21.9 p90 -78.66 129.9 35.25 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 118.712 -1.195 . . . . 0.0 109.78 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.17 142.51 40.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.646 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -171.79 -176.8 40.99 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 118.28 -1.914 . . . . 0.0 113.709 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.73 137.57 51.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -130.12 131.17 45.59 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.45 132.35 64.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.682 0.753 . . . . 0.0 109.125 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -113.54 150.44 32.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.121 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -156.72 168.15 28.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.297 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -117.15 134.01 10.97 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 144' ' ' VAL . 77.4 t60 -55.12 -76.37 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 143' ' ' HIS . 5.4 t 53.22 121.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.625 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 146' ' ' HIS . 23.7 mmt85 -62.55 -36.24 82.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.259 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 145' ' ' ARG . 85.8 t60 49.42 96.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 146' ' ' HIS . 7.8 t 61.34 131.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.317 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 15.6 tt -154.51 -16.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.348 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -61.32 -49.15 78.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.521 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.7 t -160.04 152.92 21.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.705 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.4 p -149.47 101.85 3.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.256 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -155.1 -34.09 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.627 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -73.3 130.95 41.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.611 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.39 -12.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.223 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 155' ' ' ILE . 20.3 tt -129.12 131.35 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.159 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 158' ' ' THR . 43.4 tp10 -99.4 71.91 1.79 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.604 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.05 -34.12 66.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.405 ' O ' ' OE2' ' A' ' 156' ' ' GLU . 5.0 t -132.59 153.1 51.35 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.863 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 159' ' ' THR . 1.4 t -95.25 144.83 25.52 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.281 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.2 t -59.51 130.01 87.46 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.08 -42.31 21.08 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.502 1.468 . . . . 0.0 112.975 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 78.1 p -63.83 -39.66 94.74 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.039 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -105.22 75.88 1.19 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.884 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.604 ' HB1' ' CD ' ' A' ' 165' ' ' PRO . . . -56.0 179.62 0.1 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.604 ' CD ' ' HB1' ' A' ' 164' ' ' ALA . 28.0 Cg_exo -60.44 142.58 98.39 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.709 1.606 . . . . 0.0 111.304 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -100.97 8.12 43.21 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.482 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 158.27 -154.78 25.84 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -156.46 -117.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.28 131.23 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.919 0.39 . . . . 0.0 110.256 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 91.5 m -118.41 126.22 51.61 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.068 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.12 -36.34 18.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.877 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -153.77 -73.28 0.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.766 0.317 . . . . 0.0 110.673 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 174' ' ' THR . 28.3 t-20 42.79 -109.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.618 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 173' ' ' ASN . 63.8 p -120.99 133.06 55.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.156 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -113.45 91.7 21.0 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.808 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -87.49 -17.96 2.69 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.684 2.256 . . . . 0.0 112.874 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -80.83 126.32 31.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.019 0.438 . . . . 0.0 111.546 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.35 -41.39 56.68 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.449 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -103.15 129.4 50.02 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.265 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 181' ' ' ASP . 93.0 m-20 -89.4 93.9 9.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.901 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 180' ' ' ASN . 6.6 p-10 42.59 -173.52 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.58 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.627 ' CG ' ' N ' ' A' ' 183' ' ' GLN . 60.9 t80 -174.13 177.0 2.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.969 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.627 ' N ' ' CG ' ' A' ' 182' ' ' TYR . 26.5 mt-30 -59.86 -31.4 69.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.886 0.374 . . . . 0.0 110.484 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.411 ' O ' ' O ' ' A' ' 183' ' ' GLN . 12.9 p 47.19 96.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.319 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 55.3 p30 -87.46 -175.37 5.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.558 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 60.0 m -57.92 132.3 53.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.728 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 188' ' ' ARG . 42.4 pt -88.43 -15.27 9.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.137 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 187' ' ' ILE . 81.5 mtp180 -60.03 -149.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.876 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -126.71 118.44 24.73 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.326 0.584 . . . . 0.0 111.57 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.21 153.66 37.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -135.15 142.08 13.44 Favored Glycine 0 N--CA 1.466 0.67 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.821 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.2 pp -133.39 141.89 48.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.304 -0.948 . . . . 0.0 108.755 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -153.45 174.15 32.13 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.04 138.59 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.902 0.382 . . . . 0.0 110.988 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.8 mt -111.06 131.08 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.859 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.53 148.43 32.17 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.424 ' HA3' ' CZ ' ' A' ' 134' ' ' TYR . . . 158.05 -176.89 34.99 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.4 p -138.75 142.3 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 118.728 1.264 . . . . 0.0 113.346 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.439 ' HA3' ' HZ2' ' A' ' 132' ' ' LYS . . . -103.88 144.83 15.98 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.761 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.426 ' N ' ' OG1' ' A' ' 207' ' ' THR . 14.3 t80 -137.72 105.69 5.67 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -91.59 154.22 19.2 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -176.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.441 ' CG1' ' H ' ' A' ' 203' ' ' THR . 5.3 pt -95.15 -47.1 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.652 ' O ' ' N ' ' A' ' 205' ' ' LYS . 0.7 OUTLIER -122.76 115.25 29.53 Favored Pre-proline 0 N--CA 1.433 -1.296 0 N-CA-C 100.563 -3.865 . . . . 0.0 100.563 172.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -12.15 -40.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 124.069 3.179 . . . . 0.0 117.176 -174.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 203' ' ' THR . 11.7 pttm -84.72 -32.37 23.55 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 3.2 mm? -85.4 105.14 15.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 121.475 1.943 . . . . 0.0 107.751 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 235' ' ' ARG . 1.0 OUTLIER -131.75 140.23 49.18 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 75.9 mt -93.37 135.36 34.68 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 113.734 -1.576 . . . . 0.0 108.749 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.613 ' CG ' HH11 ' A' ' 235' ' ' ARG . 42.7 m-20 -118.22 145.91 44.64 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -135.49 113.02 10.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 114.059 -1.428 . . . . 0.0 107.292 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -162.22 -177.65 35.44 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.56 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.35 152.42 49.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.594 -0.803 . . . . 0.0 110.97 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -106.88 127.28 53.29 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -112.09 150.65 30.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.295 0.569 . . . . 0.0 112.271 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' A' ' 216' ' ' ASN . 77.3 t60 -129.1 128.96 44.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.723 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 215' ' ' HIS . 97.1 m-20 51.41 107.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.462 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -143.38 99.85 3.51 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.825 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -159.84 -116.93 0.45 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 220' ' ' LEU . 18.2 tpp180 -63.61 144.98 56.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.855 0.359 . . . . 0.0 110.246 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.94 HD22 ' H ' ' A' ' 220' ' ' LEU . 1.9 mm? -57.28 -159.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.195 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 66.19 61.68 0.6 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.378 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 222' ' ' ASN . 12.4 p30 -98.52 123.9 42.95 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.001 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.7 m -63.77 -47.95 78.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.184 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -114.14 150.85 33.54 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.996 0.427 . . . . 0.0 110.78 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -161.47 21.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.886 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -97.57 40.97 1.14 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.872 0.367 . . . . 0.0 110.488 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 73.1 m -116.39 123.59 47.95 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.271 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -173.55 86.38 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.652 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -139.51 132.38 29.24 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.598 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -86.08 162.28 18.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.391 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 46.9 t -151.96 154.21 35.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.675 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.0 tt -111.02 140.12 45.82 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.28 169.25 30.26 Favored Glycine 0 CA--C 1.517 0.203 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.95 136.28 57.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.449 0.643 . . . . 0.0 111.378 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.613 HH11 ' CG ' ' A' ' 209' ' ' ASP . 81.1 mtt85 -121.27 130.21 53.54 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.95 106.29 17.2 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.575 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.589 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 3.6 tmt_? -119.79 109.14 15.25 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.229 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.545 ' CB ' ' O ' ' A' ' 237' ' ' ARG . 28.5 t80 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.679 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 3' ' ' GLU . 86.7 p -75.86 164.41 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.601 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 2' ' ' SER . 43.5 tp10 59.88 129.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.48 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 55.73 28.41 12.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.477 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 46.55 -131.21 11.86 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 129.56 -150.66 19.02 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -68.79 159.79 31.71 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.52 -73.07 0.4 Allowed Glycine 0 CA--C 1.533 1.184 0 C-N-CA 120.961 -0.637 . . . . 0.0 111.923 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.43 124.05 9.11 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 122.717 2.278 . . . . 0.0 112.822 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -144.95 148.29 33.65 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.507 ' H ' ' HB2' ' A' ' 236' ' ' TYR . 78.7 t -138.68 146.31 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.553 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -132.4 126.53 33.37 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.992 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.95 148.0 27.86 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 15' ' ' LEU . 57.2 t0 -162.6 134.58 5.36 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.581 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -173.48 -171.0 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.025 178.524 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.73 71.57 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.861 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' O ' ' O ' ' A' ' 18' ' ' ALA . 78.9 t80 -62.94 -49.65 73.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 17' ' ' TYR . . . 57.03 162.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.513 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -87.88 163.29 16.47 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.721 0.296 . . . . 0.0 110.954 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.53 ' OE2' ' N ' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -124.39 -30.72 3.36 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.667 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.53 ' N ' ' OE2' ' A' ' 20' ' ' GLU . 59.4 t-80 -166.78 -22.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 110.635 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.411 ' O ' ' O ' ' A' ' 21' ' ' HIS . 43.2 mt 58.3 118.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.581 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 24' ' ' HIS . 1.3 t -172.9 -117.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.593 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.524 ' N ' ' OG1' ' A' ' 23' ' ' THR . 15.9 m80 63.43 123.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.842 0.353 . . . . 0.0 110.502 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -135.76 94.03 3.02 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.623 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.608 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 91.7 t80 -99.08 -33.31 0.24 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.546 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 26' ' ' TYR . 89.0 Cg_endo -83.2 156.84 14.88 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.773 1.648 . . . . 0.0 111.904 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -68.14 148.11 98.32 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.883 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 31' ' ' ALA . 72.8 Cg_endo -73.2 86.75 1.1 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.18 1.92 . . . . 0.0 111.898 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 p 39.9 -96.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.335 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -57.94 151.4 44.5 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.309 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.44 -83.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.263 1.976 . . . . 0.0 111.725 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 36' ' ' LYS . 52.0 p-10 -103.06 6.01 38.41 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.442 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 36' ' ' LYS . 6.2 tmtt? 42.3 37.07 0.83 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.697 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 64.28 -4.86 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.759 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 33' ' ' ASN . 63.3 pttt -172.44 146.48 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.346 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 37' ' ' ILE . 19.6 tt -125.63 126.11 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.884 0.373 . . . . 0.0 110.389 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.2 p -102.24 -6.65 22.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.578 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.5 p -87.84 132.54 34.15 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.331 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG23 ' H ' ' A' ' 41' ' ' SER . 0.4 OUTLIER -96.98 -96.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.581 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.491 ' H ' HG23 ' A' ' 40' ' ' VAL . 86.0 p -159.37 177.66 10.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t0 72.3 -56.71 0.64 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.857 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -61.36 -44.92 96.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.969 0.414 . . . . 0.0 110.006 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.4 ' CG ' ' N ' ' A' ' 45' ' ' ARG . 88.7 t80 -60.83 155.81 18.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.149 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 25.1 ttm180 61.13 -133.66 0.67 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.6 t30 50.73 38.64 19.92 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.105 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.3 pt -90.36 45.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -76.33 97.57 4.26 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.088 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.3 p -149.19 24.8 0.91 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.024 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -74.37 137.77 42.98 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.575 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 52' ' ' VAL . 37.0 p -88.91 -35.78 16.3 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.516 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 51' ' ' SER . 35.6 t 48.79 101.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.908 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -173.1 60.95 0.26 Allowed Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.102 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.18 148.65 44.59 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.714 2.276 . . . . 0.0 112.309 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -167.19 111.51 0.72 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.702 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.37 135.13 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.639 0.257 . . . . 0.0 110.949 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 m -118.47 125.9 50.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.85 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.17 137.98 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.871 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.82 172.06 36.29 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.666 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -109.91 144.8 37.88 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 65' ' ' TRP . 44.4 t0 -150.84 130.96 13.49 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 62' ' ' PHE . 31.6 p90 -128.41 105.87 8.62 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.807 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 62' ' ' PHE . . . 6.95 95.46 0.0 OUTLIER Glycine 0 N--CA 1.481 1.692 0 O-C-N 123.251 0.345 . . . . 0.0 113.186 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.96 -110.77 0.46 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.417 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 10.2 p-90 -103.74 -177.67 3.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.73 ' NH1' ' HE ' ' A' ' 235' ' ' ARG . 75.3 ttt180 -153.42 151.42 29.88 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.27 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.5 tp -129.58 142.4 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.431 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.56 143.03 19.51 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.89 155.99 16.54 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 71' ' ' TYR . 48.2 t0 -146.25 133.11 20.1 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.573 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 49.0 p90 175.5 -172.06 0.07 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.755 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 71' ' ' TYR . . . 166.58 68.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -151.26 146.62 26.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.641 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -150.75 -127.65 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.461 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 60.23 73.43 0.48 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.556 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.659 ' N ' HD21 ' A' ' 79' ' ' ASN . 68.4 mttm -78.08 -176.9 4.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.593 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -59.7 -40.11 86.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.151 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 57.8 t30 -90.57 102.71 15.45 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.771 0.32 . . . . 0.0 110.639 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.659 HD21 ' N ' ' A' ' 76' ' ' LYS . 81.6 m-20 -159.21 176.88 11.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.457 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 48.55 -169.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.073 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt 56.28 60.94 2.91 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -61.94 -42.12 98.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.366 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.4 p -71.46 161.9 30.3 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.717 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.66 148.34 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.043 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -97.33 144.57 26.96 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.582 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.1 mm -63.45 -44.37 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.728 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -143.26 -62.56 0.41 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.494 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -165.73 54.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.84 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.3 t -99.41 119.68 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.401 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -172.8 -68.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.908 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.709 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.0 mp 46.96 94.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.324 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -80.23 -22.88 41.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.78 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.3 tptt 73.69 164.21 0.28 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.116 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -62.41 136.24 57.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.873 0.368 . . . . 0.0 110.775 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 95' ' ' ASN . 38.4 t-20 -153.12 -22.57 0.15 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.736 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.28 173.8 52.61 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 98' ' ' ARG . 2.5 mt -119.01 -145.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.585 ' H ' HG22 ' A' ' 97' ' ' ILE . 85.0 mtt85 -105.55 1.59 27.61 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.973 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.6 tt -106.21 144.26 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 57.31 98.54 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.05 0.452 . . . . 0.0 109.834 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -62.81 -40.3 96.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.524 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -125.75 145.47 50.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.935 0.398 . . . . 0.0 110.946 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.0 p -83.1 -139.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.488 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 55.23 40.61 31.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 110.233 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.431 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 4.8 p30 -86.06 103.31 14.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.765 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -68.76 -21.36 64.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.137 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 62.3 -101.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.418 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -87.55 116.94 26.01 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.82 0.343 . . . . 0.0 110.804 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.58 156.06 27.78 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.1 m -69.35 135.95 51.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.732 0.301 . . . . 0.0 110.68 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -104.7 41.05 1.38 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.662 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -153.71 48.76 0.66 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.023 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 112' ' ' HIS . . . 57.43 150.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.098 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 115' ' ' SER . 27.0 m -139.45 167.2 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.809 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 114' ' ' VAL . 4.8 p 89.28 125.13 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.779 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.4 t -155.66 149.32 25.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.738 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.5 mp -86.23 141.61 29.18 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.84 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.538 ' C ' HD22 ' A' ' 119' ' ' LEU . . . -122.0 126.57 6.5 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.538 HD22 ' C ' ' A' ' 118' ' ' GLY . 3.4 mm? -113.17 140.35 47.99 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.8 m -120.26 124.54 45.9 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.68 122.37 42.59 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.529 HG22 ' N ' ' A' ' 123' ' ' TYR . 94.4 mt -126.45 160.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -175.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.529 ' N ' HG22 ' A' ' 122' ' ' ILE . 70.6 m-85 -128.38 103.15 6.98 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 177.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.464 ' HB2' HH22 ' A' ' 235' ' ' ARG . 67.6 t0 -138.83 129.94 26.78 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.494 ' CD1' ' NZ ' ' A' ' 132' ' ' LYS . 65.0 m-85 -120.86 133.26 55.31 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.439 177.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.5 pp0? -105.71 -13.75 15.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.269 0.557 . . . . 0.0 109.559 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 129' ' ' ASP . 65.9 mt -70.9 -40.51 76.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.777 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -55.6 89.64 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 127' ' ' ILE . 90.5 m-20 47.1 -114.25 0.54 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.865 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -131.2 22.73 4.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.086 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.549 ' O ' ' CD1' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -167.28 127.3 1.45 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.492 -178.165 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.621 ' H ' HH22 ' A' ' 237' ' ' ARG . 12.8 tptm -134.63 129.56 19.47 Favored Pre-proline 0 C--O 1.238 0.5 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.497 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.38 129.96 28.56 Favored 'Trans proline' 0 N--CA 1.479 0.671 0 N-CA-C 107.404 -1.806 . . . . 0.0 107.404 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.622 ' CG ' ' NH1' ' A' ' 235' ' ' ARG . 52.0 p90 -122.64 148.6 45.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.525 0.602 . . . . 0.0 111.008 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.3 pt -141.05 163.62 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.555 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.34 173.78 41.82 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.188 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -117.26 159.78 22.12 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -127.79 130.99 49.62 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.939 0.4 . . . . 0.0 111.222 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 20.2 m -130.62 128.69 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.069 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.7 136.2 50.29 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.678 0.275 . . . . 0.0 110.931 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -147.95 158.16 43.9 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.288 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -110.85 -168.73 19.15 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 143' ' ' HIS . 4.5 p-80 -92.52 156.95 16.81 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.023 0.439 . . . . 0.0 110.807 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 39.6 t 58.04 114.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.395 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -94.64 -109.61 0.13 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.745 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -153.52 141.67 20.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.216 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 p -153.21 130.48 11.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.909 0.385 . . . . 0.0 110.517 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 96.2 mt -124.12 129.42 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.205 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -86.55 110.62 19.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.43 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.4 m -60.24 -42.13 94.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.362 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.7 p -83.63 165.21 19.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.468 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 153' ' ' LYS . 30.6 mmtp -107.55 11.58 28.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.214 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 152' ' ' LYS . 51.9 tttp 59.6 136.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.905 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.0 m 63.5 106.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.584 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 19.8 tt -131.08 142.28 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.385 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 158' ' ' THR . 97.2 mt-10 -71.74 52.5 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.505 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 63.3 t 49.81 -86.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.39 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 156' ' ' GLU . 24.7 m -66.85 133.6 50.4 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 52.4 p -67.91 137.01 54.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.84 0.352 . . . . 0.0 110.747 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 160' ' ' VAL . 7.6 p -61.76 122.93 74.83 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.11 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.65 -40.27 46.65 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.317 1.345 . . . . 0.0 112.123 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.0 m -81.77 103.14 11.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.634 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 164' ' ' ALA . 54.7 p30 -155.38 -19.73 0.11 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.637 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.525 ' N ' ' OD1' ' A' ' 163' ' ' ASN . . . 178.36 151.84 0.45 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.077 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.93 152.51 57.7 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.305 2.003 . . . . 0.0 112.072 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -91.52 35.75 0.95 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.317 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 170' ' ' THR . . . 82.08 18.48 67.16 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 58.94 -147.68 0.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 110.454 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.5 m -92.4 24.26 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.654 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 167' ' ' GLY . 2.9 t -144.92 157.09 44.26 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.822 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.9 t -82.23 173.22 12.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.326 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -81.99 132.39 35.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.345 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -103.75 105.99 16.36 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.851 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 63.7 p 41.2 -137.91 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.067 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -85.52 150.06 53.15 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.115 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.56 158.6 39.94 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.699 2.266 . . . . 0.0 111.974 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -69.26 -76.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.448 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.5 p -81.17 166.89 20.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -80.39 94.92 6.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.473 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 181' ' ' ASP . 50.1 p30 -69.16 -19.0 64.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.733 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 180' ' ' ASN . 98.3 m-20 -90.22 110.73 21.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.021 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -103.6 6.84 37.47 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.085 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -87.11 49.23 1.78 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.521 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.3 t -138.69 134.22 33.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.595 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -143.15 106.55 4.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.225 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 27.9 p -75.98 160.41 29.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.302 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.656 HG23 ' N ' ' A' ' 188' ' ' ARG . 18.8 tt -155.95 -54.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.584 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.656 ' N ' HG23 ' A' ' 187' ' ' ILE . 79.4 mtp85 39.96 84.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.223 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.413 HH11 HG13 ' A' ' 187' ' ' ILE . 76.0 mtt85 -143.21 77.95 1.58 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.663 0.744 . . . . 0.0 111.417 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.45 156.85 33.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -120.4 130.73 8.47 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.275 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.9 mp -135.83 148.62 48.76 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.631 0.729 . . . . 0.0 110.583 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.5 174.21 42.6 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.94 146.82 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 117.418 0.609 . . . . 0.0 110.2 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.9 tt -115.77 144.6 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.849 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.21 145.19 26.1 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -173.41 -179.32 44.0 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.124 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 57.8 t -132.54 135.95 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.596 0.236 . . . . 0.0 111.305 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -108.56 122.33 6.59 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.269 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.533 ' C ' HG23 ' A' ' 207' ' ' THR . 54.3 t80 -124.91 106.55 10.08 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.685 0.794 . . . . 0.0 109.166 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.617 ' OD1' ' O ' ' A' ' 203' ' ' THR . 32.5 t70 -61.88 151.31 34.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -177.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 206' ' ' LEU . 28.9 mm -117.79 -29.12 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 176.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.617 ' O ' ' OD1' ' A' ' 201' ' ' ASP . 31.5 m -155.08 120.34 2.59 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 100.219 -3.993 . . . . 0.0 100.219 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.589 ' N ' ' OD2' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -6.54 -56.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 123.408 2.738 . . . . 0.0 115.336 -172.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.67 ' HA ' ' H ' ' A' ' 237' ' ' ARG . 37.0 pttt -83.94 -30.47 26.25 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 203' ' ' THR . 80.0 mt -78.62 110.92 14.17 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 119.62 1.1 . . . . 0.0 109.634 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.533 HG23 ' C ' ' A' ' 200' ' ' PHE . 2.1 m -125.99 145.81 50.14 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 209' ' ' ASP . 1.6 tm? -94.12 119.57 33.15 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.578 ' N ' HD13 ' A' ' 208' ' ' LEU . 45.7 t0 -106.21 145.81 31.08 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 209' ' ' ASP . . . -132.37 126.8 34.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.774 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -168.86 176.74 42.98 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 119.53 -1.319 . . . . 0.0 113.468 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -156.97 168.73 26.61 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.837 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.516 HH12 ' CD2' ' A' ' 215' ' ' HIS . 68.1 ttt-85 -108.11 124.73 50.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.038 0.447 . . . . 0.0 111.61 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.472 ' OH ' ' NH2' ' A' ' 219' ' ' ARG . 79.9 t80 -65.5 -49.65 68.22 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.266 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.516 ' CD2' HH12 ' A' ' 213' ' ' ARG . 20.6 t-160 58.84 112.97 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.411 ' O ' ' CE2' ' A' ' 214' ' ' TYR . 15.1 m120 33.53 -156.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 177.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.56 ' CB ' HH11 ' A' ' 219' ' ' ARG . 55.3 p-90 -131.67 169.26 16.41 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.091 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -140.39 24.13 2.66 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.56 HH11 ' CB ' ' A' ' 217' ' ' TRP . 7.8 mpt_? -65.19 179.85 0.67 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.037 0.446 . . . . 0.0 110.751 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' A' ' 222' ' ' ASN . 11.1 mp 58.91 151.32 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.007 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 66.94 -26.19 0.12 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.315 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.542 ' H ' ' C ' ' A' ' 220' ' ' LEU . 98.0 m-20 54.68 51.56 13.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.569 0.223 . . . . 0.0 111.507 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 77.1 m -123.65 130.27 52.4 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.792 0.33 . . . . 0.0 110.433 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.432 ' HD3' ' H ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -102.38 138.42 39.33 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.219 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 225' ' ' PHE . 88.8 t80 -152.16 8.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.688 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -143.37 151.76 40.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 110.832 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.5 p -131.95 171.5 13.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.131 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -143.96 155.87 44.2 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 110.888 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -139.48 159.97 40.93 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.646 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -75.82 155.88 34.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.429 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 60.8 m -134.33 153.62 51.78 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.357 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 90.0 mt -97.7 149.35 22.38 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.829 0.347 . . . . 0.0 110.129 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -157.47 176.74 34.55 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.493 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 11.2 m -128.27 131.71 68.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.73 ' HE ' ' NH1' ' A' ' 66' ' ' ARG . 62.2 ttt180 -117.83 142.27 47.5 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.507 ' HB2' ' H ' ' A' ' 11' ' ' VAL . 15.8 m-85 -108.55 125.26 51.62 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.67 ' H ' ' HA ' ' A' ' 205' ' ' LYS . 99.1 mtt180 -126.4 90.19 3.14 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 7.2 t80 . . . . . 0 C--O 1.219 -0.513 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.077 -177.866 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.5 m -70.67 139.91 51.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.762 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -111.23 -8.11 14.39 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.258 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' GLY . 47.4 p-10 -89.7 2.82 54.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.592 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' ASP . . . -56.53 -157.38 0.01 OUTLIER Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.55 133.65 9.29 Favored Glycine 0 N--CA 1.468 0.787 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -130.97 138.04 49.53 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.69 142.86 14.27 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.85 111.28 2.47 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.98 1.787 . . . . 0.0 112.772 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -107.57 169.7 8.42 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.498 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 12' ' ' GLN . 61.0 t -126.04 157.72 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.464 0.65 . . . . 0.0 112.43 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.525 ' N ' HG12 ' A' ' 11' ' ' VAL . 53.9 mt-30 -130.94 130.98 44.14 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.281 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.86 135.12 29.24 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.452 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.99 144.47 25.88 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 tp -139.39 123.7 18.08 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.985 0.421 . . . . 0.0 110.617 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -170.6 -42.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.852 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -85.12 141.4 30.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.319 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.61 144.08 48.95 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.342 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.526 ' O ' ' CD2' ' A' ' 19' ' ' TYR . 28.8 p90 -107.2 105.97 16.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.287 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -139.91 122.9 16.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.0 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -170.04 84.97 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.761 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.4 mt -117.39 100.86 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.843 0.354 . . . . 0.0 110.487 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' ' 24' ' ' HIS . 44.2 p -145.8 164.86 30.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.493 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 23' ' ' THR . 59.9 m-70 59.65 128.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.003 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -68.56 136.83 53.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.43 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.95 165.0 2.81 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.988 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.57 149.39 87.22 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.728 1.618 . . . . 0.0 112.087 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.527 ' H ' ' HD2' ' A' ' 29' ' ' PRO . 2.0 mt-10 -171.98 -52.49 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.628 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HD2' ' H ' ' A' ' 28' ' ' GLU . 89.8 Cg_endo -82.43 -165.28 0.32 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.258 1.972 . . . . 0.0 112.578 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.6 m 61.97 151.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.085 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 60.54 69.87 1.08 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.058 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 33' ' ' ASN . 23.6 Cg_exo -62.27 144.51 95.49 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.518 2.145 . . . . 0.0 111.655 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 32' ' ' PRO . 82.3 m-20 47.12 -178.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.802 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -162.78 12.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.767 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.92 -46.46 84.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.441 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 38' ' ' SER . 63.0 mttp -151.89 -173.71 4.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.016 0.436 . . . . 0.0 111.034 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.1 mt 47.02 -87.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.694 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' LYS . 4.6 m -87.78 112.1 22.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.176 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.8 t -152.14 152.49 32.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.65 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.77 -23.49 25.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.216 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m 49.37 -112.57 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.702 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -148.69 129.3 14.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.986 0.422 . . . . 0.0 110.927 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -134.99 83.54 2.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.914 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 38.23 -103.82 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.992 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -138.62 -161.61 1.2 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.038 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -71.06 175.92 4.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.273 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.1 pt -69.99 -13.54 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.651 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 61.41 133.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.529 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.6 t -139.68 161.98 36.22 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.417 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -69.91 141.37 53.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.686 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 52' ' ' VAL . 11.7 t -109.05 -0.45 19.48 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.096 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 53' ' ' HIS . 59.9 t 55.25 164.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.572 ' N ' HG12 ' A' ' 52' ' ' VAL . 70.6 t60 -153.96 90.78 3.26 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.76 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.26 144.87 99.24 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.71 1.607 . . . . 0.0 110.84 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -70.55 161.26 30.98 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.226 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.13 161.81 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.376 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.5 t -148.23 133.24 18.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.982 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.14 157.51 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.615 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.57 -170.25 38.22 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.309 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -112.9 153.96 27.12 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 47.4 p-10 -141.47 129.2 21.62 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 121.634 0.73 . . . . 0.0 112.842 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 62' ' ' PHE . 4.2 p90 -127.46 148.24 50.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.676 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -43.26 111.14 0.35 Allowed Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.34 -83.42 0.27 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.581 ' CD1' ' N ' ' A' ' 65' ' ' TRP . 1.4 p-90 -143.92 169.86 17.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.953 0.406 . . . . 0.0 111.5 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.476 HH21 ' NH1' ' A' ' 237' ' ' ARG . 54.8 mtt180 -129.39 172.61 11.34 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.578 0.704 . . . . 0.0 111.369 -178.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.4 mt -140.58 132.59 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.12 152.76 31.65 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.97 159.65 15.63 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 71' ' ' TYR . 41.3 t0 -157.2 167.21 31.04 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.424 -178.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.474 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 97.5 m-85 82.16 -126.08 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 125.08 1.488 . . . . 0.0 111.855 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 71' ' ' TYR . . . 71.32 101.96 0.06 Allowed 'General case' 0 CA--C 1.532 0.272 0 O-C-N 123.676 0.61 . . . . 0.0 111.262 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -160.19 107.09 1.59 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.918 0.39 . . . . 0.0 110.962 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -125.36 133.15 52.66 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.42 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -165.4 23.23 0.05 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.304 -0.559 . . . . 0.0 111.211 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -63.21 -42.9 99.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.65 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -157.29 132.6 9.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.834 0.35 . . . . 0.0 111.011 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -108.55 145.61 34.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.24 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 57.5 p30 -83.78 163.2 20.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.76 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -145.27 138.12 26.2 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.641 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -103.42 155.26 18.62 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.266 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 82' ' ' TYR . 49.3 p90 -119.95 131.11 55.08 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.583 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.3 m -76.27 -68.64 0.57 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.611 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.28 162.94 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.372 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -67.6 139.22 56.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.336 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 88' ' ' ASN . 86.7 mt -108.1 126.44 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.473 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -91.45 -0.81 57.67 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.507 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.667 ' H ' HG22 ' A' ' 86' ' ' ILE . 12.6 m120 -88.5 9.25 24.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.494 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.56 131.31 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.913 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -136.53 -139.27 0.15 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.099 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.8 mm 59.38 42.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.261 0.553 . . . . 0.0 109.707 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 94' ' ' GLU . 60.0 ttm-85 -62.26 -43.1 99.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.635 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp 51.2 -88.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.373 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 92' ' ' ARG . 14.6 tm-20 -68.54 125.29 26.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.303 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -149.17 18.34 0.96 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.981 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.82 11.66 0.03 OUTLIER Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.365 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.0 pt -127.28 154.19 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.787 0.327 . . . . 0.0 110.543 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -144.09 65.12 1.3 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.702 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 100' ' ' ASP . 10.4 tp -67.34 -41.17 86.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.565 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.499 ' N ' HG23 ' A' ' 99' ' ' ILE . 99.5 m-20 53.24 -99.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.527 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 38.11 66.31 0.5 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.022 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -145.34 152.26 39.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.305 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 85.5 m -61.32 -44.93 96.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.34 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' A' ' 106' ' ' GLN . 41.6 tt0 -81.88 119.7 24.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.158 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.405 ' O ' ' O ' ' A' ' 106' ' ' GLN . 99.3 m-20 -99.34 33.76 2.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.45 ' H ' ' HG2' ' A' ' 104' ' ' GLU . 88.6 mt-30 56.5 160.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.99 0.424 . . . . 0.0 110.867 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.59 -31.12 71.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.871 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.52 9.84 12.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.699 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.37 -33.36 87.03 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.9 p -128.33 163.0 25.75 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.055 0.455 . . . . 0.0 110.75 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -73.18 148.17 44.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.873 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -134.18 136.79 44.0 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.747 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -175.33 -110.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.335 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.5 t 45.44 81.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.404 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.3 m -81.89 148.44 28.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.13 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.9 m -143.29 152.26 41.47 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.943 0.401 . . . . 0.0 111.718 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.46 165.71 32.35 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.963 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -143.31 147.16 18.43 Favored Glycine 0 C--N 1.342 0.909 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.841 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.74 151.93 38.93 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.5 m -135.58 118.07 15.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.007 0.432 . . . . 0.0 111.559 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.77 131.15 43.77 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.506 HD11 HE22 ' A' ' 12' ' ' GLN . 96.8 mt -125.29 158.71 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.414 0.626 . . . . 0.0 112.661 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.491 ' N ' HG22 ' A' ' 122' ' ' ILE . 63.3 m-85 -112.95 122.09 46.6 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.301 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -109.07 122.83 48.1 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.783 0.677 . . . . 0.0 110.095 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.478 ' O ' ' CB ' ' A' ' 126' ' ' GLN . 0.5 OUTLIER -111.51 177.67 4.58 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.214 0.53 . . . . 0.0 110.954 -179.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 131' ' ' PHE . 2.4 tp-100 88.24 128.16 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.933 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.8 tt -118.67 -3.97 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.749 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 40.3 p-10 -151.02 -45.13 0.12 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.326 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 73.9 m-20 -71.97 -158.41 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.59 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -128.27 25.98 5.77 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.66 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 0.1 OUTLIER -138.65 111.28 7.62 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.292 0.951 . . . . 0.0 113.119 -177.186 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.416 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -131.12 137.15 30.03 Favored Pre-proline 0 C--N 1.351 0.661 0 CA-C-N 118.145 0.43 . . . . 0.0 110.424 177.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.16 116.66 3.39 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 122.089 1.859 . . . . 0.0 110.033 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.416 ' CE1' ' C ' ' A' ' 197' ' ' GLY . 36.5 p90 -81.12 129.97 34.81 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.798 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 91.4 mt -133.96 140.13 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.974 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -173.17 -172.97 39.19 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.698 -1.239 . . . . 0.0 112.785 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.55 142.23 33.53 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.533 ' H ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -121.52 133.48 55.03 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.323 0.582 . . . . 0.0 110.161 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.6 m -129.25 131.63 67.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.005 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.48 130.92 55.83 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.558 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 142' ' ' GLY . 90.6 t80 -134.1 161.63 34.33 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 111.946 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.512 ' N ' ' CG ' ' A' ' 141' ' ' TYR . . . -168.21 174.91 43.05 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -101.76 126.98 48.73 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 117.231 0.515 . . . . 0.0 111.081 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.9 m -124.49 131.98 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.2 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -115.36 102.54 9.94 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.93 0.395 . . . . 0.0 110.963 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 147' ' ' SER . 77.9 m80 -141.74 89.61 2.21 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.692 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 146' ' ' HIS . 2.8 p 61.03 133.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.1 mm -101.32 120.8 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.885 0.374 . . . . 0.0 110.808 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.4 t0 42.51 -106.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.041 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.8 t 55.59 87.85 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.495 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.5 p -81.56 165.91 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.44 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -91.67 93.32 8.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.474 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -95.73 -7.22 37.9 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.915 0.388 . . . . 0.0 110.447 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.0 m -62.25 -46.33 89.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.646 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 41.7 pt -94.26 140.53 16.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.658 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -149.29 75.53 1.29 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.409 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.17 -43.0 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.984 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 5.7 t -117.16 145.5 43.8 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.214 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.9 p -78.41 165.88 23.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.375 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 162' ' ' SER . 33.9 m -72.17 149.14 91.8 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.256 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -38.75 89.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.036 1.824 . . . . 0.0 112.068 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 160' ' ' VAL . 69.1 m -60.48 -43.81 96.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.912 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -170.48 25.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.826 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 61.27 82.94 0.21 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -60.15 146.6 95.88 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.538 2.159 . . . . 0.0 111.903 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -60.37 -179.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.287 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -62.7 131.45 43.62 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -90.59 -7.14 53.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.709 0.29 . . . . 0.0 110.391 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 170' ' ' THR . 83.7 t -65.45 -46.64 89.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 169' ' ' VAL . 0.7 OUTLIER 31.08 51.24 0.12 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.542 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.44 ' O ' ' OG1' ' A' ' 171' ' ' THR . 0.3 OUTLIER 34.26 41.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.076 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -63.72 -76.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.025 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -151.72 110.19 3.78 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 65.8 p 44.79 -156.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 18.9 p-10 -83.83 150.24 58.56 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.656 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.58 -99.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.348 2.032 . . . . 0.0 112.191 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -88.3 141.05 28.86 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.704 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.7 m -129.98 127.09 39.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.813 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 36.77 89.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.554 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -63.53 -41.86 98.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.411 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 39.74 82.5 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.189 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -71.06 137.1 48.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.163 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 184' ' ' SER . 54.8 tt0 -48.54 -67.65 0.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.265 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 183' ' ' GLN . 7.6 t 60.04 139.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.78 0.324 . . . . 0.0 110.332 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -150.4 32.25 0.65 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.007 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 43.0 t -150.38 91.61 1.77 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.889 0.376 . . . . 0.0 111.027 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 187' ' ' ILE . 17.5 mt -143.36 51.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 190' ' ' VAL . 15.3 mmt85 -108.54 -111.79 0.31 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.475 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 42.04 -86.2 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.206 0.317 . . . . 0.0 110.28 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 188' ' ' ARG . 13.5 t -69.92 133.66 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.83 130.71 9.22 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mp -134.95 145.37 48.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.677 0.275 . . . . 0.0 110.662 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -163.44 -169.33 26.75 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.8 146.0 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.613 0.72 . . . . 0.0 112.243 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.444 HD11 HH11 ' A' ' 138' ' ' ARG . 34.1 mm -112.94 131.62 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.83 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -156.69 151.08 25.38 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.849 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.416 ' C ' ' CE1' ' A' ' 134' ' ' TYR . . . 160.39 -169.86 36.28 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.61 148.18 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.309 0.576 . . . . 0.0 111.327 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -145.9 158.79 27.79 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.602 ' N ' ' OG1' ' A' ' 207' ' ' THR . 1.6 p90 -137.96 153.41 49.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.658 0.742 . . . . 0.0 111.497 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' A' ' 201' ' ' ASP . 1.2 m-20 -56.75 142.45 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.945 -176.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 206' ' ' LEU . 72.0 mt -101.31 -23.63 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 123.065 1.412 . . . . 0.0 107.812 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.587 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.7 OUTLIER -165.13 -174.69 0.4 Allowed Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.587 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.2 OUTLIER -5.31 -93.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.144 0 CA-C-N 124.82 2.757 . . . . 0.0 114.454 -179.128 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -128.09 17.93 6.62 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 120.909 1.686 . . . . 0.0 113.297 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 206' ' ' LEU . 10.0 mp -74.46 127.32 32.76 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 176.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 200' ' ' PHE . 5.2 t -139.34 152.74 47.41 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -177.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.0 tt -97.57 141.46 30.58 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.62 144.15 50.71 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -176.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.09 114.01 19.77 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -145.02 -179.84 21.64 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 119.426 -1.368 . . . . 0.0 113.816 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -129.03 159.34 36.24 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 113.955 -1.123 . . . . 0.0 109.331 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -141.72 148.51 39.15 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -142.34 160.55 40.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.646 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.531 ' ND1' ' N ' ' A' ' 215' ' ' HIS . 0.0 OUTLIER -122.56 147.58 46.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.357 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 51.66 77.38 0.14 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.349 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -78.24 142.84 37.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.972 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 158.56 -111.54 0.49 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -128.69 143.52 50.95 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.629 HD22 ' N ' ' A' ' 220' ' ' LEU . 3.3 mm? -75.58 139.49 42.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.217 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -141.43 -173.05 3.65 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.538 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -52.59 165.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.753 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 72.3 p 49.23 82.03 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.634 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -78.9 144.28 35.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.589 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -103.62 145.92 29.33 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.603 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -139.85 137.05 34.61 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.291 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 7.7 m -147.26 -59.82 0.27 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.74 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.485 ' ND1' ' N ' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -153.96 158.58 40.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.447 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -120.47 -126.76 0.27 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.543 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.48 144.33 57.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 110.978 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 49.6 m -153.89 167.49 29.54 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.451 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 92.1 mt -86.12 143.99 27.75 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.924 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -128.11 148.21 17.67 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.1 130.21 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 122.728 -0.277 . . . . 0.0 110.433 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -130.29 116.88 18.97 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -99.74 107.13 19.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.301 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.476 ' NH1' HH21 ' A' ' 66' ' ' ARG . 76.8 mtp180 -125.44 128.04 47.47 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.976 0.417 . . . . 0.0 110.893 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 . . . . . 0 C--O 1.218 -0.583 0 CA-C-O 117.938 -1.029 . . . . 0.0 111.13 179.853 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -60.33 -41.93 94.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.585 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -150.85 128.72 11.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.262 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -89.62 112.33 23.53 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.729 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.74 -133.64 52.66 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.53 25.12 68.62 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -68.16 131.97 46.35 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.33 108.03 3.16 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.023 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.03 116.2 3.37 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 CA-C-N 119.614 1.707 . . . . 0.0 113.829 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.629 ' CZ ' ' NE ' ' A' ' 66' ' ' ARG . 11.4 p90 -115.65 167.61 10.76 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.76 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.0 t -125.71 149.32 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-O 120.926 0.393 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -118.96 139.7 51.23 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.033 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.92 156.06 44.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.85 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 38.0 p30 -150.26 136.4 18.66 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.86 170.02 16.49 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.47 -120.8 0.11 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.625 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -113.05 142.29 45.89 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.03 -163.51 1.75 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.852 0.358 . . . . 0.0 111.051 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -142.6 159.95 41.24 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.525 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -73.64 150.98 40.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.331 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -77.31 136.23 38.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.543 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 tt -95.72 133.78 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.946 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.7 m -103.68 125.71 50.35 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.488 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -78.86 -65.48 0.99 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.72 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -159.05 176.84 11.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.492 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 18.8 p90 -161.88 60.79 1.18 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.847 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.69 141.6 79.93 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.052 1.835 . . . . 0.0 111.94 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.76 ' H ' ' CD ' ' A' ' 29' ' ' PRO . 3.6 mt-10 -126.11 -38.34 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.588 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.063 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.76 ' CD ' ' H ' ' A' ' 28' ' ' GLU . 91.5 Cg_endo -90.95 10.2 2.88 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.527 2.151 . . . . 0.0 112.693 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.5 p -129.23 160.16 33.82 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.833 0.349 . . . . 0.0 110.645 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 32' ' ' PRO . . . -163.0 75.99 1.91 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.932 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 31' ' ' ALA . 32.3 Cg_exo -56.94 -143.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.736 2.29 . . . . 0.0 111.821 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 58.56 40.88 23.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -124.22 110.77 15.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.658 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -149.36 -57.9 0.2 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.429 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.7 pttm -158.45 163.82 36.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.795 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -79.22 131.57 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.148 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.1 p -149.27 -136.78 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.038 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.9 m -61.75 135.93 57.8 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.089 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.37 155.23 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.965 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.6 p -151.75 163.51 38.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.399 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -65.62 136.32 56.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.596 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -62.6 -46.57 87.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.818 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -76.35 42.81 0.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.524 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -58.48 -67.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.482 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.451 ' CG ' ' H ' ' A' ' 47' ' ' ILE . 63.3 t30 -171.92 -179.56 2.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.434 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.451 ' H ' ' CG ' ' A' ' 46' ' ' ASN . 14.3 tt -86.55 135.25 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.591 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -63.3 -41.98 99.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.784 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.5 t -92.25 168.19 11.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.012 0.434 . . . . 0.0 110.814 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -167.42 34.62 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.803 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.2 p -78.57 111.76 14.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.631 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.445 HG23 ' CD2' ' A' ' 53' ' ' HIS . 18.5 m -136.87 163.02 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.557 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.445 ' CD2' HG23 ' A' ' 52' ' ' VAL . 17.5 m-70 71.24 57.36 0.42 Allowed Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.508 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.78 148.86 65.87 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.388 2.058 . . . . 0.0 110.982 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -56.63 100.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 57' ' ' SER . 59.9 t -148.53 155.2 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.193 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.45 ' N ' HG12 ' A' ' 56' ' ' VAL . 38.5 m -135.17 148.11 49.6 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.842 0.353 . . . . 0.0 110.432 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.6 t -129.35 141.15 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.92 170.72 31.33 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 119.804 -1.189 . . . . 0.0 113.724 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -102.2 140.47 36.45 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-N 114.942 -0.629 . . . . 0.0 110.232 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' CG ' ' NH1' ' A' ' 237' ' ' ARG . 44.9 t0 -90.06 114.12 25.95 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 124.177 0.923 . . . . 0.0 113.252 -177.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' TRP . 34.3 m-85 -124.78 118.8 27.2 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.392 -1.277 . . . . 0.0 108.825 177.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.56 105.5 0.83 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.22 -52.36 0.83 Allowed Glycine 0 N--CA 1.466 0.64 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.417 ' O ' ' O ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -140.98 166.31 25.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.634 ' NH1' ' NH2' ' A' ' 237' ' ' ARG . 16.4 ttp180 -146.43 162.68 37.73 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.854 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.2 tp -135.24 134.1 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.631 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.15 137.87 23.63 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.299 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.79 137.45 40.07 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.577 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -99.0 125.67 44.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.505 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -129.09 139.56 51.94 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 73' ' ' ARG . . . -172.81 133.4 0.57 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.349 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.662 ' HE ' ' NH2' ' A' ' 75' ' ' ARG . 81.0 mtp85 38.8 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.975 0.417 . . . . 0.0 111.307 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -66.94 -39.34 87.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.145 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.662 ' NH2' ' HE ' ' A' ' 73' ' ' ARG . 84.6 mtt85 59.73 88.32 0.07 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.766 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.528 ' O ' ' CD1' ' A' ' 77' ' ' TRP . 62.3 tttm -173.39 95.25 0.11 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.675 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.528 ' CD1' ' O ' ' A' ' 76' ' ' LYS . 4.7 m-90 -148.12 121.39 8.97 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.533 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -64.74 -40.83 95.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.771 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -126.28 81.02 1.96 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.632 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -63.15 -42.17 99.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.643 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -144.54 -15.04 0.56 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.597 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.536 ' O ' ' CD2' ' A' ' 82' ' ' TYR . 31.9 p90 -114.4 108.16 16.51 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.962 0.41 . . . . 0.0 110.879 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.5 t -62.28 -44.9 95.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.295 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.7 m -149.42 3.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.187 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.5 t30 60.38 93.83 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.643 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.31 -43.41 98.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.473 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.04 102.57 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.524 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.645 HD22 ' H ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER -65.16 -35.71 81.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.355 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.51 157.43 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.355 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -70.72 -96.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.8 pt -129.13 162.02 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.628 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.522 ' N ' ' CD ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -146.17 10.05 1.13 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.371 -179.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -76.73 -8.77 57.92 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.599 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 93' ' ' LYS . 97.9 mt-10 56.51 116.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.018 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 94' ' ' GLU . 9.1 m120 57.11 117.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.887 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -155.67 152.37 23.84 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 96.1 mt -122.54 126.99 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.848 0.356 . . . . 0.0 110.423 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -165.12 50.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.761 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 102' ' ' LYS . 84.0 mt -103.3 113.95 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.846 0.355 . . . . 0.0 110.482 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -94.26 -22.73 18.21 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.137 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -63.79 -39.16 93.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.115 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.426 ' H ' HG22 ' A' ' 99' ' ' ILE . 52.8 mtmt 45.37 -113.0 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.554 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 105' ' ' ASN . 81.1 p -116.24 9.6 14.63 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.187 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 104' ' ' GLU . 1.1 tm-20 -72.51 20.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.553 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 103' ' ' THR . 90.3 m-20 55.45 169.51 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.97 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -79.59 -163.82 0.57 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.225 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.44 129.55 42.54 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.239 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -91.44 117.29 29.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.687 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.32 -168.48 26.47 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 110' ' ' THR . 2.4 t -75.83 174.75 9.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.436 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -72.96 142.46 47.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.715 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -84.33 129.31 34.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.449 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.45 146.16 54.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.398 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.3 t -70.93 131.44 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.415 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.7 t -72.34 124.7 25.65 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.1 t -171.04 133.78 0.91 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.881 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.477 ' O ' HD12 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -148.95 158.89 44.52 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.255 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 167.61 -137.28 4.53 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.002 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.1 148.81 51.98 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.4 p -153.9 139.8 18.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.68 135.55 46.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.519 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.417 ' O ' ' CB ' ' A' ' 66' ' ' ARG . 99.1 mt -122.15 133.75 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -101.73 113.75 27.2 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -90.24 113.16 24.93 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.36 105.82 16.92 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -74.77 56.97 0.74 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.614 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.6 pt -76.27 -20.48 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -135.88 -102.16 0.21 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.155 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -178.44 -27.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.859 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -99.35 -19.6 16.94 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -161.55 137.67 8.04 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.376 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.59 149.43 73.03 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.238 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.38 104.61 1.36 Allowed 'Trans proline' 0 N--CA 1.485 1.003 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.601 ' CD2' ' NH2' ' A' ' 235' ' ' ARG . 36.4 p90 -86.14 133.09 33.89 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.616 0.722 . . . . 0.0 112.352 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 tp -133.84 138.52 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.835 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.38 167.01 31.3 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.81 157.97 37.85 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -137.0 134.51 36.7 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 37.1 t -128.63 123.87 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.56 141.61 35.21 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.693 0.759 . . . . 0.0 111.996 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -103.79 157.13 17.29 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.617 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -131.0 141.42 12.7 Favored Glycine 0 N--CA 1.466 0.678 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 52.7 m170 42.65 92.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.993 0.425 . . . . 0.0 110.728 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.81 142.19 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.479 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.512 ' C ' ' H ' ' A' ' 147' ' ' SER . 87.4 mtm180 56.51 -97.26 0.07 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.169 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 69.42 -37.71 0.38 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.705 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 145' ' ' ARG . 11.3 p -77.82 168.67 19.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.43 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 96.1 mt -67.48 135.14 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.488 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -79.47 107.38 12.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.1 m -139.54 150.24 44.85 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.385 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 76.3 p -108.93 61.61 0.6 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.158 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -61.91 -44.87 95.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.49 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.401 ' CD ' ' O ' ' A' ' 155' ' ' ILE . 18.1 ptpt -147.32 146.2 29.61 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.943 0.401 . . . . 0.0 110.476 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 37.0 p -67.72 -34.97 77.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.542 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.601 HG22 ' H ' ' A' ' 156' ' ' GLU . 3.1 mt -141.21 -141.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.694 0.283 . . . . 0.0 110.262 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.601 ' H ' HG22 ' A' ' 155' ' ' ILE . 17.6 pt-20 -157.79 -8.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.378 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.47 HG23 ' N ' ' A' ' 158' ' ' THR . 32.6 m -63.03 -40.1 87.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.47 ' N ' HG23 ' A' ' 157' ' ' VAL . 24.7 m -63.9 134.39 55.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.801 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 159' ' ' THR . 10.4 t -96.18 125.46 40.72 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.004 0.43 . . . . 0.0 110.824 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.3 m -95.48 152.82 39.51 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.72 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -39.42 136.46 1.03 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.888 1.726 . . . . 0.0 112.304 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 163' ' ' ASN . 26.7 t -79.97 -115.03 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.426 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.448 ' N ' ' OG ' ' A' ' 162' ' ' SER . 53.2 p-10 -151.0 19.04 0.78 Allowed 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.28 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.666 ' HB3' ' CD ' ' A' ' 165' ' ' PRO . . . -60.72 -66.59 1.44 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.506 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.666 ' CD ' ' HB3' ' A' ' 164' ' ' ALA . 56.9 Cg_endo -67.16 143.68 65.93 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.09 1.86 . . . . 0.0 110.969 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 50.84 50.9 18.1 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.556 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -144.8 159.8 27.89 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.9 89.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.65 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 t 48.12 94.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.475 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.573 ' C ' ' H ' ' A' ' 172' ' ' TYR . 99.2 m -69.1 -73.66 0.15 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.713 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 5.1 m 64.9 -19.82 0.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.522 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.573 ' H ' ' C ' ' A' ' 170' ' ' THR . 87.9 t80 -63.84 -25.01 67.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.641 0.258 . . . . 0.0 110.78 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -65.88 101.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.527 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.6 m -63.44 -46.31 86.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.89 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -65.49 113.67 12.59 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.859 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 178' ' ' THR . 92.3 Cg_endo -83.14 116.17 2.39 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 121.714 1.609 . . . . 0.0 111.758 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 179' ' ' GLN . 32.4 mmtp 40.33 -89.21 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.757 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 176' ' ' PRO . 21.3 m 58.68 -78.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.708 0.289 . . . . 0.0 110.609 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.514 ' N ' ' O ' ' A' ' 177' ' ' LYS . 11.7 tp-100 -90.55 104.36 16.95 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.21 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -63.56 -40.96 98.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.817 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -83.6 98.39 9.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.092 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -99.31 -47.93 4.99 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.503 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -157.44 142.17 16.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.112 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 18.9 m 38.16 88.14 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.112 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -126.14 93.87 3.93 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.442 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 27.3 t -155.14 131.51 10.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.025 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 187' ' ' ILE . 20.2 tt -142.63 127.58 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.713 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -165.94 23.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.834 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.57 ' HE ' ' HA ' ' A' ' 189' ' ' ARG . 2.2 tpm_? -64.79 -14.23 58.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 191' ' ' GLY . 3.5 p -119.22 158.54 20.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 177.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.403 ' N ' HG22 ' A' ' 190' ' ' VAL . . . -142.07 142.97 12.28 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 119.042 -1.551 . . . . 0.0 113.092 -177.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.87 146.03 35.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.362 -0.919 . . . . 0.0 110.005 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -165.55 175.47 41.26 Favored Glycine 0 C--N 1.314 -0.673 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.2 m -133.47 150.17 31.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.9 pt -119.96 151.82 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.74 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -167.75 158.7 11.16 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.931 0.872 . . . . 0.0 112.478 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.482 ' C ' ' CE2' ' A' ' 134' ' ' TYR . . . 174.12 -165.57 37.27 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.61 135.69 57.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.356 0.598 . . . . 0.0 110.037 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -102.91 136.72 13.01 Favored Glycine 0 C--O 1.224 -0.513 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.996 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.93 109.79 9.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 45.8 p30 -54.97 144.74 22.24 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -176.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.7 tt -125.98 2.05 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.809 1.29 . . . . 0.0 109.292 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.582 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -160.56 162.66 22.9 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 100.327 -3.953 . . . . 0.0 100.327 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.582 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.3 OUTLIER -10.57 -79.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.775 2.317 . . . . 0.0 113.771 -177.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 237' ' ' ARG . 12.8 mptt -129.03 25.4 5.56 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.472 0.578 . . . . 0.0 110.304 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 236' ' ' TYR . 3.4 tp -78.92 110.69 14.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 53.6 p -106.25 145.64 31.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 14.9 tp -106.25 122.18 45.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 111.991 -2.368 . . . . 0.0 106.03 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -110.09 136.37 49.44 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -175.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -108.68 112.69 25.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 173.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -145.88 179.41 22.94 Favored Glycine 0 N--CA 1.463 0.486 0 C-N-CA 119.28 -1.438 . . . . 0.0 113.938 -175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.22 157.26 43.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.244 -1.478 . . . . 0.0 109.742 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -107.97 133.05 52.85 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' A' ' 217' ' ' TRP . 74.3 t80 -114.67 108.05 16.29 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 216' ' ' ASN . 52.9 p-80 -106.93 132.04 53.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.082 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 215' ' ' HIS . 59.5 t30 57.67 148.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.123 0.487 . . . . 0.0 111.42 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.422 ' O ' ' OH ' ' A' ' 214' ' ' TYR . 14.0 m-90 -63.68 -42.12 98.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.598 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 121.69 -90.11 0.44 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 34.6 -148.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.764 0.316 . . . . 0.0 111.483 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 220' ' ' LEU . 2.2 mm? -74.75 159.37 32.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.247 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 220' ' ' LEU . 97.4 mt-10 59.46 127.48 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.844 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 10.1 m120 55.6 51.75 12.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.672 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 21.1 p -70.08 137.94 51.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.55 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.52 ' HD3' ' H ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -84.63 158.49 20.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.845 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 227' ' ' THR . 33.8 t80 -134.56 130.04 35.94 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.83 0.348 . . . . 0.0 110.695 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.4 tttt 37.42 -95.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.39 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 225' ' ' PHE . 6.0 m 39.87 83.9 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.761 0.315 . . . . 0.0 110.999 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.669 ' CD2' ' H ' ' A' ' 229' ' ' GLU . 83.6 t60 -102.47 -119.02 0.19 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.581 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.669 ' H ' ' CD2' ' A' ' 228' ' ' HIS . 43.5 tt0 -68.34 130.47 42.98 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.98 0.419 . . . . 0.0 110.584 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -168.49 29.49 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.438 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.2 t -139.89 125.79 19.6 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.863 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 86.2 mt -108.65 104.49 13.8 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -98.71 121.55 7.22 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.663 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 71.1 t -115.55 125.05 72.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.601 ' NH2' ' CD2' ' A' ' 134' ' ' TYR . 1.7 mtt180 -133.33 144.43 49.65 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.509 0.671 . . . . 0.0 111.515 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.473 ' HA ' HD12 ' A' ' 206' ' ' LEU . 6.9 t80 -103.09 103.3 13.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.378 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.634 ' NH2' ' NH1' ' A' ' 66' ' ' ARG . 55.9 ttm-85 -130.59 129.76 43.16 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.484 ' C ' ' O ' ' A' ' 237' ' ' ARG . 69.6 m-85 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 118.025 -0.988 . . . . 0.0 112.547 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 3' ' ' GLU . 11.6 m 45.18 -92.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.564 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 1' ' ' ALA . 32.8 tp10 57.71 156.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.08 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -76.98 117.08 18.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.448 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.66 169.49 37.65 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.92 -143.72 0.41 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -92.18 136.38 33.23 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 110.605 -0.146 . . . . 0.0 110.605 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -110.11 96.2 0.92 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.204 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.567 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 94.0 Cg_endo -84.35 119.68 2.4 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 122.962 2.441 . . . . 0.0 111.749 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.567 ' CG ' ' O ' ' A' ' 9' ' ' PRO . 71.9 m-85 -152.01 -175.94 5.45 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.639 HG22 ' N ' ' A' ' 12' ' ' GLN . 12.5 p -124.46 163.86 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -174.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.639 ' N ' HG22 ' A' ' 11' ' ' VAL . 10.7 tm0? -135.31 149.92 49.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.805 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.04 130.75 15.98 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -101.97 130.96 48.62 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.99 0.424 . . . . 0.0 111.957 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.83 155.44 47.79 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.526 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.61 124.19 7.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.392 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -102.15 3.62 38.67 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 110.375 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.75 -30.17 71.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.085 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -75.31 135.72 40.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.735 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.36 -78.02 0.56 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.836 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -145.32 132.8 20.77 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.678 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -127.33 129.96 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.521 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.09 -62.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.272 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 25' ' ' ASP . 70.2 m80 -66.53 -41.78 88.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.682 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 42.2 t0 56.48 159.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.115 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -54.0 110.21 1.96 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.76 -23.19 14.59 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.642 1.561 . . . . 0.0 112.567 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -156.27 91.21 2.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.449 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.05 147.79 72.8 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.068 1.845 . . . . 0.0 111.668 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.1 p -57.61 -40.41 79.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.553 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 43.28 80.43 0.29 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.553 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.86 144.35 98.74 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.366 2.044 . . . . 0.0 112.004 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 58.12 36.72 26.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.065 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HG3' ' H ' ' A' ' 36' ' ' LYS . 26.1 pttm -64.22 -36.52 84.35 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.369 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 36' ' ' LYS . 9.1 m120 56.88 39.63 29.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.282 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 35' ' ' ASN . 54.1 mtmt 55.17 112.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.864 0.364 . . . . 0.0 110.748 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.62 126.22 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.495 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -162.5 -63.46 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.691 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.7 p -132.64 109.74 9.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.617 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 41' ' ' SER . 20.0 m -133.92 135.45 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.349 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 40' ' ' VAL . 33.7 m -55.25 -165.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.736 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -79.72 55.82 2.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.372 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -82.19 142.65 32.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.804 0.335 . . . . 0.0 110.478 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -72.6 140.27 47.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.18 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -144.6 -35.3 0.34 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.364 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 54.02 80.74 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.444 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.447 ' C ' ' H ' ' A' ' 49' ' ' THR . 19.8 tt -123.6 161.93 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.987 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 67.27 -2.55 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 49' ' ' THR . 35.4 m -92.36 -4.0 54.5 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.04 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -58.91 -4.8 0.51 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.066 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.478 ' OG ' ' N ' ' A' ' 52' ' ' VAL . 40.4 t -60.83 -170.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.592 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.478 ' N ' ' OG ' ' A' ' 51' ' ' SER . 4.6 t 61.52 117.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.329 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -131.77 87.91 43.91 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.055 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HG2' HH21 ' A' ' 138' ' ' ARG . 36.9 Cg_exo -57.69 144.88 92.03 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.443 2.095 . . . . 0.0 110.638 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -148.23 -43.09 0.16 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.56 139.5 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 p -141.88 153.49 44.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.02 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.17 147.44 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.362 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.46 -154.08 10.6 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -135.99 154.47 51.07 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 53.5 p30 -121.84 149.63 43.08 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -176.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -126.53 159.95 31.98 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 112.246 -2.252 . . . . 0.0 105.14 175.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.58 100.7 0.1 OUTLIER Glycine 0 CA--C 1.535 1.301 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.259 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.562 ' O ' ' CD1' ' A' ' 65' ' ' TRP . . . 61.84 48.52 83.34 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.771 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 64' ' ' GLY . 16.7 m95 -165.8 89.24 0.42 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.609 ' NH1' ' NH1' ' A' ' 235' ' ' ARG . 70.9 ttt180 -127.33 150.43 49.59 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -176.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.43 141.35 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.397 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.72 137.91 19.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.384 0.611 . . . . 0.0 112.488 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.88 156.13 16.81 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -151.39 159.03 44.45 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -160.64 165.99 29.65 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.46 -1.7 . . . . 0.0 108.902 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.73 -165.16 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.13 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.42 ' NH1' ' HE ' ' A' ' 75' ' ' ARG . 15.7 tpt180 -126.12 124.16 39.94 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.898 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -174.03 -10.69 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.524 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.42 ' HE ' ' NH1' ' A' ' 73' ' ' ARG . 37.7 ptt180 -71.79 141.99 49.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.167 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -87.12 137.0 32.72 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -114.54 128.95 56.6 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.895 0.379 . . . . 0.0 110.559 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -147.8 95.82 2.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.334 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -96.71 9.09 42.7 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.246 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -150.02 170.41 18.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.054 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -88.79 -170.98 3.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.926 0.394 . . . . 0.0 110.758 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -62.38 -36.33 81.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.387 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.5 p -134.88 156.71 48.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.982 0.42 . . . . 0.0 110.904 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.6 t -76.86 133.59 30.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.607 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ILE . 62.7 t30 64.74 94.84 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.695 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.407 ' O ' ' O ' ' A' ' 85' ' ' ASN . 23.9 mm 60.34 140.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.687 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -65.49 140.44 58.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.766 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 89' ' ' VAL . 59.8 t-20 -77.44 150.79 34.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.177 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.534 ' N ' ' OD1' ' A' ' 88' ' ' ASN . 5.9 t -82.68 100.92 6.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.366 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.9 mtp180 -84.36 -59.92 2.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.664 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.9 tt -152.61 145.24 15.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.459 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -73.2 136.49 44.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 110.902 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -156.23 138.28 14.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.281 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 95' ' ' ASN . 80.8 tt0 -154.13 133.1 12.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.785 0.326 . . . . 0.0 110.706 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 94' ' ' GLU . 88.7 m-20 -152.77 170.19 20.9 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.493 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 97' ' ' ILE . . . -81.17 -172.1 45.92 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 96' ' ' GLY . 1.6 tp 35.32 96.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.481 0.658 . . . . 0.0 111.186 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -53.18 118.82 4.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.945 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 100' ' ' ASP . 17.2 tt -68.64 -37.64 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.34 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.429 ' N ' HG23 ' A' ' 99' ' ' ILE . 98.6 m-20 57.42 152.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.729 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -70.71 -167.34 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.399 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -73.5 -15.45 61.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.81 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.4 p -104.08 118.84 37.62 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.582 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -83.94 -80.26 0.19 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.408 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 106' ' ' GLN . 28.2 t-20 -141.21 97.09 3.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.393 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 105' ' ' ASN . 50.7 tt0 46.16 98.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.756 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -161.39 100.25 1.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.486 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 56.51 35.77 26.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.487 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.61 7.68 65.81 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.2 p -133.58 160.89 36.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.966 0.412 . . . . 0.0 110.972 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 42.85 -123.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.93 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -75.41 141.79 43.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.913 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -158.39 -79.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.314 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.69 -34.36 69.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.7 m -70.35 145.69 50.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.856 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.8 m -139.57 154.56 47.65 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.578 HD22 ' N ' ' A' ' 117' ' ' LEU . 3.0 mm? -87.2 132.12 33.98 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.364 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.69 138.81 14.47 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tp -149.45 140.01 22.53 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.7 p -157.12 155.64 31.38 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.365 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.91 137.34 52.09 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.474 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 123' ' ' TYR . 4.6 mp -126.31 156.13 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.348 0.594 . . . . 0.0 111.175 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.47 ' N ' HG22 ' A' ' 122' ' ' ILE . 57.6 m-85 -117.48 113.05 21.47 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.837 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -106.64 122.9 47.26 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.201 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -75.68 104.01 6.04 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.037 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -71.2 -29.7 65.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.136 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.8 -41.67 88.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.421 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -58.65 126.81 29.17 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.581 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.48 -21.87 59.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -128.1 -48.94 1.33 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.529 ' O ' ' CD2' ' A' ' 131' ' ' PHE . 52.9 p90 -115.65 132.59 56.59 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.14 110.77 41.03 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.319 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.14 109.63 1.58 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 N-CA-C 108.882 -1.238 . . . . 0.0 108.882 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 134' ' ' TYR . 1.8 p90 -83.21 132.73 35.05 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.223 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 63.6 mt -134.33 154.87 38.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.75 -173.16 44.89 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 118.113 -1.994 . . . . 0.0 113.858 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.91 141.98 50.73 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.434 HH21 ' HG2' ' A' ' 54' ' ' PRO . 78.7 ttt180 -123.66 131.23 53.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.992 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.04 130.44 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.235 0.541 . . . . 0.0 111.477 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.26 117.8 34.92 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.961 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -120.31 140.97 50.47 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.952 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.99 -144.19 4.65 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -83.86 109.6 17.69 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.811 0.339 . . . . 0.0 110.438 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.3 p -143.94 156.37 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.008 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 56.9 79.07 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.813 0.339 . . . . 0.0 110.407 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 146' ' ' HIS . 64.3 t-80 -169.24 59.33 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.599 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 78.4 p -65.88 -55.62 16.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.029 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 21.1 tt -155.53 147.32 12.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.441 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 150' ' ' SER . 32.1 t0 -144.71 -143.03 0.14 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.187 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.519 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 22.1 m -68.84 138.26 54.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.748 0.309 . . . . 0.0 110.446 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.7 p -90.54 162.32 15.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.76 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.83 -37.9 89.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.971 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 64.5 mttp 59.73 20.59 9.33 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.615 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 156' ' ' GLU . 74.5 p -136.44 161.89 34.59 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.023 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 94.8 mt 54.0 -87.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.389 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 154' ' ' THR . 18.2 pt-20 -133.58 161.81 33.61 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.041 0.448 . . . . 0.0 111.11 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.3 m -118.78 132.84 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.184 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 5.7 p -78.84 154.26 29.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.564 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 21.7 p -79.88 164.83 23.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.35 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.37 149.69 97.24 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.122 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -40.25 -55.68 1.75 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.173 1.915 . . . . 0.0 112.69 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.1 p -159.09 164.02 35.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.701 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 164' ' ' ALA . 51.5 p-10 -84.09 -32.32 24.83 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.694 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.524 ' N ' ' OD1' ' A' ' 163' ' ' ASN . . . -179.04 78.87 0.21 Allowed Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.365 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 166' ' ' ASN . 90.2 Cg_endo -80.22 151.85 20.8 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.372 2.048 . . . . 0.0 111.731 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 165' ' ' PRO . 71.4 m-20 58.45 141.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.949 0.405 . . . . 0.0 110.835 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -85.65 174.7 48.54 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.93 111.53 20.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.762 0.315 . . . . 0.0 110.533 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.3 t 38.34 84.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.098 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 50.7 p -82.06 -100.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.494 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.6 m -166.96 97.68 0.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.795 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 173' ' ' ASN . 98.7 m-85 -74.37 -107.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.232 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.495 ' CG ' ' H ' ' A' ' 174' ' ' THR . 60.8 t30 43.92 -171.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.944 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.495 ' H ' ' CG ' ' A' ' 173' ' ' ASN . 2.5 m 66.75 0.08 1.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.63 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.14 147.34 79.81 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.527 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.45 154.44 45.34 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.28 1.987 . . . . 0.0 111.984 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -92.31 80.39 4.98 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.777 0.322 . . . . 0.0 110.277 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 65.5 p -85.1 167.4 15.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -55.03 174.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.803 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 65.7 t30 57.46 53.28 7.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -61.37 -42.04 98.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.628 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 184' ' ' SER . 93.7 t80 -144.87 -69.26 0.3 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.518 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 49.2 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 182' ' ' TYR . 12.3 p -155.42 161.9 40.89 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.897 0.38 . . . . 0.0 110.804 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -99.68 118.73 36.83 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.713 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.3 t -146.99 -156.22 0.7 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.414 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 96.0 mt 54.63 90.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.09 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -115.71 42.95 2.19 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.649 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 49.72 26.62 1.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.155 0.502 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.46 136.69 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -102.05 111.66 4.12 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.1 pp -143.76 159.13 43.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 112.375 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -177.93 -155.66 14.67 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.68 157.0 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 117.247 0.523 . . . . 0.0 110.747 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.9 pt -130.08 145.41 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.874 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -156.19 150.52 25.57 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.086 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 175.9 -173.5 46.3 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.8 143.94 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 117.731 0.765 . . . . 0.0 111.066 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -143.41 160.72 27.66 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.14 152.38 49.9 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.45 0.643 . . . . 0.0 111.532 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 206' ' ' LEU . 6.3 p30 -69.36 146.89 51.76 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 113.717 -1.583 . . . . 0.0 115.195 -175.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 43.8 mt -119.91 -1.17 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 123.335 1.54 . . . . 0.0 107.123 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.541 ' O ' ' C ' ' A' ' 204' ' ' PRO . 0.2 OUTLIER -165.15 147.98 6.96 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 100.5 -3.889 . . . . 0.0 100.5 178.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.541 ' C ' ' O ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -6.62 -67.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 123.249 2.633 . . . . 0.0 114.191 -176.178 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 237' ' ' ARG . 58.8 mmtt -130.77 33.07 4.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.359 0.982 . . . . 0.0 112.292 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 201' ' ' ASP . 0.9 OUTLIER -92.55 108.07 19.69 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 176.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.0 t -137.35 154.88 49.94 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -174.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.96 141.85 45.1 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 113.023 -1.899 . . . . 0.0 107.578 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -135.73 147.89 48.63 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.27 150.6 43.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -179.36 -172.89 44.04 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.612 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -123.55 167.98 13.2 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.843 -0.678 . . . . 0.0 109.837 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -140.85 141.66 34.64 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.599 0.238 . . . . 0.0 110.84 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.417 ' HB3' ' HE1' ' A' ' 217' ' ' TRP . 2.3 m-85 -109.75 11.21 24.54 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.256 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 216' ' ' ASN . 50.0 p-80 -37.6 115.42 0.41 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 215' ' ' HIS . 7.7 t-20 24.33 105.86 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.855 0.722 . . . . 0.0 112.643 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.417 ' HE1' ' HB3' ' A' ' 214' ' ' TYR . 0.5 OUTLIER -71.4 152.96 42.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.815 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 102.44 -21.03 42.53 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.33 -41.21 94.2 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.528 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 90.4 mt -129.53 113.97 15.51 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.769 0.318 . . . . 0.0 110.715 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -71.03 -38.62 72.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.786 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 50.3 -99.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.516 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.3 m 58.09 98.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.291 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -141.67 154.51 45.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.501 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.14 -47.24 87.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.88 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -143.55 128.2 18.14 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.645 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 88.3 m -127.43 129.79 48.13 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.39 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -100.58 139.37 36.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.603 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 55.65 -178.22 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.169 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -155.59 -88.62 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.326 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 50.5 m -132.74 124.19 27.66 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.12 135.83 54.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.287 0.565 . . . . 0.0 111.578 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -102.1 151.14 18.35 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.724 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.86 129.76 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.609 ' NH1' ' NH1' ' A' ' 66' ' ' ARG . 93.7 mtt180 -133.41 140.92 47.6 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.421 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 26.2 t80 -113.52 102.06 9.94 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 102.203 -3.258 . . . . 0.0 102.203 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.572 ' O ' ' HB2' ' A' ' 205' ' ' LYS . 62.1 ttp85 -148.82 136.65 20.66 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.474 ' OXT' ' O ' ' A' ' 237' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.934 -179.763 . . . . . . . . 2 2 . 1 stop_ save_